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001 [Oral 036]
Calpain activity is essential for cell recruitment, myofi broblast 
differentiation and angiogenesis in early stages of skin wounding
Dany Nassar1, Emmanuel Letavernier2, Laurent Baud2, Selim Aractingi1, Kiarash 
Khosrotehrani3,1 1INSERM_U938, Saint Antoine Research Center, Paris, France, 
2Nephrology, Univ Paris 6, France, 3Centre for Clinical Research, University of 
Queensland, Brisbane, Australia
Calpains are calcium-dependant intracellular cysteine proteases that play major role 
in cytoskeleton and adhesion molecule rearrangements. Since these phenomena 
alter cell motility, infl ammation, angiogenesis and fi brosis, we asked whether such 
inhibition may affect wound healing. We used a transgenic mouse overexpressing 
ubiquitously and constitutively the natural calpain inhibitor, calpastatin. Surgical skin 
wounds were performed on wild-type (WT) and Calpastatin transgenic mice (CPST-
TG). Wound closure was delayed in CPST-TG mice on days 3, 7 and 10. The bigger 
delay was at day 3 (Residual wound: 114% in CPST-TG vs 41 % in WT, p<0,001), 
suggesting impairment of wound contraction. Immunolabeling revealed a reduction 
in αSMA+ cells in CPST-TG wounds on day 3 (7% v/s 15%, p<0,05), with a 71% 
decrease in α-SMA RNA. We also found less CD45+ cells in CPST-TG wounds (19% 
v/s 34%, p<0,05). On day 7, cell proliferation of the epidermis and the granulation 
tissue (106 v/s 152 vessel/mm2, p<0,05) were decreased in CPST-TG animals. Vessels 
density was reduced, with a 28% decrease in VEGFa RNA. Epidermization -measured 
on K14 labelled sections-was also impaired. Finally, WT skin transplanted on CPST-
TG recipient showed healing impaired on days 3 and 5, with a reduction in blood 
vessel density and CD45+ cells counts. In vitro, CPST-TG fi broblasts expressed 
lower αSMA levels upon TGFβ stimulation. All these results show a prominent 
role for calpain in the formation of the granular tissue and the differentiation of 
myofi broblasts resulting in delayed angiogenesis, proliferation and epidermization.
002 [Oral 037]
Topical Simvastatin Accelerates Wound Healing in Diabetes by Enhancing 
Lymphangiogenesis
Jun Asai1, Hideya Takenaka1, Kentaro Kajiya2, Saburo Kishimoto1, Norito Katoh1
1Dept of Dermatology, Graduate School of Med Science, Kyoto Prefectural Univ of 
Medicine, Kyoto, Japan, 2Shiseido Innovative Science Research Ctr, Yokohama, Japan
Impaired wound healing is one of the common complications of diabetes. Recent 
studies have shown reduced lymphangiogenesis and angiogenesis during diabetic 
wound healing, and this may represent a new therapeutic target. We previously 
reported that infi ltrating macrophages in granulation tissues can be differentiated into 
new lymphatics during wound healing, and that this function is also attenuated in 
diabetes. In the present study, we tested the hypothesis that topical application of 
simvastatin, a HMG-CoA reductase inhibitor, would accerelate wound healing via 
promotion of lymphangiogenesis in genetically diabetic mice. We also evaluated the 
effects of simvastatin on lymphatic endothelial cells (LECs) and macrophages, both of 
which contribute to lymphangiogenesis. Full thickness skin wounds were created on 
the backs of diabetic mice. Animals were treated with simvastatin (50 µg per wound) 
or vehicle topically. Application of simvastatin resulted in signifi cant acceleration of 
wound recovery, and this acceleration was notable for increased lymphangiogenesis 
in the wound. Simvastatin also promoted infi ltration of LYVE-1 positive macrophages, 
which seemed to be incorporated into newly formed lymphatics. In vitro, simvastatin 
did not promote LEC proliferation, but directly promoted capillary morphogenesis 
on both LECs and macrophages. These results suggest that both pre-existing LECs 
and infi ltrating macrophages contribute to newly organized lymphatic vessels 
induced by simvastatin. In conclusion, a simple strategy of topical application 
of simvastatin may have signifi cant therapeutic potential for enhanced wound 
healing in patients with impaired microcirculation, such as that found in diabetes.
003 [Oral 038]
How do Peroxisome-Proliferator-Activated-Receptors regulate the expression of 
Cathepsin in endothelial cells? 
Gabi Reichenbach, Igor Hrgovic, Monika Doll, Jens Gille, Roland Kaufmann, Markus 
Meissner Institute of Dermatology, University-Hospital Frankfurt a.M.,  Germany
Malignant tumor cells recruit vasculature and stromal cells through production and 
secretion of stimulatory growth factors and cytokines to activate their local host 
tumour microenvironment. In this context, the reorganization of the extracelluar 
matrix is an important tumour initiated process. In the last years a group of 
lysosomal proteases, the cathepsins, as well as ligand-activated transcription factors 
Peroxisome-Proliferator-Activated-Receptors (PPARs), were described to be crucial 
in the process of metastasis and angiogenesis. We therefore explored the effect of 
PPARα and PPARδ agonists on cathepsin expression by endothelial cells. Both inhibit 
the endothelial cathepsin B protein expression in a time and dose concentration 
dependent manner. We further investigated whether the inhibition in cathepsin B 
protein synthesis by PPARα and PPARδ ligands is mediated by changes in the mRNA 
expression level. Treatment with PPARα agonist suppressed cathepsin B mRNA 
accumulation, whereas PPARδ ligands failed to change the mRNA expression levels. 
Analysis of 5´-deletional cathepsin B promoter-based constructs revealed, that 
PPARα ligands mediate their inhibitory effects on cathepsin B expression through an 
E-box-binding site in close proximity to the transcriptional start site. EMSA analysis 
demonstrated that PPARα activator suppresses the binding of USF1/USF2 at the E-box 
located between the base pairs -16 and +17 at the cathepsin B promoter sequence. In 
conclusion, our data identify for the fi rst time endothelial cathepsin B expression as 
a novel target for PPARα and PPARδ agonist. That gives a new aspect in their modes 
of action and might enhance there potential as a class of therapeutic compounds.
004
Egln3 as a key element of differential regulation of HIF1 activity by acute and 
chronic hypoxia in epidermal keratinocytes
Lynda Weir, Douglas Robertson, Irene Leigh, Andrey Panteleyev University of 
Dundee, Dundee, United Kingdom
Hypoxia-induced factor 1 (HIF1 - a heterodimer of HIF1α and HIF1β or ARNT) is 
essential for cellular adaptation to low oxygen. As such, it plays an important role 
in skin development, wound healing, tumorigenesis and barrier function. However, 
mechanisms controlling epidermal HIF1 activity remain unknown. Using primary 
mouse and N-TERT human epidermal keratinocytes and ARNT-defi cient and 
-overexpressing cells exposed to ambient (21%) or low oxygen conditions (1%) 
we studied mechanisms controlling HIF1α and ARNT levels in the epidermis. In 
normoxia HIF1α protein is both nuclear and cytoplasmic whilst ARNT is nuclear. 
Under hypoxia, HIF1α mRNA falls down in two steps (at 1h and after 24h), while 
protein increases during acute hypoxia (<5h), then declines way below its normoxic 
level. ARNT mRNA remains constant all the time, while protein is steady under acute 
hypoxia only, being signifi cantly downregulated during subsequent chronic stage. 
This suggests that HIF1α is controlled post-translationally during acute hypoxia and 
ARNT during chronic hypoxia. As a result, HIF1 transcriptional activity is detected in 
normoxia, increases in acute hypoxia and drops in chronic phase (TransAm assay). 
All these effects are not affected by Ca++ level. We also found that EGLN3 is a key 
factor of HIF1α protein stability in the epidermis and is tightly regulated by ARNT 
through HDAC-dependent mechanisms. EGLN3 mRNA level steadily increases 
under hypoxia, but protein appears to be post-translationally modifi ed showing 
decrease during acute phase of hypoxia. Our results expose the complexity of 
epidermal hypoxia pathway regulation and outlines future steps for its exploration.
005
Blood and lymph vessel density in Caucasian skin
Christina M. Reinisch1, Undine Knolle1, Erwin Tschachler1,2 1Medical University 
of Vienna, Department of Dermatology, Vienna, Austria, 2Centre de Recherches et 
d’Investigations Épidermiques et Sensorielles (CE.R.I.E.S.), Neuilly, France
The aim of the present study was to provide data on blood- and lymph vessel 
density in human healthy skin in a Caucasian population. Special regard was put 
on a potential difference in sun-exposed and sun-protected body regions as well 
as changes possibly occurring during aging. Skin of 10 different body regions was 
analysed by immunohistochemical staining of paraffi n sections for von Willebrand 
Factor and LYVE-1. The age range of the donors (n=87) was in between 20 - 94 
years. The overall amount of blood vessels detected per skin section (=0,6mm2) 
was 20,62 ± 2,78 (mean ± standard deviation). The highest number was found in 
breast skin (24,30 ± 8,23) and the lowest in skin from the thigh (15,93 ± 8,32). 
Lymph vessel density was remarkably lower with 3,89 ± 1,17 lymph vessels per 
skin section, the highest amount could be demonstrated in neck skin (5,8 ± 3,11) 
and the lowest in skin from the forehead (2,19 ± 1,02). Blood vessel density was 
5,75 ± 1,85 fold higher than lymph vessel density. Neither body region nor donor 
age exerted a signifi cant infl uence on blood or lymph vessel density in our study 
population. In summary, we found a high inter-individual variability of vessel density 
in every body region but no signifi cant effect of age or sun-exposure in our Caucasian 
study population. This might refl ect ethnic as well as individual differences in skin 
aging and predisposition to develop certain skin diseases like for example rosacea.
006
The role of thymidine phosphorylase in the induction of early growth response 
protein-1 and thrombospondin-1 by 5-fl uorouracil in human cancer carcinoma cells
Shigeto Matsushita, Ryuji Ikeda, Katsushi Yamada, Shin-ichi Akiyama, Takuro Kanekura
Kagoshima University, Graduate School of Medical and Dental Sciences, Kagoshima, 
Japan
5-Fluorouracil (5-FU) is widely used for treatment of various cancers including 
cutaneous squamous cell carcinoma, extramammary Paget carcinoma, and so 
forth.  Thymidine phosphorylase (TP), an enzyme involved in reversible conversion 
of thymidine to thymine, is identical to angiogenic factor and platelet-derived 
endothelial cell growth factor (PD-ECGF). TP is expressed higher in a variety of 
malignant tumors than adjacent non-neoplastic tissues and thought to affect the 
metabolic process and the anticancer effect of 5-FU. To investigate the molecular 
basis of this effect,human gastric carcinoma AZ521 cells and epidermoid carcinoma 
KB cells were transfected with TP cDNA, and AZ521/TP and KB/TP were cloned. 
AZ521/TP and KB/TP cells overexpressed TP, were more sensitive to 5-FU than the 
counterpart parental cells. 5-Formyltetrahydrofolate (leucovorin; LV) enhanced the 
sensitivity of AZ521/TP cells to 5-FU, but not of the parental cells by stabilizing the 
complex of thymidylate synthase (TS) and 5-fl uoro-deoxyuridine-monophosphate 
(FdUMP). The complex of TS and FdUMP was increased in AZ521/TP cells treated 
with LV but not in the parental cells treated with LV. Furthermore, 5-FU increased the 
expression of early growth response protein-1 (Egr-1) and an angiogenesis inhibitor, 
thrombospondin-1 (TSP-1), in KB/TP cells but not in the parental cells. TPI, a inhibitor 
for TP (Ki=2.36x10-9M), attenuated the induction of Egr-1 and TSP-1 by 5-FU, while 
LV increased the expression of these proteins. These fi ndings demonstrate that 
the TP activity has a principal role in the production of FdUMP in TP-expressing 
cells, and FdUMP is implicated in the induction of Egr-1 and TSP-1 in KB cells.
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Hypothyroidism improves random-pattern skin fl ap survival in rats
Sina Rahimpour1, Behtash G. Nezami1, Negin Karimian1, Maryam Sotoudeh-
Anvari2, Sara Khalaj1, Laleh Montaser-Kouhsari1, Ahmadreza Dehpour1
1Pharmacology department, school of medicine,Tehran University of Medical 
Sciences, Tehran, Iran, Islamic Republic of, 2Department of surgical and clinical 
pathology,Terhan Heart Center,Terhan University of Medical Sciences,Tehran, Iran, 
Islamic Republic of
The protective effect of hypothyroidism against ischemic or toxic conditions is shown 
in various tissues. We investigated the effect of hypothyroidism and acute local effect 
of propylthiouracil (PTU) and methimazole (MMI) on the outcome of lethal ischemia 
in this fl ap model. Forty-two Sprauge-Dawley rats were randomly divided into 7 
groups. In all groups, dorsal fl aps with caudal pedicles were elevated at midline and 
fl ap survival was measured at the seventh day after surgery. The fi rst group served as 
control and received 1 ml of 0.9% saline solution into their fl ap before fl ap elevation. 
In groups 2 and 3, hypothyroidism was induced by administration of either PTU 0.05% 
or MMI 0.04% in their drinking water for four weeks. Next four groups received local 
injections of MMI (10, 20, 50 or 100 µg/fl ap) before fl ap elevation. Local PTU injection 
was ignored due to insolubility of the agent. Hypothyroidism was induced in chronic 
PTU and MMI treated groups, and animals in these groups showed signifi cant increase 
in their fl ap survival compared to control euthyroid rats (79.47 ± 10.49% and 75.48 
± 12.93% vs. 52.26 ± 5.75%, respectively, P< 0.01). Acute local treatment of skin 
fl aps with MMI failed to signifi cantly affect the fl ap survival. This study demonstrates 
for the fi rst time that hypothyroidism survives random-pattern skin fl aps in rats.
 
008
VEGF plays a key role enhancing epidermal and blood vessel protection against 
stress
Ludivine Mur1, Cedric Pouzet1, Catherine Serre1, Catherine Gondran1, 
Eric Bauza1, Jean Marie Botto1, Claude Dal Farra2, Nouha Domloge1
1Vincience ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP Corporate 
Research Center, Wayne, United States
Vascular endothelial growth factor (VEGF) is a crucial element of endothelial cells 
and angiogenesis and plays diverse roles in skin photoaging, hypoxia, and wound 
healing. We investigated the expression of VEGF-A and VEGFR-2 (Flk-1), its major 
receptor, in different cell lines by RT-PCR. VEGF-A and Flk-1 immunofl uorescence 
studies showed that IV09.006, a compound designed to target VEGF pathway, 
increased the expression of these two proteins in normal human keratinocytes 
(NHK) and endothelial cells. Ex vivo studies showed that VEGF-A expression in the 
epidermis is mainly located in the suprabasal layers. UVB irradiation and H2O2 
stresses increased VEGF-A expression in the epidermis. In parallel, pre-treatment with 
IV09.006 was shown to protect skin from stress damage. For in vivo evaluation, we 
used chicken chorio-allantoïc membrane (CAM). IV09.006 active was applied directly 
on the CAM for 24h, and then a stress induced by UVB irradiation (60 mJ/cm2) or 
H2O2 (10 mM) was applied. A time course observation of the blood vessel network 
was performed after each stress condition. Our study showed that pre-induction 
of VEGF-A and Flk-1 enabled a better maintenance of the blood vessel network, 
preventing vasodilatation and coagulation induced by stress. Taken together, these 
results indicate that the positive modulation of VEGF-A and Flk-1 expression could be 
linked to a better preservation of the epidermis from UVB and oxidative stress-induced 
damage, as well as a protection of the blood vessel network from these stresses.
009 [Oral 109]
A unique population of infl ammatory macrophages induced by iron impairs 
cutaneous wound healing
Anca Sindrilaru1, Thorsten Peters1, Corina Baican2, Johannes Weiss1, Meinhard 
Wlaschek1, Cord Sunderkötter3, Karin Scharffetter-Kochanek1 1University of Ulm, 
Dept of Dermatology & Allergic Diseases, Germany, 2University of Cluj-Napoca, Dept 
of Dermatology & Venerology, Cluj-Napoca, Romania, 3University of Münster, Dept of 
Dermatology, Germany
Uncontrolled macrophage activation is now considered to be a critical event in the pathogenesis 
of chronic infl ammatory disorders like arteriosclerosis, multiple sclerosis and chronic venous 
leg ulcers (CVU). However, it is still unclear which environmental cues induce persistent 
activation of macrophages in vivo and how macrophage-derived effector molecules maintain 
chronic infl ammation and affect resident fi broblasts essential for tissue homeostasis and repair. 
We used a complementary approach studying human subjects with CVU, a model disease for 
macrophage-driven chronic infl ammation, while establishing a murine model closely refl ecting 
its pathogenesis. Here we show that iron overloading of macrophages in CVU and in iron-
dextran-treated murine full-thickness excisional wounds induce a novel macrophage population 
in situ which up-regulate CD163, the hemoglobin-haptoglobin scavenger receptor for iron. 
CD163hi wound macrophages mount a persistent pro-infl ammatory activation state with high 
expression of M1 markers (TNFahighIL-12highCD11bhighCCR2high) and the concomitant intermediate 
expression of anti-infl ammatory M2 markers (IL-4RamedDectin-1medCD36medCD206med), suggestive 
for an incomplete switch towards the tissue repair-promoting M2 activation phenotype. We 
show that ‘hybrid’ M1/M2 activated macrophages - via enhanced TNFa and hydroxyl radicals 
release – perpetuate infl ammation and install a p16INK4a-dependent senescence program in 
resident fi broblasts eventually leading to tissue breakdown and impaired wound healing.
Understanding the role of macrophage activation for persistency or resolution of infl ammation 
in chronic venous ulcers and other chronic infl ammatory diseases holds substantial 
promise for the development of novel therapies for these diffi cult-to-treat conditions.
010 [Oral 110]
Toll-like receptor signaling in dendritic cells is suffi cient to mediate Imiquimod-
induced psoriasis-like skin infl ammation in mice 
Christian Wohn1, Errol Prens2, Sabina Onderwater1, Edwin Florencia2, Heike 
Weighardt3, Björn Clausen1 1Dept of Immunology, ErasmusMC, University Medical 
Center, Rotterdam, Netherlands, 2Dept of Dermatology, ErasmusMC, University 
Medical Center, Rotterdam, Netherlands, 3Institut für Umweltmedizinische Forschung, 
Heinrich-Heine-Universität Düsseldorf, Germany
Psoriasis is a common infl ammatory skin disease characterized by sharply demarcated chronic 
red plaques covered by white scales. Based on the observation that Imiquimod (IMQ) treatment 
leads to de novo development or relapse of psoriasis in patients, we established a new mouse 
model for human psoriasis. Daily application of IMQ onto mouse back skin induces infl amed scaly 
lesions resembling plaque type psoriasis. These lesions show increased epidermal proliferation, 
abnormal cell differentiation, neoangiogenesis and infi ltrates consisting of neutrophils, CD4+ 
T cells, conventional and plasmacytoid dendritic cells (DC). We previously demonstrated that 
lesion development is critically dependent on IL-23 and IL-17. However, the cell types triggering 
the infl ammatory process remain elusive. IMQ activates diverse cells of the immune system after 
binding to toll-like receptors (TLR)-7/8. To investigate the role of different (skin) DC in initiating 
IMQ-induced psoriasis, we generated MyD88-defi cient mice in which TLR-signaling can be 
conditionally switched on by Cre-mediated excision of a stop cassette (MyD88stp/stp mice). As 
expected, MyD88stp/stp animals are resistant to IMQ-induced psoriasis. In contrast, mice with selective 
reconstitution of TLR signaling in all CD11c+ DC acquire full-blown psoriasiform skin disease 
following IMQ painting. Intriguingly, mice with TLR signaling restricted to Langerin+ DC subsets, 
including epidermal Langerhans cells and Langerin+ dermal DC, develop attenuated disease. 
These data imply that DC are suffi cient to mediate IMQ-induced psoriasis. In ongoing experiments 
we are further dissecting the requirement of different DC subsets for the induction of disease.
011 [Oral 063]
Human IL-10 producing regulatory B cells control CD4+ T cell proliferation
Jean-David Bouaziz1, Sébastien Calbo2,3, Maud Maho-Vaillant2, Anne 
Saussine1, Martine Bagot1, Armand Bensussan1, Philippe Musette2
1INSERM U976, Saint Louis Hospital, Paris, France, 2INSERM U905, Charles Nicolle 
Hospital, Rouen, France, 3Singapore Immunology Network, Agency for Science, 
Technology and Research, Biopolis, Singapore
The existence of interleukin 10 (IL-10) producing regulatory B cells that down-
modulate infl ammation has already been validated in mice. Especially, a potent subset 
of regulatory B cells with a CD1dhighCD5+CD19high phenotype was found to decrease 
contact hypersensitivity in an IL-10-dependent manner. In humans, a transitional 
B cell subset has recently been shown to exhibit regulatory capacities in vitro.We 
investigated the existence of IL-10 producing B cells in human blood and spleen 
and evaluated their phenotype. We also tested the optimal in vitro conditions to 
trigger IL-10 production by B cells and tested their capacities to regulate CD4+CD25- 
T cell proliferation.We were able to detect after ex vivo short time stimulation, IL-10 
producing B cells in human blood and spleen (1.8% and 1.1% of blood and spleen 
human B cells produced IL-10 as detected by intracellular cytokine staining). Blood 
IL-10 producing B cells were relatively enriched within the memory (CD27+) and 
transitional (CD38highCD24high) B cell subsets but IL-10 producing B cells were 
detected within the whole B cell lineage. Combined CpG-B and anti-immunoglobulin 
stimulation, rather than CD40L-CD40 pathway, was the most potent stimulus 
for inducing IL-10 secretion (ELISA assay). Under these conditions of stimulation, 
human blood B cells inhibited CD4+ CD25- T cell proliferation in vitro in an IL-
10-dependent mechanism.These fi ndings imply that promoting or inhibiting IL-10 
production by human B cells may represent potential targets for modulating immune 
responses in human pathology, including dermatological infl ammatory diseases.
012 [Oral 064]
The genetics of murine epidermolysis bullosa acquisita
Ralf Ludwig, Andreia de Castro Marques, Hengameh Sadeghi, Susen Mueller, Steffen 
Moeller, Detlef Zillikens, Saleh Ibrahim Department of Dermatology, University of 
Luebeck, Germany
Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease, 
characterized by auto-antibodies to type VII collagen (COL7). EBA can be induced in 
mice by immunization with a fragment of the non-collagenous domain 1 of murine 
COL7 or by transfer of anti-COL7 antibodies. Unlike other autoimmune diseases, 
e.g. rheumatoid arthritis or Lupus, little is known about the genetic susceptibility 
for EBA and/or related autoimmune blistering diseases. We therefore used the 
EBA mouse model to address the hypothesis that disease induction depends on 
the MHC haplotype and additional genes outside the MHC. Mice from different 
inbred and MHC congenic strains were immunized with recombinant murine 
COL7.  Three distinct responses were observed: (i) severe disease in SJL/J (H2s) and 
MRL/MpJ (H2k), (ii) mild and transient disease in C57Bl/10.s (H2s), (iii) resistance 
in C57Bl/6J (H2b), NZM2410/J (H2z), DBA/1J (H2q), NOD/ShiLtJ (H2g7) and 
C57Bl/10.q (H2q) mice. Overall, susceptibility to EBA was strongly associated 
with H2s and H2K. We then used a 4-way intercross we recently generated to 
map quantitative trait loci, QTL, linked to EBA.  Active or passive EBA was induced 
in 530 intercross mice genotyped with 1400 SNP markers, Illumina MD array, 
and disease phenotypes were evaluated. HAPPY mapping software was used to 
identify QTL associated with EBA. In total, we identifi ed six loci controlling disease 
onset and/or severity, located on Chr. 1, 6, 12, 15, 19. Our fi ndings suggest that 
susceptibility to experimental EBA is linked to the MHC haplotype. Furthermore, 
preliminary QTL mapping data suggest that numerous non-MHC genes are involved.
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013 [Oral 065]
Novel cleavage sites and specifi c neoepitopes on shed ectodomain of collagen XVII/
BP180: role in autoimmune blistering diseases
Wataru Nishie1, Stephanie Lamer2, Andreas Schlosser2, Emilia Licarete1, Claus-Werner 
Franzke1, Silke C. Hofmann1, Joanna Jackow1, Cassian Sitaru1, Leena Bruckner-
Tuderman1 1Dept of Dermatology, University Medical Center Freiburg, Germany, 
2Core Facility Proteomics, Center for Systems Biology (ZBSA), Freiburg, Germany
Collagen XVII/BP180 is a type II transmembrane protein in basal keratinocytes which 
provides stable adhesion between epidermis and dermis. Its ectodomain can be shed from 
the cell surface, and autoantibodies from patients with bullous pemphigoid and linear IgA 
bullous dermatosis are known to preferentially react with the cleaved fragment. Previous 
studies have suggested the development of neoepitopes on the shed ectodomain, however 
the pathomechanisms are still unclear. In this study, we investigated how certain antibodies 
can react specifi cally with the shed ectodomain of collagen XVII, but not with the full-
length form, and their role in blister formation. First, a new polyclonal antibody recognizing 
the stretch from Leu524 to Gly532 preferentially reacted with the shed ectodomain, but not 
with the full-length form, indicating that a neoepitope was actually localized at this site. 
Second, the antibody could induce granulocyte-dependent dermal-epidermal separation in 
cryosections of normal human skin, suggesting its pathogenicity. Third, a novel method using 
mass spectrometry revealed physiological cleavage sites, and different amino-termini were 
found at Asp514, Leu524, Glu525 and Gly526, among which Asp514 and Glu525 were blocked by 
acetylation and pyroglutaminate, respectively. Finally, in silico prediction of B-cell epitopes 
demonstrated that the antigenicity of the Leu524 to Gly532 region increased substantially after 
shedding, regardless of the different cleavage sites. These data demonstrate that physiological 
shedding of collagen XVII generates neoepitopes in the released ectodomain and suggest 
a pathogenic role for neoepitope-specifi c antibodies in autoimmune blistering diseases.
014 [Oral 066]
Mast cell committed progenitors travel through peripheral tissues and lymph - 
implication for the accumulation of mature mast cells due to infl ammatory signals
Frank Siebenhaar1,2, Ulrich H. von Andrian2, Marcus Maurer1 1Dept of Dermatology 
and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany, 2Dept of Pathology, 
Harvard Medical School, Boston, MA, United States
Hematopoietic stem and progenitor cells (HSPCs) have been shown to re-circulate through 
blood, lymph, and extramedullary tissues and to give rise to tissue-resident myeloid cells, 
preferentially dendritic cells, upon infl ammatory stimuli. Recently, mast cell-committed 
progenitors (MCPs) have been described among HSPCs in the bone marrow of adult 
mice. Here, we demonstrate that Lin-Kit+Sca-1-Ly6c-CD27-FcεRIα-β7-integrin+T1/ST2+ 
MCPs similarly travel though blood, peripheral tissue, and lymph. We show that MCPs are 
detectible in blood and peripheral tissue, i.e. skin, and that mouse thoracic duct lymph 
contains MCPs that possess mast cell (MC) reconstitution capacity. FTY720 treatment, a 
potent sphingosine-1-phosphate (S1P) receptor antagonist, results in the depletion of MCPs 
from lymph indicating that the egress of MCPs from peripheral tissue into the lymph is 
a S1P receptor dependent mechanism. Prolonged topical application of the phorbolester 
phorbol 12-myristate 13-acetate (PMA) results in pronounced dermal MC accumulation. 
Pertussis toxin (PTx) treatment markedly impaired the recruitment of MCPs to PMA 
treatment sites and reduced the number of accumulating MCs. Thus, we demonstrate 
that the migration of MCPs into peripheral tissue, i.e. the skin, requires the expression 
of functional Gαi-coupled receptors. In summary, our fi ndings indicate that MCPs traffi c 
through bone marrow, blood, periphery tissue and lymph under physiological conditions, 
and that MC accumulation due to infl ammatory signals depends on the recruitment 
of MCPs and/or the inhibition of their egress from tissue sites. The characterization 
of the regulation of MCP traffi cking in detail could lead to a better understanding 
of MC-mediated diseases and the development of novel therapeutic strategies.
015 [Oral 067]
Epidermal EGFR signaling controls leukocyte infi ltration in the skin and prevents 
systemic disease
Francesca Mascia1, Gary Lam1, David Threadgill2, Stuart Yuspa1
1NCI-NIH, Bethesda, United States, 2UNC, North Carolina, United States
The skin rash that occurs during the anti EGFR therapy of cancer patients shows 
the importance of EGFR control on skin immune-homeostasis. To better understand 
the pathogenetic role of EGFR inhibition in the skin, we developed an epidermally 
targeted mouse model of EGFR ablation. By crossing Keratin 5 driven Cre recombinase 
transgenics with EGFR fl oxed mice, EGFR was ablated in the epidermis. The double 
transgenic mice did not display a clear phenotype at birth. After the fi rst week and for 
their entire life, double transgenics showed a strong phenotype with skin infl ammation 
and aberrant hair growth and hair loss cycles. The appearance of the skin phenotype 
(7/8 days after birth) was concomitant with tissue infi ltration of total lymphocytes 
(CD45), mast cells (toluidine blue) and macrophages (F4/80). In the second week 
of life, the neutrophilic infi ltrate was also abundant as detected by myeloperoxidase 
assay. Tissue samples isolated from skin of adult double transgenics contained high 
mRNA levels of a subset of infl ammatory mediators namely CCL17, CCL20, CCL2, 
TNF-alpha, IL-6, IL-17, IL-18, and G-CSF. Targeted knockout mice also displayed 
hematological abnormalities with a higher number of circulating neutrophils, 
platelets and lower numbers of lymphocytes. Extramedullary hematopoiesis was 
detected in the spleen and plasma levels of G-CSF, IL-1ra, IL-17, IL-6 and CCL2 
were elevated. These data indicate that the chronic absence of EGFR expression 
in the epidermis triggers not only local but also systemic infl ammatory responses.
016 [Oral 068]
Desmoglein 3-specifi c T cells induce Experimental Autoimmune Dermatitis (EAD), a 
novel model for interface dermatitis
Michiyoshi Kouno1, Hayato Takahashi1, Taketo Yamada2, Keisuke Nagao1, Masayuki 
Amagai1 1Department of Dermatology Keio University School of Medicine, Tokyo, 
Japan, 2Department of Pathology Keio University School of Medicine, Tokyo, Japan
Desmoglein 3 (Dsg3), a transmembrane component of desmosomes in the skin, is 
the autoantigen in pemphigus vulgaris (PV). We recently established Dsg3-specifi c 
CD4+ T cell (Dsg3 T cell) clones that induced PV phenotype. Herein, we cloned T 
cell receptors (TCR) from Dsg3 T cells and developed transgenic (tg) mice expressing 
these TCRs. In these tg mice, tgDsg3 T cells escape from central deletion and are 
found in periphery. Surprisingly, instead of inducing PV phenotype, tgDsg3 T cells 
induced clinical phenotype characterized by scaly erythematous lesions, which 
histology displayed interface dermatitis, as determined by CD4+ T cell infi ltration in 
the dermo-epidermal junction with vacuolar degeneration and apoptosis. When these 
TCRs were retrovirally transduced into wild-type (WT) CD4+ T cells (rvDsg3), the 
cells acquired antigen-specifi city identical to tgDsg3 T cells. RvDsg3 T cells evoked 
similar clinical phenotype, and histological changes in skin, mucous membranes and 
esophagus, where Dsg3 was expressed. Cytokine profi les revealed that both rvDsg3 
and tgDsg3 T cells had lost the Th2-phenotype that parental T cell clone displayed, 
and produced IFN-γ and IL-17. To evaluate the roles of these cytokines, we compared 
the phenotypes induced by WT, IFN-γ KO, or IL-17 KO rvDsg3 T cells. Strikingly, 
defi ciency for IFN-γ, but not IL-17, lead to dramatic loss of acute phenotype. Our 
model, designated experimental autoimmune dermatitis (EAD), provides a valuable 
tool to understand the pathophysiology of T cell-mediated infl ammatory skin diseases 
including lichen planus and lupus erythematosus, that display interface dermatitis.
017 [Oral 069]
Platelet-activating factor blockade inhibits Th17 pathway and suppresses psoriatic-
like skin disease in K5.hTGF-beta1 transgenic mice
Tej Pratap Singh1,2, Barbara Huettner2, Harald Koefeler2, Gerlinde Mayer1, Katrin 
Wallbrecht3, Michael P Schön3, Peter Wolf1 1Research Unit for Photodermatology, 
Department of Dermatology, Medical University of Graz, Austria, 2Center for 
Medical Research, Medical University of Graz, Austria, 3Department of Dermatology, 
Venereology and Allergology, Georg August University, Göttingen,, Germany
Platelet activating factor (PAF), a potent biolipid mediator, is involved in a variety of 
cellular transduction pathways and plays a prominent role in inducing infl ammation 
in different organs, including the skin. We utilized K5.hTGF-beta1 transgenic 
mice, which exhibit an infl ammatory skin disorder and molecular and cytokine 
abnormalities with strong similarities to human psoriasis, in order to evaluate the 
role of PAF and its receptor in the pathogenesis of the skin phenotype. We found that 
injecting PAF into the skin led to infl ammation and accelerated the manifestation of the 
psoriatic phenotype in transgenic mice by a local effect, as assessed by macroscopic 
and microscopic fi ndings. In contrast, injecting mice with PAF receptor antagonist 
PCA-4248 lowered the PAF level (most likely by depressing an autocrine loop) and 
neutrophil accumulation in the skin and blocked disease progression. This effect of 
PAF blockade was similar to that of PUVA and paralleled by a decrease of abnormally 
elevated mRNA and/or protein levels of Th17-related cytokines IL-17A, IL-17F, IL-23, 
IL-12A, and IL-6, and its transcription factor STAT3. In contrast, PCA-4248 treatment 
upregulated the mRNA levels of COX2 and IL-10 in the dorsal skin and release of IL-
10 in the serum and skin. This implies that specifi cally interfering with PAF may be an 
option to induce cytokine pathways with disease suppressive activity and develop novel 
anti-psoriatic therapeutic strategies in particular for infl ammatory disease variants.
018 [Oral 070]
MiR-155 is overexpressed in atopic dermatitis and modulates T cell proliferative 
responses by targeting CTLA-4
Eniko Sonkoly1, Peter Janson1, Marja-Leena Majuri2, Terhi Savinko2, Nanna Fyhrquist2, 
Liv Eidsmo1, Ning Xu1, Florian Meisgen1, Tianling Wei1, Maria Bradley1, Jan Stenvang3, 
Sakari Kauppinen3, Harri Alenius2, Antti Lauerma2,5, Bernhard Homey6, Ola Winqvist1, 
Mona Ståhle1, Andor Pivarcsi1 1Karolinska Institutet, Stockholm, Sweden, 2Finnish 
Institute of Occupational Health, Helsinki, Finland, 3Santaris Pharma, Hoersholm, 
Denmark, 4Copenhagen Institute of Technology, Aalborg University, Denmark, 
5University of Helsinki, Finland, 6Heinrich-Heine-University, Dusseldorf, Germany
MicroRNAs are short, noncoding RNAs that suppress gene expression at the post-
transcriptional level. Atopic dermatitis is a common chronic infl ammatory skin disease 
characterized by the presence of activated T cells within the skin In this study, we 
aimed to explore the role of miRNAs in the pathogenesis of atopic dermatitis. Using 
TaqMan MicroRNA Low Density Arrays, we showed that miRNAs are deregulated in 
atopic dermatitis skin lesions as compared with healthy skin. MiR-155 was one of the 
highest-ranked up-regulated microRNA in atopic dermatitis. In situ hybridization as 
well as quantitative PCR analysis of miR-155 in FACS-sorted dermal cells showed that 
miR-155 was predominantly expressed in infi ltrating immune cells in atopic dermatitis 
lesions. MiR-155 was up-regulated during T cell differentiation/activation and was 
markedly induced by T cell activators in PBMCs in vitro and by superantigens and 
allergens in the skin in vivo. We identifi ed CTLA-4, an important negative regulator of 
T cell activation, as a direct target of miR-155, using in silico prediction and validation 
by luciferase reporter assays. Overexpression of miR-155 in T helper cells resulted 
in decreased CTLA-4 levels accompanied by an increased proliferative response. 
Our results show that miR-155 is signifi cantly overexpressed in atopic dermatitis. 
Overexpression of miR-155 may contribute to chronic skin infl ammation by increasing 
the proliferative response of T helper cells via the down-regulation of CTLA-4.
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A peptide within HSP70i driving vitiligo development
John D. Nieland1, Jeffrey Mosenson2, Andrew Zloza3, Jared Klarquist2, Thor Las 
Holtet4, Anke Kretz-Rommel4, Jose A. Guevara-Patino3, I. Caroline Le Poole2
1Aarhus School of Engineering, Aarhus, Denmark, 2Loyola University Medical Center, 
Maywood, IL, United States, 3University of Chicago, Chicago, IL, United States, 
4Anaphore, Inc, La Jolla, CA, United States
Published studies from our lab support the ability of HSP70i, secreted in increased 
amounts by vitiligo melanocytes, to activate dendritic cell (DC) mediated 
cytotoxicity. HSP70i also accelerated TRP-2 DNA vaccine induced, T cell mediated 
depigmentation in C57BL/6 mice, but not in HSP70i knockout animals. To challenge 
the concept that HSP70 may be targeted to interfere with vitiligo development, we set 
out to identify an intramolecular peptide crucial to the depigmentation process. DNA 
encoding an exposed 13-mer peptide was subjected to site-directed mutagenesis. 
The choice was based on homology to a stretch of amino acids within microbial 
Hsp70 previously held responsible for binding to and activating human DC. Four 
different mutant sequences and wildtype HSP70 were used to vaccinate C57BL/6 
mice in combination with TRP-2 encoding DNA, measuring depigmentation by 
scanning and image analysis over time. The ability to augment depigmentation 
was signifi cantly impaired for 3 mutant sequences, implicating an 11-mer peptide 
crucial to inducing vitiligo. Western blot analysis using polyclonal and monoclonal 
antibodies to HSP70i probing homogenates of transiently transfected COS cells 
revealed a monoclonal antibody reactive with the molecular region of interest. 
The results demonstrate a crucial role for peptide QPGVLIQVYEG in inducing 
vitiligo and reveal opportunities for blocking the roaming peptide from activating 
dendritic cells and recruiting melanocyte-reactive T cells to the skin. This work was 
recently fi led as a continuation of parent patent application PCT/US2008/076266
020 [Oral 017]
The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of 
autoreactive CD8+ T cells
Karin Loser1, Thomas Vogl2, Thomas A. Luger1, Johannes Roth2, Stefan Beissert1
1Univeristy of Münster, Department of Dermatology, Münster, Germany, 2University of 
Münster, Department of Immunology, Germany
Autoimmunity results from a confl ict of regulatory mechanisms controlling self-
tolerance and the interaction of CD40 on antigen-presenting cells with its ligand CD40L 
plays an important role during (auto)immune responses. Within the skin, transgenic 
overexpression of CD40L in keratinocytes leads to systemic autoimmunity as evidenced 
by autoantibodies, nephritis, and autoimmune dermatitis, which can be adoptively 
transferred by injecting CD8+ T cells into naive recipients. However, the mechanisms 
linking the local micromilieu and the development of autoreactive CD8+ T cells in CD40L-
induced autoimmunity are poorly understood. Myeloid-related proteins (Mrp) such as 
Mrp8 and Mrp14 are damage associated molecular pattern molecules (DAMPs) highly 
up-regulated in various autoimmune disorders. Hence, we investigated the relevance of 
Mrp8 and Mrp14 for the development of functional autoreactive T cells and could show 
that local Mrp8/14 production is essential for the induction of autoreactivity in CD8+ T 
cells and the development of systemic autoimmunity. This effect is mediated via TLR4 
signaling and up-regulation of the transcription factors Runx-1 and RORc in CD8+ T 
cells leading to increased IL-17 expression. Notably, Mrp8 and Mrp14 expression was 
increased in cutaneous lesional lupus erythematosus (LE) and enhanced concentrations of 
Mrp8/14 were detectable in patient’s serum. Strikingly, stimulation of CD8+ T cells from 
LE patients with Mrp8 and Mrp14 proteins resulted in a signifi cant up-regulation of IL-
17 expression indicating that Mrp8/14 play also an important role during human MHC 
class I-mediated cellular autoimmunity. Together, these data present the fi rst link between 
local expression of a DAMP-molecule and the development of systemic autoimmunity.
021 [Oral 023]
Identifi cation of slan (6-sulfo LacNAc+) dendritic cells as a novel proinfl ammatory 
DC population in atopic dermatitis driving strong Th17 and Th1 responses
Anja Hänsel1, Wojchiech Baran2, Jens Ingwersen3, Ernst Peter Rieber3, Michael 
Meurer2, Knut Schäkel1 1Department of Dermatology, University Hospital Heidelberg, 
Heidelberg, Germany, 2Department of Dermatology, Faculty of Medicine of the 
Technical University Dresden, Dresden, Germany, 3Institute of Immunology, Faculty 
of Medicine of the Technical University Dresden, Dresden, Germany
Atopic dermatitis (AD) is a chronic infl ammatory skin disease with a key role for 
dendritic cells (DC) and T cells. Recently several studies provided evidence for the 
presence of IL-17 and IL-22 producing T cells in AD. IL-17 was shown to augment 
the production of proinfl ammatory cytokines by keratinocytes, while IL-22 induced 
inhibits genes involved in terminal differentiation of keratinocytes. A DC subset that 
preferentially induces IL-17 and IL-22 producing T cells has not yet been described. 
Within the perivascular dermal infl ammatory infi ltrate of lesional AD we identifi ed 
high numbers of proinfl ammatory DC selectively expressing 6-sulfo LacNAc (slan). 
We previously described slanDC as a distinct and separate population of human 
blood DC serving as the major source of IL-12 as well as of TNF-α. In addition to 
blood, slanDC were found within the local infl ammatory infi ltrate in psoriasis and 
rheumatoid arthritis. When stimulating slanDC and for comparison  CD1c+ DC 
purifi ed from blood with the TLR4-ligand LPS, slanDC produce by far higher levels 
of the cytokines (IL-1ß, IL-6, IL-23) that are involved in the programming of IL-17 
and IL-22 producing T cells. In line with this, slanDC by far excelled CD1c+ DC in 
programming of IL-17, IL-22 and IFN-γ producing T cells as determined by ELISA 
and by intracellular cytokine staining. Instead, CD1c+ DC effi ciently programmed T 
cells to produce IL-10. Characterizing slanDC as a DC population highly effective in 
programming Th17/Th22 cells together with their identifi cation in AD provides strong 
evidence for an important proinfl ammatory role for slanDC in AD.
022 [Oral 001]
Halting angiogenesis by non-viral somatic gene therapy alleviates psoriasis and 
murine psoriasiform skin lesions
Katrin Wallbrecht1, John R. Zibert2, Lluis M. Mir3, Grete K. Jacobsen4, Veronique 
Trochon-Joseph5, Louise S. Villadsen2, Ruggero Cadossi6, Lone Skov2, Michael P. Schön1
1Dept Derm, Georg August Univ, Göttingen, Germany, 2Dept Derm-Allergol, Univ 
Copenhagen, Denmark, 3CNRS, Inst Gustave-Roussy, Villejuif, France, 4Bartholin Inst, 
Copenhagen, Denmark, 5BioAlliance Pharma SA, Paris, France, 6IGEA S.r.l., Carpi, Italy
Dysregulated angiogenesis is a hallmark feature of psoriasis, a common skin disorder that 
affects 2% of the population. Induced expression of adhesion molecules, such as the integrins 
alpha5beta1 and alphaVbeta3, on sprouting blood vessels is crucial for angiogenesis and is a key 
to using these receptors as therapeutic targets. Besides targeting components of the VEGF signaling 
pathway, adamalysin protein family members, also referred to as ADAMs (a dis¬integrin and 
metalloproteinase), are potential players interfering with angiogenesis. ADAM-15 (metargidin, a 
metalloprotease-RGD-disintegrin) is the only adamalysin known to bind integrins alpha5beta1 and 
alphaVbeta3. Using xenotransplantation of human psoriasis in two distinct models as well as a murine 
psoriasis-like skin disorder in K5.TGFb1 transgenic mice as independent angiogenesis-related skin 
disorders, we demonstrate that anti-angiogenic non-viral somatic gene therapy reduces the cutaneous 
microvasculature and alleviates the infl ammatory skin disorders. Transient muscular expression of the 
disintegrin domain (RDD) of metargidin (ADAM-15) by in vivo electroporation signifi cantly reduced 
cutaneous angiogenesis and vascularization in all three models. As demonstrated by red fl uorescent 
protein-coupled RDD, the treatment resulted in muscular expression and cutaneous deposition 
of the gene product. High-resolution ultrasound demonstrated reduced cutaneous blood fl ow in 
vivo following electroporation with RDD, but not control plasmids. In addition, angiogenesis- and 
infl ammation-related molecular markers, keratinocyte proliferation, epidermal thickness as well as the 
clinical disease scores were signifi cantly downregulated in all models. Thus, non-viral antiangiogenic 
gene therapy can indeed alleviate psoriasis and other angiogenesis-related infl ammatory skin disorders.
023 [Oral 008]
The role of human microRNA-125b in psoriasis
Ning Xu, Petter Brodin, Tianling Wei, Florian Meisgen, Liv Eidsmo, Mona Ståhle, 
Enikö Sonkoly, Andor Pivarcsi Karolinska Institute, Stockholm, Sweden
MicroRNAs (miRNA) are recently discovered regulators of gene expression, which play 
important roles in both physiological and pathological processes. In a genome-wide 
screen for miRNAs, we identifi ed a specifi c miRNA expression profi le in psoriasis, 
distinct from that of healthy skin. One of the miRNAs deregulated in psoriasis skin 
was microRNA-125b (miR-125b). Our studies presently focus on identifying the 
potential role(s) of miR-125b in psoriasis. MiR-125b is signifi cantly down-regulated 
in psoriasis compared to healthy skin, as shown by quantitative real-time PCR.  In situ 
hybridization data showed that the major cell type responsible for suppressed miR-
125b levels in psoriasis lesions is keratinocytes. To explore the role of miR-125b on 
cellular functions we transfected miR-125b precursor miRNAs (to overexpress miR-
125b) and miR-125b inhibitor oligonucleotides (to reduce its activity) into primary 
human keratinocytes and performed functional assays. Overexpression of miR-125b 
suppressed keratinocyte proliferation and induced the expression of several known 
differentiation markers such as involucrin, cytokeratin 10 and fi laggrin. We identifi ed 
keratinocyte growth factor receptor (KGFR/FGFR2) as a direct target for suppression 
by miR-125b, which was verifi ed by luciferase reporter assays. Overexpression of 
miR-125b in keratinocytes suppressed the expression of KGFR at the protein, but not 
the mRNA level. Immunohistochemistry data showed that the expression of KGFR 
was up-regulated in psoriasis epidermis. Taken together, our results demonstrate a 
role for miR-125b in the regulation of keratinocyte proliferation and differentiation, 
partially through the regulation of KGFR. Loss of miR-125b in psoriasis skin lesions 
may contribute to the hyperproliferation and aberrant differentiation of keratinocytes.
024
Generalized alopecia patients have an abnormal retro-nuchal erythema which 
responds to freezing with cessation of hair loss and regrowth
Kiumars Pirkalani, Zahra Talaee Rad, Bahman Khodabakhsh Mehr Medical group, 
Tehran, Iran, Islamic Republic of
In a long term survey, about 90% of 270 alopecia universalis patients demonstrated a 
geographic, pink and symptom free erythema in the back of the neck which resolved 
during treatment for alopecia with medications such as systemic corticosteroids, 
Hydroxychloroquine and Diphencyprone and even spontaneous remission and 
recurred after recurrence of the alopecia. Less than 10% of normal individuals 
showed this newly defi ned sign. This difference was statistical highly signifi cance 
(p<0.003). We concluded that this might be the etiology of alopecia in terms of 
site of antigen shedding and not an epiphenomenon.Twelve patients underwent 
skin biopsy at the site which showed mild partial atrophy of the epidermis, fi ne 
fi brosis of the dermis with a mild increase and ectasia of superfi cial vascular 
plexus associated with mild melanin incontinence in pigmented macrophages, 
orthokeratotic hyperkeratosis, irregular acanthosis, perivascular accumulation of 
lymphoid cells, individual apoptotic cells resembling civette bodies in addition 
to classic histology of alopecia. Thirty three patients at different stages of alopecia 
received single session of local freezing with Nitrous oxide at -79 degrees centigrade. 
Six patients did not responded completely and received another session 3-4 weeks 
later. All patients responded with a 60-100% reduction of surface area. Thirteen 
patients and 9 additional patients showed reduction of hair loss and regrowth 
of hair, respectively. Provided the very large number of our alopecia patients 
at different stages of disease and under different treatments this local physical 
modality shows much promise. A large immune histological study is underway.
 www.jidonline.org S5 
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Cerebrolysine improves angiogenesis in a local skin irradiated chronic wounds via 
IL-1β - and IL-8-mediated pathway
Igor Khalin Kharkiv National Medical University, Kharkiv, Ukraine
Chronic wounds (CW) are having failed to progress through the normal healing stages 
and therefore enter a state of pathologic infl ammation. The CW are mostly caused 
by ischemia. The aim of the present study was to discover the effect of cerebrolysine 
(aminoacid medicine with neurotrophic action) on the interleikin-8 (IL-8) -involved 
angiogenesis pathway, and on the interleikin-1β (IL-1β) level in a local skin irradiated 
CW model produced on the thigh of guinea pigs (GP). Animals were randomized to 
the following groups: intact, GP with radiated CW without treatment and animals 
with CW treated by paravulnar cerebrolysine administration (1 ml/kg 1 time a 2 days). 
The animals were sacrifi ced on 21st day after treatment beginning and wounded skin 
tissues were used for histological evaluation and for ELISA cytokines analysis and the 
blood for ELISA. Non-treated animals showed impaired wound healing with delayed 
angiogenesis: increased IL-1β and IL-8 levels in blood and tissue comparing with 
control without any morphological improving features. Cerebrolysine signifi cantly 
decreased IL-1β and IL-8 levels: in blood to 70% and 38%, in tissue to 23% and 
45%, respectively. Moreover, histologicaly epithelium had basal membrane, 
dermis – new collagen fi bers, and microcirculatory system demonstrated high 
CD34 expression (new endothelial cells). The current study provides evidence that 
cerebrolysine improves angiogenesis in CW and promotes switching pathological 
infl ammatory stage to proliferative. Thus, cerebrolysine action doesn’t limited by 
neurotrophic function but extends to the dermatrophic, which is can be explained 
by the common origin of both nerve tissue and skin from embryonic ectoderm.
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Inhibitory effect of vitamin C and sodium L-ascorbyl-2-phosphate on the production 
of infl ammatory cytokines
Kenichi Kaneko1, Takaya Mineo1, Nobuhiro Kato1, Hiroshi Ikeno2
1Basic Development Section, Holistic Beauty Research Institute,Wamiles Cosmetics 
Inc., 2-3-12 Konan, Konan-ku, Yokohama, Kanagawa, Japan, 2Ikeno Clinic, Ginza 1-14-
4, 3F, Chuo-ku, Tokyo, Japan
Anti-infl ammatory effect of vitamin C and its derivatives against oxidative stress-
induced infl ammation has been reported. However, there are few reports on the 
effect of vitamin C and its derivatives for their inhibitory action against bacterial-
stimulated infl ammation. We investigated the anti-infl ammatory effect of vitamin 
C and L-ascorbyl-2-phosphate (APS; a stable derivative of vitamin C) on bacterial 
peptidoglycan-induced production of infl ammatory cytokines. Neonatal human 
keratinocytes (NHEK(F)) were cultured for a period of 48 hours. 80-90 percent-
confl uet cells were treated for 2 hours with vitamin C and APS. Peptidoglycan from 
Staphylococcus aureus was then added at a fi nal concentration of 0.1 mg/mL. Twenty-
four hours after the stimulation with peptidoglycan, the amount of each cytokine 
such as TNF-α, IL-1α, IL-8 in the culture supernatant fl uid was measured by ELISA 
and compared. While treated with vitamin C and APS, and twenty-four hours of a 
peptidoglycan stimulation, the production of TNF-α, IL-1α, and IL-8 were signifi cantly 
inhibited in the culture medium. The inhibitory effect was concentration-dependent 
of the sample in the range from 0.02mM to 2mM. This showed that vitamin C and APS 
have an in vitro anti-infl ammatory effect. According to some papers, the antioxidant 
effect of vitamin C inhibits the activation of transcription factor, NF-κB. The anti-
infl ammatory effect discussed in this study may also arise from antioxidant effect.
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Topical therapeutic effect of Korean red ginseng and its genuine constituents in an 
atopic dermatitis mouse model
Hei Sung Kim1, BJ Kim1, BK Kim2, SK Yoon2, JY Lee1, HO Kim1, YM Park1
1Department of Dermatology, Seoul St. Mary‘s Hospital, Seoul, Korea, Republic of, 
2Department of Biomedical Sciences, Research Institue of Molecular Genetics, The 
Catholic University of Korea, Seoul, Korea, Republic of
Ginseng (the root of Panax ginseng C.A. Meyer, family Araliaceae) possesses various 
biological activities, including anti-infl ammatory and anti-tumor actions. Korean 
red ginseng saponin fraction (KRGS) and its constituents, ginsenosides Rg3, Rf and 
Rg2 have been shown to potently inhibit mouse passive cutaneous anaphylaxis 
reaction induced by IgE. They also have anti-allergic properties, proved by the 
potent inhibition of β-hexosaminidase release from RBL-2HE cells induced by IgE 
with antigen. However, their effects on atopic dermatitis (AD) have not been studied 
yet. In this study, we induced atopic dermatitis (AD)-like skin lesions in NC/Nga 
mice by repeatedly applying 2-choloro-1,3,5-trinitrobenzene (TNCB). We then 
examined whether topical application of KRGS and its ginsenosides Rh2 and Rg3 
have active immune modulating effect in this AD animal model. The therapeutic 
effects of these agents were evaluated using clinical skin severity scores, histological 
changes in skin (epidermal thickness and mast cell infi ltration), cytokine (IL-4, TNF-a, 
IFN-r) expressions in skin and total serum IgE. 0.1% KRGS, 0.1% Rh2 and 0.1% 
Rh2 +0.1% Rg3 all potently suppressed mouse ear swelling and also signifi cantly 
reduced the mRNA expression of IL-4 and TNF-a compared with the TNCB control 
group (p< 0.05). Our results indicate that topical KRGS and its ginsenosides Rh2 and 
Rg3 have therapeutic potential as an effective and safe topical supplement for AD.
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Differential Regulation of Antimicrobial Peptides in Contact Dermatitis
Ulf Meyer-Hoffert, Julia Knoop, Stefanie Dressel, Jürgen Harder, Jochen Brasch, 
Regine Gläser University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany
Antimicrobial Peptides (AMP) are important effector molecules of the skin to protect 
the host from surrounding microorganisms. Their expression can be induced by 
various stimuli. Herein, we analysed the expression  of  AMP in contact dermatitis. 
Patients undergoing epicutaneous testing were included in this study (n=32). Contact 
dermatitis was induced by sensitization with ≥ one allergen in approximately 50% 
of these patients, all other patients served as controls. Skin washing fl uids were 
obtained during contact eczema. Secreted AMP were measured by established 
ELISA in the washing fl uids. In addition, colony-forming units (CFU) of bacteria 
were quantifi ed by plating a standardized amount of washing fl uid onto blood 
agar plates. The expression of AMP was further assessed by immunohistochemical 
staining in skin biopsies 72 hours after the contact eczema was induced. Psoriasin 
secretion was signifi cantly increased 72 hours after the contact eczema was induced; 
however, 24 hour occlusion per se induced psoriasin  expression at control sites. 
RNase 7 secretion did not increase after contact eczema was induced. Yet, RNase 7 
secretion was decreased 24 hours under occlusive conditions. Immunohistochemical 
analyses revealed an up-regulation of psoriasin and hBD-3 expression at sites of 
contact eczema, whereas RNase 7 and hBD-2 were not induced. The number of 
bacteria increased signifi cantly 24 hours under occlusive conditions and decreased 
to starting levels in contact eczema. In conclusion, psoriasin and hBD-3 in 
contrast to RNase 7 and hBD-2 are induced during contact dermatitis. Increased 
psoriasin expression might be caused by occlusion and not by allergic reaction.
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Interferon alpha enhances IL-22 receptor expression on epidermal keratinocytes
Mikiko Tohyama, Lujun Yang, Teruko Tsuda, Saori Miyawaki, Yuji Shirakata, Koji 
Sayama, Koji Hashimoto Ehime Univ Graduate School of Medicine, Ehime, Japan
It has been noted that interferon alpha (IFN-α) often exacerbates psoriasis. Moreover, 
recent reports demonstrated that plasmacytoid dendritic cells, principal IFN-
α-producing cells, infi ltrate into the psoriatic lesions in the early phase.  These 
fi ndings indicate that IFN-α plays a pathogenetic role in the development of 
psoriasis.  However, the role of IFN-α in psoriasis has not been fully elucidated. 
We recently reported that IL-22 receptor (IL-22R) expression is enhanced in 
the epidermis of psoriatic lesion.  The increase of IL-22R enhances the function 
of IL-22, which is one of the most important cytokines in the pathogenesis of 
psoriasis.  Therefore, we examined whether IFN-αmediates the expression of IL-
22R. The IL-22R expression in epidermal keratinocytes was examined using living 
skin equivalent model (LSE). An LSE is constructed by stratifi ed and air-lifted 
keratinocytes on collagen gel containing fi broblasts. Interestingly, IFN-α signifi cantly 
enhanced IL-22R mRNA expression in the epidermal keratinocytes of LSE four 
hours after stimulation in a dose-dependent manner.  The increase of IL-22R 
expression on cell membrane was confi rmed by immunostaining and by fl ow 
cytometry analysis.  Finally, STAT3 phosphorylation of epidermal keratinocytes 
was enhanced, when LSE pre-treated with IFN-α was stimulated by IL-22. These 
fi ndings suggest that IFN-α participates in the development of psoriasis by enhancing 
epidermal keratinocyte responsiveness to IL-22 via increase of IL-22R expression.
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Towards a better understanding of paraneoplastic pemphigus pathogenesis : 
identifi cation of the p170 antigen recognized by PNP autoantibodies.
Isabelle Schepens, Fabienne Jaunin, Nadja Begré, Ursula Läderrach, Katrin Markus, 
Takashi Hashimoto, Bertrand Favre, Luca Borradori Berne University, Inselspital, 
Berne, Switzerland
Paraneoplastic pemphigus (PNP) is a devastating autoimmune blistering disease, 
involving mucocutaneous and internal organs, and associated with underlying 
neoplasms. PNP is characterized by the production of autoantibodies targeting 
proteins of the plakin and cadherin families involved in maintenance of cell 
architecture and tissue cohesion. Nevertheless, the identity of an antigen of 
Mr 170,000 (p170), thought to be critical in PNP pathogenesis, has remained 
unknown. Using an immunoprecipitation and mass spectrometry based approach, 
we identifi ed a candidate protein (CP) as p170. We assess that p170 is CP, based 
on several lines of evidence : 1) the tryptic mass profi le of the immunoprecipitated 
p170 has a signifi cant match with that expected for CP; 2) p170 is recognized 
by anti-CP antibodies and can be immunoprecipitated from culture media of 
human keratinocytes, in the same manner as CP; 3) PNP sera immunoprecipitate 
recombinant CP from cell extracts, whereas binding to CP was never observed with 
sera obtained from normal volunteers as well as patients with autoimmune bullous 
diseases of the skin; 4) pre-incubation of p170-reactive PNP sera with recombinant 
CP selectively abrogated reactivity of the PNP sera with p170 by immunoblot or 
immunoprecipitation, as well as the labelling of the epidermal granular cell layers, 
where CP is predominantly expressed. Our study unravels CP, a non structural 
protein expressed in stratifi ed epithelia and other tissues as a new class of target 
antigens in this paraneoplastic autoimmune multiorgan syndrome and opens a new 
challenging investigation avenue for a better understanding of PNP pathogenesis.
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 S6 Journal of Investigative Dermatology (2010), Volume 130 
031
Time-dependent increase in growth associated protein (GAP)-43 immunoreactive 
nerve fi bres in allergic contact dermatitis
Husameldin El-Nour Karolinska Institutet, Stockholm, Sweden
Our aim was to investigate the expression of the axonal growth marker, growth 
associated protein (GAP)-43, in skin biopsies from nickel-allergic patients (n= 10) 
obtained at different time points (0, 6, 24, 48, and 72 h) after challenge with nickel 
sulphate.The skin biopsies were fi xed in a mixture of 4% formalin with 0.2% picric 
acid and rinsed in 0.1 M phosphate buffer containing 10% sucrose for at least 24 h, 
before being cut into 14 µm thick sections and stained using immunohistochemistry 
and a streptavidin-biotin technique. The total (epidermis+dermis) numbers of GAP-
43 immunoreactive nerve fi bres were found to be increased (p<0.05) in a time-
dependent manner from 28 (median) fi bres/section recorded at 0 h, to 43, 57, 
64 and 89 fi bres/section recorded at 6, 24, 48 and 72 h, respectively. Also when 
counting the immunoreactive nerves in individual layers of the skin, epidermal 
GAP-43 positive nerve fi bres were noted to be higher (p<0.01) at 48 h (45 fi bres/
section) and 72 h (72 fi bres/section), compared to 0 and 6 h (medians 14 and 23, 
respectively). At 24 h the median for epidermal GAP-43 labeled nerves was 34. 
Individual counting of the dermal GAP-43 immunoreactive nerve fi bres also revealed 
a time dependent increase (p<0.01) in the number of these fi bres particularly when 
comparing 0 h with 48 and 72 h. Our fi ndings suggest the contribution of re-
generating nerves to allergic contact dermatitis during the kinetics of infl ammation.
032
Fli1 expression is epigenetically suppressed in dermal fi broblast and endothelium 
in systemic sclerosis
Hiroshi Fujiwara, Masaaki Ito Niigata University, Niigata, Japan
Fli1 is a physiological negative regulator of collagen gene expression in dermal 
fi broblast. The reduced expression of Fli1 was reported in systemic sclerosis 
(SS) fi broblast. In the study of cultured fi broblast, gene promoter methylation 
of Fli1 was related to reduced expression of Fli1 and to overexpression of type 1 
collagen. Herein we demonstrate that Fli1 promoter was specifi cally methylated in 
dermal fi broblast and endothelium in SS with in situ study. Fli1 protein expression 
was reduced in dermal fi broblast and endothelium in SS disclosed with anti-Fli1 
antibody stain. The reduction was more pronounced in sclerotic SS than in atrophic 
SS. mRNA in situ hybridization revealed reduced transcription of Fli1 in those 
cells, but not in other cell types, e.g. adipocyte, arector pili myocyte. When RT-
PCR for Fli1 was performed on whole tissue extract, no difference was observed 
among sclerotic and atrophic stage SS, and control. Methylation specifi c PCR on 
bisulfi te-treated DNA extracted from whole tissue revealed that Fli1 promoter was 
partly methylated. In order to disclose which cell’s Fli1 promoter was specifi cally 
methylated, we performed methylation detection with in situ hybridization (MDISH). 
MDISH revealed that Fli1 promoter was specifi cally methylated in dermal fi broblast 
and endothelium, but not in other cell types, e.g.  adipocyte, arector pili myocyte. 
The mechanism of the cell-type specifi c DNA methylation remains to be elucidated.
033
Mouse model with bi-phasic skin-reaction induced by trimellitic anhydride closely 
refl ects atopic dermatitis and the profi le of some compounds which attenuated the 
late phase reaction
Mari Nogami-Itoh, Tomoya Shiro, Masashi Takeda, Michinori Ozawa
Drug Research Division, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Osaka, Japan
Atopic dermatitis is a common, chronic, relapsing infl ammatory skin disease 
frequently affecting infants and children. Due to the steadily increasing incidence, 
especially in children, there is a high medical need for new therapies as well as 
improved animal models. In this study, we developed a new mouse model by 
repeated treatment with Trimellitic anhydride, and investigated the suitability as an 
atopic dermatitis model for the prediction of the treatment effi cacy. We studied the 
profi le of the model and demonstrated that it showed bi-phasic skin reaction with 
marked infi ltration of infl ammatory cells and histological changes of the infl amed 
skin. The late-phase reaction observed 8-hours after the evocation was mediated by 
T cells as well as mast cells. We also tested the effect of various anti-allergic agents 
and found that only prednisolone suppressed the late-phase reaction in contrast 
the immediate-phase was suppressed by anti-histamines. These fi ndings gathering 
with the results of cytokine profi le and increased serum IgE levels indicated that 
our model closely refl ects disease characteristics. Besides the characterization 
of the models, we also tested some newly synthesized compounds on this model 
and found one that showed strong inhibition of late-phase reaction even treated 
after evocation. In summary, we present an improved mouse model for atopic 
dermatitis suggesting possession of the predictive power for therapeutic treatment.
034
Tape-stripping -induced psoriasis is associated with mast cell IL-6 and appearance of 
dermal cells showing IL-33 and IL-6 receptor
Mireille-Maria Suttle1, Gunnar Nilsson1,2, Erna Snellman1,3, Ilkka T. Harvima1
1Department of Dermatology, University of Eastern Finland, Kuopio, Finland, 
2Department of Internal Medicine, Karolinska Instituted, Stockholm, Sweden, 
3Department of Dermatology, University of Tampere, Tampere, Finland
Degranulation of mast cells is among the earliest changes during the development of 
psoriatic lesion, and activated mast cells can release a wide range of proinfl ammatory 
cytokines, e.g. IL-6 and TNF-α. To study expression of IL-6 in mast cells and changes 
in cells positive for IL-6 receptor (IL-6R, CD126) and IL-33 (a known inducer of 
IL-6 in mast cells), the nonlesional skin of 18 psoriatic patients was tape-stripped, 
the Köbner reaction was induced in 8 patients as judged at the 2-3 week follow-
up, and skin biopsies were collected before the tape-stripping and at time points 
2h and 3d or at 1d and 7d for immunohistochemical and double-staining analyses. 
The PASI score and total mast cell numbers did not differ between Köbner-positive 
and -negative groups. In contrast, the percentage of mast cells showing IL-6 was 
about 1.5-fold higher in all time-point biopsies in the Köbner-positive than in the 
Köbner-negative subjects, even in the untreated skin. The total number of IL-6R+  cells 
increased in the upper dermis in the Köbner-positive group at 3-7 days. However, 
the cells increased even more in the Köbner-negative group, a change possibly 
related to Foxp3+ cells. Similarly, dermal IL-33+ cells increased in number in the 
Köbner-positive group at 3-7 days, but did not so in the Köbner-negative group. 
In summary, mast cell IL-6 is associated with the lesion induction already in the 
untreated nonlesional skin and thereafter both IL-6R+ and IL-33+ cells increase at 
3-7 days. This suggests a new “vicious circle” in the early psoriatic pathogenesis.
035
Familial Japanese fever (Nakajo-Nishimura syndrome): a novel autoinfl ammatory 
syndrome with periodic fever, skin eruptions and partial lipodystrophy
Nobuo Kanazawa1, Fukumi Furukawa1, Masahiro Matsunaka1, Hirotoshi Sugino2, Koh-
ichiro Yoshiura3, Hiroaki Ida4 1Dept of Dermatology, Wakayama Medical University, 
Japan, 2Sugino Pediatric Clinic, Hiroshima, Japan, 3Dept of Human Genetics, Nagasaki 
University Graduate School of Biomedical Sciences, Japan, 4Department of Medicine, 
Kurume University School of Medicine, Kurume, Japan
There is a distinct disease reported fi rst by Nakajo in 1939 and second by Nishimura et al in 
1950, both written in Japanese, and further by Kitano et al in 1975 as “a syndrome with nodular 
erythema, elongated and thickened fi ngers, and emaciation” in the Archives of Dermatology. 
Only about 20 cases have been reported exclusively in Japan, however, the disease is registered 
in databases for rare inheritable diseases as Nakajo syndrome (MIM256040) or Nakajo-
Nishimura syndrome (ORPHA2615). This disease seems to be autosomal-recessively inherited, 
because of frequent parental consanguinity and appearance in sibships. It begins with pernio-
like eruptions in early-infancy getting worse in winter. Some patients periodically develop high 
fever, nodular erythemas and myositis. Lipomusculoatrophy, without signifi cant power loss, and 
joint contracture gradually progress mainly in upper part of the body forming the characteristic 
thin facial appearance and elongated clubbed fi ngers. Infl ammatory changes, such as high serum 
CRP and hyper-g-globulinemia are observed without appearance of distinct autoantibodies. 
Skin biopsy shows infi ltration of infl ammatory cells in whole dermis and subcutaneous tissue 
with vasculopathy. Calcifi cation of basal ganglia is revealed by head CT scanning. Notably, 
most cases were concentrated in Kansai and Tohoku areas of Japan, including Wakayama 
prefecture. Here we report the summary of 12 cases experienced in our Department. Among 
them, 9 cases were accompanied with periodic fever. Based on our observations, we propose 
to designate the disease as “familial Japanese fever”, in contrast with familial Mediterranean 
fever, a distinct entity of hereditary autoinfl ammatory syndrome discovered in Japan.
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Autoantibodies from patients with bullous pemphigoid cross-react with murine 
collagen XVII/BP180, but do not activate murine complement and granulocytes
Alina Sesarman1, Eva Oswald1,2, Mircea T. Chiriac3, Kinga Csorba1,2, 
Vlad Vuta1, Vasile Feldrihan1, Leena Bruckner-Tuderman1, Cassian Sitaru1
1Department of Dermatology, University of Freiburg, Germany, 2Faculty of Biology, 
University of Freiburg, Germany, 3Institute for Experimental Research in Bio-Nano-
Sciences, Molecular Biology Center, Babes-Bolyai University, Cluj-Napoca, Romania
Bullous pemphigoid (BP) is an autoimmune disease characterized by the production of autoantibodies 
against two hemidesmosomal proteins BP230 and BP180. A major limitation for reproducing the 
disease by transferring patients‘ autoantibodies into mice has been attributed to a lack of pathogenic 
autoantibody cross-reactivity with murine BP180. Thus, several animal models were developed 
using the passive transfer of antibodies generated against the murine autoantigens or by the use of 
patients‘ autoantibodies in mice expressing human BP180. However, these models do not reproduce 
all main features of the human disease. Interestingly, in silico mapping of B cell epitopes shows partly 
overlapping antigenic determinants in the murine compared with the human antigen. Therefore, in 
this study we analyzed the cross-reactivity of BP patients‘ autoantibodies with the murine skin. We 
show, that IgG autoantibodies from 17 of 25 BP sera (68%) and, importantly, BP autoantibodies 
purifi ed against the immunodominat domain of BP180 stained the murine skin by indirect 
immunofl uorescence microscopy. When injected into neonatal mice (n=6), BP autoantibodies 
bound to the epidermal basement membrane, but failed to activate murine complement and 
to induce subepidermal blisters. These fi ndings were confi rmed ex vivo by a lower ability of BP 
autoantibodies to fi x murine compared with human complement and a reduced ability to activate 
murine granulocytes when compared with human cells. In addition to providing essential mechanistic 
insights into the experimental models of pemphigoids, these fi ndings have broad implications for 
pathogenetic studies and for the development of more specifi c therapies of autoimmune diseases.
 www.jidonline.org S7 
ABSTRACTS
037
Different expression patterns of podoplanin in psoriasis, atopic dermatitis and 
lichen ruber
Martin Ullmann, Ute Wering, Tanja Schüler, Leena Bruckner-Tuderman, Vivien Schacht
University Medical Center Freiburg, Freiburg, Germany
The 38 kDa glycoprotein podoplanin is expressed in lymphatic endothelial cells 
and keratinocytes. Our previous studies showed that podoplanin defi ciency results 
in congenital lymphedema. However, its biological function has remained mainly 
unknown. In the present study we investigated the podoplanin expression pattern in 
infl ammatory skin diseases such as psoriasis, atopic dermatitis and lichen ruber for 
deduction of possible regulatory mechanisms podoplanin is involved in. Thirty tissue 
samples of patients suffering from psoriasis vulgaris, atopic dermatitis and lichen ruber 
were collected. Non affected skin of safety margins after excision of malignant tumors 
was used as a control. The mouse monoclonal anti-human D2-40 and the rat monoclonal 
Ki67 antibodies were used for immunohistochemical stainings of paraffi n embedded 
tissue sections. A positive immunoreaction product for podoplanin was found in 53% 
(16/30) of the psoriasis patients in the basal keratinocytes along the basal membrane. 77 % 
(23/30) tissue samples showed podoplanin expression in the suprapapillary 
plates, whereas this staining pattern was not found in the control skin. Podoplanin 
positive lymphatic endothelial cells highlighted elongated and dilated lymphatic 
capillaries in the dermal papillae of all tissue samples from psoriasis patients and 
all patients suffering from atopic dermatitis. However, elongated lymphatics in 
sections showing lichen ruber were restricted to areas occupied by an infl ammatory 
infi ltrate of lymphocytes. Coexpression of podoplanin and Ki67 was only seen 
in a few basal keratinocytes in all stained tissue sections. In conclusion, we found 
different podoplanin expression patterns in infl ammatory skin diseases suggesting 
different immunological regulatory mechanisms podoplanin is involved in.
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FcgammaRIV Promotes, while FcgammaRIIB Protects from Autoantibody-induced 
Tissue Damage in Autoimmunity to Type VII Collagen
Michael Kasperkiewicz1, Sabina Wende1, Falk Nimmerjahn2, Misa Hirose1, Kathrin 
Kalies3, Enno Schmidt1, Jürgen Westermann3, Jörg Köhl4,5, Detlef Zillikens1, Ralf J. 
Ludwig1 1Dept of Dermatology, Univ of Lübeck, Germany, 2Lab of Exp Immunol & 
Immunotherapy, Nikolaus-Fiebiger Centre for Molec Medicine, Univ of Erlangen-
Nuremberg, Germany, 3Inst of Anatomy, Univ of Lübeck, Germany, 4Inst for Systemic 
Infl ammation Research, Univ of Lübeck, Germany, 5Div of Molecular Immunol, 
Cincinnati Children‘s Hosp Med Center & Univ of Cincinnati College of Med, USA
Epidermolysis bullosa acquisita (EBA) is an autoimmune bullous disease mediated by 
autoantibodies against type VII collagen, the major component of anchoring fibrils of 
the dermal-epidermal junction. When passively transferred into mice, rabbit IgG against 
type VII collagen induces Fc-dependent activation of complement, the recruitment 
of leucocytes into the skin, and subepidermal blistering. Since co-expression of 
activating and inhibitory Fc gamma receptors (FcgammaRs) is believed to represent an 
immunoregulatory checkpoint by establishing a threshold for immune cell activation, we 
determined the role of different FcgammaRs in experimental EBA using knock out mice 
or function blocking antibodies. Mice lacking the common gamma chain of activating 
FcgammaRs were completely resistant to experimental EBA induction. Regarding 
the contribution of the 3 known activating FcgammaRs, inhibition of FcgammaRIV 
led to an almost complete protection from EBA induction, while FcgammaRI and 
FcgammaRIII deficiency had no or little effect on disease, respectively. In contrast, 
deficiency of inhibitory FcgammaRIIB led to an over 2-fold enhanced disease severity. 
We also observed that induction of EBA altered the ratio of expression of inhibitory and 
activating FcgammaRs towards the activating FcgammaRIV. Our observations suggest 
targeting of FcgammaRIV and FcgammaRIIB as potential therapeutic options in EBA.
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The sebocyte-own corticotropin-releasing hormone system is an amplifi er of 
infl ammation
Christos C. Zouboulis1, Ruta Ganceviciene2, Katharina Krause1, Silvia Angres1, Sabine 
Fimmel3, Stefan R. Bornstein4 1Depts of Dermatology, Venereology, Allergology & 
Immunology, Dessau Med Ctr, Germany, 2Ctr of Dermatovenereol, Vilnius University 
Hospital, Lithuania, 3Lab for Biogerontology, Insti of Clinical Pharmacol & Toxicology, 
Charité Univ Berlin, Germany, 4Dept of Internal Medicine, Univ of Dresden, Germany
Activation of the hypothalamic-pituitary-adrenal axis, which is the main adaptive response to 
chronic systemic stress, requires production of corticotropin-releasing hormone (CRH). CRH has 
also been detected in peripheral tissues, including the skin. Human sebaceous glands and cultured 
human SZ95 sebocytes express CRH, CRH-binding protein (CRH-BP) and CRH receptors (CRH-R) 
1 and 2 at the mRNA and protein levels as we have shown by RT-PCR and immunohisto- and 
immunocytochemistry. CRH and urocortin, a peptide which shares a 45% homology with CRH, 
inhibit SZ95 sebocyte proliferation, which can be restored by α-helical-CRF, a CRH antagonist. 
CRH upregulates 3β-hydroxysteroid dehydrogenase/Δ5-4 isomerase mRNA levels and testosterone 
accordingly downregulates CRH-R1 and CRH-R2 mRNA expression in a negative feedback manner. 
Moreover, CRH enhances the basal synthesis, while antalarmin, a non-peptidic selective CRH-R1 
antagonist, reduces the increased production of neutral lipids in SZ95 sebocytes. CRH also stimulates 
interleukin (IL)-6 and IL-8 release from SZ95 sebocytes but has no effect on IL-1α and IL-1β production 
or the IL1β-induced IL-8 release in these cells. Infl ammation, such as acne, and proinfl ammatory 
signalling, such as UVB or the bacterial antigen MALP-2 amplify intracellular CRH levels, while 
dexamethasone inhibits the intracellular CRH synthesis in SZ95 sebocytes. No CRH release could 
be detected; CRH-BP expression was amplifi ed in differentiating sebocytes of acne-involved skin. In 
conclusion, infl ammatory signals can enhance intracellular CRH levels in human sebocytes leading 
to CRH-R1-associated lipogenesis and amplifi cation of infl ammation by secretion of proinfl ammatory 
cytokines. These events are sensitive to dexamethasone or specifi c CRH-R1 antagonists.
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Enhanced NF-κB activation with NLRP3 activator correlates with disease activities 
in cryopyrin-associated periodic syndrome
Takashi Satoh, Naotomo Kambe, Hiroyuki Matsue Chiba University, Chiba, Japan
Cryopyrin-associated periodic syndrome (CAPS) is known as an autoinfl ammatory 
disease associated with mutations in NLRP3 and clinically characterized by urticarial 
rash. More than 50 mutations have been identifi ed and most of them locate in exon 
3. Those mutants induce spontaneous ASC-dependent NF-κB activation, that was 
associated with disease activities of the patients: e.g. an R260W mutant of NLRP3, 
which was identifi ed in milder subtype of CAPS, showed lower NF-κB activation 
potential , whereas Y570C identifi ed in the most severe cases with brain atrophy 
and episodes of epilepsy showed the strongest NF-κB activity. However, G755R 
located in exon 4 does not show spontaneous NF-κB activation, even though her 
clinical symptom is quite severe. To explore the discrepancy in a G755R mutant, 3 
reported mutants outside exon 3 (G755R, G755A and Y859C) were cloned. G755A 
was identifi ed in a typical CAPS patient. A patient with Y859C had only 1 episode of a 
transient rash and was noteworthy for the absence of fever. In the presence of R837, an 
NLRP3-infl ammasome activator, a G755R mutant showed remarkably enhanced NF-
κB activation comparable with Y570C, which level was higher than that of R260W. 
For 2 other mutations located outside exon 3, G755A showed slightly increased NF-
κB activation with R837, but not Y859C. Thus, the enhanced NF-κB activation after 
stimulation with R837 correlates with disease activities, including mutations outside 
exon 3. We believe that, in addition to an excess production of IL-1β, enhanced NF-
κB activation may contribute to disease-onset and the clinical manifestations of CAPS.
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Impaired hapten sensitization in patients with autoimmune disease. Results from an 
experimental sensitization study.
Nannie Bangsgaard1, Kåre Engkilde2, Marianne Løvendorf1, Torkil Menné1, Jørgen 
Olsen3, Lone Skov1 1Dept of Dermato-Allergology, Univ Hospital of Copenhagen 
Gentofte, Hellerup, Denmark, 2National Allergy Res Centre, Dept of Derm-Allergol, 
Univ Hosp Copenhagen Gentofte, Hellerup, Denmark, 3Dept of Cell & Molec Med, 
Univ Copenhagen, Denmark
An inverse relation between contact allergy and autoimmune diseases has been suggested from 
epidemiological studies. The relation has not been investigated experimentally and the immunological 
mechanisms are unknown. We demonstrate in a controlled experimental sensitization study impaired 
senisitization to a strong hapten Diphenylcyclopropenone among 23 patients with psoriasis and 22 
patients with diabetes type I compared to 23 healthy controls. Sensitization ratios were signifi cantly 
lower in the psoriatic and diabetic groups 26 % and 36 % respectively compared to the healthy 
group 65%.  Odds ratio for a patient with psoriasis or diabetes type I to become sensitized was 
0.18 (95% CI 0.039 - 0.85) and 0.74 (95% CI 0.55 - 1.01) respectively. To investigate the possibility 
of active immunological down-regulation in the elicitation phase, mRNA was extracted from skin 
biopsies from challenge sites and gene expression profi les analysed with microarray technology. 
No difference in mRNA expression profi les were found between the groups, when comparing 
responders and non-responders individually. Furthermore no specifi c mRNA expression was found 
in the challenged skin of non-responders, indicating that non-respondence was not due to an 
active down-regulation. Collectively the results demonstrate impaired hapten sensitization among 
patients with two different autoimmune diseases and suggest that the immunological background 
for this is not to be found in the elicitation but more likely in the induction phase. The highly Th17 
directed cytokine milieu of autoimmune patients may interfere with the differentiation of naïve T 
cells necessary for the contact allergic reaction; however, further studies are needed to clarify this.
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Endocytosis of desmoglein 1, plakoglobin and IgG in skin of pemphigus foliaceous 
patients
Dyah A.M. Oktarina, Duco Kramer, Marcel F. Jonkman, Hendri H. Pas
Center for Blistering Diseases, Department of Dermatology, University Medical Center 
Groningen, University of Groningen, Groningen, Netherlands
Pemphigus foliaceous (PF) is one of the two main forms of pemphigus and is 
characterized by circulating IgG to the desmosomal cadherin desmoglein (Dsg) 1 
and subcorneal blistering of the skin. Previously we have shown that PF IgG induces 
aggregation of Dsg1, plakoglobin (PG) and IgG outside of desmosomes, visualized 
in immunofl uorescence of PF patient skin as a granular IgG deposition pattern with 
few coarse IgG aggregates per cell. Older immunoelectron microscopic studies have 
suggested that in PF skin endocytosis of desmosomes takes place. The purpose of the 
present study was to verify this endocytosis and, if present, to investigate its relation 
with the IgG aggregates. We performed double immunofl uorescence staining on 
10 skin biopsies of six PF patients for IgG, Dsg1 and 3, desmocollin 1 and 3, PG, 
desmoplakin, plakophilin 3, and early endosomal marker 1 (EEA1). EEA1 did not 
colocalize with the IgG aggregates in the basal and suprabasal layers but did contact 
them in the upper spinous layers. In these same keratinocytes, endosomes were present 
in the cytoplasm and contained IgG, Dsg1 and PG but not other cadherins or plaque 
components. Endocytosis was present in lesional skin but not in non-lesional skin, 
situating it at a later stage in the pathogenesis. Our results confi rm that endocytosis of 
IgG bound components occurs in PF patient skin. Based on the molecular composition 
of the endosomal cargo we conclude that these endosomes do not take up complete 
desmosomes but instead clear the IgG/Dsg1/PG aggregates from the cell membrane.
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The involvement of miR-203 in NF-κB signalling
Tianling Wei, Enikö Sonkoly, Andor Pivarcsi, Mona Ståhle Karolinska Institutet, 
Stockholm, Sweden
MicroRNAs are small, non-coding RNAs that regulate gene expression post-transcriptionally 
and play important roles in various biological processes. We previously identifi ed miR-203 
as a skin- and keratinocyte-specifi c microRNA that regulates keratinocyte differentiation. 
NF-κB plays a central role in skin morphogenesis and homeostasis. Perturbation in its 
activity has been linked to developmental skin defects, infl ammatory skin diseases and 
skin cancer. Using Human Signal Transduction Pathway Finder PCR Array, we found that 
overexpression of miR-203 in primary keratinocytes by transfection of a synthetic miR-
203 precursor regulated several genes in the NF-κB pathway. Quantitative PCR analysis 
of NF-κB downstream genes in keratinocytes overexpressing miR-203 showed that 
IL-8, CCL-20 and IL-1α were suppressed by miR-203. In order to explore whether miR-
203 modulates NF-κB activation also in stimulated cells, we overexpressed miR-203 in 
primary keratinocytes followed by treatment with TNF-α and TPA, well-known activators 
of the NF-κB pathway in keratinocytes. IL-8, CCL-20 and IL-1α were induced in stimulated 
keratinocytes and this induction was signifi cantly suppressed by miR-203. To further 
investigate the role of miR-203 in regulating NF-κB signalling, we used bioinformatic 
tools to predict the potential target genes of miR-203 involved in NF-κB signalling 
pathways. We identifi ed IL-8 as one of potential direct targets for post-transcriptional 
suppression by miR-203. In keratinocytes overexpressing miR-203, IL-8 protein production 
was signifi cantly suppressed in culture supernatants, as determined by ELISA. Taken 
together, miR-203 suppresses several genes involved in NF-κB signalling, suggesting 
a potential role for miR-203 in keeping skin homeostasis and controlling infl ammation.
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The protein kinase C inhibitor sotrastaurin inhibits the chemokine CCL20 in primary 
human fi broblasts in vitro
Barbara Wolff-Winiski, Nicole Schöfmann, Gerda Herzig Novartis Institutes for 
BioMedical Research, Dermatology, Vienna, Austria
Sotrastaurin is a potent and selective inhibitor of the protein kinase C (PKC) isoforms 
θ, α and β, with lesser activity on PKCδ, ε and η. It has shown a clinical effect and 
histological improvement of skin lesions in a 2-week study in psoriasis patients. In 
addition to inhibiting T cell proliferation and cytokine release by T cells, sotrastaurin 
also has an effect on keratinocytes and macrophages in vitro. In the present study, we 
investigated the effect of sotrastaurin on cytokine and chemokine production, as well 
as proliferation, in primary human dermal fi broblasts (HDF). Cells were stimulated 
in microtiter plates in the presence or absence of graded compound concentrations 
with different proinfl ammatory stimuli alone or in combination (TNF-α, IFN-γ, IL-17, 
IL-1ß). After 24 hours, IL-6, IL-8, CCL2, CCL5, CCL20 and CXCL10 were measured 
in the supernatants by ELISA. In unstimulated cells treated with sotrastaurin, 
proliferation was determined after 72 hours by staining of cellular protein. Regardless 
of the stimulation conditions, sotrastaurin potently inhibited CCL20 secretion at 
clinically achievable skin concentrations (IC50 0.1 - 0.5µM). CCL5 was inhibited only 
at micromolar concentrations, while IL-6, IL-8, CCL2 and CXCL10 were unaffected 
by sotrastaurin. Concentrations up to 10µM were not cytotoxic to HDF. The present 
study indicates that sotrastaurin, in addition to its immune modulatory properties has 
very selective effects on cytokine production in fi broblasts, suppressing the chemokine 
CCL20, which may thus inhibit recruitment of T cells to lesional psoriatic skin.
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GED507L a new PPARγ agonist inhibits the infl ammatory response in human skin 
and PBMCs: perspectives for the treatment of psoriasis
Arianna Mastrofrancesco1, Daniela Kovacs1, Giorgia Cardinali1, Nicaela Aspite1, 
Monica Ottaviani1, Francesca Viti2, Giammaria Giuliani2, Emanuela Camera1, Mauro 
Picardo1 1San Gallicano Dermatological Institute (IRCCS), Rome, Italy, 2Giuliani Spa, 
Milan, Italy
Activation of peroxisome proliferator-activated receptors (PPARs) by corresponding 
ligands has been shown to regulate important functions in skin including proliferation 
and differentiation, as well as infl ammatory responses. PPARγ is the PPARs members 
that antagonizes infl ammatory signalling by interference with the NF-kB activation. 
Agonizing PPARγ pathway with pharmacological ligands has shown to be benefi cial in the 
amelioration of symptoms in psoriasis. However, some studies have reported their notable 
cytotoxicity limiting their application. A novel class of PPARγ agonist has been designed to 
increase specifi city of the ligand-receptor interaction associated with a low cytotoxicity. 
We investigated the effects of GED507L (0,01-0,5 mM) exerted on infl ammatory response 
in: i) TNF-α-stimulated normal human primary keratinocytes (NHKs); ii) LPS-stimulated 
peripheral blood mononuclear cells (PBMCs) from psoriatic patients and healthy controls; 
iii) biopsies collected from plaque type psoriatic subjects. Our results demonstrated that 
GED507L signifi cantly suppressed the expression of TNF-α, IL-6 and IL-8 induced by 
TNF-α at mRNA and protein levels in NHKs. GED507L infl uenced the NF-kB pathway 
by decreasing TNF-α-mediated cytoplasmic degradation of IkBα and by reducing nuclear 
accumulation of p65 subunit through PPARγ activation. The molecule inhibited the 
induction of the infl ammatory keratin K6 up-regulated in psoriatic skin. In adddition we 
found a modulatory effect of GED507L on the release of TNF α, IL-12, IL-21 and IL-23 in skin 
biopsies and in LPS-stimulated PBMCs Our data demonstrated a strong anti-infl ammatory 
activity of GED507L and suggested its possible role in the treatment of psoriasis.
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The role of a novel PPARg agonist (GMG-43AC) in the control of sebogenesis and 
infl ammatory processes: prospective for an innovating treatment of acne
Monica Ottaviani1, Arianna Mastrofrancesco1, Daniela Kovacs1, Matteo Ludovici1, 
Christos C Zouboulis2, Giammaria Giuliani3, Emanuela Camera1, Mauro Picardo1
1San Gallicano Dermatological Institute (IRCCS), Rome, Italy, 2Dessau Medical Center, 
Dessau, Germany, 3Giuliani Spa, Milan, Italy
Increased sebum production and infl ammation are accounted amongst the major 
factors involved in the pathogenesis of acne. A growing body of evidence indicates that 
peroxisome proliferators-activated receptor gamma (PPARg), one of the three PPARs 
isoforms, offers a promising target for the treatment of acne. PPARg controls lipogenesis 
in sebaceous gland cells and exerts anti-infl ammatory activities in various cell types 
by inhibiting the expression of pro-infl ammatory mediators, such as cytokines. We 
have investigated the capacity of a newly designed PPARg agonist (GMG-43AC) to 
exert anti-infl ammatory and sebum regulating effects. To this end human primary 
keratinocytes (NHKs) were challenged with oxidative and biological stimuli such as 
hydrogen peroxide (H2O2) and LPS to induce pro-infl ammatory cytokines expression. 
GMG-43AC inhibited signifi cantly and dose-dependently the induction of TNFa and 
IL-6 at mRNA and protein levels in the non toxic interval of concentrations 10-500 
µM. GMG-43AC at the same concentrations induced PPARg mRNA expression. The 
modulation of lipid synthesis by GMG-43AC was evaluated in SZ95 stimulated with 
the combination linoleic acid/testosterone.  In SZ95 the increased PPARg mRNA 
expression by 1 mM GMG-43AC was associated with a signifi cant reduction of the 
sebaceous lipids synthesis, as demonstrated with the assay of Nile Red incorporated 
into neutral lipids and by gas chromatography-mass spectrometry analysis. 
These results highlighted the ability of GMG-43AC to counteract infl ammation 
and induced sebogenesis making it a potential new drug in the therapy of acne.
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Myeloid cells, and not T cells, are the main source of TNF-a in plaque-type psoriasis
Patrick Brunner, Frieder Koszik, Madeleine Kalb, Irene Klein, Georg Stingl
Medical University Vienna, Vienna, Austria
The spectrum of tumor necrosis factor (TNF)-a-producing cells is not clearly defi ned 
in psoriasis. The elucidation of this question should allow us to better understand the 
mode of action, effi cacy and, perhaps, also the risks of an anti-psoriatic therapy with 
TNF-a-antagonists. Using conventional immunofl uorescence methods, we were not 
able to detect TNF-a in sections of lesional psoriatic skin, but by the application of 
a tyramide amplifi cation system we obtained reproducible and fi rm stainings.TNF-a 
was exclusively found on dermal leukocytes coexpressing CD11c and HLA-DR and, 
to a lesser extent, CD163. This marker profi le is consistent with that of mDCs and 
macrophages. Consistently, we found corresponding populations of TNF-a-producing 
mDCs and monocytes in unstimulated PBMCs of psoriatic patients. More importantly, 
their number closely correlated with disease activity. These myeloid PBMCs expressed 
CCR2, whose ligands CCL2, CCL7 and CCL11 were strongly upregulated in lesional 
psoriatic skin. In healthy persons, anti-TNF-a-stainings of skin and blood yielded 
essentially negative results. In vitro, we confi rmed that TNF-a-antagonists are able to 
induce apoptosis in, as well as complement killing and antibody-dependent cellular 
cytotoxicity of TNF-a producing cell lines. In vivo, infl iximab therapy reduced the 
number of TNF-a-producing cells in the peripheral blood of psoriatic patients 24 
hours after administration.Our data strongly suggest that myeloid cells (dendritic 
cells, monocytes/macrophages) are the main source of TNF-a in stable plaque-type 
psoriasis. This highlights the importance of these cells in disease pathogenesis.
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ROS-induced Activating Transcription Factor 3 (ATF3) Generates Solid Protection 
against Bacterial Endotoxins but Causes Severe, Interleukin 6-dependent 
Susceptibility to Bacterial Infections
Wolfram Hoetzenecker1, Bernd Echtenacher2, Florian Woelbing1, Emmanuella 
Guenova1, Juergen Brueck1, Ivana Glocova1, Tilo Biedermann1, Kamran Ghoreschi1, 
Martin Röcken1 1Dept of Dermatology, Tübingen, Germany, 2Dept of Immunology, 
Regensburg, Germany
Systemic bacterial infections such as cellulitis generate severe oxidative stress and may result in 
severe shock. Fever and toxic symptoms result from TLR-signals like lipopolisacharide (LPS) that 
cause an infl ammatory cytokine release syndrome. As activation of the negative transcription factor 
ATF3 provides protection against innate immune activation by LPS and LPS-induced death. ATF3 
initiates a negative feedback loop in the NFkB signal pathway. Here, we found that oxidative stress, 
as it occurs during sepsis, strongly enhances ATF3 expression and production by LPS-triggered 
dendritic cells or peritoneal macrophages. In vivo, reactive oxygen species (ROS) stress resulting 
from glutathione depletion enhanced LPS-induced ATF3 4-fold, inhibited IL-6 mRNA and protein 
production >90% in vivo, and signifi cantly decreased the risk of LPS-induced lethality. This 
protection was fully reversed by the ROS scavenger N-acetyl-cysteine and strictly dependent on 
ATF3-induction, as ROS stress affected neither cytokine production nor survival in ATF3-/- mice. 
We speculated that the increased awareness of ATF3-/- mice to innate signals such as LPS 
established solid protection against systemic infection: >90% of ATF3-/- mice survived 
conditions of bacterial infection after cecal perforation that were lethal in 100% of wild type 
(wt) mice. Depletion of gluthatione further increased susceptibility of wt mice to bacteriemia, 
whereas ATF3-/- remained unaffected. In contrast, ATF3-/-xIL-6-/- double knock out mice 
died as rapidly as wt mice directly showing that ATF3-mediated suppression of IL-6 caused 
susceptibility to bacteriemia. These insights are essential for the management of bacterial and 
fungal infections, especially in the ever increasing community of immune compromised patients.
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The Activating Transcription Factor 3 (ATF3) critically determines the post-septic 
immune suppression (CARS) in humans
Wolfram Hoetzenecker1, Emmanuella Guenova1, Bernd Echtenacher2, Konrad 
Hoetzenecker3, Juergen Brueck1, Florian Woelbing1, Tilo Biedermann1, Kamran 
Ghoreschi1, Martin Röcken1 1Department of Dermatology, Tuebingen, Germany, 
2Dept of Immunology, Regensburg, Germany, 3Department of Surgery, Vienna, Austria
Following systemic infections or trauma, patients are at high risk of severe secondary 
infections of bacterial, fungal or viral origin. This post-septic immune paralysis, termed 
CARS, is currently most relevant for sepsis-associated lethality. Yet, the molecular 
mechanisms underlying this phenomenon are elusive. ATF3 is the fi rst transcription factor 
in the NF-kB signalling pathway induced after innate immune stimulation. Thereby, ATF3 
negatively regulates the transcription of IL-6 and TNF. Analysing the role of ATF3 during 
CARS in humans, we fi rst show a signifi cant and close correlation of severely suppressed 
glutathione-levels with the strong induction of ATF3 and the loss of activation induced IL-6. 
We therefore speculated that ATF3 might be a key transcription factor responsible for the 
postseptic immune suppression and the increased susceptibility to opportunistic infections. 
To test this hypothesis we used CLP (cecal ligation and puncture), one of the best-established 
models of bacterial sepsis. We fi rst induced sublethal CLP in wild type (wt) and ATF3-/- 
mice, to closely imitate the clinical conditions in mice. Subsequently, we challenged mice 
during the postseptic CARS phase with the fungal pathogen Aspergillus fumigatus, at doses 
that are non-pathogenic to healthy mice. Post-septic wt-mice rapidly succumbed to this 
sub-lethal pulmonary Aspergillus fumigatus infection. In sharp contrast, ATF3-/- mice had 
not only a signifi cantly prolonged survival, 20% of these mice even survived this infection 
that was lethal in 100% of wt mice. Thus, ATF3 is a critical regulator of postseptic immune 
suppression, that determines susceptibility to and the course of opportunistic infections.
050
Anti-desmocollin autoantibodies in pemphigus herpetiformis and pemphigus 
vegetans: IgG antibodies to desmocollins 1-3 are the key factor for their 
characteristic phenotypes
Norito Ishii, Kwesi Teye, Takahiro Hamada, Takako Ishikawa, Sachiko Sakaguchi, 
Shunpei Fukuda, Hiroshi Saruta, Tadashi Karashima, Shinichiro Yasumoto, Takashi 
Hashimoto Department of Dermatology, Kurume University School of Medicine, and 
Kurume University Institute for Cutaneous Cell Biology, Kurume, Fukuoka, Japan
Recent progress in molecular biology has revealed that IgG autoantibodies in classical pemphigus 
react with desmoglein 1 (Dsg1) and/or Dsg3.  Pemphigus herpetiformis and pemphigus vegetans are 
considered to be variants of pemphigus foliaceus and pemphigus vulgaris, respectively.  Although 
some pemphigus herpetiformis and pemphigus vegetans cases have been reported to react with 
desmocollins (Dsc), the pathogenic role of anti-Dsc autoantibodies in both diseases is at present 
unknown.  In this study, to further investigate IgG reactivity with Dsc in pemphigus herpetiformis 
and pemphigus vegetans, we examined immunological profi les by immunoblotting using epidermal 
extracts and cDNA-transfection method and ELISA for Dsc1-3.  We collected 15 patients each 
of pemphigus herpetiformis and pemphigus vegetans, whose diagnoses were made by clinical, 
histological and immunological fi ndings.  By cDNA-transfection method, 13 cases of pemphigus 
herpetiformis and 10 cases of pemphigus vegetans showed IgG reactivity to Dsc1-3 in various patterns, 
while 20 classical pemphigus sera and 10 normal sera were negative.  ELISA for Dsc1-3 confi rmed 
the results in cDNA-transfection method.   A few sera also reacted with Dsc by immunoblotting. 
These results indicate that Dsc1-3 are autoantigens specifi c for pemphigus herpetiformis and 
pemphigus vegetans, but not for classical pemphigus.  Some sera did not react with Dsg, further 
suggesting a signifi cant role of anti-Dsc antibodies in the pathogenecity of pemphigus herpetiformis 
and pemphigus vegetans.  Anti-Dsc autoantibodies may reduce Dsc expression in keratinocytes, 
which results in characteristic phenotypes of these diseases.  Furthermore, our studies demonstrated 
that cDNA-transfection method and ELISA are useful tools to detect anti-Dsc autoantibodies. 
051
The expression and the role of thrombospondin-2 in systemic sclerosis
Ikko Kajihara, Masatoshi Jinnin, Takamitsu Makino, Toshikatsu Igata, Satoshi 
Fukushima, Hironobu Ihn Kumamoto University, Kumamoto, Japan
Systemic sclerosis (SSc) is an acquired disorder which typically results in fi brosis of 
the skin and internal organs. Although the pathogenesis of this disease is still unclear, 
it includes infl ammation, autoimmune abnormality, and vascular damage, leading 
to activation of fi broblasts and disturbed interactions with different components of 
the extracellular matrix, mainly collagen. Despite recent advances in understanding 
the regulation of collagen gene expression, the mechanisms responsible for the 
pathologic increase in the expression of collagen genes in SSc have not been 
elucidated. The thrombospondins (TSPs) are a family of multifunctional extracellular 
glycoprotein. The family consists of 5 subtypes and is classifi ed into 2 subgroups: TSP-
1 and TSP-2 are homotrimers consisting of three identical subunits, while TSP-3, TSP-
4 and -5 (so-called cartilage oligomeric protein) forms homopentamers. TSP-1 has 
been reported to be overexpressed and contribute to autocrine transforming growth 
factor-β (TGF-β) signaling in cultured fi broblasts derived from SSc. Also, in a previous 
report, TSP-5 was shown to be increased in SSc fi broblasts. In this study, we found 
that TSP-2 was also expressed in cultured human dermal fi broblasts. Additionally, 
unlike TSP-1 and TSP-5, TSP-2 production was decreased in SSc fi broblasts both in 
vivo and in vitro. Accordingly, we tried to clarify the mechanisms of down-regulated 
TSP-2 in SSc fi broblasts, and discussed the role of TSP-2 in the pathogenesis of SSc.
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High Prevalence of HLA-Cw6*0602 irrespective of Phenotype in Childhood Psoriasis
Josefi n Lysell, Maria Liljander, Fabio Sánchez, Mona Ståhle Karolinska Institutet, Dept 
of Medicine, Dermatology and Venereology unit, Stockholm, Solna, Sweden
The heterogeneity of psoriasis is becoming increasingly evident and the strategy 
to stratify for subgroups such as childhood psoriasis is likely to prove rewarding in 
understanding the full spectrum of the disease. HLA-Cw*0602 is the candidate gene 
with the strongest genetic association to psoriasis but its mechanism of action is still 
unknown. We have examined and genotyped 246 children with onset of psoriasis 
before 15 years of age for HLA-Cw*0602. The phenotypic distribution in the group 
(18% guttate vs. 82% plaque) was surprisingly similar to the phenotypic distribution 
in our earlier examined patients with adult onset of psoriasis (22% guttate vs. 78% 
plaque). This phenotypic distribution, with plaque psoriasis as the main phenotype, 
is in accordance with earlier reported clinical studies of childhood psoriasis. 
Genotyping was performed by using the allele specifi c PCR phototyping technique 
described by Bunce et al., 1995. Irrespective of phenotype, we found signifi cantly 
higher representation of HLA-Cw*06 in this paediatric cohort compared to patients 
with adult onset, 69% vs. 39%. In concordance with what has been reported the 
background HLA-Cw*0602 prevalence in matched healthy controls was 10%. This 
material shows that high prevalence of HLA-Cw*0602 in childhood psoriasis is 
primarily attributed to the early onset of disease and not by the guttate phenotype.
053
Priming of adaptive immune responses by different subsets of skin dendritic cells
Marta Polak, Louise Newell, Chris Pickard, Peter Friedmann, Eugene Healy, Michael 
Ardern-Jones School of Medicine, University of Southampton, United Kingdom
Epicutaneous sensitisation in atopic dermatitis (AD) is thought to cause Th2 biased 
responses, possibly due to enhanced allergen penetration or an AD-specifi c 
microenvironment in the skin. We sought to investigate the effect of cytokine 
milieu during priming on the polarisation of adaptive immune responses and the 
capacity of different human cutaneous dendritic cell (DC) subsets to prime naïve 
T-lymphocytes. We were able to model priming of autologous T cells to the chemical 
contact sensitiser dinitrochlorobenzene (DNCB) comparing human epidermal (LCs) 
and dermal DCs (DDCs) and MoDCs in different in vitro conditions. Using fl ow-
cytometry and Elispot assays we assayed the proliferation, phenotype and function of 
primed T-lymphocytes. The DNCB-specifi c responses peaked at day 17 post priming. 
Both LCs and DDCs potently activated T lymphocytes and induced proliferation and 
expression of skin homing markers. Although we found that both LCs and DDCs were 
able to induce expansion of antigen-specifi c IFN-γ producing cells and that a Th2 
cytokine environment skewed T-cell priming outcomes towards Th2 profi les, LCs were 
signifi cantly better inducers of Th2 and Th17 polarised cells (p<0.01). Despite the 
greater ability of LCs to polarize T lymphocytes towards Th2, DCs from both epidermal 
and dermal compartments sensitize to DNCB with a dominant Tc1/Th1 outcome. 
Thus the site of residence and also microenvironment of the priming cutaneous DC 
regulates the adaptive immune response outcome suggesting that differences in 
antigen penetration and tissue milieu in AD may both contribute to Th2 skewing.
 
054
Heparin serves as a natural stimulant of infl ammasome and exacerbates the 
symptoms of TRAPS
Shun Ohmori, Ryosuke Hino, Motonobu Nakamura, Yoshiki Tokura University of 
Occupational and Environmental Health, Kitakyushu, Japan
Tumour necrosis factor receptor (TNFR)-associated periodic syndrome (TRAPS) is a rare 
autosomal dominant disorder characterized by recurrent episodes of fever, myalgia, 
abdominal pain, conjunctivitis and skin eruptions with mutations in the TNFRSF1A 
(TNFR superfamily 1A) gene. We saw a 16-year-old woman with a one-year history of 
wheal and episodic fever. Genetic evaluation revealed a missense mutation (p.T61I) 
in TNFRSF1A gene, leading to the diagnosis of TRAPS. Her mother and grandfather 
had the similar symptoms and the same gene mutation. On admission, she had an 
episode of shock and dyspnea when injected with even a small amount of heparin 
for venous lock. This urged us to investigate whether heparin is one of the stimulants 
for infl ammasome. Peripheral blood mononuclear cells (PBMCs) from the patient 
and normal subjects were incubated with heparin at 1 unit/ml in the absence of LPS, 
and IL-1β concentration in the supernatants was measured. Heparin stimulated the 
patient’s PBMCs, but not normal PBMCs, to produce IL-1β. ATP, instead of heparin, also 
induced the production of IL-1b by the patient’s PBMCs, indicating that the abnormal 
TNFR signaling in the patient’s PBMCs can replace LPS stimulation. To further 
examine the ability of heparin, THP-1 cells were cultured with heparin and/or LPS. In 
the presence of LPS, heparin enhanced IL-1β production in a dose dependent manner 
up to 1 unit/ml, which was inhibited by a caspase-1 inhibitor. These results indicate a 
novel fi nding that heparin is one of the natural stimulants to activate infl ammasome.
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Mite allergen is a danger signal for the skin
Koji Sayama, Xiuju Dai, Yuji Shirakata, Mikiko Tohyama, Saori Miyawaki, Satoshi 
Hirakawa, Koji Hashimoto Ehime University Graduate School of Medicine, Toon, 
Ehime, Japan
Atopic dermatitis (AD) is a highly pruritic chronic infl ammatory skin disorder caused 
by multiple factors. Among them, house dust mite (HDM) allergens are important for 
the onset and exacerbation of AD. In airway allergy, HDM allergens activate innate 
immunity. However, there is limited knowledge regarding the activation of innate 
immunity by HDM in the skin. The infl ammasome is a key regulator of pathogen 
recognition and infl ammation, and can be activated by various stimuli. In this study, 
we investigated whether HDM allergens activate the infl ammasome in human 
epidermal keratinocytes. HDM extracts from Dermatophagoides pteronyssinus (Der 
p) and Dermatophagoides farinae (Der f) activated caspase-1 and induced caspase-1-
dependent release of IL-1β and IL-8 from keratinocytes, indicating that HDM activate 
the infl ammasome in these cells. Release of IL-1β in response to HDM depended on 
cysteine protease activity. Group 1 HDM allergens (Der p 1 and Der f 1) also induced 
the release of IL-1β and IL-8 through their cysteine protease activity, but treatment 
of keratinocytes with recombinant group 2 allergens (Der p 2 and Der f 2) had no 
signifi cant effect on IL-1β release. This is the fi rst report showing that HDM allergens 
activate the infl ammasome. In AD, disruption of the epidermal barrier facilitates HDM 
allergens to impact viable keratinocytes, resulting in infl ammasome activation and IL-
1b and IL-8 release. HDM allergen is a danger signal for the skin and HDM-induced 
activation of the infl ammasome plays a pivotal role in the pathogenesis of AD.
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Regulatory mechanisms of collagen expression by interleukin-17 signaling in 
scleroderma fi broblasts
Taiji Nakashima, Masatoshi Jinnin, Ikko Kajihara, Takamitsu Makino, Satoshi 
Fukushima, Yuji Inoue, Hironobu Ihn Kumamoto University, kumamoto, Japan
Scleroderma, or systemic sclerosis (SSc), is a generalized connective tissue disease 
which is characterized by autoimmune abnormality, microvascular obliteration and 
increased deposition of extracelluar matrix (ECM) such as collagen, resulting in 
fi brotic lesions. The ECM synthesis and deposition are thought to be regulated by 
cytokines such as transforming growth factor (TGF)-b. Despite recent advances in 
understanding the regulation of ECM expression, the mechanisms responsible for 
the pathologic collagen accumulation in SSc have not been elucidated. Interleukin 
(IL)-17 is a proinfl ammatory cytokine produced by the Th17 CD4+ T cell lineage. 
Although IL-17 has been linked to the pathogenesis of various infl ammatory and 
autoimmune diseases and serum IL-17 levels are reported to be elevated in SSc, the 
role of IL-17 signaling in the pathogenesis of SSc has been poorly understood. In 
this study, we found that cultured human dermal fi broblasts express IL-17 receptor 
A (IL-17RA), essential for biologcal activity of IL-17. The expression of IL-17RA in 
SSc fi broblasts was signifi cantly decreased compared with normal fi broblasts. 
We then expected IL-17 signaling may play a role in the ECM accumulation 
in this disease. Based on the changes in the expression profi le of ECM genes 
by IL-17 in vitro, we will discuss the possible role of IL-17 signaling in SSc.
057
The Role of IL-17 in Different Clinical Subtypes of Psoriasis
Senem Buyukkara Yilmaz, Nilüfer Cicek, Mesut Coskun, Olcay Yegin, Erkan Alpsoy
Akdeniz University, Antalya, Turkey
Psoriasis is a chronic, recurrent infl ammatory skin disorder of unknown aetiology. 
Patients with psoriasis exhibit elevated levels of pro-infl ammatory cytokines and 
a neutrophile and lymphocyte infi ltration both in dermis and epidermis. Recent 
fi ndings have revealed a potential role for IL-17 responses in the pathogenesis of 
psoriasis. 70 patients with psoriasis (30 psoriasis vulgaris, 20 guttate psoriasis, 20 
pustular psoriasis) and 50 age- and sex- matched healty volunters were enrolled 
in the study. Serum IL-17 levels were examined by ELISA. Serum IL-17 levels of 
pustular psoriasis (9.6±12.6) were signifi cantly higher than healthy controls (4.4±4.1) 
(p=0.02). Although serum levels of IL-17 in psoriasis vulgaris (6.2±5.6) were higher 
than healthy controls, the difference was not statistically different. The serum IL-17 
levels in patients with guttate psoriasis (4.3±3.6) did not show a signifi cant difference 
compared with healthy controls. When we evaluate psoriasis vulgaris patients 
according to the disease severity, the serum IL-17 levels were found signifi cantly 
higher in patients with PASI≥10 (11,30±6,0) than in patients with PASI<10 (3,39±2,6) 
and healty controls (p<0.001). The Pearson correlation anlysis showed a positive 
correlations between the serum IL-17 levels and PASI. Our results suggests that IL-
17 may play an important role in pustular psoriasis and severe psoriasis psoriasis.
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Anti-laminin γ1 pemphigoid mediated by IgA autoantibodies
Katarzyna Wozniak1, Takashi Hashimoto2, Shunpei Fukuda2, Bungo Ohyama2, Norito 
Ishii2, Cezary Kowalewski1 1Medical University of Warsaw, Warsaw, Poland, 2Kurume 
University School of Medicine, Kurume, Japan
Anti - laminin γ1 pemphigoid is a novel autoimmune subepidermal blistering 
disorder. Clinically, it may resemble bullous pemphigoid, linear IgA bullous 
dermatosis or dermatitis herpetiformis. Immunologically, anti - laminin γ1pemphigoid 
is characterized by the development of IgG antibodies directed against basement 
membrane zone protein with molecular weight of 200kD. Here, we report a fi rst 
case of anti-laminin g1 pemphigoid mediated by IgA antibodies with clinical features 
resembling pemphigus herpetiformis localized on traumatized areas. Histopathology 
of lesional skin showed dermal-epidermal separation with microabscesses 
composed of neutrophils in the dermal papillae. Direct immunofl uorescence 
disclosed the presence exclusively of linear in vivo bound IgA along basement 
membrane zone. Using laser scanning confocal microscopy we found that in vivo 
bound IgA was localized above collagen IV and colocalized with laminin-332. 
Indirect immunofl uorescence showed the presence of circulating IgA antibodies 
on the fl oor of artifi cial blister of salt split skin. Western immunoblot analysis using 
dermal extract confi rmed the reactivity of circulating IgA antibodies with the 200kD 
antigen corresponding to laminin-γ1. Immunelectronmicroscopy disclosed the 
reactivity of circulating IgA autoantibodies within lower lamina lucida. To the best 
of our knowledge, this is the fi rst case fulfi lling immunopathological criteria for anti-
laminin γ1 pemphigoid mediated by IgA antibodies with unusual clinical features.
059
Differential skin expression of Caveolin-1 and Allograft-infl ammatory factor-1 in 
chronic Graft-Versus-Host Disease suggests a specifi c role in the pathogenesis of 
Scleroderma
Ilaria Tinazzi1,2, Chiara Colato2, Domenico Biasi2, Paul Emery1, Francesco Del Galdo1
1University of Leeds, Leeds, United Kingdom, 2University Hospital of Verona, Verona, 
Italy
The role of the immune system in the pathogenesis of Scleroderma is still unclear. 
Sclerodermoid-GVHD (Scl-GVHD) shows a tissue pathology similar to SSc providing 
a indirect evidence of this role. To determine the specifi city of AIF-1 and caveolin-1 
in the immunopathogenesis of skin fi brosis we analyzed their level of expression 
in 8 skin biopsies of scl-GVHD and 3 non scl-GVHD. Histopathological analysis 
confi rmed intense tissue fi brosis in scl-GVHD without the vessel rarefaction typical 
of SSc whereas cGVHD was characterized by dense infi ltrate and no skin fi brosis. 
Immunofuorescence studies followed by CLSM were conducted and quantitative 
analysis of fl uorescence was determined by Image J software. AIF-1 expression 
was increased by 6.3 fold in Scl-cGVHD ( ±1.06; p= 0.0146) compared both with 
healthy and GVHD skin. The pattern of expression was mostly in perivascular and 
tissue infi ltrating mononuclear cells, whereas microvascular endothelial cells did not 
show any AIF-1 expression despite what has been previously shown in SSc. Cav-1 
immunofl uorescence was decreased in Scl-GVHD  ( - 2.68 fold; p=0.0289), mostly 
due to lack of expression in stromal cells, since endothelial cells showed a conserved 
expression for Cav-1. AIF-1 expression in infi ltrating cells correlated with the presence of 
tissue fi brosis and fi broproliferative vasculopathy in GVHD. The decreased expression 
of cav-1 is peculiar and specifi c of skin fi brosis regardless of its origin and therefore 
a good marker of tissue fi brosis. Transcriptome analysis of the same skin biopsies is 
on going to dissect the specifi c pathways associated with the different phenotypes.
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Mesenchymal Stem Cells Exert an Inhibitory Effect on the Activation of Macrophages 
in vitro -  Implications for the Non-Healing State of Chronic Venous Leg Ulcers
Yu Qi1, Anca Sindrilaru1, Stefan Wieschalka1, Markus Rojewski2, Heidi Hainzl1, 
Andrea Schlecht1, Hubert Schrezenmeier2, Karin Scharffetter-Kochanek1
1Dept of Dermatology & Allergic Diseases, University of Ulm, Germany, 2Dept of 
Transfusion Medicine & Immunogenetics, University of Ulm, Germany
There is accumulating evidence that activated macrophages play a major pathogenic 
role in the non-healing state of chronic venous leg ulcers (CVU). Previously; we found 
macrophages persist in high numbers and are highly activated in chronic venous leg 
ulcers. In addition, severe dermatoliposclerosis in the chronic venous leg ulcers leads to a 
progressive loss of the subcutaneous mesenchymal stem cell niche. Autologous or allogeneic 
transfer of mesenchymal stem cells represents a promising treatment which may control 
persistent macrophage activation and rescue the regenerative capacity of these diffi cult-
to-treat wounds. We therefore studied the role of MSCs on macrophage activation using 
co-culture of bone marrow or adipose tissue derived MSCs with activated macrophages. 
Macrophages were effectively stimulated with the combination of LPS and IFNγ, leading 
to enhanced release of NO, IL-12 and TNFα. We found that the co-incubation with BM-
MSCs resulted in a signifi cant reduction of NO release from activated macrophages at 
the ratios (MSCs:macrophages) of 1:10, 1:50, 1:200 and 1:1000. While the suppression 
effect was only detected at the ratios (MSCs:macrophages) of 1:10 and 1:50 when AT-MSCs 
were applied. In the murine model of full-thickness excisional wounds in wildtype mice 
both BM-MSCs and AT-MSCs injected around the wounds signifi cantly accelerated wound 
healing when compared with wounds injected with PBS. Collectively, these data show that 
MSCs exert a suppressive effect on macrophage activation, and in vivo, both BM-MSCs and 
AT-MSCs accelerated wound healing in wildtype mice. Thus, topical application of MSCs 
may qualify as a promising therapy in macrophage-dominated impaired wound healing.
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Computational Analysis of sclerodermoid-GVHD and Scleroderma skin transcriptomes 
reveals the main pathways involved in the immunopathogenesis of skin fi brosis
Ilaria Tinazzi1,2, Chiara Colato2, Domenico Biasi2, Paul Emery1, Francesco Del Galdo1
1Scleroderma Programme - Leeds Institute of Molecular Medicine, Section of 
Musculoskeletal diseases, University of Leeds, UK, 2Univ Hospital of Verona, Italy
Scleroderma is a chronic disease involving autoimmune activation, fi broproliferative 
vasculopathy and tissue fi brosis. Microarray analysis of scleroderma skin biopsies 
identifi ed an intrinsic gene signature associated with Scleroderma. Besides the putative 
role that can be hypothesized by the known gene product function, it is not clear 
which genes within this signature are specifi cally involved in the immunopathogenesis 
of Skin Fibrosis. Sclerodermoid GVHD (Scl-GVHD) is a form of chronic GVHD 
that shares with Scleroderma tissue fi brosis, induced by the immune trigger and 
the fi broproliferative vasculopathy, with the remarkable difference of increased 
angiogenesis, absent in Scleroderma. To identify which genes of the Scleroderma 
intrinsic gene signature are of potential importance in bridging the immune activation 
and the skin fi brosis we analyzed the level of expression of  the scleroderma gene 
signature within scl-GVHD and non scl-GVHD transcriptomes, by pathway focused 
qPCR array. Of the 80 genes analyzed, 46 were differentially expressed in cGVHD 
biopsies and 34 remained peculiar of Scleroderma.  78.3% of the differentially 
expressed genes had a similar pattern of regulation in SSc. 25% were similarly expressed 
in both cGVHD variants, whereas 16.6% were specifi c of Scl GVHD. Remarkably, 
this analysis allowed to identify specifi c chemokines ( CCL5, CXCL9-10-11) involved 
in the fi brotic versus non fi brotic response in GVHD and a specifi c modulation of 
WNT and Hedge-Hog pathway peculiar of Scleroderma and scl-GVHD skin biopsies. 
Identifi cation of the source of l expression of these genes by immunohistochemistry 
will shed light in unraveling the events bridging immune activation and skin fi brosis.
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Topoisomerase I Gene Mutations In Patients With Systemic Sclerosis (Scleroderma)
Lidia Rudnicka1,2, Urszula Nowicka2, Malgorzata Olszewska2 1CSK MSWiA, Warsaw, 
Poland, 2Warsaw Medical University, Warsaw, Poland
A hallmark of systemic sclerosis (SSc) is the presence of antinuclear antibodies. 
In 30-90% of patients these are antibodies directed against various epitopes of 
topoisomerase I. Neither etiology of the disease nor factors causing development of 
these antibodies are known. The aim of the study was to analyze the gene sequence 
of topoisomerase I in patients with systemic sclerosis. A total of 96 patients with 
SSc (including 45 patients with circulationg anti-topoisomerase I antibodies) 
were included into the study. All patients fulfi lled the ACR (American College of 
Rheumatology) for the diagnosis of SSc. In all patients cDNA was isolated from 
peripheral blood mononuclear cells. The study was performed with the use of 
heteroduplex analysis and  automated cDNA sequencing. The sequence of exons 20 
and 21, which encode the active site of topoisomerase I was analyzed. In 3/45 (6.6%) 
Topo I(+) patients tree diverse mutations in Exon 21 were identifi ed, in 22/45 of these 
patients (48,9%) mutations in exon 20 were observed. These abnormalities were not 
seen in Topoi(-) patients with SSc or healthy controls. We conclude that mutations in 
the gene, which encodes topoisometase I, may contribute to development of anti-
topoisomerase I antibodies and possibly also to development of systemic sclerosis.
063
Therapeutic Inhibition of Hypoxia Prevents Psoriasis-like Arthritis in a Small Animal 
Model
Kerstin Fuchs1, Stefan Wiehr2, Gerald Reischl3, Bernd J. Pichler2, Manfred Kneilling1, 
Martin Röcken1 1Dept of Dermatology, Univ of Tübingen, Germany, 2Lab for Preclinical 
Imaging & Imaging Technology of the Werner-Siemens Foundation, Radiology, Univ of 
Tuebingen, Germany, 3Radiopharmacy, Radiology, Univ of Tübingen, Germany
Auto-antibodies against Glucose-6 phosphate-isomerase (GPI) induce arthritis in mice that closely 
resembles human psoriasis arthritis (PsoA). Angiogenesis and hypoxia play a major role in organ-
specifi c autoimmune diseases such as GPI triggered arthritis. Hypoxia induces angiogenesis via 
stabilization of the transcription factor hypoxia inducible factor (HIF)-1α and induction of pro-
angiogenic mediators. The aim of our study was to analyze whether inhibition of hypoxia may 
protect from joint destruction. Methylene blue (Mb), a derivate of hemoglobin should inhibit 
hypoxia by interfering the nitric oxide activation synthase pathway and inhibition of nitric oxide 
synthase and guanylate cyclase. We injected GPI-serum or control-serum in mice to induce 
joint infl ammation. After two days we started daily Mb-treatment (0,23mg/kg) or PBS-treatment. 
To investigate the effects of Mb-treatment, we measured ankle swelling and hypoxia in arthritic 
joints by [18F]Fluoromisonidazole (FMISO) and positron emission tomography (PET). Additionally 
we analyzed mRNA expression of HIF-1α/2α, pro-angiogenic, and pro-infl ammatory mediators 
as well as H&E-, and pimonidazol-stained slices of arthritic- and healthy joints. Mb-treatment 
nearly completely suppressed GPI-arthritis and protected mice from pannus formation and joint 
destruction. Investigating hypoxia in vivo using [18F]FMISO-PET we detected a 55% reduction 
in tracer uptake four days after initiation of Mb-treatment. We performed histology and real-
time PCR analysis (HIF-1α/2α, pro-angiogenic, and pro-infl ammatory mediators) to correlate 
in vivo investigations with the molecular changes of PsoA. Thus, anti-hypoxic Mb-treatment 
is a powerful tool to suppress hypoxia-induced angiogenesis and to protect mice from joint 
destruction. [18F]FMISO-PET provides a quantitative method to detect treatment responses in PsoA.
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ß2 integrin-dependent release of oxygen radicals from macrophages is required for 
TGF-ß1 activation in cutaneous wound repair
Andrea Schlecht, Yu Qi, Susanne Schatz, Karin Scharffetter-Kochanek, Anca Sindrilaru
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany
Patients suffering from Leukocyte Adhesion Defi ciency Syndrome type 1 (LAD1) with 
impaired ß2 integrin expression and function due to mutations in the gene encoding 
their common ß chain (CD18) present with spontaneous skin ulcerations and severe 
wound healing disturbances. In a model of full thickness excisional wounds we 
previously found that disruption of the ß2 integrin signaling pathway in CD18-/-, 
Vav3-/- and Rac2-/- mice results in delayed wound healing. This is due to impaired 
formation of the phagocytic synapse between apoptotic neutrophils and macrophages 
leading to impaired oxidative burst and reduced release of active TGF-ß1 at the 
wound site. However, the underlying mechanism is poorly understood. We here 
investigated whether the ß2 integrin-dependent release of ROS by macrophages 
upon phagocytosis of apoptotic neutrophils is responsible for TGF-ß1 activation 
during wound healing. In vitro co-culture experiments of wildtype macrophages 
with apoptotic neutrophils induced high amounts of active TGF-ß1 which were 
reduced by co-incubation with oxygen and nitrogen radicals scavengers. Notably, 
injection of the oxidative burst inducer Rotenone in wound margins of wildtype and 
CD18-/- mice enhanced the oxidative burst at wound sites and virtually rescued the 
wound healing defect of CD18-/- mice to wildtype levels. These results suggest that 
TGF-ß1 may be activated at wound sites by ROS and that in CD18 defi ciency a 
reduced oxidative burst leads to reduced active TGF-ß1 release and eventually to 
impaired wound healing. Modulation of the oxidative burst in wound margins may 
be a promising therapeutic approach for LAD1 patients but also to prevent fi brosis.
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Curcumin protects from infl ammatory autoimmune disease by inducing immuno 
suppressive DC and inhibiting Th1/Th17 responses
Jürgen Brück, Ivana Glocova, Martin Röcken, Kamran Ghoreschi Department of 
Dermatology, Tübingen, Germany
Curcumin is a yellow pigment isolated from the rhizomes of the plant Curcuma 
Longa. Curcumin may possess anti-infl ammatory activities and therefore is 
traditionally used for the treatment of infl ammatory disorders in Asia. First, we 
investigated the activities of curcumin on the differentiation of mouse dendritic 
cells  in vitro. We started by comparing gene expression of curcumin-treated DC or 
control DC after activation through TLR4 using PCR-Microarrays. Curcumin induced 
expression of genes of the TNF superfamily and NFkB inhibitory genes in DC and 
inhibited the production of infl ammatory cytokines. To investigate the biological 
effect of curcumin  in vitro, we isolated CD4+ T cells from SJL mice immunized 
with PLP peptide in CFA. These CD4+ T cells were activated with APC and PLP 
peptide. T-cells primed in the presence of curcumin showed signifi cantly inhibited 
IFN-g and IL-17 expression and an increased expression of the Th2 cytokines IL-4 
and IL-10. We next analyzed the effects of curcumin in vivo. Mice were fed with 
curcumin, immunized with PLP in CFA and pertussis toxin. Whereas control mice 
developed severe EAE, mice treated with curcumin remained healthy or developed 
only mild EAE. The protection from EAE by curcumin treatment was associated 
with a suppression of IL-12/IL-23p40 and subsequent Th1 and Th17 responses. In 
contrast curcumin treatment induced IL-4 and IL-10 in activated CD4+ T cells. Even 
though the molecular mechanism, by which curcumin interacts with IL-12/IL-23p40 
expression still requires further analysis, treatment with the natural extract curcumin 
is promising as therapeutic approach for infl ammatory autoimmune disease.
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Fumarates improve Psoriasis and Multiple Sclerosis by inducing type II dendritic 
cells
Kamran Ghoreschi1, Christina Keller1, Caishu Deng2, Jürgen Brück1, Susanne Feil3, 
Robert Feil3, Amy E. Lovett-Racke2, Michael K. Racke2, Ralf Dringen4, Martin Röcken1
1Department of Dermatology, Tübingen, Germany, 2Department of Neurology and the 
Center of Immunology, Dallas, United States, 3Interfaculty Institute of Biochemistry, 
Tübingen, Germany, 4Center of Biomolecular Interactions Bremen, Bremen, Germany
Fumarates improve multiple sclerosis and psoriasis, two diseases in which both IL-12 
and IL-23 are responsible for pathogenic T helper (Th) cell differentiation. However, 
both diseases show opposing responses to most of the established therapies. First we 
show in humans that fumarate-treatment induces IL-4-producing Th2 cells in vivo and 
generates type II dendritic cells (DC) that produce IL-10 instead of IL-12 and IL-23. 
In mice, fumarates also generate type II DC that induce IL-4-producing Th2 cells in 
vitro and in vivo and protect mice from experimental autoimmune encephalomyelitis 
(EAE). Type II DC result from fumarate-induced glutathione-depletion, followed by 
increased hemoxygenase-1 (HO-1) expression and impaired STAT1-phosphorylation. 
HO-1-induction prevents IL-23p19 transcription without affecting IL-12p35, while 
STAT1 inactivation prevents IL-12p35 transcription without affecting IL-23p19. As a 
consequence, glutathione-depletion by small molecules like fumarates induces type 
II DC in mice and in humans that ameliorate infl ammatory autoimmune diseases. This 
therapeutic approach improves Th1- and Th17-mediated autoimmune diseases such 
as psoriasis and multiple sclerosis by interfering with IL-12 and IL-23 production.
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The role of chemerin, a new adipokine, in psoriasis
Nakajima Hideki1, Nakajima Kimiko1, Yamamoto Mayuko1, Tarutani Masahito1, 
Takahashi Michiko2, Takahashi Yutaka2, Sano Shigetoshi1 1Department of 
Dermatology,Kochi Medical School, Kochi University, Nankoku, Japan, 2Division of 
Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Kobe 
University Graduate School of Medicine, Kobe, Japan
Chemerin is a newly identifi ed adipokine and an agonist of chemokine-like receptor 1 
that is expressed by cells of the innate immune system. Chemerin stimulates chemotaxis 
of plasmatoid dendritic cells (pDC) and neutrophils, and high systemic chemerin level was 
found as an independent marker of the metabolic syndrome. Recently, strong expression 
of chemerin together with pDC and neutrophils in the dermis of early psoriasis lesions was 
reported. To investigate the association of chemerin with psoriasis, we examined whether 
circulating chemerin was elevated in psoriasis patients and whether it correlated with 
metabolic syndrome. Circulating chemerin levels were signifi cantly elevated in psoriasis 
patients compared to those in chronic dermatitis patients and healthy controls. Serum 
chemerin levels did not positively correlate with body mass index, however, serum high 
chemerin level signifi cantly correlated with hypercholesterolemia and hypertriglyceridemia 
in psoriasis patients by the logistic regression analysis. Interestingly, chemerin level 
showed a decrease after cyclosporine treatment, and the change in chemerin values was 
closely associated with alternations in PASI score. We also examined chemerin expression 
and chemerin mRNA levels in psoriatic lesions and healthy control skin. Expression of 
chemerin was observed in the epidermis of psoriatic or control skin. In contrast to the 
previous report, chemerin expressing cells were not detected in the dermis of active 
psoriatic lesions. Chemerin mRNA levels were mostly unchanged in the lesional skin 
compared with nonlesional skin from psoriasis patients. Systemic chemerin elevation 
may be relevant to the pathomechanism of psoriasis and metabolic syndrome risk factors.
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Development of an ELISA for the specifi c detection of autoantibodies in anti-p200 
pemphigoid
Stephanie Groth1, Andreas Recke1, Katerina Vafi a1, Ralf J. Ludwig1, Takashi 
Hashimoto2, Detlef Zillikens1, Enno Schmidt1 1Department of Dermatology, University 
of Lübeck, Lübeck, Germany, 2Department of Dermatology, Kurume University School 
of Medicine, Kurume, Japan
Anti-p200 pemphigoid is a subepidermal blistering skin disease characterized 
by autoantibodies against a 200-kDa protein (p200) of the dermal-epidermal 
junction. Recently, the laminin γ1 chain has been identifi ed as target antigen 
in this disease and the C-terminus was described as an immunodominant region 
of laminin γ1. Diagnosis of anti-p200  pemphigoid requires detection of serum 
IgG at the dermal side of 1 M salt-split skin by indirect immunofl uorescence 
microscopy and labelling of a 200 kDa protein by Western blotting of dermal 
extract. However, preparation of dermal extract is not widely available limiting the 
possibility of diagnosing this disease to a few laboratories. In this study, we report 
on the development of a simple, sensitive and specifi c ELISA using a recombinant 
monomeric C-terminal fragment of human laminin γ1 (hLAMC1-cterm) expressed 
in E. coli. By this novel ELISA, serum reactivity with hLAMC1-cterm was detected 
in sera from 27 of 35 (77%) patients with anti-p200 pemphigoid, 6 of 101 (6%) 
with bullous pemphigoid, 0 of 10 with epidermolysis bullosa acquisita, 3 of 14 
(21%) with anti-laminin 332 pemphigoid, 0 of 51 with pemphigus vulgaris, and 
1 of 131 (0.8%) healthy volunteers. In order to explore the role of conformational 
epitopes and posttranslational modifi cations in eukaryotic cells, hLAMC1-cterm was 
produced in human HEK293 cells. However, using human cell-expressed hLAMC1-
cterm, the sensitivity of the ELISA did not change. The novel ELISA using E.coli-
expressed hLAMC1-cterm greatly facilitates the diagnosis of anti-p200 pemphigoid.
069
Human monoclonal antibodies bind desmoglein 3 epitopes shared by pemphigus 
vulgaris patient autoantibodies and synergistically induce loss of adhesion between 
keratinocytes
Valentina Calabresi1, Anna Sinistro1, Giovanni Di Zenzo1, Giulia Di Lullo2, Biagio 
Didona3, Masayuki Amagai4, Bungo Ohyama5, Takashi Hashimoto4, Giovanna 
Zambruno1, Antonio Lanzavecchia2 1Molecular & Cell Biology Lab, IDI-IRCCS, Rome, 
Italy, 2Inst for Research in Biomedicine, Bellinzona, Switzerland, 3I Dermatology Div, 
IDI-IRCCS, Rome, Italy, 4Dept of Dermatology, Keio Univ School of Medicine, Tokyo, 
Japan, 5Dept of Dermatology, Kurume Univ School of Medicine, Fukuoka, Japan
Pemphigus vulgaris (PV) is a life-threatening autoimmune blistering disease of skin and mucous 
membranes associated with autoantibodies against the adhesion molecules desmoglein (Dsg)3 
and Dsg1. We have previously isolated and cloned 16 Dsg-specifi c human monoclonal antibodies 
(hMabs) from 2 patients with active PV by using a method for effi cient immortalization of IgG+ 
memory B cells. Most of the hMabs recognizing calcium-dependent conformational epitopes 
were mapped by a system based on domain swapped molecules between Dsg3 and Dsg2, 
which have similar structures but distinct epitopes. Specifi cally, 8 hMAbs reacted against the 
extracellular (EC) 2 subdomain, 1 with the EC3 and 4 against the EC5. The study of pathogenic 
effects of hMabs, assessed by in vitro keratinocyte dissociation assay and passive transfer in 
neonatal mice, showed a different capability to induce loss of keratinocyte adhesion. Furthermore, 
PV sera were able to block hMabs binding on Dsg3 indicating that the targeted regions were 
bound also by autoantibodies from different PV patients. Finally, hMabs, each displaying a very 
low fragmentation index by the in vitro dissociation assay, showed a synergistic pathogenic effect 
when used in combination in the same conditions. In conclusion, the cloned hMabs shared 
Dsg3 epitopes with PV sera and were able to mimic the combined effects of the polyclonal 
IgG from PV patients. They could thus represent valuable tools for studying the role of Dsg3 in 
epithelial cell adhesion and mechanisms of Dsg3 processing/presentation in PV pathogenesis.
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The vast majority of pemphigus vulgaris patients possess circulating autoantibodies 
reacting with an immunodominant epitope on desmoglein 3
Giovanni Di Zenzo1, Valentina Calabresi1, Anna Sinistro1, Giulia Di Lullo2, Davide 
Corti2, Biagio Didona3, Giuseppe Cianchini4, Giovanna Zambruno1, Antonio 
Lanzavecchia2 1Molecular and Cell Biology Laboratory, IDI-IRCCS, Rome, Italy, 
2Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland, 3I Dermatology 
Division, IDI-IRCCS, Rome, Italy, 4V Dermatology Division, IDI-IRCCS, Rome, Italy
Pemphigus vulgaris (PV) is a potentially fatal autoimmune mucocutaneous disease 
associated with production of IgG autoantibodies to desmoglein 3 (Dsg3). The binding of 
autoantibodies to Dsg3 on keratinocytes leads to loss of intercellular adhesion and blister 
formation. We report the characterization of a Dsg3-specifi c human monoclonal antibody 
(hMab) previously isolated from a patient with active PV using a method for effi cient 
immortalization of IgG+ memory B cells. The IgG1 hMab, termed PVA224, reacted with 
a conformational and calcium-dependent epitope on Dsg3 and induced a histological 
profi le similar to human PV when injected into neonatal mice. PVA224 carried only a few 
somatic mutations (seven amino acid replacements in the CDRs of VH and VL) that will be 
analyzed by reversion to the germline to determine their contribution to binding. Of note, 
the vast majority of PV patients possessed circulating autoantibodies reacting with the same 
Dsg3 epitope recognized by PVA224, as determined by ELISA cross-competition assays. In 
particular, 48 out of 51 (94 %) PV patient sera and none of 40 control sera strongly inhibited 
the PVA224 binding to Dsg3. In addition, the ability to block PVA224 binding in PV 
patients fl uctuated in parallel with disease severity during disease course, suggesting a role 
of this pathogenic hMab in monitoring PV disease. In conclusion, the pathogenic PVA224 
hMab could represent a valuable diagnostic tool for disease monitoring, as well as a lead 
to design therapeutic approaches based on blocking peptides or anti-idiotypic antibodies.
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E6005, a Novel Topical Phosphodiesterase 4 Inhibitor, Ameliorated Pruritus and 
Infl ammation in Mouse Atopic Dermatitis Models
Ishii Naoto1, Wakita Hisashi1, Shirato Manabu1, Hishinuma Ieharu2, Miyazaki 
Kazuki1, Takase Yasutaka1, Asano Osamu1, Yamamoto Eiichi1, Kusano Kazutomi1
1Eisai Tsukuba Research Laboratories, 1-3, Tokodai 5-chome, Tsukuba-shi, Ibaraki 300-
2635, Japan, 2Eisai Inc., 4 Corporate Drive, Andover MA 01810, United States
E6005, a novel Phosphodiesterase (PDE) 4 inhibitor with a new chemical structure, 
has been developed as a topical agent for atopic dermatitis (AD). The aim of this 
study was to assess the pharmacological potential of E6005 as a new therapeutic 
approach for AD in vitro and in vivo with a focus on the anti-pruritus effect. In vitro, 
E6005 showed a potent and selective inhibition of PDE4 with an IC50 of 2.8 nM, 
and suppressed production of a wide variety of cytokines from PBMCs (IL-2, IL-
4, IL-12, IFN-γ and TNF-α). To assess the effi cacy in AD, we studied the effect of 
topically applied E6005 on skin infl ammation, pruritus and atopic dermatitis-like skin 
symptoms in mouse models. Topical application of E6005 decreased the ear thickening 
in chronic skin infl ammation, accompanied by the inhibition of local cytokine/
chemokine expression. Of interest, E6005 exhibited a suppression of scratching 
behavior in an allergic pruritus model immediately after a single application. In 
addition, the treatment with E6005 ameliorated atopic dermatitis-like skin symptoms 
in a mouse AD model. Finally, E6005 showed a lower emetic potential than the 
second generation PDE4 inhibitor cilomilast. These results indicate the therapeutic 
potential of E6005 for AD based on both anti-pruritus and anti-infl ammatory effects.
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Modulation in the expression of substance P in the skin and brain of atopic mice 
during chronic mild stress
Louise Lönndahl1, Klas Nordlind1, Husameldin El-Nour1, Mikael Holst2, Björn Johansson3
1Dermatology & Venereology Unit, Dept of Medicine, Solna, Karolinska Univ Hospital, 
Karolinska Inst, Stockholm, Sweden, 2Pediatric Endocrinology Unit, Dept of Woman 
& Child Health, Astrid Lindgren Children‘s Hospital, Stockholm, Sweden, 3Dept of 
Clinical Neuroscience, Karolinska University Hospital, Stockholm, Sweden
Stress is known to worsen the symptoms of atopic dermatitis (AD). There is a 
bidirectional communication between the skin and the neuroendocrine system. 
Substance P is likely to play an important role in the development and pathogenesis of 
AD. We used NC/Nga atopic mice to examine a possible connection between chronic 
mild stress and changes in expression of substance P and its receptor (R) neurokinin 
(NK)1 in the skin and brain. The mice were divided into three groups (8 mice in each): 
SE (stressed eczema), NSE (non-stressed eczema) and SC (stressed control). Ears and 
brains of the mice were investigated by using RT-PCR and immunohistochemistry. 
In the skin, there was a decrease in the number of substance P immunoreactive 
nerve fi bres, while the expression of NK1R immunoreactivity was highest, in the 
eczematous groups compared to the control group, SC. Using RT-PCR we found a 
high tendency to an increase in mRNA for NK1R in the skin of SE compared to the 
NSE mice. There was a tendency to an increase of the substance P immunoreactivity 
in the SE compared to NSE group in the prefrontal cortex. A decrease in substance P 
immunoreactivity in the hippocampus was found in the SE compared to NSE group. 
In the amygdala there was an increase in the substance P immunoreactivity in the SE 
compared to the SC group. An exposure to chronic mild stress in NC/Nga mice results 
in a modulation of expression of substance P in skin and brain regions related to stress.
 www.jidonline.org S13 
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The new undecyl-rhamnoside (APRC11) inhibits P.acnes-induced infl ammation in 
keratinocytes
Marguerite Leveque4, Olivia Isard1,2, Anne-Chantal Knol1,2, Marie-Françoise Aries4, 
Jean-Michel Nguyen3, Amir Khammari1,2, Nathalie Castex-Rizzi4, Brigitte Dreno1,2
1INSERM U892, Nantes, France, 2Unit of Dermato Cancerology – CIC Biothérapies 
U0503, Nantes University Hospital, Nantes, France, 3SEB-PIMESP Saint Jacques 
Hospital, Nantes University Hospital, Nantes, France, 4Pierre Fabre Dermo-
Cosmétique, Cell Pharmacology, Toulouse, France
Acne vulgaris is a chronic skin disease of pilosebaceous glands in which infl ammation 
plays a central role. In order to develop new therapies against the development of 
infl ammatory events, we evaluated the effect of a new undecyl-rhamnoside, namely 
the undecyl-rhamnoside APRC11, on the keratinocytes infl ammation and scarring 
markers. For this purpose, natural human keratinocytes taken from 6 healthy donors 
were fi rst pre-incubated for 24 hours with increasing concentrations of APRC11(0.3 
to 3 μM) or Zinc Gluconate (Zn, 15μM) which was used as reference molecule for 
its anti infl ammatory activity. Then, keratinocytes were stimulated with P.acnes MF 
(Membrane Fraction) for 6 hours, in the presence of the same APRC11 concentrations 
or Zn. Different markers of infl ammation or scarring were evaluated at protein level 
using ELISA tests and a Luminex array system, and at mRNA level using a Luminex-
based Quantigene array system. Results showed a signifi cant increase in IL-1α, IL-
1RA, IL-6, IL-8 and MMP-9 expressions after P.acnes stimulation. Treatment with 
APRC11 down regulated the P.acnes-induced cytokines expression (IL-1α, -40%; IL-
8, -26% and MMP-9, -38%) and up-regulated IL-1RA (+27%). These regulations were 
noted at both protein and mRNA levels. In conclusion, the new undecyl-rhamnoside 
APRC11 is able to inhibit the P.acnes-induced infl ammation in natural human 
keratinocytes, confi rming its interest in infl ammatory acne and matrix remodelling.
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Expression of the 27kD and 90kD heat shock proteins in psoriatic skin
Daniela Mairhofer1,2, Melitta Kitzwögerer1,3, Rosalynne M. Nazarian4, Alice 
Lobo4, Richard J. Geller6, Martin C. Mihm4, Constanze Jonak5, Franz Trautinger1,2
1Karl Landsteiner Inst of Derm Research, St.Pölten, Austria, 2Dept of Dermatology, 
Landesklinikum St.Pölten, Austria, 3Dept of Pathology, Landesklinikum St.Pölten, 
Austria, 4Dept of Pathology, Massachusetts General Hospital, Boston, MA, United 
States, 5Dept of Dermatology, Medical Univ of Vienna, Austria, 6Emerson Hospital, 
Concord, MA, United States
Heat shock proteins (hsp) are a group of highly conserved proteins that are essential in cytoprotection, 
cell physiology, infl ammation, and keratinocyte differentiation. Their role in psoriasis is largely 
unknown. In the current study a collection consisting of 30 archival samples from various stages 
and clinical variants of psoriasis and 9 samples of normal skin was investigated for the expression 
of hsp27 and hsp90 by immunhistochemistry. As in normal skin hsp27 in psoriatic epidermis was 
associated with keratinocyte differentiation. In addition psoriatic skin samples sometimes showed 
positive staining in the basal cell layer and in subcorneal areas of neutrophil aggregation. A striking 
fi nding in almost all samples was the specifi c loss of hsp27 in the characteristic dilated and tortuous 
capillaries of psoriatic papillae whereas endothelial cells of all other vessels of normal and psoriatic 
skin were regularly positive. Hsp90 was expressed within the entire epidermis and appendages with 
higher intensitiy in the basal layer without any apparent difference between normal and psoriatic 
skin. In contrast to normal skin hsp90 was found in all nucleated cells of psoriatic dermis including 
endothelial cells, leukocytes, and fi broblasts. Our fi ndings indicate that hsp90 may be induced in 
psoriatic skin in response to infl ammation. The differential expression of hsp27 in capillary versus 
postcapillary endothelium points to a role of hsp27 in angiogenesis and the endothelial pathology 
associated with psoriasis. Based on these fi ndings further studies are warranted to investigate 
the functional role of hsp in psoriasis and the possible therapeutic use of hsp modifying agents.
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Modulation of autoantibody isotypes and Fc receptor expression by intravenous 
immunoglobulin
Misa Hirose1, Michael Kasperkiewicz1, Norito Ishii2, Sabina Wende1, Ellen 
Rentz3, Falk Nimmerjahn4, Detlef Zillikens1, Rudolf A Manz5, Ralf J Ludwig1
1Dept of Derm, Univ of Lübeck, Germany, 2Dept of Derm, Kurume Med Univ, 
Fukuoka, Japan, 3Biotest AG, Dreieich, Germany, 4Dept of Biol, Univ of Erlangen-
Nürnberg, Germany, 5Inst for Systemic Infl am Research, Univ of Lübeck, Germany
High dose intravenous immunoglobulin G (IVIG) is used to treat refractory autoimmune diseases, 
including epidermolysis bullosa acquisita (EBA). EBA is characterized by autoantibodies to type 
VII collagen and blistering on skin and mucous membranes. We investigated effects of IVIG in 
immunization-induced EBA in mice. After disease manifestation, mice were treated with either 
methylprednisolone (MP, 20mg/kg/day i.p.) or IVIG (2g/kg once/week) for 4 weeks. While EBA 
progressed in untreated control mice, 31% of mice treated with MP, and 64% of IVIG-treated 
mice showed improvement. Compared to non-treated EBA mice, direct immunofl uorescence (IF) 
microscopy showed reduced complement deposition in skin of IVIG-treated mice, while total 
immunoglobulin G (IgG) deposition was unaltered. By direct IF microscopy, IgG subclass analysis 
demonstrated reduced deposition of complement fi xing IgG2 autoantibodies after IVIG compared to 
non-treated mice. To investigate a possible effect of IVIG on FcgR, leukocytes of IVIG-treated and non-
treated EBA mice were evaluated by fl owcytometry for expression of activating and inhibitory FcgRs. 
The number of FcgRIIB positive germinal centre B cells was increased and Gr-1 positive granulocytes 
showed a reduced FcgRIIB expression compared to non-treated EBA mice. In addition, FcgRIV 
expression on Gr-1 positive granulocytes was down-regulated by IVIG treatment and this reduction 
was more prominent than reduction of FcgRIIB. We demonstrate that IVIG is effective in experimental 
EBA, which is mediated by modulation of autoantibody-isotypes towards non-complement fi xing 
autoantibodies and diminishing the expression of FcgRIV levels on effector cells. These fi ndings 
may have implications for more specifi c treatment regimens of autoantibody-mediated diseases.
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The CD18 Hypomorphic Psoriasis Mouse Model - Insight into the Pathogenesis of 
a Complex Disease
Kamayani Singh1, Honglin Wang2, Lisa Borkner1, Anca Sindrilaru1, Thorsten Peters1, 
Meinhard Wlaschek1, Karin Scharffetter-Kochanek1 1Department of Dermatology 
and Allergic Diseases, University of Ulm, Ulm, Germany, 2Shanghai Institute of 
Immunology, Institute of Medicine Science, Shanghai Jiao Tong University School of 
Medicine, Shanghai, China
Psoriasis is a chronic disease affecting skin in 2-3% of the general population. 
We previously showed that the CD18hypo PL/J mouse with a mutation resulting 
in a reduced expression of the common chain of ß2 integrins (CD11/CD18) 
spontaneously develops a skin disease that closely resembles human psoriasis. 
Interestingly, when backcrossed onto the C57BL/6J background no psoriasiform 
dermatitis developed, suggesting that apart from the CD18 hypomorphic mutation 
a small number of modifi er genes are required for the precipitation of the disease. 
Backcross analysis between susceptible CD18hypo PL/J mice and the resistant 
CD18hypo C57BL/6J strain and a genome-wide linkage analysis identifi ed susceptible 
loci on chromosome 6 and chromosome 10. Using a congenic approach, we 
identifi ed a 9-cM fragment on chromosome 10 with genes being responsible for 
the psoriasiform disease. Continuous backcrossing identifi ed a 1.2cM fragment 
which - if intercrossed - resulted in the disease. As we recently found that regulatory 
T cells as well as activated macrophages play a central role in the psoriasiform 
disease, our efforts will now concentrate on identifying potential modifi er genes 
which in conjunction with the CD18 hypomorphic mutation are responsible 
for the dysregulation of these cellular key players and the psoriasiform disease.
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Alterations in the structure and lipid composition of the stratum corneum in atopic 
dogs are normalized by food supplementation with essential fatty acids (Megaderm®) 
Iuliana Popa1, N Remoue1, Bilal Osta1, Didier Pin2, Marek Haftek1, Hugues Gatto3, 
Jacques Portoukalian11University of Lyon-1, Lyon, France, 2National Veterinary School 
of Lyon, Marcy l‘Etoile, France, 3Virbac SA, Carros, France
Whereas numerous reports have shown alterations of lipids in the human atopic 
skin, little information is available about the lipid composition and organization of 
the dog atopic skin. In the present study, the structure of the atopic dog epidermis 
was investigated by electron microscopy of biopsies, and the composition of 
free and protein-bound lipids of the stratum corneum was analyzed after tape 
stripping of non-lesional areas. The effect ESDR of a treatment of atopic dogs by 
food supplementation with a mixture of essential fatty acids (Megaderm®) was 
also studied on skin samples taken before and after treatment. Electron microscopy 
revealed that the non-lesional skin of atopic dogs exhibited an abnormal and 
largely incomplete structure of the lamellar lipids with little cohesion between the 
corneocyte strata. The stratum corneum of atopic dogs was characterized by an 
important heterogeneity in the lipid content of the successive layers. This feature 
was noticeable in the protein-bound lipids, and mostly in the omega-hydroxylated 
ceramides. Following oral treatment of atopic dogs with the mixture of essential 
fatty acids, the lipid content of the stratum corneum markedly increased and the 
distribution of the different classes of protein-bound lipids (cholesterol, fatty acids 
and ceramides) became much more homogenous in the successive layers of the 
stratum corneum. The study by electron microscopy confi rmed that the organization 
of lamellar lipids was normal in the skin of treated dogs. Our results show that 
the dog could be considered as a suitable model for studies on atopic dermatitis.
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MN8001, a dendritic polyglycerol, inhibits type I allergic responses
Julia Trosien1, Pia Welker2, Marcus Maurer1, Martin Metz1 1Charité-Universitätsmedizin 
Berlin, Berlin, Germany, 2Mivenion GmbH, Berlin, Germany
More than 20% of the world population suffer from type I allergic conditions such 
as atopic dermatitis, urticaria, or allergic rhinitis. Standard allergy treatments often 
fail to achieve symptom control, necessitating the development of novel drugs. 
Dendritic polyglycerols have been described to have anti-infl ammatory properties. 
Here, we investigated the effects of the dendritic polyglycerol MN8001 on type I 
allergic responses using passive systemic anaphylaxis (PSA) in mice as a model. 
C57BL/6 mice were sensitized by intraperitoneal injection (i.p.) of IgE anti-DNP. 
After 24 h, the animals were subcutaneously injected with MN8001 (30 mg/kg 
bodyweight) or vehicle and PSA was elicited 10 min later by i.p. injection of DNP. 
20 minutes after induction of PSA, vehicle-treated mice had a mean temperature 
drop of 3.5°C +/- 0.2 while  that of MN8001-treated mice was only 1.6°C +/- 0.3, 
p<0.005. Allergic type I reactions are caused by mast cell degranulation, which 
results in the release of biologically potent mediators such as histamine, cytokines 
and proteases. To test whether MN8001 can inhibit mast cell degranulation in PSA, 
we measured mouse mast cell protease-1 (mMCP-1), which is known to directly 
correlate with mast cell activation status. Notably, mMCP-1 concentrations in serum 
of MN8001-treated mice were reduced by ~50% when compared to vehicle-treated 
animals (6.0±1.1 pg/ml vs. 11.8±2.2 pg/ml, p<0.05). Our results indicate that the 
dendritic polyglycerol MN8001 potently reduces allergic hypersensitivity reactions 
in mice. Additional investigations are needed to further identify the mechanism 
of action and the treatment potential of the substance for allergies in humans.
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In situ Mycoplasma infection as aetiological factor in genital lichen sclerosus
Pónyai Katinka1, Pintér Dóra1, Blazsek Antal1, Merksz Miklós3, Kiss Attila3, 
Mazán Mercédesz1, Ostorházi Eszter1, Stipkovits László2, Kárpáti Sarolta1
1Semmelweis Univ Hungary, Dept of Dermatology, Venerology & Dermatooncology, 
Budapest, Hungary, 2Hungarian Academy of Sciences, Molecular Medicine Research 
Group, Budapest, Hungary, 3Heim Pál Hospital Dept of Urology, Budapest, Hungary
The pathogenesis of genital lichen sclerosus (GLS) is obscure: infections, infl ammatory and 
autoimmun processes were most commonly implicated. Since the genital localization of 
GLS we examined, whether systemic Mycoplasma (M.) or in situ urogenital M. hominis, 
M. genitalium, M. fermentans, or U. urealyticum infections could induce chronic skin 
infl ammation with sclerotic conditions. 21 male patients, who underwent therapeutic 
circumcision, have been selected for this study. 17 with GLS and 4 without GLS (WGLS) 
matched in age. (i) Preputial skin samples were histological examined. (ii) To determine 
prevalence of M.  DNA we utilized the previously described method of Strömer et al for 
broad range real-time PCR (RT-PCR) identifi cation of clinically important mollicute species 
on a Roche LC480 (Roche, Masnnheim, Germany). Skin samples were assayed for DNA 
using the QiaAMP DNA FFPE Kit (Qiagen, Hilden, Germany). Furthermore 14 GLS serum 
samples were evaluated also by: (iii) RT-PCR for general detection of M. DNA (MagnaPure 
Compact system - Roche, Masnnheim, Germany), (vi) and by M. pneumoniae/genitalium 
and Borrelia burgdorferi ELISAs. Skin samples from 13/17 (p<0.0001) GLS patients were M. 
RT-PCR positive, presenting a signifi cant difference to WGLS group (0/4, p<0.0002). 9/14 
cases showed serum M. RT-PCR positivity. M. pneumoniae /genitalium ELISA IgG positivity 
was detected in 4/14, IgM in 2/14 GLS cases without IgA antibodies. No Borellia burgdorferi 
seropositivity was observed. Our data indicate that chronic, latent genital M. infection could 
be a modifying factor of the local immune system and may contribute to development of GLS.
080
Increase in IL-17A and IL-22 producing CD8 T cells in lesional psoriatic skin
Pieter Res, Gamze Piskin, Onno de Boer, Chris van der Loos, Peter Teeling, Jan Bos, 
Marcel Teunissen Academic Medical Center, Amsterdam, Netherlands
T cells that produce IL-17A and IL-22 have been suggested to play an important role 
in the pathogenesis of psoriasis. We determined the presence and distribution of such 
cells in situ as well as the frequency and heterogeneity of skin-derived CD4 and 
CD8 T cells that produce these cytokines. Double-stained sections from psoriatic and 
normal skin were analyzed by spectral imaging and in vitro-activated skin-derived T 
cells were analyzed by fl ow cytometry. We found that IL-17 was mainly expressed by 
mast cells and neutrophils and IL-22 by macrophages and dendritic cells, whereas 
only an occasional IL-17pos T cell and no IL-22pos T cells could be detected in psoriatic 
skin. Activation of skin-derived T cells in vitro, however, revealed that substantial 
percentages of cutaneous T cells were able to produce IL-17A or IL-22 or both. 
Remarkably, the percentages of CD8 T cells that expressed IL-17A and/or IL-22 (Tc17 
and Tc22) were signifi cantly higher in psoriatic dermis and even more pronounced 
in psoriatic epidermis than in normal skin. On the other hand, psoriatic skin and 
normal skin contained similar percentages of IL-17Apos and/or IL-22pos CD4 T cells 
(Th17 and Th22). Overrepresentation of Tc17 and Tc22 cells in psoriatic skin could 
result from a local disease related expansion and thus indicates a possible role in the 
pathogenesis of psoriasis. As IL-17A and IL-22 are crucial in psoriasis, also non-T 
cells that express IL-17A and/or IL-22 may represent potential targets for therapy.
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Comprehensive analysis of intact sebaceous lipids to investigate the fate of free fatty 
acids in human sebocytes
Emanuela Camera1, Arianna Mastrofrancesco1, Matteo Ludovici1, Daniela Kovacs1, 
Monica Ottaviani1, Christos C. Zouboulis2, Mauro Picardo1 1Lab of Cutaneous 
Physiopathology & Integrated Center of Metabolomics Research, San Gallicano 
Dermatological Institute (IRCCS), Rome, Italy, 2Depts of Dermatology, Venereology, 
Allergology & Immunology, Dessau Medical Center, Germany
Various long chain free fatty acids (FFA) have demonstrated a considerable lipogenetic activity in 
human sebocytes. However, little is known on the metabolic fate of exogenously added FFA and 
their capacity to promote sebaceous lipogenesis. To investigate how FFA are processed in human 
sebocytes to form sebaceous lipids, we exposed the SZ95 sebaceous gland cell line to exogenously 
supplied saturated (C16:0), monounsaturated (Δ9 C16:1, and Δ9 C18:1), and polyunsaturated 
(Δ9,12 C18:2, Δ9,12,15 C18:3 and Δ5,8,11,14 C20:4) FFA, each at the concentration 100 µM 
for 24 h. Lipid species were directly and simultaneously analyzed in crude cell extracts by RR-
RP-HPLC/TOF MS, which allowed selecting and profi ling the intact lipids belonging to their 
respective sebaceous classes, such as triacylglycerols (TAG), diacylglycerols  (DAG), wax esters 
(WE), cholesteryl esters (CE), and FFA. Structure elucidation of individual neutral lipids was 
undertaken by MS/MS experiments. The RR-RP-HPLC/TOF MS and MS/MS analysis proved 
that the exogenously supplied FFA were uploaded into SZ95 cells and incorporated into the 
above neutral lipid classes as unprocessed acyl moieties. Moreover, exogenously added FFA 
underwent multiple metabolic processing, which included single and double desaturation 
steps, oxidation, and elongation by two carbon atoms units. The newly formed FFA were 
incorporated into neutral lipids and contributed to the multiplicity of acylglycerols (TAG and 
DAG), WE, and CE species induced by naïve exogenous FFA. Unequivocal identifi cation and 
intracellular levels of species formed following lipogenic stimuli by FFA provided further insights 
into the enzymatic pathways concurring to the synthesis of sebaceous lipids in culture systems.
082
Intense pulsed light‘s effect on infl ammatory acne vulgaris is associated with 
alterations in TLR2 and IL-8 expression
Marisa Taylor, Maria Gonzalez, Rebecca Porter Cardiff University, Cardiff, UK
In acne vulgaris P. acnes binds to toll like receptor 2 (TLR2), activating the NFκB 
pathway resulting in the production and release of several infl ammatory cytokines 
including IL-8.  Intense pulsed light (IPL) is a broad-spectrum high intensity visible 
light source that has been said to be anti-infl ammatory; however the mechanism is 
uncertain. This study aimed to determine whether IPL had any effect on well known 
markers of infl ammation including IL-8 and TLR2. Twenty-nine patients with mild 
to moderate acne on their backs were treated with fi ltered IPL (peak emission at 
530 nm) 4 times over 9 weeks.  4 mm punch biopsies of clinically uninvolved skin 
within the treatment area were taken at baseline, 2 days after the fi rst treatment and 
1 week after the fi nal irradiation. There was a signifi cant but small improvement in 
infl ammatory lesion counts of 33.5% (p = 0.003).  TLR2 and IL-8 RNA expression 
was evaluated in 11 cases via semi-quantitative PCR and visualised on 2% agarose 
gel. In 45.5% of cases, TLR2 and IL-8 were clearly down regulated, whereas the 
levels remained stable in 27.3% and increased in 27.3%. For each case, the trends 
noted in TLR2 expression were identical to the changes noted for IL-8. Using 
band intensities estimated through the AlphaImager® spot densitometry utility, 
there was a mean increase of 44.0% ± 79.79 in TLR2 and 3.24% ± 26.0 in IL-8 
mRNA expression. Despite the clinical reduction in infl ammatory lesion counts, 
IPL’s anti-infl ammatory effect may not be mediated via the TLR2-IL8 pathway. 
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Licochalcone A protects against oxidative stress via activation of Nrf2
Jochen Kühnl, Kolbe Ludger, Jeannine Immeyer, Stäb Franz, Wenck Horst, Neufang 
Gitta Beiersdorf AG, Hamburg, Germany
Licochalcone A, a reversely constructed chalcone or retrochalcone, has previously 
been shown to possess strong anti-infl ammatory properties. Licochalcone A inhibits 
the secretion of pro-infl ammatory eicosanoids and cytokines. These anti-infl ammatory 
effects are associated with the inhibition of NFκB signaling. In this study we focused 
on the anti-oxidative properties of Licochalcone A. We show that Licochalcone A 
protects against oxidative stress mediated by reactive oxygen species in in vitro 
experiments as well as in vivo after topical application on the skin. Licochalcone A 
inhibited the formation of reactive oxygen species in UVA-irradiated or hydrogen-
peroxide treated human dermal fi broblasts as well as in pro-infl ammatory activated 
neutrophils. Mechanistically, Licochalcone A induced nuclear translocation of the 
transcription factor Nrf2 in primary human fi broblasts, resulting in a many-fold 
increase in the mRNA and protein levels of the cytoprotective and anti-infl ammatory 
enzyme heme oxygenase-I. Furthermore, Licochalcone A incubation increases the 
mRNA expression level of the glutamate-cysteine ligase regulatory subunit. Staining 
of intracellular thiols after Licochalcone A treatment revealed an elevated glutathione 
level in primary human dermal fi broblasts compared to non-treated control cells. 
These results correlated with in vivo experiments, showing a decrease in UVA-
induced and ROS-dependent ultra-weak photon emission after topical application 
of Licochalcone A. We conclude from these data that Licochalcone-induced 
Nrf2 activation is an important contributor to cytoprotection in human skin cells.
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A possible role for LFA-1, CD39 and CD73 in regulatory T and B cells in psoriasis
Sarah Terras1, Ilse Mollet1, Melissa Dullaers2, Nanja van Geel1, Jo Lambert1
1Department of Dermatology, Ghent University Hospital, Ghent, Belgium, 2Laboratory 
of Immunoregulation and Mucosal Immunology, Department of Pulmonary Medicine, 
Ghent University Hospital, Ghent, Belgium
Regulatory T cells (Tregs) play a key role in autoimmune skin diseases such as psoriasis. 
The mechanisms by which Tregs mediate their function are not yet fully elucidated. 
Lymphocyte-function-associated protein-1 (LFA-1; CD11a/CD18), CD39 and CD73 
on the surface of Tregs, are thought to play an important role. As regulatory functions 
were also recently attributed to B cells, we assessed the role for these markers in 
regulatory T and B cells in peripheral blood and skin of healthy donors and psoriatic 
patients. No difference was seen in frequencies of circulating CD4+, CD4+FOXP3+, 
CD4+CD25+FOXP3+, and  CD19+ cells between healthy and psoriatic patients, 
although a lower frequency of CD8+ cells was observed in blood of psoriatic patients 
(p=0.0841). In contrast, a higher infi ltrate of CD8+ cells was detected in lesional 
psoriatic skin, tending to express more CD11a and CD18, as compared to non-
lesional skin (p=0.0547; p=0.0781). The expression level of CD18 on CD19+ B cells 
was lower in psoriatic patients as compared to healthy donors. Higher frequencies of 
CD39+ and CD39+CD73+ T cells were observed in both healthy and psoriatic skin, as 
compared to the peripheral blood. Circulating Tregs showed a higher expression of 
CD11a in psoriasis (p=0.03111), without an increased CD18-expression. This suggests 
a role for CD11a in the dysfunction of Tregs in psoriasis. The altered expression of 
CD18 on B cells in psoriasis suggests a role for B cells in the pathogenesis of psoriasis. 
Further research on T and especially B cells is needed to elaborate these fi ndings. 
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TGF-β considered as an immuno-regulator in healthy controls becomes pathogenic 
in systemic sclerosis by regulation of IL-13 synthesis
Julie Baraut1, Dominique Farge1,2, Elena Ivan Grigore1, Francette Jean-
Louis1, Elodie Begue1, Zakia Hadjali1, Franck Verrecchia3, Laurence Michel1
1INSERM U976, Hôpital Saint Louis, PARIS, France, 2Service de Médecine Interne, 
Hôpital Saint Louis, PARIS, France, 3INSERM U957, Nantes, France
Systemic sclerosis (SSc) is an auto-immune disease characterized by skin 
fi brosis and internal organ dysfunction. Fibrosis observed in SSc patients is due 
to excessive collagen (type 1) deposition. It has been shown that TGF-β and IL-
13 are closely involved in collagen production and elevated levels of these two 
cytokines have been observed in SSc serum. TGF-β activates directly collagen 
synthesis whereas IL-13 promotes fi brosis by stimulating TGF-β production. In 
the present study, we analyzed TGF-β effect on IL-13 expression by lymphocytes 
from SSc patients compared to healthy donors. Jurkat cell line was used as a Th2 
model to study the TGF-β signaling pathway involved in IL-13 production. Analysis 
of IL-13 promoter activity, IL-13 mRNA and protein expression was studied in 
response to TGF-β exposure (5ηg/mL and 10ηg/mL), during 2 to 48hours. Our 
results show that TGF-β inhibits IL-13 production by 20 to 40% in normal T 
lymphocytes and in Jurkat cell line, as shown by downregulation of promoter 
activity, mRNA and protein expression level. By using specifi c inhibitors, we 
demonstrated that TGF-β inhibits IL-13 through activation of both MAPkinase 
(p38 pathway) and Smad pathways to induce repression of GATA-3 transcription 
factor. In contrast to Jurkat cell line and normal T lymphocytes, TGF-β induces an 
increase in IL-13 mRNA and protein production by 35 to 43% in SSc lymphocytes. 
TGF-β might be considered as an immuno-modulator in normal situation 
and conversely, as a potent immuno-activator in SSc pathological situation.
086
Participation of IL-13 in the cytokine network of psoriasis
Johann Gudjonsson, Xianying Xing, MaryBeth Riblett, James Kochkodan, Andrew 
Guzman, James Elder, Andrew Johnston Department of Dermatology, University of 
Michigan, Ann Arbor, MI, United States
Recent genetic studies have shown that a variant in the IL4/IL13 region on 
chromosome 5 contributes to increased risk of psoriasis.  This variant (rs20541) 
leads to nonsynonymous basepair change in the IL13 gene.  Although IL-13 has 
traditionally been classifi ed as a Th2 cytokine its role in psoriasis is unknown. IL13 
mRNA (n=38, p<0.01) and protein levels (n=12, p<0.01) were increased in lesional 
psoriatic compared to uninvolved skin.  Flow cytometric analysis of lesional skin 
lymphocytes demonstrated that the IL-13 was derived from CD4 and CD8+ T-cells 
(2-3% of total).  There was increased expression of both chains of the IL-13 receptor 
(IL-4R and IL13-Rα1) in lesional compared to uninvolved psoriatic skin (n=38, 
p<0.0001, p<0.05, respectively) whereas IL13RA2, a soluble inhibitor of IL-13 was 
decreased (n=38, p<0.05).  Immunohistochemistry and fl uorescent microscopy 
revealed staining for IL-4R and IL-13Rα1 in psoriatic epidermis with intense foci 
of co-localization limited to few cells within the infl ammatory infi ltrate.  These 
cells corresponded to monocytes as confi rmed by fl ow cytometry.  Using cytokine-
stimulated post-confl uent NHKs we observed a dose-dependent induction of IL4R 
and IL13RA1 with IFN-γ and IL-22 (>3-fold, p<0.01).  IL-13 synergized with IFN-γ 
in the induction of CXCL9 and CXCL10 by NHKs (p<0.001, p=0.08, respectively 
n=3) whereas it suppressed IFN-γ- and IL-17-induced CCL20 and DEFB4 expression 
(p<0.01, n=3). Our results suggest that IL-13 plays a complex role in psoriasis acting 
both on the epidermis and the infl ammatory infi ltrate potentially leading to shifts 
in the polarization of the infi ltrate through its activity on chemokine production.
087
Immunopathology of “neutrophilic“ primary cicatricial alopecias
Matthew Harries1, Christopher Griffi ths1, Ralf Paus1,2 1The University of Manchester, 
Manchester, United Kingdom, 2University of Lubeck, Lubeck, Germany
Folliculitis decalvans and dissecting cellulitis are two clinically distinct cicatricial 
alopecias characterised by a predominantly neutrophilic infi ltrate on scalp histology 
in association with hair follicle destruction and fi brosis. The pathogenesis of these 
disorders is unknown, but damage to epithelial hair follicle stem cells (eHFSC) located 
at the hair follicle bulge is thought to be a crucial pathogenic event. The aim of this study 
is to map the infl ammatory cell infi ltrate of the «neutrophilic» cicatricial alopecias and 
specifi cally to examine whether eHFSC damage and bulge immune privilege collapse 
play a role in disease pathogenesis. Paired frozen biopsies of lesional and un-involved 
scalp skin from affected patients (n=10), along with paraffi n-embedded samples from 
patients (n=12) and normal controls (n=15) were examined. Immunohistochemical 
staining with CD1a, CD4, CD8, CD56, CD68, mast-cell tryptase, FoxP3, CD209, 
CD123, Ki67 and CXCR3 was performed and mapped to defi ned epithelial 
compartments of the hair follicle as well as the corresponding connective tissue 
sheath. Further, stains for apoptosis (TUNEL), immune privilege (MHC I and MHC II) 
and eHFSC (K15) were also examined. Semi-quantitative immunohistomorphometry 
at the bulge showed signifi cant up-regulation of MHC class I (p=0.007), along 
with increased MHC class II+ cells, in lesional compared to uninvolved scalp 
skin. Further, keratin 15 expression was signifi cantly reduced (p=0.04) in diseased 
tissue; whereas bulge Ki67+ and TUNEL+ cells were signifi cantly more prominent.
These results support the idea that bulge eHFSC damage is a key component in 
disease pathogenesis, and that bulge IP collapse is present in established disease. 
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Characterisation of T cell infi ltration in guttate and chronic psoriasis
Liv Eidsmo, Mona Ståhle Karolinska Institutet, Stockholm, Sweden
T cell infi ltration into the skin is associated with disease severity in psoriasis. A 
heterogeneous pattern of T cell infi ltration, with CD8+ epidermal T cells and several 
different types of  dermal CD4+ and CD8+ T cells has been proposed. The aim 
of the present project was to characterise the profi le of T cells infi ltrating into the 
skin during different clinical manifestations of psoriasis. The Stockholm Psoriasis 
cohort was utilised to collect skin biopsies from acute guttate and plaque psoriasis 
followed by FACS analysis of tissue derived cells and confocal microscopy of 
cryopreserved skin biopsies. T cell infi ltration in epidermis was more pronounced 
during chronic as compared to guttate psoriasis.  The number of T cells correlated 
to the epidermal hyperplasia in agreement with the notion that epidermal T cell 
infi ltration drives the pathogenic process. Organised dermal lymphoid structures 
containing CD8+, CD4+ and FoxP3+ T cells together with dendritic cells were 
predominantly detected in dermis of chronic psoriasis. In chronic lesions the 
endothelium of dermal blood vessels frequently expressed peripheral node 
addressin (PNAd) which primarily if found on blood vessels in lymph nodes. One 
known function of PNAd is interactions with CD62L expressed on naive T cells 
as well as central memory cells. Our results indicate differential T cell infi ltration 
in acute (guttate) and chronic (plaque) psoriasis. The presence of lymphoid blood 
vessels in the chronically infl amed skin could potentially allow different subtypes 
of circulating lymphocytes to enter the lesions as compared to normal skin.
089 [Oral 042]
The role of the receptor tyrosine kinase Axl in intercellular adhesion and signalling 
in cutaneous squamous cell carcinoma
Monika Cichon, Ian Mackenzie, Edel O‘Toole Centre for Cutaneous Research, 
BICMS, Barts and the London SMD, Queen Mary University of London, London, 
United Kingdom
Axl is a receptor tyrosine kinase upregulated in many tumours including cutaneous 
squamous cell carcinoma (SCC) and breast cancer. Axl expression in cancer is 
associated with metastasis and poor prognosis. We hypothesized that Axl might play a 
role in intercellular adhesion which when disrupted leads to tumour progression and 
metastasis. To study this hypothesis, we established stable knock-down (KD) of Axl 
in cutaneous SCC and breast cancer cell lines overexpressing Axl. Subsequently, we 
studied colony morphology, intercellular adhesion and cell adhesion-related signalling 
pathways. We found that Axl KD led to formation of tighter colonies and increased 
strength of cell-cell interactions. Western blotting analysis and immunofl uorescence 
staining of cell monolayers or organotypic cultures revealed that Axl KD in skin 
cancer cell lines caused re-distribution of cell junctional components such as alpha-
catenin, p120-catenin, plakoglobin, ZO-1 and claudin-1 to the membrane (similar 
to control HaCaT keratinocytes). Live cell imaging revealed impaired migration of 
cells with Axl KD compared to controls. Furthermore, there was decreased nuclear 
localization and activation of beta-catenin and reduced phosphorylation of GSK3 
in those cells suggesting that Axl plays a role in Wnt signalling. Our recent gene 
array data show changes in cell-matrix adhesion molecules that we are going to 
investigate further. We also observed that Axl expression correlates with putative 
cancer stem cell markers CD44 and ALDH-1 indicating that Axl might play a role 
in cancer stem cell resistance to chemotherapy. In conclusion, our results suggest 
that Axl is a promising target for future therapeutic intervention in skin cancer.
090 [Oral 043]
Defective granulation tissue formation in mice with specifi c ablation of integrin-
linked kinase in fi broblasts - role of RhoA/ROCK signaling and TGFβ1 levels
Katrin Blumbach1, Manon C. Zweers1, Georg Brunner2, Andreas S. Peters1, Markus 
Schmitz1, Jan-Niklas Schulz1, Christopher P. Denton3, Reinhard Fässler4, Thomas 
Krieg1, Beate Eckes1 1Dermatology, University of Cologne, Cologne, Germany, 2Cancer 
Research, Fachklinik Hornheide, Münster, Germany, 3Rheumatology, UCL, London, 
United Kingdom, 4Max-Planck Institute, Martinsried, Germany
The extracellular matrix is a key regulator of cell functions, e.g. proliferation, differentiation 
and migration. Binding of matrix macromolecules to integrins initiates the assembly of 
large intracellular multiprotein complexes, the focal adhesions, which mediate cell-
extracellular matrix communication. Integrin-linked kinase (ILK) is a central adapter 
recruited to integrin β1 tails in focal adhesions, connecting the outside environment 
to the actin cytoskeleton. Wound healing critically relies on mechanical activities of 
fi broblasts responding to forces transmitted across focal adhesions. Here, we report the 
generation of mice with inducible inactivation of ILK specifi cally in fi broblasts. Excisional 
wounds in these animals are characterized by absence of myofi broblasts, disturbed 
granulation tissue formation and strongly reduced wound contraction. Primary skin 
fi broblasts derived from such mice failed to secrete normal levels of TGFβ1 and showed 
strongly diminished αSMA expression, indicating that myofi broblast differentiation was 
hampered. This defect was rescued by exogenous TGFβ1, underscoring the importance of 
fi broblast-generated locally active TGFβ1 for myofi broblast function. ILK-null fi broblasts 
were also characterized by abnormal morphology due to impaired cell spreading. This 
was found to be due to enhanced RhoA/ROCK signaling. Addition of ROCK inhibitor 
Y-27632 not only restored cell morphology but also largely rescued TGFβ1 amounts in 
culture supernatants. We conclude that ILK is crucial for fi broblasts by limiting RhoA 
activity, which, if uncontrolled, precludes myofi broblast differentiation and function. 
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Transmembrane Collagen XVII Is Involved In The Glomerular Filtration Barrier 
Failure In Knock Out Mice
Jyri Moilanen1, Raija Sormunen3,4, Claus-Werner Franzke2, Stefanie Loeffek2, Raija 
Soininen3,4, Leena Bruckner-Tuderman2, Kaisa Tasanen1, Helena Autio-Harmainen4, 
Tiina Hurskainen1 1Dept of Derm, Univ of Oulu & Clin Res Center, Oulu Univ Hosp 
Finland, 2Dept of Derm, Univ Med Ctr Freiburg, Germany, 3Bioctr Oulu, Univ of Oulu, 
Finland, 4Dept of Path, Univ of Oulu, Finland, 5Dept of Paed, Oulu Univ Hosp, Finland
Collagen XVII is a hemidesmosomal transmembrane component required for epithelial adhesion 
in skin. We have recently shown that collagen XVII is also expressed by podocytes, the visceral 
epithelial cells of the glomerulus. The role of collagen XVII in glomerular fi ltration barrier was 
further analyzed in collagen XVII knockout mice. Homozygous mice survived to birth, but 
had high neonatal mortality and growth retardation. As expected, all Col17-/- mice developed 
blisters and detachment of epidermis by applying mild mechanical trauma, non-pigmented 
hair growth and partial hair loss. Histopathology of skin showed subepidermal blistering, and 
electron microscopy revealed rudimentary and poorly developed hemidesmosomes, splitting 
of cutaneous basement membrane at the hemidesmosomal level and degeneration of basal 
keratinocytes. In addition to skin, the lack of collagen XVII caused several abnormalities in 
kidneys under physiological conditions. Autopsy of the Col17-/- mice revealed smaller and 
paler kidneys than those isolated from age matched control animals. In electron microscopy 
the number of glomeruli and the number and formation of podocytes and the foot processes 
was altered in mutant mice. Furthermore, a massive effacement of podocyte foot processes was 
detected, but no major slit diaphragm disruption. The glomerular basement membrane was 
detached especially on its endothelial side. Expression and localization of collagen IV was similar 
in control and mutant mice. We propose that collagen XVII is a novel component that attaches 
endothelial cells and podocyte foot processes to the glomerular basement membrane. It probably 
contributes to podocyte maturation and differentiation and may have a role in glomerular fi ltration.
092 [Oral 006]
Role of Caveolin-1 in Desmosomal Homeostasis and Desmoglein-Mediated Signaling
Donna Brennan1, Sirkku Peltonen2, Alicia Dowling1, Walid Medhat1, Kathleen Green3, 
Francesco Del Galdo4, My Mahoney1 1Thomas Jefferson University, Philadelphia, PA, 
United States, 2University of Turku, Turku, Finland, 3Northwestern University, Chicago, 
IL, United States, 4St James’s University Hospital, Leeds, United Kingdom
Desmosomal cadherins are often found aberrantly expressed in various carcinomas. 
These cadherins can modulate signaling pathways directly relevant to epithelial 
cell proliferation and survival, however the mechanism by which these proteins 
could activate mitogenic signaling is not well understood. Using biochemical and 
immunological means, we demonstrate that desmogleins (Dsg) bound to and co-
localized with caveolin-1 (Cav-1), the major protein of the specialized membrane 
microdomains caveolae. Caveolins have been implicated as modulators of 
signal transduction through the binding of key mitogenic signaling molecules 
to their scaffolding domains. Here we show by discontinuous sucrose-gradient 
ultracentrifugation the localization of Dsg with Cav-1 in the lipid raft fractions. 
Disruption of caveolae formation shifted Cav-1 and Dsg into non-raft fractions and 
compromised desmosomal cell-cell adhesion. Sequence analysis revealed that the 
intracellular cadherin segment of Dsg contain the putative Cav-1 binding motif. Using 
a cell permeable drug delivery competing peptide resembling the Cav-1 scaffolding 
domain, we showed that the peptide bound to Dsg further confi rming a Dsg-Cav-1 
interaction. Finally we demonstrate that Cav-1 modulates Dsg expression in the skin and 
may play an important role during the skin tumor development and the pathogenesis 
of pemphigus. In summary, the data presented here provide tantalizing clues that 
the mechanism by which Dsg mediate intracellular signaling may involve Cav-1.
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Epidermal Tight Junction Maintains Calcium Distribution in Human Reconstructed 
Epidermis and Regulates the Epidermal Differentiation
Hiroyuki Sasaki1, Tetsuo Maeda2, Shohei Kuroda2, Masumi Kurasawa2, Ai Oba2, 
Takuya Yamamoto2 1The Jikei University School of Medicine, Minato-ku, Tokyo, Japan, 
2Pola Chemical Industries Inc., Totsuka-ku, Yokohama, Japan
Tight junctions (TJs) among adjacent epithelial cells control paracellular permeability 
of solutes. Epidermal TJs are considered as restrictions on molecular movement to assist 
stratum corneum as secondary barrier in the skin. However, a role of TJ on molecular 
distribution in the epidermis is not closely studied. Calcium ion (Ca2+), a well-known 
differentiation inducer for keratinocytes, distributes forming vertical gradient peaked 
at stratum granulosum. In this study, we applied sodium caprate (C10) which elicits 
dilations of TJ on human reconstructed epidermis, and investigated Ca2+ distribution 
in the epidermis. The localization of Ca2+ in the epidermis was observed by ion-
capture cytochemistry and electron energy-loss spectroscopy of the transmission 
electron microscope. After C10 treatment, the epidermal Ca2+ localization was largely 
altered compared to the untreated epidermis. Ca2+-containing precipitates appeared 
in intra- and extra-cellular spaces of the stratum corneum, and large clusters of Ca2+-
containing precipitates were occasionally observed in the stratum corneum and 
the stratum granulosum. Additionally, abnormal differentiation (e.g. parakeratosis) 
was also observed in the stratum granulosum. To confi rm that these changes were 
caused by TJ disruption, we observed the structure of TJ strands by freeze fracture 
replica method, and measured trans-epidermal Ca2+ permeability by quantifying 
diffused Ca2+ through the epidermis. As a result, the TJ strands were fragmented and 
the Ca2+ permeability increased. These data suggest that the epidermal TJ maintains 
Ca2+ under the stratum corneum, and regulates the epidermal differentiation.
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Phospholipid Scramblase 1 is Secreted by an Unconventional Mechanism and 
Interacts with the Extracellular Matrix Protein 1 in the Dermal Epidermal Junction 
Zone of Human Skin
Joseph Merregaert1, Johanna van Langen2, Uwe Hansen1, Ellen Steenackers1, 
Peter Ponsaert1, Abdoel El Ghalbzouri3, Xavier Van Ostade1, Sandy Sercu1
1University of Antwerp, Wilrijk/Antwerp, Belgium, 2University Hospital of Muenster, 
Muenster, Germany, 3Leiden University Medical Center, Leiden, Netherlands
In an effort to defi ne the biological functions of extracellular matrix protein 1 (ECM1) a yeast-two-
hybrid screen was performed. This led to the identifi cation of the type II transmembrane protein, 
phospholipid scramblase 1 (PLSCR1) as a binding partner. This interaction was confi rmed by co-
immunoprecipitation, and pull down experiments with GST-tagged ECM1a fragments identifi ed 
that this interaction occurs within the tandem repeat region of ECM1a. Immunohistochemical 
staining revealed a partial overlap of ECM1 and PLSCR1 in human skin at the basal epidermal 
cell layer. Both proteins are deposited at the basal membrane in a dermal fi broblast dependent 
manner in human skin equivalents. Furthermore, immunogold electron microscopy of ultrathin 
human skin sections showed that ECM1 and PLSCR1 co-localize in the extracellular matrix. 
Using antibodies against ECM1 or PLSCR1 cross-linked to magnetic immunobeads we were 
able to prove the PLSCR1/ECM1 interaction in human skin extracts. Confocal microscopy 
on cultured keratinocytes demonstrated intracellular separation of both proteins with ECM1a 
in Golgi apparatus secretory vesicles and PLSCR1 mainly at the plasma membrane, thereby 
excluding intracellular interaction. Using different experimental set-ups we were able to 
exclude involvement of the Golgi apparatus, lysosomal transport, membrane translocation and 
palmitoylation as potential mechanisms for PLSCR1 secretion. However, methyl-β-cyclodextrin 
reduced the release of PLSCR1 from HaCat monolayer cultures. In summary, we here demonstrate 
that PLSCR1 interacts with the tandem repeat region of ECM1a in the dermal epidermal 
junction zone of the human skin and that PLSCR1 is secreted by a lipid raft-dependent pathway.
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Collagen deposition assessment in burn scar tissue using second harmonic 
generation and multi-photon microscopy
Alice Chen1, Pei-Yun Liu1, Celia McNeilly2, Leila Cuttle1, Margit Kempf1, 
Mark Kendall2, Roy Kimble1, Hiroshi Shimizu3, James McMillan1,3
1Centre for Children‘s Burns Research, Queensland Children’s Medical Research 
Institute, University of Queensland, Brisbane, Australia, 2Australian Institute for 
Bioengineering & Nanotechnology, Univ of Queensland, Brisbane, Australia, 3Dept 
of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
High-resolution, high-contrast, three dimensional images of live cell and tissue 
architecture can be obtained using second harmonic generation (SHG), which 
comprises non-absorptive frequency changes in an excitation confocal laser 
line. SHG does not require any exogenous antibody or fl uorophore labelling, 
and is capable of capturing images from unstained sections and of several key 
endogenous biomolecules, in a wide variety of species and from different types 
of processed tissue. Here, we examined normal control human skin sections 
and human burn scar tissues using SHG on a multi-photon microscope (MPM). 
Examination and comparison of normal human skin and burn scar tissue 
demonstrated clear fi brous dermal staining similar to dermal fi bre collagen signal. 
Fluorescence-staining confi rmed MPM-SHG collagen colocalisation with antibody 
staining for dermal collagen I but not fi bronectin or elastin. Furthermore, we 
were able to detect collagen MPM-SHG signal in human frozen sections as well 
as in unstained paraffi n embedded tissue sections. This same approach was also 
successful in localising collagen in porcine and ovine skin samples, and may be 
particularly important when species-specifi c antibodies may not be available. 
Taken together, our results demonstrate that MPM SHG-detection is a useful tool for 
examination of collagen architecture in human, porcine and ovine dermal tissue.
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Identifi cation and characterisation of DSPIa, a novel isoform of human desmoplakin
Rita M. Cabral1, Hong Wan2, Clare L. Cole3, Dominic J. Abrams4, David P. Kelsell1, 
Andrew P. South1,3 1Centre for Cutaneous Research, Blizard Institute of Cell and 
Molecular Science, University of London, United Kingdom, 2Centre for Clinical and 
Diagnostic Oral Sciences, Institute of Dentistry, St Bartholomew‘s Hospital and The 
London School of Medicine and Dentistry, University of London, London, United 
Kingdom, 3Centre for Oncology & Molecular Medicine, University of Dundee, 
Ninewells Hospital & Medical School, Dundee, United Kingdom, 4Department of 
Cardiac Electrophysiology, St Bartholomew‘s Hospital, London, United Kingdom
Desmoplakin is a ubiquitous component of desmosomes and desmosome-
like structures, such as the cardiomyocyte area composita. Two major isoforms, 
desmoplakin I (DSPI) and desmoplakin II (DSPII) are encoded by alternative mRNA 
transcripts differentially spliced from the same gene. The resulting proteins are 
identical in amino acid sequence with the exception that DSPII contains only one 
third of the central alpha-helical rod domain present in DSPI. Here we describe a 
novel minor isoform of desmoplakin that is also produced by alternative splicing 
of the desmoplakin gene and that we name desmoplakin Ia (DSPIa). DSPIa is 
an alternatively spliced DSPI mRNA with a unique splice donor site that is 90% 
homologous to and downstream of the DSPII specifi c donor. The resulting DSPIa 
mRNA is in-frame and encodes a protein that has a central alpha-helical rod 
domain of intermediate size and that is 156 amino acids larger than DSPII and 
443 amino acids smaller than DSPI. We demonstrate, through recombinant 
expression and short interfering RNA knockdown, that the DSPIa protein is readily 
detectable, albeit at substantially lower levels than the dominant isoforms, DSPI and 
DSPII. DSPIa mRNA has a similar tissue distribution to that of DSPI and of DSPII.
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The interstitial collagenases MMP-13 and MMP-14 are dispensable for the early 
onset of skin morphogenesis
Birgit Seyfarth1,2, Alexander Schild1,2, Cornelia Mauch1,2, Paola Zigrino1,2
1University of Cologne, Cologne, Germany, 2Centre for Molecular Medicine (CMMC), 
Cologne, Germany
Connective tissue metabolism in skin is characterized by equilibrium of continuous 
synthesis and degradation of interstitial collagens e.g. the fi brillar collagen types I and 
III. These collagens are substrates of MMP-14 and MMP-13 the major collagenases 
synthesized by murine fi broblasts in vitro. MMP-14 defi ciency in vivo results in 
death of mice by 3 weeks of age and several skeletal abnormalities, while MMP-13 
defi ciency has no obvious phenotype. We have analyzed the effect of ablation of 
MMP-14 on collagen metabolism in vivo and in vitro. Histological analysis did not 
display any abnormality in skin architecture and collagen distribution in MMP-14 
knockout mice. In vitro, analysis of collagen expression in fi broblasts isolated from 
MMP-14 knockout animals showed accumulation of collagen type I as compared 
to control fi broblasts. Similarly, in human dermal fi broblasts silencing of MMP-14 
resulted in an elevated collagen type I deposition on culture dishes. Nevertheless 
protein extraction of neonatal skin from MMP-14 knockout animals did not show any 
difference in collagen amount when compared to wild type animals. To investigate 
the role of MMP-13 in collagen metabolism, we generated mice carrying ablation of 
both genes. Surprisingly, mice depleted for both collagenolytic enzymes were born 
and recapitulate the MMP-14 knockout phenotype. Skin architecture and collagen 
distribution in these animals did not show any obvious difference or evidence for early 
fi brosis. In summary, our results show that ablation of both collagenases is compatible 
with birth and is dispensable for collagen metabolism in newly formed skin.
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Epithelial-mesenchymal transition in skin fi brosis and tumor progression
Motonobu Nakamura, Yoshiki Tokura University of Occupational and Environmental 
Health, Kitakyushu, Japan
Epithelial-mesenchymal transition (EMT) is a process by which epithelial cells lose 
their epithelial characteristics and acquire mesenchymal-like phenotypes.  EMT was 
initially described in early embryogenesis, however, we have recently revealed a role 
of EMT in the pathogenesis of postmenopausal frontal fi brosing alopecia.  The aim 
of this study was to examine whether EMT took place also in systemic sclerosis and 
spindle cell squamous cell carcinoma (SCC).  Immunohistochemisty using antibodies 
against EMT markers, Snail homolog 1 (SNAI1), Twist1 (TWIST1), and N-cadherin 
(CDH2), revealed that these proteins were expressed in the eccrine glands and hair 
follicles of patients with diffuse cutaneous SSc (dSSc) and spindle cell SCC cells. 
Real-time PCR analysis showed that SNAI1 mRNA expression was augmented in the 
skin of dSSc patients and spindle cell SCC.  In a bleomycin injection-induced SSc 
model in mice, bleomycin promotes both Snai1 and collagen type 1 α1 (Col1a1) 
expression in the skin.  To examine whether EMT inducer, TGF-β1, can evoke EMT 
in vitro, we cultured mouse keratinocyte cell line, PAM212 cells, in the presence 
of TGF-β1.  TGF-β1 induced the spindle-shaped morphology of PAM212 cells and 
upregulated the expression of Snai1 and Col1a1, while it had no effect on other 
mesenchymal markers, indicating a partial recapitulation of EMT by TGF-β1 in 
vitro.  These results suggest that EMT may be involved in the pathogenesis of SSc 
and spindle shaped SCC.  A suppression of EMT, e.g. inhibition of SNAI1 and/or 
TGF-β1, may become a new therapeutic approach for SSc and spindle shaped SCC.
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Platelet-B16 melanoma interactions augment integrin-mediated tumor cell adhesion 
and promote lung metastasis formation
Anke Lonsdorf1, Alexander Enk1, Harald Langer2 1Dept. of Dermatology, University 
Hospital of Heidelberg, Heidelberg, Germany, 2Dept. of Cardiovascular Medicine, 
University Hospital of Tübingen, Tübingen, Germany
Fundamental aspects determining the molecular basis for the reciprocal relationship 
between metastasizing tumor cells and soluble components of the coagulation cascade 
have recently become understood. However, the involvement of platelets, the cellular 
component of thrombus formation, in the pathogenesis of cancer metastasis is still poorly 
comprehended. Systemic platelet depletion before i.v. inoculation of luciferase-transduced 
murine B16 (B16-luc) into syngeneic C57BL/6 mice resulted in a more than 30 % decrease 
in  micrometastasis as determined by bioluminescence analysis. While we found no 
signifi cant platelet mediated effect on the growth of subcutaneously implanted B16 
tumors, chemotaxis and migration, we determined an up to 50fold augmented adhesion 
of melanoma cells on immobilized platelets under static conditions and an up to 6fold 
increase in platelet-mediated B16 adhesion to endothelial cells under shear stress. Blocking 
mAb to alphaV integrin, highly expressed on 97,8% of B16 cells and blocking mAb to 
GPIIbIIIa, the most abundant platelet adhesion receptor, both signifi cantly abrogated 
the platelet-mediated increase in in vitro B16 adhesion. Furthermore, systemic platelet 
depletion and an integrin αvβ3 antagonist synergistically decreased the B16 lung tumor 
burden up to 90% in vivo.  Exploiting a model of intravital microscopy current experiments 
further elucidate the role of platelet-mediated B16 interactions with endothelial cells in 
the murine mesenteric microcirculation. Together, our results highlight a signifi cant 
involvement of integrin-mediated interactions between platelets and tumor in the early 
phase of B16 lung metastasis and suggest that  specifi c targeting of adhesion molecules 
involved in this process may represent a promising strategy for therapeutic intervention.
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Correlations of skin elasticity, fat mass and mimetic muscle function with sagging 
of human cheek
Tomonobu Ezure, Jyunichi Hosoi, Satoshi Amano Shiseido Co., Ltd., Yokohama, Japan
Facial sagging is associated with aging, although the mechanism remains unclear. To 
clarify the mechanism, we examined the relationship of sagging severity at the cheek 
to skin elasticity, fat mass and facial muscle function. Faces of 108 healthy Japanese 
female volunteers (age range: 20s-60s) were photographed at the angle of 45 degrees. 
Standard scores of sagging severity were established by analyzing the photographs. 
We examined the correlations of sagging scores with skin elasticity measured with a 
CutometerR, fat content estimated by bioelectrical impedance analysis, and mimetic 
muscle function (lip sealing force) in middle-age female volunteers (age range: 
30s-40s) with a wide range of sagging scores. Since the upper, lower and lateral areas 
in the cheek may independently show severe sagging, a six-grade score of sagging 
severity was separately established for each area. Scores in each area were signifi cantly 
positively correlated with age (age range: 20s-60s). In middle-age volunteers, 
sagging scores were signifi cantly negatively associated with skin elasticity. Body fat 
percentage was signifi cantly positively correlated with sagging scores in the lower 
and lateral areas, though the correlation was weak in the upper area. Mimetic muscle 
function was signifi cantly negatively correlated with sagging score at the upper area 
of cheek. This result led us to search for activators of myocyte function. We found that 
Sanguisorba offi cinalis L. extract could activate myocytes, in terms of respiratory activity 
measured with Alamar blue. In conclusion, cheek skin sagging may be associated 
with increased fat mass and functional decline of dermis and mimetic muscle.
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Increased Mechanical Tension by Injection of Cross-Linked Hyaluronic Acid Dermal 
Filler Restores Collagen-I Production in Naturally-Aged Human Skin
Gary Fisher, Taihao Quan, Laure Rittié, Yuan Shao, Zhaoping Qin, James Varani, 
Jeffrey Orringer, John Voorhees University of Michigan, Ann Arbor, MI, United States
During natural aging, human skin becomes thin and fragile.  These changes largely result 
from fragmentation and reduced production of type I collagen (COL-I), which comprises the 
bulk of the dermal extracellular matrix (ECM).  We hypothesize that COL-I fragmentation 
reduces mechanical tension within the ECM, thereby creating an environment that down-
regulates COL-I production.  Injection of cross-linked hyaluronic acid dermal fi ller (CL-HA) 
has been shown to stimulate increase mechanical tension within the dermis in photoaged 
skin.  Therefore, we have examined the impact of increasing mechanical tension by 
injection of CL-HA, in aged (>80 years) human skin.  Fibroblasts within CL-HA-injected 
dermis displayed a stretched morphology, indicative of increased mechanical tension.  CL-
HA stimulated expression of HSP47 and prolyl-4-hydroxylase (5-9-fold, N=10, p<0.01), two 
enzymes that are required for COL-I synthesis.  CL-HA induced COL-I mRNA (6-fold, N=10, 
p<0.01) and protein (3-fold, N=10, p<0.01).  Immunohistology revealed increased COL-I 
expression in fi broblasts.  COL-I production is strongly regulated by the TGF-β pathway. 
Notably, CL-HA increased fi broblast expression of type II TGF-β receptor (TβRII, 3-fold, 
N=10, p<0.01) and its downstream effector CTGF/CCN2 (4-fold, N=10, p<0.01).  Injection 
of CL-HA into dermal equivalents mimicked the effects observed in vivo, whereas injection 
of monomeric HA had no effect.  CL-HA-induced COL-I production was blocked by TβRI 
kinase inhibitor.  These data support the concepts that reduced dermal ECM structural 
integrity in aged skin down-regulates COL-I production, and aged skin retains substantial 
capacity to up-regulate COL-I synthesis.  These fi ndings provide rationale for therapeutic 
intervention to induce COL-I production to improve the health of aged human skin.
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Regulation of Cell Shape and Mechanical Tension in Aging Human Dermal 
Fibroblasts
Siming Chen1, Qian Zheng1, John Lyga1, Aysegül Temiz Artmann2, Kurt Scudder3, 
Uma Santhanam1 1Avon Products, Inc., Suffern, New York, United States, 2Institute for 
Bioengineering, Dept of Medical and Molecular Biology, Jülich, Germany, 3Accelrys 
Inc., San Diego, California, USA
Skin aging is a complex process involving a series of cellular and extracellular matrix 
events. Recent studies indicate that both intrinsic aging and photodamage can lead 
to alterations of normal cellular behaviors. The important factors contributing to 
this process include degradation of extracellular matrix and a partial breakdown 
of focal adhesion complexes. This matrix damage is believed to lead to changes 
in mechanical tension and collapse of the cell shape of dermal fi broblasts. To 
better understand changes in cell shape and tension during the skin aging process, 
we developed a model to mimic these changes in vitro. It was observed that 
irradiation of human dermal fi broblasts with UVA leads to distinct changes in cell 
shape. A customized software program was developed to quantify various cell 
shape parameters. In addition, a novel CellDrumTM system was used for in-vitro 
measurements of mechanical properties of cell monolayers. This system allows for 
the evaluation of properties such as the rigidity and contractile strength of cells. 
The experiments showed reduced cell tension in cells from old donors compared 
to young donors, and UV treatment of these cells further decreased cell tension. 
In order to improve cell shape and mechanical properties in aged cells, we 
developed a technology that is a blend of novel plant extracts and bioactive synthetic 
molecules. It was observed that treatment of cells with this novel technology 
improves cell shape and mechanical tension in cells from older donors, suggesting 
that this technology may be benefi cial in improving the appearance of aging skin.
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Identifi cation and validation of modulators of ECM1 expression in keratinocytes and 
reconstructed human skin equivalent
Gaëlle Saintigny1, Abdoel El Ghalbzouri2, Ellen Steenackers3, Joseph Merregaert3
1CHANEL Parfums Beauté, Pantin Cedex, France, 2Department of Dermatology, 
Leiden University Medical Center, Leiden, Netherlands, 3Laboratory of Molecular 
Biotechnology, University of Antwerp, Wilrijk, Belgium
The extracellular matrix protein 1 (ECM1) is an 85kDa secreted glycoprotein 
present in the dermal-epidermal junction (DEJ) zone of the human skin. It interacts 
with skin structural and extracellular matrix molecules (perlecan, laminin 332, 
fi bulin-1C/D,-3) as well as dermal interstitial molecules (MMP-9, collagen type 
IV, FN, HA) providing a role in maintaining the functional integrity of human 
skin. Previous studies have shown that ECM1 expression is down regulated in 
intrinsically aged skin. Therefore, selectively enhancing ECM1 expression may be 
a potent way to maintain the integrity of the basement membrane and to prevent 
related skin disorders. The aim of this study was to identify new ingredients able 
to stimulate ECM1 production and to assess their putative benefi cial effects on 
the DEJ zone in human reconstructed skin. Thirty compounds were screened, 
among which 6 revealed a signifi cant stimulation of ECM1 expression in HaCat 
keratinocyte monolayer cultures. The effect of three actives on epidermal 
morphogenesis and basement membrane formation was studied in reconstructed 
human skin equivalents (HSE) by immunohistochemical analysis of proliferation, 
differentiation and markers of the basement membrane. Positive compounds 
could be candidates to fi ght intrinsic skin aging and its related negative effects.
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Short And Long Forms Of Latent TGF-Beta Binding Protein (LTBP)-4 Are 
Independently Regulated In Cultured Fibroblasts And Human Tissues
Anna K. Kantola, Merja J. Ryynänen, Filip Lhota, Jorma Keski-Oja, Katri Koli
University of Helsinki, Dept of Pathology, Helsinki, Finland
Transforming growth factor (TGF)-beta is secreted and targeted into the extracellular 
matrix (ECM) in association with one of the latent TGF-b binding proteins (LTBPs). 
Activation of TGF-b from the latent complexes is a central regulatory step in TGF-b 
signaling. LTBPs target the growth factor into the ECM and expose it to activating 
mechanisms in specifi c ways. Disruption of LTBP-4 gene causes severe developmental 
abnormalities in both humans and mice. Transcripts for two N-terminally distinct 
LTBP-4 variants, LTBP-4S (short) and -4L (long), have been identifi ed. In the current 
work, we have characterized the differences in the expression, processing, and ECM 
targeting of these LTBP-4 variants. Heart and skeletal muscle displayed expression 
of both variants. Interestingly, liver expressed mainly LTBP-4L and lung as well 
as small intestine LTBP-4S. This tissue-specifi c expression pattern was found to 
originate from control of transcription by two independent promoters. Accordingly, 
LTBP-4S and -4L proteins were secreted and processed differently. During secretion 
LTBP-4L was complexed with TGF-b1, whereas the majority of LTBP-4S was 
secreted in a free form. In addition, LTBP-4S was effi ciently incorporated into the 
ECM, while full-length LTBP-4L was not readily detectable in the ECM. These data 
suggest that the functions of LTBP-4 are modifi ed by tissue-specifi c expression 
of the two N-terminally distinct variants, which in addition exhibit signifi cant 
differences in cellular processing and targeting.  These features provide the basis 
for understanding the molecular diversity in LTBP-4 structure and function.
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Ultrastructural analysis of acantholysis in pemphigus foliaceus reexamined from the 
current perspective
Gerda van der Wier, Marcel F. Jonkman, Hendri H. Pas, Gilles F.H. Diercks
Center for Blistering Diseases, Dept of Dermatology, University Medical Center 
Groningen, Netherlands
Pemphigus foliaceus (PF) is an auto-immune skin disease characterized by autoantibodies 
against desmoglein 1 and subcorneal blistering as a result of acantholysis. The exact 
mechanism how pemphigus antibodies induce acantholysis is not clear: theories mentioned 
are steric hindrance of desmoglein adhesion, desmoglein depletion of desmosomes by 
infl uencing assembly and disassembly, desmoglein compensation, disturbed cellular 
signalling, and keratin skeleton collapse. Original electron microscopy (EM) studies date 
back before these theories were formulated. In this EM study, we studied skin of PF patients 
to gain more insight into the mechanism of acantholysis considering the new theories. Three 
Nikolsky positive (N+) and two lesional biopsies from skin of PF patients were studied by 
light microscopy and EM. Subcorneal blistering was observed in two N+ biopsies and the 
lesional biopsies. At the granular and spinous layer we saw desmosomes torn off behind the 
desmosomal plaque, half-desmosome remnants, hypoplastic desmosomes and a reduction 
of the number of desmosomes in N+ and lesional skin. All biopsies showed intercellular 
interdesmosomal widening in the basal cell layer. Two N+ biopsies and the lesional biopsies 
showed a reduced number of desmosomes, and hypoplastic desmosomes in the basal cell 
layer. Keratin skeleton collapse was not observed. Steric hindrance does not explain the 
phenomenon of intracellularly torn-off desmosomes. The hypoplastic desmosomes and 
reduction of the number of desmosomes suggest that desmoglein depletion by disturbed 
assembly or disassembly of desmosomes is a major mechanism in the pathogenesis of PF. 
The pathology in the lower epidermis is suggestive for compensation by desmoglein 3.
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Structural diversity of human and mouse collagen XVII extracellular linker domain 
cause differences in shedding behavior
Joanna Jacków1, Cassian Sitaru1, Kaisa Tasanen2, Leena Bruckner-Tuderman1, Claus-
Werner Franzke1 1Univ Medical Center Freiburg, Germany, 2Univ of Oulu, Finland
The epithelial adhesion molecule collagen XVII represents a transmembrane 
component of hemidesmosomes. In our previous studies we have extensively 
analyzed ectodomain shedding of human collagen XVII within its extracellular 
linker domain NC16A. This is catalyzed by metalloproteinases of the ADAMs family 
and depends rather on structural molecule motifs than on specifi c amino acid 
sequences. Since the extracellular linker domain of human and murine collagen 
XVII shows high amino acid diversity, the goal of this study was to compare 
shedding of transiently transfected human and mouse collagen XVII constructs with 
defi ned deletions within their linker domain. In previous studies we have already 
analyzed ten human collagen XVII deletion constructs. Here, we investigated six 
linker domain deletion constructs of murine collagen XVII. Their normal membrane 
integration and Golgi transition was demonstrated by cell surface biotinylation and 
Endo H insensibility. The shortest deletion of human collagen XVII which resulted in 
non-shedding was a 20 amino acid deletion spanning Ale528 to Glu547. In contrast, 
deletion of 20 corresponding amino acids in murine collagen XVII (Glu534 to Glu553) 
do not result in decreased shedding. It revealed that the shortest deletion in murine 
collagen XVII which led to complete loss of shedding was a 32 amino acid deletion, 
from Lys513 to Ser544. Secondary protein structure predictions of human and mouse 
linker domains indicated signifi cant differences in their molecular structures. 
Our results suggest that human and murine collagen XVII molecules vary in their 
extracellular linker domain structure which in turn can alter regulation of shedding.
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Antifi brotic Effects of Dextran Sulphate on Keloid Fibroblasts
Meng-Chi Wu, Chao-Kai Hsu, Sheau-Chiou Chao, Mei-Hui Yang, Ling-Yi Hung, J. 
Yu-Yun Lee Department of Dermatology, National Cheng Kung University Medical 
College and Hospital, Tainan, Taiwan
Keloid is caused by abnormal wound healing process with excessive fi broblastic 
proliferation and overproduction of extracellular matrix. Despite numerous studies, 
the pathogenesis and optimal therapy have not been fully established. Dextran sulfate 
(DS) is sulfuric acid esters of polysaccharide, which has been used for treatment of 
hypercholesterolemia, atherosclerosis, and keloid (intralesional injection, 60 mg/ml, 
low molecular weight 3500-4000 with sulfur content 3-6%). DS has been shown 
to have various inhibitory effects on various cell types, including antiproliferative, 
anti-adhesive and anti-hyaluronidase effects. We sought to elucidate the antifi brotic 
effects of DS on normal fi broblasts (NF) and keloid fi broblasts (KF) and the 
mechanism involved. Our results showed that high molecular weight DS (molecular 
weight 500,000) at relatively low concentrations (25-100 µg/ml) displayed dose-
dependent inhibitory effects on NF and KF in cell proliferation, migration, adhesion 
and gel contraction of the stressed delayed released fi broblast-populated collagen 
lattices. Compared with NF, DS showed a greater anti-proliferative effect on KF (DS 
100 µg/ml, p=0.047). RT-PCR studies showed variable inhibitory effects on mRNA 
expression of TGF-β1, β2, β3 (TGF-β1 > β2 >> β3) but mild or no obvious inhibitory 
effects on MMP-1, collagen, fi bronectin, and IL-6 mRNA expression. In conclusion, 
our study showed that DS at relatively low concentrations displays suppressive 
effects on cell proliferation, migration, adhesion, contraction of collagen gel, and 
mRNA expression of TGF-β of normal and keloid fi broblasts, and these results lend 
supports to the therapeutic effects of intralesional injection observed clinically.
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Kindlin-1 and -2 have overlapping functions in epithelial cells: implications for 
phenotype modifi cation
Yinghong He, Philipp Esser, Leena Bruckner-Tuderman, Cristina Has
University of Freiburg, Freiburg, Germany
Kindlins are a novel family of intracellular adaptor proteins in integrin-containing 
focal adhesions. Kindlin-1 and -2 are expressed in the skin, but whether and how 
they cooperate in adult epithelial cells has remained elusive. Here, we uncovered the 
overlapping roles of kindlin-1 and kindlin-2 in maintaining epithelial integrity and 
show that the phenotype of kindlin-1 defi cient cells can be modulated by regulating 
kindlin-2 gene expression, and vice versa. The experimental evidence is provided by 
use of human keratinocyte cell lines which express either both kindlins, just kindlin-1 
or kindlin-2, or none of them. Double defi ciency of kindlin-1 and -2 had dramatic 
negative effects on focal adhesion formation and actin cytoskeleton organization, 
but also on cell adhesion, proliferation, directional migration and activation of β1 
integrin, whereas defi ciency of one kindlin only showed variable perturbation of these 
functions. Cell motility and formation of cell-cell contacts were particularly affected 
by lack of kindlin-2. These results predict that kindlin-1 and -2 can functionally 
compensate for each other, at least in part. The high physiological and pathological 
signifi cance of the compensation was emphasized by the discovery of environmental 
regulation of kindlin-2 expression. UVB irradiation induced loss of kindlin-2 in 
keratinocytes and had negative effects on kindlin-1 defi cient cells. This fi rst example 
of environmental regulation of kindlin expression has implications for phenotype 
modulation in Kindler syndrome, a skin disorder caused by kindlin-1 defi ciency.
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Biosensors in monitoring concentration of anesthetics in tissues
Yosip Sharkan1, Yuriy Andrashko1, Iryna Sharkan1, Taras Dasyuk2
1Uzhgorod National University, Uzhgorod, Ukraine, 2Danylo Halytskyy Lviv National 
Medical University, Lviv, Ukraine
Nowadays, in the period of swift development of dermatosurgery and cosmeticology, 
actual is a problem of anesthetizing of operative interventions and small invasion 
manipulations with the clear monitoring of concentration and distribution of 
anethetic matters in tissues. During  operating or other medical manipulations 
with the using of acesodynes, which in most cases are toxic, it is  necessery to 
control  strictly  concentrations of  aenestetics  for an organism and fast of leading 
out due to physiology processes.Existing  methodologies and apparatus are 
extraordinarily high-costs and bulky, and  practically does not allow to conduct 
monitoring in vivo. An alternative to such  methods is using of biosensory devices. 
They consider small invasion fi ber-optics biosensores of refl acting type with a sensitive 
element on the butt end of  general optical channel, which is entered directly in 
the tissues of organism. The nanocomposite membrane structure of photochromic 
biomolecules of  bacteriorodopsin in porous polymeric or inorganic sol- gelnic 
matrixes  will be used in a role of anesthetics element. Change of parameters of 
photocycle in membranes structures with bacteriorodopsin under the action of 
anesthetics  is the basis in methodology of controling anestethic  concentration. 
Besides of reversibility, high sensitivity peculiar for bacteriorodopsin is high 
quickness of response, due to the microporosity of matrixes, allowes to create 
small invasion biosensors of anestetics which work in the real mode of time.
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Differential expression of latent transforming growth factor β-binding proteins in 
intrinsically aged skin
Abigail Langton1, Michael Sherratt2, Rachel Watson1, Christopher Griffi ths1
1Dermatological Sciences, The University of Manchester, United Kingdom, 
2Regenerative Biomedicine, The University of Manchester, United Kingdom
The dermal elastic fi bre network imbues skin with its capacity to recoil. In intrinsically 
aged skin however, loss of this mechanical property contributes to an aged 
appearance. Elastic fi bres are structurally complex, and as a consequence the effects 
of ageing on the composition of these macro-molecular assemblies remains poorly 
defi ned. In this study, we have used an Affymetrix® microarray-based approach to 
detect age-related changes in gene expression of elastic fi bre-associated molecules. 
Skin biopsies (6mm diameter) were obtained from photoprotected buttock of three 
young (24-26 years) and three aged (74-75 years) male volunteers. Biopsies were 
bisected and processed for total RNA extraction, cDNA synthesis and hybridization 
(Affymetrix® U133A oligonucleotide array). A comparison of the gene expression 
profi les from young and aged individuals revealed that whilst the expression of 
the majority of elastic fi bre components was unchanged with age, latent TGFβ-
binding protein (LTBP)-2 was up-regulated (p<0.05) and LTBP-3 was down-regulated 
(p<0.05). Differential expression and translation of these genes was confi rmed by 
quantitative real-time PCR and immunohistology. Whilst the functional implications 
of this altered expression profi le remain to be determined, LTBPs-2 and 3 are thought 
to play important roles in controlling and maintaining elastic fi bre deposition, 
structure and TGFβ signalling. As a consequence aberrant LTBP expression may 
infl uence both tissue mechanical properties and homeostasis in ageing skin.
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MMP-9, -10, and -26, and TIMP-1 expression in relation to fi laggrin mutations in 
atopic dermatitis
Veronica Widen-Karlsson2, Susanna Virolainen3, Cilla Söderhäll4, Tiina Skoog4, 
Mia Kero3, Juha Kere4, Ulpu Saarialho-Kere1, Sari Suomela1 1Dept of Dermatology, 
Helsinki University Central Hospital, Finland, 2Dept of Clinical Science & Education, 
Karolinska Institutet, Stockholm, Sweden, 3Dept of Pathology, Helsinki Univ Central 
Hospital, Finland, 4Dept of Biosciences & Nutrition & Clinical Research Centre, 
Karolinska Institutet, Stockholm, Sweden
In addition to skin cancer and wound healing, matrix metalloproteinases (MMPs) have been 
implicated in atopic dermatitis (AD) related features, such as infl ammation and processing of proteins 
needed for an intact epidermal barrier. A major component of the skin permeability barrier, fi laggrin 
(FLG), is the strongest candidate gene for AD. We determined three common FLG mutations in 28 
clinically moderate to severe AD patients and studied by immunohistochemistry the expression of 
MMP-9, -10, and more novel MMP-26 as well as TIMP-1 proteins in relation to FLG expression in 
AD. Only one of our 28 patients carried a FLG_S3247X mutation and two carried a FLG_R501X 
mutation. None of the patients carried a FLG_R2447X mutation or was a compound heterozygote. 
Our patient carrying a FLG_S3247X mutation had a distinct, faint and dotted immunostaining 
pattern of FLG both in the lesional and non-lesional skin, confi rming the impact of FLG mutations 
to the skin epidermal barrier. The MMP profi le refl ected rather the histological features of the 
sample than the FLG mutation status. Basal and suprabasal keratinocytes expressed MMP-10 
in 14/28 and MMP-26 in 15/28 of the AD samples, refl ecting possibly the basement membrane 
disruptions. Even in non-lesional samples, MMP-10 (7/28), but not MMP-26, was demonstrated in 
keratinocytes. Infl ammatory cells i.e. neutrophils (11/28) or macrophages (11/28) expressed MMP-
9 and macrophages (11/28) MMP-10. Expression of TIMP-1 protein was encountered not only in 
the lesional AD samples but also in the non-lesional samples in macrophage/fi broblast-like cells.
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A potential role for oxygen in the photodegradation of fi brillin microfi brils by UVB 
radiation
Sarah Thurstan, Christopher Griffi ths, Neil Gibbs, Rachel Watson, Michael Sherratt
The University of Manchester, Manchester, United Kingdom
Exposure to ultraviolet radiation is thought to accelerate skin ageing via the activation and/
or the enhanced expression of extracellular matrix (ECM) proteases. Whilst such enzyme-
mediated pathways may play a role in photoageing, we have previously demonstrated that 
key ECM components (fi brillin microfi brils, fi bronectin and type I collagen) are differentially 
degraded by UVB in enzyme-free environments. However, it remains unclear whether this 
UVB-induced damage occurs directly by photon absorption or indirectly via reactive oxygen 
species (ROS) intermediates. In this study we have characterised the effects of UVB irradiation 
in both ambient-oxygen and depleted-oxygen environments on microfi bril structure. 
Aliquots of Cos-1 cell-derived microfi brils were adsorbed to hydrophilic mica substrates 
either: i) without any exposure to UVB radiation, ii) following exposure to 500mJ/cm2 UVB 
radiation (TL12; 280-315nm) in ambient-oxygen conditions or iii) after exposure to the 
same UVB dose in an depleted-oxygen environment (achieved by bubbling with N2 for 
10min). Adsorbed microfi brils were subsequently imaged by atomic force microscopy. 
Relative microfi bril fl exibility (quantifi ed via the angle between adjacent microfi bril 
beads) was signifi cantly increased (Mann-Whitney U test, p = <0.0001) following UVB 
exposure in both ambient oxygen and depleted-oxygen conditions (median angle: 
control = 170o; ambient-oxygen = 161o; depleted-oxygen = 165o). In the oxygen-
depleted environment however, these UV-radiation induced structural changes were 
signifi cantly abrogated (Mann-Whitney U test; ambient-oxygen vs. depleted-oxygen; p 
= 0.0031).These fi ndings suggest that UVB-induced ROS play an important role in the 
photodegradation of ECM proteins in photoaged skin independent of protease activity.
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Loss of type VII collagen in cutaneous SCC increases cell invasion through TGF-beta 
signalling
Vera Martins1, Mei Chen2, Karin Purdie1, Edel O‘Toole1 1Centre for Cutaneous 
Research, BICMS, Barts and the London SMD, Queen Mary University of London, 
London, United Kingdom, 2Dept of Dermatology, Univ of Southern California, Los 
Angeles, CA, United States
Mutations in the type VII collagen (ColVII) gene cause the severe blistering disorder, recessive 
dystrophic epidermolysis bullosa (RDEB), associated with increased risk of metastatic squamous 
cell carcinoma (SCC). We have previously shown that transient knock-down of ColVII (siCOL7) 
increased SCC migration/invasion, with disorganised epithelial differentiation and increased 
epithelial-mesenchymal transition. Increased expression of chemokines (CXC) and p-Smad2/3 
was also observed in siCOL7 invading cells suggesting involvement of TGF-beta signalling. 
Furthermore, results from Illumina gene expression arrays demonstrated changes in TGF-beta 
targets. In this study, we explored further the role of TGF-beta in invasion of SCC cells with 
absent ColVII. Stable knock-down of ColVII was generated in SCC cell lines using a lentiviral 
shRNA system. Tracking of single cells by live cell imaging suggested that ColVII-knock-down 
cells (shCOL7) move faster, forming longer membrane protrusions, and create longer tracks 
when compared to control cells (shC). Interestingly, addition of a TGF-beta type I receptor 
inhibitor, SD-208, inhibited shCOL7 cell movement in monolayers and reduced the number of 
cell islands invading into 3-D collagen:matrigel gels. ColVII-knock-down cells showed increased 
phosphorylation of ERK1/2, downstream of the TGF-beta receptor complex. Moreover, shCOL7 
3-D epidermal-dermal composites demonstrated increased expression of the TGF-beta-related 
proteins CTGF in the dermis and CLIC4 in epidermis compared to control. Immunostaining of 
RDEB SCC tumours suggested similar fi ndings in vivo. Our results suggest that the TGF-beta 
pathway may play a critical role in migration and epithelial-mesenchymal interaction of SCC 
cells with absent ColVII providing a possible explanation for the accelerated metastasis in RDEB.
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Maturation and assembly of microfi brils in vitro
Elizabeth Naylor, Michael Sherratt, Christopher Griffi ths, Rachel Watson
The University of Manchester, Manchester, United Kingdom
Most extracellular matrix components form long-lived assemblies whose structures 
vary in remodelling and diseased tissues. Fibrillin-rich microfi brils, for example, are 
composite components of the elastic fi bre system which confer elasticity in skin. 
Whilst ageing impacts greatly on this system, previous studies have demonstrated 
that a number of topical treatments, including retinoids, can stimulate deposition 
of fi brillin. However, it is unknown whether these interventions result in the 
formation of structurally and functionally competent microfi brils. Therefore, it is 
important to develop a model system with which to study microfi bril maturation 
in response to exogenous agents. Here, we employ quantitative biochemical and 
ultrastructural approaches to characterise the ability of cultured human dermal 
fi broblasts (HDF) to synthesise mature microfi brillar assemblies.Microfi brils were 
isolated from HDF cultures at 1-, 2- and 3-weeks post-confl uency using a well 
established bacterial collagenase and size exclusion chromatography approach. 
Microfi brillar components including fi brillins-1 and -2, MAGP-1 and decorin were 
identifi ed by immunodetection and quantifi ed by densitometric analysis. With the 
exception of fi brillin-2, these components accrued signifi cantly with increasing time 
in culture (Mann Whitney U test: p<0.05: relative signal intensity (RSI) at week 1: 
fi brillin-1 6.9x105 (SD 5.1x105); MAGP-1 6.3x105 (SD 6.2x104); decorin 6.3x105 
(SD 1.0x105): RSI at week 3: fi brillin-1 1.3x106 (SD 2.1x105); MAGP-1 2.1x106 (SD 
2.6x105); decorin 1.1x106 (SD 4.8x104). Therefore, given the observed increase in 
microfi bril complexity with time in culture and the apparent reciprocal relationship 
between fi brillin-1 and -2 expression, we suggest that cultured HDFs may 
provide a robust experimental system with which to study microfi bril maturation.
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Integration of innate immune signalling pathways in epidermal barrier dysfunction 
and hyperkeratosis
Ryan O‘Shaughnessy1, Gehad Youssef1, Ishaan Choudhary1, John Harper2,1
1UCL Institute of Child Health, London, United Kingdom, 2Great Ormond Street 
Hospital for Sick Children, London, United Kingdom
The signalling mechanisms activated in barrier defective epidermis are yet to be fully 
elucidated. Understanding of these mechanisms and how they result in hyperkeratosis will 
lead to better directed therapies for hyperkeratotic disorders such as the ichthyoses. We have 
modelled a severe epidermal barrier defect using siRNA knockdown of the principle gene 
mutated in lamellar ichthyosis (LI), Transglutaminase-1, in transformed rat keratinocytes and 
created an in vitro organotypic culture model that closely mimics the disease. A principle 
signalling pathway that was activated in this model was the NFkappaBeta pathway, 
mediated by constitutive degradation of IkappaBalpha, consistent with this, interleukin-1 
alpha (IL1A) expression was markedly (30 fold+) increased. All LI patients tested had 
increased IL1A and treatment of wildtype organotypic cultures with IL1A was suffi cient to 
induce hyperkeratosis. Treatment of disease mimic organotypic cultures with IL-1 receptor 
antagonist (IL1RA) led to a dose-dependent decrease in hyperkeratosis without a reduction 
in non-polar lipids in the cornifi ed layer, which has the potential as a treatment to reduce 
scaling without the requirement to constantly apply emollients. IL1A blockade by IL1RA 
didn’t prevent the IkappaBalpha. Kinases active in the Tgm1 siRNA expressing cells, 
downstream of IL1A and NFkB, were inhibited with IL1RA treatment, while activation of 
kinases upstream of NFkB and downstream of toll-like receptors was maintained. Based 
on these fi ndings we propose a model in which there are two pathways upstream of NFkB, 
an IL1A mediated hyperkeratosis pathway, and a barrier dysfunction “sensor” pathway, 
mediated by Toll-like receptor signalling and constitutive IkappaBalpha degradation.
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Thyrotropin-releasing hormone (TRH) controls mitochondrial function and 
biogenesis in human keratinocytes in situ
Jana Knuever1, Burkhard Poeggeler1, Erzsébet Gáspár1, Tamás Bíró2, Balázs Toth2, 
Thomas Hellwig-Buergel3, Matthias Klinger4, Ralf Paus1 1Dept of Dermatology, Univ 
of Luebeck, Germany, 2Dept of Phys, Univ of Debrecen, Hungary, 3Dept of Physiology, 
Univ of Luebeck, Germany, 4Department of Anatomy, Univ of Luebeck, Germany
Thyroid hormones can stimulate mitochondrial capacity and metabolic potential. Here, we have 
asked whether thyrotropin-releasing hormone (TRH), the key hypothalamic integrator of energy 
metabolism, directly modulates mitochondrial functions in normal human skin. After showing that 
human epidermis expresses TRH receptor protein, organ-cultured human skin was treated with 
TRH (5-100 ng/ml) for 12-48 hrs.  While this did not alter epidermal morphology, TRH signifi cantly 
increased immunoreactivity for the mitochondria-selective subunit I of respiratory chain complex IV 
(MTCO1). Since this suggested an up-regulation of mitochondrial biogenesis,  transmission electron 
microscopy was performed. This revealed an increased number of perinuclear mitochondria in 
individual keratinocytes in TRH-treated epidermis. In human epidermal extracts, TRH signifi cantly 
enhanced mitochondrial complex I and IV enzyme activity. This effect could be further increased by 
adding respiratory substrates (malate, glutamate). Furthermore, TRH treatment signifi cantly increased 
the oxygen consumption of human skin in situ. TRH also signifi cantly stimulated the transcription of 
several mitochondrial key genes (MTCO1, mitochondrial transcription factor A [TFAM], heat shock 
protein 60 [HSP60], peroxisome proliferator-activated receptor gamma coactivator alpha [PGC-1α] 
and brain and muscle ARNT-like protein 1 [BMAL1]) as well as the amount of synthesized mitochondrial 
DNA. These fi ndings document complex stimulatory effects of TRH on mitochondrial function, and 
identify TRH as a potent novel neuroendocrine stimulator of mitochondrial activity and biogenesis 
in human skin epithelium in situ. Furthermore, we demonstrate that, contrary to conventional 
wisdom in mitochondrial research, human epidermis offers an excellent model system for dissecting 
neuroendocrine controls of human mitochondrial biology under physiologically relevant conditions.
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p63 and p53 transcription factors co-regulate RUNX1 to control proliferation to 
differentiation transition in human interfollicular epidermis
Ingrid Masse1, Laetitia Barbollat-Boutrand1, Claude Caron de Fromentel2, Jérôme 
Lamartine1 1Université de Lyon; Université Lyon 1; CNRS UMR5534 Centre de 
Génétique Moléculaire et Cellulaire, Lyon, Villeurbanne, France, 2INSERM UMR590 
Unité d‘Oncogenèse et de Progression Tumorale, Centre Léon Bérard, Lyon, France
The interfollicular epidermis is continuously renewed thanks to a regulated balance 
between proliferation and differentiation. The transcription factor deltaNp63 
plays a key role in the control of this process. It has recently been shown that 
deltaNp63 directly regulates the RUNX1 transcription factor expression in mouse 
keratinocytes and we have shown in the lab that RUNX1 is implicated in the 
proliferation to differentiation transition control in human keratinocytes. In this 
study, we investigated RUNX1 transcriptional regulation by deltaNp63 in human 
primary keratinocytes. We demonstrated that deltaNp63 directly binds two different 
RUNX1 regulatory DNA sequences and modulates its expression differentially 
in proliferative or confl uent human primary keratinocytes. We also showed that 
this RUNX1 expression regulation by deltaNp63 is p53 dependent and that co-
regulation of RUNX1 by p53 and deltaNp63 lies on differential binding and 
activation of RUNX1 regulatory sequences. Collectively, these data shed light on 
the role of p53 for interfollicular epidermal homeostasis regulation, in cooperation 
with deltaNp63, via the regulation of RUNX1 transcription factor expression.
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Hornerin is a component of cornifi ed cell envelopes which may contribute to atopic 
dermatitis epidermal barrier defect
Julie Henry1, Chiung-Yueh Hsu1, Marek Haftek2, Isabelle Gardinal-Galera1, Kiyotaka 
Hitomi3, Catherine Jean-Descoster4, Anne-Marie Schmitt4, Carle Paul1, Guy Serre1, 
Michel Simon1 1UMR5165, CNRS-Toulouse III University, Toulouse, France, 2E4169A, 
Lyon I University, Lyon, France, 3Nagoya University, Nagoya, Japan, 4Pierre Fabre 
Dermo-Cosmétique, Toulouse, France
Although loss-of-function mutations in the fi laggrin gene have been strongly associated with atopic 
dermatitis (AD), it has been suggested that other epidermal barrier related genes may account for 
the predisposition to the disease. A single nucleotide polymorphism within the gene encoding 
hornerin (HRNR) has recently been linked with AD susceptibility. HRNR shares numerous common 
features with fi laggrin. Confl icting reports have been published concerning HRNR expression in the 
epidermis, and its role in epidermal barrier function is still unknown. To analyze HRNR expression 
and to characterize its function in human skin, we produced polyclonal anti-peptide antibodies. 
Immunohistochemical, confocal and immunoelectron microscopy analysis of normal skin sections 
showed that HRNR colocalizes with profi laggrin on keratohyalin granules in the upper granular 
layer. It was also detected in the entire cornifi ed layer at the corneocyte periphery. Detected in 
western as numerous immunoreactive bands, HRNR was relatively insoluble and only extracted 
from normal epidermis with urea- and/or reducing agent-containing buffers. These data suggested 
that HRNR could be a component of cornifi ed cell envelopes. To prove this hypothesis, we used 
cell envelopes purifi ed from plantar stratum corneum. Immunodetection of proteolytic peptides and 
immunoelectron microscopy analysis confi rmed the presence of HRNR in these structures. Moreover, 
in vitro assays with a recombinant form of HRNR showed that it is a substrate of transglutaminase 
3. As a whole, these data demonstrate that HRNR is a component of cornifi ed cell envelopes. Its 
reduced expression in AD lesions may contribute to the barrier defect observed in the disease.
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Involvement of Proteinase Activated Receptor -2 on Mite-induced Atopic Dermatitis 
Model in Filaggrin Defi ciency Mouse
Catharina Moniaga1, Se Kyoo Jeong2, Yoshiki Miyachi1, Kenji Kabashima1
1Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, 
Japan, 2NeoPharm Co., Ltd., Daejeon, Korea, Republic of
The barrier abnormality by a loss-of-function mutation in the gene encoding 
fi laggrin (FLG) is an important factor in the pathogenesis of atopic dermatitis (AD). 
Recently, we have demonstrated that fl aky tail (Flgft) mice, essentially defi cient 
in fi laggrin, denote human AD in the steady state and by topical application of 
Dermatophagoides pteronyssimus mite extracts that acts as a protease-activated 
receptor-2 agonist. PAR-2 is known to be involved in epidermal permeability barrier 
function and mediates itch in AD. However, the relevancy between PAR-2 activation 
and fi laggrin defi ciency has not been revealed. In this study, we utilized a newly 
developed specifi c PAR-2 antagonist agent on mite allergen-repeated exposure-
induced AD model in Flgft mice. We found that PAR-2 was strongly expressed in 
keratinocytes of Flgft mice compared to control mice. Application of the PAR-2 
antagonist improved the clinical manifestation of mite-induced AD model in Flgft 
mice. In addition, epidermal hyperproliferation and increased pH in accord with 
production of Th2 and proinfl ammatory cytokines of Flgft mice were inhibited by the 
PAR-2 antagonist. Moreover, total cells in skin draining lymph nodes,  mite specifi c 
IgE, and transepidermal water loss were reduced in the PAR-2 antagonis-treated 
group. These results suggest that fi laggrin-defi ciency induces PAR-2 expression in 
keratinocytes, which further shifts the Th2 skewed condition and exacerbates AD.
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IGFBP7 plays a critical role in the pathogenesis of psoriasis
Janna Nousbeck1,2, Miri Bidder1, Dana Fuchs2, Andrea Gat2, Meri Gini2, Hagit 
Matz2, Ilan Goldberg2, D. Enk Claes3, Ofer Sarig2, Amos Gilhar1, Eli Sprecher2
1Technion – Israel Institute of Technology, Haifa, Israel, 2Tel Aviv Sourasky Medical 
Center, Tel Aviv, Israel, 3Hadassah Hebrew Univ Medical School, Jerusalem, Israel
Psoriasis has been shown to result from combined immunological and epidermal 
defects. We recently demonstrated that IGFBP7 is downregulated in the psoriatic 
epidermis and regulates three processes typically abnormal in psoriatic keratinocytes: 
proliferation, apoptotic activity and differentiation. Since IGFBP7 was found to 
oppose psoriasis-associated abnormalities in epidermal cells, we hypothesized 
that IGFBP7 may play a role in the pathogenesis of the disease. To substantiate 
this hypothesis, we assessed the pathological features of three dimensional 
organotypic cell cultures following RNAi-induced IGFBP7 down-regulation. We 
observed that the absence of IGFBP7 expression in the stratifying epidermis was 
associated with marked with marked hyperkeratosis and acanthosis. Supporting 
a role for IGFBP7 in psoriasis, we demonstrated that down-regulation of IGFBP7 
induces ERK1/2 phosphorylation in keratinocytes as seen in psoriasis. These results 
suggested that IGFBP7 may play a role in the pathogenesis of psoriasis. To assess 
this possibility, we treated SCID mice grafted with human skin in which psoriasis 
had been induced with NK cells for 10 days with (1) PBS (n=5), (2) dexamethasone 
(n=5; 2 µg/mouse/day) and (3) recombinant IGFBP7 (n=5; 2,4 µg/mouse/day). All 
mice treated with PBS developed psoriasis. In contrast, dexamethasone cured 
psoriasis in 5/5 of the mice. Recombinant IGFBP7 cured psoriasis in 3/5 mice 
with an additional mouse showing partial response. Taken altogether, our data 
position IGFBP7 as a key regulator of keratinocyte differentiation and proliferation 
and provide evidence for IGFBP7 contribution to the pathogenesis of psoriasis.
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Deimination of fi laggrin-2 increases its proteolysis by calpain I
Chiung-Yueh Hsu1, Julie Henry1, Anne-Aurelie Raymond2, Stefana Balica3, 
Catherine Jean-Decoster4, Hidenari Takahara5, Anne-Marie Schmitt4, Carle Paul1,3, 
Guy Serre1, Michel Simon1 1UMR5165, CNRS-University of Toulouse, Toulouse, 
France, 2UMR5089, CNRS-University of Toulouse, Toulouse, France, 3Department of 
Dermatology, Toulouse University Hospital, Toulouse, France, 4CERPER, Pierre Fabr, 
Toulouse, France, 5School of Agriculture, university of Ibaraki, Ibaraki, Japan
Filaggrin-2 (FLG2), a member of the S100 fused-type protein family, shares numerous common 
features with fi laggrin, a key protein implicated in the epidermal barrier functions. Both display 
a related structural organisation, an identical pattern of expression and localisation in human 
epidermis, and proteolytic processing of a large precursor. Here, we tested whether FLG2 is a 
substrate of calpain 1, a calcium-dependent protease directly involved in fi laggrin catabolism. In 
addition, deimination being critical for fi laggrin degradation, we analyzed whether FLG2 deimination 
interferes with its proteolytic processing. To this aim, we fi rst produced a recombinant form of FLG2 
corresponding to subunits B7 to B10 fused to a carboxy-terminal His-tag. Incubation with calpain 
1 in the presence of calcium induced a rapid degradation of the recombinant protein, and the 
production of several peptides, as shown by Coomassie blue stained gels and Western blotting 
with anti-FLG2 or anti-His antibodies. The degradation was not observed when a calpain 1-specifi c 
inhibitor was added. MALDI-TOF mass spectrometry confi rmed this result and further evidenced the 
production of non-immunoreactive smaller peptides. The calpain cleavage sites identifi ed by Edman 
degradation were shown to be frequent in the repeat-B domain. Moreover, immunohistochemical 
analysis of normal human skin revealed co-localization of FLG-2 and calpain 1 in the granular 
layer. Finally, the FLG2 deiminated by human peptidylarginine deiminases was shown to be more 
susceptible to calpain 1 than the unmodifi ed protein. Altogether, these data suggest that calpain 1 
is essential for the proteolytic processing of FLG2, and that deimination accelerates this process.
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The Ubiquitous Dermokine Delta Directly Interacts With Rab5 And Modulates Its 
Activity In The Early Endocytic Pathway
Emilie A. Leclerc, Leila Gazeilles, Guy Serre, Marina Guerrin, Nathalie Jonca
UMR 5165 “Epidermis Differentiation and Rheumatoid Autoimmunity Unit”, CNRS – 
University Toulouse III (IFR 150, INSERM – CNRS – University Toulouse III – CHU), 
CHU Purpan, Toulouse, France
The Dermokine (Dmkn) gene is highly expressed by granular keratinocytes. Its 
expression leads to four families of proteins with as yet unknown functions. The 
secreted α, β and γ isoforms share an epidermis-restricted expression pattern, 
whereas the δ isoform is intracellular and ubiquitous. To get an insight into Dmknδ 
function, we performed yeast two-hybrid screening and identifi ed the small 
GTPases Rab5 as partners for Dmknδ. The Rab5 proteins are known to regulate 
membrane docking and fusion in the early endocytic pathway. GST pull-down 
assays confi rmed the direct interaction between Rab5 and Dmknδ. We also showed 
that Dmknδ was able to bind both inactive (GDP-bound) and active (GTP-bound) 
forms of Rab5 in vitro but preferentially targeted GDP-bound form in HeLa cells. 
Transient expression of Dmknδ in HeLa cells led to the formation of punctate 
structures colocalized with endogenous Rab5 and clathrin, indicating Dmknδ 
involvement in the early steps of endocytosis. Interestingly, Dmknδ expression 
rescued the Rab5S34N-mediated inhibition of endosome fusion. Moreover, 
Dmknδ caused the enlargement of vesicles positive for Rab5 by promoting GTP 
loading onto the small GTPase. Altogether, our data suggest that Dmknδ is involved 
in the early endosomal traffi cking by activating Rab5 function. This work will be 
pursued by studying Dmknδ function and more widely the endovesicular traffi c 
in the granular keratinocyte, which is a polarized cell with high secretory activity.
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Insulin/IGF-1 signaling controls epidermal morphogenesis by regulating G2/M cell 
cycle progression
Heike Stachelscheid1,4, Bjorn Schumacher2,3, Jens Bruning2,3, Carien Niessen1,2
1Department of Dermatology, University of Cologne, Cologne, Germany, 2Cologne 
Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases 
(CECAD), University of Cologne, Germany, 3Institute for Genetics, University of 
Cologne, Germany, 4Center for Molecular Medicine Cologne, Germany
The skin epidermal barrier protects the organism from external challenges and dehydration. 
The establishment, maintenance and restoration of this epithelia barrier is driven by a life 
long selfrenewal of epithelial progenitor cells. Recently, we identifi ed insulin/IGF-1 signaling 
as key determinants of epidermal morphogenesis and proliferative potential. We observed 
a progressive decrease in the number of suprabasal layers in insulin receptor (IR), IGF-1 
receptor (IGF-1R) or IR/IGF-1R (dko) knockout mice, which was fi rst obvious at E16.5. Here 
we examined how IR/IGF-1R signalling regulates epidermal morphogenesis and proliferative 
potential. At E16.5 no difference was found in the number of BrdU positive cells, which is 
incorporated during S-phase of the cell cycle. However, the number of anaphase spindles 
was reduced both at E16.5 and in vitro in cultured keratinocytes in the absence of IR/IGF-1R 
signaling, thus suggesting a block in G2/M of the cell cycle. FACS analysis confi rmed this 
arrest. Loss of IR/IGF-1R also increased expression of key cell cycle regulators, such as p53 
and cyclin G1.  The observed cell cycle arrest was also associated with increased activation 
of the stress kinase p38 MAPK, and its downstream targets stratifi n (14-3-3s), both previously 
implicated in G2/M arrest. At the moment we are examining if these alterations are cause or 
consequence of the phenotypes induced by epidermal loss of IR and/or IGF-1R. In addition, 
we ask if the arrest is temporary or more permanent resulting in senescent cells. Finally, 
our fi ndings may help to understand how increased IGF signalling drives carcinogenesis.
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Hair follicle stem cell derived progeny drives sebaceous gland regeneration
Monika Petersson, Heike Brylka, Andreas Kraus, Catherin Niemann
Centre for Molecular Medicine Cologne (CMMC), Cologne, Germany
Mammalian epidermis comprises a highly dynamic and compartimised epithelium 
consisting of the interfollicular epidermis, the hair follicles (HF) and associated 
sebaceous glands (SG). Functional SG release sebum into hair shaft and are important 
for barrier aquisition and protection against pathogens and/or environmental 
assaults. The high cellular turn-over of the SG requires a constant replacement 
of cells.Currently, two hypothesis concerning the involvement of distinct stem 
cell (SC) or progenitor populations in the process of SG renewal are discussed:
(1) residing unipotent progenitors located at the periphery of the SG are 
committed to sebaceous lineage. (2) SC or progenitors from different epidermal 
compartments migrate towards the SG and renew them. We have generated an 
inducible Cre-mouse model to map the fate of individual HFSC-derived progeny 
and to investigate sebaceous commitment in vivo. From these lineage tracing 
approaches we have learned that single progenitors emanated from the HFSC 
niche continuously drive SG regeneration. These cells exit their niche and transit 
through different epidermal progenitor compartments. Our data imply a certain 
hierarchy of multipotent keratinocytes contributing to epidermal homeostasis. 
Directing basal keratinocytes into sebocyte lineage by manipulating one of the 
crucial regulators of fate decision, Lef1, we could identify HFSC-derived progeny 
as cells of origin building up ectopically formed SG. Strikingly, new progenitor 
compartments adjacent to the de novo differentiating sebocytes were established.
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Synthetic Peptide K5 Effi ciently Detects in situ Transglutaminase1 Activity; Its 
Application for Diagnosis of Lamellar Ichthyosis 
Masashi Akiyama1, Kaori Sakai1, Teruki Yanagi1, Satoshi Fukushima2, Hironobu Ihn2, 
Kiyotaka Hitomi3, Hiroshi Shimizu1 1Dept of Dermatology, Hokkaido University 
Graduate School of Medicine, Sapporo, Japan, 2Dept of Dermatology & Plastic Surgery, 
Faculty of Life Sciences, Kumamoto University, Japan, 3Dept of Applied Molecular 
Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Japan
Lamellar ichthyosis (LI) is a genetically heterogeneous, severe genodermatosis showing widespread 
hyperkeratosis of the skin. Transglutaminase 1 (TGase1) defi ciency by TGase1 gene (TGM1) 
mutations is the most prevalent cause of LI. Screening of TGase1 defi ciency in skin is essential 
to facilitate the molecular diagnosis of LI. However, cadaverine, the most widely used substrate 
for TGase activity assay, is not isozyme specifi c. Recently, a human TGase1 specifi c, highly 
preferred substrate peptide K5 (pepK5) was generated. To evaluate its potential as a diagnostic 
tool for LI, we performed pepK5 labeling of TGase1 activity in normal human and LI skin. 
Ca2+-dependent labeling of FITC-pepK5 was clearly seen in the upper spinous and granular 
layers of normal human skin where it precisely overlapped with TGase1 immunostaining. Both 
specifi city and sensitivity of FITC-pepK5 labeling for TGase1 activity were higher than those 
of FITC-cadaverine labeling. FITC-pepK5 labeling colocalized with involucrin and loricrin 
immunostaining at cornifi ed cell envelope forming sites. FITC-pepK5 labeling was markedly 
reduced in LI patients with TGM1 mutations, but not affected in congenital ichthyosis patients 
without any TGM1 mutation. The present results clearly indicate that pepK5 is a powerful tool 
to distinguish LI patients with TGase1 defi ciency from ichthyosis patients with other causative 
genetic defects. Furthermore, FITC-pepK5 labeling was negative in LI patients carrying TGM1 
truncation mutations and partially abolished in the other LI patients harboring missense mutations. 
It might be possible to differentiate LI patients with nonsense/truncation mutations and those 
with missense mutations, although pepK5 fl uorescence labeling is not completely quantitative. 
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Skin cellular senescence expression control by a new orchid extract
Frederic Bonte, Francoise Pellicier, Emmanuelle Noblesse, Jean Christophe 
Archambault, Jean Hubert Cauchard LVMH Recherche, St Jean De Braye, France
Cellular senescence plays an important role in skin aging. Active DNA replication S 
phase cells are characteristic of young cells.  A β-Galactosidase staining Kit was used 
to histochemically detect senescence in young and old skin tissue. In vitro replicative 
senescence of human skin fi broblasts is performed from early stage passages (3P 
young cells) up to 22 passages (22P aged cells). Flow cytometry was used to analyse 
the difference of cell cycle stage distribution in young and aged fi broblasts population 
and in treated fi broblasts. The populations repartition in each cell cycle stage (G2+M; 
S, Go/G1) at 3P and 22P passage  and with or without an orchid extract treatment 
were evaluated using MXP software. To investigate mechanisms induced during 
senescence developpement cell Cyclins profi les were determined using specifi c 
protein array. Vanda coerulea orchideaceae stem ethanol/water 90/10 purifi ed 
extract was tested at 25µg/mL. In vivo beta galactosidase biomarker positive cells 
were found more numerous in aged skin and senescence-associated-β-galactosidase 
expression in human fi broblast cultures increased as a function of passage number. 
Young fi broblasts show 10.8% of G2+M, 4.55% S and 84.15 % G0/G1 respectively 
compared to 7.6, 1.2, 91.2 % in 22 passages fi broblasts. The 24 h Treatment with 
Vanda extract delays the entry in senescent state, 22P treated fi broblast population 
expressing 10.85% in G2+M phase, 4.7% S phase and 83.90% G0/G1 as in early 
passage young population. Cyclin E, which controls the G1 to S phase entry activation, 
was found decreased in old cells and, with cdk2, restaured by orchid treatment. 
ABSTRACTS
 S22 Journal of Investigative Dermatology (2010), Volume 130 
127
Skin cells antioxidant and anti-infl ammatory activities of phenanthrene constituants 
from Orchid
Charlotte Simmler1, Frederic Bonte2, Patrice Andre2, Annelise Lobstein3 1Guerlain, 
Levallois Perret, France, 2LVMH Recherche, St Jean De Braye, France, 3University of 
Strasbourg, France
Anti-infl ammatory processes are known to be involved in skin ageing and PLA2 
enzyme supplies arachidonic acid to downstream COX-2 for the synthesis of 
PGE-2. New biologically active constituents from Vanda coerulea Griff.ex.Lindl 
(Orchidaceae), were isolated and structurally determined by 1D and 2D NMR 
spectroscopic spectroscopic studies. Biological screening on various extracts 
revealed that stem extract displayed in vitro DPPH / OH radical scavenging activity 
and inhibition of PGE-2 release from irradiated (UVB 60mJ/cm
2) Normal Human 
Epidermal Keratinocytes (NHEK). Antioxidants experiments (DPPH, •OH/luminol 
chemiluminescence) and PGE-2 quantifi cation (Elisa) were carried on 96-well 
plates with quercetol and indomethacine (1µg/ml) as positive references. COX-2 
activity was measured using PGE-2 production Elisa test. Phytochemical analysis 
of stem extract yielded phenanthrene derivatives: imbricatin (1), methoxycoelonin 
(2), gigantol (3) and to a lesser content fl avidin (4) and coelonin (5). They all 
displayed radical scavenging activities, compounds 1, 2 and 4, 5 being more 
potent free radical scavengers than (3). Major phenanthrene derivatives (1-3) 
were also able to inhibit PGE-2 release from irradiated (UVB 60mJ/cm
2) NHEK 
with IC50 of 1.06μM for (1) and 4.36μM for (2).  Major antioxidant phenanthrenes 
from Vanda coerulea stem extract showed also skin anti infl ammatory properties 
by means of PGE-2 release inhibition on NHEK. Inhibition of COX-2 enzyme 
activity was found with (1) and (2) (IC50 12μM and 8μM, respectively) but not 
with (3), confi rming a selective biological interest of these secondary metabolites. 
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Abnormal lipid composition of stratum corneum in haemodialysis patients
Weronika Chorazyczewska1, Adam Reich1, Jacek Szepietowski1,2 1Department of 
Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, 
Poland, 2Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish 
Academy of Sciences, Wroclaw, Poland
The aim of the study was to analyse the lipid composition of the stratum corneum in 
patients undergoing haemodialysis and to evaluate its infl uence on the perception 
of uremic pruritus. 80 patients on haemodialysis (30 females and 50 males) in 
the age between 25 and 90 years (mean 59.9±15.6 years) were compared with 
32 healthy volunteers (19 females and 13 males) in the age between 22 and 86 
years (mean 59.7±16.0 years). Epidermis specimens were collected from the 
area of 1 cm2 on one lower leg by scraping and lipids were isolated using a two-
step chloroform/methanol/water extraction. Lipid composition of the stratum 
corneum was assessed according to 3-step thin layer chromatography (TLC). 
The level of identifi ed lipid classes was demonstrated as a percentage of the total 
lipids that were isolated. In addition, transepidermal water loss (TEWL), electric 
impedance of the stratum corneum, clinical severity of xerosis as well as the 
presence and intensity of pruritus using Visual Analogue Scale and a 4-point 
Itch Questionnaire was evaluated in each subject. All results were analysed 
statistically. Patients on haemodialysis in comparison to healthy controls showed 
signifi cantly decreased level of cholesterol (22.5±8.0% vs. 28.5±9.7%, p=0.001) 
and triacylglycerols (6.5±5.8% vs. 10.5±6.4%, p=0.002) in the stratum corneum, 
while the content of ceramides was markedly increased (33.4±8.7% vs. 25.1±9.5%, 
p<0.001). However, there was no relationship between observed abnormalities 
in epidermal lipids and the degree of xerosis as well as the pruritus intensity.
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Siascopy detects intraindividual differences of skin ageing between sun-exposed and 
sun-protected skin
Daniel Stimpfl e, Andreas Serra, Ralph Braun, Lars E French, Günther FL Hofbauer
University Hospital Zurich, Zurich, Switzerland
To date, photoaging of the skin is hard to quantify in live patients. Sun light has a 
decisive infl uence on the content of collagen, haemoglobin and melanin of human 
skin. We report on the quantifi cation of skin aging within individuals using the recently 
described SIAscopy method. SIAscopy (Spectrophotometric Intracutaneous Analysis) 
measures the refl ectance of light by the chromophores collagen, hemoglobin and 
melanin in the skin with a depth up to 2mm. By SIAscopy, volunteers and patients were 
assessed at three different sun-exposed spots (forehead, cheek, back of the hand) and 
at a non-sun-exposed part of the body (buttocks), all axisymmetrically on both sides. 
The measurements were performed once for a total of 8 measurements per patient. A 
total of 79 subjects aged 18 to 81 years showed a signifi cant difference between the 
sun-protected part of the body compared to sun-exposed parts. (Buttocks to back of the 
hand: melanin p<0.001; collagen p<0.001; haemoglobin values p<0.001. Buttocks 
to cheek: melanin values p<0.001; collagen values p=0.005; haemoglobin values 
p<0.001; buttocks to forehead: melanin values p< 0.0007; collagen values p=0.03; 
haemoglobin values p<0.001; all values Bonferroni-corrected). SIAscopy clearly 
distinguishes sun-protected skin intraindividually from sun-exposed areas of the 
skin by the quantifi cation of the chromophores collagen, haemoglobin and melanin.
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Epidermal expression of host response genes upon skin barrier disruption in normal 
skin and uninvolved skin of psoriasis and atopic dermatitis patients
Heleen de Koning, Marijke Kamsteeg, Diana Rodijk-Olthuis, Ivonne van Vlijmen, Piet 
van Erp, Patrick Zeeuwen, Joost Schalkwijk Department of Dermatology, Radboud 
University Nijmegen Medical Centre, Nijmegen, Netherlands
Recent genetic studies have indicated that skin barrier abnormalities play a 
role in the pathogenesis of atopic dermatitis (AD) and psoriasis. Defi ciencies in 
skin barrier formation or repair may expose epidermal cells to environmental 
stimuli such as microbial components which could in turn evoke a response that 
is shaped by the genetic background of the host. Here we investigated the effect 
of experimental skin barrier disruption on the expression of host defense genes in 
uninvolved epidermis of psoriasis and AD patients and healthy controls. Skin barrier 
disruption was induced by tape stripping of the stratum corneum or by sodium 
dodecylsulphate (SDS) application. Quantitative PCR was performed on epidermal 
sheets and immunohistochemistry on whole skin biopsies. Skin barrier disruption 
only marginally affected the mRNA expression levels of pattern recognition receptors 
(PRRs). However, mRNA and protein levels of antimicrobial proteins (AMPs) were 
strongly elevated and of similar magnitude in psoriasis and AD patients and healthy 
controls. In cultured keratinocytes from the three groups, Th2 cytokines partly 
reduced the Th1-cytokine mediated induction of several AMPs. We conclude that 
skin barrier disruption induces AMP expression similarly in AD and psoriasis patients 
without requiring transcriptional upregulation of PRRs. Our data indicate that the 
expression of AMPs in human epidermis is a complex process driven by many factors 
including skin barrier integrity, cytokine environment and genetic predisposition. 
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Determination of Skin Aging In Vivo Using Multi Photon Laser Scanning Microscopy 
(MPLSM) in the Stratum Granulosum
Vivien Lutz1, Christian-Dennis Rahn1, Stefan Puschmann1, Roger Wepf2, Ulrich 
Hintze1, Stefan Gallinat1, Horst Wenck1, Klaus-Peter Wittern1, Frank Fischer1
1Beiersdorf AG, Hamburg, Germany, 2Electron Microscopy Center (EMEZ), Zurich, 
Switzerland
In the process of skin aging the growth rate of the epidermis decreases resulting in 
an increase of corneocyte size. Furthermore, light and electron microscopy revealed 
an enhanced keratinocyte size with in vitro aging. In this study we investigated the 
infl uence of aging on the size of keratinocytes of the stratum granulosum in vivo. 
Multi photon laser scanning microscopy (MPLSM) allows in vivo imaging without 
contrast agents due to the auto fl uorescence of the keratinocytes. The endogenous 
fl uorophores are NAD(P)H and fl avin coenzymes (in glycolysis in cytoplasm and 
in citric acid cycle, β-oxiodation and oxidative phosphorylation in mitochondria 
matrix). Therefore, the autofl uorescence of the cytoplasm of the keratinocytes allows 
a specifi c imaging of the cells. Automated image analysis can be used in order to 
obtain the area of a suffi cient number of granulosum cells (Agran). The procedure is a 
combination of Voronoi sectioning and active contours. Young skin shows smaller cell 
areas in the stratum granulosum compared to the skin of elderly volunteers (+13%). 
Since keratinocytes grow slower with age they have more time to get wider in the 
stratum granulosum. This result supports the in vitro fi nding and explains the increased 
corneocyte size. Thus, Agran is a useful parameter to differenciate skin age in vivo.
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Stratum Corneum Depth and NMF Distribution Displayed Signifi cant Differences 
Between Dry and Healthy Skin
Li Feng, Carol Vincent, Nandou Lu, Heather Shaeffer, Stella Arcella, Carol Bosko, 
Helen Meldrum, Prem Chandar Unilever R&D, Trumbull, CT, United States
While Natural Moisturization Factors (NMFs) are essential for maintaining stratum 
corneum (SC) water content and hydration level, there has been little evidence regarding 
NMF variations in healthy and dry skin. To determine whether there is any difference in 
NMF levels between individuals with healthy skin and those with dry skin, sequential 
tape strips from 62 subjects with varying visual dryness grades were collected for 
protein, free amino acid (FAA) and NMF analyses. The results demonstrated that dry 
skin subjects had signifi cantly more accumulated proteins which were stripped off by 
the tape strips. In addition, dry skin subjects showed signifi cantly lower normalized 
FAA across the stripped SC depth (p=0.002 for peak), and the FAA peak appeared 
in the deeper layer of the SC in dry skin. Furthermore, HPLC analysis of pyrrolidone 
carboxylic acid (PCA), the prominent component of NMF, correlated well with 
FAA on the tape strips (R2=0.73), and accounted for approximately 9% of total FAA 
regardless of skin condition. PCA also exhibited very similar SC distribution to FAA, 
and its level in dry skin was signifi cantly lower compared to healthy skin (p=0.006 
for peak). This suggested that profi laggrin break down occurs in the deeper SC, and 
the production of NMF (hence the profi laggrin expression) may be lower in dry skin 
subjects. These results confi rmed that NMF levels are critical for skin conditions, and 
lower NMF production may be associated with dry skin. Therapies and moisturizers 
that help to maintain SC NMF level may be viable routes for dry skin management.
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ER signaling is activated to protect human keratinocyte from ER stress provoked by 
the environmental dose UVB
Kentarou Mera1,2, Ko-ichi Kawahara2, Ko-ichi Tada1, Kazuhiro Kawai1, Teruto 
Hashiguchi2, Ikuro Maruyama2, Takuro Kanekura1 1Department of Dermatology, 
Kagoshima, Japan, 2Department of Molecular Medicine, Kagoshima, Japan
Proteins are folded properly in the endoplasmic reticulum (ER). Various stresses such 
as hypoxia, ischemia, or starvation interfere the ER function leading to the ER stress 
defi ned by accumulation of unfolded protein (UP) in the ER. ER stress is avoided 
by UP response (UPR) and ER-associated degradation (ERAD). Signaling pathways 
to avoid UP are activated by 3 major ER molecules, ATF6, IRE-1, and PERK. We 
investigated the ER signaling in human keratinocytes irradiated by environmental 
dose ultraviolet B (UVB) using HaCaT cells. UVB irradiation at 20 mJ/cm2 resulted 
in signifi cant growth retardation and decrease of Ero1-Lα expression at 1 to 4 
hours (h), indicating that UVB provoked ER stress in HaCaT cells. Expression of 
intact ATF6 was decreased and ATF6 was translocated into nuclei. Expression of 
XBP-1, a downstream molecule of IRE-1, and calnexin, an ER chaperone whose 
expression is regulated by XBP-1, and ubiquitination of UP were induced by 10 
mJ/cm2 UVB at 4 h. PERK that regulates apoptosis was not phosphorylated. These 
results demonstrate that UVB irradiation generates UP in HaCaT cells and UPR 
and ERAD systems are activated to protect cells from UVB-induced ER stress.
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Epimorphin-derived peptide antagonists remedy epidermal parakeratosis triggered 
by unsaturated fatty acid
Yoji Okugawa, Yohei Hirai Nanobiology Center and Department of Bioscience, 
School of Science and Technology Kwansei Gakuin Univ, Sanda-shi, Hyogo, Japan
Unsaturated fatty acid affects calcium infl ux in keratinocytes and triggers the epidermal 
hyperplasia with perturbation of the keratinization program, which is supposed to be 
relevant to the acne and comedone formation caused by accumulation of excess 
sebum.  Here, we show that the antagonistic peptide of epimorphin (EPn1: a circular 
compound composed of CGSIEQSC) clearly remedy the oleic acid-induced abnormal 
behaviors in epidermal keratinocytes.  In culture, treatment with oleic acid augmented 
extracellular secretion of epimorphin in HaCaT keratinocytes and prevented the 
epidermal terminal differentiation including programmed cell death (anoikis) and the 
cornifi ed envelope formation.  Intriguingly, however, simultaneous addition of EPn1 
peptide appeared to restore these keratinocyte differentiation programs.  In the hairless 
mice skin, the topical application of oleic acid caused epidermal hyperplasia with the 
decrease of enucleation in outer epidermal layers, which was dramatically hampered 
by the administration of EP peptide.  These results demonstrate that abnormal 
differentiation in the epidermal keratinocytes caused by unsaturated fatty acid is 
attributed to the overstimulation of epimorphin signaling and suggest the possible usage 
of EPn1 for the therapeutic purpose such as for acne and hyperkeratotic skin disease.
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Ameliorating effect of Yokukansan on atopic dermatitis-like lesions and scratching 
behavior in socially isolated NC/Nga mice
Naoko Funakushi1, Takuji Yamaguti3,4, Ju Jiang1,2, Sachiko Imamura4, Takatoshi Kuhara2, 
Hajime Suto1,2, Yoshio Kase4, Hiroyuki Kobayashi3, Hideoki Ogawa1,2, Shigaku Ikeda1,2
1Dept of Dermatology, Juntendo Univ School of Medicine, Bunkyo-ku Tokyo, Japan, 
2Atopy(Allergy) Research Center, Juntendo Univ Grad School of Medicine, Tokyo, 
Japan, 3Center for Advanced Kampo Medicine & Clinical Research, Juntendo Univ 
School of Medicine, Bunkyo-ku Tokyo, Japan, 4Tsumura Res Labs, Ibaraki, Japan
Long-lasting itch is an intolerable sensation in all patients, especially in patients with serious atopic 
dermatitis. Irresistible itch leads to chronic, habitual scratching behavior, a vicious spiral called 
the ‘itch-scratch cycle‘. Effective antipruritic drugs are in high demand for many patients with 
atopic dermatitis. In the present study, the effect of Yokukansan, which is a traditional Japanese 
medicine, on the development of atopic dermatitis-like lesions and scratching behavior was 
investigated in socially isolated NC/Nga mice. Ten-week-old male NC/Nga mice were divided 
into three groups (n=5/group): control (nontreated), Yokukansan and fexofenadine. All mice 
were kept in isolation under conventional conditions for 6 weeks. Dermatitis score, scratching 
and grooming behaviors, and transepidermal water loss (TEWL) were measured once a week 
or in three weeks during the experimental period. N-methyl-D-aspartate (NMDA) receptor and 
glutamate transporter-1(GLT-1) mRNAs were evaluated on the terminal day of the experiment. Both 
Yokukansan and fexofenadine inhibited the aggravation of skin lesions and the increased in TEWL. 
However, scratching and grooming behaviors which are indices of itch sensation were decreased 
signifi cantly after treatment with Yokukansan, but not affected by fexofenadine. Expressions of 
NMDA receptor and GLT-1 mRNA increased and decreased, respectively. Such abnormalities 
were also ameliorated by treatment with Yokukansan, but not affected by fexofenadine. These 
results suggest that Yokukansan ameliorates the aggravation of atopic dermatitis-like lesions and 
scratching behavior. In particular, the effect on itch sensation by Yokukansan may be related 
to the ameliorative effect against the dysfunction of NMDA receptor or GLT-1 in the skin.
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AQP3 expression in keratinocytes is involved in hyperplasia in atopic dermatitis
Kyoko Nakahigashi1, Kenji Kabashima1, Akihiko Ikoma1, Yoshiki Miyachi1, Mariko 
Hara-Chikuma1,2 1Department of Dermatology, Graduate School of Medicine, Kyoto 
University, Kyoto, Japan, 2Innovative Beauty Science Laboratory, Kanebo Cosmetics 
Inc., Kanagawa, Japan
Aquaporin-3 (AQP3) is a water/glycerol transporting protein expressed in keratinocytes 
of the epidermis. Previous studies have shown that AQP3-mediated water and glycerol 
transport is involved in keratinocyte migration and proliferation, respectively. AQP3 
expression was also found to be increased in atopic dermatitis (AD) skin; however, the role 
of AQP3 in the pathogenesis of AD remains unknown. To test the hypothesis that AQP3 
is involved in keratinocyte hyperproliferation during AD development, we used AQP3-
defi cient mice and human keratinocytes. In the murine AD model, which was generated 
by repeated applications of ovalbumin or hapten, AQP3 expression was remarkably 
increased in the wild-type AD epidermis. AQP3-defi cient mice exhibited less severe 
epidermal hyperplasia and lower transepidermal water loss than wild-type mice. The 
number of proliferating cell nuclear antigen-positive cells decreased in AQP3-defi cient 
AD epidermis compared to that in wild-type AD epidermis, suggesting the involvement 
of AQP3 in epidermal hyperplasia in AD. In human keratinocytes, overexpression of 
AQP3 by transfection of AQP3 cDNA facilitated proliferation and water/glycerol transport. 
Immunoblot analysis of various AD-related cytokines and chemokines indicated that 
AQP3 expression specifi cally increased by thymus and activation-regulated chemokine 
CCL17/TARC, which is known to be a Th2 chemokine and a specifi c marker for AD. 
Coincidentally, CCL17 treatment markedly enhanced keratinocyte proliferation. These 
results suggested that AQP3 is involved in the pathogenesis of AD development in which 
increased AQP3 expression was implicated in keratinocyte proliferation. AQP3 inhibition 
by topical drugs may be benefi cial for the therapy of epidermal hyperplasia in AD.
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Appearance in Japanese Women Correlates with the Presence of Inosotides and 
Lysolipids, Both Signifi cant Inhibitors of age-related NADH Oxidase Activity
D. James Morré1, Dorothy M. Morré1, Dale G. Kern2, Steve M. Wood2, Hidekazu 
Toyoda3, Helen E. Knaggs2 1NOX Technologies, Inc., West Lafayette, Indiana, United 
States, 2Nu Skin Enterprises, Inc., Provo, Utah, United States, 3Nu Skin Japan Co., Ltd., 
Tokyo, Japan
Accumulation of oxidative damage in proteins is considered to be a major 
contributor to skin deterioration during aging.  Recent work has suggested that age-
related NADH oxidase (arNOX), a signifi cant generator of superoxide exterior to 
the cell, may contribute to accelerated apparent aging.  Metabolic profi les from a 
cohort of 46 age-matched Japanese women aged 46 to 59 years, approximately half 
appearing younger (2 to 8.5 years, average 4.5 years) and half appearing older (5 
to 11.3 years, average 6.2 years) than their chronological ages, were analyzed for 
levels of metabolites.  Metabolites within all classes (lipids, carbohydrate, energy, 
amino acids, etc.) comprised the 471 profi led in this study.  A statistical cutoff of 
p≤0.05 was employed to indicate signifi cant metabolite differences.  arNOX activity 
in serum and saliva was assayed from measurements of superoxide production based 
on the reduction of ferricytochrome c by superoxide as monitored from the increase 
in absorbance at 550 nm with reference at 540 nm.  arNOX levels in the group 
appearing younger than their chronological age were lower than those in the older 
appearing group.  Only a limited number of metabolites achieved strong statistical 
signifi cance with metabolites related to lipid metabolism distinguishing the two 
groups.  Elevated levels of inositides and lysolipids, both naturally-occurring arNOX 
inhibitors, were found in the younger looking group.  Thus, apparent age appears to 
correlate closely with naturally-occurring inhibitors of endogenous circulating arNOX.
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Quantitative digital morphometry reveals decreased expression of desmoglein 3, 
but increased expression of desmoglein 2, in basal cell carcinomas
Monika Bowszyc-Dmochowska1, Justyna Gornowicz1, Agnieszka Seraszek2, Elzbieta 
Kaczmarek2, Marian Dmochowski1 1Department of Dermatology University of 
Medical Sciences in Poznan, Poznan, Poland, 2Department of Bioinformatics and 
Computational Biology University of Medical Sciences in Poznan, Poznan, Poland
Three isoforms, each in two splicing variants, of desmocollin (DSC1-3) and four 
isoforms of desmoglein (DSG1-4) are known in humans, each one arising from a 
different gene and having characteristic expression. In normal human epidermis 
DSG2 is expressed at the low level, and was reported to be restricted to the lowermost 
epidermis. DSG2 expression fades with keratinocyte differentiation, whereas DSG3 
expression decreases somewhat gradually from the basal into the spinous cell layers. 
The aim of this pilot study was to examine expression patterns of both DSG2 and 
DSG3, adhesive molecules, in basal cell carcinoma (BCC) and to compare them with 
those in normal epidermis. Using immunoperoxidase staining on frozen tissues with 
monoclonal antibodies against human DSG2 and DSG3, we evaluated DSG2 and 
DSG3 expressions in specimens from 15 and 34 BCC patients, respectively. Intensities 
of positive immunostaining signals of these proteins in BCC-affected and BCC-free 
areas on serial sections were measured using digital microscopic image analysis 
with quantitative morphometric software. There was a signifi cant overexpression 
of DSG2 and signifi cantly lower expression of DSG3 in BCC tissue compared to 
normal epidermis. We found no signifi cant correlation between DSG2 and DSG3 
expression in BCC tissue, but there was a signifi cant correlation (r=+0.5868) between 
those markers in non-BCC-affected epidermis. Our data might suggest that DSG2 and 
DSG3 indeed play different roles in proliferation and differentiation in BCC-free versus 
BCC-affected human epidermis. Seemingly, the expressions of DSG2 and DSG3 are 
coordinated in normal epidermis, but this apparent coordination is lost in BCC tissue.
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Identifi cation and Characterization of MDR1 as a Sebum Secretion Transporter in 
Hamster Sebocytes
Takashi Sato, Hirokazu Kurihara, Noriko Akimoto, Akira Ito Department of 
Biochemistry and Molecular Biology, Tokyo University of Pharmacy and Life Sciences, 
Hachioji, Tokyo, Japan
Sebum secretion plays an important role in the formation of a physiological barrier formation 
on the skin surface. It is thought to be regulated by a holocrine mechanism that is associated 
with the apoptosis of sebaceous gland cells (sebocytes). On the other hand, ATP-binding 
cassette (ABC) transporters participate in the membrane transport of various substrates 
including lipids. However, whether apoptosis or ABC transporters are associated with sebum 
secretion is not well understood. In the present study, we examined the involvement of 
apoptosis or ABC transporters in sebum secretion in hamster sebocytes. The measurement of 
intracellular and extracellular triacylglycerols (TG), major sebum components, revealed that 
levels of extracellular TG increased along with the accumulation of intracellular TG during 
insulin-induced sebocyte differentiation. In addition, differentiated hamster sebocytes (DHS) 
exhibited apoptosis-independent phosphatidylserine exposure and tolerance against Ca2+ 
infl ux and apoptosis by the apoptosis inducer, A23187. Furthermore, transporter activity 
using an ABC transporter substrate, Rhodamine 123, was highly detectable in DHS rather than 
the undifferentiated sebocytes. An ABC transporter activator, BzATP, also enhanced not only 
transporter activity but also sebum secretion in DHS. Moreover, MDR1 (multidrug resistance 
1)/ABCB1 was constitutively detectable, and both transporter activity and sebum secretion 
were suppressed by MDR1 antibody in the DHS. These results provide novel evidence that 
sebum secretion is mediated by MDR1 in an apoptosis-independent manner in DHS. Finally, 
these fi ndings should help to accelerate the understanding of the functions of sebaceous 
glands, and may contribute to the development of therapies for skin diseases such as acne.
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Purifi cation and Identifi cation of Sphingomyelin Deacylase from Rat Skin
Mari Nogami-Itoh1, Yasuhiro Teranishi1, Hiroshi Kuwahara1, Masanori Kusumoto1, Keiji 
Nakamura1, Mitsuhiko Matsumoto1, Jun Sakai1, Toru Kimura1, Makoto Kawashima1
1Drug Research Division, Dainippon Sumitomo Pharma Co., Ltd., Osaka, Osaka, 
Japan, 2Department of Dermatology, Tokyo Women‘s Medical University, Shinjyuku, 
Tokyo, Japan
Abnormal expression of sphigomyelin (SM) deacylase activity, that hydrolyzed 
sphingomyelin to sphigosylphosphorylchorine (SPC) and fatty acids, was reported 
in the epidermis of atopic dermatitis (AD) patients. SM deacylase is multifunctional 
enzyme infl uencing infl ammatory systems and natural ceramide metabolism, 
which are considered to be etiologic factor of AD. Although SM hydrolyzing 
activity was certainly present, for many years, the enzyme itself was unidentifi ed. 
To identify SM deacylase active protein we established suitable methods for 
measuring activity, enzyme purifi cation, and protein identifi cation. The specifi c 
enzyme activity was measured by tandem mass spectrometer by monitoring 
production of SPC. Solubilized proteins from the 10000 xg supernatant of various 
rat organs were assayed for SM deacylase activities, and we found that the activity 
was higher in the order of skin > lung > heart. No activity was detected in other 
organs. A protein spot on 2D-PAGE gel with strong correlation with SM deacylase 
activity was analyzed, and we identifi ed the active protein as beta subunit of acid 
ceramidase (AC). Further, we found that SM deacylase activity was detected from 
AC beta subunit by reduction of recombinant with dithiothreitol. SM deacylase 
active fractions by isoelectoric focusing of reduced AC were well correlated with 
the distribution of AC beta subunit but not AC alpha subunit. These results may 
provide new insight to ceramide metabolism and its role in AD pathophysiology.
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Systemic recruitment of myeloid cells upon deletion of IKK2 from epidermal 
keratinocytes 
Snehlata Kumari, Manolis Pasparakis, Ingo Haase University of Cologne, Germany
We have previously described the phenotype of mice with epidermis specifi c 
deletion of IKK2, the main regulator of NFkappaB activity. Four to fi ve days after 
birth, these mice start to develop a skin disease that resembles human psoriasis and is 
characterized by a mixed infl ammatory infi ltrate and hyper proliferation of epidermal 
keratinocytes. We could also show that skin macrophages play a pathogenic role in 
the development of this infl ammatory skin condition. Here we have asked by which 
mechanisms immune cells are recruited into the skin of these mice. We have found 
that, immediately after birth, IKK2 negative epidermal keratinocytes generate pro 
infl ammatory signals that tailor the resulting skin infl ammation specifi cally towards 
a myeloid cell dominated innate immune response. After birth, the fi rst transcription 
dependent signal was the up regulation of members of the IL-19 family of cytokines 
which are known to mediate interactions between epithelia and monocytes/ 
macrophages. Up regulation of IL- 19 and IL- 24 as well as phosphorylation of STAT3 
in epidermal keratinocytes were detectable at P1 and preceded the fi rst macroscopic 
and microscopic changes of the skin. This was followed by an increased production 
of other pro-infl ammatory cytokines and of myeloid cell recruiting chemokines 
without regulation of lymphocyte directed chemokines. These mice showed signs 
of extramedullar myelopoiesis and an increased fraction of CD11b positive cells 
but no changes in B- and T- lymphocyte in the peripheral blood. Our results show 
that epidermal keratinocytes can control a systemic, myeloid cell dominated innate 
immune response by NFkappaB dependent mechanisms.
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The induction of mouse beta-defensin 3 expression in skin barrier disruption is 
mediated by TNF-alpha
Kerstin Ahrens, Graziella-Francesca Podda, Juergen Harder, Ehrhardt Proksch
Department of Dermatology, Kiel, Germany
The physical permeability barrier and antimicrobial proteins of the innate immune 
system protect the skin against microbiological infection. We previously showed that 
expression of mouse beta-defensin-3 (mBD-3), which is an ortholog of human beta-
defensin-2 (hBD-2), respectively, is stimulated by acute barrier disruption induced by 
tape-stripping or acetone treatment of mouse skin in vivo. Also, we found that mBD-3 
mRNA expression is induced in primary mouse keratinocytes by treatment with tumor 
necrosis factor alpha (TNF-alpha) in vitro. We asked whether the induction of mBD-3 
after skin barrier disruption depends on TNF-alpha signaling and whether TNF-alpha is 
the only cytokine mediating mBD-3 induction after skin barrier disruption. An anti-TNF-
alpha antibody was injected in hairless mice for blocking TNF-alpha activity 24 hours 
before skin barrier disruption. Six hours after barrier disruption by acetone treatment, 
skin samples were harvested for mRNA isolation and for immunohistology. Realtime PCR 
analysis with mBD-3 specifi c primers revealed a signifi cant induction of mBD-3 gene 
expression by skin barrier disruption compared to untreated controls. Mice injected with 
an anti-TNF-alpha antibody before barrier disruption showed a signifi cant decreased 
in mRNA induction compared to mice without anti-TNF-alpha antibody treatment. 
Immunohistology using a specifi c anti-mBD-3 antibody confi rmed these results on the 
protein level. In summary, we showed a crucial role of TNF-alpha in the induction 
of mBD-3 by skin barrier disruption. However, the anti-TNF-alpha pretreatment did 
not completely block the induction of mBD-3 expression. This might be a hint for an 
involvement of additional cytokines in the induction of mBD-3 by barrier disruption.
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Primary human keratinocytes and fi broblasts under hyperglycaemic conditions and 
of diabetic origin show reduced susceptibility to Cx43 targeting
Simone Pollok1, Ann-Catherine Pfeiffer1, Ralf Lobmann2, Ingrid Moll1, Johanna 
Maria Brandner1 1Department of Dermatology and Venerology, University Hospital 
Hamburg-Eppendorf, Hamburg, Germany, 2Department of Endocrinology, 
Diabetology and Geriatrics, Clinical Centre Stuttgart - Buergerhospital, Stuttgart, 
Germany
Connexin 43 (Cx43) is downregulated during early wound healing (WH) at cutaneous wound 
margins. Several mouse models and the dysregulation of Cx43 in diabetic chronic wounds 
indicate that this downregulation is important for WH. Therefore, Cx43 is a promising target 
to accelerate WH. We have previously shown that Cx43 targeting is benefi cial to improve 
WH in infant and adult human keratinocytes and fi broblasts. However, cells isolated from 
diabetic patients, although showing no difference in Cx43 expression and localisation 
compared to non-diabetic cells, exhibit a reduced susceptibility to Cx43 targeting by Cx-
mimetic peptide Gap27. Additionally, diabetic keratinocytes migrate signifi cantly slower 
than non-diabetic keratinocytes. One possible reason for this “diabetic phenotype” might 
be the hyperglycaemia of diabetic donors. To investigate this hypothesis, we determined 
the behaviour of non-diabetic cells under hyperglycaemic conditions. We show here that 
cells under hyperglycaemia exhibit signifi cant similarities to cells from diabetic origin. They 
exhibit higher fi bronectin protein levels whereas there are only minor infl uences on Cx43. 
Hyperglycaemia in scratch wound assays leads to decreased migration rates. Application 
of Gap27 or Cx43-specifi c antisense oligonucleotides under these conditions does not 
result in accelerated migration although it does under physiologic glucose concentrations. 
These data show that the altered phenotype of cells of diabetic origin might be due to the 
hyperglycaemic conditions of the diabetic donors. This is also supported by the loss of “diabetic 
phenotype” during long-term culture of cells of diabetic origin in euglycaemic conditions.
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Involvement of DHCR24 in the physiology of epidermal keratinocytes in oxidative 
stress conditions
Frédéric Minner, Daniel Van Vlaender, Yves Poumay Cell and Tissue Laboratory, 
URPHYM, University of Namur (FUNDP), Namur, Belgium
Oxidative Stresses applied to keratinocytes perturb epidermal homeostasis and 
mechanisms are initiated to repair epidermal tissue. While earlier works focused on 
the damaging aspects of reactive oxygen species, it was discovered that hydrogen 
peroxide (H202) can act as a signalling molecule and be benefi cial for skin wound 
healing. Because H202 induces a modifi ed differentiation profi le similar to the 
profi le induce by cholesterol depletion of keratinocytes by methyl-b-cyclodextrin 
and because 3β-hydroxysteroid-Δ24 reductase (DHCR24), involved in cholesterol 
biosynthesis pathway is also implicated in the cellular responses to oxidative 
stress, we investigated functions of DHCR24 in the physiology of keratinocytes 
submitted to an oxidative stress. We show an increase of expression of DHCR24 
in the suprabasal layers of epidermis by immunohistochemical labelling and in 
serum-free autocrine conditions where the confl uence of cultured keratinocytes 
corresponds to a strong commitment toward epidermal differentiation. Interestingly, 
identical alterations in differentiation markers are detected in H202-treated cultures 
of keratinocytes, exactly as in vivo at the wound margin of injured skin. After an 
oxidative stress, keratinocytes reveal a decreased expression of keratin-10, fi llagrin 
and loricrin, while the expression of keratin-14 and involucrin is not altered. This 
decrease of expression is amplifi ed when DHCR24 is previously inhibited by 
siRNA. We show equally that the expression of miR-203, microRNA suspected 
in regulation of differentiation in keratinocytes, undergoes durable decreased 
expression after oxidative stress. Our results show that oxidative stress induced by 
hydrogen peroxide perturbs durably the process of differentiation in keratinocytes 
and suggest that DHCR24 moderates this perturbation in these conditions.
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CD44 regulates tight junction assembly and barrier function
Nina Kirschner1, Marek Haftek2, Carien M Niessen3, Martin J Behne1, Ingrid Moll1, 
Johanna M Brandner1 1Dept of Dermatology and Venerology, University Hospital 
Hamburg-Eppendorf, Hamburg, Germany, 2Université de Lyon, EA4169 Laboratory 
for Dermatological Research, E. Herriot Hospital, Lyon, France, 3Dept of Dermatology, 
Center for Molecular Medicine Cologne, University of Cologne, Germany
Upon barrier disturbance adult CD44 knock-out (KO) mice show delayed recovery 
of epidermal barrier function. This correlates with loss of apical polarization of 
lamellar body (LB) secretion. In simple epithelia tight junctions (TJ) are crucial for 
barrier function and regulate the polarized targeting of vesicles to either the apical or 
basolateral membrane. In addition, they are important for murine epidermal barrier 
function. Therefore we hypothesized that CD44 regulates TJ and associated cell polarity 
complexes, which in turn contributes to altered skin barrier function in CD44 KO mice. 
We show a delay in embryonic barrier formation associated with a loss of apical LB 
localization in CD44 KO mice which correlates with alterations in localization and/
or expression levels of TJ proteins as well as the polarity protein Par3. Simultaneously, 
activity of the small GTPase Rac1, a major regulator of TJ barrier function, was 
reduced. Importantly, normalization of barrier function at E18.5 was paralleled by the 
recovery of these proteins. Tape stripping experiments revealed that loss of CD44 also 
affected TJ proteins upon induced disturbance of the barrier in adult mice. In primary 
keratinocytes, cell polarization and TJ barrier function was impaired in CD44 KO 
cells. An alteration of differentiation associated markers was also observed, but less 
pronounced and chronologically subsequent to alterations of TJ proteins. Together, 
the results reveal an important function for CD44 in the assembly and function of 
TJ, suggesting their involvement in the skin barrier phenotype of CD44 KO mice.
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Filaggrin mutations and their impact on stratum corneum lipid levels and skin 
physiology in patients with eczema
Jakob Mutanu Jungersted1, Elke Rodriguez2, Helene Scheer2, Martin Mempel2, 
Hansjörg Baurecht2, Julie Hogh3, Lars Hellgren3, Gregor Jemec1, Tove Agner4, 
Stephan Weidinger2,5 1Dept of Dermatology, Roskilde Hosp, Univ of Copenhagen, 
Denmark, 2Dept of Dermatology, Technische Univ Muenchen, Germany, 3Tech Univ 
of Denmark, Copenhagen, Denmark, 4Dept of Dermatology, Bispebjerg Hospital, 
Denmark, 5Dept of Dermatology, Christian-Albrechts-Univ, Kiel, Germany
Filaggrin (FLG) mutations cause ichthyosis vulgaris and are strong risk factors for eczema. Alterations 
in stratum corneum lipid levels, skin pH and trans-epidermal water loss (TEWL) are characteristic 
features of eczema. In order to examine the impact of FLG mutations on skin physiology parameters 
and their potential infl uence on ceramide levels, we investigated 49 German individuals with 
and without eczema and information on the two common FLG mutations R501X and 2282del4. 
Stratum corneum lipid analysis was carried out by high performance thin layer chromatography, 
and TEWL, erythema, skin hydration and pH were measured. In 27 individuals an additional 
24-hour irritation patch test was performed.Eczema patients with FLG mutations (FLGmut) had 
signifi cantly higher erythema than patients without FLG mutations. FLGmut individuals displayed 
signifi cantly higher skin pH values than FLGwt individuals. The highest TEWL and lowest skin 
hydration values were observed in FLGmut eczema patients. FLGmut eczema patients also showed 
signifi cantly lower ceramide 4 and signifi cantly higher ceramide 7 levels as compared to both 
healthy control groups. However, ceramide 7 and ceramide 1 levels also signifi cantly differed 
between FLGwt eczema and FLGwt controls. No signifi cant differences were observed for ceramide 
2, 3, 5 and 6. Our results provide preliminary evidence that the elevation of skin pH might be 
related to FLG status rather than eczema, and that FLG mutations are associated with increased 
TEWL and decreased skin hydration. Furthermore, they confi rm previous fi ndings of altered 
ceramide levels in eczema, which however appear to be due to mechanisms other than FLG.
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Enhanced contact allergen and UVB induced keratinocyte apoptosis in the absence 
of CD95/Fas/Apo-1 
Kristina Behrendt1, Alina Hedrych-Ozimina1, Zhenyue Hao2, Ruth 
Pofahl1, Doreen Ussath1, Renate Knaup1, Thomas Krieg1, Ingo Haase1
1University of Cologne, Department of Dermatology, Germany, 2The Campbell Family 
Institute for Cancer Research, Ontario Cancer Institute, Toronto, Canada
FAS/ CD95/ Apo-1 is an ubiquitously expressed cell surface receptor involved in 
the initiation of programmed cell death. Its function in epidermal keratinocytes 
has been incompletely defi ned. Apart from its pro- apoptotic role, Fas has also 
been implicated in anti-apoptotic signaling in different systems. In skin, available 
evidence from in vitro studies points to important roles of Fas in the pathogenesis 
of contact dermatitis and in keratinocyte apoptosis induced by ultraviolet light. 
To elucidate the role of Fas in the epidermis in vivo and to test its requirement 
for DNFB induced contact dermatitis as well as for UVB induced keratinocyte 
apoptosis, we used conditional gene targeting technology to specifi cally delete 
the fas gene in the epidermis of C57/Bl6 mice. Unexpectedly we found that 
keratinocyte apoptosis induced by both a contact allergen and by UVB irradiation 
was signifi cantly enhanced in Fas negative epidermis as shown by TUNEL staining, 
counting of sunburn cells and staining for active Caspase 3. In addition, the absence 
of Fas did not result in changes of the ear swelling response, the development of 
infl ammation and of epithelial spongiosis in contact hypersensitivity, and Fas was 
not required for keratinocyte apoptosis following UVB irradiation in vivo and in 
vitro. Hence, our results demonstrate that, in the epidermis in vivo, Fas exerts anti 
apoptotic functions that outweigh its pro apoptotic role in contact hypersensitivity 
responses of the skin and in the tissue response of the epidermis to UVB irradiation.
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Impact Of Angiotensin II On Nhuman Keratinocyte Functions : Involvement In The 
Migration Process
Jocelyne Franchi2, Adeline Muscat1, Morwenna Le Guillou1, Clarisse Marteau2, 
Géri Méduri1, Sylvianne Schnebert2, Bruno Fève1 1INSERM U693 Centre Hospitalo-
Universitaire de Bicêtre, Le Kremlin-Bicêtre, France, 2LVMH Recherche, Parfums et 
Cosmetiques, Saint Jean de Braye, France
The tissue renin angiogenin system (RAS), which acts independently of the systemic 
RAS, is considered to play an important role in tissue repair in heart and kidney. 
Previous work documented the expression of angiotensin II receptors in the human 
skin. However, little data is available at present on the expression of the various 
components of the RAS in the human skin and on the functions of this cutaneous 
RAS. Using a model of human reconstituted skin on fi lters, we have shown that the 
key players of the SRA are induced during the in vitro maturation of the epidermis, 
ie renin, angiotensin II converting enzyme, and angiotensin II type-1 and type-2 
receptors. This observation is in line with the distribution of the constituents of the 
RAS in normal skin, showing a stronger expression in the superfi cial layers than in 
the basal layers of the epidermis. Strikingly, the production of angiotensin II in the 
culture medium is negatively correlated with the age of the keratinocytes donor. 
The proliferation of keratinocytes is not modifi ed in the presence of angiotensin II. 
Conversely, angiotensin II stimulates the migration of human keratinocytes, by an 
angiotensin II receptor-dependent process. In addition, the peptide induces a moderate 
increase of several proteins refl ecting epidermal maturation (fi laggrin, cytokeratines, 
involucrin). These results indicate that the RAS is expressed in human skin, and that it 
could control phenomena essential for the processes of cutaneous healing and repair.
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Activation of the Aryl Hydrocarbon Receptor In Human Keratinocytes and 
Relevance To Chloracne
Alison Forrester1, Mark Graham2, Faith Williams1, Nick Reynolds1 1Newcastle 
University, Newcastle upon Tyne, UK, 2Astra Zeneca, Loughborough, UK
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes chloracne in humans and is a 
potent activator of the arylhydrocarbon receptor (AhR). However, it remains unclear 
whether chloracne inducing potential of AhR agonists relates to binding affi nity, 
duration of activation and/or down-regulation of the receptor. Currently, no in vitro 
skin model for chloracne exists but TCDD induces aberrant differentiation of epidermal 
equivalents with early induction of involucrin and a compacted stratum corneum. We 
studied the effects of TCDD and non-chloracnegenic agonists β-naphthofl avone (β-
NF) and the physiological agonist 2-(1’H-indole-3’-carbonyl)-thiazole-4-carboxylic 
acid methyl ester (ITE), which shows similar affi nity to TCDD. β-NF showed ~2 
fold AhR activation in keratinocytes using XRE-dependent Luciferase assay whereas 
ITE induced activity to a similar degree (~8 fold) as TCDD.  Expression of CYP1A1 
(utilised as readout of AhR activation) and AhR were determined by Western blotting. 
TCDD, ITE and β-NF induced CYP1A1 expression and degraded AhR to a similar 
degree. As expected, TCDD induced compaction of the stratum corneum in human 
epidermal equivalents. Notably, both β-NF and ITE induced similar changes. 
Reduced viable cell layers were seen with all 3 agonists and involucrin staining 
occurred in closer proximity to the basal layers suggesting early onset of terminal 
differentiation. We conclude that high and low affi nity xenobiotic and physiological 
agonists induced activation and down-regulation of AhR in keratinocytes and 
induced similar phenotypic changes in epidermal equivalents. Therefore, these 
data suggest neither interaction with AhR or early induction of differentiation in 
epidermal equivalents correlate with the ability of AhR agonists to induce chloracne.
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Interactions between human primary keratinocytes and the dorsal root ganglion-
derived neuronal cell line, the F-11.C. 
Christelle Le Gall-Lanotto1, Eric Andrés2, Nicolas Lebonvallet1, Sandra Médina2, 
Ulysse Pereira1, Laurent Misery1 1European universty of Brest, Brest, France, 2Natura 
Innovation, Paris, France
The epidermis can be considered as a true sensory tissue. Indeed, there‘s a 
dynamic communication between epidermal cells and the free nerves endings 
send by sensory neurons of the peripheral nervous system. However, little is 
known concerning the functional interactions between the sensory fi bers and the 
keratinocytes constituting the epidermis. Therefore, it‘s diffi cult to reproduce these 
interactions in vitro. We developed an in vitro model based on the co-culture of 
human primary keratinocytes (KH) and a dorsal root ganglion cell line, the F-11. 
F-11 are classically used to mimic authentic, peptidergic, nociceptive neurons. 
We fi rst describe the morphological and functional characteristics of F-11 in a 
basal keratinocyte medium (KM) and then analyze the infl uence of KH on these 
properties. We demonstrated that F-11 survive and differentiate well in the KM and 
that addition of neurotrophins was not necessary. Therefore, F-11 expressed sensory 
neuron markers and release SP and CGRP after activation by capsaicin. We noted 
that neuropeptide release could be obtained even at low calcium concentration and 
that axonal outgrowth was not infl uenced by the external Ca²+ concentration. These 
properties were reproduced when F-11 were cocultured with KH but KH had no 
signifi cant infl uence on axonal development or neuropeptides release. Here, we 
described for the fi rst time the culture of F-11 neurons with another cell type. This 
coculture model in which keratinocytes and neurons are maintained in low Ca²+ 
concentration may be useful to increase the in vitro alternative for studying and 
characterizing the close communication between keratinocytes and sensory neurons.
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Exposure to electromagnetic radiation alters skin homeostasis
Muriel Cario-Andre1, Delphine Simon1,2, Catherine Pain1, Alexia Daubos1, Richard 
Fitoussi2, Katell Vié2, Rachid Anane3, Rachid Ennamany3, Lionel de Bedetti2
1University V Segalen; Inserm U876, Bordeaux, France, 2Laboratoire Clarins, Pontoise, 
France, 3Eurostest, Cestas, France
In this study we have looked at the effects of a strong acute electromagnetic 
radiation exposure (GSM basic, 900 MHz, SAR 2 mW/g, 6 hours) on a model of 
pigmented reconstructed epidermis. We have analyzed the variation in expression 
and localisation of various epidermal markers (stress, differentiation, proliferation) 
2, 6 and 24 hours after exposure. By immunohistochemistry, no changes were found 
in the localisation of epidermal markers of differentiation/proliferation, presence 
of apoptotic cells and induction of p53 and Hsp70. By western-blot, Hsp70 was 
not found induced at 2 and 6 hours; caspase 3 was not activated at 2 and 6 hours 
but a slight increase was observed at 24 hours. A transient oxidation of proteins 
was detected 2 hours after exposure. A decrease at 2 and 6 hours was found in 
the levels of fi laggrin, loricrin, cytokeratin 5 and involucrin. On the contrary, 
cytokeratins 14 and 10 were markedly increased at 2 hours followed by a decrease 
at 6 hours. The level of fi laggrin was not fully recovered at 24 hours contrary to 
cytokeratins 5 and 10. Loricrin and cytokeratin 14 were markedly increased at 24 
hours in possible correlation with the signifi cant decrease in activity of the 20S 
proteasome. In conclusion, our data indicate that exposure to 900 MHz frequency 
do not seem to induce cellular stress but induce alteration of the epidermal 
barrier which may alter the protective capacity of the skin against external factors.
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High-resolution and three-dimensional analysis of atopic dermatitis affected stratum 
corneum using atomic force microscopy
Christian Gorzelanny1, Marie-Christine Apfel1, Karin Roters2, Volker Huck2, Thomas 
A. Luger2, Stefan W. Schneider1 1Medical Faculty Mannheim, Heidelberg University, 
Mannheim, Germany, 2University of Münster, Münster, Germany
In the present study we used atomic force microscopy (AFM) to analyse the 3D 
topography of native stratum corneum (SC) obtained by tape stripping. AFM 
enables high resolution imaging of native human stratum corneum in a nanometric 
scale without any sample preparation. Therefore, an accurate calculation of the 
surface area and volume of single corneocytes is possible. Atopic dermatitis (AD), 
characterised by an impaired physical barrier results in an increased dehydration 
of the skin and thus to a shrinking of corneocytes. In comparison to the skin of 
healthy volunteers, AFM analysis revealed a dramatic change of the morphology 
of single corneocytes in skin samples obtained from AD patients. In AD affected 
skin, corneocytes are regularly decorated with cellular humps that are completely 
absent in healthy skin. These humps have an average height of 170 nm and a lateral 
extension of about 600 nm. Moreover, the volume and the surface of corneocytes 
in AD affected skin is signifi cantly smaller than in healthy skin, indicating a cellular 
shrinking. In line with these fi ndings intercellular gaps between single corneocytes 
are more prominent in atopic skin while they are barely visible in healthy skin. 
In conclusion, AFM gain access to the three dimensional morphology of the 
SC. The fi ndings of changed corneocytes morphology in AD affected patients 
envision AFM as an innovative tool to investigate the dysfunction of the 
epidermal barrier in correlation to the severity of AD and to evaluate therapeutic 
interventions on the reconstitution of the SC toward a healthy morphology.
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A decline of TRPV6 function derives from a decrease of vitamin D activation 
and accounts for disturbed epidermal calcium gradient followed by skin barrier 
alteration in aged skin
Minyoung Jung1, Yoonhee Lee1, Byung-Il Yeh2, Seung Hun Lee3, Eung Ho Choi1
1Dept of Dermatology, Yonsei Univ Wonju Coll of Medicine, Wonju, Korea, Republic 
of, 2Dept of Biochem, Yonsei Univ Wonju Coll of Medicine, Wonju, Korea, Republic 
of, 3Dept of Dermatology, Yonsei Univ College of Medicine, Seoul, Korea, Republic of
Epidermal Ca++ regulates keratinocyte differentiation and plays an important role in 
forming skin barrier. Because epidermal Ca++ gradient is restored with the recovery of 
skin barrier after its disruption, a disturbance in the recovery of Ca++ gradient delays 
skin barrier recovery. TRPV6 as a calcium ion channel, belonging to the superfamily 
of transient receptor potential channels constitutes an apical Ca++ entry mechanism 
in active Ca++ transport in the intestine, which has been also found in the epidermis 
of mammalian skin recently. TRPV6 modulates an infl ux of Ca++ into keratinocyte, 
and its expression is directly up-regulated by 1α, 25 dihydroxyvitamin D3. Facial 
skin of aged humans showed the loss of epidermal Ca++ gradient, and the synthesis of 
cutaneous vitamin D3 was declined with aging. We hypothesized that this disrupted 
epidermal Ca++ gradient is caused by a decrease of TRPV6 function due to decreased 
vitamin D activation with aging. The mRNA expression of TRPV6 and vitamin D 
receptor (VDR) on fully aged skin (87 weeks old hairless mice) decreased; moreover 
their mRNA expression was not enough increased after 3-day low-dose (50mJ/
day) UVB irradiation compared to young skin. Western blot for TRPV6 and VDR 
protein expression showed very similar results with mRNA. Topical ketoconazole, 
an inhibitor of 1α, 25 dihydroxyvitamin D3, decreased TRPV6 expression even 
after UVB irradiation under immunohistochemical stain. In conclusion, a decline 
of TRPV6 function could be derived from decreased vitamin D activation and 
accounts for disturbed epidermal Ca++ gradient and altered skin barrier in aged skin.
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Epidermal Neuropilin 1 protects keratinocytes from UVB-induced apoptosis through 
regulation of Bcl-2
Anna Riese, Yvonne Meyer, Thomas Krieg, Peter Kurschat Uniklinik Köln, Institut für 
Dermatologie, Cologne, Germany
Neuropilins (NRP1 and NRP2) are transmembrane receptors which regulate 
endothelial cell and neuron function. They are able to mediate signals from VEGFs 
and class 3 semaphorins. It was shown that NRP1 is also expressed on keratinocytes, 
but its function is still unclear. To elucidate the role of epidermal NRP1 in vivo, we 
generated epidermis-specifi c Neuropilin 1 defi cient mice. These mice are viable and 
do not display obvious skin or hair defects. But we found that deletion of epidermal 
NRP1 leads to increased apoptosis after UVB irradiation in vitro and in vivo. There is 
a signifi cant increase of active caspase 3 positive cells in the epidermis of K14Cre-
NRP1 (-/-) mice 24h after irradiation. By Western Blot analysis we could show that 
NRP1 controls the expression of Bcl-2, a pro survival member of the Bcl-2 family. 
After irradiation the amount of Bcl-2 decreases in NRP1 defi cient keratinocytes 
in vitro and in vivo. The amount of DNA damage in the irradiated skin of control 
and NRP1 defi cient animals is equal. Therefore DNA repair mechanisms do not 
seem to be disturbed. We conclude that Neuropilin 1 is dispensable for normal 
skin development but has an important anti-apoptotic role in UVB response 
where NRP1 protects keratinocytes from apoptosis through modulation of Bcl-2.
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Improvement of skin barrier function by topically applying PPARa agonist
Mayumi Sugimoto1, Mitsuo Kimura1, Tatsuyuki Midorikawa1, Tetsushi Serizawa1, 
Motoyasu Ohdera1, Yasuo Kitajima2 1LION corporation, Odawara, Kanagawa, Japan, 
2Kizawa Memorial Hospital, Minokamo, Gifu, Japan
Stratum corneum (SC) prevents the water transpiration from the body and the invasion 
of irritants as a skin barrier. Chronic skin barrier dysfunction is considered to be 
one of the causes of skin disorders characterized by itch and dry skin. HR-1 hairless 
mice fed a special-diet HR-AD are known to develop characteristic dermatitis 
demonstrating a variety of abnormality as follows: thickened epidermis, decreased 
dermal water content (DWC), increased transepidermal water loss (TEWL) and 
increased scratching behavior. In the past study, we showed that the skin penetration 
of exogenous substances was increased in HR-AD-fed hairless mice. Therefore, 
we considered that HR-AD-fed hairless mice were useful as a chronic skin barrier 
dysfunction model. Furthermore, we showed the decrease of intercellular lipid and 
abnormal expression of some factors which constitute SC in the model mice skin. 
Peroxisome proliferator activated receptors (PPAR) belong to the family of nuclear 
hormone receptor that regulates transcription of several genes involved in lipid 
metabolism. Recently, it has been reported that PPARa which is one of the subtypes 
also controls the expression of various SC components in epidermal homeostasis. 
In this study, we investigated the improvement of skin barrier dysfunction in this 
model by topical applying a PPARa agonist for 4 weeks. As a result, we showed 
the reduction of the skin penetration of substances and the recovery of expression 
of SC components in HR-AD-fed hairless mice. These results indicate that 
activation of intraepidermal PPARa is useful to improve skin barrier function.
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Toll like receptor 2 and 4 are expressed intracellularly in human keratinocytes
Conrad Blobel, Rüdiger Panzer, Ehrhardt Proksch, Regina Fölster-Holst
UKSH, Campus Kiel, Clinic for Dermatology, Allergology and Venerology, Kiel, 
Schleswig-Holstein, Germany
Toll like recepetors (TLR) are pattern recognition receptors recognizing pathogen 
associated molecular pattern. Most of the TLR are expressed on the cell surface 
of immune cells, like lymphocytes, macrophages and dendritic cells, except 
TLR3, 7, 8 and 9 which are expressed intracellularly. Human keratinocytes 
constitutively express various members of the TLR family in particular TLR 2 and 
4. TLR2 and 4 are known to recognize lipoteichoic acid and lipopolysaccharide, 
respectively. We investigated the expression of TLR in human keratinocytes by 
immunohistochemistry and fl uorescence microscopy using specifi c antibodies. In 
contrast to the common model our results revealed an intracellular expression of 
both TLRs. TLR2 expression in healthy skin showed a staining of basal epidermis with 
a granular expression pattern. TLR4 expression was pronounced in the basal cell 
layers also, but in contrast to TLR2 the pattern was not granular but homogenous. 
We speculate that the uncommon subcellular localisation of TLR expression in 
keratinocytes may prevent the skin from sustained immune reaction as the surface 
of the skin is not sterile but in steady contact to microorganisms. In contrast immune 
cells are located in a sterile environment unless a pathogen has invaded the host. 
This concept is supported by the basal expression pattern which makes it likely 
that TLR activation necessitates the invasion of the epidermis by the pathogen.
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Identifi cation of LCE6A, a New Member of the Family of Constitutive Proteins of the 
Cornifi ed Envelope “Late Cornifi ed Envelope”
Nathalie Jonca1, Eve Toulza1, Gaëlle Saintigny2, Guy Serre1, Marina Guerrin1
1UMR5165 CNRS-Toulouse III University, Toulouse, France, 2Chanel Parfums Beaute, 
Pantin, France
The most superfi cial epidermis layer, the cornifi ed layer, is composed of corneocytes 
resulting from the transformation of the underlying granular keratinocytes. 
The cornifi ed envelope is formed during cornifi cation and replaces the plasma 
membrane of granular keratinocytes. It is made up of proteins covalently linked 
by transglutaminases and confers the corneocytes their rigidness and resistance, 
primordial to ensure the cornifi ed layer its extreme strength. We recently described for 
the fi rst time the transcriptome of granular keratinocytes by a large scale analysis. This 
study allowed the identifi cation of more than 3,000 genes expressed by this cell type, 
among which LCE6A, coding for a new member of a family of constitutive proteins of 
the cornifi ed envelope. Quantitative RT-PCR and immunohistochemical experiments 
demonstrated LCE6A is specifi cally expressed by granular keratinocytes in human 
epidermis. In vitro, LCE6A actually is a substrate for transglutamisases and in situ 
crosslink assays performed on human skin cryosections show that it is covalently linked 
to the cornifi ed envelopes. It was recently demonstrated that the deletion of LCE3B 
and LCE3C was an important susceptibility factor for psoriasis. Moreover, the absence 
of the envelope proteins involucrin, periplakin and envoplakin alters the mechanical 
resistance of mouse cornifi ed envelopes. These results suggest that variations in 
the protein composition of the envelope may weaken the corneocyte envelope.
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Natural PPARα agonist evaluation on in vitro and ex vivo models of Atopic Dermatitis
Stéphanie Bredif1, Francine Joly2, Johan Rocheteau1, Caroline Baudouin1, Alexandra 
Bierry2, Sébastien Garnier1, Philippe Msika1 1Laboratoires Expanscience, Epernon, 
France, 2SEPhRA, Puteaux, France
Atopic Dermatitis (AD) is a chronic dermatosis involving skin barrier defects, altered 
immune response and exacerbated infl ammation. Activators of PPARs (Peroxisome-
Proliferator-Activated Receptors) have been recently described to be able to 
ameliorate infl ammatory as well as barrier features of AD. An emollient containing 
2% of patented Sunfl ower Oleodistillate (SO) has been specifi cally formulated to treat 
AD. SO is a natural PPARα agonist with demonstrated anti-infl ammatory activities 
and ability to induce key epidermal lipids synthesis. In this study, we have evaluated 
SO and the emollient on in vitro and ex vivo models of infl ammation and AD. The 
expressions of various markers were analysed by quantitative RT-PCR or ELISA assay. 
Infl ammation was induced on reconstructed human epidermis by PMA. Emollient 
topical application inhibited expression of infl ammatory mediators (ICAM1, IL1α, 
PGE2). Normal human keratinocytes were treated by IL4. SO was able to restore 
IL4-repressed gene expression of differentiation markers as fi laggrin, involucrin, 
beta-glucocerebrosidase and sphingomyelinase. The cytokine environment of AD 
was mimicked on skin explants by treatment with TNFα, IL4 and LPS. Emollient 
topical application signifi cantly inhibited the release of infl ammatory mediators TSLP, 
TARC and RANTES as well as gene expression of kallikrein-7 and OSMR (involved 
in pruritus); furthermore gene expression of barrier markers as fi laggrin, loricrin 
and beta-glucocerebrosidase were signifi cantly enhanced. The benefi cial effects 
on barrier, infl ammation and pruritus of an emollient containing a natural PPARα 
agonist have been demonstrated on experimental models mimicking AD Th2 context.
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Regulation of epidermal differentiation evidenced by gene silencing of extracellular 
matrix protein 1
Takahiro Hamada1, Norito Ishii1, Noritaka Oyama2, Shinichiro Yasumoto1, John 
McGrath3, Takashi Hashimoto1 1Dept of Dermatology, Kurume Univ School of 
Medicine & Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan, 
2Dept of Dermatology, Fukushima Medical Univ, Fukushima, Japan, 3St John‘s Institute 
of Dermatology, King‘s College London, London, UK
Extracellular matrix protein 1 (ECM1) is an 85-kDa glycoprotein with wide tissue 
distribution, including the dermis and the entire epidermis.  ECM1 plays a role in bone 
development, angiogenesis, and cancer biology.  Its relevance to dermatology is highlighted 
by loss-of-function mutations in the ECM1 gene in lipoid proteinosis and autoantibodies to 
ECM1 in lichen sclerosus.  Both diseases histopathologically show variable hyaline changes 
in the dermis as well as epidermal atrophy and hyperkeratosis, demonstrating that ECM1 
contributes to both dermal and epidermal homeostasis.  To explore the role of ECM1 in 
keratinocyte biology in more detail, we knocked down expression of ECM1 using small 
interfering RNA (siRNA) in HaCaT cells.  We targeted exon 10 of ECM1 to ensure knockdown 
of all major splice variants of ECM1, including ECM1a and ECM1c (predominantly expressed 
in basal keratinocytes) and ECM1b (suprabasal keratinocytes).  HaCaT cells were grown to 
90% confl uency in culture medium containing 1.8 mM calcium.  After siRNA treatment, 
RNA was extracted and global gene expression was measured using Whole Human Gene 
Expression Microarray (Agilent).  For epidermal differentiation, siRNA-treated HaCaT cells 
showed up-regulation of genes encoding keratin 1, S100A7 and calmodulin-like 5 proteins. 
For small proline-rich proteins (SPRRs), SPRR1A and SPRR1B (SPRR1 subfamily members) 
were up-regulated in siRNA-treated cells, while SPRR2A-F (SPRR2 subfamily protein) was 
down-regulated.  Although previous studies identifi ed some in vivo functional redundancy 
for ECM1 in epidermal differentiation, our fi ndings indicate that there are specifi c processes 
of epidermal differentiation and cornifi cation in which ECM1 plays an important role.
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Stress related overexpression of ABCG2 transporter in keratinocytes: a putative 
target to modulate the effi cacy of photodynamic therapy
Attila Bebes1, Kornélia Kis1, Tünde Nagy2, Anita Kurunczi2, Hilda Polyánka3, 
Zsuzsanna Bata-Csörgö1,3, Lajos Kemény1,3, Attila Dobozy1,3, Márta Széll3
1Department of Dermatology and Allergology, University of Szeged, Hungary, 2SOLVO 
Biotechnology, Szeged, Hungary, 3Dermatological Research Group of the Hungarian 
Academy of Sciences, University of Szeged, Hungary
Xenobiotic transporters of the ATP binding cassette protein superfamily play an important 
role in maintaining the biochemical barrier of various tissues, however the precise role 
of these transporters in skin is not known. Previously we have shown that the ABCG2 
transporter is highly expressed in proliferating keratinocytes. However, abrogation of ABCG2 
function using gene silencing and specifi c inhibition with the non-toxic fumitremorgin C 
analogue Ko-134 did not affect the proliferation of HaCaT keratinocytes, suggesting that 
this transporter is not essential for cell proliferation. Next, we aimed to investigate whether 
ABCG2 transporter contributes to cellular stress response in keratinocytes. Irradiating 
healthy human skin with ultraviolet light-B (UV-B) resulted in the induction of ABCG2 
protein expression in the granular layer of the epidermis. In an in vitro experiment Ko-
134 inhibition of ABCG2 in UV-B irradiated keratinocytes signifi cantly decreased cell 
viability. These results suggested that ABCG2 contributes to cellular stress response in 
keratinocytes. As the extrusion of porphyrins is one of the known physiological functions 
of ABCG2, the transporter is a promising target molecule for improving photodynamic 
therapy applications based on porphyrin photosensitization. We demonstrated that 
specifi c inhibition of ABCG2 using Ko-134 signifi cantly decreased cell viability in delta-
aminolevulinic acid (DALA) sensitized HaCaT keratinocytes, suggesting that targeting 
of this xenobiotic transporter by specifi c inhibitors may modulate therapy effi cacy 
in dermatological disorders, such as non-melanoma skin cancer, psoriasis and acne.
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Betaine increases tight junction integrity in epidermal keratinocytes
Heli Putaala, Kirsti Tiihonen, Nina Rautonen Danisco Finland, Health & Nutrition, 
Kantvik, Finland
Transepithelial electrical resistance (TEER) is used as a measure of tight junction 
integrity in vitro, and this study illustrates the effect of betaine, which is used as 
osmolyte to improve hydration status of skin, on epidermal keratinocyte tight 
junctions. Normal human epidermal keratinocytes were differentiated in cell 
culture inserts in vitro for 4 days and during the differentiation, TEER, as well as 
expression of tight junction proteins, occludin (OCLN), zonula occludens-1 (ZO-
1) and claudin-4 (CLDN-4) were measured. Differentiated keratinocytes were 
treated from the outside with 10, 50, 100, 250 and 500 µM betaine, and effect 
on tight junctions was assessed with TEER at 1h, 12h and 24 h after test substance 
application. The keratinocyte TEER as well as the expression of CLDN-4 but not 
ZO-1 or OCLN, increased during the 4-day differentiation process, indicating that 
the model is suitable to study tight junctions in epidermal keratinocytes. Betaine 
induced increase in TEER in a time-dependent manner with maximum increase 
of 47 % at 24 h with 500 µM betaine. The study indicates that betaine improves 
tight junction functionality in the epidermis and may improve the hydration status 
of skin also by improving tight junction strength at granular layer of the epidermis.
162
The p75 neurotrophin receptor is involved in early keratinocyte differentiation
Francesca Truzzi, Alessandra Marconi, Roberta Lotti, Katiuscia Dallaglio, Elisabetta 
Palazzo, Tiziana Petrachi, Carlo Pincelli Univ of Modena and Reggio Emilia, Italy
p75 neurotrophin receptor (p75NTR) mediates NT signals alone or as a co-receptor of 
the high affi nity receptor Trk. While trk receptors stimulate proliferation and survival 
in human keratinocytes, the role of p75NTR in the skin is yet to be defi ned. We 
evaluated the expression and function of p75NTR in human keratinocytes. p75NTR 
was only expressed in the basal keratinocyte layer and confi ned to transit amplifying 
(TA) cells. Moreover, calcium treatment of subconfl uent keratinocytes induced the up-
regulation of p75NTR concurrently with the expression of the differentiation markers 
involucrin and citokeratin 10. p75NTR retroviral infection of stem cells induced 
a more differentiated phenotype with the same features of TA cells. On the other 
hand, when p75NTR was silenced, calcium treatment failed to induce differentiation 
in subconfl uent keratinocytes, as shown by the absence of involucrin expression. 
By immunohistochemistry, p75NTR positive keratinocytes did not express the 
proliferation marker MIB-1. Consistently, in vitro data confi rmed that p75NTR positive 
cells proliferated to a lesser extent, as compared to p75NTR negative cells. Because 
psoriasis is characterized by alteration of keratinocyte differentiation we evaluated the 
expression and function of p75NTR in this disease.  p75NTR was absent in lesional 
psoriatic skin and p75NTR levels were signifi cantly lower in psoriatic than in normal 
TA keratinocytes, as shown by western blotting and FACS analysis. Northern Blot 
revealed no modulation in mRNA of psoriatic keratinocytes compared to normal, 
suggesting that this receptor undergoes a post-trascriptional modulation.  These results 
suggest that p75NTR acts as a “switch on-off” protein in keratinocyte differentiation. 
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E-FABP mediates human keratinocyte differentiation
Katiuscia Dallaglio, Alessandra Marconi, Francesca Truzzi, Roberta Lotti, Elisabetta 
Palazzo, Tiziana Petrachi, Thomas Bertalot, Carlo Pincelli University of Modena and 
Reggio Emilia, Modena, Italy
Epidermal differentiation is controlled by increased intra-cellular calcium infl ux and 
is dependent, among other factors, by lipid metabolism. Epidermal fatty acid-binding 
protein (E-FABP) is a lipid carrier involved in keratinocyte differentiation and it is 
over-expressed in psoriasis. Psoriasis is characterized by defective differentiation and 
is associated with co-morbidities, including increased fat absorption. We evaluated 
the role of E-FABP in keratinocytes. We show by immunohystochemistry that 
E-FABP is localized in suprabasal layers of normal human skin, overlapping CK10 
and involucrin distribution. Upon treatment of cultured human keratinocytes with 
calcium, E-FABP expression is upregulated from 48 up to 120 hrs. E-FABP levels 
are highest in confl uent keratinocytes, similarly to CK10 and involucrin expression. 
E-FABP is mostly expressed in post mitotic cells from both normal and psoriatic 
epidermis, whereas it is nearly absent in stem and transit amplifying cells. Transfection 
of normal human keratinocytes with recombinant (r) E-FABP induces a marked 
overexpression of CK10, as compared to controls. When keratinocytes treated with 
rE-FABP are seeded onto dermal equivalents, they generate a complete epidermis. 
Nevertheless, rE-FABP+ model displays an increased number of corneocytes retaining 
the nucleus. Moreover, E-FABP+ model shows changes in the pattern expression 
of CK10, psoriasin and E-FABP itself that resemble those observed in psoriatic 
epidermis. These data suggest that E-FABP is important for keratinocyte differentiation 
and might be involved in the aberrant differentiation process of psoriasis.
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Ultraviolet A induced oxidation identifi es distinct populations in azathioprine-
treated primary human keratinocytes
Nadia Djerbi, Guergana Iotzova-Weiss, Piotr Dziunycz, Caroline Hyde, Lars E 
French, Günther FL Hofbauer Department of Dermatology, University Hospital 
Zurich, Zurich, Switzerland
Treatment with azathioprine is related to a higher risk for the development of 
cutaneous malignancies. The thiopurines azathioprine, 6-thioguanine (6-TG) 
and 6-marcaptopurine (6-MP) are immunosuppressants and anti-infl ammatory 
agents mainly used in organ transplantation and autoimmune disease. 6-TG, 
the active metabolite of azathioprine and 6-MP, integrates into DNA as a 
purine analog. Persistence of incorporated 6-TG, even after discontinuation of 
azathioprine, has been shown in skin. It is known that UVA interacts with 6-TG 
generating the mutagenic agents reactive oxygen species (ROS) and a fl uorescent 
6-TG photoproduct, 2-aminopurine-6-sulfonate. Therefore, in order to determine 
whether 6-TG shows a distinct distribution in azathioprine treated primary human 
keratinocytes after discontinuation of the treatment we used a ROS assay that allows 
the detection of a fl uorescein derivative by fl ow cytometry. Flow cytometry analysis 
suggests that 6-TG treatment alone induces an increase in ROS over untreated 
cells. Furthermore, UVA-assisted induction of ROS allows the discrimination of two 
distinct sub-populations within these keratinocytes. Further analysis of keratinocyte 
sub-populations will yield better characterization and may allow the identifi cation 
of keratinocyte stem cells such as label-retaining and slowly cycling cells.
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Deletion of the late cornifi ed envelope genes LCE3B and LCE3C confers susceptibility 
to chronic hand eczema with allergic contact dermatitis
Sonja Molin1, Sigrid Vollmer1, Elisabeth Weiss2, Thomas Ruzicka1, Jörg Christoph Prinz1
1Department of Dermatology and Allergology, Ludwig Maximilian University, Munich, 
Germany, 2Department of Biology II, Ludwig Maximilian University, Munich, Germany
Chronic hand eczema (CHE) is a common skin disease with a high disease burden. 
Its pathogenesis is multifactorial and involves both, endogenous predisposition and 
environmental triggers. According to current concepts, an impaired epidermal skin 
barrier function may be essential for the development of CHE. It may increase the 
penetration of allergens through the epidermis, reduce the resistance against irritant 
damage and is likely to be based upon genetically determined modifi cations in the 
structure of the cornifi ed envelope. The aim of this study was to assess the role of a 
deletion in the late cornifi ed envelope genes LCE3B and LCE3C in the development 
of CHE. In total, 153 German patients with clearly defi ned CHE subtype were 
screened for the LCE3C_LCE3Bdel-deletion by allele-specifi c polymerase chain 
reaction. The prevalence of this variant in CHE patients was compared to that in 
268 healthy individuals. Overall allele frequency and number of deletion carriers 
did not differ in patients and controls. Nevertheless, when the deletion carriers were 
classifi ed according to clinical subtypes a signifi cant association of the LCE3C_
LCE3Bdel allele with CHE due to delayed-type hypersensitivity became apparent. 
In the allergic contact dermatitis subgroup the number of deleted alleles and the 
frequency of individuals carrying at least 1 deleted allele prevailed [49/74 versus 
25/74 alleles; p=0,0397; 95% confi dence interval (CI) 0,99-3,17; 81% deletion 
carriers with at least 1 LCE3C_LCE3Bdel allele]. In conclusion, a deletion of late 
cornifi ed envelope genes may contribute to manifestation and maintenance of CHE 
subtypes involving delayed-type hypersensitivity, i.e. allergic contact dermatitis.
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Effects of the re-innervation of organotypic skin explants on the epidermis
Nicolas Lebonvallet1,2, Nicholas Boulais1, Christelle Le Gall-Ianotto1, Ulysse Peirera1, 
Dominique Gauché2, Eric Gobin1, Christine Jeanmaire2, Louis Danoux2, Gilles Pauly2, 
Laurent Misery1 1Université de Bretagne occidentale, laboratoire de neurobiologie 
cutanée, Brest, France, 2Laboratoires Sérobiologiques, Division de COGNIS France, 
Pulnoy, France
The nervous system takes part in skin homeostasis and interacts with skin cells. 
In in vitro organotypic skin models, these interactions are lost due to absence of 
nerve endings.We have developed an in vitro organotypic skin model based on a 
re-innervated human skin explant using primary sensory neurons from the dorsal 
root ganglia of rats. After 10 days of co-culture of skin explant and neurons, a dense 
network of nerve fi bers was observed. The epidermis and dermis presented many 
new structures that showed immunoreactivity to PGP9.5 and pan-neurofi laments 
antibodies. Epidermal thickness, cell density and quality were all higher when skin 
explants were cultured in the presence of neurons. Semaphorin 3a and number 
of proliferative epidermal cell were not modifi ed in the epidermis. Nerve growth 
factor amounts were higher in the control skin explant. In vitro re-innervated 
skin explants appear to be more similar to normal in vivo skin than to non-re-
innervated skin explants. Hence, this new model of co-cultured skin explants 
and neurons allows better epidermal quality and could be very useful for studies 
concerning interactions between the skin and its peripheral nervous system.
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Caspase-14 is required for fi laggrin degradation to natural moisturizing factors in 
the skin
Michael Devos*1,2, Esther Hoste*1,2, Patrick Kemperman3, Geertrui Denecker1,2, 
Sanja Kesic4, Nico Yau4, Barbara Gilbert1,2, Saskia Lippens1,2, Petra Van Damme5, Kris 
Gevaert5, Richard B. Presland6, Peter Caspers3,7, Peter Vandenabeele1,2, Wim Declercq1,2
1Molecular Signaling and Cell Death Unit, Dept for Molecular Biomedical Research, 
VIB, Ghent, Belgium, 2Dept of Biomedical Molecular Biology, Ghent, Belgium, 3Dept 
of Dermatology and Venereology, Erasmus MC, Rotterdam, Netherlands, 4Coronel 
Institute of Occupational Health, Academic Medical Centre, Univ of Amsterdam, 
Netherlands, 5Dept of Medical Protein Research, VIB-Ghent Univ, Ghent, Belgium, 
6Depts of Oral Biology & Medicine (Dermatology), Univ of Washington, Seattle, WA, 
United States, 7River Diagnostics BV, Rotterdam, Netherlands
Caspase-14 is mainly expressed in suprabasal epidermal layers and activated 
during keratinocyte cornifi cation. Caspase-14 defi cient mice display a reduced 
epidermal barrier function and an increased UVB radiation sensitivity. We found 
that although profi laggrin, a protein with a pivotal role in skin barrier function, is 
processed correctly to its functional fi laggrin monomeric unit in caspase-14-/- mice, 
these mice accumulate proteolytic fi laggrin fragments in the epidermis. We show 
here that the accumulation of these fi laggrin fragments is due to a defect in fi laggrin 
degradation in the cornifi ed layers of caspase-14-/- skin. Consequently, this lack of 
normal fi laggrin degradation results in a signifi cant reduction in the levels of natural 
moisturizing factors, such as urocanic acid and pyrollidone carboxylic acid, in the 
skin from caspase-14 defi cient mice as compared to wild-type mice. In addition, 
we demonstrate that caspase-14 can directly cleave the fi laggrin monomer. Taken 
together, our data identify caspase-14 as a crucial protease in fi laggrin catabolism.
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Development of a dynamic mathematical model of epidermis reveals critical 
importance of increasing the proportion of both cycling stem and transient 
amplifying cells, in the development of psoriatic plaques.
Sophie Weatherhead1,2, Jennifer Hallinan1, Anil Wipat1, Peter Farr2, Nick Reynolds1,2
1Newcastle University, Newcastle-upon-Tyne, United Kingdom, 2Royal Victoria 
Infi rmary, Newcastle-upon-Tyne, United Kingdom
Mathematic modelling allows exploration of the contribution of specifi c quantifi able 
parameters to processes such as epidermal homeostasis.  We created a stochastic 
agent-based model which combines known kinetic parameters with histological 
features characteristic of normal and psoriatic epidermis. Iterative stimulation of the 
model allowed rigorous testing and establishment of robust boundaries including 
analysis of cell cycle time and the proportion of cells dividing, within which the 
model remained stable. In contrast to adjusting cell cycle times, the model showed 
a critical role for an initiating «cytokine» stimulus and a resulting increase in the 
proportion of actively dividing stem cells and the number of rounds of transient-
amplifying (TA) cell division within ‘uninvolved’ epidermis.  The model showed 
excellent concordance with existing data including an absolute increase in both the 
proliferative and differentiating compartments and a reduction in both total epidermal 
turnover time and transit time of differentiating cells.  Adjusting cell cycle length within 
defi ned boundaries had no signifi cant impact on the model.  Importantly, the model 
remained stable and became independent of a continuous cytokine stimulus through 
production of «autocrine» factors. In summary, we have developed a stochastic 
model of epidermal homeostasis which has allowed us to create for the fi rst time 
an in silico model of psoriasis development.  The model has the potential to provide 
insight into psoriatic plaque development and the impact of treatment modalities.
 www.jidonline.org S29 
ABSTRACTS
169
Sirt6 play an essential anti aging role in skin cells
Audrey Amoyel1, Rachel Chabert1, Noelle Garcia1, Claude Dal Farra2, Nouha Domloge1
1Vincience , ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP Corporate 
Research Center, Wayne, NJ 07470, United States
 SIRT6 is a member of the Sirtuins genes family which regulates fundamental 
processes in aging and lifespan control. It has been shown that SIRT6 knockout 
mice display premature aging symptoms and that this effect is partly due to its role 
on the stabilization of the telomeric chromatin and to its implication on the NF-κB 
regulation pathway. Hence, we were interested in studying the impact of modulating 
SIRT6 on cell aging, using IV09.009, a selective SIRT6 inducer.  Our studies of human 
fi broblasts and keratinocytes, aged in vitro by repeated subcultures, demonstrated 
that IV09.009 was able to increase SIRT6 expression in these cells. Furthermore, we 
were interested in investigating the involvement of SIRT6 towards telomeres. As the 
Telomere-Associated Protein TRF2 has an important role in telomeric protection, we 
evaluated this protein level. This study showed that long term application of SIRT6 
inducer increased the expression of this protein, allowing a better stabilization of 
the chromosome ends. Moreover, we observed in aged fi broblasts an enhancement 
of Collagen I expression which indicates a better functioning suggesting an anti 
aging effect. Finally, SIRT6 implication in keratinocytes differentiation as another anti 
aging aspect, was demonstrated by IV09.009 effect on enhancing involucrin and 
transglutaminase-1 expression. These results confi rm the important role of SIRT6 in 
cell differentiation and aging and that Sirt6 is a key target for anti aging approaches.
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Proteasome  activation helps alleviate methylGlyoxal (MGO) induced  ultrastructural 
damage in skin  cells
Gopinathan Menon,2, Catherine Gondran1, Ludivine Mur1, Claude Dal Farra2, Nouha 
Domloge1 1Vincience , ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP 
Corporate Research Center, Wayne, NJ 07470, United States
Previously we have shown benefi cial effects of IV08.013, an inducer of proteasome 
activation, on cultured fi broblasts and keratinocytes. Presently, we examined 
the ultrastructure of  human epidermal  keratinocytes and fi broblasts, subjected 
to oxidative stress by MGO (0.2 and 0.4 mM for 24h), and  subsequently treated 
with IV08.013 for 48 hours. We observed that effects of MGO stress was more 
pronounced in keratinocytes, which showed extensive cytosolic  vesicules, evidence 
of ER stress, as well as altered  keratin fi lament organization. Fibroblasts seemed 
more resistant to MGO induced damage compared to keratinocytes, but displayed 
hallmarks of ER stress. In both cell types, some cells were more damaged than 
others, possibly refl ecting cell-cycle related susceptibility to stress. In general, 
IV08.013 treated cells displayed increased   numbers of autophagic vacuoles, 
as well as healthier cellular organelles such as mitochondria and Golgi complex. 
However, some of the cells - both keratinocytes and fi broblasts - (presumably 
irreparably damaged) did not display signs of repair and recovery. Our preliminary 
observations also suggest that cells stressed with a higher dose of MGO show better 
recovery following treatment with IV 08.013, possibly due to a threshold effect on 
ubiquitination as well as induction of autophagy. These studies confi rm the role of 
proteasome system on cell good functioning and its interest in the anti aging fi eld
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Modulating Caspase-14 expression helps DNA protection and repair against UVB 
irradiation
Laurine Bergeron1, Audrey Amoyel1, Catherine Gondran1, Noelle Garcia1, Claude 
Dal Farra2, Nouha Domloge1 1Vincience , ISP Global Skin Research Center, Sophia 
Antipolis, France, 2ISP Corporate Research Center, Wayne, NJ 07470, United States
Caspase-14 was described to play a role in epidermal barrier formation, the 
upregulation of caspase-14 expression by UVB irradiation suggests its implication 
in the UV-stress response. Using IV08.003, which we developed as a caspase-14 
inducer, we studied caspase-14 role in barrier recovery, as well as in UVB repair 
and protection. Human skin samples were submitted to repeated tape-stripping. 
Biopsies were then performed on stripped and adjacent undamaged area, and 
treated with IV08.003 for 72h. Our results showed better recovery of the cornifi ed 
layer in treated biopsies. Moreover, cultured human keratinocytes (HK) were pre-
treated with IV08.003 for 24h, and then irradiated with 50 mJ/cm2 of UVB. 
Expression of CPDs and of 8-Oxo-2’-deoxyguanosine (8-oxodG) were investigated 
1 hour after UVB stress. This study showed a markedly reduced signs of DNA 
damage in IV08.003 pre-treated cells.Similarly, in skin biopsies where caspase-14 
was pre-induced, we noticed fewer signs of UV stress and less CPDs staining, 
compared to control. Moreover, active caspase-3 level was also reduced in pre-
treated biopsies. Interestingly, a reduction of DNA damage markers and active 
caspase-3 was also observed when HK and skin biopsies were fi rst irradiated 
with UVB and then treated with IV08.003, indicating a repair effect. These results 
strongly suggest that enhancing caspase-14 is a relevant method for protecting the 
epidermis against UV irradiation and facilitating DNA repair after UV damage.
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Regulation of biological mechanisms by sucralfate, an actor of epidermal re-
epithelization
Antony Caruana, Isabelle Ceruti, Helene Duplan, Helene Hernandez-Pigeon, 
Nathalie Castex-Rizzi Pierre Fabre Dermo Cosmétique, Toulouse, France
Wound healing is a multicellular process that, in skin, aims at barrier restoration. 
Epidermal regeneration is a crucial step in this process. It involves the combination 
of two cellular processes, proliferation and migration, temporally and locally 
orchestrated by specifi c molecular mediators (growth factors, cytokines, ECM, 
integrins and enzymes). Sucralfate, a basic salt of sulphated sucrose, has proven 
its effi cacy in the healing process of skin wounds. The purpose of our study 
was to examine its action on proliferation and migration of human epidermal 
keratinocytes in culture and elucidate some of the molecular mechanisms involved. 
Normal human keratinocytes were submitted to 48h-treatment with increasing 
concentrations of sucralfate. Cell proliferation was assessed by the measurement of 
BrdU incorporation. HaCaT keratinocytes migration was analyzed with the Oris Cell 
System. Then we performed a HaCat culture with sucralfate to assay the expression 
of molecular mediators involved in wound healing at the transcriptional level with 
real-time RT-PCR and at the protein level by immunolabeling. Our results showed 
that sucralfate was able to stimulate cell proliferation and to enhance cell migration. 
We also showed that, following sucralfate treatment, the expression of hyaluronane 
synthase 2 (proliferation), MMP9 (migration) and activin A (cell migration and 
proliferation) was signifi cantly induced with kinetic characteristics close to 
treatment with EGF or TGFb. Together, the present data obtained in vitro support 
the positive action of sucralfate on skin wound healing by improving epidermal re-
epithelization through the specifi c regulation of the expression of molecular actors.
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Mitochondria boosters helps reducing cell oxidative stress induced by tobacco
Sandrine Pinacolo, Rachel Chabert, Noelle Garcia, Nouha Domloge Vincience , ISP 
Global Skin Research Center, Sophia Antipolis, France
It is well documented that tobacco contributes to premature skin aging. Cigarette is 
considered as a key source of oxidative stresses, in addition to others stresses such 
as UV rays. In this study, we developed a method to examine the effects of cigarette 
smoke, as an oxidative stress inducer, on normal human keratinocytes. In parallel, we 
evaluated the effect of two active ingredients that boosts mitochondria, on helping 
reducing this stress. A preliminary study on keratinocytes morphology revealed that 
tobacco smoke induces characteristic stress damage within the fi rst hour. Hence, the 
following tests were performed 1h after tobacco smoke stress. Our studies showed 
that ROS level increased signifi cantly in cells exposed to tobacco smoke compared to 
unstressed control. This effect was modulated by IV08.001 or IV08.005 application, 
compounds demonstrated to protect and enhance mitochondria functions in cells. 
In stressed cells, the reduction of ROS level in smoke-exposed cells, treated with 
the compounds indicates that these cells were better protected from ROS damage. 
Moreover, HSP27 proteins studies revealed that smoke induced an increase in 
HSP27 expression, however, treated cells that were stressed, exhibited a reduced 
level of HSP27 expression compared to control, suggesting less stress in these 
cells. These results confi rm the oxidative stress caused by cigarette smoke on the 
skin, that this stress affects mitochondria, and suggest that mitochondria boosters 
and protectors are of interest reducing smoke-induced premature skin aging.
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Evaluation of the features of skin aspect using in vivo confocal microscopy
Yolene Guérif-Ferreira1, Gilles Oberto1, Arlette Berghi1, Karine Cucumel1, Claude 
Dal Farra2, Nouha Domloge1 1Vincience , ISP Global Skin Research Center, Sophia 
Antipolis, France, 2ISP Corporate Research Center, Wayne, NJ 07470, United States
Skin aging and dryness depends on variety of different factors. In order to trace 
the stages of these changes, we investigated, through in vivo confocal microscopy 
(Vivascope® 1500), the following skin parameters, on the forearm: horny layer and 
epidermal thickness; granular cell morphology and organization. The number, height, 
and morphology of dermal papillae were investigated for skin aging changes. On the 
forearm, the thickness of the horny layer in normal, hydrated skin is around 8µm, 
while the thickness of the whole epidermis is around 55 µm. Corneocytes are well-
organized, cohesive, and granular cells possess a cobblestone pattern. Keratinocytes 
in moisturized skin, on the other hand, are arranged in a regular honeycomb-like 
architecture. Moreover, the horny layer and epidermis are thinner than in normal 
skin, due to the excellent cohesion of cells. In dry skin, by contrast, architectural 
disruption of the epidermis is noticeable, and is accompanied by a thickening of the 
stratum corneum and epidermis. In aged skin, we observed a signifi cant statistical 
correlation between age and thickness of the horny layer as well as with age and 
epidermal thickness. Indeed, with age, the thickness increased. Regarding dermal 
papillae, we found the number and the height in a reverse correlation with age. 
Dermal papillae became smaller, less defi ned, and irregular in shape. These results 
confi rm that VivaScope® is useful and complementary to macroscopic observation in 
the evaluation of skin changes.
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Combining tyrosinase inhibitor and proteasome activator exhibits interesting 
whitening effect on skin. Histological and transmission electron microscopy studies
Gopinathan Menon2, Magalie Bonnans1, Noelle Garcia1, Nouha Domloge1
1Vincience , ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP Corporate 
Research Center, Wayne, NJ 07470, United States
Whitening products have become central in skin care research. Decreasing skin 
pigmentation involves mechanisms including inhibiting tyrosinase activity, as well 
as TRP-1 and TRP-2. Tyrosinase is the rate limiting enzyme, and TRP-1 ( DHICA 
oxidase) and TRP-2 ( Dopachrome tautomerase)  are related gene products that 
are known to modulate the melanosomal matrix. In previous studies, we have 
showed that (IV08.013), a natural extract, exhibits whitening properties by inhibiting 
tyrosinase activity. Our studies have also revealed that (IV09.020), a compound that 
stimulates cell proteasome system, exhibits a lightening effect on ex vivo skin. As in 
silico simulations predicted synergy between these two approaches, we evaluated 
the whitening effect of (IV08.013) alone and in combination with (IV09.020) on 
human ex vivo skin.  Examination of skin sections stained with Fontana-Mason 
(FM) revealed a noticeable decrease in melanin content in the epidermis, in both 
condition, compared to the controls. This decrease in melanin was more noticeable 
in the combination condition. Transmission Electron microscopy (TEM) revealed a 
lightening effect at the level of melanosomes in both conditions. Moreover, TEM 
study also showed that the combination of the two compounds resulted in lightest 
melanosomes, and melanophagosomes, confi rming the synergy between the two.
These studies support the interest of combining different mechanisms in order to 
decrease melanin expression in skin, and suggest that proteasome boosters are good 
candidate to combine with tyrosinase inhibiting extracts for whitening purposes.
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Studies of TRF2 telomeric protein role in aging
Laurine Bergeron1, Audrey Amoyel1, Christelle Plaza1, Celine 
Meyrignac1, Catherine Gondran1, Claude Dal Farra2, Nouha Domloge1
1Vincience, ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP Corporate 
Research Center, Wayne, NJ 07470, United States
Telomere shortening is one of the main characteristics of cellular aging. A complex 
of proteins called shelterin can bind directly to the TTAGGG repeats of telomeres, 
leading to their stabilization in T-loops. Among these proteins, TRF2 plays a central 
role as a binding platform for other telomere-associated proteins. Our previous studies 
have shown that positive modulation of TRF2 protein expression was associated with 
a decrease in the cellular senescence marker beta-galactosidase. In the present study, 
we further investigated the effect of TRF2 modulation in a model of accelerated, in 
vitro senescence induced by methylglyoxal (MGO). Morphological changes were 
observed in fi broblasts aged by replicative senescence in parallel to MGO-induced 
senescence. Fibroblasts were treated or not with the previously described TRF2 inducer 
(IV08.007). Morphological evaluation showed that TRF2-induced cells showed fewer 
signs of aging, compared to untreated cells. Aged phenotype was also associated with 
modifi cations of the cytoskeleton protein vimentin, observed in replicative and MGO-
induced aging. Treatment with IV08.007 tended to limit the increase in vimentin 
expression in aged cells.  Studies on aged fi broblasts using the senescence-associated 
beta-galactosidase (SABG) marker revealed, in TRF2-induced cells, a reduction in the 
number of SABG-positive cells. Our results confi rmed that the TRF2 telomeric protein 
plays an important role in the appearance of a senescent phenotype, and suggest 
that modulation of TRF2 expression can be of interest in anti-aging applications.
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Impact of a lightly crosslinked PVP polymer on α-hydroxy, and b-hydroxy-acids on 
skin. Ex vivo skin model for structural studies
Magalie Bonnans1, Antony Luschen2, Hani Fares2, Noelle Garcia1, Claude Dal Farra2, 
Nouha Domloge1 1Vincience, ISP Global Skin Research Center, Sophia Antipolis, 
France, 2ISP Corporate Research Center, Wayne, NJ 07470, United States
Chemical peelings with alpha-hydroxy and beta-hydroxy acids are largely utilized 
for skin rejuvenation. We were interested in developing an ex vivo model to evaluate 
peeling products in early stage, distinguishing between the proper peeling effect and 
other skin damage signs. Using this model, we evaluated the exfoliating effect of 
glycolic acid and salicylic acid from lightly cross-linked PVP polymer (LPVP) gel 
formulations and compared them to simple solutions. Our kinetic studies of glycolic 
acid in LPVP gel included 5min, 10min, 1h, 2h, 3h and 4h. This study showed that 
3h at least were necessary to alter the epidermis. Recovery was evaluated after 6 
days. Then we proceeded on testing glycolic acid and salicylic acid in different 
LPVP gels. These studies showed that aqueous LPVP gel allowed better skin 
morphology whereas alcoholic LPVP gel seemed to alter aggressively the skin. They 
also showed that 50% glycolic acid in aqueous LPVP gel damaged less the skin 
compared to the alcoholic or aqueous solution. Concerning 10% salicylic acid, only 
the epidermis treated with salicylic acid in LPVP gel showed signs of regeneration 
after 6 days. Hence, with the developed protocol we were able to compare the 
impact of LPVP polymer on the different formulations containing alpha-hydroxy 
and beta-hydroxy acids, and to evaluate the degree of peeling or damage into skin.
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Mitochondria boosting exhibits rejuvenating effects on skin comparable to light-
emitting diodes (LEDs).  In vitro and in vivo studies.
Y Guerif-Ferreira1, R Chabert1, N Garcia1, G Oberto1, F Janssen3, T Welss3, C Dal 
Farra2, N Domloge1 1Vincience, ISP Global Skin Research Center, Sophia Antipolis, 
France, 2ISP Corporate Research Center, Wayne, NJ 07470, United States, 3Henkel AG 
& Co. KGaA, Research and development skin care, Duesseldorf, Germany
Interest in anti-aging approaches has grown signifi cantly in recent years, among 
them mitochondrial boosting and light-emitting diodes (LEDs) known to target 
mitochondria. In this regard we were interested in evaluating the anti-aging effect 
of boosting mitochondria by cosmetic formulation, and to compare it to the bio-
physical LED approach in in vitro and in vivo studies. Studies on cultured human 
fi broblasts and keratinocytes showed that boosting mitochondria activity by cosmetic 
compounds revealed anti-aging properties like enhancing cell fi bronectin, collagen 
III, TG-1, and involucrin; and decreasing cellular ROS level, within 72h. Interestingly, 
similar effects are described for treating the skin with specifi c anti-aging LED light. 
For the in vivo double blind study, 12 volunteers applied a cream containing the 
mitochondria boosting cream formula or placebo on the forearm. Treated skin was 
compared to LED-exposed skin. Evaluation by in vivo confocal microscopy showed 
that, after 2 months, both booster-cream and LED similarly and signifi cantly improved 
the skin structure. Interestingly, at day 28 signifi cant improvement of many parameters 
of skin rejuvenation was seen only with the booster-cream. These parameters 
included epidermal thickness, granular cell shape and organization, dermal papilla 
morphology and embellishment. These results suggest that direct mitochondria 
boosters in formulated cream would act faster for anti-aging effect than LED.
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Fluorescein-Isothiocyanate Induced Sensitization Indicates a Damaged Skin Barrier 
in Transglutaminase 3 Knockout Mice
Péter Bognár1, Judit Hársing1, Ilona Németh1, Mazán Mercédesz2, Susan 
John3, Neil Smith3, Mats Paulsson3, Sarolta Kárpáti1,2, Erzsébet Temesvári1
1Department of Dermatology, Venerology and Dermatooncology, Semmelweis 
University, Budapest, Hungary, 2Hungarian Academy of Sciences, Molecular Research 
Group, Budapest, Hungary, 3Center for Biochemistry and Center for Molecular 
Medicine Cologne, University of Cologne, Cologne, Germany
Recently more structure proteins and enzymes have been identifi ed as signifi cant contributors 
to a normal skin barrier, which lack or damage results in defected skin functions, bent to 
enhanced percutan sensitization.The aim of this essay is to evaluate whether transglutaminase 
3 (TGM3) knockout mice exhibit a defective skin barrier. Since we could not indentify 
signifi cant physical differences between knockout and wild type (C57BL/6) mice indicating 
damaged barrier functions, we performed a fl uoerescein-isothiocyanate (FITC) sensitization 
test. Mice aged 8-12 weeks, were sensitized by a 24h long occlusive application of 
FITC on day 1 and 8, were reexposed on day 15 and were monitored in 24h and 48h, 
by mouse ear swelling test, and histology. Out of the 38 TGM3 -/- mice 14(36%) exhibited a 
signifi cant (>20%) ear thickening (ET) at 24h, and 31/38 (81%) at 48h. In the control group 
0/ 22 (0%) mice at 24h and 5/22 (17,8%) at 48h  had signifi cant pathology. The extent 
of ET among TGM3 -/- mice (n=38) was 13,98% at 24h, and 47,10% at 48h, displaying a 
signifi cant difference to the wild type animals (n=22), where ET was  7.03% at 24h (p<0,05) 
and 14,64% (p<0,001) at 48h. While the histopathological signs of skin infl ammation in 
TGM3 knockout mice were more conspicuous, in the number of infi ltrating mastocytes no 
signifi cant difference was found. Our data prove that TGM3 -/- mice display a signifi cantly 
enhanced skin sensibilization rate to FITC. This observation indicates a defected skin 
barrier in these animals showing that TGM3 is a key enzyme of the functional skin barrier.
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The structure and regulation of miR-203 gene in keratinocytes
Florian Meisgen, Ning Xu, Tianling Wei, Enikö Sonkoly, Andor Pivarcsi, Mona Ståhle
Karolinska Institute, Stockholm, Sweden
Recently, our group identifi ed a keratinocyte-specifi c microRNA, miR-203, and 
showed that this microRNA is crucial for keratinocyte differentiation. To date little is 
known about the factors that are responsible for preferential expression of miR-203 
in the skin as well as about its structure, biogenesis and turnover in keratinocytes. 
To get insights into the structure of the miR-203 gene, we used 5´RACE to identify 
the transcriptional start site. To learn more about its transcriptional regulation, 
we cloned the putative promoter region of miR-203 and identifi ed several AP-1 
transcription factor binding sites. We therefore investigated the infl uence of the AP-1 
complex and the MAPK signaling pathway on the expression of miR-203. Chemical 
inhibition of the MAPK pathway and knock-down of AP-1 members showed that 
the expression of miR-203 is negatively regulated by the EGF-induced MAPK 
signaling pathway and by JNK, a regulator of AP-1. These results suggest that the 
activation of AP-1 by the MAPK pathway inhibits the expression of miR-203 and 
thus prevents differentiation of keratinocytes. Interestingly, the miR-203 gene resides 
in a classical CpG island, suggesting that it is regulated by epigenetic mechanisms 
such as DNA methylation. To get insight into the long term regulation of miR-203, 
we are currently profi ling the CpG methylation pattern of the miR-203 gene locus. 
Preliminary data from bisulfate-converted DNA show that the miR-203 gene locus 
is partly methylated in PBMCs, which do not express miR-203. Thus, methylation 
represents a putative mechanism to silence miR-203 in cells other than keratinocytes.
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Adipose tissue-derived mesenchymal cells support more effi ciently than dermal 
fi broblasts the growth of kerationcytes through secretion of KGF-1 and PDGF-BB
Vassilia-Ismini Alexaki, Despoina Simantiraki, Marianna Panayiotopoulou, Marilena 
Kampa, Efstathios Stathopoulos, Elias Castanas Medical School, University of Crete, 
Heraklion, Greece
Epidermal organization and homeostasis are regulated by mesenchymal infl uences 
through paracrine actions. Until today, dermal fi broblasts are used as the classical 
feeder layer to support keratinocyte growth in vitro, and in skin substitutes used to 
cover burns and non-healing wounds. We examined the potential use of human 
adipose tissue-derived mesenchymal cells (ADMC), a novel source of mesenchymal 
stem cells, instead of dermal fi broblasts in 2D and 3D keratinocyte (primary and 
HaCaT) cultures. We show that ADMC induce cell proliferation through induction 
of cell cycle progression, as well as migration of keratinocytes more effi ciently 
than fi broblasts. This effect does not require cell contact and is, at least partially, 
mediated by KGF-1 and PDGF-BB, which are more prominently expressed in 
ADMC than in fi broblasts. Furthermore, replacement of fi broblasts by ADMC in 
the dermal compartment of organotypic cultures leads to an artifi cial epidermis 
with a structure resembling more to that of normal skin, concerning cytokeratins 
14, 1 and 10 expression. However, in the presence of ADMC cytokeratins 5 and 
19 are abnormally highly expressed in all epidermal layers compared to fi broblasts. 
In conclusion, ADMC could serve as supportive cells for primary keratinocyte 
cultures, while due to their high abundance and the great cell yield obtained 
during isolation compared to dermal fi broblasts, they comprise an interesting 
cell source, with potential aspects for clinical use in artifi cial skin substitutes.
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Comparative analysis of esterase activity in reconstructed human skin models and 
excised human skin
Wiebke Klipper, Franzisca Marie Baetz, Günther Weindl, Monika Schäfer- Korting
Institute for Pharmacy, Freie Universität Berlin, Berlin, Germany
To date, reconstructed 3D models of human skin and epidermis have mainly 
been characterized regarding their barrier function and validated for the use in in 
vitro tests for skin corrosion and skin irritation. A great deal less is known about 
their metabolic capacity concerning activation of prodrugs and toxifi cation 
or detoxifi cation of chemicals and drugs. In this study, we aimed to compare 
the esterase activity in commercially available reconstructed human skin and 
epidermis models and excised human skin. Metabolite profi ling of the double ester 
prednicarbate by HPLC-UV and determination of enzyme kinetic parameters Vmax 
and KM using fl uorescein diacetate as a model substrate was performed in parallel. 
After 24 hours prednicarbate exposure, prednisolone was detected as the main 
metabolite, however, the relative amount ranked as: full-thickness (epidermis and 
dermis) skin model ~ epidermis model > excised human skin. The similar results 
for full-thickness and epidermis models can be explained by the higher esterase 
activity in human keratinocytes as compared to fi broblasts which contribute very 
little to the total activity. The formation rates of fl uorescein fi tted the Michaelis-
Menten model. In accordance with prednicarbate metabolism, Vmax of fl uorescein 
diacetate cleavage was highest in full-thickness skin models and lowest in excised 
human skin. KM values did not markedly differ between the test matrices. In 
conclusion, our results indicate that reconstructed human skin models may be 
useful to quantitatively address esterase activity of native human skin, although an 
increased activity compared to normal human skin should be taken into account.
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The weak rate of sphingolipid biosynthesis shown by basal keratinocytes isolated 
from aged versus young donors is fully rejuvenated after treatment with peptides 
of a potato hydrolysate
Iuliana Popa1, Nabil Abdul-Malak2, Jacques Portoukalian1 1University of Lyon-1, Lyon, 
France, 2BASF Beauty Care Solutions, Lyon, France
A new study was carried out to bring more informations on the effect of the potato 
hydrolysate Lipidessence®. Basal keratinocytes were established in culture from 
freshly excised skin samples of two groups of 5 donors, a young one (25 to 36 year-
old) and an aged one (59 to 70 year-old). The results showed a downward trend in the 
content of all lipid fractions in untreated keratinocytes of aged donors as compared 
to young ones. We found major differences between young and old donors in the 
response of keratinocytes to Lipidessence® treatment. Whereas the lipid content of 
cells from young donors increased either moderately or actually decreased in some 
cases versus untreated controls, the lipid biosynthesis was strongly stimulated in aged 
donors’ keratinocytes whose lipid contents globally became close to those found in 
young donors.  However, the changes elicited by Lipidessence® treatment were not 
seen at the same extent extensive for all lipid classes. Cholesterol increased up to 
threefold and alpha-hydroxy fatty acids were augmented up to sevenfold, whereas 
the increase in normal fatty acids was quite moderate. In sphingolipids labeled by 
incubation of keratinocytes in culture medium containing [14C]-serine, ceramides 
and glucosylceramides in cells from aged donors showed the highest uptake of 
radioactivity, with somewhat less incorporation in sphingomyelin and gangliosides. 
Therefore, it seems that Lipidessence® has a much more potent stimulatory 
activity on the lipid biosynthesis of basal keratinocytes of aged donors, thereby 
normalizing the cellular lipid content that obviously decreases along with ageing.
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The use of a precursor as a source of exogenous bio-available linoleic acid: assessment 
of the skin metabolism and of the nourishing effect of a cream containing it
Veronique Raufast1, Christelle Merial-Kieny2, Helene Hernandez-Pigeon1, Nathalie 
Castex-Rizzi1, Helene Duplan1 1R&D Pierre Fabre Dermo-cosmetic, Toulouse, France, 
22Laboratoires Dermatologiques Avène, Lavaur, France
Skin aging is associated with lipid content modifi cations, such as age-dependant 
decrease in epidermal linoleic acid. Here, we used a prodrug approach providing 
the linoleoyl monoglycerate (LMG), that could undergo biotransformation into 
free linoleic acid, under epidermal esterase action. Using ex vivo skin model and 
radiolabeled [C14]-linoleyol glycerate we investigated the skin metabolism of 0.5 
to 2% LMG emulsion, topically applied. We demonstrated the prolong release of 
exogenous linoleic acid into the skin from LMG. After 24h, the 1% emulsion gave 
the highest percentage of enzymatic release. As it was partial, we studied the ability 
of LMG and free linoleic acid to stimulate some epidermal differenciation markers 
involved in the barrier function against water loss. The keratinocyte expression of 
Tansglutaminase 1, ABCA12 transporter and beta-glucocerebrosidase were induced, 
with a higher effect of the free form. Moreover, we analyzed de novo synthesis of 
epidermal lipids, in human skin explants, treated or not by the formulated LMG in 
association with intermediate size hyaluronate fragments (HAFi). Evaluation was 
performed using the incorporation of the radioactivity into acetate and specifi c 
lipids were analysed on chromatographic system. We showed a signifi cant increase 
in the three classes of cutaneous lipids, cholesterol, ceramides and fatty acids. 
Together, these data demonstrated the interest of using the prodrug technology to 
liberate, exogenous linoleic acid to compensate the endogenous decrease with 
aging, and hydrating glycerol into the skin. Moreover, this study has demonstrated 
the nourishing effect of a cosmetic product containing the association HAFi-LMG. 
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The tight junction protein, claudin-7 is increased in photoaged human epidermis
Suha Althubaiti, Christopher Griffi ths, Neil Gibbs, Rachel Watson, Catherine O’Neill
Dermatological sciences, The University of Manchester, Manchester, United Kingdom
Epidermal tight junction (TJ) plays an important role as a barrier which protects 
the skin against water loss and penetration by pathogens. Human skin is subject to 
intrinsic and extrinsic ageing which both cause a reduction in skin barrier function. 
The major environmental insult to human skin is chronic sun exposure, termed 
photoageing. In this study, we investigate whether the TJ protein claudin-7 is altered 
in intrinsic and extrinsic skin ageing. Punch biopsies (6mm diameter) were taken from 
healthy Caucasian volunteers (age range, 18-30 and 65-75 years; n=8 per group) from 
photoprotected hip and upper inner arm and from photoexposed forearm. Cryosections 
(10µm) were prepared, stained with a polyclonal antibody to claudin-7 (Zymed Labs) 
and visualised using an FITC-conjugated secondary antibody. Staining intensity was 
quantifi ed using ImageJ software (NIH). Immunofl uorescence confi rmed the epidermal 
expression of claudin-7 in the granular layer of the epidermis. Image analysis shows 
a signifi cant difference in the expression pattern between photoprotected (hip, upper 
inner arm) and photoexposed (forearm) sites (repeated measures ANOVA; p = 0.018 
and p = 0.019 respectively). However, no signifi cant changes observed between 
young and aged photoprotected buttock (unpaired Student’s t-test; p = 0.397). This 
study indicates that claudin-7 is up-regulated in chronically photoaged human skin in 
vivo. Further work is required to look at the effect of acute UVB exposure on claudin-7 
expression in vitro and to clarify the mechanisms underlying these observations.
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Phospholipase C signalling in cutaneous squamous cell carcinoma
Emily Ruban, Vera Martins, Marco Falasca, Edel O‘Toole Centre for Cutaneous 
Research and Centre for Diabetes, BICMS, Barts and the London School of Medicine 
and Dentistry, London, United Kingdom
Phospholipase C (PLC) is an enzyme that triggers cell growth, differentiation and 
migration through activation of pathways like protein kinase C (PKC).  Recent work 
from our group showed that knock-down of type VII collagen (ColVII), the main 
component of anchoring fi brils, in SCC cell lines leads to increased expression of 
an isoform of phospholipase C, PLC-β4, previously known to be expressed in neural 
tissue. In this study, we used siRNA technology to examine the function of PLC-β4 
in cutaneous SCC. Immunostaining of a panel of SCC samples revealed expression 
of PLC-β4, mainly in poorly differentiated tumours. Organotypic 3-D cultures 
generated with SCC cells with ColVII knock-down (siCol7) and control (siC) cells 
demonstrated that PLC-β4 and PKCα are both localised to the basal layer in control 
and have homogenous expression throughout the epidermis in siCol7 cultures. 
Successful knock-down of PLC-β4 (siPLC-β4) was achieved in a cutaneous SCC 
cell line. A time-course analysis by immunoblotting demonstrated potent inhibition 
of PLC-β4 expression up to 6 days post-transfection. Expression of PKCα was also 
decreased in siPLC-β4 cells up to 4 days post-transfection. High proliferative activity, 
characteristic of SCC, is associated with ERK activation and siPLC-β4 cells had 
decreased phosphorylation of ERK1/2.  In a scratch assay of confl uent cells, siPLC-β4 
cells display markedly decreased migration compared to control. Experiments 
in progress include 3D cultures to examine the role of PLC-β4 in differentiation, 
invasion and calcium mobilization assays. The data, so far, suggest that PLC-β4 may 
be an important player in the migration of aggressive/poorly-differentiated SCC.
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The role of cell polarity in epidermal morphogenesis and homeostasis 
Michaela Niessen1,2, Jeanie Scott1,3, Panagiota A Sotiropoulou4, Cedric Blanpain4, 
Michael Leitges5, Carien M Niessen3,6 1Department of Dermatology, Cologne, Germany, 
2International Graduate School for Genetics and functional Genomics, Cologne, 
Germany, 3Center for Molecular Medicine, Cologne, Germany, 4Interdisciplinary 
Research Insititute, Free University of Brussels, Brussels, Belgium, 5The Biotechnology 
Centre of Oslo, University of Oslo, Norway, 6Cologne Excellence Cluster on Cellular 
Stress Responses in Aging-associated Diseases (CECAD), University of Cologne, 
Germany
Cell polarity is crucial for tissue morphogenesis and maintenance by regulating a variety of 
functions, such as barrier function, migration and cell shape. Atypical protein kinase C (aPKC) 
is a key player in the regulation of polarity, although most of its functions have been studied in 
lower organisms or in mammalian simple epithelial cells. To examine how polarity regulates the 
formation and maintenance of a stratifying epithelium, we inactivated aPKCλ in the epidermis 
and its appendages using the K14-Cre recombinase (aPKCλepi-/-). Loss of aPKCλ resulted in a 
hyperthickened interfollicular epidermis, enlarged sebaceous glands, misshaped hair follicles and 
keratinocyte cell shape changes. Murine hair follicles undergo constant cycles of degeneration, 
rest and growth. In contrast, aPKCλepi-/- hair follicles (HF) failed to enter resting phases of the 
hair cycle. This was associated with increased proliferation in vivo and vitro and a loss of label 
retaining cells in the HF bulge. Detailed immunohistochemical and FACS analysis revealed 
major alterations in HF differentiation and stem cell markers in the absence of epidermal 
aPKCλ, suggesting that changes in cell fate underlie some of the observed phenotypes. Loss 
of aPKCλ resulted in altered expression of several components of the Hedgehog pathway, 
which might provide a molecular explanation how aPKCλ regulates epidermal morphogenesis 
and maintenance. Overall, our analysis indicates a key role for aPKCλ in the regulation of 
stem/progenitor cell proliferation, differentiation and maintenance of stratifying epithelia.
188
Analysis and Partial Characterization of Murine Filaggrin-2
Britta Hansmann, Kerstin Ahrens, Ulf Meyer-Hoffert, Jens-Michael Schröder
University Hospital of Schleswig Holstein, Department of Dermatology, Kiel, Germany
Expression of the “S100 fused-type“ family is upregulated during formation of the 
outermost epidermal cell layer, the stratum corneum. Here a member of the murine 
S100 fused-type proteins, the profi laggrin-related fi laggrin-2, was partially analyzed 
on mRNA and protein level. It shows a highly conserved organization similar to all 
known S100 fused-type proteins on genomic, mRNA and protein level. The 5’ and 3’ 
BALB/c mouse mRNA sequence was verifi ed by RACE and results in a 2362 amino 
acid long protein. The characteristic S100/EF-hand-domains at the N-terminus are 
followed by 14 repeat domains of 73-80 amino acids in length fl anked by a spacer 
sequence related to the profi laggrin B-domain and the C-terminus. To compare 
the murine to the human expression pattern different tissues were analyzed by 
RT-PCR, immunohistochemistry, and Western Blot. The murine fi laggrin-2 shows 
expression patterns on mRNA and protein level similar to the human fi laggrin-2 and 
was detected in the upper cell layers of skin at different body locations, tongue, 
esophagus, and forestomach. Cultured BALB/c keratinocytes showed an elevated 
fi laggrin-2 mRNA expression upon CaCl2-stimulation whereas barrier disruption 
had no signifi cant effect on either mRNA or protein expression. The presence 
of multiple bands lower than the expected full length protein in SDS-treated skin 
extracts indicates a processing of fi laggrin-2 as already known for profi laggrin. 
Since the expression of murine fi laggrin-2 is regulated differentiation-dependent as 
also known for the human homologue the protein might be involved in terminal 
differentiation and may even have fi laggrin-supporting function during this process.
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Profi laggrin constitutively provides a basal antimicrobial reservoir for the skin
Felix Behrendt, Jonathan Hartmann, Sarah Babian, Dennis Karsch, Christian 
Schulz, Ties Latendorf, Britta Hansmann, Zhihong Wu, Jens-Michael Schröder
Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany
The stratum corneum of the outermost skin layer employs numerous antimicrobial 
peptides to protect from microbial infection. However, it remains unclear which 
molecular components maintain a basal and constitutive reservoir of antimicrobial 
activity. We previously revealed that protein fragments of hornerin and fi laggrin-2, 
two members of the S100 fused-type protein family, possess strong antimicrobial 
activities. Fragments of profi laggrin, another member of the S100 fused-type 
protein family, might be a novel source of the antimicrobial barrier function of 
the skin. Seven different peptides, representing parts of the N-terminal domain, 
the C-terminal region, and two fragments located within the repetitive regions 
were recombinantly expressed. Radial diffusion assays showed that some of these 
fragments exhibited antimicrobial activity against the tested microbes, including 
E. coli, S. aureus, P. aeruginosa and C. albicans. As fi laggrin occupies up to 
10% of total protein of the cornifi ed cell envelope in the stratum corneum, our 
results suggest that profi laggrin may constitutively provide a basal antimicrobial 
reservoir for the skin to fi ght micro-organisms at the earliest stage of infection.
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Epidermal Calcium Concentrations in a Murine Atopic Dermatitis Mouse Model 
Visualized by Fluorescence Lifetime Imaging
Christian Boernchen1, Jan Leo Rinnenhtal2, Eva Peters3, Johanna Brandner1, Ingrid 
Moll1, Raluca Niessner2, Martin Behne1 1Dermatology, UKE Hamburg, Germany, 
2Neurology, Charite Berlin, Germany, 3Psychotherapy, University Giessen, Germany
Calcium is a major player of regulation of keratinocyte differentiation and proliferation. 
It is involved in establishing barrier function of skin which is, in part, maintained 
through Ion-selective tight junctions localized in the Stratum granulosum (SG), the 
cornifi ed envelope in the Stratum corneum (SC), and the extracellular lipid matrix 
of the SC. Earlier experiments showed a calcium gradient in normal skin increasing 
from the basal layer to its peak in the Stratum granulosum and an abrupt drop in the 
lower Stratum corneum. Atopic dermatitis is associated with an impaired epidermal 
barrier function, increased epidermal proliferation and changes in differentiation of 
epidermal keratinocytes. Several reports indicate changes of epidermal calcium and 
an infl uence of external calcium on eczema. We here are using a defi ned inducible 
murine atopic dermatitis model, OVA, to assess changes of the epidermal calcium 
distribution compared to normal skin by using two-photon fl uorescence lifetime 
imaging microscopy (FLIM). We reproducibly induce an eczema as evidenced in 
gross morphology (erythema and scaling), a broadened epidermis in standard 
histology (H&E), and function (increased TEWL). Our fi rst results in FLIM-experiments 
show increased calcium values throughout a major part of the broadened epidermis 
with a less steep increase, where normal, untreated murine skin shows a narrow 
epidermis with lower calcium values overall, increasing towards the SG. Our 
ongoing investigation will further detail the epidermal calcium distribution, and its 
dependence on the state of the eczema, be it acute or chronic, and on its treatment.
191
Skin barrier disruption caused by insect bites selectively upregulates skin‘s 
antimicrobial protein expression
Ehrhardt Proksch, Stefanie Dressel, Claudia Neumann, Kerstin Ahrens, Jens-Michael 
Jensen, Jürgen Harder, Regine Gläser Dept. of Dermatology, Venerology and 
Allergology, University Hostpitals of Schleswig-Holstein, Campus Kiel, University of 
Kiel, Kiel, Germany
Insect bites lead to toxic and allergic reactions, infl ammation, itch, and pain. 
Infections occur only occasionally, though bites disrupt the skin barrier and may lead 
to invasion of bacteria into the skin. We ask whether antimicrobial proteins (AMPs) 
may be responsible for the low rate of infections. We determined the expression 
of human beta defensin (hBD)-2 and -3, human neutrophil peptide (HNP)-1-3, 
RNase 7, psoriasin (S100A7), and cathelicidin LL-37 by immuno-histochemistry in 
skin samples obtained from insect bite lesions. Skin explants injured by pinpricks 
served as control. H&E staining after insect bites revealed an infi ltrate of lymphocytes, 
neutrophils, eosinophils, and mast cells in the dermis. In the epidermis adjacent to 
the insect bite channel moderately increased staining for hBD-2 and -3, and RNase 7 
was found, whereas a pronounced increase of psoriasin expression was noted. Within 
the insect bite channel and in the adjacent dermis, but not within the epidermis, 
we found an intense staining for LL-37 and HNP-1-3, both mainly derived from 
neutrophils. In bullous insect bite reactions staining for LL-37 and HNP 1-3 was 
found within the blister fl uid. In the pinprick controls induction of hBD-3, RNase 7, 
and LL-37 occurred. In summary, we found upregulation of hBD-3, RNase 7, and LL-
37 in insect bites and in pinpricks probably due to barrier disruption. The induction 
of psoriasin may be caused by the insect poison. This data indicates that AMPs protect 
skin against infections after skin barrier disruption caused by stinging and pinpricks.
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Lipid Signaling Through Liver X Receptor Alters Functions of Dendritic Cells
Daniel Torocsik, Laszlo Nagy University of Debrecen, Medical and Health Science 
Center, Debrecen, Hungary
Dendritic cells (DC) respond to changes in their lipid environment by changing their 
gene expression and immunophenotype. Some of these changes are mediated via 
the members of the nuclear receptor superfamily such as Peroxisome Proliferator 
Activated Receptors (PPARs), Retinoic Acid Receptor (RAR) and Vitamin D Receptor 
(VDR), that were found to support a tolerogenic DC phenotype.The Liver X Receptor 
(LXR) is also a nuclear receptor of oxysterols and as such regulates gene expression in 
response to changing lipid environment. In our work we found that LXRs are present 
and can be activated throughout human dendritic cell differentiation in monocyte 
derived DCs as well as in blood derived DCs. Administration of LXR specifi c natural 
or synthetic activators induced target gene expression accompanied by increased 
expression of several DC maturation markers such as CD80 and CD86. In mature 
DCs upon ligation with TLR4 or TLR3 ligands LXR activation also augmented the 
production of infl ammatory cytokines, underpinned by prolonged NFkB signaling. 
The overall outcome of such activation of the LXR programmed DCs resulted in 
an increased capacity to activate CD4+ T cell proliferation. Supporting such an 
infl ammatory role we found that LXR positive DCs are present in reactive lymph 
nodes from patients with tuberculosis and sarcoidosis and was present also in DCs 
of tumor associated lymph nodes. We propose that activation of LXR represents a 
novel lipid-signaling paradigm that alters the infl ammatory response of human 
DCs, therefore the role for LXR activation of DCs in vivo calls for further studies.
 www.jidonline.org S33 
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Interferon γ represses cancer cell proliferation through Tumor Necrosis Factor 
Receptor 1-mediated cell cycle arrest
Sonja Fischer, Heidi Braumüller, Thomas Wieder, Martin Röcken
Eberhard-Karls-University, Dept of Dermatology, Tübingen, Germany
Even though most cancer immunotherapies are based on cytotoxic cells, an 
increasing number of data show that successful cancer immunotherapy depends 
on interferon γ (IFNγ)-producing T cells, either CD8+ T cells or T helper 1 (Th1) 
cells. Mice that develop endogenous cancer due to aberrant p53 and Rb regulation 
(RIP1-Tag2 mice) undergo multistage carcinogenesis due to T antigen 2 (Tag2) 
expression in pancreatic β cells. Treatment of RIP1-Tag2 mice with antigen-specifi c 
Th1 cells doubled lifespan by arresting tumor growth, angiogenesis and tumor 
cell proliferation without causing cytotoxicity. Importantly, prevention of tumor 
development strictly required both IFNγ and TNFR1-signaling, as shown by antibody 
blocking or knockout mice like RIP1-Tag2xTNFR1-knockout (TNFR1ko) mice. 
Based on these fi ndings, we investigated the direct effects of IFNγ and TNF on Tag2-
expressing cancer cells from normal RIP1-Tag2 mice, on TNFR1-defi cient and STAT1-
defi cient cancer cells from RIP1-Tag2xTNFR1ko and RIP1-Tag2xSTAT1ko mice 
in vitro. We analyzed the effects on proliferation, cell cycle arrest and apoptosis. 
In RIP1-Tag2 tumor cells, both IFNγ and TNF strongly suppressed proliferation, 
surprisingly without inducing apoptosis. Instead, both cytokines induced cell cycle 
arrest. As expected, IFNγ failed to induce cell cycle arrest in STAT1koxRIP1-Tag2 
cells, while TNF failed to induce cell cycle arrest in TNFR1ko cells. Surprisingly, 
IFNγ-mediated cell cycle arrest also required TNFR1 expression, as TNFR1ko 
cells resisted to IFNγ-induced cell cycle arrest. Detailed analysis, including 
gene arrays in knockout cell lines, revealed that IFNγ induces TNF production by 
cancer cells, that arrest cell cycle through autocrineTNFR1-mediated signals.
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Cross-talk of novel phenotypes of MDSC and regulatory T cells (Tregs) during the 
melanoma growth
Taku Fujimura1,3, Karsten Mahnke1, Sabine Ring1, Viktor Umansky2, Setsuya Aiba3, 
Alexander Enk1 1Dept of Dermatology, Univ Hospital Heidelberg, Germany, 2German 
Cancer Research Center, Heidelberg, Germany, 3Dept of Dermatology, Tohoku Univ, 
Graduate School of Medicine, Sendai, Japan
Myeloid derived suppressor cells (MDSC) comprise a phenotypically heterogeneous population 
of cells (CD11b+, Gr-1+), which can be found in tumor-bearing mice and in patients with cancer. 
Though several reports suggest that MDSC suppress the activity of T cells during tumor growth, 
the exact mechanism of their suppressive function is still unclear. To investigate the further 
mechanisms of suppressive function of MDSC, we fi rst investigated the regulatory molecules 
(B7H1, B7H3, B7H4) on MDSC during ret melanoma growth. FACS analysis reveals that only 
tumor-derived CD11b+Gr-1+ cells highly express these regulatory molecules. To analyze the 
suppressive function of MDSC, we isolated CD11b+ cells by MACS and co-cultivated them with 
syngeneic CD4+ T cells and allogeneic bone marrow derived dendritic cells. Interestingly, tumor-
derived CD11b+ cells suppress the proliferation of CD4+ T cells, which is abrogated by blocking 
of B7H1 molecules. Moreover, to assess the “cross-talk” of CD4+CD25+Foxp3+ T cells (Tregs) and 
MDSC, we examined the MDSC from Treg-depleted and non-depleted tumor-bearing mice. After 
in vivo depletion of Tregs by intraperitoneal injection of PC61, the expression of B7H-families is 
signifi cantly downregulated on CD11b+ cells isolated from tumors. Furthermore, though there 
was no signifi cant differences in the suppressive function of MDSC isolated from Treg-depleted 
and non-depleted mice, the IL-10 production from MDSC isolated from Treg-depleted mice was 
signifi cantly downregulated compared to non-depleted mice. Our results suggest that tumor 
infi ltrating CD11b+ cells highly express B7H regulatory molecules in the existence of Tregs in tumor 
microenvironment, and that these MDSC suppress T cell proliferation during melanoma growth.
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Treg defi cient in IL-10 do not suppress the CHS reaction due to a lack of adenosine 
production
Sabine Ring, Alexander Enk, Karsten Mahnke University Hospital Heidelberg, 
Heidelberg, Germany
Transferred CD4+CD25+Foxp3+ regulatory T cells (Treg) from wild type (wt) mice 
suppress the elicitation phase of murine contact hypersensitivity (CHS) reactions. 
In contrast, Treg isolated from IL-10 defi cient (IL-10-/-) mice fail to reduce the CHS 
reaction. Recently we have shown that hapten application activates wt Treg in 
vivo via ATP, resulting in degradation of extracellular ATP into immunosuppressive 
adenosine. Therefore, adenosine is a key mediator of Treg induced suppression. 
When measuring adenosine production of IL-10-/- Treg by HPLC, we recorded 
signifi cantly lower amounts of adenosine as compared to wt Treg. Using the fl ow 
chamber to assess the adherence of CD4+ effector T cells on endothelial cells, 
mimicking infl ammatory reactions, we show that wt Treg become activated via the 
P2X7 receptor and prevent the adherence of CD4+ T cells to activated endothelial 
cells through adenosine and A1 adenosine receptors. In contrast, the IL-10-/- Treg 
failed to block adherence of effector T cells to the endothelium. Analyzing the 
calcium fl ux in Treg, which accompanies signal transduction through the P2X7 
receptor, we showed signifi cantly reduced calcium concentrations in IL-10-/- Treg as 
compared to wt Treg after stimulation with ATP. In aggregate, our data indicate that 
the defect of IL-10-/- Treg in suppressing CHS reactions is not attributed to the lack of 
IL-10 production. In contrast we show that IL-10-/- Treg have a defect in reacting to 
ATP and in producing adenosine. Thus these data have to be taken into account when 
using IL-10-/- Treg in assessing Treg-mediated suppression in other disease models.
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Over-expression of epidermal protease-activated receptor-2 leads to spontaneous 
pruritic skin lesions in mice
Akihiko Ikoma1, Ferda Cevikbas1, Victoria Fong1, Eric Camerer2, Shaun Coughlin3, 
Martin Steinhoff1 1UCSF Depts Dermatology and Surgery, San Francisco, United 
States, 2INSERM Cardiovascular Research Center, Paris, France, 3UCSF Cardiovascular 
Research Institute, San Francisco, United States
Epidermal expression of protease-activated receptor-2 (PAR-2) is increased in various 
infl ammatory skin diseases with pruritus such as atopic dermatitis. Moreover, local 
application of PAR-2 agonists induces itch in patients with atopic dermatitis. These 
indicate a major involvement of PAR-2 in skin infl ammation and itch associated 
with atopic dermatitis. However, the precise mechanism how epidermal PAR-
2 is involved in infl ammation and itch has not been clarifi ed as of yet. Therefore, 
we  investigated the role of PAR-2 in infl ammation and pruritus by behavioral and 
histological analyses, immunohistochemical staining, double-immunofl uorescence, 
and quantitative polymerase chain reaction in transgenic mice that over-express PAR-
2 in keratinocytes. Our data show that PAR-2 over-expressing mice spontaneously 
develop eczematous skin lesions in ears accompanied by enhanced scratching 
behavior. The histological analysis of the lesional skin revealed epidermal acanthosis 
and infl ammatory infi ltrates in the papillary dermis. Immunofl uorescence labeling 
of PGP9.5 has shown increased nerve fi ber sprouting in transgenic mice as 
compared to wild-type mice. The up-regulated expression of nerve growth factor 
(NGF) was determined by quantitative polymerase chain reaction. Together, our 
results suggest that over-expression of epidermal PAR-2 leads to atopic dermatitis-
like skin infl ammation accompanied by enhanced scratching behavior, increased 
release of NGF and nerve sprouting. Thus, antagonizing PAR-2 may be benefi cial for 
the treatment of infl ammatory and pruritic skin diseases such as atopic dermatitis.
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Optical Imaging (OI)- and Positron Emission Tomography (PET)-investigations reveal 
different migration and activation patterns of T cells after either intra-venous or 
intra-peritoneal administration
Christoph M. Grießinger1, Daniel Bukala1, Kerstin Fuchs2, Ivana Glocova2, 
Walter Ehrlichmann3, Martin Röcken2, Bernd J. Pichler1, Manfred Kneilling2
1Laboratory for Preclinical Imaging & Imaging Technology of the Werner Siemens-
Foundation, Dept of Radiology, Eberhard Karls Univ, Tübingen, Germany, 2Dept of 
Dermatology, Eberhard Karls Univ, Tübingen, Germany, 3Radiopharmacy, Dept of 
Radiology, Eberhard Karls Univ, Tübingen, Germany
Specifi c T cell based immunotherapy for cancer or autoimmune diseases require suitable 
administration routes to ensure appropriate T cell homing to the target site. The aim of our study was 
to analyse differences in CD4+ T helper (Th1) cell homing and bio-distribution after intra-peritoneal 
(i.p.) and intra-venous (i.v.) administration by PET and OI. Ovalbumin (OVA)-T cell receptor (TCR) 
transgenic CD4+ T cells derived from DO.11.10 mice were cultured together with irradiated antigen 
presenting cells, OVA peptide, CpG 1668, anti-IL-4, and IL-2 to generate Th1 cells. OVA-Th1 cells 
were labelled with 0.7 MBq [64Cu]PTSM or with Cy5 vibrant dye solution. [64Cu]PTSM labelled 
OVA-Th1 cells were followed in vivo for up to 48 hours, and Cy5-labelled OVA-Th1 cells for up to 
4 weeks. We injected 107 [64Cu]PTSM- or Cy5-labelled OVA-Th1 cells into naive mice and analysed 
their migration properties using PET/ CT and OI.  Additionally, we investigated [64Cu]PTSM-/Cy5-
labelled OVA-Th1 cells by bio-distribution and fl ow cytometry (FACS). After i.p. injection OVA-Th1 
cells accumulated into the perithymic-, inguinal-, and axillary lymph nodes, as well as into the 
mesenteric lymphatic tissue even after 4 weeks. After i.v. administration OVA-Th1 cells migrated 
predominantly into the lung, liver and spleen. Interestingly, only after i.v. administration, OVA-Th1 
cells migrated into the bone marrow. PET and OI data were confi rmed by FACS- and bio-distribution 
analysis. Thus, signifi cant differences exist in T cell migration and bio-distribution after either i.v. or 
i.p. administration. These surprising fi ndings are relevant for T cell based specifi c immunotherapy.
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Reciprocal regulation of IL-10 and IL-17 in human Th17 cells  
Christina Zielinski, Antonio Lanzavecchia, Federica Sallusto Institute for Research in 
Biomedicine, Bellinzona, Switzerland
Th17 cells have emerged as a new T helper cell lineage involved in the clearance 
of extracellular bacteria and fungi. A dys-regulated Th17 response, however, can 
induce severe tissue destruction and autoimmunity. Therefore, mechanisms must 
be in place to shield the host from immune-mediated damage. We demonstrate 
that human Th17 cells transiently produce the anti-infl ammatory cytokine IL-10 
upon stimulation. Interestingly, IL-10 expression was accompanied by reciprocal 
down-regulation of IL-17, leading to a functional regulatory Th17 cell phenotype 
after the peak of the effector response. The ability of Th17 cells to express IL-10 
was, however, restricted to certain antigen specifi cities. Ex vivo isolated C. albicans 
specifi c Th17 cells could not produce IL-10 in comparison to S. aureus specifi c 
Th17 cells. This was due to differential priming requirements of these Th17 cell sub-
populations. IL-1beta instructed naïve T cells to develop into a pro-infl ammatory 
non-IL10 expressing Th17 cells subset. Th17 cell priming with S. aureus, however, 
was not IL-1beta dependent, leading instead to the generation of IL-10 producing 
Th17 cells with self-regulatory activities. Our results identify pathogen dependent 
differential priming requirements for human Th17 cells and demonstrate that 
IL-1beta is a molecular switch for determining a functional memory for IL-10 
expression. This has important consequences for the physiological termination of 
pro-infl ammatory immune responses and the limitation of bystander damage in 
certain pathogen microenvironments. Targeting IL-1beta early in the differentiation 
process of Th17 cells might therefore represent a promising therapeutic strategy 
to confer anti-infl ammatory properties to these culprits of autoimmune diseases.
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CD8+ T cell migration to hapten exposed skin sites requires CD4+ help in a murine 
model
Nanna Fyhrquist1, Henrik Wolff1,3, Antti Lauerma1,2, Harri Alenius1 1Finnish Institute 
of Occupational Health, Helsinki, Finland, 2University of Helsinki, Helsinki, Finland, 
3Helsinki University Central Hospital, Helsinki, Finland
The relative contribution of CD4+ and CD8+ T cells to contact hypersensitivity 
(CHS) responses has been much debated. In an adoptive transfer model of CHS, 
we investigated the role of the respective T cell subset during the effector response. 
Magnetic bead separated CD4+ and CD8+ T cells from oxazolone (OXA) sensitized 
C57BL/6 mice were transferred into syngeneic RAG-/- mice. Ear swelling, 
infl ammatory cell recruitment, the expression of infl ammatory mediators, and the 
extent of cell apoptosis in ear and lymph node tissue were analyzed at 24 hours 
after OXA challenge. The CD4+ T cell reconstituted RAG-/- mice developed a potent 
CHS response to topical OXA, including ear swelling, immune cell infi ltration, 
and expression of infl ammatory cytokines and chemokines. Adding CD8+ T cells 
to the CD4+ T cell transfers further amplifi ed the CHS response, including the 
recruitment of plasmacytoid dendritic cells, the expression of T cytotoxic/helper type 
1 infl ammatory mediators, and the induction of apoptosis in the epidermal layer 
of the skin. Unexpectedly, in the absence of CD4+ T cells, CD8+ T cells were not 
suffi cient to mediate the effector phase of CHS in the RAG-/- host environment. These 
data show that CD4+ T cells can elicit strong CHS responses, which CD8+ T cells 
may further amplify. Conversely, in the absence of CD4+ T cells, fully differentiated 
CD8+ T cells fail to migrate to the skin and mediate CHS. The results shed new light 
on the relative importance of CD4+ and CD8+ T cell interaction during the effector 
phase of CHS.
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Effect of IL-10-modulated tolerogenic DC in a humanized mouse model of lethal 
GvHD
Henric Adler1, Fanny Kryczanowsky1, Fabian Hermann1, Helen Martin2, Stephan 
Sudowe1, Christian Taube2, Kerstin Steinbrink1 1Department of Dermatology, 
University Medical Center Mainz, Mainz, Germany, 2III. Medical Clinic, University 
Medical Center Mainz, Mainz, Germany
Tolerogenic dendritic cells play a critical role in induction and maintenance of peripheral 
tolerance. We have previously demonstrated in vitro that IL-10 modulated human dendritic 
cells (IL10DC) display a tolerogenic phenotype and induce anergic regulatory CD4+ and CD8+ 
T cells (iTreg). iTregs might be exploited therapeutically for suppression of severe immune 
responses including allergies, autoimmunity or transplantation rejections. As a preclinical 
screening system for the in vivo effi cacy of tolerogenic IL-10DC, we choose a model of graft 
versus host disease (GvHD) in humanized NOD-Scid mice. Transfer of human PBMC into 
newborn NOD-Scid mice resulted in lethal GvHD within 2-3 months, characterized by 
growth retardation, weight loss, infl ammatory reaction of the skin and multiple organs and 
death of animals. Treatment of GvHD with a single or multiple doses of unloaded IL-10DC, 
did neither prevent growth retardation, nor affect symptom-free time and overall survival 
of the animals to a signifi cant extent. Human IL-10DC, which express CXCR4 but reduced 
levels of CCR7, did reach secondary lymphoid tissue as demonstrated by recovery from 
spleen and lymph nodes. Organ infi ltration (lung, skin) by human cells and the percentage 
of human CD4+ in spleen, lymph nodes and peritoneum were comparable in animals 
treated with IL-10DC and controls. In contrast, multiple treatments with IL10DC resulted 
in a decrease of infi ltrating CD8+ T cells. These data show, that in vitro generated human 
IL-10DC without additional antigen loading are able to reach secondary lymphatic tissues 
in NOD-SCID mice but do not modulate experimental lethal GvHD to a signifi cant extent.
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E-cadherin on epidermal γδ T cells is an inhibitory receptor
Youhei Uchida, Kazuhiro Kawai, Takuro Kanekura Kagoshima University Graduate 
School of Medical and Dental Sciences, kagoshima, Japan
Dendritic epidermal T cells (DETCs) are γδ T cells that reside in the murine epidermis 
and play important roles in immunoregulation, tumor surveillance, and wound healing. 
DETCs constitutively express a homophilic adhesion molecule, E-cadherin and a 
receptor for E-cadherin, αEβ7 integrin. Functional differences between E-cadherin-
mediated and αEβ7 integrin-mediated adhesion of DETCs to E-cadherin-expressing 
epidermal keratinocytes have not been determined. In this study, we analyzed roles 
of E-cadherin and αEβ7 integrin in activation of DETCs. Both E-cadherin and αEβ7 
integrin were expressed on resting DETCs, but only E-cadherin was down-regulated 
upon activation. Short-term adhesion of resting DETCs to E-cadherin-expressing 
keratinocytes was primarily mediated by αEβ7 integrin. When DETCs were cultured 
on recombinant E-cadherin-coated plates, binding of E-cadherin on DETCs to plate-
bound E-cadherin was observed 24 h but not 1 h after the initiation of culture. Blocking 
of interactions between αEβ7 integrin and E-cadherin inhibited killing of transformed 
keratinocytes by DETCs. Cytokine production by DETCs in response to suboptimal TCR 
cross-linking was augmented by co-ligation of αEβ7 integrin. Therefore, αEβ7 integrin 
on DETCs acts as a co-stimulatory receptor. In contrast, co-ligation of E-cadherin on 
DETCs inhibited activation of DETCs by TCR cross-linking. These results suggest that 
E-cadherin on DETCs is an inhibitory receptor and that E-cadherin-mediated adhesion 
of resting DETCs to normal keratinocytes in uninfl amed skin regulates activation 
thresholds of DETCs to prevent self-reactivity. Down-regulation of E-cadherin after 
activation may be essential for DETCs to exert effector functions through αEβ7 
integrin-mediated adhesion to stressed, damaged, or transformed keratinocytes.
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Mast cells play a key role in host defense against lethal herpes simplex virus infection 
Rui Aoki1, Tatsuyoshi Kawamura1, Youichi Ogawa1, Fumi Goshima2, Yukihiro 
Nishiyama2, Shinji Shimada1 1University of Yamanashi, Yamanashi, Japan, 2Nagoya 
University Graduate School of Medicine, Nagoya, Japan
Mast cells are known as immunoregulatory cells in both innate and adaptive immune 
responses. Several lines of evidence indicated that mast cells played signifi cant 
roles in host defense against bacteria. However, the protective role of mast cells 
in viral infections is unknown. Here, we have examined the role of mast cells in 
herpes simplex virus (HSV) infection. In our previous report, mast cell-defi cient 
KitW/W-v (W/W-v) and wild-type (WT) mice were intradermally infected with HSV-
2. Surprisingly, HSV-induced zosteriform lesions in W/W-v were much severer 
than those in WT, and the mortality in W/W-v was signifi cantly higher than that in 
WT. We extensively assessed whether the different responses specifi cally refl ected 
the lack of mast cells in W/W-v, rather than other c-kit-related differences, using 
W/W-v reconstituted with bone marrow-derived mast cells (BMMCs) from WT.  Nine 
weeks after intradermal transfer of BMMCs into W/W-v, reconstituted mice were 
intradermally injected with HSV. The severe mortality in W/W-v was completely 
recovered by intradermal reconstitution of BMMCs. In addition, HSV titers at HSV-
infected skin lesions in W/W-v were higher than those in WT. We next examined 
the cytokine production by BMMCs via HSV-infected keratinocytes in vitro. 
TNF-α was signifi cantly increased in BMMCs treated by supernatants of HSV-
infected keratinocytes. Unexpectedly, in the number of CD8α+ CD205+ dendritic 
cells, HSV-spesifi c CTLs and regulatory T cells in the lymph nodes, there was no 
signifi cant deference between W/W-v and WT. Thus, our fi ndings suggest that mast 
cells play a key role in host defense at HSV-infected sites through TNF-α production. 
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Dietary vitamin D3 protects against bacterial skin infection
Beda Muehleisen1, Tara Jaleel2, Katherine Radek3, Richard Gallo1 1Division of 
Dermatology, UCSD, San Diego, United States, 2School of Medicine, University of 
Alabama, Birmingham, United States, 3Dept. of Surgery, Loyola University, Maywood, 
United States
In skin infection vitamin D metabolism is activated to induce expression of the 
antimicrobial peptide cathelicidin, as well as CD14 and TLR2, thus enabling 
increased response to microbes. The aim of this study was to assess if exposure to 
vitamin D3 is physiologically relevant for increasing resistance to infection. Human 
keratinocytes (NHEK) stimulated in culture with 100nM 25-D3 for 24h showed 150-
fold higher cathelicidin mRNA and 25-fold increased CD14, but when co-stimulated 
with a low-MW-(<10kDa)-fraction of S.aureus (SA113), expression further increased 
for cathelicidin (510-fold) and CD14 (190-fold). There was no increase with the low 
MW SA fraction alone, indicating a synergistic effect of 25-D3 and SA. Functional 
relevance was seen in a bacterial killing assay in which lysates from NHEK co-
stimulated with 25-D3 and SA most effi ciently killed S. aureus-deltaMPRF(3-fold 
decrease in SA growth). Based on these observations we wished to develop a mouse 
model to test the importance of vitamin D in vivo. Mice lacking the 1α-hydroxylase 
enzyme CYP27B1 were fed a special chow devoid of vitamin D3 for 3 weeks to achieve 
vitamin D defi ciency (n=7), and were then compared to CYP27B1-/- mice receiving 
vitamin D (2200 IU/kg) in their diet (n=6). 3 days after injection sc. with 107CFU 
of Group A streptococcus NZ131, mice lacking vitamin D in their diet developed 
signifi cantly larger skin lesions (30.4±14.95mm vs. 5.72±1.12mm, p<0.05) and had 
more bacteria (2-fold increase, p<0.05) than when receiving vitamin D. Our results 
show that vitamin D3 intake may protect from bacterial infection in vitro and in vivo.
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Innate signals of non-pathogenic bacteria induce IL-10 producing dendritic cells, 
regulatory Th cells and clear atopic dermatitis
Thomas Volz1, Audrey Gueniche2, Björn Knaudt1, Eva Schuck1, Emmanuella 
Guenova1, Susanne Kaesler1, Martin Röcken1, Tilo Biedermann1 1Eberhard Karls 
University, Dept. of Dermatology, Tübingen, Germany, 2L’OREAL Recherche, Clichy, 
France
Immune homeostasis at surface organs is maintained by non-pathogenic bacteria. 
These have also been successfully administered for therapy of infl ammatory diseases 
of the gut. As topical application to treat skin diseases has not been reported, we 
performed a prospective, double-blind, placebo controlled trial to investigate the 
therapeutic potential of non-pathogenic, gram-negative bacterium Vitreoscilla 
fi liformis (Vf) applied to atopic patient skin. Vf lysate mediated reduction of SCORAD 
was highly signifi cant. To unravel underlying mechanisms, consequences on the 
most important surface organ immune sentinels, the dendritic cells (DC), were 
analyzed. While different Vf preparations uniformly lead to DC maturation, purifi ed 
Vf LPS induced little IL-10 and high levels of IL-12p70 that was dependent on TLR4. 
In contrast, DC stimulated with complete Vf lysate produced little IL-12 but large 
amounts of IL-10. Most importantly, IL-10 production was not dependent on TLR4 but 
on TLR2 signalling suggesting the presence of a dominant immuno-modulatory TLR2 
ligand. Indeed, priming naïve Th cells with Vf stimulated DC induced an IL-10++ 
Th cell phenotype. Functional assays were carried out demonstrating that IL-10++ 
Th cells strongly suppressed T effector cells. This indicates that effective treatment of 
atopic dermatitis by application of non-pathogenic bacteria is the result of i) TLR2 
dependent IL-10 induction in DC, ii) priming of IL-10++ regulatory Th cells, and iii) 
the consecutive suppression of cutaneous effector T cells. Our data demonstrate a 
new therapeutic strategy for infl ammatory skin diseases and point towards a general 
principle of how non-pathogenic bacteria stabilize the immune barrier of surface organs.
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Macrophages as sentinels directing the quality of skin repair
Tina Lucas1, Ari Waisman2, Thomas Krieg1,3, Sabine Eming1 1Department of 
Dermatology, University of Cologne, Cologne, Germany, 2First Medical Department, 
University of Mainz, Mainz, Germany, 3Cologne Excellence Cluster on Cellular Stress 
Responses in Aging-Associated Diseases (CECAD), University of Cologne, Germany
Substantial evidence in different model organisms indicates that the immune 
system is of primary importance in determining the quality of the repair response, 
including the extent of scarring as well as the restoration of organ structure and 
function. However, the relationship between repair and the immune response 
is complex and not completely understood. Indeed, there is evidence for both 
negative and positive roles. To unravel the dual role of the innate immune 
response in diverse repair mechanisms, we developed a novel mouse model that 
allows conditional depletion of macrophages during the sequential stages of the 
wound healing response. Depletion of macrophages restricted to the early stage 
of the repair response (infl ammatory phase) signifi cantly reduced the formation 
of a vascularized granulation tissue and impaired epithelialization as well as 
wound closure kinetics. Furthermore, differentiation of macrophages towards an 
M2-phenotype was attenuated. However, these wounds revealed minimal scar 
formation. In contrast, depletion of macrophages restricted to the consecutive mid 
stage of the repair response (phase of tissue formation) resulted in severe hemorrhage 
in the wound tissue. Under these conditions, transition into the subsequent phase 
of tissue maturation and wound closure did not occur. Finally, macrophage 
depletion restricted to the late stage of repair (phase of tissue maturation) did not 
signifi cantly impact the outcome of the repair response. These results demonstrate 
for the fi rst time that macrophages exert distinct functions during the diverse phases 
of skin repair, which are crucial to control the natural sequence of repair events.
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TGF-β and IL-10 are critical regulators of Langerhans and dendritic cell function 
in vivo 
Mathilde Girard-Madoux1, Junda Kel1, Boris Reizis2, Björn Clausen1 1Dept of 
Immunology, Erasmus MC, Univ Medical Center, Rotterdam, Netherlands, 2Dept of 
Microbiology & Immunology, Columbia Univ Medical Center, New York, USA
TGF-β and IL-10 are immunoregulatory cytokines that suppress dendritic cell (DC) 
maturation in vitro. TGF-β is also required for Langerhans cell (LC) development and 
TGF-β-defi cient mice lack epidermal LC. Whether TGF-β and IL-10 govern LC and 
DC homeostasis and function in vivo remains elusive. To this aim, we generated mice 
with a DC-specifi c knockout of, respectively, the TGF-β and IL-10 receptor (DC-
TβR1del and DC-IL10Rdel mice). While initial LC seeding occurred in DC-TβR1del mice, 
the cells disappeared from the epidermis within a week after birth. TβR1-defi cient LC 
matured spontaneously and gained migratory potential, based on increased expression 
of MHC-II, co-stimulatory molecules and CCR7, and down-regulation of E-cadherin. 
In contrast, the frequency and phenotype of (Langerin+) dermal DC was unaffected. 
In the absence of LC, low-dose contact hypersensitivity (CHS) in DC-TβR1del mice 
was diminished, but restored to wild-type at a higher hapten dose effi ciently targeting 
TβR1-defi cient dermal DC. IL-10R-defi cient DC retained their immature phenotype 
in vivo, but produced elevated levels of proinfl ammatory cytokines following in vitro 
stimulation. While IL-10-defi cient mice develop enhanced CHS, induction of CHS in 
DC-IL10Rdel mice was indistinguishable from controls at 24h post hapten challenge. 
In contrast, ear swelling was increased at 48h. Adoptive T-cell transfer experiments 
revealed that T-cell reactivation and not sensitization by IL-10R-defi cient DC leads to 
enhanced CHS. Our data identify TGF-β as a critical factor controlling LC homeostasis 
in the steady-state and, on the other hand, demonstrate that IL-10 signaling in 
DC is essential to prevent an exaggerated effector T-cell response in the skin.
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The antimicrobial peptide murine beta defensin-14 induces immunosuppression via 
switching CD4+CD25- cells into regulatory T cells
Fatemeh Navid, Kerstin Ahrens, Thomas Schwarz, Agatha Schwarz
University Clinics Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany
Ultraviolet radiation (UVR) suppresses the adaptive immune response in an antigen-
specifi c fashion via induction of CD4+CD25+ regulatory T cells (Treg). In contrast, 
the innate immune response appears to be induced by UVR through the release of 
antimicrobial peptides (AMPs) in the skin. These diverse effects may contribute to a 
protective mechanism after UVR, by protecting the skin from microbial attacks on the 
one hand, but taming T cell-driven pathologic reactions on the other hand. Hence, 
we asked whether AMPs can contribute to photoimmunosuppression. Recently, 
we observed that the UVR-regulated murine beta defensin (mBD)-14 increased the 
expression of the Treg specifi c marker Foxp3 and CTLA-4 in CD4+CD25- T cells. 
To investigate the biological relevance of this fi nding, CD4+CD25- T cells were 
incubated with mBD-14 and injected into naïve C57BL/6 mice before sensitization 
with 2,4-dinitrofl uorobenzene. 5 days later ear challenge was performed. In contrast to 
untreated cells, the contact hypersensitivity (CHS) response was signifi cantly reduced 
upon injection of mBD-14-treated cells. Direct injection of mBD-14 into naïve mice 
also abrogated the CHS response. The suppression could be adoptively transferred into 
naïve recipients in an antigen-specifi c fashion, indicating that Treg were developed 
in the mBD-14 injected donors. mBD-14 did not suppress sensitization in interleukin 
(IL)-10 knockout mice, suggesting that the immunosuppressive effect of mBD-14 
is mediated via IL-10. Through its immunosuppressive capacity mBD-14 might be 
able to cope with a microbial attack without inducing an infl ammatory reaction.
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The role of basophils in skin Th2 response using newly generated basophil specifi c 
conditional depletion model
Atsushi Otsuka1, Yusuke Minegaki1, Chisa Nakashima1, Masato Kubo2, Yoshiki 
Miyachi1, Kenji Kabashima1 1Department of Dermatology, Kyoto University, Kyoto, 
Japan, 2Laboratory for Signal Network, Research Center for Allergy and Immunology, 
RIKEN, Kanagawa, Japan
Basophils have recently been reported to elicit antigen (Ag) presenting in a certain 
condition. However it remains unknown whether basophils play a central role in the 
induction of cutaneous Th2-type immune responses. We have previously reported that 
HS4 region of IL-4 gene is essential for basophils to produce IL-4. Taking advantage 
of this system, we have newly generated BaS TRECK transgenic (Tg) mice in which 
a diphtheria toxin (DT) receptor is knocked-in to the HS4 region, and analyzed 
the role of basophils in cutaneous immune responses.We initially confi rmed that 
basophils in BaS TRECK Tg mice were completely depleted by treatment with DT. We 
then evaluate the effect of basophil-defi ciency on single hapten challenge-induced 
classic contact hypersensitivity (CHS) and repeated hapten exposure-induced 
chronic CHS responses. The classic CHS response as a representative of delayed-
type hypersensitivity was comparable between DT-injected BaS TRECK Tg mice and 
wild-type mice, suggesting that basophils are dispensable for CHS. On the other 
hand, in chronic CHS model as a representative of cutaneous Th2 skewing responses, 
skin infl ammation was signifi cantly decreased in BaS TRECK Tg mice. In addition, 
basophil-GFP mice showed that basophils were accumulated in the neighbors of T 
cells in the skin lesion of repeated CHS responses. These results indicated that activated 
basophils might interact with T cells to induce or maintain Th2-type skin responses.
These data suggest that basophils play a central roll in skin Th2 response and might 
be a novel key factor in the pathogenesis of Th2-type cutaneous immune responses.
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Sensitization to Dermatophagoides pteronyssinus and Tyrophagus putrescentiae in a 
group of cats and dogs owners
Elzbieta Meszynska1,2, Krzysztof Solarz3, Piotr Szilman3, Danuta Wiechula2, Ligia 
Brzezinska-Wcislo1 1Silesian University of Medicine, Department of Dermatology, 
Katowice, Poland, 2Silesian University of Medicine, Department of Toxicology, 
Katowice, Poland, 3Silesian University of Medicine, Department of Parazytology, 
Katowice, Poland
The frequency of allergic diseases is growing and this phenomenon is being recorded 
all over the world. Mites are more frequently identifi ed as factors provoking and 
inducing the symptoms of allergy.This work was aimed to determine a level of 
sensitisation to particular protein fractions Dermatophagoides pteronyssinus-LD and 
Tyrophagus putrescentiae –TP in a group of 15 dog owners and 9 cat owners. In the 
group of cat and dog owners serum was collected and frozen in order to determine 
a level of specifi c IgE directed against antigens DP and TP. Extracts of purifi ed 
mite bodies after standarization were separated, Western-Blotting and incubation 
with antibodies of 2nd order. Obtained results were compared with standard of 
mass particles of Biorad company and based on it. In the group of dog owners 23 
% shown a positive reaction to all determined TP protein fractions, none for DP, 
appropriately 22% and 0% for cat owners. Average quantity of allergens causing 
allergy of a single person amounts to almost 3 and oscillates from 0 to 6 for TP, 
from 0-5 with average above 3 for DP for dog owners, from 1-6 (above 3) for TP 
and from 0-5 (above 3) for DP in a group of cat owners. The DP antigen which 
makes allergic most often is 45.7 kDa (over 89% cat owners and 77% dog owners), 
for TP 78 kDa (89% cat owners) and 45.7 kDa (62% dog owners). Long lasting 
exposure to mite allergens may cause allergic diseases, including bronchial asthma.
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Human Demodex mite extracts stimulate an immune response in vitro
Noreen Lacey1, Siona Ni Raghallaigh1, Christos. C Zouboulis2, Frank. C Powell1
1University College Dublin, Clinical Research Centre, Department of Dermatology, 
Mater Misericordiae University Hospital, Dublin 7, Ireland, 2Departments of 
Dermatology, Venerology, Allergology and Immunology, Dessau Medical Centre, 
Dessau, Germany
Demodex mites (n=10 per treatment) were obtained by standardised skin surface 
biopsies from a rosacea patient and mechanically lysed in cell medium. The 
immortalised human sebaceous gland line SZ95 was employed to determine the 
immune response to Demodex mite extract on both gene and protein expression 
levels, at 4 h and 24 h post exposure. A cell stimulant and untreated control cells 
served for comparison. The expression of genes CAMP, KLK5, SERPINB3, IL6 and 
IL8 were assessed by quantitative real time PCR. The protein expression level of 
the antimicrobial peptide cathelicidin (LL-37) was determined by Western blot 
analysis. No signifi cant change in mRNA levels for CAMP, KLK5 or SERPINB3 were 
found in response to Demodex mite extracts at the 4 h and 24 h time points. At 
24 h a signifi cant increase in mRNA expression levels of IL8 (2000 fold) and IL6 
(20 fold) was found, along with increased expression of LL-37 by cells treated with 
Demodex extract. Demodex mite extracts stimulate a sebocyte immune response 
by increasing antimicrobial peptide synthesis and pro-infl ammatory chemokine 
and cytokine levels. These events may cause the perifollicular neutrophilic 
infi ltrate demonstrated histopathologically in patients with papulopustular rosacea.
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Inhibition of H1-receptors does not aggravate sepsis in mice
Elizabeth Doyle1,2, Takeshi Watanabe3, Torsten Zuberbier1, Marcus Maurer1,2, Martin 
Metz1,2 1Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité 
–Universitätsmedizin Berlin, Berlin, Germany, 2Department of Dermatology and 
Allergy Centre, Odense University Hospital, Odense, Denmark, 3Graduate School of 
Medicine, Kyoto University, Kyoto, Japan
Sedating and non-sedating H1R antihistamines and H2R-blockers are widely used 
for the treatment of allergies, insomnia and motion sickness, or the prevention 
and treatment of gastric ulcers, respectively. However it has been shown that 
histamine receptors are also involved in innate immune responses to bacteria 
and that pharmacological blockade in patients can negatively affect the outcome 
of severe bacterial infections. To characterize the contribution of the individual 
histamine receptors in such infections in more detail, we induced septic peritonitis 
in H1R -/- or WT mice, and in C57BL/6 mice treated with 1st generation H1R 
antihistamine, H2R antagonist, H3R/H4R antagonist, second generation H1R 
antihistamine, or vehicle. While H1R-/- mice as well as C57BL/6 mice receiving the 
second generation H1R antihistamine desloratadine did not show any differences 
in morbidity and mortality in this model as compared to WT or C57BL/6 mice 
treated with vehicle, signifi cant increases in morbidity were observed for all 
other treatment groups as compared with vehicle. These fi ndings indicate that 
histamine contributes to some extent to optimal host responses in mice with 
septic peritonitis by receptors other than H1R and that pharmacological blockade 
of histamine receptors may impair innate immune responses. In the model used 
here, which mimics perforated appendicitis in humans, modern second generation 
antihistamines can be considered as safe medications without any relevant effects 
on morbidity and mortality, probably because of their higher H1R specifi city.
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Expression of pattern recognition receptors in normal and infl amed human 
epidermis: upregulation of dectin-1 in psoriasis
Heleen de Koning1,2, Diana Rodijk-Olthuis1, Ivonne van Vlijmen-Willems1, Leo 
Joosten1,2, Mihai Netea1,2, Joost Schalkwijk1,2, Patrick Zeeuwen1,2 1Radboud University 
Nijmegen Medical Centre, Nijmegen, Netherlands, 2Nijmegen Centre for Molecular 
Life Sciences, Nijmegen, Netherlands, 3Nijmegen Institute for Infection, Infl ammation 
and Immunity, Nijmegen, Netherlands
Human epidermis plays an important role in host defense by acting as a physical barrier and 
signaling interface between the environment and the immune system. Pattern recognition 
receptors (PRRs) are crucial to maintain homeostasis and provide protection during 
infection, but are also causally involved in auto-infl ammatory diseases. This study aimed to 
investigate the epidermal expression of PRRs and several associated host defense molecules 
in healthy human skin, psoriasis and atopic dermatitis. Microarray analysis and qPCR were 
performed on epidermal sheets and immunohistochemistry on whole-skin biopsies of 
normal skin and chronic psoriasis and atopic dermatitis lesions. In vitro, primary human 
keratinocytes were stimulated with cytokines mixtures and PRR ligands. Many PRR genes 
are transcribed in normal human epidermis. Only a few genes were differentially induced 
in psoriasis (CLEC7A (dectin-1), TLR4 and MRC1) or atopic dermatitis (MRC1, IL1RN and 
IL1β) compared to normal epidermis. A remarkably high expression of dectin-1 mRNA was 
observed in psoriatic epidermis and this was corroborated by immunohistochemistry. In 
cultured primary human keratinocytes, dectin-1 expression was induced by interferon-γ, 
interferon-α and Th17 cytokines. Keratinocytes were unresponsive, however, to dectin-1 
ligands such as β-glucan or heat-killed Candida albicans, nor did we observe synergy with 
TLR2/TLR5 ligands. In conclusion, many PRRs and other host defense genes are expressed 
in human epidermis, and RIG-like helicases, TLR2 and TLR3 are the most abundant PRRs. 
Upregulation of dectin-1 in psoriatic lesions appears to be controlled by psoriasis-associated 
cytokines. Its role in the biology of skin infl ammation and infection remains to be explored.
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Lesional skin of patients with chronic atopic dermatitis shows increased proportions 
of IL-31 positive T cells and a Th2/Th22 dominance
Krisztina Szegedi1, Sanja Kezic2, Marcel B.M. Teunissen1, Jan D. Bos1, Rosalie M. 
Luiten1, Pieter C. Res1, Maritza A. Middelkamp-Hup1 1Department of Dermatology, 
Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 
2Coronel Institute for Occupational Health, Academic Medical Center, University of 
Amsterdam, Amsterdam, Netherlands
IL-31 plays an important role in pruritus, a prominent feature of atopic dermatitis (AD). 
Because IL-31 is mostly produced by T cells, local T cell responses may be responsible 
for the increased level of IL-31 mRNA observed in AD lesions. We therefore investigated 
whether lesional AD skin contains an increase in IL-31 producing T cells by determining 
the cytokine profi le of the infi ltrated T cells. T cells were isolated from chronic AD lesions 
(>3 months), peripheral AD blood and healthy skin. After in vitro stimulation with PMA/
ionomycin, the intracellular expression of IL-31, IFN-γ, IL-13, IL-17 and IL-22 was measured 
using fl ow cytometry. Lesional AD skin contained signifi cantly higher percentages of IL-31-
producing T cells compared to autologous blood and healthy skin (CD4: AD skin 9.9%; AD 
blood 1.2%; healthy skin 1.3% and CD8: 12.7%; 1.8% and 1.7% respectively). This may be 
due to local activation and subsequent expansion of these T cells, causing overproduction of 
IL-31 and consequently increased pruritus in AD. The majority (>77%) of the IL-31 positive 
T cells did not co-produce any of the other cytokines under investigation, and may thus 
represent a distinct T cell subset. The remaining IL-31 positive T cells predominantly co-
produced IL-22 and/or IL-13 and only rarely IFN-γ or IL-17, showing a closer association 
with the Th2/Th22 cytokine profi le. In comparison to healthy skin, the AD lesional skin 
cytokine milieu was generally more shifted towards a Th2/Th22 cytokine profi le, disputing 
the widely accepted view that chronic AD lesions are dominated by a Th1 response.
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The role of OX40 ligand and OX40 receptor in atopic dermatitis
Tiina Ilves, Ilkka Harvima University of Eastern Finland, Kuopio, Finland
The interaction between OX40 ligand (OX40L) and OX40 receptor has been suggested 
to be a novel pathogenetic factor in atopic dermatitis (AD). Therefore, the purpose of 
this study was to investigate the expression and signifi cance of OX40L and OX40 in 
the lesional and nonlesional skin of 17 patients with AD using immunohistochemistry 
and cultivation of peripheral blood mononuclear cells (PBMCs). Control group 
consisted of 10 patients with psoriasis vulgaris. The staining intensity of OX40L and 
the number of OX40+ cells in the dermis were signifi cantly greater in the lesional 
skin than in the healthy-looking skin both in AD (p<0,001) and psoriasis (p=0,01 and 
p<0,001 respectively), but neither molecule correlated markedly with the clinical 
severity of AD. The stainings were slightly more intense in AD than in psoriasis. LAD-
2 human mast cell line stimulated with phorbol myristate acetate (PMA) expressed 
OX40L. A cell membrane preparation from non-stimulated or PMA-stimulated LAD-2 
cells was incubated with PBMCs in the presence or absence of blocking monoclonal 
antibodies (up to 30 µg/ml) towards OX40L, CD30L or ICAM-1. The PBMC 
proliferative response of 3 AD patients was strongly increased by PMA-stimulated 
LAD-2 membranes, but it was inhibited by 42-89% in the presence of 30 µg/ml anti-
OX40L. This inhibition was comparable with that by anti-CD30L and anti-ICAM-1. In 
summary, OX40L and OX40 receptor are strongly expressed in the lesional skin and the 
blocking of their interaction may provide opportunities for drug development in AD.
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Differentiation of MUTZ-3 cells to Langerhans-like cells and integration into a 
three-dimensional full-thickness skin model
Vesselina Laubach1,2, Nadja Zoeller1, Maila Rossberg1, Kerstin Goerg1, Karsten Mewes3, 
Stefan Kippenberger1, Juergen Bereiter-Hahn2, Roland Kaufmann1, August Bernd1
1Department of Dermatology and Venerology, J.W. Goethe-University, Frankfurt/
Main, Germany, 2Kinematic Cell Research Group, J.W. Goethe-University, Frankfurt/
Main, Germany, 3Henkel AG & Co. KGaA, Düsseldorf, Frankfurt/Main, Germany
Here we show that MUTZ-3 cells, derived from a CD34+ human acute myeloid 
leukemia, can be differentiated into Langerhans-like cells in the presence of a 
cytokine cocktail including GMCSF, TGFbeta1 and TNFalpha. As differentiation 
markers served the expression of langerin (CD207), CD1a, CCR6, Birbeck 
granules and the ability to antigen internalization. The aim of the present study 
was to integrate differentiated MUTZ-3 cells (MUTZ-LCs) into a three-dimensional 
fullthickness skin model consisting of primary human keratinocytes and fi broblasts. 
Keratinocytes were seeded on top of a dermal equivalent composed of fi broblasts 
seeded into a collagen matrix (Henkel AG & Co. KGaA, Düsseldorf). After 24h, 
MUTZ-LCs were seeded on top followed by a second keratinocyte seeding 24h 
later. After further 24h, the models were lifted up to the airliquid interface (ALI). 
Histological evaluation performed after 10-12 days featured a fully stratifi ed 
epidermis with all characteristic epidermal strata. The identifi cation of MUTZ-
LC within the full-thickness skin model was performed by immunohistochemical 
stainings against langerin. Langerin-positive cells were detected suprabasally within 
the epidermis indicating that keratinocytes and/or fi broblasts provide environmental 
conditions for long-time maintenance of MUTZ-LCs. This skin model provides a 
tool to further investigate the interaction between Langerhans-like cells and other 
skin cells and particularly learn more about the cutaneous immune response.
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Foxp3+ regulatory T cells control infl ammation in the murine model of atopic 
dermatitis
Sari Lehtimäki, Antti Lauerma, Henrik Wolff, Harri Alenius, Nanna Fyhrquist
Finnish Institute of Occupational Health, Helsinki, Finland
The role of Foxp3+ regulatory T cells (Treg) in the pathogenesis of atopic 
dermatitis (AD) is controversial. We analysed how depletion of Treg cells in 
conditional knockout mice (DEREG) infl uenced the outcome of the infl ammatory 
response in the mouse model of AD. AD-like skin infl ammation was induced by 
repeated exposure of shaved and tape stripped skin to topical ovalbumin. Treg 
cells were depleted during the last week of challenge in DEREG mice, which 
express diphtheria toxin (DT) receptor-EGFP fusion protein under the control of 
the foxp3 locus. Blood, skin and draining lymph node samples were collected for 
analysis. Depleting Treg cells by DT in the DEREG mice resulted in a signifi cantly 
exacerbated immune response compared to the wild type mice, including 
increased infl ammatory cell infi ltration and enhanced cytokine expression in the 
skin as well as elevated IgE levels in the serum. These results suggest that Foxp3+ 
Treg cells are critically involved in the regulation of AD-like skin infl ammation.
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Decreased TNF-α synthesis by macrophages restricts cutaneous immunosurveillance 
by memory CD4+ T cells during ageing
Elaine Agius1,2, Katie Lacy1,2, Milica Vukmanovic-Stejic1, Anna P Papageorgiou3, Sue 
Hall4, John R Reed1,2, John Curnow5, Leonie S Taams6, Ann Jagger6, Judilyn Fuentes-
Duculan7, Chris Buckley5, Mike Salmon5, James Krueger7, John Greenwood3, Nigel 
Klein4, Malcolm Rustin2, Arne N Akbar1 1Immunology, Univ College London, UK, 
2Dermatology, Royal Free Hospital, London, UK, 3Cell Biology, Inst of Opthalmology, 
Univ College London, UK, 4Infectious Diseases & Microbiology unit, Institute of Child 
Health, Univ Coll London, UK, 5MRC Centre of Immune Regulation, Div of Immunity 
& Infection, Univ of Birmingham, Edgbaston, UK, 6Immunobiology, King’s Coll London 
School of Medicine, UK, 7Lab for Invest Derm, Rockefeller Univ, New York, USA
There is an age-related increase of cutaneous malignancy and infection. However, the 
exact mechanism of the decline in immunity in the skin of old subjects is unknown. To address 
this, we induced cutaneous delayed type hypersensitivity responses to either candida (n=74), 
tuberculin purifi ed protein derivative (PPD)(n=52) or varicella zoster virus (VZV)(n=26) antigens in 
young and old subjects. Old individuals showed signifi cantly lower clinical responses and decreased 
antigen-specifi c CD4+ T cell infi ltration after injection. This was unrelated to expression of CCR4, 
CLA or CD11a on T cells or their physical capacity for migration.  Instead, there was signifi cantly 
reduced expression of E-selectin, ICAM-1 and VCAM-1 on dermal endothelium at the site of antigen 
injection in old subjects.  The cytokines TNF-α and IFN-γ that are pre-requisite for endothelial 
activation were signifi cantly reduced in old donor skin. In particular, TNF-α was produced by CD163+ 
macrophages in the skin of the young, but was absent in these cells from old volunteers. Collectively 
we show that decreased recall responses to bacterial, fungal and viral antigens in the elderly are due 
to decreased conditioning of the skin microenvironment by “innate” macrophage-derived cytokines 
and not a systemic T cell defect per se. The resulting decrease in immunosurveillance by T cells 
may contribute to the increased incidence of cutaneous malignancy and infection during ageing
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Formation of DC-Treg aggregates depends on adenosine
Sabine Ring, Alexander Enk, Karsten Mahnke University Hospital Heidelberg, 
Heidelberg, Germany
CD4+CD25+Foxp3+ regulatory T cells (Treg) suppress the sensitization phase of murine 
contact hypersensitivity reactions (CHS) by blocking the activation and antigen-
presenting capacity of dendritic cells (DC) in the draining LN. This suppression is 
dependent on the close interaction between DC and Treg and the formation of gap-
junctions. To further elucidate the underlying mechanisms, we set up antigen-non-
specifi c co-cultures of DC and Treg in vitro. Using video microscopy we show formation 
of large DC-Treg clusters within 2h. In contrast, DC established hardly any stable 
contacts with polyclonal CD4+ T cells. Life images sampled over 2h demonstrated fast 
movement of the DC in the cocultures, resulting in frequent contacts with the rather 
immobile Treg. Next we analyzed the role of adenosine, which is produced by the Treg 
via the ectonucleotidases CD39 and CD73, in the aggregation between DC and Treg. 
We detected, that inhibition of adenosine production by the CD39-blocking agent 
POM-1 abolished the formation of clusters between DC and Treg signifi cantly. This 
consequently led to a reduced formation of gap junctions and resulted in abrogation of 
DC-Treg interaction. In aggregate our data indicate that the formation of antigen-non-
specifi c aggregates between DC and Treg, which is one prerequisite for Treg to exert 
immunosuppressive actions on DC, is dependent on adenosine produced by Treg.
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Tissue derived ATP activates CD4+CD25+FoxP3+ regulatory T cells and stimulates its 
own degradation to immunosuppressive adenosine during contact hypersensitivity 
reactions
Sabine Ring, Alexander Enk, Karsten Mahnke University Hospital Heidelberg, 
Heidelberg, Germany
Intravenously injected naïve CD4+CD25+FoxP3+ regulatory T cells (Treg) suppress 
the elicitation phase of hapten induced contact hypersensitivity (CHS) reactions. 
To determine the underlying mechanisms of suppression, we fi rst compared the 
activation status and the suppressive capacity of the Treg before injection and 
after injection and elicitation of a CHS reaction. We show by fl ow cytometry 
and by in vitro suppression assays that naïve Treg become activated in the blood 
(upregulation of CD69) and demonstrate augmented suppressive capacity after i.v. 
injection. Further, we recorded elevated levels of ATP in the blood after hapten 
application to the skin, and blocking of the ATP-specifi c P2X7 receptor on Treg 
before injection completely abrogated their suppressive function. This clearly 
indicates involvement of ATP and P2X7 receptors in activation of Treg in vivo. When 
analyzing the fate of the tissue-derived ATP, we found that ATP was degraded to 
adenosine by the ectonucleotidases CD39 and CD73 expressed by Treg. Our data 
obtained in the CHS model further indicate that Treg-derived adenosine engages 
with A1 receptors expressed by the vascular endothelium, leading to reduced 
expression of the adhesion molecules E- and P-selectin. Thus, effector T cells are 
unable to migrate from the blood to the tissue and as a consequence, the CHS 
response is suppressed. These data, in addition to defi ning a novel mechanism of Treg 
mediated immune suppression, elucidate a novel nucleoside-mediated regulatory 
feedback loop, in which the pro-infl ammatory “damage associated molecule” 
ATP activates immunosuppressive cells, preventing exacerbated infl ammation.
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Depletion of DEC205+ dendritic cells by a specifi c single chain fragment variable 
(scFv) toxin
Michael Maas1, Theron S. Johnson1, Alexander E. Enk1, Dirk M. Nettelbeck2, Karsten 
Mahnke1 1University Hospital Heidelberg, Germany, 2DKFZ, Heidelberg, Germany
CD8+ DEC205+ CD11c+ Dendritic cells (DC) are able to crosspresent antigens via 
MHC-I and are involved in the induction of FoxP3+ Treg. In order to study their 
function in more detail, we set out to devise a novel tool to deplete this DC subset 
in vivo. We generated a single-chain fragment variable (scFv) specifi c for the murine 
DEC205 surface antigen (CD205). This scFv was fused to Pseudomonas aeruginosa 
Exotoxin A (ETA), an inhibitor of the cellular protein synthesis, leading to induction 
of apoptosis. The respective DNA sequences were cloned into a bacterial 6xHis- and 
c-myc-tag containing vector and the bacterial expressed recombinant scFv fusion 
proteins were affi nity-purifi ed. As controls, a nontoxic DEC205-specifi c scFv and a 
β-Gal specifi c scFv fused to ETA were generated. To assess targeting capabilities of 
the cloned constructs, cultivated DC were incubated with scFv and stained thereafter 
with myc-tag specifi c antibodies. Evaluation via fl uorescence microscopy showed 
effective binding of the DEC205 specifi c scFv constructs. To reveal functionality of 
the anti-DEC205-ETA scFv, DC were incubated with graded doses of the scFv and 
induction of apoptosis was analyzed. Here a signifi cant depletion of DEC205+DC 
was achieved by treatment with anti-DEC205-ETA scFv but not with control scFv. 
Specifi city of the toxic effect was validated by incubation of DEC205- fi broblasts with 
anti-DEC205-ETA scFv that did not lead to apoptosis. Thus, our data show that anti-
DEC205-ETA scFv is an effi cient tool for the depletion of DEC205+ DC and further 
experiments will reveal the role of this DC subpopulation in tolerance and immunity.
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Intradermal CpG treatment reduces lung infl ammation but induces IFN-γ mediated 
airway hyperreactivity in a murine model of natural rubber latex allergy
Rita Haapakoski1, Piia Karisola1, Nanna Fyhrquist1, Terhi Savinko1, Henrik Wolff1,4, 
Kristiina Turjanmaa2, Timo Palosuo3, Timo Reunala2, Antti Lauerma1, Harri Alenius1
1Finnish Institute of Occupational Health, Helsinki, Finland, 2Tampere University 
and University Hospital, Tampere, Finland, 3National Institute of Health and Welfare, 
Helsinki, Finland, 4Helsinki University Central Hospital, Helsinki, Finland
Asthma and other allergic diseases are continuously increasing causing considerable 
economical and sociological burden to the society. Hygiene hypothesis proposes 
that lack of microbial Th1-like stimulation during early childhood leads to increased 
Th2-driven allergic disorders later in life. Immunostimulatory CpG-ODN (Cytosine-
phosphate-Guanosine Oligodeoxynucleotide) motifs are candidate molecules for 
immunotherapeutic studies as they have been shown to shift the Th2 response toward 
Th1 direction and reduce allergic symptoms. Using natural rubber latex (NRL) -induced 
murine model of asthma, we demonstrated that intradermal CpG administration with 
allergen reduced pulmonary eosinophilia, mucus production and Th2-type cytokines 
but unexpectedly induced airway hyperreactivity (AHR) to inhaled metacholine, one 
of the hallmarks of asthma. We found that induction in AHR was dependent on STAT4 
but independent of STAT6 signalling. CpG treatment increased production of IFN-γ 
in the airways and shifted the ratio of CD4+/CD8+ T cells towards CD8+ dominance. 
By blocking soluble IFN-γ with neutralizing antibody, AHR diminished and the CD4+/
CD8+ ratio returned back to CD4+ dominance. These results indicate that increased 
production of IFN-γ in the lungs may lead to severe side effects such as enhancement of 
bronchial hyperreactivity to inhaled allergen. This should be taken into consideration 
when planning prophylaxis treatment of asthma with intradermal CpG injections.
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Biodegradable Polylactic Acid Particles for Transcutaneous Drug Delivery and Skin 
Cell Targeting
Fiorenza Rancan1, Sarah Amselgruber1, Sabrina Hadam1, Sevérine Munier2, Thierry 
Delair3, Bernard Verrier2, Wolfram Sterry1, Ulrike Blume-Peytavi1, Annika Vogt1 
1Clinical Research Center for Hair & Skin Science, Dept of Dermatology and Allergy, 
Charité-Universitätsmedizin Berlin, Berlin, Germany, 2Institut de Biologie et Chimie 
des Protéines, UMR 5086 CNRS, Lyon, France, 3Univ de Lyon, UMR CNRS 5223 ‘IMP’, 
Laboratoire des Matériaux Polymères et Biomatériaux, Villeurbanne, France
In our previous studies we have shown that biodegradable polylactic acid (PLA) and biocompatible 
polystyrene (PS) particles preferentially accumulate in hair follicles, where release of the 
incorporated lipophilic compounds or translocation of intact particles to the viable epidermis 
occurred, respectively. In this study, we aimed to investigate the suitability of polymeric particles 
for the transcutaneous delivery of peptides and Langerhans cells (LCs) targeting. We applied HIV-
p24-loaded PLA and PS particles on human skin explants and studied particle penetration in hair 
follicles (HFs), particle translocation into the epidermis and their ability to induce the maturation 
of LCs. We found that both PLA and PS particles released the surface-adsorbed HIV-p24 peptide 
after their internalization by LCs in vitro hereby inducing the expression of maturation markers. 
Upon topical application on the skin surface, particles preferentially accumulated in HFs openings 
and penetrated in 52±11% of HFs. PS but not PLA particles were found to be associated with 
LCs after 16h of incubation on excised human skin. Nevertheless, partial maturation of LCs (e.g. 
up-regulation of CD83 but not of CD80) was observed after treatment with both PS and PLA p24-
loaded particles. Thus, both particle types may allow the transcutaneous delivery of adsorbed 
peptides. However, while PS-particles targeted LCs upon translocation across the skin barrier, 
PLA particles accumulated and released the HIV-p24 peptide in the HFs. Both mechanisms, i.e. 
transcutaneous delivery of drug-loaded particles and particle-based delivery of incorporated 
drugs, may open interesting new strategies for skin cell targeting and transcutaneous vaccination.
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IL-33 and its receptor complex are upregulated in atopic dermatitis
Terhi Savinko1, Antti Lauerma1, Ulpu Saarialho-Kere2, Henrik Wolff1, Sampsa 
Matikainen1, Harri Alenius1 1Finnish Institute of Occupational Health, Helsinki, 
Finland, 2University of Helsinki, Helsinki, Finland
IL-33 is a recently described cytokine which belongs to the IL-1 family and is known 
to amplify Th2 response. IL-33 signals through the IL-1 receptor-related protein 
ST2 and IL-1 receptor accessory protein IL-1RAcP. To explore the role of IL-33 and 
its receptor complex in atopic dermatitis (AD), we characterized their expression 
profi les in lesional and nonlesional AD skin. The expression of IL-33 was also 
investigated in vitro. Skin biopsies were taken from either lesional or nonlesional skin 
of AD patients. In addition, clinically healthy back skin of atopy patch test-positive 
patients was treated with topical application of house dust mite in petrolatum. The 
expression of IL-33, ST2 and IL-1RAcP was studied by real-time PCR. To further 
investigate the cellular source of IL-33, human dermal fi broblasts were stimulated 
with proinfl ammatory, Th2- and Th1- cytokines. mRNA expression of ST2 and IL-
1RAcP was upregulated in lesional skin of AD patients when compared to nonlesional 
skin. Both IL-33 mRNA and ST2 mRNA levels in the human skin biopsies were 
signifi cantly induced after allergen application. In vitro studies showed that cultured 
human dermal fi broblasts produce high levels of IL-33 mRNA when stimulated with 
a combination of TNFα and IFNγ. These fi ndings suggest that IL-33-ST2 interaction 
is important in the pathogenesis of AD, especially in the induction of acute lesions.
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Prevention of carcinoma development by tumor-specifi c Th1 cells
Heidi Braumüller, Thomas Wieder, Gintautas Bulotas, Sonja Fischer, Martin Röcken
Eberhard-Karls-University, Dept. of Dermatology, Tübingen, Germany
Most cancer immunotherapies rely on CD8-positive cytotoxic T cells (CTL), capable 
of causing either tumor cell lyses or apoptosis. Due to tumor escape mechanisms like 
tumor-induced antigen-specifi c T cell tolerance, CTL often fail to effi ciently eradicate 
tumors in vivo. Interferon-gamma (IFNγ)-producing CD4+ T cells (Th1 cells) are 
incapable of directly recognizing MHC-class II-negative cancer cells. Surprisingly, 
various studies showed that adoptive transfer of Th1 cells can circumvent tolerance 
induction and effi ciently arrest tumor growth in vivo. To elucidate the mechanisms 
underlying tumor growth arrest by Th1 cells, we investigated the development of 
islet carcinomas, resulting from aberrant Rb and p53 expression in a model tumor 
with well-described multistage carcinogenesis. Tumor-specifi c Th1 cells reduced 
cell proliferation in a strictly IFNγ-dependent manner in vivo, without causing cell 
death or apoptosis. Simultaneously Th1 responses preserved the normal structure, 
antigen-profi le and functions of the tumor-prone, transgenic islet cells. Expression 
of the classical islet cell differentiation marker insulin (ins) and glucose transporter 
2 (Glut2) revealed that in Th1-treated mice ins and Glut2 remained fully preserved. 
In sharp contrast, islet cells from sham-treated mice grew 5-10 times more rapidly, 
lost their normal structure, acquired a malignant antigen-pattern, and completely lost 
the typical islet cell functions. Sham-treated cancer cells showed a 50 % reduction 
of the differentiation marker ins and complete loss of Glut2. Thus, Th1 immunity 
can not prevent tumors through cytotoxic effects or apoptosis. Th1 immunity induces 
potent cytostatic effects that prevent carcinoma development in cancer-prone 
precursor cells, a mechanism that underlies interferon-induced tumor dormancy.
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A functional role of stimulator of interferon gene (STING) in antiviral response of 
human epidermal keratinocytes
Yohei Nishikawa1, Yasushi Matsuzaki1, Chihiro Hagiwara1, Noriko Takiyoshi1, Kazuyuki 
Kimura1, Hajime Nakano1, Tadaatsu Imaizumi2, Kei Satoh2, Daisuke Sawamura1
1Department of Dermatology, Hirosaki University Graduate School of Medicine, 
Hirosaki , Aomori, Japan, 2Department of Vascular Biology, Institute of Brain Science, 
Hirosaki University Graduate School of Medicine, Hirosaki , Aomori, Japan
The innate immune system is the fi rst line of defense against microbial pathogens, 
and the production and secretion of type I interferons (IFN) plays an important 
role of the innate response to RNA viruses. Retinoic acid-inducible gene-I (RIG-I) 
is a cytoplasmic protein that recognizes viral double-stranded RNA to induce IFN 
response. In previous studies, we demonstrated that RIG-I expression in human 
epidermal keratinocytes (HaCaT) is regulated by cytokine stimulation and UVB 
exposure. On the other hand, a novel protein called STING (stimulator of interferon 
gene) has been proposed as an important signaling adaptor protein that functions 
downstream of RIG-I signaling. STING was localized to the outer membrane of the 
mitochondria and the endoplasmic reticulum, and detected in a variety of human 
tissues including heart, spleen, kidney, placenta, lung and peripheral leukocyte. In 
this study, we identifi ed the up-regulated STING expression by cytokine stimulation 
in HaCaT cells, indicating that STING protein may function as the innate immune 
system defense in the skin. Furthermore, we analyzed the interaction between 
RIG-I and STING in a suffi cient antiviral response of human keratinocytes.
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PPAR-alpha defi ciency triggers allergic contact dermatitis by affecting regulatory T 
cells through lack of IL-2
Sandrine Dubrac1, Andreas Elentner1, Kristina Schoonjans2, Johan Auwerx2, Matthias 
Schmuth1 1Department of Dermatology, Innsbruck Medical University, Innsbruck, 
Austria, 2Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
The aim of our work was to decipher the cellular basis of the pro-infl ammatory skin 
phenotype of PPAR-alpha defi cient mice. After challenge with a contact allergen, 
contact hypersensitivity reaction was increased and prolonged in PPAR-alpha 
defi cient mice when compared to wild type mice. Numbers of T-lymphocytes in the 
skin of PPAR-alpha defi cient mice were increased and showed enhanced expression 
of the activation marker CD25 when compared to controls. After antigen challenge, 
percentages of Treg in the blood, the skin draining lymph nodes and the skin were 
decreased in PPAR-alpha defi cient mice when compared to controls. Moreover, 
PPAR-alpha defi ciency impaired the production of IL-2 in lymph nodes, whereas 
production of TGF-beta remained unchanged. Injection of PPAR-alpha defi cient 
mice with IL-2 restored the size of the Treg population in the skin draining lymph 
nodes of challenged mice. In vivo induction of Treg from wild type CD4+CD25- 
T-cells was impaired when adoptively transferred into PPAR-alpha defi cient mice 
as compared with wild type mice and reversed by injection of IL-2. Furthermore, 
PPAR-alpha defi cient Treg exhibited  impaired suppressive capacity when compared 
to wild type Treg in mixed leukocyte reactions. Co-adoptive transfer of both CD4+ 
T cells and Treg confi rmed poor suppressive capacity of PPAR-alpha defi cient Treg 
in vivo presumably due to reduced IL-10 and perforin/granzyme B. Injection of IL-2 
fully restored the expression of perforin in PPAR-alpha defi cient mice but partially 
the expression of granzyme B. In conclusion, PPAR-alpha defi ciency aggravates 
skin contact hypersensitivity by affecting Treg function through lack of IL-2.
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The expression of dual specifi city phosphatase 1 is dysregulated in psoriasis vulgaris
Rasmus Boye Kjellerup, Claus Johansen, Knud Kragballe, Lars Iversen
Aarhus University Hospital, Aarhus C, Denmark
The dual specifi city phosphatase 1 (DUSP1) is an important negative regulator 
of p38 MAPK activity. The purpose of this study was to investigate DUSP1 in 
psoriasis. The experimental setup included in vitro culturing of normal human 
epidermal keratinocytes (NHEKs), punch biopsies from nonlesional and lesional 
skin from patients with psoriasis or nickel-induced allergic contact dermatitis, and 
RT-qPCR. We found that the DUSP1 mRNA expression was signifi cantly induced 
in NHEKs in response to stimulation with IL-1beta (36 fold) or TNF-alpha (9 fold). 
For both stimuli the DUSP1 mRNA expression peaked after 1 hour and returned 
to baseline after 3 hours. Using chemical inhibitors, we demonstrated that the IL-
1beta-induced expression of DUSP1 was mediated through the p38 MAPK-MSK1/2 
signaling pathway. Both the IL-1beta level as well as the activity of the p38 MAPK-
MSK1/2 pathway are increased in psoriasis. Nevertheless, in chronic plaque-type 
psoriatic skin from 17 patients we found that 12 patients displayed a decreased 
expression of DUSP1 mRNA whereas 5 patients showed an increase. The overall 
difference was a signifi cant reduction of approximately 26 percent. In contrast, in 
skin biopsies from 9 patients with a positive nickel patch test after 72 hours, we 
found a 1.7 fold increase in the expression of DUSP1 mRNA. Thus, it appears 
that the apparent compensatory upregulation of DUSP1 as seen in nickel-induced 
allergic contact dermatitis is defi cient in psoriasis. Dysregulation of DUSP1 is 
therefore likely to contribute to the ongoing infl ammatory response seen in psoriasis.
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Development of a human dermis equivalent model incorporating dermal 
macrophages
Nicolas Bechetoille1, Hortense Vachon2, Thomas Fontaine2, Valérie André-Frei1, 
Christopher Mueller2 1BASF Beauty Care Solutions France S.A.S, Lyon, France, 2CNRS, 
Laboratory of Therapeutic Immunology and Chemistry, IBMC, University Louis 
Pasteur, Strasbourg, France
The reconstruction of human skin in vitro by a three-dimensional skin culture system 
has already been signifi cantly improved by incorporating Langerhans cells and dermal 
dendritic cells. Yet, skin culture systems still suffer from the lack of the third immune 
cell subtype, i.e. dermal macrophages. Monocyte-derived dermal-type macrophages 
(MDdM) were seeded into dermis equivalents and cultured for 1 additional week 
without adding exogenous cytokines. Their phenotypic stability and distribution 
within the 3D culture were analyzed by immunolabelling on histological sections. 
After 1 week inside the dermis equivalent, MDdM expressed CD14, CD163, CD209 
and HLA-DR and lacked CD1a/c. In addition, MDdM released IL-10, but no TNFα, 
when stimulated by LPS. We successfully integrated stable and functional MDdM into 
dermis equivalents. Because there is increasing evidence that dermal macrophages 
and dendritic cells co-exist in a dynamic equilibrium, our model opens the possibility 
of studying the relationship and potential cross-talk between the two cell types. Such 
interactions between dermal macrophages and dendritic cells need to be clarifi ed in 
certain infectious diseases, where they elicit particular immune responses in reaction 
to bacterial or viral pathogens. Finally, with the aim of fi nding new treatments for 
infl ammatory skin diseases, we wish to use our model to fi nd ways to specifi cally 
target dermal macrophages and stimulate their release of anti-infl ammatory IL-10.
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An unexpected twist in alopecia areata pathogenesis:Are NK cells protective, and 
CD49b+ T cells pathogenic?    
Amos Gilhar1, Roberto d‘Ovidio2, Ralf Paus3 1Skin Research Laboratory. The B. 
Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, and Flieman 
Medical Center, Haifa, Israel, 2Associazione Italiana Dermatologi Ambulatoriali, Bari, 
Italy, 33Dept. of Dermatology, University of Luebeck, Germany
Natural killer (NK) cells have become a recent focus of interest in alopecia areata (AA) 
research. To further investigate their role in an established mouse model of AA, lesional 
skin from older C3H/HeJ mice with AA was grafted to young C3H/HeJ female mice, 
and NK cells were depleted by continuous administration of rabbit anti-Asialo GM1. 
As expected, this signifi cantly reduced the number of pure NK cells in murine skin, as 
assessed by NKp46 quantitative immunohistochemistry. Quite unexpectedly, however, 
the onset of hair loss in C3H/HeJ mice was accelerated, rather than retarded. NK cell 
depletion was accompanied by a signifi cant increase in the number of perifollicular 
CD49b+T cells in the alopecic skin of anti-Asialo GM1-treated mice. These 
fi ndings underscore the need to carefully distinguish in future AA research between 
pure NK cells and defi ned subsets of CD49b+ lymphocytes, since they may exert 
diametrically opposed functions in hair follicle immunology and immunopathology.
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Upregulation of TLR2 expression in keratinocytes in psoriatic skin can be caused 
by cytokines
Rüdiger Panzer, Kerstin Ahrens, Jürgen Harder, Ehrhardt Proksch
UKSH, Campus Kiel, Clinic for dermatology, allergology and venerology, Kiel, 
Schleswig-Holstein, Germany
The innate immune system supports the physical skin barrier in antimicrobial 
defense. Human keratinocytes constitutively express various members of the toll-like 
receptor (TLR) family, important for innate immunity including TLR2. TLR2 recognizes 
pathogen associated molecular pattern of gram-positive bacteria such as lipoteichoic 
acid. Its expression has been shown to be upregulated in keratinocytes of psoriatic 
skin. TLR4 recognizes lipopolysaccharide, a cell wall component of gram-negative 
bacteria. Confl icting data exist about the expression of TLR4 in psoriasis. We asked 
whether TLR2 and TLR4 expression is stimulated by cytokines in human keratinocyte 
culture in vitro. The expression of human TLR2 and TLR4 was assessed by realtime 
PCR analysis and subsequent gel electrophoresis for verifi cation. For stimulation 
experiments we used cytokines which have been described to be involved either in 
Th1 or Th2 dominated immune responses: Interleukin (IL)-1 β, IL-4, IL-5, IL-6, IL-13, 
IL-15, IL-17, IL-18, IL-20, IL-31, Interferon (IFN) γ, tumor necrosis factor (TNF) α and 
tissue derived growth factor α. We found a signifi cant upregulation of TLR2 expression 
in keratinocyte cell culture by stimulation with IL-1 β and IFN γ. This induction was 
potentiated when stimulation with both cytokines was performed. Stimulation with 
interleukin 4 and 5 also resulted in a slight upregulation of TLR2. TLR4 expression 
was not stimulated by the cytokines tested. As IFN gamma is a typical Th1 cytokine 
it may be responsible for the induction of TRL2 expression seen in psoriatic skin.
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Adjuvant activity of Gram-positive bacteria on grass pollen results in the induction 
of infl ammatory Th1 responses and reduced IL-10 production
Iris Bellinghausen1, Bettina König1, Wolf-Meinhard Becker2, Stephan Grabbe1, Arnd 
Petersen2, Joachim Saloga1 1Univ Medical Center, Dept of Dermatology, Mainz, 
Germany, 2Research Center Borstel, Clinical & Molec Allergology, Borstel, Germany
Recently, it has been established that pollen grains contain Th2-enhancing activities 
besides allergens. The aim of this study was to analyze whether pollen carry additional 
adjuvant factors like microbes and which immunologic effects they may exert. Timothy 
pollen grains were collected, disseminated on agar plates, and the growing microorganisms 
were cultivated and defi ned. Extracts were performed from selected microbes, physically 
inactivated, and used to determine their infl uence on immune cells. A complex mixture of 
bacteria and moulds was detected on grass pollen. Besides Gram-negative bacteria that are 
known to favor Th1-directed immune responses, molds were determined being sources of 
allergens themselves. Therefore, we focused on Gram-positive bacteria which were found 
in high numbers, e.g. Bacillus cereus, Bacillus subtilis, and Bacillus sphaericus. Contact 
of immature dendritic cells (DC) from grass pollen allergic donors with most of these 
inactivated bacteria induced their maturation similar to LPS as measured by fl ow cytometry 
and by their production of IL-6 and IL-12p40. When CD4+ T cells were stimulated with 
mature autologous DC, which had been pulsed with Gram-positive bacterial extracts 
plus grass pollen allergen, a reduced production of IL-4, IL-5 and IL-10 and an enhanced 
production of IFN-gamma was observed compared to T cells which were stimulated with 
allergen-pulsed DC alone, while proliferation was not affected. Our data indicate that 
grass pollen are colonized by several microorganisms that infl uence the immune response 
differently. Gram-positive bacterial components may serve as adjuvants by augmenting DC 
maturation and infl ammatory Th1 responses while reducing tolerogenic IL-10 production.
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TLR3 mediated cytotoxicity in keratinocytes is inhibited by co-stimulation with 
oligodeoxynucleotides
Øystein Grimstad, Brita Pukstad, Jørgen Stenvik, Terje Espevik Norwegian University 
of Science and Technology, Dept of Cancer Research and Molecular Medicine, 
Trondheim, Norway
TLR3 is an important sensor of viral infections and injury of self in keratinocytes, 
and modulation of TLR3-induced responses may be of clinical relevance. Stimulation 
with the TLR3-ligand polyI:C induces a toxic effect, shown by up-regulation of high 
mobility group protein B1 and reduced responses in a MTT- assay. We analyzed the 
proinfl ammatory and cytotoxic effects of polyI:C in keratinocytes, and found these to be 
TLR3 dependent, demonstrated by the use of siRNA for TLR3. Interestingly, co-stimulation 
with oligodeoxynucleotides inhibited all polyI:C induced effects. This inhibition was 
mediated by competition of endocytic uptake of polyI:C and oligodeoxynucleotides. 
With these fi ndings we see a promising potential for oligodeoxynucleotides 
in the treatment of both viral skin infections and infl ammatory skin disorders.
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Vaccination of Cutaneous T Cell Lymphoma with a Telomerase-specifi c Peptide
Christoph Schlapbach1, Daniel Yerly2, Werner J. Pichler2, Nikhil Yawalkar1, Robert 
E. Hunger1 1Department of Dermatology, University of Bern, Bern, Switzerland, 
2Department of Allergology, University of Bern, Bern, Switzerland
Primary cutaneous T-cell lymphoma (CTCL) is a non-Hodgkin lymphoma with slow 
progression to advanced stages despite therapy. The enzyme telomerase is critically 
involved in tumor cell immortalization. Due to its relatively specifi c expression in a 
broad range of tumor tissues, telomerase is an attractive target for tumor therapy. In 
this study, we present an immunotherapy approach to induce T cell specifi c immune 
responses against telomerase expressing cancer cells. CTCL patients were vaccinated 
with a telomerase specifi c peptide using GM-CSF as adjuvant. Objective tumor-
response was assessed by standardized whole body photography. The T cell response 
was assessed by proliferation assay and measurement of cytokine-production upon 
antigen stimulation. Immunohistochemistry and immunofl uorescence was performed 
on tumor tissue samples. 6 patients have completed the vaccination. 4 patients 
showed no objective tumor response and 2 patients even showed progression of the 
tumor lesions. Positive DTH reactions to the vaccinated peptide was detected in 2/6 
patients. A telomerase-specifi c T cell immune response was seen in 1/6 patient in 
vitro. In summary, no clinical response to the vaccination was detected although two 
patients showed a positive DTH reaction and a positive proliferative response was 
observed in one patient. It remains to be assessed whether the poor effi cacy of the 
vaccination may be due to the immunosuppressive environment observed in CTCL.
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Differential expression pattern of antimicrobial peptides in nasal mucosa and 
secretion
Regine Gläser1, Stefanie Dressel1, Jürgen Harder1, Martin Laudien2
1Dept. of Dermatology, Venerology and Allergology, University Hospital of Schleswig-
Holstein, Kiel, Germany, 2Department of Otorhinolaryngology, Head and Neck 
Surgery, University Hospital of Schleswig-Holstein, Kiel, Germany
The intact nasal barrier is a prerequisite for a functioning defense of the upper 
airway system. Antimicrobial peptides (AMP) are known to play an important role in 
maintaining barrier function and until now there is little available data about AMP 
in respect of nasal mucosa. This study was addressed to gain further insight into the 
differential AMP expression and secretion pattern according to defi ned anatomical 
regions of the nose. ELISA was applied to quantify concentrations of RNase-7, 
psoriasin, hBD-2, hBD-3 and LL-37 in nasal secretions of 20 healthy volunteers and 
immunohistochemistry was used to detect the local cellular sources of AMP in the 
vestibulum nasi and the mucosa of the turbinates. Expression of RNase 7 and psoriasin 
could be detected in all nasal secretions, whereas LL-37 was only detected in 16, 
hBD-2 in 5 and hBD-3 in 6 specimens. In the vestibulum nasi luminal cell layers could 
be demonstrated as cellular sources for hBD-3 and RNase 7, whereas psoriasin was 
found in all layers of the stratifi ed squamous epithelium. LL-37 was only detected in 
one sample. In turbinate biopsies hBD-3 and LL-37 were detectable in the epithelium, 
stroma cells and submucosal glands, RNase 7 was only present in submucosal glands. 
These data demonstrate that the epithelium of the nose contains a chemical defense 
shield through the expression and secretion of various AMP. Our results could be 
the base for further investigations, concerning infl ammatory and autoimmune 
diseases of the nose and paranasal sinus in respect of dysregulated AMP pattern.
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Production of LL-37 during herpes simplex virus types 2 infection in human 
keratinocytes enhances HIV susceptibility in Langerhans cells, but not in Dendritic 
cells
Youichi Ogawa, Tatsuyoshi Kawamura, Shinji Shimada University of Yamanashi, 
Yamanashi, Japan
Recent studies have shown that patients who were infected with HSV-2 had three 
times the risk of acquiring HIV. Since Langerhans cells (LC) were thought as initial 
cellular targets in sexual transmission of HIV, we tested whether HSV-2 affected HIV 
susceptibility in LC. To assess the direct effects, monocyte-derived LC (mLC) were 
exposed with HSV-2 before HIV infection. HIV infection was analyzed by HIV p24 
intracellular staining. Interestingly, HSV-2 did not directly affect HIV susceptibility 
in mLC. As for the indirect effects, we tested whether antimicrobial peptides 
(AMPs), including αDefensin 5, 6 and βDefensin 1, 2, 3, 4 and LL-37 affected HIV 
susceptibility in LC because it has been reported AMPs affected HIV susceptibility. 
Surprisingly, only LL-37 dramatically enhanced HIV susceptibility in mLC, whereas 
other AMPs did not. On the other hand, HSV-2 infection in keratinocytes increased 
the expression of vitamin D receptor and the production of LL-37. In contrast, LL-
37 decreased HIV susceptibility in monocyte-derived DC (mDC). To assess the 
physiological effects, we used ex vivo skin explant model. Epithelial sheets were 
incubated with HSV-2 before HIV infection, and then fl oated. The emigrating LC 
from HSV-2 treated epithelial sheets signifi cantly enhanced HIV infection compared 
with LC from non treated epithelial sheets.Regarding mechanisms, LL-37 induced 
signifi cant up-regulation of cell surface CD4 and CCR5 on mLC, whereas it induced 
down-regulation of cell surface DC-sign on mDC. Furthermore, in mLC, LL-37 
signifi cantly decreased an innate HIV suppressor factor, TRIM5α. Given these data, 
LL-37 produced from HSV-2 infected keratinocytes enhances HIV susceptibility in LC.
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UV-induced tolerance to a contact allergen is impaired in polymorphic light eruption
Leena M. Koulu, Jarmo K. Laihia, Hanna-Helena Peltoniemi, Christer T. Jansén
Department of Dermatology, University of Turku, Turku, Finland
Polymorphic light eruption (PLE) is a common skin disorder provoked by exposure 
to ultraviolet radiation (UVR). Its clinical symptoms resemble those of a contact 
allergic reaction. PLE is generally considered a T-cell-mediated autoimmune reaction 
towards a yet unidentifi ed antigen formed in the UVR-exposed skin. Predisposition 
to such an immune reaction may result from aberrant epitope formation, increased 
immune reactivity to a universal epitope, or from diminished propensity to UVR-
induced immunosuppression or to the induction of tolerance. In a study comprising 
a total of 24 PLE patients and 24 healthy sex- and age-matched controls, we found 
that both groups demonstrated similar immunosuppression of contact sensitization 
to diphenylcyclopropenone by prior exposure to solar-simulating UVR. However, 
only one out of 13 PLE patients (8%) vs. 6 out of 11 controls (55%) that had been 
immunosuppressed by UVR exhibited a state of immunotolerance towards the 
same allergen after one year (p=0.023). We conclude that the impaired propensity 
to UVR-induced allergen-specifi c immunotolerance may promote recurrent PLE.
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The caspase-5 expression is upregulated in psoriasis
Maria Luise Salskov-Iversen, Claus Johansen, Knud Kragballe, Lars Iversen
Aarhus University Hospital, Aarhus, Denmark
Caspase-5 belongs to the family of infl ammatory caspases, which activates the 
pro-infl ammatory cytokines IL-1b and IL-18.  The purpose of this study was to: 
1) characterise caspase-5 expression in psoriatic skin, 2) investigate caspase-5 
mRNA induction in cell cultures, 3)investigate the signalling pathways involved in 
caspase-5 mRNA induction.  RNA and protein was purifi ed from paired biopsies 
from nonlesional and lesional psoriatic skin and used for RT-PCR and Western 
blotting. Cultured human keratinocytes and PBMC´s from healthy donors were 
stimulated with TNF-α, IFN-γ, IL-17a, IL-4 or LPS. In other experiments, PBMC´s 
were pre-incubated 45 minutes with inhibitors of the p38 MAPK or NF-kB signalling-
pathways before LPS stimulation.  We found a 20.0 fold upregulation (p<0.05) of 
caspase-5 mRNA and a 1.4 fold increase in caspase-5 protein (p<0.05) in lesional 
psoriatic skin compared with nonlesional skin. In in vitro PBMC cultures, LPS 
induced a 20 fold (p<0.05) increase in caspase-5 mRNA after 12 hours stimulation, 
whereas IFN-γ induced a 3.6 fold (p<0.05) increase in both kerationcyte and PBMC 
cultures. In PBMC´s, pre-incubation with a NF-kB-inhibitor signifi cantly reduced 
the stimulatory effect of LPS.  In conclusion, both caspase-5 mRNA and protein are 
signifi cantly upregulated in lesional psoriatic skin compared with nonlesional skin. 
In vitro studies of keratinocytes and PBMC´s reveal that IFN-γ induces caspase-5 
mRNA in both cultures, and that caspase-5 mRNA can be induced through the 
NF-kB signalling pathway. These fi ndings suggest, that both keratinocytes and 
infi ltrating leucocytes contribute to the maintenance of the positive feedback-loop 
between IFN-γ and caspase-activated proinfl ammatory cytokines found in psoriasis.
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Frequency and function of CD4+CD25+FOXP3+ regulatory T cells in atopic dermatitis
Krisztián Gáspár1,2, Sándor Baráth3,4, Georgina Nagy1,2, Edit Gyimesi3,4, Sándor Sipka3,4, 
Margit Zeher3, Éva Remenyik1, Andrea Szegedi1,2 1Department of Dermatology, 
Debrecen, Hungary, 2Department of Dermatological Allergology, Debrecen, Hungary, 
33rd Department of Internal Medicine, Debrecen, Hungary, 4Regional Immunology 
Laboratory, Debrecen, Hungary
Atopic dermatitis (AD) is a chronic infl ammatory skin disease resulted partly of type I and 
type IV hypersensitivity reactions triggered by T helper 2 (Th2) cells. The explanations behind 
the Th2 dominance in the disease are still controversial. We addressed the question whether 
the Th2 cell domination is associated with a reduction and/or functional impairment of 
CD4+CD25+FOXP3+ regulatory T cells (Treg) essential for the maintenance of Th1- Th2 
balance. Peripheral blood of AD patients with severe clinical symptoms and extremely high 
serum IgE levels (>2000 U/ml) were investigated. Flow cytometry was utilised to determine 
the percentage of CD4+CD25brightFOXP3+ Tregs and CLA+CD4+CD25brightFOXP3+ Tregs in the 
samples of AD patients and healthy controls. For detection of suppressor activity of CD4+CD25+ 
Tregs, they were cocultured with CD4+CD25- effector T cells, and for T cell stimulation, 
anti-CD3/CD28 microbeads were applied alone or with Staphylococcus Enterotoxin B 
(SEB). The proliferation of the cells was measured by EZ4U colorimetric cell proliferation 
assay. Signifi cantly increased number of CD4+CD25brightFOXP3+ Tregs and also of CLA+ 
CD4+CD25brightFOXP3+ Tregs were found in the peripheral blood of AD patients compared to 
healthy individuals. The degree of suppressor activity of CD4+CD25+ regulatory T cells were 
decreased in both anti-CD3/CD28 and SEB stimulated subgroups compared to control. Our 
data suggest coincidently with the literature that the pathogenesis of AD cannot be explained 
with the absence of CD4+CD25+FOXP3+ Treg cells, moreover the number of these cells is 
increased in the peripheral blood. At the same time the function of Tregs may be impaired.
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Immature 6-sulfo LacNAc (slan)-expressing dendritic cells display a unique capacity 
of Fc gamma RIII-mediated binding of immune complexes
Thomas Döbel1, Jana Babatz2, Katja Rückert2, Anja Hänsel1, Marc Schmitz2, Ernst 
Peter Rieber2, Knut Schäkel1
1Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany, 
2Department of Immunology, Faculty of Medicine of the Technical University of 
Dresden, Dresden, Germany
The ability of immune complexes to induce potent humoral immune responses has 
long been known. However, to our knowledge no comparative data of the capacity 
of immune complex binding of different dendritic cell (DC) subtypes have been 
generated. We have previously described 6-sulfo-LacNAc expressing DCs (slanDC) 
within human blood which stand out by their high level expression of the low affi nity 
Fc gamma receptor III (CD16). SlanDC are highly proinfl ammatory, serve as the major 
and early source of IL-12, IL-1 beta and TNF-alpha and can become infl ammatory 
dermal dendritic cells in psoriasis. Comparative binding studies of IgG complexes 
revealed a much higher capacity of slanDC to bind immune complexes compared 
to CD1c+ DCs, pDCs and monocytes. Blocking experiments further revealed that the 
selective expression of CD16 by slanDC enabled this outstanding capacity. CD16 
also proved critical for slanDC to phagocytose IgG-opsonized sheep red blood cells. 
Finally, a higher proliferation of specifi c T cells was observed when antigen was 
targeted to CD16 on slanDC. During maturation expression of CD16 is rapidly lost 
by the action of metalloproteinases while maturation markers such as CD86, CD80, 
CD83 and MHC class II are upregulated. Taken together the expression of CD16 
equips immature slanDC with a unique capacity to capture immune complexes for the 
subsequent presentation of antigen to T cells. Given the fact that slanDC can become 
infl ammatory dermal DCs, the high capacity to capture immune complexes adds an 
important function to these cells in terms of bridging innate and adaptive immunity.
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Analysis of interleukin-7 receptor-a gene single nucleotide polymorphism in 
Behcet‘s diseases
Akiko Hirofuji1, Koichiro Nakamura1, Tetsuya Tsuchida1, Akira Meguro2, Nobuhisa 
Mizuki2 1Saitama Medical University, Saitama, Japan, 2Yokohama City University, 
Yokohama, Japan
Behcet disease (BD) is an infl ammatory skin disease affecting various organs. 
Interleukin-7 (IL-7) functions as a T cell proliferation molecule. The association of 
IL-7 receptor (IL-7R) a single nucleotide polymorphism (SNP) has been reported 
in several diseases.To elucidate the participation of IL-7Ra gene in BD, we 
investigated IL-7Ra SNP frequencies of BD patients and healthy controls. There 
were no signifi cant differences in the IL-7R (-1085) SNP genotype and allele 
frequencies between BD patients and healthy controls. There was a signifi cant 
difference in the IL-7Ra (-449) SNP genotype frequencies between BD patients 
and controls. No signifi cant relationships were observed between IL-7Ra (-1085, 
-449) SNP genotype frequencies in patients with or without skin involvement, 
arthralgia, oral aphtha, genital ulcers, and between complete and incomplete 
types of BD, respectively. However, a signifi cant difference was observed in the 
IL-7Ra (-1085) SNP genotype frequencies between ocular involvement and non-
involvement (p<0.001). These results suggest that IL-7Ra may therefore be associated 
with the pathogenesis of BD in terms of ocular involvement. Further experiments 
will be required to elucidate the role of IL-7 signaling in the pathogenesis of BD. 
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Induction of allergen tolerance in birch pollen allergic patients by specifi c 
immunotherapy is established by differentiated cellular and humoral immune 
responses
Christian Möbs, Lea Mayer, Caroline Slotosch, Michael Hertl, Wolfgang Pfützner
Philipps-University, Marburg, Germany
Clinical effi cacy of allergen specifi c immunotherapy (SIT) is well accepted; however, 
the underlying immune mechanisms leading to allergen tolerance are still focus of 
intensive research. In a long-term study we characterized allergen-specifi c T cell 
frequencies and serum antibody levels in birch pollen allergic patients (n=15) receiving 
SIT over a 3-year period. Peripheral blood T cell subsets were quantifi ed by ELISPOT 
(Th2, Th1, type 1 regulatory T (Tr1) cells) or FACS analysis (CD4+CD25+CD127low 
regulatory T cells). Finally, birch pollen-specifi c IgE and IgG4 serum concentrations 
were determined. Interestingly, results showed distinguished immune reaction 
patterns at different time points of the 3-year treatment. During the induction phase, 
SIT-treated allergic subjects developed an increase of allergen-specifi c Tr1 cells, 
which was maintained over the fi rst year of SIT and led to a decreased Th2/Tr1-
ratio. In contrast, the number of CD4+CD25+CD127low regulatory T cells remained 
unchanged. However, allergen-induced increases of the different Bet v 1-specifi c T 
cell populations ceased to appear in the subsequent course of SIT. Of note, while 
there were no substantial alterations in Bet v 1-specifi c IgE serum levels, a progressive 
increase of allergen-specifi c IgG4 antibody concentrations was seen over the whole 
observation period. In summary, we here show that SIT is accompanied by a transient 
increase of allergen-specifi c Tr1 cells, followed by reduced numbers of both Bet 
v 1-specifi c Th2 and Tr1 cells, while allergen-specifi c ‘blocking’ IgG4 antibodies 
continue to rise. These data suggest a differential impact of cellular and humoral 
immune parameters on the development and preservation of allergen tolerance.
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Analysis of the frequency of regulatory T cells in recovered SJS/TEN patients
Naoya Yoshioka, Riichiro Abe, Junko Murata, Nao Saito, Yasuyuki Fujita, Daichi 
Hoshina, Hiroshi Shimizu Hokkaido University Graduate School of Medicine, 
Sapporo, Japan
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-
threatening adverse drug reactions. SJS/TEN is thought to be mediated by 
imuunological responses including cytotoxic T cells, and soluble factors, such 
as soluble Fas ligand and granulysin. Moreover, previous papers have reported a 
relationship with SJS/TEN and regulatory T cells (Treg). Treg expresses chemokine 
receptors required for skin homing, such as CLA and CCR4. Thus, we aimed to 
investigate the frequency of Treg and changes in Treg surface markers in SJS/TEN. In 
this study, SJS/TEN patients and healthy controls were included. The expression of 
surface markers (CCR4, CCR5, CCR6, CCR10, CLA, CTLA-4 and CD45RA) in Treg 
in peripheral blood was analyzed using FACS. The frequency of Treg (CD4+CD25high) 
cells in CD4+ T cells from patients with SJS/TEN (6.47±3.53%, n=6) were 
signifi cantly increased from those of healthy subjects (1.47±1.70%, n=12)(p<0.01). 
However, there was no difference in surface markers expression between SJS/TEN 
and healthy control. Previous studies reported that the function and frequency in 
Treg on TEN at the resolution stage was normal. However, our results showed the 
frequency of Treg with SJS/TEN at the resolution stage was elevated in comparison 
with healthy control group. Our data also, suggested that the frequency of Treg in 
recovered SJS/TEN patients could increase to compensate for their declined function.
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Differential expression of interleukin-1 receptors in normal and psoriatic T 
lymphocytes
Ferenc Kovács-Sólyom1, Judit Prihoda1, Lajos Kemény1,2, Rolland Gyulai1 1Dept of 
Dermatology & Allergology, Univ of Szeged, Szeged, Hungary, 2Dermatological 
Research Group of the Hungarian Acad of Sciences, University of Szeged, Hungary
According to our previous results regulatory T cells are functionally defective in psoriasis, 
however, the reasons are unknown. In this study we investigated the possible role of 
interleukin-1 receptors in psoriasis pathogenesis, with emphasis on regulatory and effector 
T cells. Effector (CD4+CD25-, Teff) and regulatory (CD4+CD25+CD127-, Treg) T cells 
were isolated from normal and psoriatic blood. Expression of type 1 (signal-transmitting) 
and type 2 (decoy) interleukin-1 receptors, and IL-1R antagonist (IL-1RN) mRNAs were 
determined by real-time RT-PCR. Cell surface, intracellular and soluble protein expression 
was investigated by fl ow cytometry and ELISA. Upon CD3/CD28 activation, IL-1R1 mRNA 
expression was increased in normal Teff and Treg. Interestingly, while CD3/CD28 activation 
did not infl uence IL-1R1 expression in psoriatic Treg, activation induced stronger IL-1R1 
mRNA expression in psoriatic Teff compared to normals. Expression of decoy receptor (IL-
1R2 and soluble IL-1R2) mRNA was elevated in activated normal Teff and Treg. Psoriatic Teff 
and Treg, however, more rapidly and more intensively increased their IL-1R2 and sIL-1R2 
expression. Expression of IL-1 receptor antagonist (IL-1RN) was moderately increased upon 
activation in both normal effector and regulatory T cells. However, expression was markedly 
downregulated in psoriatic Treg, and highly activated in psoriatic effector cells. IL-1R2 protein 
expression was constant in normal cells, but signifi cantly increased in activated psoriatic 
effector cells compared to regulatory T cells. Our data suggest that differential expression 
of genes in the interleukin-1 pathway in normal and psoriatic T lymphocytes may underline 
some functional differences in these cells, and may have a role in psoriasis pathogenesis.
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The mandatory role of PI3-kinase pathway in IL-4 and IL-13 production by basophils 
stimulated with IgE and antigen
Jun-ichi Sakabe1, Etsushi Kuroda2, Motonobu Nakamura1, Yoshiki Tokura1 1Department 
of Dermatology, University of Occupational and Environmental Health, Kitakyushu, 
Japan, 2Department of Immunology and Parasitology, University of Occupational and 
Environmental Health, Kitakyushu, Japan
Basophils are potent IL-4-producing cells and may therefore contribute to the process 
of polarizing immune responses and allergic skin responses. We have shown that the 
PI3-kinase pathway is a crucial signal pathway for IL-4 production by IL-3-stimulated 
basophils. Stimulation with IgE + antigen (Ag) also activates basophils to produce 
IL-4 and is thought to activate a signal pathway different from IL-3 stimulation. In this 
study, we investigated whether PI3-kinase pathway regulated IgE+Ag-induced IL-4 
production by murine basophils in vitro and in vivo experimental systems. Freshly 
isolated and cultured murine basophils were enriched for CD49b (DX-5)-positive 
cells and CD117 (c-kit)-negative cells, respectively, with auto-MACS. The enriched 
cells produced substantial levels of IL-4 in response to IgE + Ag. Treatment of basophils 
with PI3-kinase inhibitor, LY294002 and rapamycin or cyclosporine A signifi cantly 
inhibited IL-4 release from IgE + Ag-stimulated basophils. Interestingly, these signal 
inhibitors also suppressed IL-13 production in basophils. Mice sensitized with i.v. 
injection of TNP-specifi c IgE displayed the ear swelling after s.c. administeration of 
TNP-OVA. Rapamycin and  cyclosporin A, which strongly suppressed IL-4 and IL-
13 production by basophils, downmodulated the ear swelling. Our results indicate 
that PI3-kinase signaling is a critical pathway in both IL-3- and IgE+Ag-induced IL-4 
production by basophils, and suggest that IgE-mediated allergic infl ammation might 
be controlled by PI3-kinase signaling via the induction of IL-4 and IL-13 production.
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IL-20, IL-21 and p40: Potential Biomarkers of Treatment Response for Ustekinumab
Anne Gedebjerg, Claus Johansen, Knud Kragballe, Lars Iversen Aarhus University 
Hospital, Aarhus, Denmark
Biologic agents targeting specifi c cytokines in the infl ammatory cascade are effective 
in the treatment of psoriasis.The purpose of this study was to investigate the molecular 
effects of the biologic agent ustekinumab in lesional psoriatic skin and to identify 
potential biomarkers of treatment response for ustekinumab. Biopsies from 12 
patients with psoriasis were examined before and 4, 28, and 112 days after the onset 
of ustekinumab therapy. Cytokine mRNA expression was measured by quantitative 
reverse transcription-polymerase chain reaction. The expression of the following 
genes were investigated: p40, p19, IL-17A, IL-17C, IL-20, IL-21, IL-22, IL-1β, IL-6, 
IL-8, TNF-α, IFN-α, β-defensin, IRF-7, IL-23R, and IL-12Rβ1. The clinical changes 
were detected by Psoriasis Area and Severity Index score. At baseline, the mean PASI 
score for all patients was 15.2 and there was no difference between responders and 
non-responders. Six patients were clinical responders with a mean baseline PASI 
score of 17.2 and a mean percent improvement of 91.1 (range 71.5-100; SEM= 3.1) 
at day 112. No or little change in PASI was seen in the non-responders. At baseline 
IL-20, IL-21, and p40 mRNA expression in lesional psoriatic skin was signifi cantly 
upregulated by a factor 3, 2, and 2 respectively, in non-responders compared 
with responders. No signifi cant differences were seen at treatment start in the 
expression of the other genes studied between responders and non-responders This 
study suggests p40, IL-20 and IL-21 as potential biomarkers of treatment response 
for ustekinumab based on their signifi cantly upregulation among non-responders.
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IFN-γ induces bulge immunoprivilege collapse and may cause epithelial stem cell 
exhaust
Katja C Meyer1, Stephan Tiede1, Matthew J Harries2, Jennifer E Kloepper1, Ralf Paus1,3
1Dept of Dermatology, Univ of Lübeck, Germany, 2Dermatological Sciences, The Univ 
of Manchester, UK, 3School of Translational Medicine, University of Manchester, UK
The hair follicle (HF) bulge immunoprivilege (IP) may serve to protect the vital epithelial HF stem 
cells (HFSCs) from (auto)-immune-mediated attacks, ensuring ongoing cyclic HF-regeneration. 
Primary cicatricial alopecias (PCA) are infl ammatory hair disorders that result in HF-destruction 
as a consequence of irreversible HFSC damage and depletion. Therefore, we investigated bulge 
IP-characteristics of the HFSC-rich HF-bulge by quantitative immunohistochemistry, qPCR and 
microarray-analysis. These studies revealed high expression of the immunoinhibitory surface 
molecule CD200, of proopiomelanocortin, indoleamine-2,3-deoxygenase, HLA-E, and very low 
expression of MHC-II and b2-microglobulin, on normal human bulge HFSC. This indicates that these 
HFSCs indeed enjoy relative IP in-situ. Immunohistochemistry of paired biopsies from lesional and 
non-lesional scalp skin from PCA-patients, suggested IP-collapse accompanied by downregulation 
of K15 and CD200 and upregulation of b2-microglobulin, MHC-I and -II, and vimentin expression 
in the bulge of PCA specimens. This was confi rmed by microarray analysis. Therefore, we next 
assessed the effects of the recognized IP-collapse-inducing cytokine, IFN-γ, on human cytokeratin-
15-(K15)-promoter-driven GFP+HFSCs. IFN-γ fi rst up-regulated K15 and K15-promotor-driven 
GFP expression on the gene and protein level in-situ and in-vitro. Subsequently, however, IFN-γ 
decreased proliferation, enhanced sensitivity to cytotoxic agents, impaired colony-forming-
capacity of K15-GFP+ human HFSCs, induced a fi broblastoid morphology, and CD68 expression, 
and downregulated the HFSC markers K15, b1-integrin and CD200. These fi ndings suggest that 
IFN-γ can induce HFSC-depletion in PCA by promoting progenitor cell differentiation and/or 
epithelial-mesenchymal-transition (EMT), besides the induction of bulge IP collapse. Together, these 
events may lead to cytokine-induced HFSC exhaust as a key element in the pathobiology of PCA.
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Expression and function of the natural cytotoxicity receptor NKp46 on circulating 
malignant CD4+ T lymphocytes of Sézary syndrome patients
Natacha Remtoula1, Simona Sivori3, Martine Bagot1,2, Alessandro Moretta3, Armand 
Bensussan1, Anne Marie-Cardine1 1INSERM U976, Paris, France, 2Dermatology 
Department, Saint Louis Hospital, Paris, France, 3Genova University, Experimental 
Medicine Department, Genova, Italy
The natural cytotoxicity receptors NKp30, NKp44, and NKp46 were identifi ed 
as activating receptors mainly expressed by NK lymphocytes. Here we show that 
peripheral blood malignant CD4+ T lymphocytes from patients with Sézary syndrome, 
an aggressive form of cutaneous T cell lymphoma, express NKp46 at their cell surface. 
Although NKp46 does not behave as an independent functional receptor, its engagement 
provides a strong inhibiting signal on the malignant T lymphocyte CD3-induced 
proliferation. We show that this inhibition is correlated to a decreased phosphorylation 
of the CD3ζ chain associated to NKp46 and/or the TCR/CD3 complexes. Our results 
reveal that, in addition to KIR3DL2/CD158k expression, NKp46 could represent an 
additional marker on the circulating malignant T lymphocytes of Sézary patients, and 
that its aberrant expression could participate to the pathophysiology of the disease. 
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The contact allergen 2,4-dinitrochlorobenzene does not affect microRNAs’ -155, 
-125b and -146a expression in skin explants, keratinocytes and monocyte derived 
dendritic cells
Eirini Vavatsikou, Chris Pickard, Tilman Sanchez-Elsner, Eugene Healy
University of Southampton, Southampton, United Kingdom
MicroRNAs are small non-protein coding RNA-transcripts that control gene expression in 
a post-transcriptional manner, affecting several cellular processes including development, 
differentiation and disease. MicroRNAs are crucially important in the immune system 
and their deregulation leads to infl ammatory diseases. Recent evidence showed miR-
155, miR-146a and miR125b to be deregulated in infl amed skin. In particular miR-155 
is critical in antigen presentation by dendritic cells; miR-146a is transcribed by NFkappaB 
and miR-125b silences TNF-alpha. Thus, these microRNAs are implicated in processes 
that take place in the sensitization process of allergic contact dermatitis (ACD), when 
the Langerhans cells (LC) migrate from the epidermis to present the hapten to T-cells. In 
this project, these microRNAs’ expression profi les were investigated using an ACD model 
which involved the application of the allergen 2,4-dinitrochlorobenzene (DNCB) onto 
skin tissue ex vivo, human primary keratinocytes and monocyte derived dendritic cells 
(MoDCs) in vitro, in order to elucidate their role in ACD initiation. Migration experiments 
showed consistent LC depletion after DNCB application (N=8). However, qPCR data 
from DNCB treated skin explants showed variable expression of miR-155, -125b and 
-146a (31.9±55.5, 2.3±1.3, -1.2±2.5 fold difference respectively). In DNCB stimulated 
MoDCs, the microRNAs expression was variable  between different volunteers (N=8) and 
exposure time (6, 24 and 48h). Primary human keratinocytes expressed the aforementioned 
microRNAs but failed to show any signifi cant modulation in their expression (-0.7±1.6 miR-
155, -0.01±2.6 miR-125b, 2.9±4.0 miR-146a). In conclusion, this data shows that miR-
155, miR-125b and miR-146a don’t play an important role in skin sensitization to DNCB.
250
The serum- and glucocorticoid-inducible kinase 1 is critical for early but dispensable 
for delayed type mast cell responses
F Wölbing1, M Sobiesiak2, E Shumilina2, S Kaesler1, R.S. Lam2, N. Matzner2, I.M. 
Zemtsova2, A. Lupescu2, N. Zahir2, D. Kuhl3, M. Schaller1, F. Lang2, T. Biedermann1
1Dermatology, Eberhard Karls University of Tübingen, Germany, 2Physiology, Eberhard 
Karls University of Tübingen, Germany, 3Center for Molecular & Cellular Cognition, 
Medical Center Hamburg-Eppendorf, Hamburg, Germany
Mast cell activation determines IgE mediated immediate type allergic reactions and also some 
prototypic T cell mediated contact-hypersensitivity-responses (CHS). It was still undefi ned whether 
early and delayed mast cell activation are consecutive events or independently regulated. Among 
others, crosslinking of FcεRI receptors activates phosphoinositol-3 (PI3)-kinase. PI3-kinase is known 
to activate the serum- and glucocorticoid-inducible-kinase 1 (SGK1). We aimed to investigate the 
role of SGK1 for early and delayed mast cell responses. SGK1 knockout (sgk1-/-) and wild-type mice 
were sensitized with DNP-specifi c-IgE and challenged with DNP to elicit anaphylaxis. Anaphylaxis 
with a fast decline in body temperature (1,74±0,41°C) was detected in sgk1+/+ mice while sgk1-/- 
mice showed no anaphylactic reaction. Degranulation as detected by release of β-hexosaminidase 
was signifi cantly reduced in bone marrow derived mast cells (BMMC) from sgk1-/- mice. In mast 
cell dependent CHS to TNCB the ear swelling was signifi cantly impaired in sgk1-/- only during the 
early response (4 and 8 hours) whereas no difference in CHS responses was detected at 24 hours. In 
agreement with these data we could show that SGK1 is crucial for early cytokine release, but not for 
delayed type cytokine secretion by BMMC. In conclusion, our data demonstrate for the fi rst time that 
consecutive early and delayed type mast cell activation pathways can be regulated independently 
even following the same stimulus. Based on this specifi city, targeting SGK1 may be highly promising 
to treat immediate type allergic responses while sparing critical delayed type mast cell responses.
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Streptococcal extract-induced activation of CLA+ T cells and epidermal cells 
coculture in psoriasis: gene expression, protein expression and in vivo hyperplasia 
capacity
Marta Ferran1, Ana B Galvan1, Catalina Rincon2, Ana M Giménez-Arnau1, Ramon 
M Pujol1, Luis F Santamaria-Babi1,2 1Department of Dermatology. Hospital del Mar-
Institut Municipal d’Investigació Mèdica (IMIM), Barcelona, Spain, 2Biomedical 
Research Institute (IRB), Barcelona, Spain
Psoriasis is associated with streptococcal throat infections and increased occurrence of 
such infections in patients. Up to know it has not been clarifi ed whether Streptoccocal 
extract can induce T-cell dependent keratinocyte activation, Th17/Th22 cytokine 
production and in vivo epidermal hyperplasia in psoriasis. We have generated a coculture 
system comprising circulating CLA+/CLA- memory T cells and autologous epidermal 
cells to test streptococcal extract activation activity in patients with psoriasis and 
healthy individuals. The results show for the fi rst time that streptococcal extract induces 
a strong activation of the autologous coculture of circulating CLA+ T cells together with 
epidermal cells in cells from psoriatic patients. No activity was present with CLA negative 
cells from psoriatic patients or in healthy subjects. Streptococcal extract induced IL-17, 
IL-22, IP-10, IL-8, IFN-g, and ICAM-1 gene expression only with psoriatic CLA+ T cells 
and autologous epidermal cells, either from lesional, and interestingly from non-lesional 
psoriatic skin. Gene expression was confi rmed at protein level. Coculture supernatants 
of CLA+ T cells and epidermal cells activated with extract induced signifi cant epidermal 
hyperplasia and lymphocyte infi ltration when injected intradermally into mouse skin in 
vivo, as well as keratins 16 and 6 at the gene expression. The study shows that Streptococal 
extract preferentially induces keratinocyte and CLA+ T cell (Th1, Th17, Th22) activation 
and in vivo epidermal hyperplasia This ex vivo approach might contribute to clarify the 
role of streptoccocal infections in early molecular mechanisms of psoriasis development.
252
Systemic IL-4 treatment suppresses IL-23 and abrogates infl ammatory responses in 
T cell mediated delayed type hypersensitivity
Emmanuella Guenova, Wolfram Hoetzenecker, Sebastian Hoerber, Yulia Böttcher, 
Anna Teske, Thomas Volz, Martin Schaller, Martin Röcken, Tilo Biedermann
Department of Dermatology, Eberhard Karls University, Tuebingen, Germany
Over decades, the scientifi c debate on T-cell mediated delayed-type hypersensitivity 
reactions (DTHR) was focused on Th1/Tc1 and Th2/Tc2 cells. IFN-γ producing Th1 
cells were considered to be the primary effector cells and IL-4 producing Th2 cells 
to be the counter-regulator of DTHR responses. Indeed, systemic IL-4 treatment 
was shown to reverse established DTHR. More recently, experimental evidence 
on the role of Th17/Tc17 in DTHR increased, but the role of the Th17 sustaining 
IL-23, especially in the context of successful IL-4 treatment, remained elusive. We 
used a model of TNCB-induced DTHR. TNCB challenge in sensitized mice induced 
ear swelling and skin infl ammation. Interestingly, the infl ammatory infi ltrate was 
dominated by both Th17 cell-associated IL-23 and IL-17. Systemic IL-4 treatment of 
these mice resulted in reduction of ear swelling and normalized skin morphology. 
Moreover, we found that IL-4 therapy selectively suppressed cutaneous IL23A 
mRNA expression. In agreement with the critical role of IL-23 in sustaining Th17 
responses, effi cient IL-4 treatment also suppressed IL17A mRNA in mouse ears. To 
further analyze the selective suppression of IL-23 by IL-4, bone marrow-derived 
dendritic cells (BMDC) were allowed to mature in an IL-4 dominated milieu. In these 
BMDC IL-4 suppressed IL-23 while promoting up regulation of IL-12. Unraveling 
the molecular mechanism, we found that IL-4 exerts its regulatory effect in a STAT6 
dependent manner. Our fi ndings not only assign cutaneous DTHR as IL-23 and 
Th17 dependent. We also demonstrate a novel strategy to selectively target IL-23, 
which might be benefi cial in the treatment of Th17-mediated autoimmune diseases.
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Hidradenitis suppurativa and innate immunity: a target for zinc gluconate
Anabelle Brocard2, Anne-Chantal Knol1, Hélène Aubert-Wastiaux1,2, Eric Blouin4, 
Dominique Moyse3, Gérard Guillet5, Fabienne Léonard6, Amir Khammari2,1, Brigitte 
Dréno2,1 1INSERM, U892, Nantes, Nantes, France, 2Unité de Cancéro-Dermatologie-
CIC biothérapie INSERM0503, CHU de Nantes, Nantes, France, 3Statisticien 
consultant, La Possonnière, France, 4Laboratoires Labcatal, Montrouge, France, 
5Service de dermatologie, CHR Poitiers, Poitiers, France, 6Service de dermatologie, 
clinique Courlancy, Reims, France
Hidradenitis suppurariva (HS) is a chronic, suppurative, infl ammatory skin disease that 
affects mainly apocrine glands. Our hypothesis is that the development of nodules could be 
related to abnormal innate immunity at the site of nodules. Twelve patients with HS (Hurley 
stage I, II) with a minimum of two closed nodules in usual sites and a disease progressing 
for at least 6 months were included in the study. Two biopsies were performed: on a closed 
infl ammatory nodule and healthy adjoining skin. The patients were then treated for 3 months 
with zinc (Rubozinc) dose of 90 mg daily (modulator of innate immunity). A new biopsy was 
then performed on the same nodule. Two biopsies from abdominal plasties were used as 
controls. The innate immunity markers (TLR2, 3, 4, 7, 9, ICAM1, IL-6, TNF-a, IL-10, a-MSH, 
TGF-b, b-defensins 2 and 4, IGF-1) were studied by immunohistochemistry. We observed 
a signifi cant decrease in the expression of the innate immunity markers in healthy skin and 
more strongly in infl ammatory nodules of HS compared with control skins, associated with 
an increase in IL-10. After zinc treatment, we noted a signifi cant increase in the expression of 
all the innate immunity markers with more than 50% regression of the infl ammatory lesions 
in 7 patients. Our study demonstrates for the fi rst time that a defi cit of innate immunity in 
the usual sites of HS could explain the development of chronic infl ammatory nodules in this 
illness. These abnormalities are partially reversed by zinc with a partial regression of nodules.
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IL-1F5, F6, F8, and F9: a novel IL-1 family signaling system that is active in psoriasis 
and promotes keratinocyte antimicrobial peptide expression
Andrew Johnston1, Xianying Xing1, Andrew Guzman1, Marybeth Riblett1, Candace 
Matheny2, Nicole Ward2, John Voorhees1, James Elder1, Johann Gudjonsson1
1Dermatology, University of Michigan, Ann Arbor, MI, United States, 2Dermatology, 
Case Western Reserve University, Cleveland, OH, United States
Four new members of the IL-1 family have been identifi ed: pro-infl ammatory IL-1F6, -F8 and 
-F9 and the IL-1R6(RP2) receptor antagonist IL-1F5. These constitute a novel IL-1 signaling 
system that is poorly understood in skin. Because over-expression of IL-1F6 in IL-1F5 knockout 
mice leads to a psoriasiform phenotype and these two cytokines are over-expressed in psoriatic 
skin, we hypothesized that these IL-1 members play key roles in psoriasis pathogenesis. To test 
our hypothesis, we assessed expression of all IL-1 cytokines in healthy control (NN), uninvolved 
psoriasis (PN) and psoriasis plaque (PP) skin using QRT-PCR. Expression of IL-1F5, -F6, -F8, and 
-F9 were increased 2-3 orders of magnitude in PP vs. PN skin (p<0.001,all), which was supported 
immunohistologically. Moreover, treatment of psoriasis with etanercept led to signifi cantly 
decreased IL1-1F5(p=0.009), -F6(p<0.0001), -F8(p<0.0001) and -F9(p<0.0001) mRNAs, 
concomitant with clinical improvement. Similarly increased IL-1F5, -F6, -F8 and -F9 was seen 
in the involved skin of KC-Tie2 mice. Suggestive of importance in the epidermal compartment, 
treatment of normal human keratinocytes (NHK) with IL-1α and TNF-α induced 4 to 10-fold 
increases in IL-1F5, -F6, -F8, and -F9 mRNA. The effect of IL-1F8 on the expression of antimicrobial 
peptides by NHK and reconstituted human epidermis (RHE) was striking. Treatment of RHE with 
IL-1F8 increased mRNA expression of HBD2 (18-fold,p=0.0001), HBD3 (2.3-fold,p=0.024) 
and CAMP(5.6-fold,p=0.03) and protein secretion of HBD2 (6-fold,p=0.008) and HBD3 
(2.6-fold,p=0.007). Taken together, our data suggest important roles for these novel cytokines in the 
pathogenesis of psoriasis and identify these peptides as potential targets for antipsoriatic therapies.
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Effect of chronic mild stress on serotonergic expression in skin and brain of a NC/
Nga atopic mouse strain
A Rasul, H El-Nour, D Blakely, S-B Lonne-Rahm, J Forsberg, B Johansson, K Nordlind
Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
There is a bidirectional interaction between the neuroendocrine and immune systems 
in atopic dermatitis with stress being a worsening factor. The impact of chronic mild 
stress on the expression of serotonin (5-hydroxytryptamine; 5-HT), 5-HT1A, 5-HT2A 
receptors (R) and serotonin transporter protein (SERT) in the eczematous skin and brain 
of atopic NC/Nga mice was investigated. The mice were divided into three groups, 
stressed eczematous (SE), non stressed eczematous (NSE) and stressed control (SC). 
Biopsies were analysed by immunohistochemistry. There was an increased number of 
5-HT containing dermal mononuclear cells in the eczematous skin compared to the 
control, with a tendency to more 5-HT positive cells in SE compared to NSE group. 
There was an epidermal immunoreactivity for 5-HT1AR and 5-HT2AR, where the 
intensity for 5-HT1AR  was highest in the SE and NSE groups compared to SC, and 
intensity and fraction for 5-HT2AR were highest in SE and NSE compared to SC, with a 
recorded difference between SE and NSE. 5-HT2AR expression was also seen on nerve 
bundles, their number and staining intensity being decreased in the SE compared to 
NSE. SERT immunoreactivity was found on nerve bundles with a decreased number in 
the SE group compared to NSE and SC. In the CA1 area of hippocampus, there was an 
increased number of cells immunoreactive for 5-HT2AR between SE and NSE groups 
and also between SE and SC. There is a modulation of the expression of 5-HT receptors 
in the eczematous skin and brains of the atopic mice during chronic mild stress.
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Human skin and hair follicle versus nasal polyp organ culture as clinically and 
physiologically relevant model systems for studying normal human connective 
tissue-type and mucosal-type mast cell biology in situ
Koji Sugawara1, Torsten Hundt1, Vladimir Emelianov1, Michael Koennecke2, Barbara 
Wollenberg2, Ralf Paus1,3 1Department of Dermatology, University of Luebeck, 
Germany, 2Department of Otorhinolaryngology, University of Luebeck, Germany, 
3School of Translational Medicine, University of Manchester, UK
Given the key role of mast cells (MCs) in normal epithelial biology as well as in allergic diseases, 
it’s biologically and clinically important to characterize both normal connective tissue-type (CT-
MC) and mucosal-type MCs (MT-MCs). Since MCs functions mainly depend on their local tissue 
environment, it’s more important to investigate MCs within their natural tissue habitats than in 
isolation. Here, we show how this can be done, using three human tissue organ-culture assays. Since 
the connective tissue sheath (CTS) of hair follicles (HFs) represents a compartment rich in CT-MCs, 
while nasal polyps (NPs) offer an accessible source of MT-MCs. HFs, NPs, or full-thickness scalp 
skin were organ-cultured for up to 6 days in the serum-free medium. All tissues maintained viability 
and normal morphology during organ-culture. MCs were readily detectable by histochemistry 
and Kit/tryptase-immunohistology. By quantitative (immuno-)histomorphometry, the total number 
of Kit+ cells in the CTS of HFs signifi cantly increased over time, whereas that of tryptase+ (i.e. 
mature) MCs remained largely unchanged, documenting that the CTS is an important reservoir of 
skin MC progenitor cells. NPs showed signifi cantly increased number of both tryptase+ and Kit+ 
cells, suggesting that NP also contain resident progenitor cells, which continue to differentiate 
into mature MCs. MC secretagogues (substance P and cannabinoid receptor-1 antagonist) induced 
MC degranulation in HFs, skin and NPs, documenting that organ-culture conditions perfectly 
preserved MC differentiation and activation. These assays offer instructive, clinically relevant tools 
for developing novel pharmacological strategies to selectively manipulate human CT-MCs and MT-
MCs activation and/or maturation in situ.
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Filaggrin Knockout Mice as a Tool for Understanding Percutaneous Antigen Exposure 
in Barrier-disrupted Skin
Hiroshi Kawasaki1, Keisuke Nagao1, Akiharu Kubo1, Tsuyoshi Hata1,2, Hideaki 
Mizuno3, Taketo Yamada4, Masayuki Amagai1 1Department of Dermatology, Keio 
University School of Medicine, Tokyo, Japan, 2Fundamental Research Laboratories, 
KOSÉ Corporation, Tokyo, Japan, 3Brain Science Institute, RIKEN, Wako, Japan, 
4Department of Pathology, Keio University School of Medicine, Tokyo, Japan
Recent reports have revealed that the loss-of-function mutations in fi laggrin gene (FLG) cause the 
keratinizing disorder, ichthyosis vulgaris, and are major predisposing factors for atopic dermatitis 
(AD). Filaggrin is a major constituent in stratum corneum (SC). Previous epidemiological studies 
have suggested the importance of fi laggrin for skin barrier formation and that its defi ciency might 
result in increased entry of external antigens.  To better understand processes of percutaneous 
antigen exposure and pathogenesis of AD, we generated fi laggrin knockout (KO) mice. Natural 
moisturizing factors, derivatives of fi laggrin degradation, were markedly decreased in SC of 
fi laggrin KO mice. Surprisingly, transepidermal water loss, the most widely used measure for skin 
barrier function, was not enhanced. Increased outside-to-inside permeability was confi rmed by 
topical application of fl uorescent substances, however, and susceptibility of fi laggrin KO mice 
to irritant contact dermatitis demonstrated the critical role of fi laggrin in skin barrier function. 
The fl aky tail (ft/ma) mice carry 1-bp deletional mutation in FLG, which arose spontaneously 
in the ‘matted’ background. Importantly, analyses for ft/ma mice revealed that it had reduced, 
but clearly detectable amounts of mature fi laggrin protein, indicating that these mice are not 
defi cient for fi laggrin. Long-term observation revealed that whereas ft/ma mice developed 
dermatitis spontaneously, fi laggrin KO mice did not cause any cutaneous manifestation under 
SPF conditions. Our fi laggrin KO mice, purely defi cient for fi laggrin, should provide a valuable 
tool to evaluate fi laggrin function and to assess immunological consequences after percutaneous 
antigen exposure via epidermal barrier-disrupted skin, particularly in the context of AD.
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Differential capacity of human skin dendritic cell populations to polarize naïve T 
cells into IL-17, IL-21 and IL-22 producing cells
Karine Penel-Sotirakis, Elise Simonazzi, Josette Péguet-Navarro Université de Lyon, 
EA 41-69, Pavillon R, Hôpital E. Herriot, Lyon, France
Accumulating evidence now points to an important contribution of T cell-derived 
IL-17, IL-21 and IL-22 cytokines in skin immune homeostasis as well as many 
proliferative skin disorders. We therefore wondered whether the cytokine-producing 
T lymphocytes could be primed and biased by the different subsets of human skin 
DCs, i.e. epidermal Langerhans cells (LCs) and dermal DCs (DDCs), consisting 
of at least two migratory CD1c+CD14- and CD1c+/-CD14+DC subsets. DCs were 
purifi ed using antibody-coupled magnetic beads following a 2-day migration from 
separated human epidermal and dermal sheets. DCs were then co-cultured with 
allogeneic naïve T cells and cytokine secretion was explored using both ELISA 
protein assay and intracellular cell staining. Results showed that neither of skin 
DCs could induce substantial IL-17 production by naïve T lymphocytes. However, 
LCs and CD1c+CD14-DDCs were able to induce naïve CD4+T lymphocytes to 
secrete both IL-21 and IL-22 cytokines; LCs being far more effi cient in this process. 
Interestingly, the majority of IL-21 or IL-22 secreting CD4+T lymphocytes did not 
co-express IFN-γ (Th1 cytokine), nor IL-4 (Th2 cytokine). As they don’t express IL-17 
either, they may be therefore considered as distinct T helper subsets. Furthermore, 
both expression of ICOS-L co-stimulatory molecule on LC and presence of serum 
in the culture medium negatively regulated “Th21” production. Neither of IL-17, IL-
21 nor IL-22 was detectable in supernatants from naïve CD8+T lymphocytes primed 
by any skin DCs. These results add new knowledge on human skin immunology 
and mostly offer new targets for the treatment of infl ammatory skin disorders.
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Mast cells and neutrophils are major producers of IL-17A in psoriasis
Cory Rubin, Andrew Lin, MaryBeth Riblett, Jennifer Wang, Parth Shah, Allen Bruce
University of Michigan, Ann Arbor, MI, United States
IL-17A produced by T cells is thought to play a central role in the pathogenesis of 
psoriasis.  Recent work has shown that antibodies specifi cally targeting the IL-17 
pathway are highly effective in treatment of psoriasis.  Previous studies indicated that 
psoriasis lesions contain increased percentages of T cells capable of producing IL-17A 
after ex vivo stimulation.  Using dual-color immunofl uorescence, we observed that 
IL-17A secreting CD4+ and CD8+ T cells are increased in psoriasis lesions compared 
to normal appearing skin.  However, the major producers of IL-17A in psoriasis 
lesions were mast cells expressing tryptase and chymase (MC-TC cells).  Mast cell 
IL-17A colocalizes with chymase and tryptase in some granules, but is also found 
in chymase- and tryptase-negative granules.  In well developed psoriasis lesions, 
neutrophils located in the epidermis, stratum corneum, and superfi cial dermis also 
contain signifi cant amounts of IL-17A.  These observations suggest a major role for 
activated mast cells and neutrophils as producers of IL-17A in psoriasis, with signifi cant 
implications for pathogenesis and pharmacologic management of this disease.
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Necrotic Melanoma Cells Induce Il-1B Secretion  Through Nalp-3 Infl ammasome 
Activation
Samuel Gehrke, Magdalena Kistowska, Dragana Jankovic, Reinhard Dummer, 
Emmanuel Contassot, Lars E. French Dermatology Department Zurich University 
Hospital, Zürich, Switzerland
Chronic infl ammation is associated with an increased risk of carcinogenesis. The role of pro-
infl ammatory cytokines such as IL-1b in the pathogenesis of cancer is still controversial. IL-
1b mediates acute infl ammatory responses and provides a link between innate and adaptive 
immunity. Induction of IL-1b secretion is controlled by a cytosolic complex of proteins known 
as the infl ammasome. This multiprotein complex is composed of a NALP family member, 
ASC and caspase-1 and/or -5. Necrotic cells are often found in tumors, including melanoma, 
and they occur as a consequence of chaotic growth and as a result of radio/ chemotherapy. 
Necrotic cells are able to induce immune responses. Furthermore, melanomas are known to 
be infi ltrated by antigen presenting cells (APCs). The aim of our work was to assess the ability 
of necrotic melanoma cells to elicit an innate immune response through IL-1β secretion by 
APCs. To address this question, primary monocytes and the monocytic cell line THP-1 were 
exposed to necrotic melanoma cells in vitro. Interestingly, a high infl ammasome-mediated 
IL-1b secretion was observed after a 24-hr exposure to necrotic melanoma cells. We observed 
that IL-1b secretion is dependent on Nalp-3 infl ammasome and requires internalization of 
the necrosis products. Heat-treatment of necrotic melanoma cell preparations abrogated 
IL-1b secretion by APCs, suggesting a protein nature of infl ammasome-ativating agent(s). 
Taken together, our data show that necrotic human melanoma cells are highly potent 
inducers of pro-infl ammatory responses through Nalp-3-infl ammasome-induced IL-
1b secretion. Investigations aiming i) identifying the infl ammasome-activating agent(s), 
and ii) characterizing upstream events, including possible receptors, are underway.
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Anti IL-12 / IL-23 p40 therapy inhibits epidermal activation in uninvolved psoriatic 
skin
Ewout Baerveldt1,2, Armanda Onderdijk1,2, Marius Kant1,2, Eddy Florencia1,2, Johann 
Gudjonsson3, Bing Thio1, Jon Laman2, Errol Prens1,2 1Erasmus MC, Department of 
Dermatology, Rotterdam, Netherlands, 2Erasmus MC, Department of Immunology, 
Rotterdam, Netherlands, 3University of Michigan Medical School, Department of 
Dermatology, Ann Arbor, Michigan, United States
Cumulating data point towards “pre-psoriatic“ alterations in uninvolved psoriatic 
skin, such as aberrances in innate immunity and lipid biosynthesis. Despite the 
fact that ustekinumab (anti-p40) successfully targets the IL-23/Th17 axis in lesional 
skin, little is known about targeting constitutively expressed or induced IL-23 in 
uninvolved skin. We investigated the effects of ustekinumab therapy on selected 
biomarkers of epidermal activation in tape stripped (TS) uninvolved psoriatic skin. 
The selected markers of epidermal activation (and barrier function) included psoriasin 
(s100A7), hBD2, LL37, GATA3 and NGF. Biopsies were taken from uninvolved 
and TS-skin from ten patients with psoriasis prior to treatment with ustekinumab 
and again after 4 and 16 weeks of treatment. Blood was drawn for measuring 
circulating levels of IL-12, -17 and -23 in serum. Mean PASI improvement was 50% 
at week 4 and 75% at week 16 of treatment. Ustekinumab increased the baseline 
level of expression of GATA3 mRNA in uninvolved skin, whereas it progressively 
blocked TS-induced upregulation of s100A7, LL37 and NGF but not hBD2 mRNA. 
Serum levels of IL-12, IL-17 and IL-23 remained stable during treatment and 
elevated compared to healthy controls.  Our results show that ustekinumab blocks 
early activation of „pre-psoriatic“ uninvolved skin, preventing triggering of new 
psoriasis lesions. This mechanism of action together with the long half life may 
explain the prolonged clearance of psoriasis seen with ustekinumab treatment.
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In vivo education of UVR-induced regulatory T cells to inhibit the elicitation of 
contact hypersensitivity
Agatha Schwarz1, Björn Clausen2, Thomas Schwarz1 1Department of Dermatology, 
University Kiel, Kiel, Germany, 2Department of Immunology, Erasmus University, 
Rotterdam, Netherlands
Ultraviolet radiation induced regulatory T cells (UVR-Treg) inhibit the sensitization but 
not the elicitation of contact hypersensitivity (CHS) when injected i.v, because UVR-
Treg express lymph node, but not skin homing receptors and thus migrate into the 
lymph nodes but not into the skin. It was shown that the homing receptor expression 
and the migration of UVR-Treg can be altered by tissue-specifi c antigen presenting 
cells in vitro. This is also possible in vivo since i.v. injection of dinitrofl uorobencene 
(DNFB)-specifi c UVR-Treg into DNFB-sensitized mice inhibited the elicitation of 
CHS, provided the UVR-Treg were activated by an epicutaenous DNFB boost on the 
abdomen of the recipients before ear challenge. The presence of Langerhans cells 
(LC) appears to be essential for the boosting effect, since it was lost upon depletion of 
LC, as demonstrated in langerin diphtheria-toxin receptor knock in mice treated with 
diphtheria toxin. Finally UVR-Treg were induced in already DNFB-sensitized mice 
by painting DNFB onto UVR-exposed back skin. Those mice responded to a DNFB 
challenge with a pronounced ear swelling response. However, when these mice were 
in addition exposed to an epicutaneous DNFB boost on the fl ank before ear challenge, 
the CHS response was signifi cantly suppressed. This is the fi rst demonstration of in 
vivo induction of UVR-Treg and their in vivo education to inhibit the elicitation 
of CHS. This may have major implications on strategies trying to utilize Treg not 
only for the prevention but also for the treatment of immune-mediated disorders.
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Calcioptriol cream as a prophylactic treatment for polymorphic light eruption
Alexandra Gruber-Wackernagel1, Isabella Bambach1, Franz J. Legat1, Angelika 
Hofer1, Scott N. Byrne2, Franz Quehenberger3, Peter Wolf1 1Research Unit for 
Photodermatology, Department of Dermatology, Medical University of Graz, Graz, 
Austria, 2Department of Infectious Diseases and Immunology, Sydney Medical 
School, The University of Sydney, Sydney, Australia, 3Institute for Medical Informatics, 
Statistics, and Documentation, Medical University of Graz, Graz, Austria
Polymorphic light eruption (PLE) is suggested to be caused by resistance to UV-induced 
immunosuppression and simultaneous immune reactions against skin photo-neoantigens. 
Similar to UV exposure, vitamin D analogues such as calcipotriol have been reported to cause 
immunosuppression as demonstrated by suppression of in vivo contact hypersensitivity reactions. 
We therefore performed a randomized double-blind placebo controlled study to investigate the 
preventive effect of topically applied calcipotriol cream in PLE patients. Thirteen PLE patients (10 
women, 3 men; mean age, 37 years) were pre-treated at two symmetrically located test areas on 
body sites prone to disease either with calcipotriol cream or placebo cream twice daily for seven 
days before the start of phototesting with solar simulated UV radiation. Pre-treated test sites were 
assessed for minimal erythema dose, and then photoprovocation was performed with repeated daily 
near erythemal irradiation on 4 consecutive days. Photoprovocation provoked PLE lesions in 12/13 
(92%) patients. Pretreatment with calcipotriol cream signifi cantly delayed the appearance and/or 
severity of PLE symptoms in 10 (77%) patients and completely prevented symptoms in 2 (15%) 
patients. The administration of a specifi c PLE scoring system with a maximum of 12 (composed 
of ratings for affected area, infi ltration, and itching) revealed a statistically signifi cant (p<0.002) 
reduction of symptoms of more than 40% throughout the observation period starting at 48h until 
144h post photoprovocation. Visual evaluation and refl ectance spectroscopy showed reduced 
erythema but increased pigmentation at calcipotriol-treated sites in phototesting. These results 
suggest a therapeutically benefi cial role for calcipotriol cream as a prophylactic treatment for PLE.
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UVB-induced CD1a+ Langerhans‘ cell traffi cking occurs in histidinaemic human 
skin lacking urocanic acid
Joanne Tye1, John Walter2, Christopher E.M. Griffi ths1, Neil K. Gibbs1 1Dermatological 
Sciences, University of Manchester, Manchester Academic Health Science Centre, 
United Kingdom, 2Willink Biochemical Genetics Unit, University of Manchester, 
Manchester Academic Health Science Centre, United Kingdom
Ultraviolet-B radiation (UVB)-induced Langerhans‘ cell (LC) traffi cking from 
mammalian epidermis is a putative step in photoimmunosuppression. Epidermal 
trans-urocanic acid (trans-UCA) is formed from histidine by the deaminating 
action of histidase and isomerises to cis-UCA on UVB exposure. In mice, topical 
application of cis-UCA reduces epidermal LC numbers by >50%. To explore the role 
of UCA in UVB-induced epidermal LC traffi cking in humans we studied the skin 
of subjects with histidinaemia, a rare (1 in 11,000) genetic condition characterised 
by defective histidase activity and a lack of UCA. Histidinaemic (n=6) and healthy 
age, sex and skin-phototype matched control (n=6) subjects were recruited. Skin 
UCA levels were quantifi ed by HPLC. 24h after exposure to a range (20-200 mJ/
cm2) of broadband UVB (TL-12; 280-315nm) doses, visual minimal erythemal doses 
(MED) were determined for each subject and CD1a+ LC enumerated in epidermal 
sheets taken from the 200 mJ/cm2 irradiated site. Control subjects had normal 
levels of trans-UCA (mean±se; 9.8±0.6 nmol/cm2) which was not detectable in 
histidinaemic skin. Despite age, sex and phototype matching, the mean histidinaemic 
MED was lower than in controls (p=0.04; 42±7 and 74±11 mJ/cm2 respectively). 
Mean CD1a+LC density per mm2 in non-irradiated histidinaemic and control skin 
was similar (985±44 and 950±38, p=0.56). After UVB exposure there was a similar 
percentage reduction in CD1a+LC observed in histidinaemics and controls (44±4% 
and 36±2% respectively, p = 0.17). These fi ndings demonstrate that the presence 
of UCA is not essential for UVB-induced LC migration from the human epidermis.
 www.jidonline.org S45 
ABSTRACTS
265
Fractionated Illumination at low Fluence rate Photodynamic Therapy in mice
Tom Middelburg, Floor Van Zaane, Riette De Bruijn, Angelique Van Der Ploeg-Van 
Den Heuvel, Henricus Sterenborg, Martino Neumann, Ellen De Haas, Dominic 
Robinson Erasmus Medical Center, Rotterdam, Netherlands
Photodynamic therapy (PDT) for actinic fi eld cancerization is effective but painful. Pain 
mechanisms remain unclear but fl uence rate has been shown to be a critical factor. 
Lower fl uence rates also utilize available oxygen more effi ciently. We investigated 
PDT effect in normal SKH1-HR mice using low and high fl uence rate aminolevulinic 
acid (ALA) PDT and a fractionated illumination scheme. Six groups of six mice with 
different light treatment parameters were studied. Visual skin damage was assessed up 
to 7 days post PDT. Fluorescence and refl ectance spectroscopy during illuminations 
provided us with real time information about PpIX photobleaching. A novel dosing 
approach was introduced in that we used a photobleaching percentage instead of a 
pre-set fl uence. Data show similar total and maximum damage scores in high and 
low fl uence rate groups. Photobleaching of PpIX in the low fl uence rate groups shows 
a trend towards more effi cient photobleaching. Results indicate that low fl uence rate 
PDT is as effective as, and more effi cient than high fl uence rate PDT in normal mouse 
skin. Low fl uence rate PDT light protocols need to be explored in human studies in 
search for an effective and well tolerated treatment for actinic fi eld cancerization.
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Melatonin differentially regulates antiapoptotic mechanisms on a wide range 
against UV-induced damage in a human full skin model in vitro
Konrad Kleszczynski, Lena H. Hardkop, Nathalie Piskozub, Detlef Zillikens, Tobias 
W. Fischer University-Hospital Schleswig-Holstein, University of Lubeck, Germany
Melatonin has been recognized as a protective agent in many conditions related 
to oxidative stress such as neurodegenerative diseases, sepsis and aging. These 
processes are supposedly mediated through melatonin`s scavenging properties and 
antiapoptotic activity. Here, we investigated the effect of wide range (25-600 mJ/
cm2) UVB/UVA-radiation on apoptosis in a human full skin model by involvement 
of p53 protein, caspases-dependent apoptotic pathways, activation of DNA repair 
enzyme poly(ADP-ribose) polymerase (PARP), induction of oxidative stress, and the 
protective effects of melatonin. Dose- and time-dependent structural disturbances 
were found as sunburn cells and cleft formation increased signifi cantly in the 
epidermis at 200 mJ and 75 mJ at 24 and 48 h post UV-exposure, respectively. Further 
analysis revealed apoptotic events such as up-regulation of p53 visible after 24 h 
at 300 mJ while melatonin revealed a signifi cant 40% and 94% decrease after 24 
and 48 h. Concurrently, melatonin down-regulated TUNEL positivity reaching levels 
of 63% and 370% at 300 mJ after 24 and 48 h, respectively, compared to control 
samples without melatonin. Moreover, melatonin reduced UV-mediated down-
stream activation of intrinsic apoptotic pathway by suppression of casp-9 and casp-3 
as well as subsequent down-regulation of PARP. Immediate signifi cant consumption 
of catalase as UV-induced oxidative stress event was observed directly upon UV 
irradiation and melatonin signifi cantly counteracted this consumption by 25%. In 
conclusion, melatonin showed precise evidence for strong protection against UV-
induced damage by reducing a wide range of apoptosis- and DNA-damage-related 




Topical aminolevulinic acid- photodynamic therapy (ALA-PDT) for acne induces 
apoptosis of sebocytes and down-regulates TLR-2 and TLR-4 expression of sebocytes
Hei Sung Kim1, E Jeong1, JA Min1, DW Lee2, MY Son3, WJ Lee4, JY Lee1, HO Kim1, 
YM Park1 1Department of Dermatology, Seoul St. Mary‘s Hospital, Seoul, Korea, 
Republic of, 2Dr. Lee‘s New Face Skin Clinic, Seoul, Korea, Republic of, 3Department of 
immunology, Kyungpook National University, Daegu, Korea, Republic of, 4Department 
of Dermatology, Daegu, Korea, Republic of
Photodynamic therapy (PDT) is a popular therapeutic method for infl ammatory acne. 
Although acne PDT is widely performed, little is known of its exact therapeutic 
mechanism. In this study, we aimed to evaluate the effi cacy and safety of PDT on 
acne and discover its mode of action. PDT was performed in 12 patients with mild 
to moderate acne. Clinical effi cacy was assessed by counting the acne lesions and 
measuring the sebum output before and after PDT. Punch biopsies were obtained 
from the perilesional sites, before and after 3 sessions of PDT, where TUNEL stain and 
immunohistochemical staining for Fas, TLR-2 and TLR-4 was performed. There was 
signifi cant reduction in the number of infl ammatory acne lesions after PDT and also 
a decrease in sebum output. An increase in TUNEL and Fas positive sebocytes were 
observed after PDT. The expression of TLR-2 and TLR-4 in the sebaceous glands and 
epidermis decreased by 40% and 30% respectively, after PDT. Our results show that 
apoptosis of the sebaceous glands is associated with the improvement of acne by PDT. 
An extensive follow up should be made in future to measure the long term effects of PDT
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Narrow-band ultraviolet B induces signifi cant changes in composition of 
keratinocytes lipids
Adam Reich1, Dominik Schwudke2,4, Bodo Lehmann3, Michael Meurer3, Andrej 
Shevchenko2 1Department of Dermatology, Venereology and Allergology, Wroclaw 
Medical University, Wroclaw, Poland, 2MPI of Molecular Cell Biology and Genetics, 
Dresden, Germany, 3Department of Dermatology, Carl Gustav Carus Medical Faculty, 
University of Technology, Dresden, Germany, 4National Centre for Biological Sciences, 
Tata Institute of Fundamental Research GKVK, Bellary Road, Bangalore, India
UV light triggers a variety of biological responses in irradiated keratinocytes that 
might be associated with global perturbation of their lipidome. However, lipids 
that are specifi cally affected and the exact molecular mechanisms involved remain 
poorly understood. We performed a study to characterize time-dependent changes 
of the lipidome of cultured keratinocytes induced by narrow-band ultraviolet B (NB-
UVB) irradiation. Immortalized human keratinocytes (HaCaT) were cultured under 
standard conditions, irradiated with NB-UVB light (311 nm) at 400 and 800 mJ/cm2 
and collected 1, 2, 3, 6, 12 and 24 h later for lipid extraction. Lipid extracts were 
separated on silica plates in chloroform/ethanol/water/triethylamine (35:40:9:35) and 
in n-hexane/ethylacetate (5:1) followed by quantitative shotgun lipidomics analysis.
Irradiation with 800 mJ/cm2 of NB-UVB altered morphology and lipidome composition 
of HaCaT cells. Ceramide content increased two-fold 6- and 12-h postirradiation with 
800 mJ/cm2, followed by threefold increase in triacylglycerols (TAGs) that peaked 
at 24 h. In addition, we observed marked increase of various phosphatidylcholine 
and phosphatidylethanolamine ethers, whereas phosphatidylcholine-species 
with short-chain fatty acid moieties decreased. The abundance of other lipid 
species was altered to lesser extent or remained unchanged. NB-UVB affected 
the cellular lipidome of keratinocytes in strictly apoptosis-specifi c manner.
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Effects of Low Level Light on Hair Papilla Cells: Implications on Hair Growth 
Promotion 
Chih-Chieh Chan1,2, Yi-Shuan Sheen1,3, Sabrina Mai-Yi Fan2, Wei-Hung Wang2, Shiou-
Hwa Jee1, Sung-Jan Lin1,2 1Dept of Dermatology, National Taiwan Univ Hospital, 
Taipei, Taiwan, 2Inst of Biomedical Engineering, National Taiwan Univ, Taipei, Taiwan, 
3Dept of Dermatology, National Taiwan Univ Hosp Yun-Lin Branch, Yunlin, Taiwan
Cycling of hairs is maintained by perpetual dermal-epidermal interaction between 
dermal papilla cells (DPCs) and overlying keratinocytes. Conditions that disrupt the 
balance will lead to hair loss, causing clinical alopecia. Various modalities have been 
introduced to treat alopecia based on the knowledge of follicular homeostasis and 
pathophysiology. Among which low level light therapy (LLLT) has gained increasing 
popularity. Light emitting diode (LED), when designed as a LLLT, is well tolerated by 
biological tissues and has been used as a safe therapeutic device. Recently, related 
products are proven to be benefi cial in promoting hair growth, without knowing the 
actual working mechanism. We hypothesize low level light may promote hair growth by 
means of activating DPCs. To investigate the mechanisms governing follicular growth 
after LED treatment, we harvested DPCs from rat vibrissa follicles and irradiated them 
with LED of specifi c wavelength. In comparison with the untreated group, irradiated 
DPCs have a distinct higher rate of proliferation and enhanced cellular viability. Also, 
the treated group has a signifi cant higher proportion of cells in S/G2M phases of 
cell cycle. These results may be explained by increased ERK1/2 (extracellular signal-
regulated kinase-1 and -2) and Akt (protein kinase B) phosphorylation in DPCs after 
irradiation. In clinical aspects, increased numbers of DPCs can result in prolonged 
anagen phase and enlarged terminal hair caliber, forming “healthier” thick hairs. Our 
observation shows that LED treated DPCs have strengthened proliferative and survival 
signals, which may contribute to the clinical effects of low level light on hair growth.
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Prevention of UVB Radiation-induced Epidermal Damage by Expression of Heat 
Shock Protein 70
Minoru Matsuda, Tohru Mizushima Graduate School of Medical and Pharmaceutical 
Sciences, Kumamoto University, Kumamoto, Japan
Irradiation with UV light, especially UVB, causes epidermal damage via the induction 
of apoptosis, infl ammatory responses, and DNA damage. Various stressors, including 
UV light, induce heat shock proteins (HSPs) and the induction, particularly that of 
HSP70, provides cellular resistance to such stressors. The anti-infl ammatory activity 
of HSP70, such as its inhibition of nuclear factor kappa B (NF-κB), was recently 
revealed. These in vitro results suggest that HSP70 protects against UVB-induced 
epidermal damage. Here we tested this idea by using transgenic mice expressing 
HSP70 and cultured keratinocytes. Irradiation of wild-type mice with UVB caused 
epidermal damage such as induction of apoptosis, which was suppressed in 
transgenic mice expressing HSP70. UVB-induced apoptosis in cultured keratinocytes 
was suppressed by overexpression of HSP70. Irradiation of wild-type mice with UVB 
decreased the cutaneous level of IκB- α (an inhibitor of NF-κB) and increased the 
infi ltration of leukocytes and levels of pro-infl ammatory cytokines and chemokines 
in the epidermis. These infl ammatory responses were suppressed in transgenic mice 
expressing HSP70. In vitro, the overexpression of HSP70 suppressed the expression 
of pro-infl ammatory cytokines and chemokines and increased the level of IκB-α in 
keratinocytes irradiated with UVB. UVB induced an increase in cutaneous levels 
of cyclobutane pyrimidine dimers and 8-hydroxy-2’-deoxyguanosine, both of 
which were suppressed in transgenic mice expressing HSP70. This study provides 
genetic evidence that HSP70 protects the epidermis from UVB-induced radiation 
damage. The fi ndings here also suggest that the protective action of HSP70 is 
ediated by anti-apoptotic, anti-infl ammatory, and anti-DNA damage effects.
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Ultraviolet Radiation And Leucocytes Function In An Experimental Model
Smaranda Rodica Gotia1, Caius Solovan2, Smaranda Laura Gotia1, Doina Verdes3, 
Roxana Popescu3, Nicoleta Filimon4 1University of Medicine and Pharmacy, 
Department of Physiology, Timisoara, Romania, 2University of Medicine and 
Pharmacy, Department of Dermatology, Timisoara, Romania, 3University of Medicine 
and Pharmacy, Department of Cellular and Molecular Biology, Timisoara, Romania, 
4West University, Faculty of Chemistry-Biology-Geography, Timisoara, Romania
Skin is a major target of oxidative stress due to reactive oxygen species (ROS) that 
originate in the environment, produced especially by ultraviolet radiation (UVR), 
and in the skin itself. The study estimated, in psoriasis patients, the phagocytosis and 
ROS production after whole blood-exposure to UVR. Heparinized venous blood was 
taken from 20 patients with psoriasis. Blood samples were exposed to UVR for 5, 
and 15 min. in a dark room by means of an 80 W biological quartz lamp placed 
at a distance of 20 cm from the sample. The pre-irradiated state served as control. 
The activation of oxidative metabolism during phagocytosis and ROS formation were 
evaluated by nitroblue tetrazolium dye reduction test (NBT%). ROS reduced NBT dye 
to nitroformazan. In psoriasis patients, the leukocytes phagocytosis was reduced in 
basal conditions, but NBT tests increased to 7.53 ± 4.68%, and 5.33 ± 2.30% over the 
initial value (4.25 ± 3.02%), respectively with 77.17%, and with 25.4% correlated with 
the blood UVR time exposure. These high levels of NBT tests showed an increase of 
phagocytosis, the granulocytes oxidative metabolism activation induced by UVR, and 
a lot of ROS production. In psoriasis skin patients there is an infi ltrate with leukocytes 
which can produce ROS after UVR exposure and can modulate the local infl ammation. 
Experimental model can be used to quantify the leukocytes oxidative metabolism after 
UVR blood exposure. The obtained results can indirectly explain the modifi cations 
of lesions and the benefi cial effects after UVR skin contact, in psoriasis patients.
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Comparison of ALA and MAL uptake in keratinocytes
Roxane Schulten1,2, Hermann Lübbert1 1Ruhr-University Bochum, Bochum, Germany, 
2RUB Research School, Bochum, Germany
5-aminolevulinic acid (ALA) and methyl-ALA (MAL) are widely used as prodrugs, 
which are metabolized to the photosensitive compound protoporphyrin IX (PpIX) 
which is an effi cient photosensitizer in photodynamic therapy (PDT). In this study, we 
analyzed the uptake mechanism of ALA and MAL in two keratinocyte cell lines. Cells 
were incubated with 1.8 mM ALA or MAL and competitive uptake inhibitors for 30 
min. PpIX was measured fl uorimetrically after 2 h. Inhibitors used were β-alanine, (S)-
SNAP-551 and different amino acids. Both, β-alanine and (S)-SNAP-5114, inhibited 
the ALA-uptake completely, but did not reduce the uptake of MAL. For MAL-uptake, 
cysteine and histidine showed the strongest inhibitory effect, reducing the PpIX 
amount by 50%, but did not have the same inhibitory effect on the ALA-uptake. 
The results indicate that ALA and MAL are taken up by different transporter systems.
Further, to analyze the origin of the painful sensation many patients experience 
during the irradiation phase, we searched for compounds released by the irradiation 
of keratinocytes after loading with PpIX. We found that ATP was secreted upon 
irradiation at an amount that was dependant on the concentration of PpIX formed 
after ALA or MAL incubation. Inhibiting the uptake of MAL with cysteine reduced 
the ATP release. The amount of ATP released was suffi cient to stimulate sensory 
nerve endings through the activation of P2X receptors.These results indicate that ATP 
released upon irradiation from keratinocytes preloaded with PpIX is at least partly 
responsible for the painful sensation felt by many patients during PDT irradiation.
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Modifi cation of microRNA expression by baicalin in UVB irradiated mouse skin 
using a microRNA microarray
Bingrong Zhou, Dan Luo The First Affi liated Hospital Of Nanjing Medical University, 
Nanjing, China
MicroRNAs (miRNAs) are non-coding RNA molecules of 21 to 24 nt that regulate 
the expression of target genes in a post-transcriptional manner. Evidence indicates 
that miRNAs play essential roles in embryogenesis, cell differentiation, and 
pathogenesis of human diseases including skin cancer. To assess the effects of 
baicalin on UVB-mediated miRNAs expression changes in mice skin. We analyzed 
the miRNA expression profi les in 3 pairs of UVB irradiated mice, baicalin treated 
irradiated mice, and untreated mice. Real-time RT-PCR analysis was used for confi rm 
the miRNA expression changes. TargetScan and GO-analysis were employed for 
the prediction of miRNA targets. 3 miRNAs are down-regulated and 3 miRNAs 
are up-regulated in UVB irradiated mice compared with untreated counterpart. 
Differentially expressed miRNAs were predicted to have some relationships with 
photocarcinogenesis, hypomethylation and apoptosis. 3 miRNAs are down-regulated 
and 1 miRNA are up-regulated in baicalin treated irradiated mice compared with 
UVB irradiated mice. Differentially expressed miRNAs were predicted to have 
some relationships with DNA repair signaling. MiRNAs were potentially involved 
in the pathogenesis of photodamage, and differentially expressed miRNAs in 
baicalin treated group may help to treat and prevent UV-induced dermatoses.
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Protective Effect of Baicalin on Multiple Ultraviolet B Exposure-mediated damages 
in C57BL/6 mouse skin
Dan Luo, Bingrong Zhou Department Of Dermatology, The First Affi liated Hospital 
Of Nanjing Medical University, Nanjing, China
Multiple exposures to solar ultraviolet (UV) radiation cause critical damages 
that may lead to the development of several cutaneous disorders including skin 
cancer. Protection against sun-induced damage is therefore a highly desirable 
goal. Chemoprevention via plant-based agents may be a useful approach for the 
management of UV-induced neoplasia. In this study, we assessed whether Baicalin 
afford protective effect on multiple UVB exposure-mediated damages in C57BL/6 
mice skin and the underlying mechanisms. C57BL/6 mice were topically pretreated 
with baicalin (1 mg/cm2 skin area/mouse/100 µL acetone) and were exposed to 
UVB 30 minutes later (180 mJ/cm2, on alternate days ×10 exposures). The animals 
were sacrifi ced 24 h after the last UVB exposure. Skin edema, histopathology 
changes, Ki-67, PCNA, COX-2 were assesed to determine the multiple UVB induced 
photodamage. Multiple UVB exposures to C57BL/6 mice resulted in an increase in 
skin edema and hyperplasia, topical application of baicalin prior to UVB radiation 
resulted in a signifi cant inhibition of Ki-67, PCNA and COX-2, these protective 
effects of baicalin are supposed to inhibit UVB-induced skin carcinogenesis. Based 
on this data, we suggest that baicalin could be developed as an agent for the 
management of conditions elicited by multiple UV exposure including skin cancer.
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Two weeks of holiday sun exposure signifi cantly enhances the pigment protection 
factor (PPF) in Polish children
Michal Rogowski-Tyman1, Aleksandra Lesiak1, Anna Sysa-Jedrzejowska1, Antony R 
Young2, Joanna Narbutt1 1Department of Dermatology, Medical University of Lodz, 
Lodz, Poland, 2*St John’s Institute of Dermatology, King’s College London, London, 
United Kingdom
Solar UVR is the most important environmental factor on human health. Most 
human photobiological research has been with acute erythemogenic doses of UVR 
in healthy adult volunteers. However, we lack data on skin responses to natural solar 
exposure in children; this is important because childhood sunburn is a risk factor 
for melanoma. Thus, the aim of our study, within the EC-funded ICEPURE project, 
was to assess changes in parameters that determine individual skin sensitivity to 
the sun in children. The study group was 32 Caucasian children (mean age 8.9 y, 
phototypes I-IV) on a 2-week summer camp holiday (23rd June - 6th July 2009) at the 
Baltic Sea (Sztutowo 54oN).   The children were advised to use sunscreens according 
to their usual habits. In each child, redness (erythema), pigmentation and pigment 
protection factor (PPF) were measured by a UV-Optimizer at six locations (forehead, 
upper arm, lower arm, back, buttock, dorsal hand) before the holiday and 24h after 
returning home. Erythema on the back and hand increased signifi cantly after the 
camp, whereas pigmentation increased on the back, upper arm, lower arm and hand. 
The PPF increased signifi cantly on the same fi ve sites. There were no changes on the 
unexposed buttock skin. The lack of change in forehead erythema and pigmentation 
probably results from protection by a fringe and face being a site where sunscreens 
are more commonly applied. Nonetheless, there was a perhaps surprising signifi cant 
increase in PPF. Overall, we show adaptive photoprotection with limited cumulative 
erythema.
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Erythemal UVB radiation  alters the expression of Vitamin D receptor in the human 
skin  with leading to photoadaptation
Aleksandra Lesiak1, Karolina Wodz2, Rafal Pawliczak2, Michal Rogowski-Tylman1, 
Adam Wlodarkiewicz3, Michal Sobjanek3, Anna Sysa-Jedrzejowska1, Joanna Narbutt1
1Department of Dermatology and Venereology, Medical University of Lodz, Lodz, 
Poland, 2Department of Dermatology and Immunopathology Medical University 
of Lodz, Lodz, Poland, 3Department of Dermatology, Venereology and Allergology 
Medical University of Gdansk, Gdansk, Poland
UVB is one of the major factors involved in photocancerogenesis  as well  is required 
for vitamin D production. As there are discrepant results on the role of  Vitamin D 
receptor (VDR)  in skin oncogenesis, thus the aim of the study was to assess the 
expression of VDR in UVB exposed skin  . The study consisted of 4 groups of 10 
healthy individuals who were whole-body UVB irradiated for 10 days with 0.7 MED 
on each occasion, or whole-body irradiated as before followed by a single high dose 
of UVB (10x10 cm), or were irradiated only with a single dose of UVB (3 MED) on 
the small area of the body, or were unirradiated. Skin biopsies were taken in all 
participants and  VDR expression  was assessed (Western blot). The VDR expression 
was signifi cantly higher in  3 MED UVB-irradiated  group   when compared to 
unirradiated skin  (p<0.05). In the volunteers who were whole-body irradiated for 
10 days followed by a single 3 MED  UVB the VDR expression was relevantly  lower 
than in group of 3 MED (p<0.05). No changes in VDR expression were found in group 
of volunteers  exposed only to suberythemal UVB doses.   The repeated low doses 
of UVB protect against the effects of an erythemal UVB dose on VDR  expression 
what may be  the next proof of the organism’s ability to develop  photoadaptation.
278
Phototherapy with narrowband ultraviolet B enhances serum concentration of 
25-hydroxycholecalciferol  in psoriatic patients
Joanna Narbutt, Anna Brucka-Stempkowska, Dagmara Kubik, Piotr Budzisiak, Michal 
Rogowski-Tylman, Anna Sysa-Jedrzejowska, Aleksandra Lesiak Dept of Dermatology 
and Venereology, Medical University of Lodz, Lodz, Poland
The narrowband ultraviolet B radiation (UVB-NB; 311-313 nm) is used  for 
phototherapy of skin diseases. The ultraviolet B radiation leads to the change of 
accumulated in the skin 7-dehydrocholesterol into previtamin D, which is later 
converted by the thermal energy into cholecalciferol and hydroxylated in liver. 
Over 90% of daily vitamin D demand is produced in the skin under sunlight. The 
aim of the study was to determine the serum  25-hydroxycholecalciferol (25OH) 
concentration changes in the patients irradiated with  UV-NB. The study consisted 
of  47 psoriatic patients in mean age of 41 y.o.  The course of 20 irradiations with 
UVB-NB was performed in each  patient. The vitamin D  serum concentration (RIA 
method) was measured 3 times, before treatment, after 10 and after 20 irradiations. 
The mean serum concentration of 25OH before treatment  was 27ng/ml; 39 ng/ml 
after 10 irradiations and 44.3 ng/ml after 20 irradiations. 10  and 20 exposures to 
UVB-NB  caused signifi cant increase in 250H serum concentration when compared 
to the baseline results (p<0.001 for both comparisons), however we observed no 
statistically signifi cant difference between serum concentration of this parameter in 
the measurements after 10 and 20 irradiations. We found positive correlation between 
250H serum concentration after fi nal  exposure and cumulative UVB-NB dose 
(R=0.09; p<0.001). The highest  increase  in 25OH serum level  in psoriatic patients 
is observed after fi rst 10 irradiations whereas next 10 exposures did not raise  it so 
effectively what might testify to the occurrence of photoadaptation phenomenon.
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A multifunctional plant extract helps prevent photoaging
Valérie Cenizo, Amandine Lhoste, Sébastien Bonnet, Nabil Abdul-Malak, Nicolas 
Bechetoille, Valérie André-Frei BASF Beauty Care Solutions France S.A.S, Lyon, France
Photoaging is the main cause of premature skin aging. UVA radiation generates 
reactive oxygen species (ROS) that denature proteins, cause DNA mutations and 
deregulate gene expression in the dermis. Solar elastosis is a sign of photoaging 
in which non-functional elastin deposits accumulate. Elastin expression increases 
while macrophages and neutrophils secrete elastases. We fi rst observed that, while 
UVA radiation rapidly induced MMP-1 and elastin mRNA in cultured dermal 
fi broblasts, Lysyl oxidase-Like (LOXL) mRNA remained unchanged. Since LOXL 
normally creates cross-links that confer their mechanical properties to elastic 
fi bers, increasing LOXL could be a way to turn elastin accumulation into functional 
fi bers. We thus searched for a global protective agent that would inhibit elastase 
activity, increase LOXL expression and display good radical scavenging properties. 
We identifi ed a plant extract that decreased the free radical DPPH by 60% when 
used at 2%, inhibited human neutrophil elastase activity by 46% and doubled LOXL 
mRNA expression in cultured fi broblasts. Moreover, the extract inhibited type IV 
collagenase (MMP-2) activity by 30% and macrophage elastase (MMP-12) activity 
by 65%. When applied on confl uent fi broblasts in vitro for 5 days, the extract 
also boosted collagen deposition. LOXL labeling was more intense and appeared 
as droplets on thin fi brils. A double labeling with fi brillin-1 or elastin is required 
to confi rm that these latter are elastin-associated microfi brils. These in vitro results 
suggest that the aforementioned plant extract used alone or in combination with 
sunscreens could be an effective protective agent to help prevent photoaging.
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High SPF sunscreen for children intolerant skin protects from UV deleterious effects 
on DNA and immune system
Dalale Naaimi, Johan Rocheteau, Stéphanie Bredif, Caroline Baudouin, Sébastien 
Garnier, Franck Menu, Philippe Msika Laboratoires Expanscience, Epernon, France
Ultraviolet radiations (UVR) result in a number of alterations in the skin: DNA 
lesions (dimers), alteration of p53 tumor suppressor, photo-immunosuppresion 
(PIS) by phenotype alteration of Langerhans cells (LC). All together, these effects 
can contribute to cutaneous carcinogenesis. A high SPF sunscreen was specifi cally 
formulated for children intolerant skins. In addition to mineral sunblocks, it contains 
zinc gluconate; alpha-tocopherol (anti-oxidant with UVR-protective effects on 
p53 and PIS); Aloe Vera (with immuno-protective properties by preserving LC and 
inhibiting IL10 secretion after UVB) and Sunfl ower Oleodistillate (SO, which has 
hydrating and anti-infl ammatory properties).HaCaT cells, pre-treated or not with SO, 
were subjected to UVR. IL6 and IL8 release were measured by ELISA assay. Skin 
explants topically treated, or not, with the high SPF sunscreen, were irradiated by 
UVA+B. Fluorescent immunostaining of CPD (pyrimidine dimers), CD1a (LC) and 
p53 were realised.SO was able to modulate signifi cantly the release of IL6 and IL8 
induced by UVR. The sunscreen totally protected skin explants from UV-induced 
DNA damage as none pyrimidine dimer was detected. The sunscreen limited the 
raise in p53 positive cells induced by UVR (protection by 96%); and was able to 
counteract the decrease in epidermal LC induced by UVR (protection by 113%).
Exposure to sunlight during childhood is a risk factor for skin cancer such as 
melanoma. That’s why children need highly effi cient sunscreen offering surface as 
well as depth protection. This high SPF mineral sunscreen answers this need with 
active ingredients providing UV protection at two levels: immune and cell defenses.
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Narrow-band UVB alters the expression of cathelicidin and human β defensin 2 in 
skin lesions of psoriasis and atopic dermatitis
Katja Vähävihu1, Mark Peric2, Meri Ala-Houhala1, Piia Karisola3, Taina Hasan1, Erna 
Snellman1, Harri Alenius3, Timo Reunala1, Jürgen Schauber2  1Tampere University 
and University Hospital, Tampere, Finland, 2Ludwig-Maximilians-University, Munich, 
Germany, 3Finnish Institute of Occupational Health, Helsinki, Finland
Narrow-band UVB (NB-UVB) is routine treatment for psoriasis (PS) and atopic dermatitis 
(AD), but its effect on antimicrobial peptides is not well documented.  We studied the 
effect of NB-UVB on lesional expression of cathelicidin and human β defensin 2 (HBD2), 
which can act as proinfl ammatory mediators, as well as on serum 25-hydroxyvitamin 
D (25OHD) concentration. Six whole body NB-UVB treatments were given for 18 PS 
patients, 18 AD patients, and 15 healthy subjects. Respectively, skin biopsies were taken 
from seven, eight and seven subjects out of them. Antimicrobial peptide expression was 
examined by quantitative real-time PCR and serum 25OHD by radioimmunoassay. Before 
NB-UVB treatment cathelicidin (p<0.05) and HBD2 (p<0.001) expression were signifi cantly 
elevated in PS lesions compared to the skin of healthy subjects. Six NB-UVB exposures 
(12.3 SED) markedly increased cathelicidin expression while HBD2 expression decreased 
statistically signifi cantly. In AD lesions, the slightly elevated levels of cathelicidin increased 
further, whereas the signifi cantly (p<0.05) elevated HBD2 levels decreased. At the onset 
the median 25OHD concentration was 39.6 (range 15.6 - 58.5) nmol/L in PS, 29.5 (range 
15.1 - 53.2) nmol/L in AD and 48.8 (range 35.2 - 112.4) nmol/L in healthy subjects. Six NB-
UVB treatments increased serum 25OHD concentration statistically signifi cantly, by 24.3 
nmol/L in PS, by 27.1 nmol/L in AD and by 17.0 nmol/L in healthy subjects. We conclude 
that small doses of NB-UVB increase cathelicidin and decrease HBD2 levels in healing 
PS and AD skin lesions. These effects might be mediated by improved vitamin D balance.
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The dynamics of hyaluronan secretion in ultraviolet B irradiated rat epidermal 
keratinocytes 
Leena Rauhala, Lasse Hämäläinen, Sanna Pasonen-Seppänen, Raija Tammi
School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, 
Finland
Peri- and extracellular hyaluronan (HA) has profound effects on the migration, 
proliferation and differentiation of keratinocytes. Its metabolism in the dermis and 
epidermis is partly regulated by ultraviolet B (UVB) radiation, which makes it an 
indispensable target in current dermatological research.To elucidate the dynamics 
of hyaluronan secretion in cultured rat epidermal keratinocytes (REK), cells in 
monolayers were exposed to 2.5-20 mJ/cm2 of broadband UVB-irradiation and 
organotypic 3D-cultures similarly to 20 or 30 mJ/cm2 of UVB. Accumulation of HA 
and the transcript levels of assorted genes were quantifi ed at various timepoints. 
Additionally, different inhibitors were applied to unravel the intracellular signaling 
pathways involved. Moderate UVB-irradiation caused a dose-dependent increase 
in total HA. This response was clearest in the monolayers, but a slight induction 
was also seen in the organotypic cultures. Blocking the intracellular kinase MEK1/2 
in the monolayers partially reversed the effects of UVB. On the mRNA-level, 
hyaluronan synthases (HAS1-3) were dynamically regulated with HAS1 showing 
the earliest induction after just 2 h. HAS2 and HAS3 had similar profi les with 
fl uctuating upregulation between 8-36 h. A slight induction in the HA-receptor 
CD44 was seen at 24-36 h after an initial decline. Our results demonstrate that 
hyaluronan production specifi cally and rapidly responds to UVB-exposure in both 
the monolayers and the organotypic culture model. The data imply that acute 
irradiation activates signalling routes involved in the regulation of HAS-gene 
transcription, and that the MEK-ERK -pathway might be essential for the response.
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Successful phototherapy of polymorphic light eruption patients is associated with a 
recruitment of mast cells into the skin
Peter Wolf1, Alexandra Gruber-Wackernagel1, Franz Legat1, Angelika Hofer1, Isabella 
Bambach1, Gerlinde Mayer1, Markus Absenger2, Eleonore Fröhlich2, Scott Byrne3
1Research Unit for Photodermatology, Dept of Dermatology, Medical Univ of Graz, 
Austria, 2Center for Medical Research, Medical Univ of Graz, Austria, 3Dept of 
Infectious Diseases & Immunology, The Univ of Sydney, Australia
Resistance to UVB-immunosuppression is thought to be one reason for the symptoms of 
polymorphic light eruption (PLE) following UV exposure. While UVB photohardening 
is used for prophylactic therapy in PLE, little is known on how this affects the immune 
system of patients.  Dermal mast cells mediate UVB-immunosuppression and are important 
regulators of UVB-infl ammation. However, the role of mast cells in PLE is not known. 
We investigated the effect of photohardening in PLE patients on the prevalence of dermal 
mast cells, as well as Langerhans cells (LC) and skin-infi ltrating T cells.  Biopsies from 
fi ve female PLE patients (39±17 years) were taken at four time points: (1) early spring 
before photohardening, (2) late spring after photohardening, (3) summer, and (4) winter. 
Giemsa staining identifi ed mast cells, while immunohistochemical staining for CD1a and 
Langerin identifi ed LC. CD4, CD25, and Foxp3 antibodies identifi ed helper, activated 
and regulatory T cells, respectively. Sections from 17 PLE patient samples and 11 controls 
were analysed. A signifi cantly lower mast cell density in the papillary (but not reticular) 
dermis was observed in PLE patients compared to controls. Photohardening with 311nm 
UVB signifi cantly increased dermal mast cell densities in PLE patients (by 55%; p<0.05). 
Indeed, phototherapy restored dermal mast cell densities to levels similar to that of controls. 
Photohardening decreased LC densities in the epidermis (by 35%; p<0.05) but did not alter 
the CD4+, CD25+ or Foxp3+ T cell numbers in PLE skin. Our results suggest that successful 
phototherapy of PLE patients involves UVB-induced dermal mast cell recruitment.
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Proliferative potential and stage of cell cycle determines keratinocyte susceptibility 
to UV-induced apoptosis
Sophie Weatherhead1,2, Peter Farr2, Nick Reynolds1,2 1Newcastle University, 
Newcastle-upon-Tyne, United Kingdom, 2Royal Victoria Infi rmary, Newcastle-upon-
Tyne, United Kingdom
Keratinocyte apoptosis occurs in response to ultraviolet (UV) radiation, allowing 
elimination of DNA damaged cells and thereby prevents UV-induced tumour 
formation.  Understanding why some cells appear differentially susceptible to 
apoptosis may provide insight into individual variation in the apoptotic response 
and whether external factors may be able to alter the balance of apoptosis. Live cell 
imaging techniques and fl ow cytometry were utilised to investigate the differential 
susceptibility of keratinocytes at different stages of the cell cycle, and the apoptotic 
affect of UV on cells of different proliferative potential was analysed. Fresh human 
foreskin was irradiated ex-vivo with narrowband UVB at physiological doses, and the 
whole epidermis was then analysed to elucidate which cells underwent apoptosis. 
Proliferating cells were defi ned as those with a bright anti-α6-integrin signal, and 
were categorised into putative stem or TA cells according to expression of anti-
transferrin (CD71). All experiments were repeated using skin derived from different 
donors on at least 3 occasions.  Epidermal cells in G2M were signifi cantly more 
likely to undergo apoptosis than cells in G1 or S phase following UVB irradiation 
(p <0.01). In freshly isolated epidermis a median of 8% of apoptotic cells were α6-
integrin+ but CD71 - (a putative stem cell population), with apoptosis occurring in 
a median of 13% of stem cells, 20% of TA cells, and 9% of differentiating cells. 
In conclusion, we show that cell cycle is important in determining apoptosis 
susceptibility, and that stem and TA cells are sensitive to UV-induced apoptosis. 
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Photohardening restores the impaired neutrophil responsiveness to chemoattractants 
in patients with polymorphic light eruption
Akos Heinemann1, Alexandra Gruber-Wackernagel2, Viktoria Konya1, Scott N. 
Byrne3, Tej Pratap Singh2, Franz J. Legat2, Angelika Hofer2, Peter Wolf2 1Institute of 
Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria, 
2Research Unit for Photodermatology, Department of Dermatology, Medical University 
of Graz, Graz, Austria, 3Department of Infectious Diseases and Immunology, Sydney 
Medical School, The University of Sydney, Sydney, Australia
A failure to induce immune suppression after UV exposure has been implicated in the 
pathogenesis of polymorphic light eruption (PLE). This immunological resistance has 
been linked to an impaired neutrophil infi ltration into the skin following UV exposure. 
Therapeutic photohardening can restore this abnormal neutrophil infi ltration in PLE skin, 
and is thought to be responsible for the prophylactic effi cacy. The aim of this study was 
to elucidate the pathogenic mechanism of the described neutrophil defi ciency in PLE. 
Peripheral blood neutrophil responses to the chemoattractants leukotriene B4, LTB4 
and formyl-methionyl-leucyl-phenylalanin, fMLP were investigated in vitro.Samples 
from 10 PLE patients (9 female; 1 male; mean age 37 years; age range, 27 to 51 years) 
before and after 6 to 9 weeks of photohardening therapy (311-nm UVB or PUVA) were 
assessed. Flow cytometry was used to measure the changes associated with neutrophil 
activation. We found a signifi cantly reduced neutrophil responsiveness to LTB4 and 
fMLP in PLE patients (p < 0.01), which was restored to normal levels after phototherapy. 
Indeed, PLE neutrophil responsiveness to these two chemoattractants after (but not before) 
phototherapy was similar to that of age- and sex-matched healthy control subjects. 
This indicates that an abnormal chemotactic potential of neutrophils is a crucial factor 
in the pathogenesis of PLE. Normalization following photohardening may therefore 
account for the therapeutic effi cacy by restoring UV-induced neutrophil skin infi ltration.
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Patients with polymorphic light eruption have decreased levels of serum 25-hydroxy 
vitamin D: epiphenomenon or pathogenic factor?
Franz J. Legat1, Alexandra Gruber-Wackernagel1, Barbara Obermayer-Pietsch2, 
Scott N. Byrne3, Elisabeth Wehr2, Angelika Hofer1, Peter Wolf1 1Research Unit for 
Photodermatology, Department of Dermatology, Medical University of Graz, Austria, 
2Div of Endocrinology and Nuclear Medicine, Medical University of Graz, Austria, 
3Dept of Infectious Diseases and Immunology, The University of Sydney, Australia
Polymorphic light eruption (PLE) is a very common disease with an incidence of up to 20 
percent in young women between the ages of 20 and 40. The exact cause of the disease 
remains to be determined, however, an abnormal immune regulation with resistance to 
UV-induced immune suppression and simultaneous autoimmune reactions to photo-
induced neo-antigens have been implicated. Vitamin D3 has been linked via RANKL to 
the induction of T regulatory cells which is thought to play a role in the modulation of 
immunity following UV exposure. We therefore analysed 25-hydroxy vitamin D (25-OH-
VitD) serum levels by enzyme immunoassay in 24 PLE patients during different seasonal 
time points over the year: (1) early spring before photohardening, (2) late spring after 
photohardening therapy, (3) summer, and (4) winter. We found that PLE patients had 
signifi cantly decreased 25-OH-VitD levels, which were below normal limits throughout 
the year (mean values around 13 to 14 ng/ml), compared to age- and sex-matched 
control subjects (30 to 60 ng/ml). Prophylactic phototherapy with narrowband UVB 
(311nm) delivered for 6 to 9 weeks, 2 to 3 sessions per week, signifi cantly increased (by 
nearly 50%; p<0.000001) 25-OH-VitD serum levels in treated PLE patients. While low 
25-OH-VitD serum levels in PLE patients as an epiphenomenon cannot be excluded, 
another study from our laboratory shows that topical pretreatment with the synthetic 
vitamin D3 analogue calcipotriol, can be used to treat PLE patients. These studies 
indicate that low vitamin D levels may play an important role in the pathogenesis of PLE.
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2,4,6-octatrienol, a polyunsaturated alcohol, counteracts molecular markers of skin 
cell senescence
Stefania Briganti1, Enrica Flori1, Barbara Bellei1, Anna Benedusi2, Giammaria 
Giuliani2, Mauro Picardo1 1San Gallicano Dermatologic Institute, Rome, Italy, 
2Giuliani SpA, Milan, Italy
Parrodienes are synthetic congeners of psitaccofulvins a mixture of polyenals contained 
exclusively in Ara Macao red plumage. They possess a polyene structure and alcohol 
functional group and share some structural features with carotenoids, natural precursors 
of retinoids. Considering that both retinoids and carotenoids have been reported to repair 
UV-induced skin damage and to prevent aging phenomenon, we selected 2,4,6-octatrienol, 
one of the main components of parrodiene family, to study its ability to counteract photo-
accelerated cellular senescence, a phenomenon highly related to organism aging and tumor 
progression. For this purpose we adopted an experimental model based on single exposure 
of human dermal fi broblasts to 8-methoxypsoralen plus + ultraviolet-A-irradiation (PUVA) 
previously reported to activate a premature cell senescence characterized by an imbalance 
of cell antioxidant defence system.  PUVA-photoactivated fi broblasts grown in the presence 
of 2,4,6-octatrienol are partly, but signifi cantly rescued from the features of cellular 
senescence phenotype, such as cytoplasmic enlargement, expression of senescence-
associated-b-galactosidase and of matrix-metalloproteinase-1. The mechanisms by which 
2,4,6-octatrienol exerts its “anti-aging” effect does not involve a direct scavenging of PUVA-
induced reactive oxygen species, but a synergistic up-modulation of different components 
of cell antioxidant network, such as catalase or reduced glutathione, a preservation of cell 
membrane lipids such as phospholipids, or cholesterol, and the activation of intracellular 
pathways, linked to cell proliferation and anti-infl ammatory response. Moreover, 
2,4,6-octatrienol reverted p21 expression in PUVA-treated fi broblasts. Our data suggests the 
usefulness of 2,4,6-octatrienol as innovative molecule to counteract aging phenomenon. 
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UVB-311nm advances the clearance of psoriatic lesions in ustekinumab-treated 
patients
Wolfgang Weger, Angelika Hofer, Franz Josef Legat, Timea Posch-Fabian, Alexandra 
Gruber-Wackernagel, Martin Inzinger, Wolfgang Salmhofer, Peter Wolf Research Unit 
for Photodermatology, Dept of Dermatology, Medical University of Graz, Austria
Although the IL-12/23 blocking antibody ustekinumab exhibits high effi cacy in 
psoriasis, there remain about 30% of patients who do not reach a PASI75% reduction 
upon treatment. Therefore additional means of improving overall antipsoriatic 
response are needed in those patients. Similar to treatment with other biologics, one 
possibility is the combination with conventional systemic drugs, such as etretinate, 
methotrexate, and/or phototherapy. In a half-side comparison study we assessed 
whether additional 311nm-narrowband-UVB phototherapy (311nm) could add 
to therapeutic effi cacy of ustekinumab. Ten patients (5F/5M; mean age, 57 years; 
mean PASI, 13.4) with moderate to severe plaque-type psoriasis were enrolled and 
received ustekinumab 45 or 90mg s.c. depending on body weight (below or above 
100kg) at week 0 and 4. The patients were additionally treated for 6 weeks 3 times 
per week on a randomly selected body half (left or right side, except the head) with 
311nm and monitored weekly by half-body PASI. In one patient, study participation 
was stopped after 2 wks of 311nm due to a herpetic eruption. During the 6-week 
irradiation regimen, 311nm signifi cantly bolstered the therapeutic response. At 
wk6 PASI75% reduction was achieved in 7/9 (78%) vs. 1/9 (11%) comparing UV-
irradiated vs. non-irradiated body halves. The mean PASI reduction was 82% 
vs. 52% (p<0.005; paired t-test). At wk12 4/9 (44%) patients continued to have a 
better response on UV-irradiated body halves. This indicates that 311nm may be 
useful to improve the therapeutic outcome in psoriasis treated with ustekinumab, 
particularly in patients not satisfactorily responding to biologic treatment alone.
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Differential health gain of summer sunlight exposure in people of different skin 
types
Sarah Cooper1, Richard Kift2, Jacqueline Berry3, Marie Durkin1, Mark Farrar1, Ann 
Webb2, Lesley Rhodes1 1Dermatological Sciences, Epithelial Sciences Research 
Group, School of Translational Medicine, University of Manchester, UK, 2School of 
Earth Atmospheric & Environmental Sciences, University of Manchester,, UK, 3Vitamin 
D Research Laboratory, School of Biomedical Sciences, University of Manchester, UK
Public health policy advises limiting summer sunlight exposure, but provides no specifi c advice 
for darker-skinned people. This study assessed the relative vitamin D gain on following UK 
sunlight exposure recommendations in White Caucasians and South Asians. During wintertime 
(negligible ambient UVB), 86 volunteers (n=70 skin-type II, 16 skin-type V), 20-60y, Manchester, 
UK, received a simulated summer’s sunlight exposures, comprising 1.3SED, 3xweekly for 6wks, 
wearing T-shirt and UV-opaque shorts. Circulating 25(OH)D was evaluated by HPLC (n=60xII, 
10xV). A 10x10cm2 area of one buttock was left exposed (n=10xII, 6xV) and underwent 
spectrophotometric measurements. At course end, exposed and unexposed skin received an 
acute 2xMED challenge, with 24h measurements. Vitamin D status improved post-course, with 
signifi cant difference in 25(OH)D gain between types II (mean 10.2, SD7.5ng/ml) and V (4.6, 
1.9), p<0.05. Baseline L* (white-black differentiation) differed between groups, refl ecting higher 
pigmentation of V, p<0.01. The exposures darkened the skin, decreasing L* by 6.2(5.3), p<0.001, 
with 6% and 24% reduction in II and V respectively, and with strong negative correlation 
between L* decrease and 25(OH)D gain (R2= 0.94, 0.92; p<0.001). The simulated summer 
conveyed photoprotection, UV-treated skin demonstrating lower A* values (erythema) than UV-
protected skin after challenge with 2xMED, p<0.05, with 14% erythema protection in II and 50% 
in V. Thus, the same summer exposure conditions cause approximately half the 25(OH)D gain 
in darker than fair skin-types, with greater pigmentation gain contributing to this. More specifi c 
advice on sunlight exposure may be required for people of skin type V living at higher latitude.
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Little Effect on p63 but Signifi cant Effect on miR-21 and miR-125b by NB-UVB 
Phototherapy on Psoriatic Lesions
Xiaolian Gu1, Elisabet Nylander2, Philip Coates3, Karin Nylander1 1Dept of Medical 
Biosciences/Pathology, Umeå University, Umeå, Sweden, 2Dept of Public Health & 
Clinical Medicine/Dermatology & Venereology, Umeå University, Umeå, Sweden, 
3Dept of Molecular & Cellular Pathology, University of Dundee, UK
Psoriasis is an infl ammatory skin disease in which dysregulation of p63, a member of 
the p53 family and crucial for skin development and maintenance, has been shown. 
Though currently incurable, many therapies are available including narrowband 
ultraviolet B (NB-UVB) phototherapy. To further elucidate the role of p63 in psoriasis 
and increase our understanding of the mechanisms of phototherapy, we studied the 
effects of NB-UVB treatment on p63 expression. Expression of p53 was also studied 
due to its functional role in the response of skin to UV. In addition, we investigated 
expression of miR-203, miR-125b and miR-21, as these microRNAs are p63 and/or 
p53 regulators and their involvement in psoriasis pathogenesis has previously been 
suggested. Skin biopsies from 12 psoriasis patients were collected before, during and 
at the fi nal session of phototherapy. Real time RT-PCR and immunohistochemistry 
showed that epidermal p63 mRNA and protein levels were not signifi cantly affected 
following phototherapy, whereas a signifi cant increase in p53 mRNA expression 
and protein accumulation was found. NB-UVB treatment also signifi cantly affected 
expression of miR-21 and miR-125b, whereas individual clinical improvement 
seemed related to p53 status only. Our results indicate that even though NB-
UVB phototherapy causes diverse molecular changes, induction of p53 is pivotal 
for successful treatment of psoriasis, and unresolved p63 abnormality in the 
treated epidermis of psoriasis patients further indicate a role for p63 in psoriasis.
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Histidinemic mice are hypersensitive to ultraviolet B radiation-induced DNA 
damage
Leopold Eckhart1, Caterina Barresi1, Caroline Stremnitzer1, Veronika Mlitz1, 
Haiping Zhang1,2, Erwin Tschachler1,3 1Medical University of Vienna, Department 
of Dermatology, Vienna, Austria, 2Capital Medical University, Xuanwu Hospital, 
Department of Dermatology and Venerology, Beijing, China, 3C.E.R.I.E.S., Neuilly, 
France
Histidinemic mice carry a mutation in the gene encoding histidase, the enzyme 
that produces urocanic acid (UCA). The mutation is associated with greatly reduced 
histidase activity, UCA content and UVB absorption capacity of the stratum 
corneum. Here, we compared histidinemic mice and wild-type mice with regard 
to their sensitivity to ultraviolet (UV) B irradiation. The back skin of adult mice 
was shaved and exposed to 250 mJ/cm2 UVB. Newborn mice were sacrifi ced 
and exposed to 25 mJ/cm2 UVB either with or without prior topical application 
of UCA. DNA damage was quantifi ed by ELISA for cyclobutane pyrimidine 
dimers. Histidinemic mice accumulated signifi cantly more DNA damage than 
wild-type mice. Exogenous UCA reversed the UVB-photosensitive phenotype 
of histidinemic mice and increased UVB-photoprotection of wild-type mice. 
These results suggest that UCA protects mammalian skin against UVB radiation.
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UV-B irradiation induces epidermal up-regulation of heparanase expression and 
activity
Sandrine Kurdykowski1,3, Solene Mine3, Vincent Bardey3, Louis Danoux3, Christine 
Jeanmaire3, Gilles Pauly3, Eva Brabencova4, Yanusz Wegrowski1, François Xavier 
Maquart1,2 1Lab de Biologie Moléculaire et Biochimie Médicale, Fac de Méd, Reims, 
France, 2CHU de Reims, France, 3Labs Sérobiologiques, div de Cognis France, Pulnoy, 
France, 4Lab d’anatomie pathologique, Inst Jean Godinot, Reims, France
Heparan sulphate glycosaminoglycan (HSPG) is an abundant component of cell surfaces 
and extracellular matrix, and is mainly located in the basement membranes. It plays many 
roles such as in cell proliferation and differentiation, or in cell-matrix adhesion and assembly 
via protein interactions. It has been shown that HS expression decrease during ageing. 
Because UV-B irradiation from sun exposure is one of the most infl uent factor that promote 
skin ageing and because modulation of HSPG expression could be explained by changes in 
expression and function of its degrading enzyme, heparanase (HPSE) expression and activity 
were investigated after UV-B irradiation in normal human epidermal kératinocytes (NHEK). 
NHEK and reconstructed epidermis were submitted to increasing doses of UV-B. HPSE mRNA 
levels were measured using real time PCR and total enzymatic activity was quantifi ed using 
microtiter-based assay in human keratinocytes in culture. Expression and distribution of HPSE 
were also performed by immunohistochemistry on reconstructed epidermis. Our results 
showed that both HPSE mRNA level and total enzymatic activity were increased by UV-B 
in a time and dose-dependent manner in keratinocyte cultures. Protein expression of HPSE 
was also up-regulated according to the increasing dose of UV-B in reconstructed epidermis. 
In addition, we observed an intra-cellular localization of HPSE in all viable cell layers in 
both reconstructed epidermis and normal human epidermis. Increase of HPSE expression 
and activity in the epidermis after UV-B irradiation could contribute to skin photo-ageing.
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The role of vascular endothelial cells in PDT using porphyrin pre-cursors
Hannah C de Vijlder1, Henriette S de Bruijn2, Angelique van der Ploeg2, D Poel-Dirks3, 
Henricus JCM Sterenborg2, Ellen RM de Haas1, T L M ten Hagen3, Dominic Robinson2
1Erasmus Mc Dept Dermatology, Rotterdam, Netherlands, 2Erasmus Mc Dept 
Radiation Oncology, Rotterdam, Netherlands, 3Erasmus Mc Dept Surgical Oncology, 
Rotterdam, Netherlands
Using ALA we have shown in numerous studies that the effi cacy of ALA-PDT is 
signifi cantly improved by applying light fractionation. In pre-clinical models, PDT 
effi cacy using MAL is unaffected by adopting this approach. Our previous results 
show acute edema formation following ALA-PDT suggesting a role of endothelial 
cells. Cryosections of hairless mouse skin 4h after topical MAL or ALA application 
were stained with CD31. Co-localization with PpIX fl uorescence was investigated 
using spectral imaging under a confocal microscope. Images were analyzed using 
the single value decomposition algorithm to confi rm the presence of PpIX. This 
approach was used to analyze intra-vital confocal microscopy images of mouse skin 
chambers. We investigated the PpIX fl uorescence distribution in the vasculature in-
vivo during PDT. Fluorescein exclusion studies were performed to investigate the 
vascular response during illumination. PpIX fl uorescence at depth is found in cryo-
sections 4 hours after of ALA and PpIX is co-localized with vascular endothelial. 
The application of MAL shows less fl uorescence at depth and less PpIX localized 
in the skin vasculature. Intra-vital microscopy shows PpIX fl uorescence in tissue 
and endothelial cells/vasculature deep in mouse skin (even below the cutaneous 
muscularis). PDT studies show that there is a signifi cant vascular response to ALA-
PDT in the micro- vasculature close to the base of the epidermis that is absent during 
PDT with MAL. These results illustrate the signifi cant vasculature response following 
ALA -PDT and have clear implications for optimizing porphyrin pre-cursor PDT.
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Comparison of a mitochondrial and a nuclear CC to TT transition in human skin 
cells
Daniel Gebhard1, Bettina Mahler1, Katja Matt1, Katharina Burger1, Hubert M. 
Hug2, Jörg Bergemann1 1Hochschule Albstadt-Sigmaringen, Sigmaringen, Germany, 
2Kreiskrankenhaus Sigmaringen, Sigmaringen, Germany
CC to TT transitions in mitochondria and nucleus result from photo-induced 
cyclobutane pyrimidine dimers (CPDs). This damage is repaired by nucleotide 
excision repair (NER) in nucleus, but not in mitochondria. In this study we established 
an assay to quantify a CC to TT transition in mitochondrial DNA at bases 591/592 and 
then compared levels with a CC to TT transition in the p53 gene (codons 281/282). 
Fibroblasts and keratinocytes were isolated from human skin samples (n=7). DNA 
was isolated and then analyzed using probe-based allele-specifi c quantitative real-
time PCR. Copy numbers of mutated and not mutated DNA were determined for 
both positions to calculate mutation levels of mitochondrial and nuclear CC to 
TT transitions respectively. The p53 mutation was measured in four fi broblast cell 
cultures (1,81‰ - 6,46‰) and three keratinocyte cell cultures (5,81‰ - 13,44‰). In 
contrast to these fi ndings the mitochondrial CC to TT transition was only quantifi ed 
in one fi broblast sample (0,163‰) with levels remaining stable over fi ve passages. 
Compared to this, our previous work showed that levels of the p53 CC to TT transition 
signifi cantly declined during cell culture. Surprisingly, incidence and levels of the 
mitochondrial transition were much lower compared with the p53 transition. As 
CPDs remain stable in mitochondria and are removed in nucleus, we assume that 
these comparatively low mutation levels are caused by a replication disadvantage 
of mitochondrial DNA containing CPDs. This replication disadvantage might be 
an important mutation preventing mechanism and replace NER in mitochondria.
ABSTRACTS
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UVB induces HIF-1α in keratinocytes in two sequential phases
Norbert Wikonkál1, György Paragh1, Livius Wunderlich2, András Bánvölgyi1, Jozsef 
Mandl2, Sarolta Kárpáti1 1Semmelweis University School of Medicine Dept. of 
Dermatology, Budapest, Hungary, 2Semmelweis University School of Medicine Dept. 
of Medical Chemistry, Budapest, Hungary
Hypoxia in the skin is thought to play an important role in various changes that 
have long-term effects, such as chronic degenerative changes, infl ammation, 
photoaging and cancer. Vascular endothelial growth factor (VEGF) has been 
shown to be crucial player in these processes. Hypoxia inducible factor-1 (HIF-1) 
in a key regulator of the expression of VEGF which is also known to be affected 
by ultraviolet radiation. We studied the impact of a single UVB irradiation on 
the level of HIF-1 in keratinocytes by Western blots at various time points after 
irradiation. The physiological importance was confi rmed by measuring downstream 
target gene expressions by quantitative real-time PCR. UVB treatment resulted in 
an initial quick decrease of HIF-1a that was followed by a subsequent prolonged 
increase. These changes followed a strict timeline and were dose-dependent.
PI3K/AKT pathway is potentially involved in this response, so we set out to examine 
the mechanism underlying the upregulation of HIF-1α upon UVB irradiation. No 
change was observed in the total level of AKT after UVB, however, its phosphorylation 
level was found to be markedly higher. In accordance with these observations, 
wortmannin, an inhibitor of PI3-kinase effectively blocked the increase in HIF-1α. 
Similarly to previous fi ndings, UVB irradiation increased VEGF and HO-1 mRNA 
levels determined by quantitative real time PCR. It is shown that changes in HIF-
1α expression lead to a change in VEGF expression after UVB. It is presumed 
that UVB effects in the skin are partially mediated by the PI3K/AKT pathway.
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Evaluation of the impact of  810 nm laser diode irradiation on pigmented 
keratinocyte cultures‘ structure and apoptosis
Sylvie Callejon, Yongoua Sandjeu, Fabrice Pirot, Marek Haftek Université de Lyon 1, 
Lyon, France
Laser light is widely used for removal of dark hair from fair skin taking advantage 
of the localized thermolysis of pigment-rich structures. We used pigmented human 
epidermis cultures to evaluate the impact of 810 nm laser diode light on the tissue 
structure. In vitro reconstructed epidermis of phototype VI was subjected to variable 
doses of the laser radiation whereas ultraviolet light was used for irradiation of control 
cultures at „sunburn“ range (UVB+A 50 and 100 J/m²). The cultures were studied with 
light and electron microscopy at 24h after exposure. Qualitative and quantitative 
analysis showed a dose-dependent induction of morphological changes. Baseline 
TUNEL reactivity was observed on nuclear chromatin in normal non-irradiated 
tissue and was probably due to DNA breaks existing naturally or induced through 
tissue sectioning. TUNEL reaction could be quantifi ed with immunogold. The impact 
of UV irradiation was mostly focused on DNA alteration leading to selective cell 
apoptosis whereas laser exposure resulted in extensive necrosis of the lower part 
of the cultured epidermis. Lesions generated by the laser light were due to energy 
absorption by melanin contained in the basally located melanocytes. Superfi cial 
epidermal layers containing only sparsely distributed melanosomes were not visibly 
impacted by the laser treatment. Further studies are required to establish the outcome 
of depilatory laser treatment on tanned skin of phototypes I to IV, where increased 
number of melanosomes is likely to persist within the upper epidermal layers.
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Matrix Metalloproteinase (MMP)-7 Activates Heparin-binding EGF-like Growth 
Factor in Squamous Cell Carcinomas Complicating Recessive Dystrophic 
Epidermolysis Bullosa
Atte Kivisaari1, Markku Kallajoki1, Risto Ala-aho1, John McGrath2, Johann Bauer3, 
Radana Königova6, Marta Medvecz4, Wolfgang Beckert5, Reidar Grenman1, Veli-
Matti Kähäri1 1Univ of Turku, Finland, 2King’s College London, London, UK, 3General 
Hospital, Salzburg, Austria, 4Semmelweis Univ Budapest, Hungary, 5Lab for Histology 
and Cytology, Nürtingen, Germany, 6Charles Univ, Prague, Czech Republic
Tumour specifi c expression of matrix metalloproteinase (MMP)-7 has been noted in the 
cutaneous squamous cell carcinomas (SCC) in recessive dystrophic epidermolysis bullosa 
(RDEB) patients. Here, we have examined the potential role of MMP-7 in shedding of 
heparin-binding epidermal growth factor-like growth factor (HB-EGF) in RDEB-associated 
and sporadic SCCs. Tissue microarrays consisting of RDEB-associated SCCs (n=20), non-EB 
SCCs (n=60) and Bowen’s diseases (n=28) were immunostained for MMP-7, CD44 variant 
3 (CD44v3) and HB-EGF. Shedding of HB-EGF was studied in vitro using two cutaneous 
SCC cell lines. Immunohistochemical analysis showed that HB-EGF is absent in tumour 
cells when MMP-7 and CD44v3 co-localize, and that the absence of HB-EGF was more 
pronounced in RDEB-associated SCCs than in non-EB SCCs. The loss of HB-EGF in MMP-
7 – CD44v3 doublepositive areas was interpreted to indicate shedding and activation of 
HB-EGF and it was also detected in Bowen’s disease indicating its importance in the early 
phase of SCC development. Specifi c knockdown of MMP-7 expression in human cutaneous 
SCC cells by siRNA inhibited shedding of HB-EGF and resulted in diminished activation 
of epidermal growth factor receptor (EGFR) and ERK1/2, and in reduced proliferation 
of SCC cells. These fi ndings provide evidence for the role of MMP-7 in promoting the 
growth of cutaneous SCCs via shedding HB-EGF, and identify EGFR signalling as potential 
therapeutic target in RDEB-associated and unresectable sporadic cutaneous SCCs.
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Tumor suppressor activity of the developmental factor IRF6 in squamocellular 
carcinomas
Giulia Spallone1, Elisabetta Botti1, Francesca Moretti1, Valentina Pinetti1, Barbara 
Marinari1, Sergio Chimenti1, Luisa Guerrini2, Antonio Costanzo1 1University of Rome 
Tor vergata, Rome, Italy, 2Department of Biomolecular Sciences, Milan, Italy
The transcriptional regulator IRF6 is linked to the control of craniofacial development 
and epidermal proliferation. We have recently demonstrated that IRF6 is a component 
of a regulatory feedback loop that controls the proliferative potential of epidermal cells, 
being transcriptionally activated by DNp63 and inducing its proteasome-mediated 
downregulation, thereby limiting keratinocyte proliferative potential. Given the involvement 
of p63 gene in carcinogenesis, we have hypothesized that IRF6 could be also involved in skin 
carcinogenesis. Therefore, we analyzed IRF6 expression in a large series of squamocellular 
carcinomas fi nding strong downregulation of IRF6 that correlated with their invasive status. 
IRF6 downregulation seems to be mediated by methylation on a CpG island located in its 
promoter region. Exogenous expression of IRF6 in SCC cell lines induced  reduction in 
proliferation and colony formation. To identify the molecular mechanisms regulating IRF6 
potential tumor suppressive activity, we performed  gene expression analysis in primary 
human keratinocytes after siRNA-mediated IRF6 depletion.Interestingly., we found up-
regulation of cell cycle  related genes and down-regulation, among the others of 14-3-3sigma 
(stratifi n) expression. 14-3-3sigma protein is also involved in skin differentiation and is known 
to be activated by different kinds of DNA damage agents and to induce cell cycle arrest and 
tumor suppression  by hampering G2 to M progression and by inhibiting Akt kinase. We 
have found that IRF6 directly binds to 14-3-3sigma promoter and induces its transcription. 
Our data highlights a novel function for the developmental regulator IRF6 as tumor 
suppressor in skin carcinogenesis identifying 14-3-3sigma as one of potential mediators.
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Identifi cation and characterization of  SerpinA 1 as a Novel Biomarker for 
Progression of Cutaneous Squamous Cell Carcinoma
Mehdi Farshchian1, Atte Kivisaari1, Risto Ala-aho1, Markku Kallajoki2, Reidar 
Grenman3, Juha Peltonen4, Veli-Matti Kähäri1 1Dept of Dermatology, and Medicity 
Research Laboratory, Univ of Turku, Finland, 2Dept of Pathology, Turku Univ Hospital, 
Finland, 3Dept of Otorhinolaryngology, Head and Neck Surgery, Turku Univ Hospital, 
Finland, 4Dept of Anatomy & Cell Biology, Univ of Turku, Finland
The incidence of keratinocyte-derived nonmelanoma skin cancers is increasing globally due 
to cumulative recreational exposure to sunlight. No specifi c molecular markers are available 
for the early detection and progression of the invasive types of the cutaneous squamous cell 
carcinoma (SCC). In this study we have pinpointed the role of SerpinA1 in cutaneous SCC. 
Affymetrix based expression profi ling of SCC cell lines (n=8) revealed high expression of 
Serpin Peptidase Inhibitor Clade A Member 1, also known as alpha 1-antitrypsin or alpha 
1-proteinase inhibitor, compared to normal epidermal keratinocytes (n=5). Analysis with 
quantitative RT-PCR showed that SerpinA1 mRNA was markedly up-regulated in 8 cutaneous 
(p=0.03), 40 head and neck SCC cell lines (p<0.001), 4 cutaneous SCC tumors and 64 head 
and neck SCC tumors (p<0.001), as compared to corresponding normal cells and tissues. 
Western immunoblotting revealed production of SerpinA1 protein by all skin SCC cell lines 
(n=8), but only in 1 out of 5 normal keratinocyte strains. The highest SerpinA1 expression 
was observed in high grade head and neck SCCs (Grade 3), tumors of the larynx, and tumors 
with metastasis to lymph nodes. Immunostaining of tissue arrays with 148 samples revealed 
tumor cell-specifi c expression of SerpinA1 in 19 of 36 actinic keratosis, 22 of 29 Bowen’s 
disease, 67 of 71 sporadic SCCs and in all RDEB-associated SCCs (n=12). Taken together these 
in vitro and in vivo data provide evidence for an important role of SerpinA1 in progression 
of cutaneous SCC, suggesting it as an attractive diagnostic biomarker and therapeutic target.
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Endothelial cell-specifi c RAGE signaling sustains infl ammation and promotes tumor-
angiogenesis
Christoffer Gebhardt1,2, Fabian Kiessling3, Stefan Delorme1, Peter Paul Nawroth1, 
Angelika Bierhaus1, Bernd Arnold2, Alexander Enk1, Peter Angel2 1University Hospital 
Heidelberg, Heidelberg, Germany, 2German Cancer Research Center (DKFZ), 
Heidelberg, Germany, 3University Hospital Aachen, Aachen, Germany
Chronic infl ammation plays a pivotal role in the development of cancer. However, the mechanisms 
that sustain a tumor-promoting microenvironment remain largely elusive. Previously, we have 
shown that feed-forward signals downstream of the receptor for advanced glycation end-products 
(RAGE) can fuel chronic infl ammation, creating a microenvironment that promotes tumor 
formation. Mice defi cient for RAGE are resistant to DMBA/TPA-induced skin carcinogenesis and 
show severely reduced infl ammatory response to treatment with TPA accompanied by impaired 
infi ltration with subsets of innate immune cells and impaired upregulation of pro-infl ammatory 
genes. Interestingly, tumors in RAGE-defi cient mice showed severely reduced vascular density 
and impaired perfusion using confocal microscopy and perfusion-ultrasound-sonography. 
Furthermore, aortic rings explanted from RAGE-defi cient mice were characterized by impaired 
microvessel outgrowth and reduced activation of Rho, Rac, and Cdc42 as well as MMP2 and 
MMP9 expression revealing an important role of RAGE signaling in endothelial cell migration 
and endothelial progenitor cell recruitment. In order to elucidate an endothelial cell-specifi c role 
of RAGE signaling in vivo, we generated wildtype bone marrow chimeric Tie2 promoter-driven 
RAGE-defi cient mice (RageΔend). RageΔend show a signifi cantly altered infl ammatory response 
to TPA treatment characterized by impaired immune cell recruitment in the presence of epidermal 
hyperplasia thereby partly phenocopying non-conditional RAGE-defi cient mice. In conclusion, we 
provide direct genetic evidence for a novel endothelial cell-specifi c function of RAGE signaling in 
driving the strength and maintenance of an infl ammatory reaction during tumor-promotion and 
in promoting tumor angiogenesis thereby bridging the gap between infl ammation and cancer.
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Tumor derived CCL20 production critically contributes to angiogenesis and tumor 
progression 
Andreas Hippe1, Anne Schorr1, Anja Mueller-Homey2, Stefan Seeliger3, Katharina 
Jannasch4, Bettina Alexandra Buhren1, Jonathan Sleeman5,6, Nikolas Stoecklein7, 
Frauke Alves4, Thomas Hoffmann8, Bernhard Homey1 1Dept of Dermatology, Univ 
Hospital, Duesseldorf, 2Radiation Oncology, Univ Hospital, Duesseldorf, 3Pediatric 
Cardiol & Intens Care, Georg-August-Univ, Goettingen, 4Hematology & Oncology, 
Georg-August-Univ, Goettingen, 5Dept of Genetics, Univ of Karlsruhe, Germany, 
6Centre for Biomed & Med Tech, Mannheim, 7Gen-, Visceral- & Pediatric Surgery, 
Univ Hospital, Duesseldorf, 8Otorhinolaryngology, Univ Hospital Essen (all Germany)
Activation of the EGFR/Ras-signaling pathway is a crucial step in the malignant transformation of a wide 
variety of tumors. Modulation of gene expression by EGFR/Ras promotes cell proliferation and survival. 
Here, we demonstrate that the activation of Ras regulates chemokine expression in a dichotomic manner 
with an inducible set demonstrating pro-tumor and a repressible set showing anti-tumor properties. In 
particular, tumors enhance angiogenesis by upregulating the production of CCL20 through the activation 
of the EGFR/Ras-signaling pathway. In vivo, the chemokine CCL20 is over-expressed in melanoma, breast 
cancer, colon cancer, and head and neck squamous cell carcinoma in correspondance to increased ERK 
phosphorylation. Moreover, CCL20 expression is correlated to pT and pN status of tumor patients using 
large scale tissue microarrys and CCL20 expression negatively correlated to patients’ survival in breast 
cancer. Its specifi c corresponding receptor, CCR6, is abundantly expressed on endothelial cells in vitro and 
in vivo. Activation of CCR6 signaling in endothelial cells induces cell migration, in vitro-repair and leads 
to enhanced vessel formation. In vivo, CCL20 specifi cally induced increased vascularization of Matrigel 
plugs in wildtype mice, which was abrogated in CCR6-defi cient mice. Furthermore, CCL20-expressing 
B16F10 melanomas showed signifi cantly decreased tumor growth and vascularization in CCR6-
defi cient compared to wildtype using fl at panel volume computertomography. Collectively, our fi ndings 
identify a novel chemokine-driven mechanism of tumors to promote angiogenesis and progression.
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Polo-like kinase 1 inhibitors hold potential as targeted therapies for squamous cell 
carcinoma
Stephen Watt1, Celine Pourreyron1, John Foerster1, Carol Hogan1, Karin Purdie2, Leena 
Bruckner-Tuderman3, Charlotte Proby1, John McGrath4, Irene Leigh1, Andrew South1
1University of Dundee, United Kingdom, 2Queen Mary University of London, UK, 
3University of Freiburg, Germany, 4Kings College, London, UK
Squamous cell carcinoma (SCC), the most frequent neoplasm with malignant 
potential, burdens high risk groups such as immunosuppressed patients and those 
with recessive dystrophic epidermolysis bullosa, with increased incidence, metastasis 
and mortality. As yet, a specifi c therapy for SCC remains an unmet clinical need. We 
used integrative in vitro and in vivo expression profi ling followed by high-throughput 
RNAi screening to identify genes essential for SCC cell growth and survival. Cell 
viability following gene knockdown was assessed by the MTS assay. RNAi screening 
of 22 upregulated genes identifi ed by expression profi ling revealed several potential 
targets, of which polo-like kinase 1 (PLK1) produced the most potent decrease in 
SCC keratinocyte viability (40% ±2.7% of negative control siRNA), an effect not seen 
in normal human keratinocytes. This result was confi rmed in vitro and in vivo using 
PLK1 inhibitors: BI2536 and GW843682X decreased viability (9.5% ±2.8% and 
46.4% ±4.1% of control, respectively) and produced a potent cell cycle arrest (2.5-
fold increase in G2/M population) followed by apoptosis (5-fold increase in cleaved 
nucleosomes detected by ELISA) in vitro. In vivo, six cycles of intratumoural injection 
of BI2536 in SCC xenografts resulted in a marked reduction in tumour volume (10 day 
post-treatment average volume 201.7 ± 26 mm3 vs 440.5 ± 74.3 mm3 in control) and 
virtual ablation of tumour keratinocytes. We have shown effi cacy of PLK1 inhibition 
in vitro and in vivo and propose that PLK1 inhibitors represent a viable strategy for 
the treatment of cutaneous SCC.
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XPC silencing in normal human keratinocytes increases reactive oxygen species and 
triggers metabolic alterations that drive the formation of squamous cell carcinomas
Hamid Reza Rezvani1,2, Frédéric Mazurier1, Arianna Kim2, Nsrein Ali1, 
Meaghan Daly2, Hubert de Verneuil1, David R Bickers2, Alain Taieb1,3
1Inserm U876, Bordeaux, France, 2Columbia University, New York, NY, United States, 
3National Reference Centre for Rare Skin Disorders, Bordeaux, France
Genomic mutations, Warburg effect, and alterations in the levels of reactive oxygen 
species (ROS) are consistently observed in a variety of cancers. However, the inter-
relationships among these factors and their impact on the neoplastic process remain 
poorly understood. We took advantage of the intrinsic genomic instability arising in the 
nucleotide excision repair disease xeroderma pigmentosum C (XPC) to look at underlying 
molecular mechanisms. Here we show that shRNA-mediated knockdown of XPC in normal 
keratinocytes (KC) leads to the activation of the NADPH oxidase 1 which, in turn, results 
in 1) increased reactive oxygen species (ROS), 2) metabolic alteration through reduction 
of mitochondrial function but increased glycolysis, as defi ned by decreases in the NADH 
dehydrogenase subunit 1 and cytochrome c oxidase subunit III; and increases in proteins 
involved in glucose uptake and lactate generation. We also detected high levels of basal 
cell layer markers keratin 14, α6 and β1 integrin in epidermis reconstructed with XPC-
defi cient KC, which manifested epithelial hyperplasia with large and frequent extension 
of rete pegs, compared to control epidermis. These effects were also dependent on NOX1 
activation. Furthermore, XPC-defi cient KC formed SCCs in immunodefi cient mice, but 
NOX1 inhibition blocked this effect. Our results revealed that up-regulation of NOX1 alone 
has no effect on the induction of tumors, whereas NOX1 overexpression in XPC-defi cient 
KC has a synergistic effect on mitochondrial dysfunction and tumor formation. Our data 
indicate that NOX1 activation in cells lacking XPC contributes to high susceptibility to 
carcinogenesis and this may involve NOX1-mediated alteration of mitochondrial function.
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Calcineurin and ATF3: opposite role in keratinocyte cancer development versus 
senescence
Xunwei Wu1, Bach-Cuc Nguyen1, Piotr Dziunycz2, Sungeun Chang1, Yang 
Brooks1, Karine Lefort3, Günther Hofbauer2, G. Paolo Dotto1,3 1Cutaneous Biology 
Research Center, Massachusetts General Hospital, Charlestown, MA, United States, 
2Dermatology Dpt University Hospital Zürich, Zürich, Switzerland, 3Biochemistry Dpt 
University of Lausanne, Lausanne, Switzerland
Calcineurin inhibitors like cyclosporin A (CsA) are the cornerstone of 
immunosuppressive regimens for organ transplant recipients. Squamous cell 
carcinoma (SCC) of the skin is a major complication of treatment with these drugs, with 
a 65-100 fold higher risk than in the normal population.  By contrast, the incidence 
of basal cell carcinoma (BCC), the other major keratinocyte-derived tumour of the 
skin, of melanoma and of internal malignancies increases to a signifi cantly lesser 
extent. Here we report that genetic and pharmacological suppression of calcineurin/
NFAT function promotes tumour formation in mouse skin as well as in xenografts, 
in immune compromised mice, of H-rasV12 expressing primary human keratinocytes 
or keratinocyte-derived SCC cells. Calcineurin/NFAT inhibition counteracts p53-
dependent cancer cell senescence and associated decrease in tumourigenic 
potential. ATF3, a member of the “enlarged” AP-1 family, is selectively induced as 
a consequence of calcineurin/NFAT inhibition, both under experimental conditions 
and in clinically occurring tumours, and increased ATF3 expression accounts for the 
observed suppression of p53-dependent senescence and enhanced tumourigenic 
potential.  Thus, intact calcineurin/NFAT signalling is critically required for p53 
and senescence-associated mechanisms against keratinocyte tumour development.
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The production of gangliosides in actinic keratosis, basal cell carcinoma and 
squamous cell carcinoma
Ilinca Nicolae, Corina-Daniela Nicolae Dermatovenereological Research Center, 
Bucharest, Romania, 2University of General Medicine and Pharmacy Carol Davil, 
Bucharest, Romania
Gangliosides modulate several cellular functions: cell proliferation, intercellular 
adhesion, signal transduction, apoptosis, angiogenesis. The analysis of  gangliosides 
production in benign and malignant non-melanoma cutaneous tumors. The present 
study included specimens like: 16 actinic keratosis, 23 basal cell carcinoma, 37 
squamous cell carcinoma, 17 normal skin. The analysis of gangliosides included 
: Svennerholm method, Folch partition, thin layer chromatography and resorcinol 
reaction for quantitative analysis. In actinic keratosys, gangliosides concentrations 
in tumor, peritumoral tissue and normal tissue are almost equal. (t=0,274, p>0,05 
in tumoral tissue; respectively t =0, 813, p>0,05 in peritumoral tissue compared to 
normal skin). In basal cell carcinoma, gangliosides concentrations has statistically 
signifi cant increases in tumor compared with normal skin. (t= 2,376, p<0,05). 
The gangliosides values for peritumoral tissue are not different of the values for 
normal tissue. ( t = 0,891, p>0,05) In squamous cell carcinoma, gangliosides 
concentration has statistically signifi cant variations both in tumor and peritumoral 
tissue compared with normal skin ( t = 5,171, p<0,05, respectively t = 4,437, p < 
0,05). The composition and production of gangliosides is altered in non-melanoma 
tumors. The production of gangliosides can be used as a criteria for the differentiation 
of benign and  malignant proliferations and also for, potentially metastatic 
lessions.The quantifi cation of gangliosides in correlation with other histological 
markers can be the scientifi c support for modern treatment in cutaneous cancer.
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Skin cancer occurrence on antimetabolites Azathioprine and Mycophenolate 
mofetil
Nadine Leinweber, Andreas Serra, Lars French, Rudolf Wüthrich, Günther FL Hofbauer
University Hospital Zurich, Zurich, Switzerland
Renal transplant recipients develop 60-fold to 100-fold more squamous cell 
carcinoma of the skin. For some time it has been argued azathioprine may be 
deleterious due to photosensitzation of the skin to UVA and direct DNA damage 
enabled by UVA in comparison to other antimetabolites such as mycophenolate 
mofetil. In this retrospective study of the University Hospital in Zurich the intention 
was to clarify whether and how many cases of epithelial skin cancer occurred in 
renal transplant patients. The following inclusion criteria had to be met: fi rst kidney 
transplantation only, immunosuppression for at least 7 years of which at least 70% 
of the time with azathioprine or mycophenolate. Based on patient records from 
the Dermatology Department of the University Hospital in Zurich, we identifi ed 
101 eligible patients for our study. Thereafter, patients were contacted by phone 
to fi nd further treating physicians. These doctors were asked to provide us with all 
fi ndings of previous skin biopsies. Out of 50 patients treated with mycophenolate, 
36% had developed at least one squamous cell carcinoma of the skin. 56.8% 
of 51 patients treated with azathioprine developed at least one squamous cell 
carcinoma of the skin. Further analyses for confounders will be presented.
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Squamous cell carcinoma of the skin shows a distinct microRNA profi le modulated 
by UV radiation
Piotr Dziunycz1, Guergana Iotzova-Weiss1, Jyrki Eloranta2, Severin Läuchli1, Jürg 
Hafner1, Lars French1, Günther Hofbauer1 1Department of Dermatology, Zurich 
University Hospital, Zurich, Switzerland, 2Division of Clinical Pharmacology and 
Toxicology, Zurich University Hospital, Zurich, Switzerland
Cutaneous squamous cell carcinoma (SCC) is the second most common skin malignancy 
in the general population with ultraviolet radiation as most important risk factor. 
Immunosuppression dramatically increases SCC as seen in organ transplant recipients 
(OTRs) with a 60-100 fold increased SCC incidence, making it the most common malignancy 
in these patients. Recent work has revealed the existence of a class of small non-coding 
RNA species known as microRNAs, which have critical functions across various biological 
processes. We investigated the expression of four selected microRNAs in cutaneous SCC: 
miR-21, miR-184 for both of which oncogenic properties have been reported, miR-203 as 
keratinocyte-specifi c microRNA, and miR-205 as antagonist of miR-184. Using RT-PCR we 
measured expression of these microRNAs in SCCs of OTR and immunocompetent patients. 
We found increased expression of miR-21 and miR-184, decreased levels of miR-203 and no 
difference in miR-205 expression between SCC and normal skin. There were no differences 
between OTR and immunocompetent patients. We further investigated the infl uence of UV 
radiation on expression of these microRNAs in normal human keratinocytes and found 
signifi cant increases in miR-21, miR-203 and miR-205 expression after UVA radiation, while 
UVB induced miR-203 expression, decreased expression of miR-205 and had no infl uence 
on miR-21 levels. Moreover, UVA/UVB infl uence on miRs expression did not depend on 
cyclo-oxygenase activity. Taken together, our results show that miR-21, miR-203 and miR-
184 expression are altered in cutaneous SCC. We show that UV radiation impacts microRNA 
expression pattern, suggesting a possible early role for these miRNAs in SCC development.
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Infl ammation as a driver of Squamous Cell Carcinoma of the skin
Guergana Iotzova-Weiss1, Piotr Dziunycz1, Thomas Vogl1, Guenther Hofbauer1
1Dermatology Clinic, Zurich, Switzerland, 2Inst for Immunology, Muenster, Germany
Squamous cell carcinoma (SCC) is a common skin neoplasm characterized by 
infi ltrative, destructive growth and metastasis. SCC is the most common neoplasm in 
organ transplant recipients on long-term immunosuppression and occurs 60-100 fold 
more frequently than in the general population. In this study, we present the receptor 
for advanced glycation end products (RAGE) and its ligand S100A8/9 as a link between 
infl ammation and the development of human SCC. It was recently reported that RAGE 
defi cient mice are resistant to DMBA/TPA-induced carcinogenesis and exhibit a severe 
defect in sustaining infl ammation. Moreover, a relation between RAGE expression 
and the infl ammatory proteins S100A8 and S100A9 was proposed. We therefore 
investigated the role of RAGE and the S100 proteins in the development of human SCC. 
RAGE, S100A8 and S100A9 were transcriptionally upregulated in SCC with respect 
to normal epidermis and in SCC of OTR with respect to SCC of IC patients. We were 
able to induce the proliferation of human SCC-derived keratinocytes  by exposure to 
exogenous S100A8/9 which in turn was abolished by directly blocking RAGE. The 
migratory activities of normal and SCC-derived keratinocytes were also increased 
upon exposure to S100A8/9. We hypothesize that RAGE and its ligand S100A8/9 
contribute to the development of human SCC by modulating keratinocyte growth 
and migration, thus linking infl ammation and cancer development. These processes 
do not seem to be impaired by profound drug-mediated immunosuppression in OTR.
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The relationship between 24-hour urine melatonin level and skin Cancers
Reza Ghaderi, Samineh Sehatbakhsh, Mahmoud Zardast, Gholam reza Sharifzade
Birjand University of Medical Sciences, Birjand, Iran, Islamic Republic of
It has been postulated that in industrialized societies rapid light exposure at night by 
suppressing melatonin production poses a new risk for the development of breast 
cancer and perhaps other cancers like skin cancers as well. Therefore we decided to 
compare 24 -hour urinary melatonin level in skin cancers with control group. In this 
Case - Control study (studied group comprised 70 patients with skin cancer and control 
group comprised 70 healthy volunteers) we matched each group according to age and 
sex.After we collected testimonial from persons that attended in study, information 
of each person including: History of smoking, amount of daily sleeping, daily 
exercise and BMI recorded in a questionnaire that was admitted by a Dermatologist. 
The subjects collected the total volume of urine excreted during a 24-hour period. 
Melatonin in urine was calculated using ELISA method. Then data was analyzed using 
SPSS software, t, Manvitni, Kruskal Wallis and chi-square tests. Average and mean of 
24 -hour urinary melatonin level in case group was 15.9 ± 8.1 and 15.5, and in control 
group was 52.3 ± 50.4 and 47.4, that test showed signifi cant deference  between 
two groups.(Z=8.42, P<0.001) In this case - control study, there was a signifi cant 
relationship between skin cancers and low level of 24- hour urinary melatonin 
level that can set forth role of melatonin in prevention or treatment of skin cancer.
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Calcipotriol reduced induction of MMP-9 and MMP-13 in human squamous cell 
carcinoma cell line
Jitlada Meephansan, Mayumi Komine, Mamitaro Ohtsuki Jichi Medical University, 
Tochigi, Japan
VitaminD is a well-known, potent regulator of cell growth, differentiation, cell death, 
tumor invasion and angiogenesis. Production of MMP-9 and MMP-13 by tumor 
cell may facilitate tumor growth, invasion and metastasis. We aimed to investigate 
whether calcipotriol can suppress the expression of MMP-9 and MMP-13 in human 
SCC cell line [DJM cells] and to examine the mechanism of modulation of MMP-9 
and MMP-13 by calcipotriol in TNF-α treated DJM cells. The protein and mRNA levels 
of MMP-9 and MMP-13 were examined with ELISA and real-time PCR, respectively. 
Activation of signaling cascades was assessed by utilizing several inhibitors of 
signaling molecules, and by Western blot analysis. Twelve samples from patients 
with actinic keratosis, bowen disease and SCC were stained with MMP-9 and MMP-
13 antibodies. Production of MMP-9 and MMP-13 markedly increased when the 
cells were treated with TNF-α. Calcipotriol suppressed the production of MMP-9 and 
MMP-13 signifi cantly in a dose dependent manner at the protein and mRNA levels. 
Induction of MMP-9 and MMP-13 by TNF-α was partially dependent on NF-κB. 
Suppression of MMP-9 by calcipotriol was dependent on ERK, while the suppression 
of MMP-13 was dependent on p38. Calcipotriol partially inhibited activation of NF-
κB by TNF-α, which may contribute to the suppression of MMP-9 and MMP-13.
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Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix 
composition -dependent effector of MT1-MMP activity and tumor cell invasion
Olga Tatti, Mariliina Arjama, Jorma Keski-Oja, Kaisa Lehti Helsinki University, 
Helsinki, Finland
Membrane-type matrix metalloproteinases MT1- and MT2-MMP promote tumor cell 
invasion through basement membranes and collagen type I-rich tissues, whereas the 
functions of MT3-MMP in tumor invasion have remained less clear. Interestingly, 
MT3-MMP has been reported to be overexpressed in human melanoma selectively 
in the most aggressive nodular type tumors. We demonstrate here that MT3-MMP 
inhibits MT1-MMP-driven melanoma cell sprouting and single cell invasion in 
three-dimensional collagen, thus resulting in restricted, yet MT1-MMP-dependent 
expansion of compact cell colonies. In WM852 cells that have been originally 
isolated from nodular human melanoma, endogenous MT3-MMP expression 
was associated with rapid fi brin invasion and unexpectedly limited MT1-MMP-
driven collagen invasion, both of which were reversed by siRNA-mediated MT3-
MMP gene silencing. Consistent with such reverse matrix composition-dependent 
MT3-MMP functions, MT3-MMP overexpression reduced collagen invasion in 
parallel with increased fi brin invasion of Bowes cells with superfi cially spreading 
melanoma origin. Rather than altering MT1-MMP transcription, catalytically 
active MT3-MMP interacted with MT1-MMP thus impairing the proinvasive MT1-
MMP activity in collagen. While MT3-MMP, unlike MT1-MMP, is not universally 
overexpressed in primary melanoma, it was signifi cantly upregulated in pathologic 
specimens of human melanoma metastasis to lymph nodes. MT1-MMP-MT3-
MMP interactions thus seem to provide tumors with a novel mechanism to restrict 
local cell invasion but allow nodular tumor cell growth in collagen-rich tissues 
such as skin, while simultaneously promoting invasive spread into distant sites.
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Characterization and prognostic value of distinct Merkel Cell Polyomavirus 
molecular features in tumor and non tumor specimens from patients with Merkel 
Cell carcinoma
Hélène Laude1,4, Bénédicte Jonchère1,4, Eve Maubec3, Agnès Carlotti1, Eduardo 
Marinho3, Bertrand Couturaud2, Marianne Peter2, Xavier Sastre-Garau2, Marie-
Françoise Avril1,4, Nicolas Dupin1,4, Flore Rozenberg1,4 1Hôpital Cochin, Paris, France, 
2Institut Curie, Paris, France, 3Hôpital Bichat, Paris, France, 4Université René Descartes, 
Paris, France
Merkel Cell Polyomavirus (MCPyV) is associated with Merkel Cell carcinoma. MCPyV 
causal role was highly suggested by monoclonal integration of its genome and expression of 
the viral large T antigen in MCC cells. We investigated and characterized MCPyV molecular 
features in MCC, respiratory, urine and blood samples from 33 patients by quantitative PCR, 
sequencing and detection of integrated viral DNA. We examined associations between 
either MCPyV viral load in primary MCC or MCPyV DNAemia and survival. Patients with 
MCC containing above 1 copy MCPyV per cell had longer survival in complete remission 
than patients with less than 1 copy per cell (34 vs 10 months, P = 0.037). PBMC contained 
MCPyV more frequently in patients sampled alive with disease than in patients in complete 
remission (60% vs 11%, P = 0.00083). The detection of MCPyV in at least one PBMC 
sample during follow-up was associated with shorter overall survival (P=0.003). Sequencing 
of viral DNA from MCC and non MCC samples characterized common single nucleotide 
polymorphisms defi ning 8 patient specifi c strains. However, specifi c molecular signatures 
truncating MCPyV LT were observed in 8/12 MCC cases but not in respiratory and urinary 
samples from 15 patients. New integration sites were identifi ed in 4 MCC cases. Finally, 
mutated-integrated forms of MCPyV were detected in PBMC of two patients with disseminated 
MCC disease, indicating circulation of metastatic cells. We conclude that MCPyV molecular 
features in primary MCC tumor and PBMC may help to predict the course of the disease. 
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P53 mutation at early stages of keratinocyte transformation impairs TGFbeta 
sensitivity by downregulating IKKa expression
Elisabetta Botti1, Alessandro Di Stefani1, Francesca Moretti1, Barbara Marinari1, Giulia 
Spallone1, Valentina Pinetti1, Sergio Chimenti1, Lorenzo Cerroni2, Antonio Costanzo1
1Department of Dermatology, University of Rome Tor Vergata, Rome, Italy, 
2Department of Dermatology, Medical University of Graz, Austria
It has been proposed that actinic keratosis (AK) and squamous cell carcinoma (SCC)  are 
merely stages in evolution of a continuous process. Cancer-related molecular alterations 
are found in both AK and SCC. In particular dysregulation of the p53 pathway appears 
to be an early event in SCC carcinogenesis, together with disruption of TGFbeta tumor 
suppressive activity.We have previously described that IKKalpha is a DNp63 transcriptional 
target acting as a component of TGFbeta tumor suppressive pathway and that its 
downregulation  in SCC progression correlates with the loss of TGFbeta anti-proliferative 
activity.The aim of our study was to  determine when IKKa downregulation occurs in skin 
carcinogenesis and its relation with disruption of p53 pathway. Therefore, we analyzed 
the expression levels of IKKa and p53 in skin biopsies from patients affected by lesions 
at different stages of keratinocyte transformation. We observed that downregulation of 
IKKa expression already occurs at early stages of transformation (AK stage I)  correlating 
with mutant p53 accumulation in transformed keratinocytes.To study the molecular 
mechanisms underlying this observation we used a SCC cell line carrying thermosensitive 
p53. Induction of p53mutant conformation by temperature shift leads to downregulation 
of IKKa expression at both protein and mRNA level suggesting that mutant p53 may 
interfere with DNp63-mediated IKKa induction.These results suggest that p53 mutation 
may interfere with TGFbeta tumor suppressive pathway by inhibiting IKKa transcription 
in transforming keratinocytes. Increased knowledge of the interplay between p53, p63, 
IKKa and TGFbeta pathway will help in the identifi cation of innovative therapeutic targets.
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Complement Factor H and Complement factor H-like protein 1 in Cutaneous 
Squamous Cell Carcinoma
Pilvi Riihilä1, Risto Ala-aho1, Markku Kallajoki2, Reidar Grénman3, Seppo Meri4, 
Juha Peltonen5, Veli-Matti Kähäri1 1Dept of Dermatology & Venereology, & MediCity 
Research Laboratory, Univ of Turku, Finland, 2Dept of Pathology, Turku Univ Hosp, 
Finland, 3Dept of Otorhinolaryngology, Head & Neck Surgery, Turku Univ Hosp, 
Finland, 4Haartman Institute, Univ of Helsinki, Finland, 5Dept of Anatomy & Cell 
Biology, Univ of Turku, Finland
The incidence of cutaneous squamous cell carcinoma (SCC) and its precancerous forms is 
increasing globally. Infl ammation is a typical feature of cutaneous SCC. We have investigated 
the expression of complement system inhibitors in cutaneous SCC cell lines (n=8) and in 
normal human epidermal keratinocytes (n=5) by Affymetrix based expression profi ling and 
quantitative real time RT-PCR (TaqMan). In addition, expression of complement inhibitors was 
examined in tissue arrays generated from cutaneous SCCs (n=65) and actinic keratoses (n=37) by 
immunohistochemistry (IHC). The mean expression level of complement inhibitors Complement 
factor H (CFH) and Complement factor H-like protein1 (FHL-1) mRNAs was increased up to 12-fold 
and 24-fold, respectively, in SCC cells compared to normal keratinocytes. The expression of CFH 
and FHL-1 mRNAs was also signifi cantly higher in SCC tumors (n=5) than in normal skin (n=2) 
(p=0.047). IHC of SCC tissue arrays revealed that CFH was specifi cally expressed by tumor cells 
and the staining intensity increased during tumor progression from premalignant lesions (actinic 
keratoses) to invasive SCCs. The production of CFH and FHL-1 by SCC cells was up-regulated by 
by infl ammatory cytokines IL-1β and IFN-γ at mRNA and protein level, as detected by Western 
blotting. Complement factor 3 (C3) cleavage product C3c was detected in media of SCC cells and in 
tumor tissue indicating CFH and FHL-1 activity. These results show that cutaneous SCC cells express 
inhibitors of the complement system, which may play a role in SCC progression. These results 
suggest complement inhibitors as potential diagnostic markers and therapeutic targets in skin SCCs.
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A study on the prognostic value of clinical and histopathological features of 
dermatofi brosarcoma protuberans in Korean patients
Min Ji Kim1,2, Meesoo Chang1,2, Soyun Cho1,2 1Seoul National University Boramae 
Hospital, Seoul, Korea, Republic of, 2Seoul National University College of Medicine, 
Seoul, Korea, Republic of
Dermatofi brosarcoma protuberans(DFSP) is a rare spindle cell tumor with locally 
aggressive characteristics. Only few studies on the epidemiology of DFSP in Asian 
have been studied, and racial difference of the tumor has not been reported yet. 
The purpose of the study was to evaluate the epidemiological, clinical and 
histopathological characteristics of DFSP in Korean patients and determine the 
prognostic factors that affect disease-free survival. We conducted retrospective 
review of patients diagnosed with primary or recurrent DFSP between 2000 and 
2009 at Seoul National University Hospital and Boramae Hospital. Patient, tumor 
and treatment factors were analyzed for local recurrence-free survival. Pathologic 
slides were reviewed in available cases and classifi ed into subtypes. We analyzed 
data for 65 patients, of whom 36 (55.4%) were female. The mean age at disease onset 
was 34.4 years with 50% aged between 20 and 40 years. Involved sites were most 
often on trunk (66.1%). Among them, 58 patients underwent a radical excision and 
6 (9.2%) patients experienced local recurrence during 3.6 years of follow-up. Three 
cases (5%) had visceral metastasis, and 2 of them died of the disease. The recurrence-
free survival was signifi cantly related to the microscopic margins (P=0.01) and level 
of tumor invasion (P<0.005) in univariate analysis. On histopathologic study of 31 
cases, subtypes included conventional (17 cases), with myxoid degeneration (4 cases), 
Bednar (3 cases), myoid (5 cases) and fi brosarcomatous change (2 cases). c-kit staining 
for mast cell count showed negative correlation with mitosis and tumor size (P<0.05).
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Investigation of VEGF signaling on human angiosarcoma using a novel experimental 
mode
Daichi Hoshina, Riichiro Abe, Naoya Yoshioka, Hiroo Hata, Yasuyuki Fujita, Satoru 
Aoyagi, Hiroshi Shimizu Hokkaido University Graduate School of Medicine, Sapporo, 
Japan
Among human neoplasm, angiosarcoma is one of the most life-threatening. The limitation 
of experimental model of angiosarcoma has resulted in the delay of the clarifi cation of its 
biology and the development of effective therapeutic procedures. So far we have succeeded 
in establishing a novel experimental model of human angiosarcoma. Newly established 
human angiosarcoma cell line, HAMON, expressed endothelial cell surface markers such as 
CD31, VEGFR2 and Tie2. HAMON formed irregular vessel-like structures in tube formation 
assay, and had tumorigenic potency in NOD/Scid mice. Alongside it, human angiosarcoma 
tissue has been serially passaged in NOD/Scid mice and is available as in vivo experimental 
model. Although VEGF is assumed to be a key molecule for angiosarcoma biology, actual 
impact of VEGF signaling on angiosarcoma has not been fully elucidated. In this study, 
we investigated VEGF signaling on angiosarcoma and performed therapeutic experiments 
targeting VEGF signaling with recombinant anti-human VEGF antibody (bevacizumab) and 
receptor tyrosine kinase inhibitor (sunitinib). HAMON expressed not only human VEGF 
and VEGFR2 but also phosphorylated VEGFR2 constantly. Therapeutic experiment with 
bevacizumab reached growth inhibition both in vitro and in vivo, suggesting that VEGF 
positively regulated angiosarcoma growth. On the contrary, sunitinib treatment led to the 
increase of VEGF expression and tumor growth, implying that blocking of VEGR2 resulted 
in compensatory VEGF production and led to the promotion of angiosarcoma tumor growth. 
These results suggest that VEGF signaling on angiosarcoma is autoregulated through autocrine 
or paracrine loop and that the inhibition of VEGFR2 is insuffi cient to control angiosarcoma.
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Keratinocyte Growth Factor Specifi c Gene Expression Signature Associates with 
Reduced Invasiveness of Cutaneous Squamous Carcinoma Cells
Mervi Toriseva1, Risto Ala-aho1, Reidar Grenman2, Juha Peltonen1, Veli-Matti Kähäri1,2
1University of Turku, Turku, Finland, 2Turku University Hospital, Turku, Finland
We have studied the role of keratinocyte growth factor (KGF, FGF-7), a fi broblast-
derived keratinocyte mitogen and differentiation factor, in squamous cell carcinoma 
(SCC) of the skin. The levels of KGF mRNA determined by quantitative RT-PCR were 
similar in cutaneous and head and neck SCCs (HNSCCs) (n=58), as in corresponding 
normal tissue samples (n=12). The expression of KGF receptor (KGFR) mRNA 
was lower in cutaneous SCCs and HNSCCs (n=58) than in normal tissues (n=14). 
Expression of KGFR mRNA was similar or higher in cutaneous SCC cell lines (n=7) 
than in normal keratinocytes, and the levels were reduced by 24-h treatment with KGF. 
Gene expression profi ling (Affymetrix) of three cutaneous SCC cell lines treated with 
KGF for 24 h revealed a specifi c gene expression signature with down-regulation of 
various genes up-regulated in SCC cells compared to normal epidermal keratinocytes, 
including matrix metalloproteinase-13 (MMP-13). KGF induced rapid activation of 
ERK1/2 in SCC cell lines (n=4) and resulted in ERK1/2-dependent down-regulation of 
MMP-13 expression, determined with quantitative RT-PCR and immunoblotting. KGF 
treatment also resulted in reduced invasion of SCC cells through collagen. These results 
show that cutaneous SCC cells are responsive to KGF, resulting in down-regulation of 
KGFR, in specifi c gene expression signature and in reduced invasion capacity of the 
cells. These results suggest that KGF does not promote progression of cutaneous SCC, 
but rather suppresses the malignant phenotype of cutaneous SCC cells by inhibiting 
the expression of several genes specifi cally up-regulated in SCCs, including MMP-13.
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Topical treatment with imiquimod suppressed UVB-induced skin carcinogenesis in 
a mouse model 
Maki Yokogawa1, Shogo Takamura1, Mikiro Takaishi1, Ken Miyoshi1, Mitsunori Ikeda1, 
John DiGiovanni2, Shigetoshi Sano1 1Kochi University, Nankoku, Kochi, Japan, 
2University of Texas, Austin, Texas, United States
Constitutive activation of Stat3 has been found in a wide spectrum of human 
malignancies including skin cancer. Critical role of Stat3 signaling in the skin 
carcinogenesis was demonstrated by our previous studies. K5.Stat3C mice, in which 
active form of Stat3 is expressed in the skin, developed skin tumors with a shorter 
latency compared with wild-type mice by DMBA / TPA treatment or UVB irradiation. 
Their tumors rapidly progressed to squamous cell carcinoma (SCC), indicating that 
Stat3 activation contributed to early development of cancer. In our previous study 
the majority of K5.Stat3C mice showed precancerous lesions, which resemble the 
histological features of human actinic keratosis, on the ears by UVB irradiation. The 
lesions were soon converted to SCCs by continuous UVB irradiation. Imiquimod, a 
small molecule toll-like receptor 7 antagonist, has been used for the treatment of skin 
cancers/precancerous conditions, including basal cell carcinoma, Bowen’s disease, 
Paget disease, and actinic keratosis. Here, we examined whether topical imiquimod 
treatment affected the progression of UVB-induced cancer in the ears of K5.Stat3C 
mice. Topical imiquimod 5% cream treatment onto the right ears, during the 
progressive stage of UVB-induced carcinogenesis, markedly inhibited the growth of 
cancers, compared with that in the left ears. Histopathological examination revealed 
that many infl ammatory cells including plasmacytoid dendritic cells infi ltrated beneath 
the epidermis with nuclear atypicality, suggesting an anti-cancer effect of the innate 
immunity. Thus, K5.Stat3C mouse represented not only a skin cancer-prone mouse 
model, but also provided a platform to study the anti-cancer mechanism of imiquimod.
ABSTRACTS
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Expression of human constitutive photomorphogenic protein-1 in melanocytic and 
non-melanocytic skin lesions
István Balázs Németh1, Tibor Krenács2, Gergo Kiszner2, Erika Varga1, Ágnes Kinyó1, 
Ferenc Nagy4, Lajos Kemény1,3 1Dept of Dermatology & Allergology, University of 
Szeged, Hungary, 21st Department of Pathology, Semmelweis University, Budapest, 
Hungary, 3Dermatological Research Group of the Hungarian Academy of Sciences & 
University of Szeged, Hungary, 4Biological Research Center, Szeged, Hungary
Consitutive photomorphogenic protein (COP1) is a key regulator in light dependent plant 
development. COP1 is highly conserved across species and was also detected in mammalian 
cells. We have recently found that human COP1 (huCOP1) plays an important role in the 
UVB-induced signalling of human keratinocytes as a negative regulator of p53. Since p53 
plays an important role in photocarcinogenesis we studied the topographical expression 
profi le of huCOP1 and p53 proteins in human skin using tissue microarray technique, 
huCOP1 and p53 immunohistochemistry with digital scanning microscopy. Normal and 
most perilesional epidermis exhibited consistent huCOP1 expression in basal keratinocytes 
with a cytoplasmic dominance, p53 expression in normal epidermis was strictly restricted to 
basal keratinocytes. Among non-melanocytic lesions, acanthomas showed similar huCOP1/
p53 topography, in actinic keratoses huCOP1/p53 expression was extended parallel with 
hyperproliferation of basal keratinocytes. Bowen’s keratoses did not alter the pattern of 
huCOP1. In basal and squamous cell carcinoma focal huCOP1 and increased p53 expression 
could be detected. In melanocytic lesions, none of the nevi showed pronounced huCOP1/
p53 positivity compared to normal epidermis. In malignant melanomas, huCOP1/p53 
expression intensity and number of positive cells gradually increased from lentigo maligna 
melanomas to superfi cial and nodular melanomas. Our expression data suggest that huCOP1 
expression is lesion-specifi c, displaying both synergistic and antagonistic changes with 
p53, suggesting lesion specifi c alternative pathways of UVB-induced skin carcinogenesis.
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Subcutaneous Panniculitis-Like T-Cell Lymphoma Shows A Molecular 
Signature  Characteristic For Autoimmune Diseases
Pilvi Maliniemi1, Sonja Hahtola1, Liisa Väkevä1, Kristian Ovaska2, Leila Jeskanen1, 
Rudolf Stadler3, Kirsi Niiranen1, Sampsa Hautaniemi2, Annamari Ranki1 1Helsinki 
Univ Hospital, Dept of Dermatology, Finland, 2Institute of Biomedicine, Univ of 
Helsinki, Finland, 3Dept of Dermatology, Medical Center Minden, Minden, Germany
Subcutaneous panniculitis-like T-cell lymphomas (SPTL) with an α/β T-cell phenotype 
represent a group of cutaneous T-cell lymphomas (CTCL) diffi cult to diagnose and affecting 
mainly young people. The prognosis of SPTL and response to systemic steroids are usually 
favourable. Overlapping features with lupus erythematosus (LE) profundus may occur 
and  SPTL patients often have a concomitant diagnosed autoimmune disease or at least a 
laboratory parameter suggestive of an autoimmune phenomenon.To further investigate the 
molecular pathomechanism of this malignancy, we analysed altogether 12 SPTL patients 
with gene expression microarray or immunohistochemistry. We compared the expression 
profi les of SPTL skin lesions to normal subcutaneous tissue and infl ammatory panniculitis 
(erythema nodosum). Immunohistochemistry was used to show the cellular origin of the 
deregulated gene product. In addition, we analysed the same samples after successful 
treatment.The genes most signifi cantly overexpressed in the SPTL lesions were several genes 
(e.g. CXCL9, CXCL10) affecting the CXCR3 pathway, which is involved in the development 
of autoimmune diseases. Their inducer, IFN gamma was also upregulated, as has previously 
been shown in cutaneous LE subtypes. Following successful treatment with systemic steroids 
(and methotrexate in some cases), the expression of the aforementioned genes lowered. The 
expression profi les of CTCL and SPTL were surprisingly different. In conclusion, these results 
suggest that an autoimmune type infl ammation underlies the development of subcutaneous 
panniculitis like T-cell lymphoma. This is in line with the favourable response to steroids as well 
as favourable prognosis. Our results provide a novel link between autoimmunity and cancer.
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Gene expression microarray analysis of microdissected epidermis and dermis in 
mycosis fungoides and adult T-cell leukaemia/lymphoma
Keiko Hashikawa1,2, Shinichiro Yasumoto1, Kazutaka Nakashima2, Fumiko Arakawa2, 
Junichi Kiyasu2, Masanori Takeuchi2, Yoshizo Kimura2, Takekuni Nakama1, Takashi 
Hashimoto1, Koichi Ohshima2 1Department of Dermatology, Kurume University 
School of Medicine, Kurume, Fukuoka, Japan, 2Department of Pathology, Kurume 
University School of Medicine, Kurume, Fukuoka, Japan
Characteristic histopathological feature is epidermotropism in mycosis fungoides 
(MF) and adult T-cell leukaemia/lymphoma (ATLL).  In this study, to reveal the 
mechanism for epidermotropism, total RNAs were obtained from the epidermis 
and dermis of skin biopsies of MF and ATLL patients (5 epidermal samples each 
from MF and ATLL and 3 dermal samples each from MF and ATLL, and 2 epidermal 
samples from dermatitis patients used as controls) by laser capture microdissection, 
and were served for subsequent cDNA microarray experiments.  Expression levels 
of CCR4 and CLA, a well-known skin-homing receptor, were higher in the dermis 
of MF and ATLL, if compared to controls.  CCR4 was also strongly expressed in 
the epidermis of ATLL.  High expression of CCR10 was observed in the dermis of 
MF and ATLL, being higher in MF than ATLL.  CCL27 expression in the epidermis 
was higher in MF and ATLL than controls.  CCR7 and CCL21 play a role in homing 
of T cells to lymph nodes.  Expression of CCR7 in the dermis was very high in 
both MF and ATLL.  Correlation between CCR7 and CCL21 was observed in 
MF.  Subsequently, we confi rmed the expression of these chemokine receptors and 
the ligands by immunohistochemistry. These results strongly indicate that CCL27-
CCR10 interaction, CCR4 and CLA play an important role in the homing of the tumor 
cells in both MF and ATLL, while high expression of CCL21 in the dermis of MF 
retains lymphoma cells in the skin and interrupt them to migrate to lymph nodes.
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Detection of Merkel Cell Polyomavirus in Kaposi Sarcoma
Nicolas Kluger1, Vincent Foulongne2, Olivier Dereure1, Michel Segondy2, Bernard 
Guillot1 1Université Montpellier I, Service de Dermatologie, Hôpital Saint-Eloi, CHU 
de Montpellier, Montpellier, France, 2Université Montpellier I, Laboratoire de Virologie, 
Hôpital Saint-Eloi, CHU de Montpellier, Montpellier, France
We performed a systematic research of Merkel cell polyomavirus (MCPyV), a human 
virus discovered in Merkel cell carcinoma, in a series of patients with KS. DNA was 
extracted from lesional and nonlesional skin samples of patients with KS by fresh 
biopsies and superfi cial cutaneous swabs. MCPyV DNA was detected by PCR and 
quantifi ed by real-time PCR assay in samples positive for MCPyV DNA detection. 
We included 10 patients with KS (8 M, 2 F, median age 69),  8 with the classic form 
of KS (68-81 yo) and 2 HIV-related KS (41-46 yo). Overall, 80% of our patients had 
MCPyV DNA in  both healthy and affected skin, on biopsies and cutaneous swabs. 
MCPyV DNA was detected in 44% (4/9) of the biopsies, viral DNA being found 
both in affected and unaffected lesions (concordance rate 100%).  MCPyV DNA was 
detected in all cutaneous swabs (face, trunk, upper and lower limbs) from 6 subjects. 
Mucosal swabs were negative (0/4). Prevalence is higher than previously reported. 
Main limitation is the small size of our sample. Non invasive cutaneous swabs are 
sensitive enough to detect MCPyV DNA in skin of patients and healthy controls. Viral 
analysis performed on FFPE samples is less sensitive than fresh biopsies. KS lesions 
may harbor MCPyV DNA. A true link with KS pathogenesis remains speculative. 
Indeed, MCPyV seroloprevalence is higher in elderly patients. Our results may 
simply refl ect this tendancy. MCPyV may act as a co-factor in KS pathogenesis 
in a subgroup of patients, but this needs to be confi rmed by larger studies.
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Whole transcriptome analysis of cutaneous SCC cells and epidermal keratinocytes 
reveals new differentially expressed genes
Risto Ala-aho1, Asta Laiho2, Seppo Tamminen2, Attila Gyenesei2, Juha Peltonen3, 
Reidar Grénman4, Veli-Matti Kähäri1 1MediCity Research Laboratory & Dept of 
Dermatology, Univ of Turku, Finland, 2High-throughput bioinformatics group, Turku 
Centre for Biotechnology, Univ of Turku, Finland, 3Dept of Anatomy, Univ of Turku, 
Finland, 4Dept of Otorhinolaryngology, Turku Univ Central Hospital, Finland
Cutaneous squamous cell carcinomas (SCCs) are common skin cancers associated with a 
substantial risk to develop metastases. However, there is no good molecular marker for the 
early identifi cation of the malignant SCCs. We have performed a whole transcriptome profi ling 
of normal keratinocytes and cutaneous SCC cell lines using next generation sequencing. The 
analysis was carried out in four cultured normal human epithelial keratinocytes (NHEKs) and 
eight cutaneous SCC cell lines and differentially expressed transcripts were detected between 
NHEKs and SCCs using SOLiD next generation sequencing system. Thresholds for signifi cance 
were based on false discovery rate (p<0.05) and fold-change (2-fold up- or down-regulation). 
Statistical analyses revealed 284 transcripts that were signifi cantly and differentially expressed 
in SCC cells compared with NHEKs. 184 of them were signifi cantly up-regulated and 100 were 
signifi cantly down-regulated in SCC cell lines. The DNA microarray was performed also by the 
Affymetrix gene chip technology. Comparison of the differentially expressed features included 107 
genes which were detected on both platforms and 177 transcripts which were detected only by 
SOLiD. Analysis of differentially expressed pathways between NHEKs and SCCs showed signifi cant 
changes in expression levels of the cell cycle and infl ammation related genes. Furthermore, 
expression levels of the genes involved in the VEGF and Erb signaling pathways showed signifi cant 
changes between NHEKs and SCCs. These results reveal the complete gene expression profi le 
of cutaneous SCC cells. Further functional studies of the differentially expressed genes are 
required to understand the signifi cance of these genes in the carcinogenesis of cutaneous SCCs.
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Expression of tumour necrosis factor-like weak inducer of apoptosis in normal 
human skin, infl ammatory dermatoses and non-melanoma skin cancer
Sandra Peternel1,2, Teo Manestar-Blazic2, Tanja Celic3, Larisa Prpic-Massari1,2, Ines 
Brajac1,2, Marija Kastelan1,2 1Department of Dermatovenereology,School of Medicine, 
University of Rijeka, Rijeka, Croatia, 2Clinical Hospital Center Rijeka, Rijeka, Croatia, 
3Department of Anatomy,School of Medicine, University of Rijeka, Rijeka, Croatia
Tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) is a member 
of the TNF superfamily of cytokines that possesses a variety of biological effects 
including stimulation of cell growth and angiogenesis, tissue regeneration, induction of 
proinfl ammatory cytokines and stimulation of apoptosis. To investigate the role of TWEAK 
in skin biology, we performed immunofl uorescent analyses of TWEAK expression in normal 
human skin, psoriasis, lichen planus, actinic keratosis (AK), squamous cell carcinoma 
(SCC) and basal cell carcinoma (BCC). In normal epidermis, strong positive cytoplasmic 
staining for TWEAK was observed in all keratinocyte layers except the basal cell layer 
which was entirely unstained. Similar pattern of staining was found in psoriasis with 
clearly observable difference between unstained basal and occasional suprabasal cells 
and strongly stained upper layers of epidermis. This “clear cut“ difference in the staining 
pattern was not observed in lesions of lichen planus, where the overall staining intensity was 
decreased but occasional positively stained nuclei were also detected. Decreased staining 
was additionally observed in AK, particularly in the areas of cellular atypia. In SCC, strong 
signal was seen in the well-differentiated keratinocytes around squamous pearls whereas 
poorly differentiated cells showed weak or absent signal. In BCC, TWEAK was almost 
completely absent, with only a few individual cells in a limited number of BCCs positively 
stained. In conclusion, these data suggest that TWEAK is associated with keratinocyte 
differentiation in normal skin, infl ammatory dermatoses and non-melanoma skin cancer 
and that it is possibly involved in the apoptotic keratinocyte death in lichen planus.
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DNA damage response in psoriasis - expression of 53BP1 and gammaH2AX
Teo Manestar-Blazic1, Sandra Peternel1,2, Marija Kastelan1,2, Ines Brajac1,2 1Clinical 
Hospital Center Rijeka, Rijeka, Croatia, 2Department of Dermatovenereology, School 
of Medicine, University of Rijeka, Rijeka, Croatia
DNA replication stress which occurs in hyperplastic and precancerous lesions 
is associated with the activation of DNA damage response (DDR). Since psoriatic 
epidermis is also characterized by hyperproliferation of keratinocytes, we 
aimed to investigate the expression of two DDR markers, p53-binding protein 
1 (53BP1) foci and phosphorylated histone H2AX (gammaH2AX), in psoriatic 
lesions. Immunohistochemical and immunofl uorescent staining was performed 
on paraffi n-embedded tissue of lesional skin of patients with psoriasis and skin of 
healthy volunteers. The percentage of keratinocytes positive for Ki-67, 53BP1 and 
gammaH2AX and the number of foci per nucleus were determined. The number 
of cells positive for proliferation marker Ki-67, as well as the number of cells 
positive for gammaH2AX and 53BP1 foci, was signifi cantly higher in psoriasis 
when compared to normal skin. In addition, the mean number of 53BP1 foci per 
nucleus, in cells expressing foci, was higher in psoriatic than in normal epidermis. 
Positive cells were predominantly localized in the basal and suprabasal epidermal 
layers. These results indicate that psoriasis, similarly to preneoplastic lesions, is 
characterized by high proliferative index and increased expression of DDR markers. 
It is possible that potent activation of DDR in psoriasis overcomes the effects of DNA 
replication stress and represents a part of the barrier to malignant transformation.
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Expression and physiopathologic function of T-plastin in cutaneous T-cell lymphoma
Elodie Begue1, Francette Jean-Louis1, Liliane Laroche2, Hervé Bachelez3, Martine 
Bagot1,3, Armand Bensussan1, Gilles Courtois4, Laurence Michel1 1INSERM 
U976, Paris, France, 2Immuno-dermatology, Hôpital Avicennes, Bobigny, France, 
3Dermatology, Hôpital Saint-Louis, Paris, France, 4INSERM U781, Paris, France
A molecular feature of Sezary syndrome (SZ) is the abnormal expression of T-plastin 
by tumoral T-lymphocytes. T-plastin is a conserved actin-bundling protein that is 
normally not expressed in hematopoietic cells and its function in SZ T-cells is totally 
unknown. Herein, we studied T-plastin expression in a large cohort of SZ patients, 
compared with a wide range of T-cell lymphoproliferative disorders, and investigated 
T-plastin role in apoptosis resistance of tumor T-cells. Peripheral blood lymphocytes 
(PBL) of patients with SZ (n=84), MF (n=41), irrelevant lymphoproliferative disorders 
(n=18), healthy donors (n=72), SZ cell line HUT-78 and control Jurkat cells were 
studied for T-plastin expression by quantitative polymerase chain reaction assay 
and immunoblotting. Our results showed that T-plastin mRNA was expressed in 
70% of SZ patients, while any expression was detected in PBL from patients with 
other diseases or healthy donors. T-plastin expression was induced by calcium 
entry and downregulated by calcineurin inhibitors (20-98%) in T-plastin negative 
PBL from SZ patients as well as in healthy PBL.To determine T-plastin function in 
T-cells, Jurkat T-cell line was stably transfected by a T-plastin expression vector. 
Our data show that specifi c expression of T-plastin in stable Jurkat clones allowed 
apoptosis resistance in response to antineoplastic agents and this is partially 
reversed by T-plastin siRNA. Pretreatment of T-plastin positive tumor lymphocytes 
by calcineurin inhibitors downregulates T-plastin and potentiates apoptosis induced 
by antineoplastic agents. Our results confi rm that T-plastin is a specifi c marker 
of SZ tumor cells that is involved in apoptosis resistance of SZ tumor T cells.
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Ustekinumab prevents development of psoriatic alterations in a humanized mouse 
model of psoriasis
Graham Elliott Derphartox, Leiden, Netherlands
We used Ustekinumab a human monoclonal antibody directed against the p40 
subunit of interleukin 12 and interleukin 23, as a model biological in tests aimed at 
further validating a humanized mouse psoriasis model. BNX mice were transplanted 
with 5 mm diameter full-thickness skin biopsies from non-involved skin from psoriasis 
patients. After 3 weeks PBMCs, isolated from each donors blood, were activated by 
incubating for 2 days with IL-2 and SEB and injected into the corresponding transplants 
to initiate a psoriatic lesion. 1 day before injecting the cells the mice were treated 
with the test compounds. Treatment continued for 3 weeks after which the mice were 
sacrifi ced and the biopsies were analyzed for epidermal ridge thickness, keratinocyte 
proliferation (Ki67) and epidermal differentiation (cytokeratin 16). The cell incubation 
media were analyzed for IL-23. Treatments with betamethasone (± 15mg topical, 
2xday) and Ustekinumab (10mg/kg i.p, 2x week) resulted in a reduction in epidermal 
ridge thickness, expression of CK16 and number of Ki67 positive keratinocytes 
compared to the control group. There was no correlation between the concentration 
of IL-23 in the cell culture medium and the effect of cells on development of psoriasis 
characteristics. Human IL-23 was only detected in mouse serum when activated 
cells were injected into the transplants. We conclude that the psoriasis transplant 
model, using 5 mm diameter full thickness skin biopsies and BNX mice, is suitable 
for testing compounds that modulate T-cell activity by inhibiting interleukin function.
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Effi cacy of PUVA therapy compared with biologics in moderate to severe chronic 
plaque psoriasis
Martin Inzinger, Bettina Heschl, Wolfgang Weger, Angelika Hofer, Franz Josef Legat, 
Alexandra Gruber - Wackernagel, Wolfgang Salmhofer, Peter Wolf Research Unit for 
Photodermatology, Department of Dermatology, Medical University of Graz, Austria
Not much data are available comparing the clinical effi cacy of biologics to conventional 
treatments such as PUVA in moderate to severe chronic plaque psoriasis. We therefore 
analyzed available data in patients treated over a 5-year period with biologics compared 
to (previous) PUVA treatment at the Department of Dermatology, Medical University 
of Graz, Austria.  The data were extracted from the Graz Psoriasis Registry (http://www.
psoriasis-therapieregister.at).  In total, 162 patients with chronic moderate to severe plaque 
psoriasis had received 118 treatment courses of oral PUVA (8-MOP, n=86; 5-MOP, n=32) 
and/or 130 treatment courses with a biological agent (adalimumab, n=18; alefacept, n=32; 
efalizumab, n=17; etanercept, n=38; infl iximab, n=7; ustekinumab, n=18). The primary 
effi cacy assessment was psoriasis-area-and-severity-index (PASI) improvement at wk12 
for biologics and at treatment completion for PUVA (median time, 10.3 and 9.2 wks, for 
8-MOP and 5-MOP, respectively). Fifty-eight percent of PUVA-treated patients achieved 
at least PASI90% improvement, compared with 22% for adalimumab  (P=0.0050), 3% 
for alefacept (P<0.0001), 6% for efalizumab (P<0.0001), 29% for etanercept (P=0.0025), 
71% for infl iximab (ns), and 39% for ustekinumab (ns) (P-value determined by Fisher-
exact-test, comparing each biologic vs. PUVA). Sixty-nine percent of PUVA-treated patients 
achieved at least PASI75% improvement, compared with 56% for adalimumab (ns), 25% 
for alefacept (P<0.0001), 59% for efalizumab (ns), 39% for etanercept (P<0.0018), 100% 
for infl iximab (ns), and 67% for ustekinumab (ns). This implies that PUVA had signifi cantly 
superior effi cacy in psoriasis than certain biologics and similar effi cacy than infl iximab 
or ustekinumab. Clearly, prospective studies are desirable to confi rm these observations.
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Aprepitant as an antipruritic agent: results of a fi rst case series
Sonja Ständer, Ngoc Quan Phan, Dorothee Siepmann, Ilka Herrgott, Cord 
Sunderkötter, Thomas A. Luger Competence Center Pruritus, Department of 
Dermatology, University of Münster, Münster, Germany
Chronic pruritus is one of the most frequent symptoms associated with uncurable 
conditions such as renal, liver and skin diseases with a high negative impact on 
the quality of life. The symptom often does not respond to conventional treatment. 
Therefore, antipruritic therapies which target physiological mechanisms of pruritus 
need to be developed. Substance P (SP) is one major mediator of pruritus which 
binds to the neurokinin receptor 1 (NKR1). In this study we evaluated if an NKR1 
antagonist would signifi cantly decrease chronic pruritus. We applied the NKR1 
antagonist aprepitant 80 mg in a case series of 20 patients with chronic pruritus 
(12 females, 8 males; mean age, 66.7 years) for one week. This treatment achieved 
signifi cant reduction in pruritus (p<0.001, CI 1.913-5.187) in 16/20 patients (80%), 
as assessed by the visual analog scale (VAS). The mean VAS value was reduced from 
8.4 points (SD +/- 1.7) to 4.9 points (SD +/- 3.2). Interestingly, younger patients 
(n=6) responded signifi cantly better (mean pruritus reduction, 66.7±24.2%) than 
elderly patients aged over 65 years (n=14; 29.3±29.5%; p=0.012). Side effects 
were mild (nausea, vertigo and drowsiness) and only occurred in three patients.
In sum, therapy with aprepitant leads to pruritus reduction mainly in 
dermatological diseases such as atopic diathesis and prurigo nodularis. The 
high response rate suggests that an NKR1 antagonist is a promising treatment 
strategy based on the pathophysiology of chronic pruritus. Future controlled trials 
will have to confi rm the effi cacy and safety of this novel therapeutic strategy.
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Clinical and biological analysis of IL-12, IL-23, TNF-α and IL-17 specifi c targeting 
in mouse model of psoriasis
Frédérique Caillot1, Elena Rizova2, Jacqueline Benson3, Philippe Musette4
1INSERM Unit 905, Rouen, France, 2Janssen-Cilag, Issy-les-moulineaux, France, 
3Centocor Research & Development, Inc., Radnor, Pennsylvania, United States, 
4Department of Dermatology, Charles Nicolle University Hospital, Rouen, France
Psoriasis is characterized by epidermal proliferation, infl ammatory skin infi ltrate and 
vascular proliferation. Mouse models of psoriasis refl ect various aspects of human 
psoriasis. InvEE transgenic mice exhibit hyperproliferative and infl ammatory skin 
lesions induced by constitutive Mitogen Activated Proteins (MAP) kinase activation 
in keratinocytes. Tie2 mice present conditional overexpression of Tie2 (Tek tyrosine 
kinase) which leads to recruitment of lymphocytes and polynuclear leukocytes as well 
as epidermic hyperplasia. These mice have obvious clinical as well as histological 
signs of psoriasis. In this study, we investigated effects of the following four anti-
mouse antibodies in InvEE and Tie2 mice: anti-p40 (IL-12/23), anti-p19 (IL-23), anti-
IL-17A and anti-p75 (TNF). After treatment with anti-p19, anti-p40, or anti-IL-17A, 
but not anti-TNF, InvEE mice exhibited decreased clinical signs as well as a reduction 
of the extent and depth of acanthosis. In contrast, clinical signs are less important in 
Tie2 mice and clinical differences were not observed. Tie2 and InvEE mice treated 
with anti-p19 and/or anti-p40 presented a down-regulation of circulating cytokines 
such as IL-12, IL-22 and IFN-γ and an up-regulation of IL-23. Furthermore, these mice 
presented a regulation of various cutaneous cytokines implicated in angiogenesis, 
chemotactism and glucose metabolism. In conclusion, in the InvEE mouse model, 
anti-p19, anti-p40 and anti-IL-17A, but not anti-TNF, antibodies improved the clinical 
and histological signs of disease. In the Tie2 mouse model, treatment did not improve 
some signs of disease, but the two models presented similar regulation of cytokines.
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Etanercept in the treatment of toxic epidermal necrolysis
Biagio Didona, Fabio Bergamo, Annarita Giampetruzzi, Massimo Papi Istituto 
Dermopatico dell‘Immacolata, Rome, Italy
Toxic Epidermal Necrolysis(TEN) is a rare life-threatening dermatological disease 
characterized by estensive destruction of the epidermis and mucosal epithelia, 
caused by the apoptosis of the epithelial cells. A large body of evidence suggest 
that TEN is an adverse drug reaction: over 100 different medications are implicate 
as a trigger for the development of this disease. The pathogenesis of TEN is not 
entirely clarifi ed, but is appears to be mediated by a metabolic and immune 
mechanisms.  Among the players in TEN pathogenesis TNF alfa has a preminent role. 
In the early phase of TEN keratinocytes are the main source of this cytokines. TNF 
alfa acting in autocrine/paracrine manner leads to the apoptosis of keratinocytes 
and the production of NO and other cytokines and chemochines that recruit and 
activate infl ammatory cells. Up till now doesn’t exist an evidence-based therapy 
for TEN: corticosteroids, immunoglobulins , cyclosporine, plasmapheresis, 
cyclophposphamide and others drugs showed doubtful therapeutical responses 
and not ameliorate the mortality rate. Because we retained TNF alfa is the chief 
responsible in the pathogenesis of TEN, we treated six TEN’s patients (SCORTEN 
ranging from 3 to 6) with a single injection of etanercept 50 mg. An immediate 
block of the disease progression and a complete recovery within 8-10 days was 
obtained without any complications or said-effects. On the basis of these results 
we retain etanercept the drug of choice in the treatment of TEN, also because is 
antagonize as well the lymphotoxin alfa, a forgotten but important cytokine.
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Notch 1 as a potential therapeutic target in cutaneous T-cell lymphoma
Maria Kamstrup1, Edyta Biskup1, Lise Mette Gjerdrum4, Britt Lauenborg3,1, Elisabeth 
Ralfkiær4,2, Niels Ødum3,2, Robert Gniadecki1,2 1Department of Dermatology, 
Bispebjerg Hospital, Copenhagen, Denmark, 2University of Copenhagen, Faculty of 
Health Sciences, Copenhagen, Denmark, 32Institute of Medical Microbiology and 
Immunology, Rigshospitalet, Copenhagen, Denmark, 43Department of Pathology, 
Rigshospitalet, Copenhagen, Denmark
Deregulation of Notch signaling has been linked to the development of T-cell 
leukemias and several solid malignancies. Yet, it is unknown whether Notch 
signalling is involved in the pathogenesis of mycosis fungoides and Sezary 
syndrome, the most common subtypes of cutaneous T cell lymphoma. By 
immunohistochemistry of 40 biopsies taken from skin lesions of mycosis fungoides 
and Sezary syndrome we demonstrated prominent expression of Notch1 on tumor 
cells, especially in the more advanced stages. The γ-secretase inhibitor I blocked 
Notch signaling and potently induced apoptosis in purifi ed Sezary cells and in cell 
lines derived from mycosis fungoides (MyLa) and Sezary syndrome (SeAx, HuT-
78). Specifi c downregulation of Notch1 (but not Notch2 and Notch3) by siRNA 
induced apoptosis in SeAx. The mechanism of apoptosis involved the inhibition 
of NF-κB, which is the most important prosurvival pathway in cutaneous T cell 
lymphoma. Our data show that Notch is present in cutaneous T cell lymphoma 
and that its inhibition may provide a new way to treat cutaneous T cell lymphoma.
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MiR-122 regulates apoptosis in malignant T-cells derived from mycosis fungoides
Valentina Manfé1, Edyta Biskup1, Anne Rosbjerg1, Line Marie Holst1, Britt Lauenborg1,2, 
Robert Gniadecki1,2 1Bispebjerg Hospital, Copenhagen, Denmark, 2University of 
Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark
MicroRNAs (miRs), the non-coding RNAs regulating gene expression, are involved 
in the control of malignant transformation, cell proliferation and apoptosis. We have 
recently discovered that inhibition of Notch-1 by γ-secretase inhibitors (GSI) induces 
apoptosis in T-cell lines derived from cutaneous T-cell lymphomas (Kamstrup et al. 
Blood 2010, in press). Assuming that Notch-1-dependent apoptosis is regulated 
by miRs, we compared miR expression between GSI-treated and control cells by 
microarrays and RT-qPCR. We found an upregulation of miR-122 in apoptotic cells 
treated with GSI. Surprisingly, miR-122 silencing increased the sensitivity to GSI-
induced apoptosis whereas miR-122 over-expression increased cell proliferation and 
protected against programmed cell death. Screening for possible signalling pathways 
involved in the observed miR-122 effect revealed the role of NF-κB. miR-122 is not 
expressed in quiescent T-cells, but is readily detectable in lesional skin biopsies 
from patients with mycosis fungoides and in purifi ed Sezary cells. Taken together, 
our data suggest tha miR-122 is expressed in vivo in cutaneous T-cell lymphoma 
and may be involved in the protective, pro-survival circuit in malignant T-cells.
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Th2 cytokines enhance tissue kallikrein 7 expression and the serine protease activity 
of keratinocytes in atopic dermatitis
Shin Morizane1, Kenshi Yamasaki2, Ai Kazita1, Maosheng Zhan1, Richard Gallo3, 
Keiji Iwatsuki1 1Department of Dermatology, Okayama University Graduate School 
of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan, 2Department 
of Dermatology, Tohoku University Graduate School of Medicine, Tohoku, Japan, 
3Division of Dermatology, Department of Medicine, University of California, San 
Diego and VA San Diego Healthcare System, San Diego, CA, United States
The expression of kallikrein 7 (KLK7), a chymotrypsin-like serine protease, is 
upregulated in atopic dermatitis (AD) lesion and it has been considered to be involved 
in AD pathogenesis. We hypothesized that Th2 cytokines such as IL-4 and IL-13 
induce KLK7 expression in AD keratinocytes. First, we confi rmed that KLK7 protein 
expression was increased in AD lesion by immunohistochemistry (n=6), and that the 
serum level of KLK7 correlated with that of IL-4 in AD patient samples (n=37, r=0.772, 
p<0.01). Cultured normal human epidermal keratinocytes (NHEK) treated with IL-4 
(50 ng/ml) or IL-13 (50 ng/ml) increased KLK7 mRNA (2.73x, p<0.0001, or 2.55x, 
p=0.0007) and protein (8.16x, p=0.0015, or 8.96x, p=0.0010) in a time-dependent 
manner, while IFN-gamma (100 U/ml), a Th1 cytokine, and IL-17A (50 ng/ml), a Th17 
cytokine, did not. On the other hand, Th2 cytokines did not induce the expression of 
kallikrein 5, a trypsin-like serine protease, in NHEK. Furthermore, the protease assay 
with the specifi c substrate showed that IL-4 or IL-13 enhanced chymotrypsin-like 
serine protease activity in NHEK (3.23x, p=0.0005, or 2.29x, p=0.0172, respectively). 
Trypsin-like serine protease activity also increased with IL-4 or IL-13 signifi cantly 
but slightly (1.11x, p=0.0007, 1.12x, p=0.0008). These fi ndings suggest that Th2 
cytokines affect skin barrier function through increased KLK7 expression in AD.
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Diabetes impairs adipose-derived stem cell pro-healing function
Francesca Cianfarani1, Gabriele Toietta1, Giuliana Di Rocco2, Eleonora 
Cesareo1, Maurizio C Capogrossi1, Giovanna Zambruno1, Teresa Odorisio1
1Isituto Dermopatico dell‘Immacolata, IDI-IRCCS, Rome, Italy, 2Istituto Cardiologico 
Monzino, ICM-IRCCS, Milan, Italy
Adipose-derived mesenchymal stem cells (ASCs) are gaining a great consideration 
in the therapeutic application for tissue repair. Besides showing the potential to 
differentiate into cell types of different lineages, these cells are easily accessible 
and abundant. The therapeutic administration of ASCs in impaired wound healing 
has recently been reported. With the aim of assessing the therapeutic potential of 
autologous versus heterologous ASCs in the treatment of diabetic ulcers, we have 
functionally characterized diabetic ASCs and investigated their pro-healing potential. 
ASCs were isolated from the inguinal fat of streptozotocin-induced diabetic mice 
and analysed either freshly isolated as stromal vascular fraction, or following a single 
passage of culture to preserve at most the diabetic phenotype. Diabetic ASCs showed 
decreased proliferative potential when compared to non diabetic ones. The pattern 
of expression of surface markers was also altered in diabetic ASCs, with a constant 
reduction in the levels of stem cell-specifi c markers (Sca-1, CD49e, CD54, CD73 and 
CD90). Importantly, Bioplex and ELISA analyses revealed that ASCs from diabetic 
mice released signifi cantly lower amounts of different growth factors and cytokines 
(b-FGF, VEGF, PlGF, M-CSF, LIF, IL-15, MIG). Accordingly, the supernatant of cultured 
diabetic ASCs manifested reduced capacity to promote keratinocyte and fi broblast 
proliferation and migration, assessed by BrdU labelling and scratch assay, respectively. 
Our data indicate that the diabetic condition impairs ASC pro-healing activity and that 
this effect is due to decreased paracrine function. Experiments are ongoing to evaluate 
the in vivo effect of diabetic versus healthy ASC administration in diabetic wounds.
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Acrosyringium is a target of vesicle/pustule formation in palmoplantar pustulosis 
(pustulosis Palmaris et plantaris)
Masamoto Murakami1, Akemi Ishida-Yamamoto1, Vera Morhen2, Richard Gallo2, 
Hajime Iizuka1 1Asahikawa Medical College, Asahikawa, Hokkaido, Japan, 2University 
of California, San Diego, San Diego, CA, United States
Pustulosis palmaris et plantaris (PPP) is a chronic recurrent dermatosis characterized by 
intraepidermal vesicles fi lled with neutrophils, which is recalcitrant to treatment.  Despite 
the studies to dissect the nature of PPP, its pathomechanism remains unknown.  Sweat 
participates in skin innate immunity by infl uencing temperature and hydration.  In addition, 
sweat contains various antimicrobial peptides such as cathelicidins (hCAP-18/LL-37) and 
dermcidin protecting against certain bacteria, fungi, and viruses.  These antimicrobial 
peptides were used as eccrine sweat gland markers to investigate whether PPP vesicle/
pustules relate to the sweat gland.  In order to evaluate the sweat secreting function in 
PPP, the palmar lesional sweat production was measured by a portable sweat meter.  Skin 
biopsies of PPP were examined by immunohistochemistry with hCAP-18/LL-37, dermcidin, 
GCDFP-15, and EMA.  Vesicular fl uids were collected, and Western blotting for hCAP-
18/LL-37 and dot blotting for dermcidin were performed.  Polymorphonuclear leukocytes 
(PMN) from pustules and peripheral blood were collected for RT-PCR and real time PCR 
analyses for hCAP-18/LL-37.  GCDFP-15 and EMA immunohistochemistry was positive for 
the lining cells of the vesicles, suggesting the acrosyringieal nature of the vesicles.  Both 
hCAP-18/LL-37 and dermcidin expression in the fl uid were also detected, but no over-
expressions in the keratinocytes surrounding the vesicles was observed.  There was no 
signifi cant difference in hCAP-18/LL-37 mRNA levels between peripheral blood PMNs 
and lesional PMNs.  These results indicate that hCAP-18/LL-37 in the fl uid most-likely 
originates from the sweat gland and not from PMN or keratinocytes around the vesicles, 
suggesting that the acrosyringium is the primary location of PPP vesicle/pustule formation.
 www.jidonline.org S57 
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Evaluation of Immature CD19+CD21- B-lymphocytes  as a potential biomarker for 
predicting  and measuring success of steroid refractory/intolerant  chronic Graft 
versus Host Disease therapy
Robert Knobler, Zoya Kuzmina, Hildegard Greinix, Roman Weigl, Sandra Eder, Arno 
Rottal, Christoph Zielinski, Winfried Pickl Medical Univ of Vienna, Vienna, Austria
To broaden the observation that CD19+CD21- B-lymphocytes, as a possible biomarker, 
predict response to  photopheresis (ECP) ,  B cell subpopulations in peripheral blood (PB) 
of 74 patients (median age 40 years, range 20-59 years) given cyclosporine A (CSA n=24), 
tacrolimus (n=13), sirolimus (n=18) and ECP (n=19) for moderate (n=29) or severe (n=45) 
cGVHD were analyzed  by multiparameter fl ow cytometry after staining for CD19, CD27, 
CD21 and surface Ig. cGvHD activity and response to therapy were assessed prior to start of 
immunosuppressives  and every 3 months.  Prior to  immunosuppressives non-responders 
had signifi cantly (p=0.03) higher proportions of immature CD19+CD21- B-lymphocytes 
with a mean of 19.4% (range, 4.17-45) compared with a mean of 13.3% (range, 1.3-
54) in responders to 6 months of therapy.  Signifi cantly higher proportions of immature 
CD19+CD21- B-lymphocytes in non-responders compared to responders were observed. 
No signifi cant difference in memory CD27+ B-lymphocytes was observed prior to  therapy . 
After 6 months all responding patients had a signifi cant (p=0.01) decrease of percentages of 
immature CD19+CD21- B-lymphocytes from a mean of 13.3% (range, 1.3-54) prior to therapy 
to a mean of 8.2% (range, 1.1-30) 6 months later. In complete responders, the immature 
CD19+CD21- B-lymphocytes signifi cantly (p=0.04) decreased from a mean of 14.06% (range, 
1.3-54.6) to a mean of 7% (range, 1.1-36) after 6 months. In all non-responders percentages 
of immature CD19+CD21- B-lymphocytes either increased or remained unchanged after 6 
months of therapy. Relative amounts of immature CD19+CD21- B-lymphocytes assessed 
prior to start of cGVHD therapy may predict response to immunosuppressive therapy.
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Cytotoxic T lymphocyte stimulation with artifi cial antigen-presenting cells activates 
anti-melanoma natural responding cells
Jean-François Chatillon1, Florence Bayeux1, Jean-Baptiste Latouche2, Philippe Musette1
1INSERM U905, Rouen, France, 2INSERM U614, Rouen, France
Adoptive immunotherapy based on in vitro activation and expansion of tumor 
antigen-specifi c cytotoxic T lymphocytes (CTLs) is a very promising strategy that 
has been tried for many years.  Our team used artifi cial antigen-prensenting cells 
(AAPCs; Latouche and Sadelain, Nat Biotechnol, 2000) to activate CTLs against 
MART-1, an auto-antigen which is overexpressed in melanoma.One major question 
with CTL stimulation by AAPCs is about either it activates lymphocytes that react 
in natural anti-tumoral immune response or it activates minor responding cells. We 
studied the proliferation and purifi cation of MART-1-specifi c CTLs from peripheral 
blood of two healthy donors and two patients, using AAPCs stimulation and anti-
MART-1 phycoerythrin-coupled pentamer staining and magnetic sorting with anti-
PE beads. We obtained more than 95% of specifi c CTLs which were able to lyse 
specifi cally MART-1-prensenting cells in cytotoxic chromium assays. Flow cytometry 
staining revealed a high potency to produce mainly TNF-α, IFN-γ and Granzyme B. 
Among the major and expanding Vβ family for each donor after stimulation with 
AAPCs, we sequenced the highly variable CDR3 region of the β-chain of TCR and 
we found that there is at least few or one major clone among a few one which 
compose the population of a Vβ family. These particular sequences that differ 
between donors could be linked to the already described TCR sequences that 
have been found in natural anti-tumoral immune response in melanoma patients. 
In conclusion, our results indicate that stimulation of CTL with AAPCs activates 
anti-tumoral CTLs that respond in the restricted natural immune response to tumor.
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Application of Light Emitting Diode and Celecoxib (Cox-2 inhibitor) for the 
Management of Wounds
Steven Thng1, Mui Hong Tan2, Pierce Chow3, Shabbir Moochala2, Jia Lu2
1National Skin Centre, Singapore, Singapore, 2Defence Medical and Environmental 
Research Institute, Singapore, Singapore, 3Department of Experimental Surgery, 
Singapore General Hospital, Singapore, Singapore
Management of chronic wounds have always been a challenge for clinicians. Many factors 
come into play in order for wounds to heal properly and timely. These factors include control 
of infection, infl ammation, stimulation of keratinocytes and fi broblast growth as well as 
adequacy of wound vascular bed.  Of late, LEDs has been shown to upregulate keratinocyte 
proliferation in cell culture studies through upregulation of growth factors. Our study aims to 
evaluate the effi cacy of Light-Emitting Diodes (LEDs) combined with topical COX-2 inhibitor 
in the management of wounds.We used a pig model of partial thickness burn injury and 
studied effi cacy of various treatment modalities by a) wound contraction, b) Laser Doppler 
imaging, c) histology, and d) immunohistochemistry for Ki-67, proliferating cell nuclear 
antigen, and laminin. The various treatment modalities studied include LED monotherapy, 
Celecoxib monotherapy, LED + Celecoxib, Silverlon burn dressing and control group.Our 
fi ndings show that LED + Celecoxib combined treatment is very effective and achieved 
the best wound healing profi le among all treatment groups. The improvement of wound 
healing is signifi cantly better when compared to control as well as with the other treatment 
groups. Even when used alone, LED treatment of burn wounds showed good healing 
when compared to control. Our results suggest that treatment of burn wounds with LED in 
combination with topical celecoxib signifi cantly improves wound healing. This combination 
showed potential to be used as a novel therapeutic intervention for the management of 
wounds, thus possibly opening up new avenues for the management of diffi cult wounds.
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Adult Alopecia Areata-a Trichoscopic patterns study
Alin Laurentiu Tatu1 1CMI TATU G.ALIN LAURENTIU, Galati, Romania, 2University 
Dunarea de Jos/Faculty of Medicine, Galati, Romania
Dermoscopy of hair-Trichoscopy allows to explore the hair at 10 to 800 magnifi cations 
and to observe precisely the types of hair, follicular openings,the peripilar signs and 
to follow up the evolution of the disease or the treatment effi cacy prior to naked eye 
clinical observation. We wanted to fi nd wich are the most common trichoscopic 
patterns and how frequent they are in adult alopecia areata. We studied 84  adults 
with 143 plaques of alopecia areata by trichoscopy before and after 3 months of 
treatment. 71,3% of plaques had regulary distributed yellow dots-coresponding to 
hyperkeratotic plugs in hair follicle ; 51,7% had excalmation mark hair; 46,1%  had 
distrofi c –broken hair; 27,9% had cadaverised hairs-black  dots in the hair follicles;  8,8 
% had short pseudo regroing hairs-they are apparently regroing but they are atrophic 
hairs and they are a sign of activity of alopecia areata.They mostly disappear at 3 
months trichoscopic follow up; 13,2 % had corkscrew hairs; 4,8 %  had circle hairs; 
4,1 %had vellus hairs-0,03 mm or less in thickness; 3,5 %  had white dots-feature 
of fi brosis;they have extensive and three years persistent alopecia areata;  We did 
not fi nd any pseudomoniletrix hairs. The most frequent pattern  is the presence of 
regular yellow dots (71,3 %),the second ithe presence of exclamation mark hairs 
(51,7 %) and the third is the presence of distrofi c-broken hairs (46,1 %).The presence 
of pseudoregroing hairs is a sign of the activity of  alopecia areata.They are thin 
hairs that differs from normal thick real regrowing hairs-sign of the treatment effi cacy.
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Cognitive performance and neuroimaging in patients with chronic plaque psoriasis
Paolo Gisondi1, Francesca Sala2, Franco Alessandrini3, V. Avesani2, Giada Zoccatelli2, 
Alberto Beltramello3, Giuseppe Moretto2, Giuseppe Gambina2, Giampiero 
Girolomoni1 1Section of Dermatology, Department of Medicine, University of 
Verona, Italy, 2Division of Neurology, Azienda Ospedaliera Integrata, Verona, Italy, 
3Neuroradiology, Azienda Ospedaliera Integrata, Verona, Italy
Chronic plaque psoriasis is frequently associated to cardio-metabolic comorbidities, 
depression and unhealthy life behaviors (i.e. heavy smoking and drinking) which are risk 
factors for cognitive impairment. We investigated cognitive functions in patients with chronic 
plaque psoriasis. Cross sectional study on patients with moderate to severe psoriasis and 
controls. Cognitive functions were assessed through the Gainotti and Caltagirone Battery 
of Mental Deterioration. Neuro-imaging was studied by high-fi eld magnetic resonance 
imaging (MRI) with four canal-brain spool. Moreover, in pre-contrast phase, 7 patients 
were submitted to Diffusion Tensor Imaging (DTI) and to fi ber tractography. Mild cognitive 
impairment was found in 37 out 41 (90%) of patients with psoriasis compared to 26 out 
37 (70%) of controls (p=0.02). In particular, patients with psoriasis obtained lower scores 
in the delayed recall of the Rey auditory verbal learning test (p=0.04); backwards digit span 
test (p=0.002), Weigl’s sorting test (p=0.01) and Trail making test B (p=0.008). There were 
no degenerative alterations or signs of infra-supratentorial atrophy in patient with psoriasis 
investigated by the MRI. In all patients submitted to DTI a statistically signifi cant reduction 
in the brain thickness in parahippocampal gyrus, superior temporal gyrus and superior 
frontal gyrus of left hemisphere was found. Patients with psoriasis may have a precocious 
impairment of long-term verbal memory, executive functions and attention. A reduction in 
the brain thickness in the parahippocampal gyrus, superior temporal gyrus and superior 
frontal gyrus of left hemisphere possibly justifying the cognitive impairment was found.
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Bone Mineral Density And Pro-Infl ammatory Cytokines In Psoriatic Arthritis Patients
Caius Solovan1, Camelia Ciacli1, Smaranda Laura Gotia2, Camelia Gurban3, Smaranda 
Rodica Gotia2 1University of Medicine and Pharmacy, Department of Dermatology, 
Timisoara, Romania, 2University of Medicine and Pharmacy, Department of 
Dermatology, Timisoara, Romania, 3University of Medicine and Pharmacy, Department 
of Biochemistry, Timisoara, Romania
Psoriatic arthritis affects 5-40 % of the patients with psoriasis. The aim: to investigate 
bone mineral density correlated with the blood and synovial fl uid pro-infl ammatory 
cytokines, in order to better understanding the pathogenesis mechanism of psoriatic 
arthritis (PsA) for biologic therapy application and monitoring the disease‘s evolution 
under treatment. Bone mineral density in lumbar spine (L2-L4) was determined by 
dual energy X-ray absorbtiometry (DEXA) method in 27 PsA patients. The blood 
samples and knees synovial fl uid were collected from PsA patients and from 20 
healthy subjects. As pro-infl ammatory cytokines were determined IL-1, IL-6, TNF 
alfa, levels, by ELISA method (Enzyme Linked Immunosorbent Assay) using a specifi c 
kits for every interleukin. Osteoporosis and osteopenia in lumbar vertebral bone 
were present in 33 %, respectively 41 % of PsA patients, correlated with disease‘ 
stage. Serum pro-infl ammatory cytokines IL-1 (4.6 ± 2.45 pg/ml), IL-6 (11.25 ± 
4.75 pg/ml) and TNF alfa (3.5 ± 1.45 pg/ml) were higher in PsA patients than in 
control group (IL-1 = 2.32 ± 0.95 pg/ml, IL-6 = 6.55 ± 3.85 pg/ml, respectively 
TNF alfa = 1.02 ± 0.45 pg/ml), the variation was statistically signifi cant (p < 0.001). 
In PsA patients, synovial IL-6 and TNF alfa were signifi cant higher than serum 
values. Both, anti- TNF alfa antibodies and soluble TNF receptors can be equally 
effective in PsA patients, by reducing synovial tissue infl ammation.The results 
showed that the infl ammation in joint tissue can be produced especially by pro-
infl ammatory cytokines and was correlated with decreased bone mineral density.
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Lack of association between cigarette smoking and response to hydroxychloroquine 
in 200 patients with discoid lupus erythematosus
Shyamal Wahie1, Nick Reynolds1, Simon Meggitt2 1Institute of Cellular Medicine, 
Newcastle University, Newcastle upon Tyne, United Kingdom, 2Royal Victoria 
Infi rmary, Newcastele upon Tyne, United Kingdom
Hydroxychloroquine is the oral therapy of choice for discoid lupus erythematousus (DLE).Previous 
studies demonstrate that cigarette moking is common amongst patients with DLE and suggest it 
may predict response to hydroxychloroquine.However, this association has not been tested in a 
large cohort of patients.We performed a multi-centre cross-sectional observational study in patients 
with DLE.Patients satisfi ed pre-defi ned clinical and histological criteria for DLE and also had 
received hydroxychloroquine.Response to hydroxychloroquine within the fi rst 6 months of use was 
retrospectively designated following casenote review.All patients were recruited and interviewed 
by one investigator.A detailed smoking history was taken from each patient, making it possible to 
determine whether they had been smoking during the fi rst 6 months of hydroxychloroquine use. 
200 patients with DLE were recruited.Response to hydroxychloroquine within the fi rst 6 months of 
use was observed in 120 patients(60%);70 patients(35%) were non-responders;8 patients(4%) had 
therapy withdrawn early because of side effects before response could be judged and in 2 patients(1%) 
response was equivocal.During the fi rst 6 months of hydroxychloroquine use,75 patients(38%) 
were non-smokers,of whom 43(57%) responded and 29(39%) did not.125 patients(63%) were 
smokers, of whom 77(62%) responded and 41(33%) did not.There was no signifi cant difference 
for achievement of response between non-smokers compared to smokers(OR 0.78; 95% CI 
0.43-1.45; p=0.27).This is the largest study to investigate response to hydroxychloroquine 
in DLE.We confi rmed the observation that smoking is common amongst patients with DLE.
However, no signifi cant difference in response rates were noted between smokers and non-
smokers,casting doubt on the notion that smoking per se inhibits response to antimalarials in DLE.
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Immunologic characteristics of wart patients and cytokine changes after 
immunotherapy with squaric acid dibutylester
Hai Jin Park1, Seong Hyun Kim1, Moon Seub Shin1, Yoo Won Choi2, Hae Young Choi2, 
Ki Bum Myung2 1Inje University Ilsanpaik Hospital, Department of dermatology, 
Goyang-si, Korea, Republic of, 2Ewha Womans University Hospital, Department of 
Dermatology, Seoul, Korea, Republic of
Wart is a proliferative lesion on the skin caused by human papilloma virus. Contact 
immunotherapy is one of the many therapeutic options attempted to treat warts. 
However, its effectiveness differs from a patient to a patient. This study aims to 
evaluate immunologic characteristics of wart patients and cytokine changes after 
immunotherapy with squaric acid dibutylester (SADBE). Twenty two patients with fi ve 
or more warts and nine healthy individuals were enrolled in the study. With respect 
to the patients whose warts have reduced by 90% or more, we reclassifi ed them as 
a complete response group. The patients who showed 50% or less of improvement 
were reclassifi ed as a treatment failure group. We measured the expression of 
cytokine by the fl ow cytometry, using the mononuclear cells in peripheral blood. 
The wart patients displayed a lower level of IL-4, Fas ligand and TNF-α and a higher 
level of IL-12 and IFN-γ/IL-4 ratio than the control group. The levels of IL-4 and 
Fas ligand and IL-10/IL-12 ratio of the complete response group, which was lower 
before the treatment, returned to the normal level, and IFN-γ/IL-4 ratio also recovered 
the normal level after the treatment. None of these changes were observed in the 
“treatment failure group”. The fact that cytokine abnormalities detected amongst the 
complete response group before the treatment disappeared after the treatment with 
contact immunotherapy proves that SADBE normalized the immune responses and 
cured the patients who responded well to the treatment.
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Acne severity does not correlate with impairment of acne related quality of life
Amal Kokandi King AbdulAziz University, Jeddah, Saudi Arabia
Acne is a common disease especially among teenagers. It has a considerable 
psychological impact on affected individuals. The disease itself ranges from very 
mild affection to the most severe form. The aim of this study was to assess if the 
effect of acne on acne related quality of life is correlated to acne clinical severity. 
102 university female students attending the university medical clinics with acne 
complaint were examined. Cardiff Acne Disability Index (CADI) was used to assess 
acne related quality of life and global acne grading system (GAGS) was used to assess 
clinical severity of acne. There was no correlation between acne severity (GAGS 
scoring system) and quality of life impairment as assessed by CADI score (r=0.145, 
p=0.127). Additionally CADI score did not correlate with disease duration or age of 
patients. Therefore, acne clinical severity alone does not affect acne related quality 
of life changes. Many other factors might play a role. Each patient should be treated 
individually taking into consideration mild disease does not mean little effect on 
quality of life.
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Dermal Exposure to Organophosphates Interacts with the Behavioral Effects of 
Opioids in the Mouse
Goudarz Sadeghi Hashjin, Mehrnoosh Jafari
Fac. Vet. Medicine, University of Tehran, Tehran, Iran, Islamic Republic of
Azinphos methyl (AM) and malathion (MT) are organophosphates frequently used in 
agriculture and veterinary practice. They may come in contact with the skin of some 
individuals, causing adverse effects like neurotoxicity and behavioral impairment. 
Narcotics are among drugs of abuse globally with tremendous behavioral effects. 
The aim was to evaluate the possible interaction of dermal organophosphate 
exposure with these effects in an animal model. Chronic dermal effect of MT 
1% and AM 1% solutions (and tap water as control) in mice was studied. For this 
purpose, tails of animals where dipped into the solutions once daily (10 sec) for 
28 successive days. Morphine (1 mg/kg), tramadol (40 mg/kg) or saline solution 
(control) was injected to animals (SC, 3 times daily for 5 days on days 24-28). 
On day 29, the following behaviors were investigated: pain sensation, anxiety 
and learning. Dermal exposure to MT and AM caused anxiety and decreased 
exploring behavior and learning. MT and AM increased the anxiety in tramadol-
treated animals by almost 30% and 55%, respectively (P<0.05). Learning was 
also impaired by MT and AM in the morphine- and tramadol-treated animals. No 
signifi cant effect was seen on pain sensation after organophosphate exposure. 
Based on extrapolation from fi ndings of the present study in an animal model, 
the behavioral abnormalities caused by opioids may be exaggerate in people with 
history of dermal exposure to long-term, low concentrations of organophosphates. 




Carcinoid tumor arising on the abdominal wall: Calcitonin gene-related peptide as 
a candidate marker of primary cutaneous carcinoid tumor
Mizue Fuzii1, Masamoto Murakami1, Satomi Igawa1, Jiro Uehara1, Masaru Honma1, 
Yasuhiro Ito1, Hidetoshi Takahashi1, Akemi Ishida-Yamamoto1, Noriaki Toyota2, 
Yoshimune Horibe3, Hajime Iizuka1 1Department of Dermatology, Asahikawa 
Medical College, Asahikawa, Japan, 2Asahikawa City, Asahikawa, Japan, 3Division of 
Pathology, Daido Hospital, Nagoya, Japan
Carcinoid tumor, which is characterized by secretion of several neuropeptides 
and/or hormones, usually arises on stomach, intestine, and bronchi. The 
tumor often metastasizes to lymph nodes, liver and skin. However, primary 
cutaneous carcinoid tumor is extremely rare. Here, we report a case of carcinoid 
tumor arising on the abdominal skin of a Japanese man with lymph node 
metastasis. Tumor cells were positive for synaptophysin, chromogranin, cytokeratin 
(CK) -7, but negative for CK-20. Electron microscopy revealed 150-200 nm 
electron-dense granules, consistent with neurosecretery granules. No clinical or 
immunohistochemical evidence of visceral involvement was detected. Calcitonin 
gene-related peptide (CGRP) is one of the neuroendocrine peptides expressed 
on normal eccrine sweat gland. Immunohistological analysis and reverse 
transcription-polymerase chain reaction revealed that the tumor cells of skin 
and regional lymph node express CGRP. CGRP-expression was not detected in 
other carcinoid tumors originated from gastrointestinal tract or bronchi, suggesting 
that CGRP might serve as a useful marker for the skin-originated carcinoid tumor.
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An appraisal of oral retinoids in the treatment of pachyonychia congenita
Robert Gruber1, Roger L Kaspar2, Sancy A Leachman3, Michael Edlinger4, Matthias 
Schmuth1 1Department of Dermatology, Innsbruck Medical University, Innsbruck, 
Austria, 2TransDerm, Inc., Santa Cruz, California, United States, 3Department of 
Dermatology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, 
United States, 4Department of Medical Statistics, Informatics and Health Economics, 
Innsbruck Medical University, Innsbruck, Austria
Pachyonychia congenita (PC), a rare autosomal-dominant keratin disorder caused 
by mutations in keratin (KRT) genes KRT6A/B, KRT16 or KRT17, is characterised 
by painful plantar keratoderma and hypertrophic nail dystrophy. Available studies 
assessing oral retinoid treatment for PC are limited to a few case reports and case 
series. In a questionnaire-based retrospective cross-sectional survey of 30 genotyped 
PC-patients on oral retinoids at doses between 10 to 50 mg/day for 0,5 to 240 months, 
we here determined clinical score, visual analog pain scale (VAS) and side effects. 
50% of patients reported that treatment was effective and plantar hyperkeratoses had 
improved. Only 14% observed an amelioration of their pachyonychia. While 33% 
experienced decreased plantar pain, 27% reported increased pain with oral retinoid 
treatment. All patients experienced adverse effects, most commonly dry lips, eyes and 
skin. A risk/benefi t analysis favoured lower retinoid doses of ≤25 mg/d (signifi cant mean 
overall satisfaction score) for more than 5 months, compared to higher doses of >25 
mg/d for a shorter time. Acitretin was slightly more effective than isotretinoin in terms 
of overall change in calluses. In summary, therapy with oral retinoids at doses of ≤25 
mg/d for greater than 5 months is superior to higher doses, shorter treatment duration 
or no therapy in PC. Further prospective studies are needed to confi rm these fi ndings.
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Treatment of refractory melasma with combination of topical 5% magnesium 
ascorbyl phosphate and fl uorescent pulsed light in Asian patients
Zafar Shaikh, Dilawar Abbas, Ashar Ahmed Army Medical College / National 
University of Sciences & Technology (NUST), Rawalpindi, Pakistan
The conventional therapies for melasma are often unsatisfactory because of 
inadequate response and recurrence following cessation of treatment.This study was 
designed to determine the effectiveness of treating melasma with combination of 
topical 5% Magnesium Ascorbyl Phosphate(MAP) and Fluorescent Pulsed Light(FPL). 
Patients with refractory epidermal and mixed melasma were treated for 12 weeks 
with topical application of 5% MAP at night, and 3 sessions of FPL(570-950nm) 
at 3, 6, and 9 weeks (fl uence 12-14J/cm2, pulse width 12-15msec, pulse repetition 
rate 2/3Hz, spot size 3cm2).  Post-treatment follow up was continued for another 
12 weeks. Sunscreen (SPF-60) was prescribed throughout period of observation. 
Determination of treatment effi cacy was based on the Melasma Area and Severity 
Index (MASI), calculated at beginning and then at weeks 6, 12, and 24. The 
subjective assessment was done by comparing pre and post-treatment photographs 
by an independent observer and self-assessment by patients at 12th week; using a 
4-point scoring scale (1-poor, 2-fair, and 3-good, 4-excellent). Sixty fi ve patients 
completed the study.  The baseline mean MASI score of 14.80 decreased to 4.53 at 
12th week (end of treatment), and 6.35 at 24th week (end of follow up). The overall 
regression of MASI at these end-points was 69.3% and 57% (p<.001). The pre and 
post treatment photographic evaluation by independent observer and patients’ self-
assessment at 12th week showed good to excellent response (scores 3 & 4) in 52.3% 
and 44.6% cases respectively. The combination of 5% MAP and Fluorescent Pulsed 
Light could be an effective modality in treating refractory melasma in Asian patients. 
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A novel fi bronectin derived peptide (P12) limits skin necrosis when delivered iv 
within 2 hours after burn in swine
Richard Clark, Fubao Lin, Deddy Harsono, Marcia Tonnesen, Adam Singer
Stony Brook University, Stony Brook, NY, United States
Skin burn injury progresses over several days secondary to continuing tissue cell 
necrosis and apoptosis.  Fibronectin, a 500 kDa glycoprotein, is produced on-
demand by most tissue cells during embryogenesis, morphogenesis and wound 
healing to become a critical component of the provisional extracellular matrix and is 
defi cient in chronic wounds and burn patients.  Last year we reported that a 14mer, 
growth factor-binding peptide (P12) derived from the fi rst fi bronectin type III repeat 
enhanced adult human dermal fi broblast (AHDF) growth and protected AHDF from 
necrosis and apoptosis secondary to oxidative and cytokine stress.  We also showed 
that P12 reduced burn progression in a rat comb burn model. Now we demonstrate 
that P12 also limits progressive skin necrosis in a porcine hot comb model.  Burns 
were created on the backs of outbred, 20-25kg Yorkshire swine using a brass 
comb preheated in boiling water and applied for 30 seconds resulting in four full 
thickness burns separated by three unburned interspaces. 20 burns with 60 unburned 
interspaces were created on each animal.  Lactated Ringers (control) or 1, 3 or 10mg/
kg P12 were infused intravenously at 1 h (one dose), or 1 h and 24 hrs (two doses) after 
burn over 30 min using a peristalsis pump. By macroscopic and microscopic analysis, 
necrosis progressed in 90% of interspaces in controls compared to 40 and 50% of 
interspaces in animals treated with 1 and 3 mg/kg P12, respectively (P<0.001).  One 
dose was as good as two. These data suggest clinical trials with P12 are warranted.
 
352
Determining the extent to which clinically effective treatment, ustekinumab or 
etanercept, reverses the molecular disease profi le of psoriatic skin: Comparisons of 
lesional, non-lesional and normal skin
James Krueger1, Katherine Li2, Frédéric Baribaud2, Mayte Suarez-Farinas1, Carrie 
Brodmerkel2 1Rockefeller University, New York, New York, United States, 2Centocor 
Research and Development, Inc., Malvern, Pennsylvania, United States
ACCEPT, a randomized, active-controlled study, compared the effi cacy of etanercept and 
ustekinumab in 903 patients with moderate-to-severe plaque psoriasis through wk12. Skin 
biopsies were performed in a subset of patients at baseline, wks1 and 12. Microarray analyses 
(Affymetrix U133+2 array) comparing non-lesional skin (n=85) to lesional skin (n=85) 
at baseline showed several thousand probe sets differentially expressed (>2-fold change 
FDR, p<0.05) in lesional skin.  An additional 25 healthy skin biopsies were also analyzed. 
Comparison of nonlesional skin to healthy normal skin showed a series of lesional genes 
also dysregulated in non-lesional skin (DEFB4, S100A7A, CCL18, SERPINB3).  Analyses to 
understand the impact of p40 cytokine (IL-12/IL-23) or TNF-alpha blockade on resident and 
infl ammatory cells and on the expression of gene circuits that may drive chronic immune 
activation and infl ammation in the skin were completed.  In addition analyses to understand 
the residual molecular profi le or „molecular scar“ following 12 weeks of treatment were 
completed. Patients responding to each agent (>=PASI75, n=21 for etanercept, n=19 
ustekinumab) had signifi cant changes in ~4000 transcripts compared to untreated lesions, 
indicating signifi cant resolution of pathological gene circuits back to nonlesional levels. 
However, genes such as DEFB4, S100A7, CCL18 and SERPINB3 though reduced to levels 
similar to non-lesional skin were not reduced to that of healthy normal skin by either 
treatment unlike ADAM10 and HSD3B1.  Elucidation of the molecular pathways which 
remain dysregulated following effective treatment may provide insight into pathological 
mechanisms that remain active despite appearance of clinical and histologic resolution.
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Augmentation of Lipogenesis and Steroidogenesis-related Enzyme Expression by 
Gefi tinib in Sebaceous Gland Cells in vitro
Akira Ito1, Kenta Yoshida1, Noriko Akimoto1, Shin Ohta2, Masato Wakabayashi3, 
Kazuyoshi Nakazawa3, Ichiro Kurokawa4, Takashi Sato1 1Dept of Biochemistry & 
Molecular Biol, Tokyo Univ of Pharmacy & Life Sciences, Hachioji, Tokyo, Japan, 2Dept 
of Pharma Health Care & Sciences, Tokyo Univ of Pharm & Life Sciences, Hachioji, 
Tokyo, Japan, 3Dept of Pharma, Nagano Red Cross Hospital, Nagano, Nagano, Japan, 
4Dept of Dermatology, Mie Univ Grad School of Medicine, Tsu, Mie, Japan
A small-molecule tyrosine kinase inhibitor, gefi tinib, which targets the ligand-binding domain 
of epidermal growth factor (EGF) receptors, exhibits anti-tumorigenic activity in patients with 
advanced non-small cell lung cancer. Many patients treated with gefi tinib develop an acne-
like rash on the face and upper body, most likely related to keratinocyte alterations, and hair 
follicle proliferation and maturation. Although acne is characterized as a functional disorder in 
sebaceous glands and pilosebaceous units, e.g., excess sebum production, accumulation, and 
secretion, there have been no reports to date that gefi tinib may modulate sebum production 
in sebaceous glands. In the present study, therefore, we examined whether or not gefi tinib 
directly infl uenced EGF-mediated cell proliferation, sebum production, and steroidogenesis 
in hamster and human sebocytes in vitro. Western blot analysis showed that EGF receptors 
were constitutively detectable in hamster sebocytes. In addition, gefi tinib was found to dose-
dependently inhibit the EGF-mediated sebocyte proliferation. Furthermore, nile-red staining 
revealed that intracellular lipid-droplet formation was augmented by gefi tinib in both hamster and 
human sebocytes. Moreover, real-time PCR indicated that gefi tinib increased the gene expression 
of cytochrome P450 cholesterol side-chain cleavage enzyme (P450scc) and 5α-reductase in 
both sebocytes. These results provide novel evidence that gefi tinib directly facilitates sebum 
production along with the augmented gene expression of P450scc and 5α-reductase in sebocytes. 
These fi ndings are likely to increase the clinical understanding of the side effects of gefi tinib.
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Quantitative and objective area extraction of tinea unguium
Yasuki Hata1, Hitoshi Iyatomi2, Sumiko Ishizaki3, Mizuki Sawada3, Ken Kobayashi3, 
Masahiko Ozeki3, Masaru Tanaka3 1Division of Dermatology, Saiseikai Yokohamashi 
Tobu Hospital, Yokohama-city, Kanagawa, Japan, 2Department of Applied Informatics, 
Hosei University, Koganei-city, Tokyo, Japan, 3Department of Dermatology, Tokyo 
Women‘s Medical University Medical Center East, Arakawa-ku, Tokyo, Japan
Quantitative and objective evaluation of tinea unguium would be helpful for drug 
effi cacy assessments. The aims of this study are to provide a quantitative assessment 
of the tinea unguium determined by dermatologists and to develop a computer-
based quantifi cation method of lesions. We examined a total of 38 clinical images 
of tinea unguium taken by a digital camera with polarized fi lters. The six images 
were clinically easy to identify the lesion areas while the others were rather diffi cult. 
The lesions were determined based on color information with the “location mask”, 
which was generated based on a priori knowledge: nail is located near the border 
of fi nger and has an ellipse shape. Since the deviation in lesion area determined 
among dermatologists was large, we needed to defi ne a gold standard for each 
image for evaluation of the proposed method. Five dermatologists manually drew the 
border of each lesion with a tablet computer. After an assessment of the extraction by 
dermatologists, the gold standard was defi ned as the area that was selected by two 
or more dermatologists, since the standard deviation of dermatologists’ extraction 
were quite large (28.4%). Our method achieved a precision and recall score of 
84.3% and 74.7%, respectively for the 6 clear cases and similarly, 63.8% and 58.3%, 
respectively for the total 38 cases. Our preliminary method determined the lesions 
almost accurately for relatively easy cases. Although our preliminary method needs 
further investigation, we confi rmed a computer-based method has the capability to 
quantize the area of tinea unguium.
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Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous 
lipogenesis
Christos C. Zouboulis, Holger Seltmann, Theodosios Alestas Departments of 
Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, 
Dessau, Germany
Arachidonic acid (AA) activates the 5-lipoxygenase, induces leukotriene-B4 (LTB4) 
synthesis, enhances interleukin-6 (IL-6) release and increases intracellular neutral 
lipids in human sebocytes. Moreover, the enzymes of LTB4 biosynthesis are activated 
in acne-involved sebaceous glands. Zileuton, a 5-lipoxygenase inhibitor, reduces the 
number of infl ammatory acne lesions and lipogenesis in patients with acne. In this 
study, we investigated the activity of zileuton on LTB4 generation, lipid content and 
IL-6 and -8 release from human SZ95 sebocytes in vitro. Pretreatment with zileuton 
partially prevented the AA-induced LTB4 and IL-6 release and increased neutral lipid 
content. IL-6 release and neutral lipid content were also reduced under long-term 
zileuton treatment. In conclusion, zileuton prevents the activation of the leukotriene 
pathway and enhancement of lipogenesis by AA in human sebocytes in vitro.
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Biomarkers for Adamantiades-Behçet‘s disease
Christos C. Zouboulis1, Andreas Altenburg1, Aylin Kalayciyan2, Phedon Kaklamanis3, 
Helmut Orawa4 1Depts of Dermatology, Venereology, Allergology & Immunology, 
Dessau Medical Center, Dessau, Germany, 2Dept of Dermatology, Istanbul Univ, 
Cerrahpasa Med Faculty, Istanbul, Turkey, 3Med Center, Athens, Greece, 4Institute of 
Med Informatics, Biometry & Epidemiology, Charité Univ Berlin, Germany
Purpose of the stidy was to detect serological predictive course-parameters in 
Adamantiades-Behçet‘s disease (ABD). Serum/blood of 122 ABD patients in active/
inactive stages and of 75 controls was screened for IL1α, IL1β, IL8, TNFα, sICAM1, 
bFGF, CRP, ESR. Serum IL18, IL8, MIP1α and CRP and ESR were investigated 
prospectively in another 18 ABD patients (11 with disease exacerbations in two 
years) and 16 controls. Increased IL8 serum levels, but not IL1α, IL1β, IL6, TNFα, 
sICAM1, bFGF or ESR were found in active compared with inactive ABD patients 
and controls. Patients with oral aphthae and neurological features presented higher 
IL8 levels. An association of IL8 levels with the number of active clinical signs and 
the presence of severe oral aphthae was detected. Patients having systemic symptoms 
along with oral aphthae had signifi cantly higher CRP and VEGF levels during the 
symptomatic period. In the longitudinal prospective evaluation, IL18 was increased 
in active and decreased in inactive periods in the individual patient’s course. IL18 was 
elevated even in the presence of few oral aphthae or mild uveitis. Comparably, CRP 
was a useful course-indicator, while MIP1α and ESR showed no reliable correlation 
with disease activity. IL18 is the most sensitive, single sign-parameter correlating 
with disease activity in ABD, followed by IL8, which increases with the number of 
clinical signs. CRP and VEGF can also be used as biomarkers to identify systemic but 
not mucocutaneous disease. The combination of these four serological parameters 
can be useful in the follow-up of ABD patients, especially in therapeutic trials.
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Proteomics identifi ed biomarker candidates to predict the effects of histone 
decetylase inhibitors on lymphoid neplasm cell lines
Kazuyasu Fujii1, Norihiro Suzuki1, Tadashi Kondo2, Keiji Iwatsuki1 1Department of 
Dermatology, Okayama Graduate School of Medicine, Dentistry and Pharmaceutical 
Sciences, Okayama, Japan, 2Proteome Bioinformatics Project, National Cancer Center 
Research Institute, Tokyo, Japan
Histone deacetylase inhibitors (HDACi) are novel agents for the treatment of the 
patients with lymphoid neoplasms. Although the effective treatments by HDACi have 
been reported in the patients with malignant lymphoid neoplasms, the sensitivities to 
the HDACi are variable among the patients, and the molecular backgrounds of the 
different sensitivities have long been explored to optimize the therapeutic strategies. 
To clarify the proteomic differences associated with anticancer effects of HDACi, 
we examined 33 lymphoid nelplasm cell lines. The 50% inhibitory concentrations 
(IC50) value for the valproic acid (VPA) was varied between 0.2 and 6.0 mM (average 
1.8 mM) in these 33 lmphoid cell lines. The proteomic profi les of the cells were 
created by two-dimensional difference gel electrophoresis (2D-DIGE). We found 
that the intensity of 31 protein spots was positively correlated with the IC50 value 
(rs > 0.4). Among them, the intensity of nine protein spots was 1.5 times higher in 
the VPA sensitive cell lines (IC50 < 1.0 mM) than the resistant countarpart (IC50 
> 2.0mM). The proteins corresponding to these protein spots were determined by 
mass spectrometry. These proteins were involved in stress response, T cell activation, 
cell proliferation, glucose metabolism, glutathione metabolism, histone modifi cation 
and regulation of ARF protein signal transduction. The utilities of these proteins as a 
predictive biomarker for HDACi treatments will be considered in clinical specimens.
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Image analysis for senile lentigo and evaluation of therapeutic effects by 
hydroquinone
Mizuki Sawada1, Hitoshi Iyatomi1,2, Yoshifumi Maumi1, Ken Kobayashi1, Reiko Suzaki1, 
Sumiko Ishizaki1, Masaru Tanaka1 1Department of Dermatology, Tokyo Women‘s 
Medical University Medical Center East, Arakawa-ku, Tokyo, Japan, 2Department of 
Applied Informatics, Hosei University, Koganei-city, Tokyo, Japan
As effi cacy of hydroquinone for senile lentigo is often limited, evaluations of 
effectiveness would be diffi cult and unreliable.The aim of the study is to evaluate 
effi cacy of hydroquinone objectively by image analysis and subjectively by QOL 
questionnaires.Forty patients with senile lentigo were enrolled. They were instructed 
to apply hydroquinone twice daily: group A; hydroquinone (HQ) alone, B; HQ plus 
chemical peeling once a week, C; HQ plus vitamin C application and D; HQ plus 
iontophoresis with vitamin C. The patients were assessed by spectrophotometer and 
image analysis of dermoscopy at 4, 8 and 12 weeks. Skin darkness was defi ned as 
Z score using the principal component analysis: Z = 150 - {(R - 120) x 0.523 + 
(G - 73.8) x 0.578 + (B - 60.5) x 0.626}. The patients were further evaluated with 
DLQI and Skindex16.Signifi cant improvements of melanin index were demonstrated 
by spectrophotometer in group B at 8 weeks and group D at 12 weeks, but with 
no statistical differences among the groups. Image analysis of dermoscopy exhibited 
substantial decrease of Z score after the treatments in combination therapy groups, 
but with no statistical differences. DLQI scores for daily life and leisure especially 
improved in combination groups. Skindex16 scores for emotions were also 
confi rmed to be improved after the therapy by Wilcoxon t-test in combination groups.
Combination therapies were shown to be more effective than HQ 
alone by image analysis and QOL assessments. Objective image 
analyses would be useful for assessments of subtle therapeutic effects.
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Narrow-band UVB exposures increase serum D-vitamin levels in chronic kidney 
disease patients requiring dialysis
Meri Ala-Houhala, Katja Vähävihu, Taina Hasan, Erna Snellman, Heikki Saha, Timo 
Reunala Tampere University and University Hospital, Tampere, Finland
 Narrow-band UVB (NB-UVB) treatment heals psoriasis and atopic dermatitis, and 
also increases effectively serum 25-hydroxyvitamin D (25(OH)D) concentration 
in these patients. Chronic kidney disease (CKD) patients requiring dialysis are 
especially prone to vitamin D insuffi ciency and defi ciency and therefore, we studied 
whether NB-UVB exposures would improve their D-vitamin balance. Fifteen CKD 
patients (10 men, 5 women, mean age 48.3 years) received three times a week a 
total of 9 NB-UVB exposures with Medisun 700 UVB-311 apparatus. The NB-UVB 
exposures were given on the face, hands and chest, and the cumulative amount 
was 15 standard erythema doses (SED). Twelve healthy subjects (2 men, 10 women, 
mean age 43.6 years) received a similar course of NB-UVB.Before NB-UVB mean 
serum 25(OH)D was 32.5 ± 10.2 nmol/L in the CKD patients and 60.2 ± 18.0 
nmol/L in the healthy subjects (p< 0.001). After nine NB-UVB exposures serum 
25(OH)D concentration increased signifi cantly (p< 0.001), i.e. 13.8 nmol/L in the 
CKD patients and 9.0 nmol/L in the controls. One and two months after NB-UVB 
exposures mean serum 25(OH)D levels had decreased in the CKD patients but were 
still 10 % higher than initially.  The present study shows that a short course of NB-
UVB exposures increases signifi cantly serum 25(OH)D concentration in the CKD 
patients on dialysis. The effect is, however, short lasting suggesting that the patients 
need cyclic NB-UVB exposures to maintain their improved vitamin D concentration.
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Safety, tolerability, and tissue compatibility of Novabel®
Stephan Falk1, Holger Köhler2 1Pathology Associates, Frankfurt/Main, Germany, 2Merz 
Pharmaceuticals GmbH, Frankfurt/Main, Germany
This study evaluated the short and long-term safety of Novabel® (Merz 
Pharmaceuticals, Germany). Novabel is a dermal shaper based on a new Geleon® 
technology derived from marine algae for temporarily  aesthetic skin corrections.
34 adult healthy subjects received a 1 ml Novabel® injection (deep dermal to superfi cial 
subcutis of the inner left arm), at week 6 subjects received a 1 ml Novabel into the 
inner right arm (re-exposition/re-challenge). 4mm punch biopsies were obtained at 
week 6 week (right arm), at week 52 (left arm), and week 72 (right arm). Biopsies 
were analyzed microscopically. Skin irritation and sensitization were assessed using 
a 5-point scale or a 6-point scale, respectively. Palpability of implants was assessed 
at every visit. Adverse event monitoring was performed during the complete trial.
Novabel® did not show a relevant locally irritant potential. No irritation or sensitization 
was observed after rechallenge. In biopsies obtained six weeks after rechallenge 
and 52 weeks after initial injection, Novabel® was still detectable in well-defi ned 
deposits. Light microscopy analysis did not reveal any pronounced tissue response. 
Around the deposits, there was a low-grade localized physiological reaction, 
typically for biomaterial implants. There were no signs of necrosis, clinically relevant 
infl ammatory infi ltrates or calcifi cations. Degradation with a volume reduction was 
recorded after 52 weeks and even more pronounced after 72 weeks. This study 
demonstrates a high degree of local tolerability, tissue compatibility and application 
safety of Novabel®. These safety and tolerability data support the excellent tolerability 
which Novabel® showed in a pivotal clinical trial for the correction of nasolabial folds.
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Adherence To Treatment In Patients With Psoriasis
Sue Ann Chan1, Fawad Hussain2, Anthony Ormerod1 1University Of Aberdeen, 
Aberdeenshire, United Kingdom, 2Aberdeen Royal Infi rmary, Aberdeenshire, United 
Kingdom
To evaluate patient adherence to different  types of treatment in psoriasis including 
biologic therapy and factors which affects their adherence. Patients attending 
Dermatology Department for psoriasis completed a standard questionnaire. Self-
assessed Psoriasis Area and Severity Index (SAPASI), Dermatology Quality of Life 
Index (DQLI) and patients’ medication-taking behaviour  were recorded. Patient’s 
confi dence, satisfaction and reasons for missing medications were also recorded 
for each treatment modality. A total of 106 patients on various treatment modalities 
were included in the study; 98 patients were on topical treatments, 43 on oral 
systemic therapies, 39 on phototherapy and 29 patients on biologic therapies 
completed the study. The overall rate of treatment adherence was found to be 
85.8%. Rate of adherence was signifi cantly higher in patients on biologic therapies 
and patients taking oral therapies (p<0.001). Patients taking biologic therapies 
reported 100%  adherence to treatment while those on topical therapies had an 
average score of 77.32%. Patients on combination treatment also showed poor 
compliance with the topical therapies. Side effects, damage to other vital organs 
and skin malignancies from phototherapy were patients’ main concerns. 56.8% 
of patients reported that messiness of treatment prevented them from adhering 
completely to their medications. There is a signifi cant relationship between the types 
of treatment (topical, oral systemic, phototherapy, biologic therapy) and the number 
of combination of treatments and treatment adherence scores. It is very important to 
understand factors which contribute to treatment adherence and improve treatment 




Comparison of drug survival rates for adalimumab, etanercept and infl iximab in 
patients with psoriasis vulgaris
Lone Skov1,3, Knud Kragballe5, Tomas Dam1, Johan Holk Poulsen7, Erik Obitz6, Robert 
Gniadecki2,3 1Dept of Dermatology, Gentofte Hosp, Denmark, 2Dept of Dermatology, 
Bispebjerg Hosp, Copenhagen, Denmark, 3Univ of Copenhagen, Faculty of Health 
Sciences, Denmark, 4Dept of Dermatology, Roskilde Hosp, Roskilde, Denmark, 5Dept 
of Dermatology, Marselisborg Hosp, Aarhus, Denmark, 6Dermatology Private Practice, 
Virum, Denmark, 7Dept of Dermatology, Odense Univ Hosp, Denmark
Adherence to treatment is a indicator of treatment success. Long-term data on 
adherence to biologic treatment in psoriasis are lacking. Here we compared the 
TNF-α inhibitors regarding drug survival rate and safety in patients with psoriasis, 
based on data from the Danish nationwide clinical database DERMBIO. All patients, 
who received anti-TNF-α in academic referral centers were included. In total, 882 
treatment series with etanercept (n=311), adalimumab (n=427) or infl iximab (n=129) 
were administrated to 747 patients. Signifi cant positive predictors of drug survival 
were: male sex (hazard ratio [HR] 1.8, 95% confi dence intervals [CI]=1.4-2.4), 
the anti-TNFa agent and the previous response to the anti-TNFa agent (HR 5.34, 
CI=3.8-7.4). In the group of the anti-TNFa naïve patients the longest drug survival 
was observed for infl iximab, followed by adalimumab (HR vs infl iximab 3.7, CI=2.0-
6.9) and etanercept (HR vs infl iximab 3.2, CI=1.7-5.9). The overall 4-year drug 
survival is in the range of 40% for etanercept or adalimumab vs 80% for infl iximab. 
There was no difference in number of adverse events. In conclusion, the overall 
effi cacy of anti-TNFa drugs diminish with time, as envisaged by the progressive 
loss of patient adherence to treatment. The major reasons for stopping treatment 
were loss of effi cacy, followed by adverse events. Infl iximab had the best patient 
retention ability with 70% patients being still on drug after 4 years of treatment. 
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Clinical case of chronic chlamydial salpingo-oophoritis
Taras Dasyuk Danylo Halytskyy Lviv National Medical University, Lviv, Ukraine
Incidence of genitourinary chlamydiosis among young European women ranges from 
4.1 to 25%, among men - 1.2-12%. Approximately 8-19% of Ukrainian population 
is infected with Chlamydia. Patient A., complained of periodic pain in the lower 
abdomen. Anamnesis of the disease: the patient was referred by the obstetrician-
gynecologist with a diagnosis genitourinary chlamydiosis. Objective and laboratory 
study: changes in the internal organs, cardiovascular system and locomotor apparatus 
were not detected; in general and biochemical blood analyses pathological changes 
were not found. Gynecological examination: signs of left-sided salpingo-oophoritis, 
endocervicitis. Data of additional examinations: ultrasound examination of the 
uterus and adnexa; dilatation of the left fallopian tube with exudates, ovary enlarged, 
hyperechoic inclusions in ovary parenchyma. PCR and ELISA- results were positive. 
In colposcopy - signs of endo- and exocervicitis were seen. Evident lymphoid 
follicles were observed in the area of the throat. Clinical diagnosis: exacerbation 
of chlamydial salpingo-oophoritis. On the 1st day of treatment immunomodulator 
manaxx was administered. From the 3rd to the 13th day of treatment patients 
took azithromycin orally 1.0 g on the 3rd day of treatment and 0.5 g every other 
day from the 5th to the 13th days of treatment. Final examination: changes in 
blood analysis, urethra and endocervix were not found. Etiologic diagnostics of 
chlamydiosis: PCR, ELISA - results were negative, obvious decrease in amount of 
antibodies was marked. Iimmunogram: all indicators were normal. Ultrasound 
examination of the uterus and adnexa: pathology was not detected. Colposcopy 
examination: cervical mucosa without any signs of infl ammation. Clinical recovery.
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Monitoring of  NO and selenium levels in pregnant women with sexually 
transmitted  diseases
Tetyana Fartushok, Taras Dasyuk Danylo Halytskyy Lviv National Medical University, 
Lviv, Ukraine
Informative for clinical observations are tests for detection of  NO and selenium 
levels in cervical canal secretion in daily urine, which characterize general 
immunologic mechanisms.30 women, were examined during different trimesters of 
pregnancy.  Presence of infl ammatory focus is known to be accompanied by an increase 
in nitrous oxide level by means of iNOS activation under the infl uence of cytokines, 
angiotensin II, E2 prostaglandin, interferon, and endotoxins of bacteria. In the 1st 
trimester the level of  NO in cervical contents increased in 1.2 times in comparison 
with control group, in 1.3 - in the 2nd trimester, and in 1.4 - in the 3rd trimester. These 
data show that an obvious imbalance of local immunity in the cervical canal exists 
due to the presence of urogenital infection. Premature fl ow of amniotic fl uid was 
marked in case of twice increased selenium level in daily urine of pregnant women. 
A complicated obstetric anamnesis (threatened abortions, congenital defects of fetal 
development, premature fl ow of amniotic fl uid) was observed in case of decreased 
selenium level almost in 20 times in parturient women. Infl ammatory diseases of 
genitourinary organs, caused by STD, are accompanied by increased production of NO, 
which intensifi es intracellular oxidant stress and promotes adhesion of neutrophils, 
leucocytes to the endothelium that is important in infl ammatory impairment of the 
vascular wall due to infection. Monitoring of selenium level in daily urine enables 
to conclude that a lack of selenium during pregnancy is accompanied by threatened 
abortions, spontaneous abortions, and congenital defects of fetal development.
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Cytokines, chemokines and growth factors “in vitro“  and wound healing
Rossana Tiberio, Paolo Boggio, Ginevra Pertusi, Francesca Graziola, Chiarella Bozzo, 
Enrico Colombo Clinical and Experimental Medicine Department, University of 
Piemonte Orientale A. Avogadro, Novara, Italy
“Minced micrografts” is a simple, economic and effective technique recently introduced 
in our department consisting in the spreading on the bed of ulcers of a small skin 
specimen fi nely minced. We supposed that this procedure of cutaneous fragmentation 
facilitate the interaction between keratinocytes and fi broblasts and their release of 
mediators. So we decided to investigate the production of  IL-6, G-CSF, TNF-α, MCP-
1, PDGF, bFGF and VEGF (using Bio-Plex system) by 2 small specimens (diameter 
4mm) excised from healthy patient. The fi rst piece was minced and all its fragments 
were cultured in Keratinocytes Growth Medium (KGM), the second one was cultered 
in KGM without fragmentation. Samples of supernatants  were taken every 24 hours 
for ten days.The “minced” specimens produced larger amounts of PDGF and bFGF; 
the other pieces released higher amounts of  IL-6, MCP-1 and VEGF. We did not fi nd 
signifi cantly differences in TNF-α and  G-CSF release. Our results indicate that healthy 
skin fragments, that could behave as “minced micrografts”, produced  expecially 
growth factors that play a role in the proliferation phase of wound healing; they 
are normally reduced in chronic ulcers. Non-minced healthy skin released large 
amounts of proinfl ammatory cytokines that usually are important mediators of 
infl ammatory phase, but they are increased in chronic wounds delaying repair.
In conclusion  our data seem to confi rm that the success of “minced micrografts” 
on chronic and inert wound could be related to the action of PDGF and bFGF 
and to the reduction of proinfl ammatory mediators on the bed of ulcers.
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Assessment of corticoid-therapy induced skin atrophy using the DermaInspect in 
vivo multiphoton microscope
Hassan Ait El Madani1, Ana-Maria Pena1, Emmanuelle Tancrede-Bohin1, Armand 
Bensussan3, Alain Dupuy2, Martine Bagot3 1L‘Oréal Recherche - Connaissances 
Physiques, Aulnay Sous Bois, France, 2Service de Dermatologie-Hôpital St. Louis, Paris, 
France, 3INSERM UMR-S-976, Centre de Recherche sur la Peau, Paris, France
Multiphoton microscopy (MMP) is a non invasive optical imaging technique that 
allows the investigation of the 3D structure of human skin with sub-cellular resolution. 
It provides complemental modalities, mainly two-photon excited fl uorescence 
(2PEF) and Second Harmonic Generation (SHG). 2PEF signals in skin are emitted by 
endogenous chromophores such as NADP(H), fl avins, keratins, melanin or elastin, 
whereas SHG signals are specifi c for dense and ordered macromolecular structures 
such as fi brillar collagen. The aim of this study was to determine if MMP allows 
detecting the early signs of the corticoid-therapy induced skin atrophy. Four healthy 
volunteers (23-43 years) were topically treated with clobetasol propionate for 3 
weeks, under occlusion during the night, on a small region of the dorsal side of the 
left arm. The treated region was investigated using MMP at J0 (before the treatment), 
J7, J15, J22 (end of the treatment) and J60 (38 days after the end of the treatment). 
At each time point, two stacks of images were acquired in two different zones of the 
treated region. Our results show that multiphoton microscopy allows detection of 
skin modifi cations following corticoid-therapy: J7 - thinning of the stratum corneum 
compactum; J7 to J22 - modifi cation of keratinocytes morphology in the upper 
layers of the epidermis; J22 - complete de-pigmentation of the epidermis. These 
modifi cations disappear at J60. The evaluation of the skin pigmentation was fi rstly 
performed using qualitative scores, then using a quantifi cation method based on the 
fraction of the volume occupied by melanin. Both methods showed similar results.
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Circulating follicular helper T cells are increased in psoriasis
Emi Nishida, Kan Torii, Chiyo Saito, Takuya Furuhashi, Akiko Nishioka, Yoichi 
Shintani, Akimichi Morita Nagoya City University Graduate School of Medical 
Sciences, Nagoya,Aichi, Japan
Follicular helper T cells (Tfh) are involved in regulating autoantibody production, 
producing abundant interleukin (IL)-21. IL-21 generates Th17 from central memory 
T cells (Tcm) and suppresses regulatory T cell (Treg) induction. In psoriasis, Treg are 
dysfunctional and circulating CCR6+Th17 are increased. The Treg and Th17 imbalance 
is presumably an important factor for psoriasis activity. We previously reported that 
serum concentrations of IL-17 and IL-22 are signifi cantly increased in psoriasis 
patients compared to healthy volunteers. Serum IL-22 concentrations in psoriasis 
patients correlated with the Psoriasis Area and Severity Index (PASI). IL-21 is not 
known to be involved in the pathogenesis of psoriasis. Therefore, we analyzed the Tfh 
population in psoriasis patients and healthy controls. Peripheral blood was obtained 
from 47 psoriasis patients and 10 healthy volunteers. CD4+ cells were isolated from 
peripheral blood monocytes. Tfh were measured by fl uorescence-activated cell 
sorting analysis. The proportion of ICOS+T cells among CD4+ T cells was signifi cantly 
increased in psoriasis patients (3.91 ± 2.52%) compared with healthy volunteers 
(2.32 ± 1.28%). Circulating Tfh (ICOS+CXCR5+CD4+T) were signifi cantly increased 
in psoriasis patients compared with controls (0.397% versus 0.161%, p=0.040). The 
Tfh population was not correlated with other related factors, such as PASI score, 
Th17, and Treg. Some patients with guttate psoriasis had a higher Tfh population, 
suggesting that focal infection might have induced this increase. Moreover, 
Th17 were readily induced from psoriasis patient Tcm compared with healthy 
volunteers, suggesting that Tcm in psoriasis patients was already primed with IL-21.
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A case of short anagen syndrome: successfully controlled with topical minoxidil and 
systemic cyclosporine A combination therapy
Hoon Kang, Hee Dam Jung, Jung Eun Kim St. Paul‘s Hospital, College of Medicine, 
The Catholic University of Korea, Seoul, Korea, Republic of
Short anagen syndrome is a recently recognized disease and it is poorly understood. 
This disease has normal features for the hair structure, strength and hair growth 
rate and it has no relationship with total hair loss, but the clinical aspects are fi ne, 
short hair with mildly decreased overall density. Because the disease is relatively 
uncommon, there are not many reports regarding its prevalence, pathogenesis and 
treatment. We experienced one case of short anagen syndrome that was successfully 
controlled with topical minoxidil and systemic cyclosporine A combination therapy. 
We report here on this interesting case and we review the relevant literature.
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Expressional change of infl ammatory cytokines and nociceptive mediators in 
patients with female pattern hair loss complaining about trichodynia
Hoon Kang, Kwang Hyun Choi, Jung Eun Kim, Young Min Park, Hyung Ok Kim
St. Paul‘s Hospital, College of Medicine, The Catholic University of Korea, Seoul, 
Korea, Republic of
Many women worrying about hair loss by themselves usually complain about 
trichodynia. We want to evaluate the relationship between hair loss and trichodynia 
through checking out the expressional changes of several infl ammatory and 
nociceptive mediators. Fifteen female pattern hair loss (FPHL) Korean patients (28-
45 years) with M0F1 BASP type were enrolled. Tissue specimens were obtained by 
4 mm punch skin biopsy from the suspected hair loss area. mRNA expressions of 
IL-1 beta, IL-2, IL-4, IL-6, TNF alpha, INF gamma, NGF, substance P and neurokinin-
1(NK-1) receptor were determined by RT-PCR. These mediators were also checked 
in peripheral blood leukocytes. Eight scalp skin specimens were obtained from 
normal haired subjects during cosmetic surgery (22-53 years) as controls.  The 
mRNA expression of substance P, NGF and NK-1 was signifi cantly increased (p<0.1). 
Infl ammatory cytokine TNF alpha and IL-6 mRNA levels were signifi cantly higher 
as compared to controls (p<0.1). Although IL-2 mRNA was upregulated, it was no 
reached statistically signifi cance. There were no mRNA expressional correlations 
between tissue and peripheral blood leukocytes. Trichodynia induced expressional 
alteration of some infl ammatory cytokines and nociceptive mediators in FPHL 
lesional skin. Its alteration not infl uences the peripheral blood gene expressions. 
Albeit trichodynia associated hair loss is still controversial, our study propose 
the possibility of its involvement into hair loss through nociceptive mediators.
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Increased serum levels of secreted protein acidic and rich in cysteine in patients 
with localized scleroderma 
Satoshi Fukushima, Satoshi Hayano, Masatoshi Jinnin, Hironobu Ihn Kumamoto 
University, Kumamoto, Japan
Scleroderma is a connective tissue disorder characterized by cutaneous sclerotic 
changes. It is classifi ed into systemic sclerosis with internal involvement, including 
lung fi brosis and esophageal dysfunction and localized scleroderma, which is limited 
to the cutaneous tissue without systemic involvement. Secreted protein acidic and 
rich in cysteine (SPARC) is a multifunctional secreted glycoprotein found in the 
extracellular matrix. SPARC is expressed only at sites of tissue remodeling and wound 
repair. SPARC gene overexpression by cultured dermal fi broblasts from patients with 
systemic sclerosis was shown in a cDNA micro-array study. To determine the serum 
levels of SPARC in patients with scleroderma and investigate their clinical signifi cance 
in this disease, serum samples from 33 patients with systemic sclerosis, 15 patients 
with localized scleroderma, 12 patients with dermatomyositis and 15 healthy 
volunteers were examined by a specifi c enzymelinked immunosorbent assay. Serum 
levels of SPARC were signifi cantly higher in patients with localized scleroderma than 
those in other groups or healthy individuals. And the patients with elevated serum 
SPARC levels had signifi cantly larger number of sclerotic lesions and signifi cantly 
higher serum levels of anti-single strand DNA antibodies than those without them. 
These results suggested that the serum levels of SPARC might be a serological marker 
for the disease activity and the extent of skin involvement in localized scleroderma.
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Effect of anticellulite treatment on skin condition - instrumental and subjective 
analysis
Karolina Bazela1, Renata Debowska1, Bozena Tyszczuk1, Ewa Kazmierczak1, Krzysztof 
Mlosek2, Katarzyna Rogiewicz1, Irena Eris1 1Dr Irena Eris Cosmetic Laboratories, 
Piaseczno, Poland, 2Imaging Department, Medical Univ of Warsaw, Warsaw, Poland
The presence of cellulite is an aestetically unacceptable cosmetic problem for many post-
adolescent women worldwide. Therefore, appropriate research to investigate treatment 
options and objective methods measuring its effi cacy are warranted.Recent studies using 
new diagnostic techniques such as ultrasound imaging can very well defi ne cellulite-
reducing effi cacy of cosmetics. This study aimed to evaluate the effi cacy of anticellulite 
treatment (topicaly applied cream and oral supplementation) on volunteers‘ skin condition 
using non-invasive investigation techniques.The effi cacy of anti-cellulite treatment was 
assessed in a double blind placebo controlled trial. The study involved  healthy female 
volunteers aged 25 between 55 presenting a cellulite of the thighs. They took dietary 
supplement or placebo 2 times daily and applied anticellulite or placebo cream once 
daily during 4 weeks. The instrumental analysis  was performed  using 13MHz ultrasound 
(Esoate Technos), as well as Corneometer probe and Visioscan camera (Courage-Khazaka 
Electronic GmbH). Each volunteer also completed a survey concerning their own 
evaluation of the treatment.  Instrumental analysis demonstrated that anticellulite treatment 
comprising oral supplementation and topical application of anticellulite cream improved 
skin moisturization and smoothness. Using the 13MHz ultrasound we also demonstrated 
that the thickness of the subcutaneous tissue was decreased whereas dermis echogenicity 
was increased. The anticellulite treatment was very well evaluated by the volunteers. 
Although cellulite is not considered as a disease, complaints of women are real and their 
demand for care is very high. We conclude that ultrasound imaging and skin condition 
analysis can very well defi ne cellulite-reducing effi cacy from cosmetic point of view.
 www.jidonline.org S63 
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Molecular markers associated with clinical response to bexarotene therapy in CTCL
Annamari Ranki1, Liisa Väkevä1, Laura Sipilä2, Kai Krohn3 1Department of Skin and 
allergic diseases, University of Helsinki and Helsinki University Hospital, Helsinki, 
Finland, 2Dermagene Oy, Tampere, Finland, 3CliniXion Oy and Tampere University 
Hospital, Tampere, Finland
A new rexinoid, bexaroten (Targretin®), has been registered for the treatment of 
cutaneous T-cell lymphoma (CTCL) since 2002, and has reportedly induced 45% 
overall response. Mostly, the responses are partial or generate a stable, skin-restricted 
disease. We explored the usefulness of a novel cancer associated gene, the NAV3 
and corresponding chromosome 12 copy numbers as possible biomarkers to 
monitor therapeutic response to bexarotene in 21 Finnish CTCL patients.  It was a 
prerequisite that the patient had early-stage CTCL refractory to skin-directed therapy 
or had received at least one standard systemic treatment modality with no benefi t 
to the disease.  Six patients (29%) reached complete remission (CR), 12 (57%) a 
partial  response (PR, with one stable disease) and three were non-responders. The 
duration of bexarotene therapy to reach CR ranged from 1 month to 24 months. In 
the target skin lesions, an allelic NAV3 deletion was observed at low frequency in fi ve 
(24%) patients, four of whom showed an initial partial response of short duration but 
then progressed or died of disease. The fi fth patient has remained with stable disease 
on bexarotene maintenance therapy for 2 years. Chromosome 12 tetraploidy was 
found in the lesions of two of three patients with CR who remained in remission, and 
polyploidy in one patient with PR.  While such tetraploidy is a feature of proliferating 
normal T cells, this observation may refl ect a favourable anti-tumor immune response 
among the skin-infi ltrating lymphocytes.
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Transcriptional adaptation caused by vorinostat/bexarotene combination therapy in 
advanced cutaneous T-cell lymphoma
Maria Karpova1, Daniela Gunz2, Benedetta Belloni1, Michal Okoniewski3, Antonio 
Cozzio1, Karin Schad1, Katrin Baumann-Conzett1, Lars French1, Reinhard Dummer1
1Dept of Dermatology, Univ of Zurich, Switzerland, 2Merck, Sharp & Dohme Corp., 
Opfi kon-Glattbrugg, Switzerland, 3Func Genomics Ctr, Univ of Zurich, Switzerland
Despite the broad spectrum of therapeutic interventions, curative treatment for CTCL is 
challenging. In this study we evaluated transcriptional adaptation during the Phase I study of 
vorinostat/bexarotene combination therapy in patients with advanced CTCL (ClinicalTrials.gov ID: 
NCT00127101).Transcriptional profi ling was performed on skin biopsies from 15 patients: Pre- 
and On-treatment. In several cases both, tumor and plaque lesions were available for analysis. 
Human Exon 1.0 ST microarrays by Affymetrix were used and transcriptional modifi cations were 
identifi ed by Partek and R-Bioconductor, enrichment analysis (EA) was performed using Genego 
Metacore.Analysis of transcriptional adaptation showed that plaque and tumor lesions were 
equally affected by the systemic treatment. Interindividual patient’s variability was identifi ed as 
the major factor infl uencing the molecular response. EA of differentially expressed genes revealed 
that progressive patients upregulate NOTCH and ER stress-responsive cascades and downregulate 
JAK-STAT signaling. In benefi ting patients hormonal response network was the most represented 
with the emphasis on cell survival and infl ammatory response (PPRG, RXR, MIF, ELK1, HDAC1, 
SOX5). Angiogenesis regulation through IL-8 and apoptosis were downregulated. Evaluation 
of alternative splicing after 14 days of the therapy showed that genes involved in cytoskeleton 
and matrix remodeling (MMP2, COL1A2, E-cadherin), cell proliferation (JAK2, ERK1/2, STAT5), 
and other processes tend to be modifi ed. Vorinostat/bexarotene treatment caused tumor 
transcriptome to adjust, and progressive patients seem to escape through NOTCH signaling. 
Responsive patients characterized by apoptosis induction upon treatment. Results may help to 
initiate the development of personalized therapeutic strategies targeting responsive CTCL patients.
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Switching azathioprine to mycophenolate mofetil reduces UVA photosensitivity of 
the skin and DNA 6-thioguanine in PBMC of kidney transplant recipients
Günther F. L. Hofbauer1, Gilles Straub1, Piotr Dziunycz1, Rafael Meyer1, Peter 
Karran2, Natalie Attard2, York Kamenisch3, Mark Berneburg3, Lars E. French1, Rudolf 
P. Wüthrich4, Andreas L. Serra4 1Department of Dermatology, University Hospital, 
Zürich, Switzerland, 2Cancer Research Institute, Clare Hall Laboratories, South 
Mimms, Hertfordshire, UK, 3Department of Dermatology, University of Tübingen, 
Germany, 4Division of Nephrology, University Hospital, Zürich, Switzerland
Exposure to sunlight and immunosuppressive drugs are the most important risk 
factors for squamous cell carcinoma of the skin (SCC) in kidney transplant recipients 
(KTR). Azathioprine (AZA) causes incorporation of 6-thioguanine bases into DNA 
and when exposed to UVA allows direct mutagenesis. We measured photosensitivity 
and molecular changes (common deletion of mitochondrial DNA, p53 protein 
expression, IL1beta mRNA in skin biopsies, 6-TG in PBMC) in long-term KTR on 
AZA (n=23) and 3 months after switching to mycophenolate mofetil (MMF). 3 
months after switching AZA to MMF, immediate and late photosensitivity decreased 
compared to baseline values on AZA. Greater reduction in 6-thioguanine content in 
PBMC DNA correlated to greater decreases in photosensitivity. Skin biopsies from 
UVA MED fi elds showed higher amounts of common deletion on AZA by PCR, 
increased p53 expression by immunohistochemistry and increased IL1beta mRNA 
expression by qRTPCR in the same patients.The switch from AZA to MMF normalizes 
photosensitivity in KTR. This is accompanied by changes on the molecular level 
indicating not only a quantitative improvement, but also a qualitative improvement 
of photosensitivity which together should result in reduced SCC formation.
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Statins effects on the skin
Adina Dobritoiu, Dan Forsea First Dermatology Clinic of Colentina Hospital, 
Bucharest, Romania
Hypolipemiant drugs are widely-used for prevention of cardiovascular events.Statins 
and are by far the most widely used class of lipid-lowering drugs are the drugs class 
of choice for LDL-C reduction.Their cutaneous side effects reported in  medical 
literature  until present,  can be classifi ed into three types : autoimmune reactions, 
reactions due to dryness of the skin and severe reactions like –DRESS,  but, with their 
expanding use, new side effects  will inevitably continue to appear. Latest  studies 
have proved that statins have immunomodularory activities also and thus they can 
be used in treatment of several immunological conditions which are characterized 
by a Th1 immune response, like psoriasis, alopecia areata, vitiligo, lichen planus.
We  examine patients receiving statins as their treatment for dyslipidemia  and we 
observe the frequency of cutaneous side effects and the type of the reactions. We also try 
to identify the benefi ts  of  using statins in  treatment of some skin disease like psoriasis.
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Effect of Intense Pulsed Light Treatment on Transforming Growth Factor Beta 
Expression in Acne Vulgaris
Musheera Mohammad Ali, Maria Gonzalez, Fiona Ruge, Rebecca Porter Cardiff 
University, Cardiff, United Kingdom
Infl ammatory processes play a pivotal role in acne pathogenesis and alterations in 
cytokine expression may be necessary to initiate and maintain acne development. 
Signifi cant upregulation of infl ammatory cytokines such as interleukin (IL)-8 has 
been observed in infl ammatory acne. Thus, targeting these infl ammatory mediators 
maybe a viable therapeutic option. Recently, much interest has been generated in the 
use of intense pulsed light (IPL) sources in acne treatment. However, its underlying 
mechanism of action has not been elucidated. In animal and in vitro models, IPL has 
been demonstrated to enhance transforming growth factor beta (TGF-β) expression. 
TGF-β inhibits infl ammatory cytokine production via a Smad3-mediated signalling 
pathway. These fi ndings suggest that TGF-β may have a potential role in acne 
resolution in response to IPL. Therefore we investigated the in vivo effects of IPL used 
for acne treatment, on the expression of TGF-β and down-stream effects of TGF-β 
signalling. Biopsies obtained from 13 patients with acne at baseline, 48 hours after the 
fi rst IPL treatment and 7 days after the fourth treatment were immunohistochemically 
analysed to determine whether IPL alters the expression of TGF-β, Smads, and IL-8. 
Immunohistology revealed upregulation in the expression of TGF-β1 and Smad3 and 
down regulation of IL-8 in the post-IPL samples compared to baseline. These fi ndings 
suggest that the Smad3-mediated negative regulation by TGF-β may be important 
in promoting resolution of infl ammation in acne. The results of this study provide 
a framework for a potential mechanism of action of IPL in the treatment of acne.
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Expression of Glucocorticoid Receptor Alpha and Beta in Infl ammatory Dermatoses
Minna Kubin, Tiina Hurskainen, Kirsi-Maria Haapasaari, Kaisa Tasanen, Aarne 
Oikarinen, Päivi Maria Hägg University of Oulu, Oulu, Finland
Glucocorticoid receptor alpha (GRalpha) mediates the effect of systemic and topical 
glucocorticoids that are used to treat infl ammatory dermatoses, e.q. atopic eczema. 
Alternative splicing of the glucocorticoid receptor (GR) pre-mRNA generates GRalpha, 
but also GRbeta, which does not bind glucocorticoids but antagonises the activity 
of GRalpha. Thus increased expression of GRbeta could account for glucocorticoid 
insensitivity. We investigated GRalpha and GRbeta expression in lymphocytes of 
patients with severe atopic dermatitis (AD) before and after systemic corticosteroid 
treatment. Peripheral venous blood was collected from 9 patients with severe AD. mRNA 
was isolated from peripheral blood mononuclear cells. Expression of GRalpha and 
GRbeta was determined by RT-PCR and quantitated by real time PCR. The expression 
of GRalpha and GRbeta was detected in all patients with variable response of the 
mRNA levels to systemic glucocorticoid treatment. 4 of 9 patients showed increase in 
the expression of GRbeta mRNA during treatment with systemic glucocorticoid with 
a concomitant decrease in the expression of GRalpha. This correlated positively with 
clinical glucocorticoid resistance in this group of patients. In addition, we studied 
immunohistochemical localization of GRalpha and GRbeta in skin specimens 
from patients with different infl ammatory dermatoses. GRbeta signal was mainly 
found in lymphocytes and neutrophils. In conclusion, our results are consistent 
with GRbeta expression being an important mediator of glucocorticoid resistance.
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Selective activation of naturally occurring regulatory T cells (Tregs) by the 
monoclonal antibody BT-061 as a novel therapeutic opportunity in psoriasis: Early 
clinical results after single doses
Ahmed Abufarag1, Silke Aigner1, Niklas Czeloth1, Benjamin Dälken1, Helga 
Koch1, Gabriele Niemann1, Christoph Uherek1, Frank Osterroth1, Andrea 
Wartenberg-Demand1, Walter E. Haefeli2, Rudolph E. Schopf3, Alexander Enk2
1Biotest AG, Dreieich, Germany, 2University of Heidelberg, Heidelberg, Germany, 
3Johannes Gutenberg University, Mainz, Germany
Tregs down-regulate excessive immune responses. In patients with autoimmune 
diseases, reduced numbers or functional impairment of Tregs is observed. The 
humanized agonistic monoclonal antibody BT061 binds to a unique epitope of 
CD4, thereby selectively activating Tregs but not helper T-cells. In the fi rst placebo-
controlled, double-blind clinical trial of BT-061, 55 patients with moderate to 
severe chronic plaque psoriasis received a single dose of BT-061 or placebo with 
doses ranging from 0.5 mg to 20 mg i.v. and 10 mg to 25 mg s.c.. BT-061 was 
well tolerated and the majority of adverse events were mild or moderate without 
increasing in frequency and intensity with increasing doses. There was no evidence of 
an increased risk of infections, no signifi cant increase in cytokines and no depletion 
of CD4 T-cells. Effi cacy parameters showed a long-lasting effect in some of the 
patients with an improvement in PASI-score persisting for up to 90 days after single 
dose administration. 15 of 41 patients (37%) receiving BT-061 exceeded a PASI 50 
response including two patients with more than 75% improvement. Responses were 
also seen after placebo (29%), but none reached a PASI 75 response. The strongest 
improvements in PASI were observed in 2.5 mg i.v. and 25 mg s.c. dose groups.
Based on these promising results, phase II clinical trials of BT-061 in 
patients with rheumatoid arthritis and chronic plaque psoriasis are ongoing.
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Subjective effi cacy in everyday use of topical medications for scalp psoriasis
Helene S Scheer, Ralph M Trüeb, Alexander A Navarini Department of Dermatology 
at the University of Zürich, Zurich, Switzerland
Topical medications for scalp psoriasis are effective under strictly controlled study 
conditions. However, in everyday use they can be demanding for both patient and 
physician. Here we retrospectively analysed the effi cacy and pitfalls of common 
topicals for scalp psoriasis, namely calcipotriol plus betamethasone dipropionate 
scalp formulation (Xamiol), betamethasone dipropionate lotion with salicylic acid 
(Diprosalic), clobetasol-17-propionate shampoo (Clobex) and 10% salicylic acid in 
PEG (Carbowax).The data was gathered by direct or telephone interviews of scalp 
psoriasis patients at our clinic with a standardized questionnaire. We investigated 
81 cases of scalp psoriasis that had been treated with at least one of said products. 
All agents performed modestly to poorly when rated by patients on sustainability 
of effects. Xamiol and Diprosalic showed signifi cant improvements in overall 
assessment of disease activity (total sign score TSS) and Xamiol improved pruritus 
signifi cantly. Patients complied to the recommended duration of use in 62,5% 
for Xamiol and 63% for Diprosalic. Only 45% (Xamiol) and 44.4% (Diprosalic) 
of patients kept to the recommended frequency of application, while frequency 
and duration of use of Clobex differed widely from recommendations. Xamiol 
and Diprosalic had the best patient compliance to recommendations, led the 
sustainability ranking and obtained signifi cant clinical score improvements. Taken 
together, topical treatment of scalp psoriasis remains a therapeutic challenge and 
patients‘ everyday experiences do not necessarily match phase III study results.
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Long-term results in patients with recalcitrant dermatoses of palms and soles after 
bath PUVA therapy
Agnes Bretterklieber, Franz Legat, Alexandra Gruber-Wackernagel, Peter Wolf, 
Angelika Hofer Medical University of Graz, Graz, Austria
 Numerous studies confi rmed the short-term effectiveness of 8-methoxypsoralen bath 
PUVA therapy in patients with recalcitrant dermatoses of palms and soles (RDPS), 
however, little is known on long-term results.In this retrospective study we examined 
the long-term results in 79 patients (mean age, 48 years) with RDPS treated with bath 
PUVA three times a week in an 8-year period. A good clinical response (more than 
50% reduction of skin lesions) was observed after a mean of 23 treatments and a mean 
cumulative UVA dose of 39J/cm2 in 51 patients (65%). Best results were present in 
patients with hyperkeratotic eczema (17/22; 77% good clinical response) followed 
by patients with palmoplantar psoriasis (26/41; 63%), and patients with dyshidrotic 
eczema (8/16; 50%), respectively. In 2007 a questionnaire was sent to all 51 
patients with good response to bath PUVA therapy to determine long-term outcome.
Among the 34 patients (67%) who answered the questionnaire 10 (29%) 
reported continuous complete clearance and 12 (35%) reported an improved 
course of disease after PUVA therapy with reduced frequency and/or 
intensity of skin rash.  Seventy nine percent of patients reported a long-term 
reduction in the use of topical steroids in the follow-up (mean, 4.3 years). In 
addition, 67% of patients reported a durable improvement of quality of life.
These data show that bath PUVA has a benefi cial infl uence on the course of disease in 
patients with recalcitrant RDPS and may lead a long-lasting clearance of skin lesions.
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Calcitonin infusions in systemic sclerosis -a retrospective study of clinical effects
Laura Schmidt, Cornelia Erfurt-Berge, Michael Sticherling Hautklinik 
Universitätsklinikum Erlangen, Erlangen, Germany
Vasculopathy apart from fi brosis and immunological features characterizes systemic 
sclerosis (SSs) and will result in the characteristic Raynaud phenomenon. n vitro studies 
indicate an important role of the calcitonin gene related peptide as mediator of sensory 
nerve innervation as well as in circulation. In fact, defi ciency of this neuropeptide has 
been demonstrated in SSc. Though its therapeutic application has been advocated, it 
has only rarely been applied clinically. In our hospital this treatment has been used 
for a decade and results were now evaluated in a retrospective study by monitoring 
the disease activity and organ involvement as well as serological parameters. 49 
patients with limited (n=32), diffuse (n=10) or undifferentiated SSc (n=7) have been 
followed-up for a median of 12,2 +/- 10,3 cycles of intravenous calcitonin (100U 
per day for 10 days every cycle), each one with an interval of 3-6 months. Whereas 
creatinine clearance improved slightly during continuing treatment, it deteriorated 
again after stop of treatment. Cardiologic functions remained stable in 65% of 
patients, whereas lung function (total lung capacity, CO-diffusion) improved in 14% 
of patients, remained stable in 46 % of patients and deteriorated in 37%. Serological 
parameters (ANA, BSR, CRP) were unchanged or without statistical signifi cance. In 
a written questionnaire about their evaluation of clinical responses, 58 % of patients 
gave the overall judgement of „good“, 17% modest, 29% neutral, 4% „bad“. With 
regard to the limitations of a retrospective study, prospective studies are necessary to 
examine the positive clinical effects of calcitonin treatment indicated in this study.
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Impaired hyaluronate production is restored by defi ned size hyaluronate fragments 
in corticosteroid-induced skin atrophy
Laurent Barnes, Frédérique Ino, Denise Grand, Pierre Carraux, Lionel Fontao, Jean-
Hilaire Saurat, Gürkan Kaya University Hospital of Geneva, Geneva, Switzerland
Hyaluronate and its cell receptor CD44 contribute to skin homeostasis, as selective 
suppression of CD44 expression in mouse epidermis leads to skin atrophy. Topical 
application of intermediate size hyaluronate fragments (HAFi) results in an epidermal 
hyperplasia accompanied by an increase in CD44 expression and hyaluronate 
synthesis in mouse skin. In is study we explored the effect of corticosteroid and 
HAFi treatment on hyaluronate synthesis in vivo and in vitro. Clobetasol propionate 
impaired signifi cantly the hyaluronate production and the expression of hyaluronate 
synthase 3 (HAS3) in cultured human keratinocytes and HAFi could restore this 
effect. Topically applied clobetasol propionate (0.05%) decreased epidermal and 
dermal hyaluronate staining and epidermal HAS2 and HAS3 expression in SKH1 
hairless mice. Simultaneous topical application of HAFi with clobetasol propionate 
restored the hyaluronate staining and HAS2 and HAS3 expression. Topically applied 
betamethasone dipropionate (0.05%) resulted in a decreased expression of HAS3 
in human skin which was reversed by HAFi.  Our results suggest that hyaluronate 
metabolism plays an important role in corticosteroid-induced skin atrophy and that 
HAFi may be a therapeutic option for reducing atrophic effects of topical corticosteroids.
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Expression of steroidogenic protein mRNAs in human skin and hair follicles and in 
vitro steroid effects on dermal fi broblasts and keratinocytes
Elena Pomari1,3, Silvia Barbon1, Paolo Pertile2, Luisa Dalla Valle1, Marie Julie 
Thornton3, Lorenzo Colombo1 1Comparative Endocrinology Laboratory, Department 
of Biology, University of Padova, Padova, Italy, 2Cutech, Padova, Italy, 3Centre for Skin 
Sciences, University of Bradford, Bradford, United Kingdom
In humans, compared to testosterone (TST) and estradiol (E2), signifi cantly higher levels 
of adrenal steroids dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) 
circulate. Since human skin and hair follicles (HFs) are important target tissues, we 
have analyzed mRNA expression of key steroidogenic proteins cytochromes P450scc, 
P450c17, P450arom, steroid sulfatase (STS), OATP2B1 and 5α-reductase 1 and 2 in female 
abdominal skin biopsies (n=4), epidermal keratinocytes (n=3) and HF (n=5 donors). The 
whole transcriptome of keratinocytes after 24h incubation with DHEA-S (10µM), TST 
(50nM) and E2 (1nM) was assessed by Gene Expression Array. Migration of a keratinocyte 
cell line (NCTC) and scalp dermal fi broblasts (n=3) in response to steroids was assessed 
with a scratch wound assay. Skin, keratinocytes and HFs expressed 5α-reductase 1, with 
the highest expression in HFs. Only HFs expressed 5α-reductase 2. All three expressed 
similar levels of STS, OATP2B1, P450scc and P450c17. Low levels of P450arom were found 
in skin and HFs, but not detected in keratinocytes. Gene expression array demonstrated 
modulation of infl ammation, proliferation and differentiation genes in response to steroids. 
All steroids stimulated NCTC migration; DHEA-S was reversed by an STS inhibitor 
(STX64). All steroids stimulated fi broblast migration; although both DHEA and TST were 
blocked by an aromatase inhibitor (Arimidex) and DHEA-S by the STS inhibitor. Human 
skin and HFs appear to be a potential synthetic site of sex steroids which can locally 
affect a multifunctional set of genes, while stimulating a migratory cell response. These 
mechanisms may have implications for hair growth, wound healing, skin aging and cancer.
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An original topical probiotic related ingrédient for dry skin: Effi cacy evaluated in a 
clinical trial with the help of bioinstrumental measurements and proteomic tools
Audrey Gueniche1, Caroline Delattre1, Eric Winstall2, Philippe Bastien1, Dominique 
Bernard1, Isabelle Castiel-Higounec1 1L‘Oréal Recherche, CLichy, France, 2Centre de 
recherche du Centre hospitalier universitaire, Québec, Canada
The aim of this study was to evaluate the effect of a novel probiotic related extract 
on some symptoms of dry skin. For this purpose, a topical cream containing a 
Bifi dobacterium lysate was tested in a randomized double-blind placebo-controlled 
trial, with sixty six female volunteers with dry skin. The volunteers applied twice 
a day the cream to the face, arms and legs for two months. Skin barrier repair 
ability, leg dryness, facial roughness and natural moisturing factors amounts in the 
stratum corneum (sc) were assessed at day 1, d29 and d57. Moreover, we used 
sc samples to perform a differential iTRAQ Peptide isobaric labeling-MS analysis.
The results showed that the treatment led to signifi cantly increase skin resistance 
compared to group who applied control cream (stripping number to obtain barrier 
function disruption was signifi cantly increased (p=0.0044) at d57). Clinical and self-
assessment revealed a signifi cant decrease in skin dryness (p=0.028). Skin urea level 
for the active extract treated group increased while this natural moisturizing factor 
decreased in the control group in the same period of time. Proteomic evaluation showed 
that the levels of some proteins associated with the desquamation process increased 
while the quantity of some other proteins related to the SC immaturity decreased.The 
results of this study demonstrate that this specifi c bacterial extract have a benefi cial 
effect on skin hydration and epidermal barrier homeostasis and thus may protect 
against environmental potentially irritating agents, external aggressions or stressed 
psychological conditions.  This bacterial extract then prevents and treats skin dryness.
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The fatty acid profi le of the skin surface lipid layer in patients with papulopustular 
rosacea
Siona Ni Raghallaigh1, Katrin Bender2, Noreen Lacey1, Lorraine Brennan2, Frank Powell1
1Mater Misericordiae University Hospital, Dublin, Ireland, 2UCD School of Agriculture, 
Food Science and Veterinary Medicine, UCD Conway Institute, Dublin, Ireland
Patients with papulopustular rosacea (PPR) frequently complain of dry, sensitive 
skin. We have previously demonstrated that PPR patients have reduced skin surface 
hydration levels, but normal sebum casual levels. This suggests that it may be 
the quality and not the quantity of sebum that plays a role in PPR. We therefore 
examined the skin surface fatty acid composition of 25 PPR patients and compared 
the results with 25 age and sex matched controls. Lipids were collected by placing a 
sebutape on the degreased skin of the central nose for 1 hour. Lipids were removed 
from the sebutape by a solvent procedure, and analysed by gas chromatography-
mass spectrometry. 58 fatty acids were identifi ed in the skin surface lipids. Of 
these, it was possible to quantify 28 and semi-quantify 27. The fatty acid with the 
highest concentration was palmitic acid (C16:0), followed by palmitoleic acid 
(C16:1 6+ 9), C17_1**, oleic acid (C18:1 9) and myristic acid (C14:0). There 
were statistically signifi cant lower levels of the saturated fatty acids undecanoic 
acid (C11:0), behenic acid (C22:0), tricosanoic acid (C23:0) and lignoceric acid 
(C24:0), and the monounsaturated fatty acid cis-11-eicosenoic acid (C20:1) in the 
PPR group. There is increasing evidence that sebaceous fatty acids play a role in 
the maintenance of skin barrier integrity. We propose that the imbalance between 
skin surface saturated and unsaturated fatty acids may contribute to the cutaneous 
symptoms of PPR. These new fi ndings may have therapeutic implications for the 
development of sebum-modifying non-antibiotic treatments for PPR patients.
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Primary cutaneous marginal zone lymphoma: Studies on Borrelia infection
Nóra Eros1, Márta Marschalkó1, Judit Hársing1, Zsolt Nagy2, Judit Demeter2, 
Judit Csomor3, Ágota Szepesi3, András Matolcsy3, Sarolta Kárpáti1,4
1Department of Dermatology, Venerology and Dermatooncolgy, Semmelweis 
University, Budapest, Hungary, 21st Department of Internal Medicine, Semmelweis 
University, Budapest, Hungary, 31st Department of Pathology and Experimental 
Cancer Research, Semmelweis University, Budapest, Hungary, 4Hungarian Academy 
of Sciences, Molecular Medicine Research Group, Budapest, Hungary
Primary cutaneous marginal zone lymphoma is a B-cell lymphoma with favorable 
outcome and a 5-year survival of 100 %. Nodal or systemic dissemination is 
uncommon and the treatment is successful in almost every cases. Borrelia infection 
has been suggested to be associated with disease development. Clinicopathological 
features and results of Borrelia studies in 11 patients with primary cutaneous marginal 
zone lymphoma are presented. A Borrelia burgdorferi ELISA in sensu lato revealed IgG 
seropositivity in one and IgM seropositivity in 2 other patients. In the former case the 
IgG positivity was not confi rmed by Western blot and no Borrelia burgdorferi DNA was 
detected in the cutaneous lymphoma by polymerase chain reaction.  These 3 patients 
have been treated with antibiotics, 2 patients responded well without recurrence, 
one patient relapsed. Two of the remaining 8 cases regressed spontaneously, 6 
patients responded completely to the surgery or radiotherapy. During the 2 to 5 years 
follow-up 3 Borrelia negative patients relapsed with treatment responsive cutaneous 
symptoms. Extracutaneous manifestations were not observed. In conclusion favorable 
course, spontaneous regression or treatment responsive cutaneous symptoms 
were observed without systemic involvement in all of our patients. The etiological 
role of Borrelia subspecies could not be confi rmed in this patients‘ population.
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Morphine Loaded Solid Lipid Nanoparticles (SLN) for the Local Treatment of Skin 
Wounds
Sarah Heilmann1, Sarah Küchler1, Nadine Wolf1, Momin Yahya2, Monika Schäfer-Korting1
1Institute for Pharmacy, Freie Universität Berlin, Germany, 2Dept of Pharmaceutics, 
National Institute of Pharmaceutical Education and Research, Punjab, India
For the treatment of severe pain caused by skin wounds opioids are administered 
orally which is often related to systemic side effects like respiratory depression or 
obstipation. Topically applied opioids appear to induce local analgesic effects as well 
as to improve wound healing, while systemic side effects are reduced. Recently, we 
documented that both opioids and the drug delivery system solid lipid nanoparticles 
(SLN) accelerate the wound healing process in 2D/3D wound healing models by 
stimulating the keratinocyte migration. Now, we aimed for a formulation of morphine 
loaded SLN to combine the positive effects of both - opioid and carrier - and to obtain 
sustained release for several days fi tting best with clinical needs in wound management.
Therefore, morphine 0,125-0,5 mg/mL was loaded onto SLN composed of Compritol® 
ATO 888 and Poloxamer 188. Stability, particle size, the effi ciency of drug-loading 
and drug release were determined according to standard procedures. The SLN 
with an average size of 195 nm are stable for at least 30 days. Morphine loading 
effi ciency was about 90 % depending on the morphine concentration. Morphine 
release from SLN was prolonged compared to morphine solution. Total morphine 
release was reached within 6 hours, whereas the release from solution was already 
fi nished after 4 hours. For a further improvement, in the next step we will incorporate 
the SLN in a hydrophilic gel in order to extend the release of the formulation.
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Towards the Pathogenesis of Cutaneous Side-Effects Induced by Inhibitors of the 
Epidermal Gowths Factor Receptor
Bettina Alexandra Buhren1, Peter Arne Gerber1, Parinaz Ansari1, Andreas Kislat1, 
Raquele Guadarrama-Gonzalez2, Colin Mackenzie2, Andreas Wollenberg3, Jürgen 
Harder4, Jens Michael Schröder4, Bernhard Homey1 1Dept of Dermatology, Univ 
Hosp, Düsseldorf, Germany, 2Inst of Medical Microbiology, Univ Hosp, Düsseldorf, 
Germany, 3Dept of Dermatology & Allergy, Ludwig-Maximilian Univ, Munich, 
Germany, 4Dept of Dermatology, Univ Hosp Schleswig-Holstein, Kiel, Germany
Recently, inhibitors of the EGFR (EGFRI), like the small molecule tyrosine kinase inhibitors 
erlotinib (Tarceva®) and gefi tinib (Iressa®), or the monoclonal antibody cetuximab (Erbitux®) 
have been established successfully as so called targeted cancer drugs in the clinical practice. 
Most frequent and most severe side-effects of this class of drugs are cutaneous toxicities occurring 
in more than 50 percent of the patients. Patients treated with EGFRI develop a characteristical 
infl ammatory papulopustular rash (acneiform rash), xerosis cutis, as well as hair and periungual 
alterations. In the course, superinfections of the rash with Staphylococcus aureus occur 
frequently. These clinical observations assume, that the EGFR critically regulates cutaneous 
infl ammation and infection. Nevertheless, the pathogenesis of EGFRI induced cutaneous side-
effects has yet to be elucidated. This study analyses the in vitro expression of chemokines and 
antimicrobial peptides in primary human keratinocytes treated with inhibitors of the EGFR 
(EGFRI) using quantitative realtime PCR. Our results demonstrate that the EGFR in fact controls 
the cutaneous expression of chemokines and antimicrobial peptides. In particular, we show that 
the blockade of the EGFR induces an overexpression of proinfl ammatory chemokines as well as 
a suppression of antimicrobial peptides in human keratinocytes. In line with these fi ndings, cell 
supernatants of EGFRI treated keratinocytes demonstrated a reduction of the cytotoxic activity 
against Staphylococcus aureus as compared to medium controls. Our results present interesting 
new insights into the pathogenesis of cutaneous side-effects associated with the use of EGFRI.
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Detection of melanoma-derived cancer-testis antigen CT16 in patient sera by a 
novel immunoassay
Pekka Rappu1, Camilla Nylund1, Noora Ristiniemi1, Janne Kulpakko1, Pia Vihinen2, 
Micaela Hernberg3, Kalle Alanen4, Markku Kallajoki4, Seppo Pyrhönen2, Jyrki Heino1
1Department of Biochemistry,University of Turku, Turku, Finland, 2Department of 
Oncology and Radiotherapy, Turku University Hospital, Turku, Finland, 3Department 
of Oncology, Helsinki University Central Hospital, Helsinki, Finland, 4Department of 
Pathology, University of Turku, Turku, Finland
Cancer-testis antigens (CTAs) are expressed mainly in various cancer tissues. 
In normal tissues they are only expressed in testis and placenta. Because of their 
restricted expression pattern, the CTAs can be potentially utilized for vaccine 
development and diagnostic applications. Cancer-testis antigen CT16 has been 
found to be expressed in lung and renal cancers as well as in melanomas. Detection 
of CT16 protein directly from melanoma patient serum could facilitate monitoring 
of tumor growth and response to therapy in CT16-positive patients. A highly 
sensitive time-resolved fl uorescence-based immunoassay measuring cancer-testis 
antigen CT16 in serum was developed. CT16 level was detectable in 14 out of 23 
metastatic patients (61%) whereas none of the healthy controls had measurable 
CT16 level. The Wilcoxon-Mann-Whitney exact test showed statistically signifi cant 
difference (P=0.006) between the groups of healthy individuals and patients with 
metastatic melanoma. Four melanoma patients had exceptionally high serum 
CT16 level. The level of S100B, a recognized marker of progressing melanoma, 
did not correlate with CT16. CT16 levels of follow-up samples of three patients 
with metastatic melanoma were found to follow disease progression independent 
on S100B. As a conclusion, our results show that CT16 protein can be measured 
directly from patient serum, and the developed assay has a potential for clinical use.
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Innovative Therapies - Discovery and Development of Mapracorat, a Topical SEGRA 
for the Treatment of Infl ammatory Diseases
Heike Schaecke2, Eugene O‘Keefe1, Hartmut Rehwinkel2, Thomas Bieber4, Keith Ward3
1Intendis GmbH, Berlin, Germany, 2Bayer Schering Pharma AG, Berlin, Germany, 
3Bausch & Lomb, Incorporated, Rochester,NY, United States, 4Univ of Bonn, Germany
Concerted efforts in research have been focused in recent years on innovative New Chemical 
Entities with improved therapeutic indices for the treatment of infl ammatory diseases. Mapracorat 
is a novel low-molecular-weight compound which belongs to the proprietary class of SELECTIVE 
GLUCOCORTICOID RECEPTOR AGONISTS (SEGRAs) that are structurally unrelated to steroids. 
Pharmacological properties of Mapracorat were studied in terms of the potential anti-
infl ammatory and side effects in functional bioassays. This novel potent compound binds with 
high affi nity and selectivity to the GR yet is more selective than traditional glucocorticoids. 
The anti-infl ammatory activity of Mapracorat was demonstrated in in vitro assays for inhibition 
of cytokine secretion and T cell proliferation. In vivo, in irritant contact dermatitis and T-cell-
mediated contact allergy models in rodents, Mapracorat showed anti-infl ammatory effi cacy 
after topical application similar to traditional GCs, mometasone furoate and methylprednisolone 
aceponate. Mapracorat, however, exhibits a better safety profi le after single and repeated 
treatment of animals. Likewise, Mapracorat was extensively studied in both in vitro and in 
vivo models of ocular disease. Mapracorat exhibits potent anti-infl ammatory effects in cell-
based systems comparable to traditional steroids, as well as potent effi cacy in animal models 
of ocular infl ammation, dry eye, and allergy. However, Mapracorat demonstrates a superior 
nonclinical ocular safety profi le with respect to the potential for elevated intraocular pressure.
Mapracorat is a potent anti-infl ammatory compound with a lower potential for side effects, compared 
with traditional glucocorticoids. It represents a promising drug candidate and is currently in clinical 
development for application in infl ammatory skin diseases and for ophthalmologic indications.
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What causes the pseudoxanthoma elasticum (PXE) skin lesions to look yellowish? : 
measurement and analysis of their optical properties
Eri Muroga1, Takaaki Maeda2, Yoshihisa Aizu2, Yuki Ogura3, Yoshiki Miyachi1, Atsushi 
Utani4 1Department of Dermatology, Kyoto Univ, Kyoto, Japan, 2Division of Science for 
Composite Functions, Muroran Institute of Technology, Muroran, Japan, 3Shiseido Life 
Science Research Center, Yokohama, Japan, 4Department of Dermatology, Graduate 
School of Biomedical Sciences Nagasaki Univ, Nagasaki, Japan
Pseudoxanthoma elasticum (PXE) is a genetic disorder characterised by calcifi cation and 
degeneration of elastic fi bers. The term pseudoxanthoma refers to the yellowish papules found 
on fl exural skin. However, mechanisms that cause the yellowish color are unknown. In this 
study, the optical properties of PXE skin lesions were examined to answer this question. First, 
a refl ectance spectrophotometer was used to measure the skin color of lesional and non-
lesional skin of 5 PXE patients. Refl ection values in the longer-wavelength ranges, as well as 
b* values (yellowness) in CIE L*a*b* space, were higher in PXE lesions, indicating that they 
were objectively more yellowish. As degeneration of elastic fi bers and calcium deposition 
occur mainly in the deeper dermis, we then performed a Monte Carlo simulation using a 
nine-layered skin model to test whether skin can be yellowish with increased light scattering 
from the dermis. By increasing the scattering coeffi cient of the reticular dermis,  simulated 
spectral pattern assimilated that of PXE lesions. b* values (yellowness) also increased. No 
differences were found regarding the content of chromophores such as melanin or blood 
vessels.Finally, to investigate if the masses of degenerated elastic fi bers actually increase 
scattering, deparaffi nized sections of biopsied specimens were examined under a dark-
fi eld stereomicroscope. Strong scattered light was observed in the areas corresponding 
to the masses of degenerated elastic fi bers. Decalcifi cation by EDTA abolished this 
increase. These results together suggested that increased scattered light from the deposited 
calcium in the reticular dermis might be the cause of yellowishness of PXE skin lesions.
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The chemokine CCL20 directs human sperm to the oocyte
Peter Arne Gerber1, Erich Bünemann1, Bettina Alexandra Buhren1, Jens Hirchenhain2, 
Norbert Neumann1, Anja Müller-Homey3, Hans-Christian Schuppe4, Jan-Steffen 
Krüssel2, Albert Zlotnik5, Bernhard Homey1 1Department of Dermatology, University 
Hospital, Düsseldorf, Germany, 2Department of Obstetrics and Gynecology, University 
Hospital, Düsseldorf, Germany, 3Department of Radiation Oncology, University 
Hospital, Düsseldorf, Germany, 4Department of Urology, Paediatric Urology and 
Andrology, Justus Liebig University, Giessen, Germany, 5Department of Physiology and 
Biophysics, University of California, Irvine, United States
The interaction of sperm with the oocyte is pivotal during the process of mammalian 
fertilization. The limited numbers of sperm that reach the fallopian tube as well as 
anatomic restrictions suggest that human sperm-oocyte encounter is not a matter 
of chance but a directed process. Chemotaxis is the proposed mechanism for re-
orientating sperm towards the source of a chemoattractant, and hence to the oocyte. 
Chemokines represent a superfamily of small (8-11 kDa), cytokine-like proteins that 
have been shown to mediate chemotaxis and tissue-specifi c homing of leukocytes. Here 
we show that human spermatozoa express chemokine receptors in a non-random 
manner and identify CCR6 as the most abundantly expressed receptor. Conversely, 
granulosa cells of the oocyte-surrounding cumulus complex as well as human 
oocytes represent an abundant source of the CCR6-specifi c ligand CCL20. In human 
ovaries, CCL20 shows a cycle-dependent expression pattern with peak expression 
in the preovulatory phase, and CCL20 protein induces chemotactic responses of 
human sperm. Neutralization of CCL20 in ovarian follicular fl uid signifi cantly impairs 
sperm migratory responses. Taken together, our study indicates that the chemokine 
CCL20 is a critical factor in the oocyte microenvironment for attracting human sperm.
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Expression of Cutaneous Lymphocyte Associated Antigen During TNF-alfa Inhibitor 
Biologic Therapy in Psoriatic Patients
P Holló1, H Jókai1, E Szlávik1, A Gál1, J Szakonyi1, B Hidvégi1, G Barna2, S Kárpáti1
1Dept of Dermatovenerology and Oncodermatology, Semmelweis University, 
Budapest, Hungary, 21st Dept. of Pathology and Experimental Cancer Research, 
Semmelweis University, Budapest, Hungary
Th-1 mediated infl ammatory answer has a major role in the pathogenesis of psoriasis. 
Homing receptor  of T-cells, the cutaneous lymphocyte associated antigen (CLA) is 
responsible for the specifi city of the infl ammation processes developing in the skin. 
Authors examined CLA expression of 17 psoriatic patients recieving TNF-alfa inhibitor 
biologic therapy. Total lymphocyte CLA expression and CD4+, CD8+  subpopulations 
of CLA+ lymphocytes were measured by fl ow cytometry before treatment, two and 
six weeks after initiation of therapy.  Correlation of CLA expression with the clinical 
severity measured by PASI during tratment was examined and evaluated in two 
groups: 13 responder and 4 relapsing patients. Results were statistically analized. 
Signifi cant difference was detected between the initial total CLA expression of the 
responder and the relapsing group, and CD4+ CLA expression between responder 
and control group. An inverse tendency in CLA expression was detected in the 
two groups reacting differently to the treatment. These results indicate that the 
level and dynamics of CLA expression might predict the effi cacy of the treatment.
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Profi ling of sebaceous lipids: discovery of novel sebum alterations in juvenile acne
Emanuela Camera1, Matteo Ludovici1, Marisa Galante1, Stefania Tilgher1, 
Monica Ottaviani1, Jo-Linda Sinagra2, Bruno Capitanio2, Mauro Picardo1
1Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics 
Research, San Gallicano Dermatological Institute (IRCCS), Rome, Italy, 2Acne Unit/
Pediatric Dermatology, San Gallicano Dermatological Institute (IRCCS), Rome, Italy
Acne is a multifactorial disease that affl icts the majority of adolescents in western 
countries. To defi ne the ultimate signifi cance of sebum in the pathogenesis of juvenile 
acne, detailed compositional information is required. We have achieved comprehensive 
and simultaneous detection of intact lipids enriching normal sebum, which presented 
a broad range of chemical structures and concentrations. Compound-mining and 
structural characterization were undertaken with HPLC/TOF-MS and MS/MS experiments, 
respectively. These approaches enabled the identifi cation of 95 and 29 families of 
triacylglycerols (TAG) and diacylglycerols (DAG), respectively. Among wax esters (WE), 28 
species contained the C16:1 fatty acyl moiety. Detection of squalene (SQ), its oxidation 
products, and 9 cholesterol esters (CE) was accomplished in the same run. Additionally, 
more than 48 free fatty acids (FFA) were found. To address lipidomics of acne sebum, we 
applied the gathered compositional and structural information for the within-class profi ling 
of individual sebaceous lipids. Sebum was collected from uninvolved forehead zones of 
20 young acne patients (14.00 ± 1.78 years, F/M=1) and from the same area of 20 age 
matched controls (14.33 ± 2.20 years), with analogous female to male ratio. Signifi cantly 
different distributions of intact components were detected among TAG, DAG, WE and FFA 
lipid classes, whereas no differences were found in the CE profi les. Moreover, levels of SQ 
epoxide were signifi cantly higher in acne subjects. This is the fi rst evidence of different 
distributional profi les of sebaceous lipids in acne. The structural information of the individual 
sebum components provided clues on the enzymatic pathways possibly affected in acne.
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Cervical spine compression leading to brachioradial pruritus: results of a prospective 
magnet resonance tomography study
Ngoc Quan Phan1, Martin Marziniak2, Ulrike Raap3, Dorothee Siepmann1, Funda 
Schürmeyer-Horst1, Esther Pogatzki-Zahn4, Thomas Niederstadt5, Sonja Ständer1
1Competence Center Pruritus and Dept of Dermatology, Univ Hospital Münster, 
Münster, Germany, 2Dept of Neurology, Univ Hospital Münster, Münster, Germany, 
3Dept of Dermatology and Allergology, Hannover Medical School, Hannover, 
Germany, 4Dept of Anaesthesiology & Intensive Care, Univ Hospital Münster, 
Germany, 5Dept of Clinical Radiology, Univ Hospital Münster, Germany
Brachioradial pruritus (BRP) describes a rare form of chronic localized itching occurring 
at the dorsolateral part of the forearms. Recent case reports suggest that BRP may 
be attributed to cervical lesions or spine neoplasms. To determine the incidence of 
cervical spine changes in BRP and to correlate the localization of spinal lesions with the 
dermatomal presence of pruritus, 40 patients (27 female, 13 male, 60.2+10.3 years) with 
BRP were investigated by magnetic resonance tomography (MRT) of the cervical spinal 
cord, chest x-ray, and skin biopsy. Patients fi lled in an itch questionnaire („NeuroDerm 
Questionnaire“) including a dermatome chart and the Northwick Park Neck Pain 
Questionnaire. All patients showed MRT changes. In 80% of the patients, stenosis of 
intervertebral foramen or protrusions of cervical disc led to nerve compression (NC). The 
localization of the NC lesions signifi cantly correlated with the dermatomal localization 
of the pruritus (Spearman‘s correlation coeffi cient: 0.938). No spinal neoplasm was 
observed. 20% had degenerative changes (DC) such as retrospondylolisthesis without 
signifi cant correlation to the dermatomal localization of pruritus. BRP as a form of 
neuropathic pruritus may originate in cervical NC but improbably by DC. Our fi ndings 
suggest that even slight cervical MRT changes may alter itch afferences leading to BRP. 
Spinal neoplasms as cause of BRP are rare but should be ruled out by cervical spine MRT.
 www.jidonline.org S67 
ABSTRACTS
397
An in vitro synergetic effect of adapalene and benzoyl peroxide (BPO) on 
infl ammatory acne lesions
Thomas Zuliani1, Amir Khammari2, Brigitte Dreno1,2 1Laboratory of Immuno-
Dermatology, CIC biotherapy INSERM 0503, University Hospital, Nantes, France, 
2Unit of Skin Cancer, CHU de Nantes, CIC biotherapy INSERM 0503, University 
Hospital, Nantes, France
Acne is a chronic infl ammatory disease of the pilosebaceous follicle characterized 
by increased sebum production, keratinocytes hyperproliferation and presence of p. 
acnes. Currently, association of retinoïds and BPO is recommended by the international 
guidelines for the treatment of acne. The purpose of this study was to investigate ex vivo 
modulator effect of Adapalene associated with BPO on keratinocytes proliferation/
differentiation and innate immunity. An immunohistochemical study was carried out 
from acne papules and non involved acne skin biopsies of the back from seven patients 
with moderate acne. Keratinocyte proliferation was measured by the Ki67 expression, 
differentiation by the integrin α2, α3, α6, fi llagrin and transglutaminase expressions 
and innate immunity by the TLR-2 and IL-8 expressions. It was demonstrated that, 
except for fi laggrin, all the markers were overexpressed in infl ammatory acne skin 
compared to non involved acne skin. Adapalene and BPO association produced 
signifi cantly greater decrease of the proliferation marker (Ki67), differentiation markers 
(integrin α2 and α6, transglutaminase) and innate immunity markers (TLR-2, IL-8) in 
infl ammatory acne skin than adapalene or BPO alone. Interestingly, the expression 
of the different markers was down regulated by adapalene and BPO association to a 
level close to the control skin. In conclusion, for the fi rst time, we have demonstrated 
here a synergistic in vitro effect of adapalene and BPO association on keratinocyte 
proliferation/differentiation and on skin infl ammation of acne lesional skin.
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Toll-Like Receptor-8 engagement on Artifi cial Antigen-Presenting Cell-expanded 
CD8+ T lymphocytes
Jean-François Chatillon1, Claire Abasq1, Emilie Fauquembergue2, Florence 
Bayeux1, Aurélie Drouet2, Jean-Baptiste Latouche2, Philippe Musette1
1INSERM U905, Rouen, France, 2INSERM U614, Rouen, France
Adoptive transfer of in vitro activated and expanded tumor antigen-specifi c cytotoxic 
T lymphocytes (CTLs) is a promising approach to cure cancer but the main problem 
encoutered is to obtain highly cytotoxic cells that could home to the tumor. 
We studied the impact of Toll-Like Receptor-8 engagement on peripheral 
CD8+ T lymphocytes expanded by co-culture with artifi cial antigen-
presenting cells (AAPCs; Latouche and Sadelain, Nat biotechnol, 2000). 
We defi ned the optimal conditions for obtaining MART-1-specifi c CTLs from 6 A2.1+ 
healthy donors, using AAPCs and anti-MART-1 phycoerythrin (PE)-coupled pentamer. 
After a 2 to 3 week co-culture, we obtained, in a donor-dependent manner, 3 to 25% of 
specifi c CTLs. We found that CTLs expressed TLR8 at the cell surface and in intracellular 
compartments. MART-1 specifi c CTLs activated by TLR8 agonist were able to induce 
an increase of cytotoxic activity against MART-1-pulsed target cells, between 10 and 
20% for four donors. However, TLR8 engagement did not change signifi cantly the 
production of cytokines implicated in cytotoxicity (TNF-α, IFN-γ and Granzyme B).
We found, using a cytotoxic assay with T2-cells pulsed with a gradient of MART-1 
peptides, that TLR8 engagement increased by ten fold the avidity of MART-1 specifi c 
CTLs to their targeted cells. In conclusion, we found that TLR8 expression levels as well 
as the increase of cytotoxity observed after TLR8 engagement were highly dependent 
on the donor. We found that TLR8 engagement increased the avidity of CTLs for their 
target cells but this mechanism is not correlated with an increase of cytokine production.
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Illness perception, psychological distress and quality of life in patients with 
cicatricial alopecias
Christine Bundy1, Christopher Griffi ths1, Ralf Paus1,2, Matthew Harries1
1The University of Manchester, Manchester, United Kingdom, 2University of Lubeck, 
Lubeck, Germany
Cicatricial (or scarring) alopecias are a diverse group of infl ammatory disorders that 
result in permanent hair loss. Very little is known about the psychological impact 
of these conditions on patient wellbeing and quality of life. The aim of this study 
was to evaluate illness perception, psychological distress and quality of life in 
patients with cicatricial alopecias.Patients with cicatricial alopecia were recruited 
from a specialist hair research clinic. The Dermatology Life Quality Index (DLQI; n 
= 88), Hospital Anxiety and Depression Scale (HADS; n = 77) and Revised Illness 
Perception Questionnaire (IPQ-R; n = 75) were used as validated measures of 
quality of life, psychological distress and illness perception, respectively. Patients 
displayed high levels of psychological distress (mean HADS score = 11.6) and 
impaired quality of life (mean DLQI score = 6.4). Participants reported signifi cant 
emotional impact from the alopecia (mean IPQ-R score = 3.49), as well as a 
low sense of personal control (mean IPQ-R score = 2.27) and treatment control 
(mean IPQ-R score = 2.57).  Stress, immune dysfunction and aging were the most 
commonly cited causal attributions for the alopecia. Psychological distress was 
associated with a strong illness identity (r=0.412; p<0.001) and beliefs that alopecia 
has serious consequences (r=0.578; p<0.001), and strong emotional representations 
(r=0.653; p<0.001). There was no signifi cant difference in psychological distress or 
quality of life between the different cicatricial alopecia disease entities examined.
The strong relationships between psychological distress and illness perceptions 
should be recognised when managing patients with cicatricial alopecia.
400 [Oral 053]
Improvement of epidermal barrier function and erythema by cis-urocanic acid 
emulsion cream in adult patients with mild to moderate atopic dermatitis
Christer T. Jansén1, Liisa Pylkkänen2, Jarmo K. Laihia2, Juha Peltonen3, Iina Volanen3, 
Lasse Leino2 1Mehiläinen Medical Center, Turku, Finland, 2BioCis Pharma Ltd., Turku, 
Finland, 3Clinical Research Services Turku, University of Turku, Turku, Finland
The effi cacy of repeated and multiple topical dosing of cis-urocanic acid (cis-UCA) 
was evaluated in adult patients with chronic mild to moderate atopic dermatitis 
(AD) up to 28 days. Thirteen female or male AD patients were treated with 5% 
cis-UCA (0.7 mg/kg daily) and placebo (Aqualan®) emulsion cream on symmetric 
volar arm skin areas twice daily for 10 days. Twelve of the patients continued 
treatment with cis-UCA (0.35 mg/kg daily) and placebo on study days 14-31. cis-
UCA treatment reduced transepidermal water loss (TEWL) vs. placebo over the whole 
treatment period (p=0.024; RMANCOVA) and vs. baseline (p=0.043). Excluding 
days 14 and 35 with no ongoing treatments, the decrease from the baseline was 
highly signifi cant for cis-UCA (p=0.003) but not for placebo (p=0.26). Erythema 
was reduced by cis-UCA only (p=0.012; excluding days 14 and 35, p=0.012). In 
a cohort of the AD patients with their baseline erythema above the mean + 1 SD 
of healthy individuals, cis-UCA reduced erythema vs. placebo on days 5 and 21 
and vs. baseline on days 14-28 (p< 0.05). In the same cohort of high-erythema 
patients, cis-UCA reduced the initial TEWL vs. placebo on days 10 (p=0.019), 21 
(p=0.005), and 28 (p=0.003). Signifi cant improvements were observed in eczema 
area and severity index (EASI) and the physician’s global assessment (PGA) for 
both treatments. The 5% cis-UCA emulsion cream improved skin barrier function 
(assessed by TEWL), erythema, and disease condition in adult patients with AD. 
The effect of cis-UCA may be the most benefi cial in subjects with active AD.
401 [Oral 026]
First double-blind randomized clinical trial of intradermal allogeneic fi broblast therapy for 
severe generalized recessive dystrophic epidermolysis bullosa randomized against placebo 
injections resulted in similar wound healing that is independent of collagen VII expression
S.S. Venugopal1,2, W.F. Yan1,2, J.W. Frew1,2, H.I. Cohn2,3, M. Sturm4, J. Fogarty4, P. 
Marinkovich5, S. Igawa6, A. Ishida-Yamamoto6, D.F. Murrell1,2 1St George Hospital, 
Sydney, Australia, 2Univ of New South Wales, Sydney, Australia, 3Jefferson Medical 
College, Philadelphia, USA, 4Cell & Tissue Therapies, Royal Perth Hospital, Australia, 
5Stanford University, Stanford, USA, 6Asahikawa Medical College, Japan
Based on the observation that intradermal injection of cultured fi broblasts increased collagen VII 
expression in unblistered skin of RDEB-GS patients at three months, we initiated a single institution, 
double-blinded, intra-patient, placebo-controlled RCT to determine the clinical and molecular 
responses of fi broblast injections in RDEB-GS chronic erosions. Five patients each with up to 6 
pairs of symmetrical wounds were injected with GMP-cultured allogeneic fi broblasts in transport 
solution (Transalyte with 2% albumex) or with transport solution alone. Wounds were biopsied 
and randomly injected at baseline and monitored at two weeks, three, six and twelve months with 
the Visitrak technique. Skin biopsies were performed at each time point to determine collagen 
VII protein and mRNA expression, anchoring fi bril numbers and morphology, and infl ammatory 
markers. All patients had rapid improvements in wound healing of both paired wounds treated 
with cultured fi broblasts and the placebo solution, an effect that lasted up to six months, was 
similar in therapeutic degree, and was unobserved in untreated wounds. Collagen VII expression 
and anchoring fi brils increased to a similar degree in both study arms for up to six months in three 
of the patients‘ wounds, however not all patients required increased collagen VII expression for 
wound healing. In conclusion, the injection of both allogeneic fi broblasts and transport solution 
alone encouraged wound healing in chronic non-healing RDEB-GS wounds, and the molecular 
results suggest increased collagen VII expression is not a requirement for this phenomenon. 
Thus, the injections provide a feasible new therapy for wound healing in patients with RDEB.
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Vitamin D serum levels are differentially infl uenced by UVB311 and UVA1 
phototherapy
Laurence Feldmeyer1, Golnar Shojaati1, Katharina-Susanne Spanaus-Schlapbach2, 
Alexander Navarini1, Barbara Theler1, Davide Donghi1, Annette Bischoff-Ferrari3, Lars 
E. French1, Günther FL Hofbauer1 1Dept of Dermatology, University Hospital Zürich, 
Switzerland, 2Institute for Clinical Chemistry, University Hospital Zürich, Switzerland, 
3Centre on Aging and Mobility, Dept of Rheumatology and Institute of Physical 
Medicine, University Hospital Zürich, Switzerland
UV phototherapy has been shown to increase 25(OH)D. Almost all studies were 
performed with UVBbb. 2 recent studies investigated the infl uence of UVBnb on 
vitamin D. Only 2 studies investigated the 25(OH)D under PUVA-therapy, with 
contradictory results. We could not fi nd any studies on the effect of UVA1 on vitamin 
D in the medical literature. We investigated the serum elevation of 25(OH)D under 
UVBnb and UVA1 therapy in patients undergoing phototherapy, in order to determine 
the effect of these nowadays frequently used wavelengths for phototherapy on vitamin 
D plasma levels, and particularly to test the dogma, that UVA has no effect on vitamin 
D. In the contrary to UVA, UVA1 has almost no overlap with the UVB spectrum. 
25(OH)D was determined before the start of light therapy, as well as 1 week after 
the start of therapy and after completion of therapy at 12 weeks. The fi rst preliminary 
results show that, as expected, serum vitamin D increases under UVBnb therapy. 
Under UVA/UVB we also have an increase in vitamin D, however, less clear than with 
UVBnb. Under UVA therapy, no increase in vitamin D was measured. In conclusion, 
as UVA exposure does not increase vitamin D synthesis, and the UVBnb-induced 
increase in vitamin D synthesis is linked to a higher risk of skin cancer, the optimum 
wavelength for production of previtamin D3 corresponding to maximal DNA damage, 
intentional UV exposition is not an appropriate way to correct a vitamin D defi ciency.
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Succesful Treatment Of 114 Patients With Alopecia Universalis (AU) With A Novel 
Oral Vaccine Based On Oral Tolerance Induction
Kiumars Pirkalani, Zahra Talaee Rad, Majid Mehdizadeh Mehr Medical Group, 
Tehran, Iran, Islamic Republic of
To reconcile the immune system with an unknown antigenic moiety of hair follicles, 
we used an oral preparation to treat refractory alopecia universalis. Oral tolerance 
induction is still theoretical. We used alopecia as the best model for it because of 
abundance of the antigen, relatively harmless disease without affecting vital organs 
and possibility of histological evaluation during the disease course.Forty seven 
patients received 800mg of autologous or allogeneic dark hair (partially hydrolyzed 
in some) in gelatin capsules TID under a strict preparation protocol as sole treatment 
and 67 in addition to other medications. Thirty of 47 patients responded although 
it was complete in about 10%. Sixty fi ve of the 67 patients who received both the 
vaccine and other medications showed a reduction of their need to other drugs 
including steroids. They relapsed very late or did not relapse till the release of this 
paper. Later control of the disease was extremely easier and only 22 patients relapsed 
in the form of total hair loss (all because of arbitrary discontinuation of treatment). 
The relapse in all others were in the areata or multiple patchy form and easy to 
treat. As the patients were on many medications exact conclusion about drug/vaccine 
interaction is diffi cult to draw but some synergy between Vitamin B6 and the oral 
vaccine and relative antagonism between concomitant corticosteroids and oral 
vaccine were encountered. We conclude that oral tolerance induction is an antigen 
specifi c option in many auto immune diseases and alopecia is the best model for it.
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Effi cacy and safety of etanercept for the treatment of moderate-to-severe psoriasis 
when used with adjunctive topical therapy as needed:  the PRISTINE Trial
Robert Strohal1, Lluis Puig2, Deborah Robertson3, Joanne Estojak3, Ronald pedersen3, 
Jeffrey Melin3, Bruce Freundlich3, Charles Molta3 1Federal University Teaching 
Hospital Feldkirch, Feldkirch, Austria, 2Hospital de la Santa Creu i Sant Pau, Barcelona, 
Spain, 3Specialty Care, Pfi zer Inc., Collegeville, PA, United States
The PRISTINE trial  (NCT00663052) assessed effi cacy and safety of 2 different dose 
regimens of etanercept (ETN) for treatment of moderate-to-severe plaque psoriasis. 
Subjects were randomised to either ETN 50 mg OW (n=137) or 50 mg BIW (n=136) 
for 12 weeks double-blind followed by ETN 50 mg OW open-label for all subjects. 
Mild topical steroids only were permitted on scalp, axillae, and groin for fi rst 12 
weeks; all potencies of topical steroids and/or vitamin D were allowed as needed 
for weeks 12-24. Primary endpoint was 75% improvement in Psoriasis Activity 
and Severity Index compared with baseline (PASI75) at week 24, evaluated for all 
randomised subjects who received at least 1 dose of ETN (n=137 for 50 mg OW/
OW; n=133 for BIW/OW). Safety was assessed for all subjects. Subjects were 
adults with stable plaque psoriasis involving body surface area ≥10% or PASI≥10, 
and deemed not candidates for ≥1 of the following:  MTX, ciclosporine or PUVA. 
251 subjects (92%) completed 24 weeks. Mean baseline PASI was 21. At week 24, 
60% in the OW/OW group and 78% in BIW/OW achieved PASI75 (P=0.0015); 
only 15 subjects (10.9%) in OW/OW and 9 (6.6%) in BIW/OW were electively 
using potent topical steroid preparations at week 24. No new safety signals were 
reported; 7 subjects (2.6%) experienced serious adverse events. Nine subjects (3.3%) 
discontinued due to adverse events. Etanercept at either dose regimen was effi cacious 
in moderate-to-severe psoriasis, with few subjects electing to use concomitant potent 
topical medications. BIW/OW regimen provided better relief of skin symptoms.
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PK/PD analysis for the prediction of the effective dosage and administration of 
SUN13834 in Phase 2a study of human atopic dermatitis
Yoshiaki Tomimori1, Yusuke Fujieda1, Maki Terakawa1, Tsuyoshi Muto1, Taisaku 
Tanaka1, Hiroshi Maruoka1, Kazuhiro Nagahira1, Atsuto Ogata1, Yoshiaki Fukuda1, 
Naohiro Watanabe2 1Asubio Pharma Co., Ltd., Osaka, Japan, 2The Jikei University 
School of Medicine, Tokyo, Japan
SUN13834, a novel chymase inhibitor, improved skin condition in animal models 
of atopic dermatitis (AD).  A PK/PD analysis to predict the effective dosage and 
administration in human AD patients was performed.The inhibition of late-phase 
reaction in biphasic skin reaction was considered important for the improvement 
of AD because immunosuppressants and corticosteroids, but not anti-histamines, 
inhibited the late-phase reaction.  SUN13834 inhibited late-phase reaction at the 
dose of 2 mg/kg (PO) or 0.4 mg/kg (IP).  The plasma concentration of SUN13834 at 
the elicitation, which meant the minimum effective plasma concentration in mice, 
was calculated to be 0.13-0.2 ng/mL.  Oral administration of SUN13834 improved 
skin condition in NC/Nga mice, which develop human AD-like skin lesions under 
conventional condition, at the dose of 15 mg/kg (BID) and 30 mg/kg (QD), but 
not 60 mg/kg (EOD).  The duration time of 15 mg/kg (BID), 30 mg/kg (QD) and 
60 mg/kg (EOD) over 0.13-0.2 ng/mL were 20.3, 12.2 and 10.1 hours, respectively, 
suggesting that it is important in NC/Nga mice to maintain the minimum effective 
concentration for more than 12 hours.  Since the IC50 values of SUN13834 for human 
chymase was 2-fold higher than that for mouse chymase, the expected minimum 
effective concentration in human plasma concentration would be 0.26-0.4 ng/mL. 
In order to maintain these SUN13834 concentrations in human subjects for a similar 
duration as the corresponding plasma levels in the NC/Nga mice, we determined the 
dosage and administration in Phase 2a study as 50 mg TID based on Phase 1 PK data.
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Safety and effi cacy of the new dermal shaper (Novabel®) for the correction of 
nasolabial folds: 18 months interim-results of a prospective, ongoing, multi-center 
study
Tatjana Pavicic1, Thomas Dirschka2, Philippe Kestemont3, Thomas Ruzicka1, Gerhard 
Sattler4, Michael Sebastian5, Volker Steinkrauss6, Ahmmed-Ziah Taufi g7, Berthold 
Rzany8 1Clinic and Polyclinic for Dermatology and Allergology, University Clinic, 
University of Munich, Munich, Germany, 2Private pactice, Wuppertal, Germany, 
3Private pactice, Nice, France, 4Rosenparkklinik GmbH, Darmstadt, Germany, 5Private 
practice, Blankenfelde, Germany, 6Private pactice, Hamburg, Germany, 7Private 
practice, Cologne, Germany, 8Charité, Berlin, Germany
Novabel® (Merz Pharmaceuticals, Germany) is a new dermal shaper based on a new Geleon® 
technology. The objective of this prospective, multi-center, open-label trial was to evaluate safety 
and effi cacy after bilateral injection for the correction of nasolabial folds in a long-term follow-up. 
Subjects (> 18 years) with moderate to severe nasolabial folds (NLF) using a 5-point severity rating 
scale (Merz Scales; SRS) were included. Novabel® was administered bilaterally into the deep dermis 
and upper subcutis with an optional touch-up within 2 weeks. The improvement was assessed by 3 
blinded, independent raters after 18 months (SRS score of the NLF). Adverse events were assessed by 
the physician at each visit as well as by patient diaries. 154 subjects have been injected with the new 
dermal shaper initially. The overall mean improvement in the SRS score 18 months after the injection 
of Novabel® was 0.8 ± 0.59 as assessed by the photo rating of 3 independent blinded raters. None of 
the subjects dropped out of the study due to non-allowed follow-up treatment of the NLF. The adverse 
events were mostly injection related events such as bruising (1.9%), redness (21.4%), swelling 
(5.8%), and pain (1.3%) within the fi rst 14 days after the injection (moderate to mild intensity). Only 
3 patients dropped out due to an adverse event which were unrelated to the Novabel® according 
to the investigator. The study demonstrated a clinically improvement in NLF 18 months after the 
injection of Novabel®. Novabel® was well tolerated leading to a signifi cant better patient comfort. 
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Belotero® Basic has a better tolerability vs Restylane®: A prospective, rater-blind, 
randomized, comparative trial
Welf Prager, Volker Steinkraus Dermatologikum Hamburg, Hamburg, Germany
Belotero® Basic is the only monophasic HA with Cohesive Polydensifi ed Matrix 
(CPM®) technology, whereas Restylane® is a biphasic, non-animal stabilized HA 
(NASHA) fi ller. The aim of this prospective, rater-blind, randomized, intra-individual 
study was to compare after a single injection the effectiveness and tolerability of 
these two HA for correction of moderate to severe nasolabial folds (NLF) and to 
demonstrate the advantage of monophasic versus biphasic HA. After a screening 
phase subjects were injected randomly with either Boletero® or Restylane® in one 
NLF in a split-face design. Rating was conducted at week 4. The rater and the subject 
were not aware of the randomization. Besides other endpoints pain experienced 
directly after injection using a 10-cm visual analog scale, feeling of  implant, and 
recommendation of the study treatments were evaluated (descriptively). 20 Patients 
were treated with a mean of 1.4 mL of  Belotero® Basic or Restylane®. Mean pain 
assessment scores on the VAS were lower for Belotero® Basic than for Restylane® 
with an intra-individual difference of -4.5 mm [95% CI: -14.0; 5.1]) in favour of 
Belotero. Moreover, less sujects reported the feeling of Belotero® Basic ompared 
to Restylane® (65% vs 75%). The majority of patients would recommend the use 
of both products, however, 25% would only recommend Belotero® Basic only (vs. 
10% Restylane® only). 85% of subjects in the Belotero® Basic group and 80% of 
subjects in the group rated the tolerability as ‘good’ to ‘very good’.Belotero® Basic 
demonstrated a numerical superiority regarding tolerability vs.Restylane® in this study.
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Baseline cardiometabolic abnormalities in subjects with moderate-to-severe plaque 
psoriasis in the PRISTINE trial
Lluis Puig1, Robert Strohal2, Joanne Estojak3, Ronald Pedersen3, Annette Szumski3, 
Deborah Robertson3, Bruce Freundlich3, Charles Molta3, Jeffrey Melin3 1Hospital 
de la Santa Creu i Sant Pau, Barcelona, Spain, 2Federal University Teaching Hospital 
Feldkirch, Feldkirch, Austria, 3Specialty Care, Pfi zer Inc., Collegeville, PA, USA
The PRISTINE trial ((NCT00663052) assessed effi cacy and safety of 2 different regimens 
of etanercept (ETN) for treatment of moderate-to-severe plaque psoriasis in subjects from 
13 countries in Europe, Asia, and Latin America. Cardiometabolic parameters were also 
assessed to further characterise this population. Descriptive baseline statistics (mean 
values) are presented herein for 273 randomised subjects. Subjects were ≥18 yrs old 
with stable plaque psoriasis involving ≥10% body surface area or PASI≥10. Subjects were 
70% male, 64% Caucasian, 33% smokers; mean age 44 yrs, BMI 28.3 kg/m2 for males 
and 29.6 kg/m2 for females, PASI 21, mean baseline hsCRP 7.37 mg/L (n=265; normal 
value <3.1 mg/L) and psoriasis duration 17 yrs. Thirty-one percent (31%) gave a history 
of psoriatic arthritis (duration 8 yrs). At baseline, 36% of subjects had hypertension; 
39% met the defi nition of metabolic syndrome (71% large waist circumference, 36% 
elevated blood pressure by history, 27% low high-density lipoproteins, 37% high 
triglycerides, and 35% high fasting glucose by history or fasting glucose ≥100 mg/dL). 
Mean Framingham 10-yr risk score was 5.63 (n=260), and mean Reynolds Risk Score 
was 4.00 (n=257). According to the 2010 American Diabetes Association Guidelines, 
14% (35/250) had diabetes mellitus (10% by history) and 34% (86/250) had prediabetes. 
In addition, 31% of diabetics (11/35) and 17% of prediabetics (14/84) had evidence of 
chronic kidney disease (based on glomerular fi ltration rate 15-59 mL/m/1.73m2 or urinary 
albumin/creatinine ratio ≥30 mg/g). In this multinational study of moderate-to-severe 
plaque psoriasis, a high prevalence of cardiometabolic abnormalities was identifi ed.
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A Pharmacometric Model of SUN13834 Effi cacy in Adult Subjects with Atopic 
Dermatitis
Bharti Shah, Charles Oo, Joseph Gertner Asubio Pharmaceuticals, Inc., Rochelle Park, 
NJ, United States
SUN13834 is a novel chymase inhibitor under development for the treatment of 
Atopic Dermatitis (AD). Subjects, 18 to 65 years old, diagnosed with AD (baseline 
total Eczema Area and Severity Index (EASI) scores of ≥5) were randomized in a Phase 
2 study of SUN13834: 120 to placebo and 120 to 50 mg tid administered orally for 
28 days with EASI scores assessed weekly. A two-compartment, fi rst-order absorption 
and elimination model adequately characterized the SUN13834 pharmacokinetic 
profi le with steady-state achieved within one week. Population pharmacokinetic 
estimates of clearance (CL/F) and volume of distribution (V2/F) averaged 113 L/h and 
106 L, respectively (NONMEM© 6.1). Between-subject variability was 42.8% for CL/F 
and 62.1% for V2/F. Residual intra-subject variability was 52.9%. Individual empirical 
Bayesian estimates of SUN13834 steady-state area under the 24-hour concentration-
time curve (AUC) were obtained for subsequent EASI score modeling. EASI score was 
adequately modeled as declining mono-exponentially over the course of treatment. 
Baseline EASI scores and fi rst-order score improvement rate constants were log-
normally distributed among subjects. Baseline EASI scores tended to be higher in atopy 
probable subjects (IgE >100 IU/mL) and improvement rates tended to be slower in 
these subjects, particularly in the placebo group. Placebo-adjusted improvement was 
greater in atopy probable than in non-atopy probable subjects treated with SUN13834.
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SUN13834 in the Treatment of Subjects with Atopic Dermatitis
Ger Rikken, Joseph Gertner Asubio Pharmaceuticals, Inc., Rochelle Park, New Jersey, 
United States
Atopic Dermatitis (AD) is a highly prevalent and symptomatic disease with 
limited treatment options.  Mast cells containing chymase predominate in 
the skin, and degranulate upon stimulation with IgE.  Chymase has been 
implicated in pruritus and biphasic allergic skin reactions consistent with AD.
SUN13834 is a potent, selective orally administered chymase inhibitor that has 
demonstrated effi cacy in animal AD models. SUN13834 was evaluated in a 
randomized, placebo-controlled, double-blind study for 28 days in 270 adults with 
AD of all severities (mean IGA = 3). Assessments included EASI, IGA, pruritus and 
insomnia.  Mean improvement in EASI was 47% vs. 38% for placebo. Based on 
a comparison of LS-means, this difference was statistically signifi cant; P = 0.006. 
Similar improvements were observed in IGA.  Consistent improvement in EASI 
was observed in all disease severities, and all EASI disease components, including 
lichenifi cation.   Signifi cantly more subjects on SUN13834 had little or no pruritus 
and sleep disturbance than placebo.    A subset of atopy probable patients (plasma 
IgE > 100 IU/mL, N=120) showed enhanced response, with a mean improvement in 
EASI of 52% vs 28% for placebo (P = 0.001).  63.1% vs 30.9% of placebo subjects 
had a ≥50% improvement in EASI (P = 0.002). There were signifi cantly more 
responders to pruritus at the fi rst time point measured (Day 8). AEs with SUN13834 
were similar to placebo except for diarrhea (5% vs 2% for placebo). SUN13834 
was effi cacious and safe in the treatment of AD subjects studied in this trial.
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Sèzary Syndrome Treated With Ecp And Interferon- Alpha
Liisa Väkevä, Annamari Ranki Helsinki University Central Hospital, Helsinki, Finland
Sèzary syndrome (SS) is a leukemic variant of primary cutaneous T cell lymphoma. 
The characteristic features include pruritic erythroderma, lymphadenopathy and the 
presence of circulating malignant T lymphocytes (Sèzary cells). In differentiating SS 
from other erythrodermic conditions, we use the following markers: monoclonality 
of the T lymphocytes (TCR analysis), the presence of at least 1000 circulating 
Sèzary cells/mm3, an expanded CD4+ population in the peripheral blood and loss 
of any T cell antigen ( CD2, CD3, CD4, CD5). The prognosis of SS is poor with 
no curative therapy. The current therapies include extracorporeal photopheresis 
(ECP), psoralen and UV-A (PUVA), chlorambusil combined with prednisolone, 
electron beam therapy, bexarotene and interferon-α.We present a 68 year-old 
woman, who developed an erythrodermic itchy skin eruption starting from the 
palms in 2004. Repeated biopsies showed eczema and psoriformic histology. 
Laboratory tests and CT- scans were normal. To control erythema and itching 
cyclosporine was introduced in 2007. Some of the symptoms alleviated, but after 
6 months of cyclosporine therapy, a follow-up biopsy revealed mycosis fungoides 
and over 40% of blood  lymphocytes had a cerebriform nucleolus. TCR from skin 
biopsies showed clonal rearrengement and axillary lymph nodes were enlarged. 
Patient was diagnosed with SS and clorambusil/prednisolon treatment started for 
3 months. The Sèzary cells were reduced to 35%. In 2009 ECP with prednisolone 
was started on 2 successive days every 4 weeks. After 2 cycles patient was 
concomitantly treated with interferon-α. The skin symptoms were clinically alleviated
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Pimecrolimus Cream Treatment Normalizes Clinical Symptoms, Skin Barrier 
Function and Antimicrobial Protein Expression in Seborrheic Eczema
Jens-Michael Jensen1, Christin Clausen1, Jochen Brasch1, Matthias Bräutigam2, 
Regine Gläser1, Thomas Schwarz1, Regina Fölster-Holst1, Ehrhardt Proksch1 1Dept of 
Dermatology, Venerology, & Allergology, Univ Hospitals of Schleswig-Holstein, Univ 
of Kiel, Germany, 2Novartis Pharma GmbH, Nuremberg, Germany
Seborrheic dermatitis is a chronic infl ammatory skin disease, etiology is only partially 
known. Since Malassezia species are often found in the lesions, topical application of 
antimycotic creams, most commonly ketoconazole, is a standard therapy. The calcineurin 
inhibitor pimecrolimus is widely used for the topical treatment of atopic dermatitis because 
of its anti-infl ammatory effects. To examine whether pimecrolimus improves clinical 
symptoms and barrier function in seborrheic dermatitis, 32 patients were treated either 
with 1% pimecrolimus cream or 2% ketoconazole cream twice daily for 4 weeks in a 
randomized, double-blinded fashion. In addition, in 25 patients skin washings were used 
for antimicrobial proteins monitoring. In a subgroup, skin biopsies were taken before and 
after treatment from the chest region. Both treatments improved clinical symptoms, but 
the pimecrolimus group reached signifi cance more quickly than the ketoconazole group. 
In both groups enhanced transepidermal water loss values decreased towards normal 
levels. Both treatments enhanced hydration which was reduced in lesional skin. Epidermal 
hyperproliferation and thickness were signifi cantly reduced only in the pimecrolimus 
group. A reduction of Malassezia spp. was seen after both treatments, but more pronounced 
using ketoconazole cream. Ketoconazole treatment revealed a slight reduction and 
pimecrolimus treatment a signifi cant reduction of hBD-2 expression, which is related to 
infl ammation and dedifferentiation (p=0.0367). This demonstrates that hBD-2 expression, 
epidermal proliferation and differentiation as well as clinical scoring were more favourable 
infl uenced towards normalization by using pimecrolimus compared to ketoconazole.
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Antipruritic potency of the triterpene betulin: results of an open-labelled trial in 
patients with chronic pruritus
Ngoc Quan Phan1, Christine Blome2, Dorothee Siepmann1, Melanie N. Laszczyk3, 
Matthias Augustin2, Sonja Ständer1 1Competence Center for Pruritus, Department of 
Dermatology, University Hospital Münster, Münster, Germany, 2CV Derm, Department 
for Dermatology and Venerology, University Hospital Eppendorf, Hamburg, Germany, 
3Birken GmbH, Department for Research and Development, Niefern-Öschelbronn, 
Germany
To date, experimental studies suggested that natural occuring triterpenes like betulin induce 
cutaneous anti-infl ammatory, anti-nociceptive effects and wound-healing. An open-labelled 
trial aimed to investigate the antipruritic effects in 64 patients with chronic pruritus on 
infl ammatory skin (group1: n=20, 10 f, 10 m; mean age 55.5 years), pruritus on unchanged 
skin (group 2: n=23, 10 f, 13 m; mean age 57.4 years) and with chronic scratch lesions 
(group 3: n=21, 13 f, 8 m, mean age 62.0 years).  A Betulin containing cream was applied 
for a period of two weeks twice daily on the affected areas. Before and after therapy, patients 
received a detailed clinical investigation with documentation of present scratch lesions 
assessed by the prurigo-score. For daily documentation of pruritus intensity patients used 
the visual analogue scale (VAS) from 0 to 10. Statistical analysis was done by intention-to-
treat analysis. An antipruritic effect was documented in 50% of group 1 (10/20), 39.1% 
of group 2 (9/23) and 57.1% of group 3 (12/21). The mean reduction of pruritus intensity 
(in percent) was 49.3% in group 1, 66.9% in group 2 and 65.3% in group 3. Patients of 
group 3 also showed a signifi cant regression of scratch lesions within two weeks of cream 
application (mean prurigo score before/after therapy: 2.73/2.04; p=0.012). Most of the 
patients (90.6%) tolerated the therapy well. The present results suggest that the topical use 
of betulin is an effective antipruritic treatment option with good compatibility in patients 
with chronic pruritus, especially in patients with chronic scratch lesions.
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Expansion of Tumor Infi ltrating Lymphocytes in a close system: interests for GMP 
production and adoptive immunotherapy
Soraya Saiagh1, Thomas Zuliani1,3, Julien David3, Sylvain Bercegeay1, Marie-
Christine Pandolfi no1, Isabelle Rodde-Astier4, Cecile Coissac4, Brigitte Dreno1
1Unit of Cell and Gene Therapy (UTCG), CIC biotherapy INSERM 0503, University 
Hospital, Nantes, France, 2Unit of Skin Cancer, CIC biotherapy INSERM 0503, 
University Hospital, Nantes, France, 3Laboratory of Immuno-Dermatology, CIC 
biotherapy INSERM 0503, University Hospital, Nantes, France, 4MacoPharma, 
Tourcoing, France
Adoptive cell therapy (ACT) consists in the isolation, ex vivo expansion and reinjection of tumor 
reactive lymphocytes. ACT has emerged as an effi cient treatment for patients with metastatic 
melanoma. However, large scale ex vivo cell amplifi cation has several logistical concerns for 
widespread availability of ACT. One critical step is the initial stimulation of Tumor infi ltrated 
lymphocytes (TIL) with feeder cells that is performed in multiple plates which have many limitations 
in terms of safety, reproducibility and handling. To address these problems we developed a specifi c 
compartmentalized bag that allows close contact between TIL and feeder cells, facilitating 
stimulation and amplifi cation in an easy handling, close system. We performed a comparative study 
of TIL proliferation after stimulation with feeder cells in the compartmentalized bags versus standard 
protocol in plates. We also examined the production of specifi c tumor reactive CD8+ T cells. 
Firstly, the level of proliferation and cell viability was as good with the bags as with the standard 
protocol. Secondly, interestingly, by majoring IFNγ production by TIL in presence of the autologous 
melanoma cell line, we found that cells stimulated in bags were enriched in reactive CD8+ T 
cells compared to cells stimulated in plates. In conclusion, we demonstrate that stimulation of TIL 
with feeder cells can be amplifi ed in a close system which is a crucial point for GMP. Moreover, 
the higher amplifi cation rate of reactive CD8+ T cells could have signifi cant impact for ACT.
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Isotretinoin and Infl ammatory Bowel Disease: Population-Based Study
Raed Alhusayen1, David N. Juurlink1, Muhammad M. Mamdani1, Richard Morrow2, 
Neil H. Shear1, Colin R. Dormuth2 1University of Toronto, Toronto, Ontario, Canada, 
2University of British Columbia, Vancouver, BC, Canada
Case reports and small observational studies suggest that isotretinoin, a popular 
medication for nodulocystic acne, may cause Infl ammatory Bowel Disease (IBD). To 
explore this association, we conducted a retrospective cohort study in the province 
of British Columbia (BC), Canada from January 1st, 1997 to December 31st, 2008.  All 
provincial residents were categorized into one of three groups according to use of 
isotretinoin, topical acne products, or none of these medications. the main outcome 
measure was the adjusted rate ratio for the risk of IBD with untreated patients as the 
reference group.  A secondary analysis examined patients with a history of IBD prior 
to exposure. Among 1,764,017 BC residents, 47,189 were prescribed isotretinoin. 
After adjusting for potential confounders, we observed an increased risk of IBD 
among young adults exposed to isotretinoin [rate ratio (RR) 1.51; 95% confi dence 
interval (CI) 1.12, 2.04). However, an increased risk was also seen with topical 
acne products (RR 1.18; 95% CI 1.00, 1.39). In the secondary analysis, exposure to 
isotretinoin among IBD patients did not increase the risk of IBD fl are up (RR 0.72; 
95% CI 0.48, 1.23). In fact, isotretinoin exposure was associated with decreased risk 
compared to topical acne products (RR 0.52; 95% CI 0.29, 0.92). In conclusion, we 
found increased risk of IBD after isotretinoin exposure. Given that the risk was also 
increased in the topical acne products group, drugs classes unlikely to cause IBD, the 
increased risk is likely related to acne vulgaris rather than acne interventions. We 
also found a decreased risk for IBD fl are up following isotretinoin exposure.
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Obesity and atopic diseases: evidence from a population-based cross-sectional 
study in Germany
Christian Apfelbacher1, Jochen Schmitt2, Adrian Loerbroks3,4 1Department of Clinical 
Social Medicine, University of Heidelberg, Heidelberg, Germany, 2Department of 
Dermatology, University Hospital Carl Gustav Carus, Dresden, Germany, 3Mannheim 
Institute of Public Health, Social and Preventive Medicine, Mannheim, Germany, 
4Competence Center for Social Medicine and Occupational Health Promotion, 
Heidelberg University, Mannheim, Germany
The purpose of this study is to analyse the assocation of obesity with hayfever, eczema and asthma in 
German children and adolescents. Data was drawn from the public use fi les of the German Interview 
and Examination Survey for Children and Adolescents (KIGGS), a nationwide cross-sectional 
representative survey conducted between 2003 and 2006. 14362 participants with no missing values 
on hayfever, eczema, asthma and obesity were eligible for analysis. The association of hayfever, 
eczema and asthma with obesity was analysed by means of multivariable logistic regression, using 
proc surveylogistic in SAS. Obesity was defi ned using German reference values (>97th age and 
sex-specifi c percentile) according to Kromeyer-Hauschild et al. In crude analyses (N=13022), the 
lifetime prevalences of ever-physician diagnosed hayfever and asthma were signifi cantly higher in 
obese compared to normal weight children (15,5 % vs 11,9%, p=0.01; 9,5% vs 5,0%, p<0.0001). 
In contrast, the lifetime prevalence of ever-physician diagnosed eczema was signifi cantly lower in 
obese compared to normal weight children (10,9% vs 14,1%, p=0.02). In multivariable analyses 
(N=9671), neither hayfever (OR 1.22, 95% CI 0.91-1.63) nor eczema (OR=0.92, 95% CI 0.71-
1.19) were signifi cantly associated with obesity. Asthma, however, was signifi cantly associated with 
obesity (OR 1.85, 95% 1.37 - 2.49). Asthma, but not hayfever or eczema, is signifi cantly associated 
with obesity in German children and adolescents. This fi nding is consistent with existing studies 
and calls for research on the mechanisms linking asthma, but not hayfever or ezcema, to obesity.
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Determinants of atopic and non-atopic eczema: results from a population-based 
cross-sectional study in Germany
Thomas Diepgen1, Jochen Schmitt2, Christian Apfelbacher1 1Department of Clinical 
Social Medicine, University of Heidelberg, Heidelberg, Germany, 2University Hospital 
Carl Gustav Carus, Technical University Dresden, Dresden, Germany
The purpose of this study is to investigate the prevalence of atopic and non-atopic 
eczema in German children and adolescents and to examine associated factors. 
Data was drawn from the public use fi les of the German Interview and Examination 
Survey for Children and Adolescents (KIGGS). 12747 children and adolescents, 
aged 3-17 years, were eligible for analysis. Allergic sensitization was defi ned 
as sensitization (specifi c IgE >= 0.35 kU/l) to at least one aero- or food allergen. 
Weighted prevalences of potential determinants were compared in atopic and 
non-atopic eczema. The weighted prevalences of atopic and non-atopic eczema 
were 8,2% (95% CI 5,3%-6,3%) and 5,8% (95% CI 5,3%-6,3%), respectively. The 
percentage of atopic eczema in all eczema cases increased signifi cantly with age 
group. The proportion of girls was signifi cantly higher in non-atopic eczema (p< 
0.0001). Family history of eczema was strongly related to atopic as well as non-
atopic eczema in the offspring (p< 0.0001). Family history of respiratory atopy was 
signifi cantly more prevalent in children with atopic eczema. Migration background 
was associated with a signifi cantly decreased prevalence of both atopic and non-
atopic eczema (p< 0.0001). Lifestyle and environmental factors (social position, 
living area, mould, pets, breastfeeding, smoking) were associated with both atopic 
and non-atopic eczema to the same degree.  Depending on age group, up to 54% 
of German children/adolescents with eczema do not show concomitant allergic 
sensitization. Both atopic and non-atopic eczema are strongly infl uenced by a family 
history of eczema, but asthma and hayfever do not play a role in non-atopic eczema.
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Suicidal Ideation, Mental Health Problems and Social Impairment are increased in 
Acne: A Population-Based Study in Adolescents
Jon Anders Halvrsen1,2, Robert S. Stern3, Florence Dalgard2, Magne Thoresen4, Espen 
Bjertness2,5, Lars Lien6 1Dept of Dermatology, Oslo Univ Hosp Rikshospitalet, Fac of 
Medicine, Univ of Oslo, Norway, 2Inst of General Practice and Community Medicine, 
Univ of Oslo, Norway, 3Beth Israel Deaconess Medical Center, Harvard Med School, 
Boston, USA, 4Dept of Biostatistics, Inst of Basic Medical Sciences, Univ of Oslo, 
Norway, 5Tibet Univ Med College, Lhasa, China, 6Inst of Psych, Univ of Oslo, Norway
Psychosocial problems in acne are scarcely explored in large adolescent populations, and the 
relation to suicide ideation and depression is of great interest because of the controversy regarding 
possible psychological side-effects of isotretinoin. In a cross-sectional, questionnaire-based 
study, a total of 4744 adolescents aged 18-19 years were invited and 3775 (80%) participated. 
Fourteen percent (n=493) of respondents reported having a lot and very much (substantial) acne. 
Suicidal ideation was more than twice as frequently reported among those with very much acne 
compared to the whole sample (24.1% versus 10.9%). Suicidal ideation remained signifi cantly 
associated with substantial acne (OR 1.80, 95% CI 1.30-2.50) in a multivariate model including 
adjustments of ethnicity, family income and symptoms of depression. Mental health problems, as 
assessed by Strengths and Diffi culties Questionnaire (OR: 2.25), low attachment to friends (OR; 
1.52), not thriving at school (OR: 1.41), never had romantic relationship (OR: 1.35), and never 
had sexual intercourse (OR:1.51) were all statistically signifi cantly associated with substantial 
acne in a multivariate model. Information from the National Prescription Database shows that 
the maximum number of isotretinoin-users in the sample was 27. Substantial acne is frequent in 
late adolescents and is associated with psychosocial problems in this population with low use of 
isotretinoin. Our fi ndings complement results from quality of life studies in acne patients. Adverse 
events including suicide, suicidal ideation and depression that have been attributed to isotretinoin 
may therefore refl ect the burden of substantial acne rather than the effects of the medication.
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Low winter levels of 25-hydroxyvitamin D, not summer levels, are associated with 
increased risk of internal cancer in organ transplant recipients
Jan Nico Bouwes Bavinck, Frank de Gruijl Leiden University Medical Center, Leiden, 
Netherlands
High serum levels of 25 hydroxyvitamin D (25(OH)-vitD) have been related to 
reduced risk of non-cutaneous (‘internal‘) cancers. Adequate summer levels and 
corresponding sun exposure are considered primary determinants of reduced risk. 
The impact of recurrent low winter levels at mid latitudes (40 - 60°) remains obscure. 
We have investigated this potential risk in organ transplant recipients (OTRs). A total 
of 6609 measurements of 25(OH)-vitD were registered from 1991 through 2007 of 
1455 OTRs, 81 of whom developed internal cancer with 304 prior measurements 
of 25(OH)vitD levels, and 78 developed cutaneous squamous cell carcinomas 
(SCC) with 341 prior measurements. Cox proportional hazard analyses were used 
to estimate the risk of cancer. In contrast to summer levels, winter levels of 25(OH)-
vitD were signifi cantly lower among people who contracted internal cancers (34 
vs. 41 nmol/l, p = 0.002). Hazard ratios showed a signifi cant increase with lower 
winter levels of 25(OH)-vitD (< 12 vs. > 50 nmol/L gave 5.6 fold increase, p = 
0.024). No trend in risk was observed with summer levels of 25(OH)-vitD. Higher 
summer levels corresponded with signifi cant increases in SCC risk (p = 0.026). 
Only winter time levels of 25(OH)-vitD were associated with the risk of internal 
cancers, which casts doubt on the effi cacy of risk reduction by increasing summer 
levels through increased sun exposure. SCC risk was related to higher levels of 
25(OH)-vitD which may be attributable to increased sun exposure. Adequate 
vitamin D supplementation from October through March would appear advisable.
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Filaggrin loss-of-function mutations are associated with early onset eczema, eczema 
severity, and transepidermal water loss at three months of age
Carsten Flohr1,2, Kirsty England1, Suzana Radulovic1, W.H. Irwin McLean3, Linda 
E. Campbell3, Jonathan Barker2, Michael Perkin1, Gideon Lack1 1Dept of Children‘s 
Allergies, MRC/Asthma UK Centre in Allergic Mechanisms of Asthma, King‘s College 
London, UK, 2St John‘s Inst of Dermatology, Guy‘s & St Thomas‘ Hospital NHS 
Foundation Trust, London, UK, 3Div of Molecular Medicine, Univ of Dundee, UK
Filaggrin (FLG) mutations are associated with eczema and skin barrier impairment, but it is unclear 
whether skin barrier impairment precedes phenotypic eczema in FLG mutation carriers, or whether 
it is primarily an epiphenomenon of disease activity. 88 infants were examined for eczema. Disease 
severity was determined by SCORAD score. Transepidermal water loss (TEWL) was measured on 
unaffected forearm skin, and venous blood samples were screened for the four commonest FLG 
mutations in the UK white population (R501X, 2282del4, R2447X, and S3247X). 31.8% (28/88) 
of children had eczema. Median SCORAD was 10.6 (range 0-31). TEWL was higher in children 
with eczema compared to unaffected infants (median TEWL [g/m2*h] 14.24 vs 11.24, p<0.001). 
Higher TEWL was associated with more severe disease (median TEWL SCORAD <15 13.76 vs 
SCORAD ≥15 29.60, p=0.029). Clinically dry skin was associated with higher TEWL, even in the 
absence of eczema (median TEWL 17.55 vs 11.08, p=0.008). 17.0% (15/88) of children carried at 
least one FLG mutation. FLG mutation carriers were more likely to have eczema by three months 
of age (OR=4.26 (1.34-13.57), p=0.014), and FLG mutations were associated with higher median 
TEWL (FLG ‘yes’ 21.59 vs FLG ‘no’ 11.24, p<0.001), even without clinical eczema (FLG ‘yes’ 
15.99 vs FLG ‘no’ 10.82, p=0.01). Already at three months, FLG mutations are associated with 
eczema phenotype and increased transepidermal water loss. The observation that TEWL is elevated 
in unaffected FLG mutation carriers suggests that skin barrier impairment precedes clinical eczema, 
but longitudinal follow up of this cohort is required.
 www.jidonline.org S71 
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Quality of Life and Self-Concept in Patients with Psoriasis
Konrad Janowski, Stanislawa Steuden, Olga Kwiecien John Paul II Catholic University 
of Lublin, Lublin, Poland
Numerous studies have documented that psoriasis can exert a profound detrimental 
effect on quality of life in the affl icted individuals. It is unclear, however, whether 
the chronic, disease-related decrease in quality of life can affect the structural 
components of personality, for instance, modify self-concept. The aim of this study 
was to investigate the relationships between the levels of health-related quality of life 
and different dimensions of self-concept in patients with psoriasis. Fifty patients with 
psoriasis completed the questionnaires measuring quality of life (Skindex-29) and 
self-concept (Adjective Check List - ACL). Lower levels of quality of life were found 
to be associated with a lower number of positive and a higher number of negative 
adjectives selected for self-description. Decreased quality of life was also related to 
lowered interpersonal needs, including nurturance (the need to engage in behaviors 
that provide material or emotional benefi ts to others) and affi liation (the need to seek 
and maintain personal friendships). Lowered quality of life was also associated with 
compromised self-control, lower personal adjustment, decreased spontaneity and 
higher attitudes of evaluation, severity, skepticism, and dissatisfaction with oneself. The 
fi ndings suggest that chronically lowered quality of life due to psoriasis co-occurs with 
negative changes in self-concept, particularly with different facets of dissatisfaction 
with oneself (lowered self-esteem) and with compromised interpersonal needs.
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Development of a new biological instrument applied to cutaneous tissues in order 
to anticipate the evolution of radiological burns
Muriel Liboutet, Cécile Martin, Sandrine Roch-Lefèvre, Laurence Roy, Gaetan Gruel, 
Philippe Voisin IRSN, Fontenays aux roses, France
Radiological accidents of past ten years are caracterized by localized dose of 
up to 2000 Gy. The diagnosis and prognosis of radiological burn evolution are 
partly based on the evaluation of the dose locally received by skin. The physical 
reconstruction of the dose helps to get this information, but requires specifi c 
knowledge of the accident geometry and irradiations conditions. However, these 
data are rarely available in case of radiological accidents. The aim of this project 
is to develop a new biological dosimeter that could be applied to cutaneous tissue. 
First, in order to avoid high-dose culture of irradiated cells, we work directly on 
human skin explants as an in vitro human model of radiological burns. Secondly, 
the Fluorescence In Situ Hybridation (FISH) is applied to skin fi broblasts directly 
isolated from skin biopsies in order to count extra chromosome segments. Human 
skin biospies are irradiated from 0 to 50 Gy. Twenty fours hours after irradiation, FISH 
painting are performed on skin fi broblasts. The number of extra chromosome per 
cell is mesured. At the same time, each explant is characterized (metabolic activity, 
histological features and KI67 immunostaining). During the conference, we will 
present whether there is a relationship between the number of extra chromosome 
segments per cell and the dose. We will then conclude of the effectiveness of your 
tool as a biological dosimeter applicable to skin or as an indicator of exposure.
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Sleep lines: facial locations and risk factors in French middle-aged Caucasian women
Randa Jdid1, Khaled Ezzedine2, Julie Latreille1, Anissa Elfakir1, Denis Malvy3, Florian 
Gruber4, Pilar Galan2, Serge Hercberg2, Erwin Tschachler4, Christiane Guinot1
1CERIES, Neuilly-sur-Seine, France, 2Centre of Research on Human Nutrition Ile de 
France, Paris/Bobigny, France, 3Departments of Internal Medicine and Tropical 
Diseases, CHU St-André, Bordeaux, France, 4Department of Dermatology, University 
of Vienna Medical School, Vienna, Austria
The aim of the study was to investigate possible risk factors for sleep lines in Caucasian 
women.  Sleep lines are different from expression wrinkles since they are not located 
on tension lines and are not related to Langer‘s lines but they are caused by individual‘s 
sleeping positions.  This study involved a sample of 542 French middle-aged women 
(44 to 70 years old).  Three standardised facial photographs (face and profi les) were 
examined independently by two dermatologists allowing for the identifi cation of 
sleep lines and the evaluation of the severity of several features.  Possible impacts of 
genes polymorphisms (MC1R, elastin, MMP1 and MMP9) were tested using logistic 
regression models.  Sixty women (11%) had facial sleep lines and showed generally 
more than one sleep line.  The sleep lines were often located on the forehead, along 
the nose, on the cheeks and under the eyes, and more rarely on the chin.  As expected, 
the sleep lines were associated with age, and the women with sleep lines showed 
also more severe signs of skin ageing.  After adjustment on possible confounders, the 
presence of two major diminished function variants of the MC1R gene was identifi ed 
as a strong risk factor for sleep lines (AOR [95% CI]: 8.25 [2.6225.97]).  No such 
association was found with the other genes tested.  Our results suggest that genetic 
variations of MC1R are important determinants of the development of sleep lines.
424
Risk Factors of Solar Lentigines in French middle-aged Caucasian Women
Emmanuelle Mauger1, Khaled Ezzedine2, Randa Jdid1, Julie Latreille1, Denis Malvy3, 
Florian Gruber4, Pilar Galan2, Serge Hercberg2, Erwin Tschachler4, Christiane Guinot1
1CERIES, Neuilly sur Seine, France, 2Centre of Reasearch on Hum Nutrition Ile de 
France, Paris/bobigny, France, 3Departments of Internal Medicine and Tropical 
Diseases, CHU St-André, Bordeaux, France, 4Department of Dermatology, University 
of Vienna Medical School, Vienna, Austria
The aim of this research was to investigate risk factors of solar lentigines in French adult 
Caucasian women.  Beforehand, a fi rst sample of 320 women completed a questionnaire 
specifi cally designed to explore sun exposure and sun protection behaviour.  These data 
were used to build a typology: different types of behaviour have been defi ned.  Then, to 
be able to assign any new individual into a given type, a decision tree was built based on 
the three most important items.  Independently, a second study was conducted on 542 
adult women.  Phenotypic data and items related to sun exposure and protection were 
collected. Moreover, MC1R polymorphisms was determined, as well as the presence of 
solar lentigines on the face.  After having assigned each woman in the sun behaviour 
typology, possible risk factors of solar lentigines were examined using logistic regression 
models. As expected, the risk of solar lentigines was found signifi cantly linked with 
age (AOR [95% CI]: 1.08 [1.051.11]), presence of freckles (3.00 [1.994.52]), dark hair 
colour (1.77 [1.092.86]) and dark skin colour (1.47 [0.922.36]). Moreover, signifi cant 
links were found with the presence of solar lentigines and the practice of nautical and 
mountain sports (1.71 [1.152.55]), the most risky behaviours regarding sun exposure 
(3.27 [1.467.31], 2.26 [1.074.76], 1.88 [0.893.95]), and a trend with the presence of 
at least one major diminished function variants of MC1R gene (1.42 [0.852.35]).  Our 
fi ndings highlight complex relationships between individuals‘ genotypic background 
and its phenotypic expression, sun exposure behaviour and sun protection habits.
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Chromosome 11q13.5 variant: No association with atopic eczema in Japanese 
population
Yukiko Nomura1, Masashi Akiyama1, Toshifumi Nomura1,2, Ikue Nemoto-Hasebe1, 
Riichiro Abe1, Irwin McLean2, Hiroshi Shimizu1 1Department of Dermatology, 
Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan, 
2University of Dundee, Dundee, United Kingdom
A single nucleotide polymorphism (SNP) on chromosome 11q13.5 [rs7927894] 
has been reported to show highly signifi cant association of a common variant of 
rs7927894 with atopic eczema (AE) in the German and Irish population. We 
evaluated the association between rs7927894 and AE in our cohort of 194 Japanese 
AE patients and 113 unrelated Japanese control individuals. 22.7% and 1.5% of 
the patients in our Japanese AE case series are heterozygous and homozygous for 
rs7927894[T], respectively. rs7927894[T] is also heterozygously and homozygously 
carried by 23.0% and 0% of the Japanese control individuals. Thus, there is no 
statistically signifi cant association between the rs7927894[T] and Japanese AE. After 
stratifi cation for Japanese specifi c FLG mutations that we previously identifi ed, 26.0% 
and 4.0% of our Japanese AE case series with FLG mutations are heterozygous and 
homozygous for rs7927894[T], respectively. 21.5% and 0.7% of the Japanese AE 
patients without FLG mutations are heterozygous and homozygous for rs7927894[T], 
respectively. There is no statistically signifi cant association between the rs7927894[T] 
and AE without FLG mutations or rs7927894[T] and AE with FLG mutations. Our 
case-control study in the Japanese population did not confi rm that rs7927894 is at 
increased risk for AE. The present data suggest that the association of rs7927894 with 
AE established in the European populations is not seen in the Japanese population.
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A Preference Based Approach to Assess Quality of Life of Family Members of 
Patients with Infl ammatory Skin Diseases
Mohammad K.A. Basra1, Owain Williams1, Rhiannon McKnight2, Sam Salek2
1Department of Dermatology and Wound Healing, Cardiff University School of 
Medicine, Cardiff, United Kingdom, 2Centre for Socioeconomic Research, Welsh 
School of Pharmacy, Cardiff University, Cardiff, United Kingdom
The aim was to assess the family impact of skin diseases using two preference based 
measures: willingness-to-pay (WTP) and time trade-off (TTO).Family members accompanying 
patients with infl ammatory skin diseases were recruited from the out-patient dermatology 
department of two secondary referral centres. Participants were asked to complete the 
Family Dermatology Life Quality Index (FDLQI), a WTP and a TTO questionnaire. These 
two questionnaires asked how much of their monthly household income and daily time, 
family members would be willing to spend if they were offered a hypothetical treatment 
that would completely suppress symptoms of patients’ skin disease. A total of 104 subjects 
(mean age=45.9 years) were recruited who were family members to patients with 13 
different infl ammatory skin diseases. The mean FDLQI score of family members was 7.9 
(SD=6.4; normal range=0-30).  Participants were willing to pay a mean of 17% (SD=21) of 
their monthly income and trade off a mean of 185 minutes (3.1 hours) per day (SD=228) 
for the hypothetical treatment. There was a highly signifi cant correlation between the 
values of two preference-based measures (rs=0.51, p<0.001) and between the FDLQI and 
the two preference-based measures (WTP to FDLQI: rs=0.34, p=0.001; TTO to FDLQI: rs 
=0.35, p=0.001).  Self-assessed disease severity was found to be the strongest predictor of 
family members’ QoL scores (β=.57, p<0.001). This is the fi rst study to assess the family 
QoL of dermatology patients using a preference-based approach that has highlighted the 
substantial secondary impact that many skin diseases can have on patients’ family members.
ABSTRACTS
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Post exposure prophylaxis (PEP) to HIV - epidemiological profi le of patients from 
the Medical University of Vienna (MUV) general hospital in years 2008-2009
Melanie C. Schreiner, Veronique Touzeau-Römer, Georg Stingl, Armin Rieger, Ahmad 
Jalili DIAID, Department of Dermatology, Medical University of Vienna, Vienna, 
Austria
PEP to HIV is a course of antiretroviral drugs administered within 72 hrs after events with high 
risk of exposure to HIV aiming to reduce the odds of established infection.We evaluated the 
putative HIV exposed individuals referred to the MUV and indicated for PEP in years 2008-
2009. Our so far analyzed data of 180 individuals (research in progress) demonstrated that:
• 44.1 % are females,
• indication type: unprotected homosexual contact [28.5%, from which 45% 
of source patients (SPs) were HIV positive], needlestick injuries (22.8%, 37.5% 
HIV positive SPs), unprotected heterosexual contact (21.4%, 20% HIV positive 
SPs), occupational exposure (12.8%, 100% HIV positive SPs), rape (11.4%) and 
needle exchange by IVDUs (2.8%) where HIV status of SPs were unknown,
• PEP regimens were Kaletra®/Truvada® (79.4%) or Combivir®/Truvada® (20.5%),
• 58.8% of individuals tolerated the PEP without any adverse events, 35.3% had minor adverse 
events (nausea, fatigue, diarrhea, abdominal discomfort or slight elevation of pancreatic 
enzymes) and in 5.8% PEP was modifi ed or discontinued (severe adverse events: strong 
diarrhea, abdominal pain and vomiting or signifi cant elevation of liver function parameters),
• 77.1% of patients missed at least one of their follow-
up visits planned at 1, 3 and 6 months after PEP start, and
• no case of seroconversion was observed.
In conclusion, approximately equal numbers of sexes seek counseling service for PEP. 
Most prevalent types of exposure include high risk sexual contact and needlestick injuries. 
Kaletra®/Truvada® combination seems to be a well tolerated and effective therapy.
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Validation and refi nement of the Millennium Criteria for atopic dermatitis
Mandy Schram, Mariska Leefl ang, Jan paul den Ottolander, Phyllis Spuls, Jan Bos
Academic Medical Center, Amsterdam, Netherlands
There is no gold standard for a defi nite diagnosis of atopic dermatitis (AD). The 
Millennium Criteria (MC) have been proposed to diagnose AD and to differentiate 
it from atopiform dermatitis (AFD). Our objective is to further refi ne the MC into 
a manageable set that can differentiate between AD, AFD and other entities. The 
hereby renewed MC will be compared with the UK criteria and the Hanifi n & Rajka 
criteria. New consecutive patients in whom the diagnosis of AD was considered 
in the differential diagnosis were screened for eligibility. Clinical diagnosis was 
performed by a panel of dermatologists and patients were assessed according to 
the various criteria lists by study investigators. To refi ne the MC, a forwards logistic 
regression model was used. The refi ned MC were then compared for validity with 
the UK and Hanifi n & Rajka criteria. Data of 210 included patients were used. 
After logistic regression of the individual criteria of the diagnostic lists, a set of 5 
criteria were identifi ed as best discriminators: typical morphology, early age of 
onset, Dennie-Morgan fold, historical and actual fl exural involvement. The refi ned 
MC were constituted from these criteria. When comparing the different list for 
validity in diagnosing AD, the refi ned MC showed a relative value of 0.81, the UK 
criteria 0.71 and the Hanifi n & Rajka criteria 0.51.This refi nement and validity study 
shows that the refi ned MC are a valid tool to diagnose AD and AFD in a hospital 
based setting and therefore could be incorporated in clinical practice and trials.
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Dermofi t: a novel software that improves novices’ diagnostic accuracy to a level 
above that of trained medical students
Roger Aldridge1, Dominik Glodzik2, Yvvone Bisset1, Lucia Ballerini2, Karen 
Robertson1, Lily Xi2, Lisa Naysmith1, Robert Fisher2, Jonathan Rees1 1Department 
of Dermatology, University of Edinburgh, Edinburgh, United Kingdom, 2School of 
Informatics, University of Edinburgh, Edinburgh, United Kingdom
The cornerstone of dermatological diagnosis is attaching semantics to images. 
Dermatologists use non-analytical reasoning to achieve this, but non-experts are not 
afforded the clinical exposure required to develop such skills. To address this we 
have developed a prototype content based image retrieval system (“Dermofi t”) to 
improve non-experts’ diagnostic accuracy. 12 test images were randomly selected 
from the Department of Dermatology’s image library. All students (n=60) attending 
their 10 day undergraduate dermatology attachment between November 2009 and 
January 2010 were enrolled. The 60 students were randomly split into two groups; 
the Dermofi t group (n=31) used our Dermofi t software to achieve a diagnostic match, 
and the non-Dermofi t group (n=29) provided a written diagnosis. On Day 1 the 
non-Dermofi t group diagnosed a median of 1 image (mean=16%) correctly and the 
Dermofi t group identifi ed a median of 12 images (mean=99%) (p<0.0001). On Day 
10 the non-Dermofi t group correctly diagnosed a median of 6 images (mean=51%) 
correctly and the Dermofi t group matched 12 images (mean=99%) (p<0.0001). We 
have demonstrated that student diagnostic scores are increased signifi cantly by using 
a structured image database coupled with matching of index and referent images. We 
have replicated similar results in lay novices. Our Dermofi t software allows users to 
achieve a high degree of diagnostic accuracy without explicit defi nitions of likeness 
or rule-based strategies, instead capitalising on the users’ intrinsic image recognition 
abilities. If scalable this could set a new paradigm for acquiring dermatological expertise.
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Living Knowledge of the Healing Plants: Results from a Cross-Sectional Study in 
Habiganj District of Bangladesh
Ariful Haque Mollik1 1Peoples Integrated Alliance, Bogra, Bangladesh, 2Biogene Life 
Care, Dhaka, Bangladesh
Dermatology has been prevalent and even endemic in various parts of the world since 
ancient times. In recent years, attention has focused on these diseases because of the 
emergence of drug-resistant varieties of these diseases. As a result, it has become 
imperative to discover novel compounds to treat such diseases. Since plants form one 
of the best sources for obtaining pharmacologically active constituents, which can 
be used as remedy for diseases like cosmetic problems of the skin, scalp, hair, and 
nails; a study of traditional medicinal practitioners in Habiganj district of Bangladesh; 
to obtain information on plants used by them as remedy for the above-ailments. It 
is noteworthy in this regard that all the above-mentioned ailments are prevalent in 
Bangladesh, and the primarily rural population of the country relies on plants or plant 
parts prescribed by the traditional medicinal practitioners to treat the above-ailments. 
Interviews were conducted of traditional medicinal practitioners with the help of a 
semi-structured questionnaire and plant specimens were photographed and identifi ed 
at the Bangladesh National Herbarium. The collected information showed that the 
following plants were used to treat dermatology: Linum usitatissimum (L.), Nigella 
sativa (L.), Aconitum napellus (L.), Agaricus albolutescens Zeller, Olea europaea (L.), 
Brassica napus (L.), Ricinus communis (L.), and Polygonum persicaria (L.). Since the 
rural patients appeared to be generally satisfi ed with the treatment offered through 
these plants, it is important to conduct proper scientifi c studies towards discovery of 
compounds of interest in these plants, which can be used as safe and effective medicines.
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Role of aryl hydrocarbon receptors (AhR) in tobacco smoke extract induced-matrix 
metalloproteinase (MMP)-1 expression
Yuko Ono1, Kan Torii1, Ellen Fritsche2, Emi Nishida1, Yoichi Shintani1, Yuji Shirakata3, 
Josef Abel2, Jean Krutmann2, Akimichi Morita1 1Dermatology, Nagoya City 
University, Nagoya, Japan, 2Institut für Umweltmedizinische Forschung, Heinrich-
Heine-University, Duesseldorf, Germany, 3Dermatology, Ehime University School of 
Medicine, Matsuyama, Japan
Epidemiologic studies suggest a link between smoking and extrinsic skin aging, and we 
previously reported that matrix metalloproteinases (MMPs) mediate connective tissue 
damage in skin exposed to tobacco smoke extracts.  Tobacco smoke contains more than 
3800 constituents, including numerous water insoluble polycyclic aromatic hydrocarbons 
that trigger the aryl hydrocarbon receptor (AhR; also called the dioxin receptor) signaling 
pathway. To analyze the molecular mechanisms involved in tobacco smoke–induced skin 
aging, we exposed primary human fi broblasts and keratinocytes to tobacco smoke extracts. 
Hexane- and water-soluble tobacco extracts signifi cantly induced MMP-1 mRNA in both 
human cultured fi broblasts and keratinocytes in a dose-dependent manner. To clarify the 
involvement of the AhR pathway, we used stable knockdown cell lines for AhR in HaCaT cells. 
AhR knockdown abolished the increase in transcription of the AhR-dependent gene CYP1A1/
CYP1B1 and MMP-1 upon treatment with either tobacco smoke extract. Furthermore, the 
tobacco smoke extracts induced 7-ethoxyresorufi n-O-deethylase activity, which was almost 
completely abolished by AhR knockdown. Likewise, treating fi broblasts with AhR pathway 
inhibitors, i.e., the fl avonoids 3-methoxy-4-nitrofl avone and a-naphthofl avone, blocked the 
induction of CYP1B1 and MMP-1.  These fi ndings suggest that the tobacco smoke extracts 
induced MMP-1 expression in human fi broblasts and keratinocytes via activation of the AhR 
pathway. Thus, the AhR pathway may be pathogenetically involved in extrinsic skin aging.
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Clinical and epidemiological characteristics of pemphigoid in Podlaskie voivodship, 
1998-2009.
Ewa Musialkowska, Agnieszka Serwin, Marta Piascik, Bozena Chodynicka 
Department of Dermatology and Venereology, Medical University of Bialystok, 
Bialystok, Poland
The purpose of the study was the analysis of clinical and epidemiological aspects of 
pemphigoid cases in 1998-2009 in Podlaskie voivodship (about 700,000 inhibitants). 
Seventy-eight cases, based on clinical picture confi rmed with direct or indirect 
immunofl uorescence studies were diagnosed: 35 males-M and 43 females -F. The 
mean incidence was 5,9 per million (the highest-10,82 in 2009) and increased since 
2001. The majority of patients (51,28%) were inhibitants of rural areas and the mean 
incidence in this group was 7,41 per million (the highest - 14,29 in 1999). The mean 
patients‘ age was 72.12+/-13,12 years (76,37+/-10,60 in M and 68,65+/-14,36 in F, 
p<0,05) and was lower in patients from urban than rural areas (66,70+/-14,95 and 
76,50+/-8,37, p<0,05, respectively). The mucosal involvement (mostly oral) was seen 
in 29,39% of patients. Fourteen patients (17,95%) had not any concomitant disorders 
before diagnosis of pemphigoid. Majority (62,82%) had cardiological diseases. 
Almost half of patients were treated with drugs that are known to induce pemphigoid. 
Malignances were found in 6 patients before and 6 - after diagnosis of pemphigoid 
(15,38%). The incidence of co-morbidities rose signifi cantly during the treatment of the 
disease. The mortality rate was 26,92%, 16, 88% of patients died during the fi rst year 
after diagnosis of pemphigoid. The study results indicate that pemphigoid remains an 
important multidisciplinary disorder in ageing society, adversely affecting life style in 
the elderly. These patients require careful and systematic follow-up to diagnose internal 
organ diseases, including these, that might be induced by therapy of pemphigoid.
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Co- morbidities in Patients with Psoriasis: A Pilot Study on 100 Czech Patients
Katerina Juzlova, Jana Stranska, Jana Hercogova Charles University of Prague, Prague, 
Czech Republic
The aim of the study is to confi rm the hypothesis of the increased prevalence of 
metabolic syndrom, atherosclerosis and autoimmune infl ammatory gastrointestinal 
diseases is higher in patients with chronic plaque psoriasis. 35 patients with 
plaque psoriasis of PASI 0-20 (av.5,0) and BSA from 0%-80% (av.13,1 )and 65 
controls were included between January and May 2010. Questionnaires, physical 
investigation inc. blood pressure, waist perimeter, BMI index and laboratory testing 
(serological tests of markers of IBD and coeliac disease, blood count, iron level, 
total protein and glucose level, lipid spectra, CRP) were performed.Results will be 
presented and the hypothesis that patients with chronic plaque psoriasis are suitable 
for selective screening and the well-timed intervention will be recommended.
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Evidence that adequate vitamin D levels can be maintained in healthy adults in the 
absence of environmental ultraviolet radiation exposure
Shantini Rice1, Mirran Carpenter1, Laura Maria Vearncombe1, Adam Fityan1, Janis 
Baird2, Eugene Healy1 1University of Southampton, UK, 2MRC Epidemiology Resource 
Centre, University of Southampton, UK
Exposure to sunshine increases vitamin D in humans and many groups advocate 
regular exposure to sunlight to maintain vitamin D levels. However, ultraviolet 
radiation (UVR) exposure is associated with increased risk of skin cancer, and the 
wavelengths that are most effi cient at vitamin D production are also carcinogenic. 
Many publications in the literature state that UVR exposure is the main source of 
vitamin D in man, yet it is unclear whether regular exposure to sunshine is necessary 
for maintenance of adequate levels. In order to establish whether UVR is the major 
source of vitamin D, and whether sun exposure is required to maintain adequate 
vitamin D concentrations, we conducted a systematic review of studies looking 
at UVR exposure and serum vitamin D levels. Multiple databases (n=21) were 
searched using synonyms of vitamin D, UVR, diet and supplementation; 29,095 
articles were screened by two independent reviewers. Two-hundred and forty-seven 
studies reporting the effect of UVR on serum levels of vitamin D in healthy adults 
were assessed; these included interventional and observational studies on different 
ethnicities and skin types. Seventeen studies provided 25 sets of participants from 
populations that received negligible UVR for prolonged periods. In 15/25 data sets, 
the mean serum 25OHD level of the participants remained adequate (>50nmol/L) 
despite absent UVR. This suggests that sun exposure is not the dominant source of 
vitamin D in these populations and that suffi cient levels of vitamin D can be achieved 
solely through diet and or supplementation in the absence of regular UVR exposure.
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Children and adolescents’ health related quality of life in relation to eczema, asthma 
and hay fever: results from a population-based cross-sectional study
Uwe Matterne1, Jochen Schmitt2, Thomas L. Diepgen1, Christian Apfelbacher1 
1Department of Clinical Social Medicine, University Hospital Heidelberg, Ruprecht-
Karls-University Heidelberg, Germany, Heidelberg, Germany, 2Department of 
Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, 
Germany, Dresden, Germany
We attempted to quantify the impact of eczema, asthma and hay fever on health-related 
quality of life in a large community-based sample of children and adolescents (n = 6518, 11-
17 years) by means of univariate and multivariate analyses (adjusting for sociodemographics, 
psychological functioning and atopic co-morbidity) and to identify the areas most affected by 
each condition. We analysed data from the public use fi les of the German Health Interview 
and Examination Survey for Children and Adolescents by general linear model analyses for 
complex samples. The grouping variable was presence of the allergic condition (in the past 
four weeks and 12 months). Total health-related quality of life was signifi cantly reduced 
when eczema or hay-fever was present but not when asthma was present within the past 
four weeks and 12 months (univariate analysis). Multivariate analyses revealed an impact 
of hay fever but not of eczema or asthma within the last 12 months on total health-related 
quality of life. Total health-related quality of life was signifi cantly affected when eczema 
and hay fever but not asthma was present within the last four weeks even after controlling 
for psychological functioning. The pattern of association with the subscales varied among 
conditions. While 6 – 20% of variance in total and subscales was accounted for, most of this 
variance appeared to be due to variation in SDQ scores. All conditions affect health-related 
quality of life (total and/or subscales) even after controlling for psychological functioning. 
The association is stronger when presence within the last four weeks is considered.
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Epidemiology of chronic pruritus: Population-based cross-sectional study on 
prevalence, correlates and characteristics
Uwe Matterne1, Christian Apfelbacher1, Tamara Strassner1, Adrian Loerbroks2, Elke 
Weisshaar1 1Department of Clinical Social Medicine, Occupational and Environmental 
Dermatology & Health Services Research, University Hospital Heidelberg, Ruprecht-
Karls-University Heidelberg, Germany, Heidelberg, Germany, 2Mannheim Institute of 
Public Health, Social and Preventive Medicine, University of Heidelberg, Germany, 
Mannheim, Germany
We aimed at providing prevalence estimates (point, 12-months, lifetime) of chronic pruritus (> 
6 weeks) in the general population, assessing its association with sociodemographic variables 
and describing its characteristics. 4500 individuals received a validated postal questionnaire. 
A reminder was sent after 2 months to all non-responders. The remaining non-responders were 
contacted by telephone if their number was listed in the telephone directory; if the number 
could not be obtained a third reminder including a shortened version of the questionnaire 
was sent. Logistic regression modelling was performed with current, 12-months and lifetime 
chronic pruritus as the dependent variables, and the following independent variables: sex, 
age, occupational status, schooling, ethnic origin and place of residence (urban vs. rural). The 
response rate was 57.8%. The point prevalence of chronic pruritus was 13.5% (95% CI 12.2%-
14.9%), the 12-months prevalence 16.4% (95% CI 15.0%-17.9%) and the lifetime prevalence 
22.0% (95% CI 20.4%-23.7%). Multivariate analyses found only ethnic origin to independently be 
associated with chronic pruritus. Ethnic origin other than German increased the odds for current 
and 12-months chronic pruritus. Chronic pruritus is endured for many years (46.8% for more 
than 3 years). The impact of chronic pruritus on quality of life and affect appears to depend on 
severity rather than the presence of the symptom alone. To the best of our knowledge this is the 
fi rst study providing estimates of the point-, 12-months and lifetime prevalence of chronic pruritus 
in the general population. It suggests a high burden of the symptom in the general population.
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Differential effects of a tertiary individual prevention programme for patients with 
occupational skin disease depending on diagnosis
Uwe Matterne, Thomas L. Diepgen, Elke Weisshaar Department of Clinical Social 
Medicine, Occupational and Environmental Dermatology & Health Services 
Research, University Hospital Heidelberg, Ruprecht-Karls-University Heidelberg, 
Germany, Heidelberg, Germany
The purpose of this investigation was to evaluate whether the effects of a 3 week inpatient 
tertiary individual prevention programme on socio-cognitive determinants (attitudes, control 
beliefs, perceived social norms and intention) of skin protection behaviour vary between 
patients with work related atopic dermatitis and other work related skin diseases. A total of 
101 patients (14 inpatients with work related atopic dermatitis and 87 inpatients with other 
work related skin diseases) completed measures on socio-cognitive determinants of skin 
protection behaviour before and after a 3-week inpatient tertiary prevention programme. 
Mixed model analyses, using maximum-likelihood estimation tested whether there were 
differential effects of the intervention on socio-cognitive determinants of skin protection 
behaviour. Although patients with atopic dermatitis reported more favourable cognitions 
towards skin protection behaviour than patients with other skin diseases at admission, these 
cognitions deteriorated or remained on the same level. Patients with other forms of work 
related skin disease on the other hand developed more favourable cognitions during the 
intervention. Professionals working in the fi eld of work related skin disease should not 
cease to assist atopic dermatitis patients in achieving optimal skin protection behaviour. 
Tertiary individual prevention measures may need to pay more attention to the needs 
of individuals with an occupationally relevant atopic dermatitis. This may contribute to 
their being able to remain active in the workforce. The alternative would entail regular 
sick leave, poorer quality of life and economic hardship for the atopic dermatitis patient.
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Discrepancy in patient and physician global assessments of dermatologic diseases.
Stefano Tabolli, Alessandra Spagnoli, Francesca Sampogna, Calogero Pagliarello, 
Damiano Abeni, Andrea Paradisi IDI IRCCS, Rome, Italy
To investigate discrepancy in the perception of dermatologic diseases (DD) severity 
between patients and physicians.A descriptive study was performed: 2459 patients 
with DD rated their level of disease severity on a fi ve level scale: very mild, 
mild, moderate, severe, very severe (PtGA) . Physician global assessment (PhGA) 
was performed on the same scale. 53 physicians were involved in an out-patient 
setting for three weeks (March 2010) in a dermatologic research hospital, Rome, 
Italy. Patients were predominantly females (59%), with an high education and the 
majority were employed; mean age was  45.9 ±18.5 for females and 44.5 ±18 
for males. No discrepancy between PhGA and PtGA was observed in 37% of 
cases; PtGA under-rated compared to the physician in 35%; and PtGA over-rated 
relative to the physicians in 28%.Statistically signifi cant differences were observed 
between PtGA and PhGA in each of the fi ve levels of judgement (p<0.001). Higher 
percentages of patients, in respect to physicians, reported very mild, severe and 
very severe evaluations. Physicians tended to overestimate for mild and moderate 
levels. Differences were observed between male and female physicians in the 
severity judgement, reaching a statistically signifi cant difference for the very mild 
level (p<0.001) where females were more represented. The perceived severity 
disease in DD was different between patients and physicians and it was different 
in patients in respect to sex. Only for very mild DD there was a difference in 
PhGA between males and females, with males underestimating the severity.
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Assessment tools to measure pruritus intensity: study on validity of visual analogue 
scale (VAS), numeric rating scale (NRS) and verbal rating scale (VRS)
Ngoc Quan Phan1, Adam Reich2, Christine Blome3, Matthias Augustin3, Jacek C. 
Szepietowski2, Sonja Ständer1 1Clinical Neurodermatology and Competence Center 
for Pruritus, Department of Dermatology, University of Münster, Münster, Germany, 
2Department of Dermatology, Venereology and Allergology, Wroclaw Medical 
University, Wroclaw, Poland, 3CV Derm, Department of Dermatology and Venerology, 
University Hospital Eppendorf, Hamburg, Germany
The most commonly used tool for self-report of itch intensity is the visual analogue 
scale (VAS). Similar measurement tools are the numeric rating scale (NRS) and 
verbal rating scale (VRS). We herein present data of the fi rst study on reliability and 
concurrent validity of VAS, NRS and VRS. 200 randomly selected chronic pruritus 
patients of our out-patient department (88 m, 112 f, mean 62.06 years) recorded 
their pruritus by VAS (10 cm line), NRS (0-10) and a four-point VRS scale. Mean 
point difference of VAS to NRS was -0.26 to 0.70. Pearson’s correlation coeffi cient 
for VAS with NRS was 0.939; p<0.01. On the VRS, 26 patients stated to have no 
itch («0») which was scored on average as 0.11 (VAS) and 0.10 (NRS); 96 patients 
to have low («1») pruritus (mean VAS/mean NRS: 1.36/1.90), 54 patients to have 
moderate («2») pruritus (mean VAS/mean NRS: 4.28/4.83) and 16 patients to have 
severe («3») pruritus (mean VAS/mean NRS: 8.79/8.56). 9.5% did not record their 
pruritus intensity by VAS, 2.5% not by NRS and 4.0% not by VRS. Spearman’s 
correlation coeffi cient for VAS with VRS was 0.788 and for NRS with VRS 0.859; 
p<0.01. In sum, all scales especially NRS and VAS showed a high correlation and 
concurrent validity with a low point difference of mean 0.39, SD 0.96. Thus, all 
scales are applicable in clinical trials to assess valid data of itch intensity. However, 
the discrimination of itch intensity on the VRS is not as sensitive as on VAS and NRS.
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Melanoma screening in the nuclear power plant in Hungary 
Veronika Toth1, Beata Somlai1, Zsofi a Hatvani1, Sarolta Karpati1,2, Jozsef 
Szakonyi1 1Semmelweis University, Department of Dermatology, Venerology and 
Dermatooncology, Budapest, Hungary, 2Hungarian Academy of Sciences, Molecular 
Medicine Research Group, Budapest, Hungary
Many exogenous, occupational reasons may play role in the formation of melanoma 
and non-melanoma skin cancer. Attempts have been made to reveal the relationship 
between ionizing radiation and melanoma formation. Some of these studies 
suggested increased incidence of melanoma. Hungary’s single nuclear power plant 
is the Paks Nuclear Power Plant, the nominal total power of the blocks increased to 
500MW in 2009. The question was raised, weather the melanoma incidence is higher 
or not among the workers of the power plant. Between 2008 and 2009 October 
we screened 556 nuclear workers, 281 men and 275 women for melanoma and 
non-melanoma skin cancer. We investigated also the number of sunburns, the skin 
type, the number of nevi and the nuclear risk of work. In both genders most of the 
examined workers were in the age group between 50-54 years (22% of the men, 25% 
of the women). 28% of the men and 25% of the women worked 20 to 24 years in 
the plant.We confi rmed in one patient in situ melanoma, and in two patients basal 
cell carcinoma histologically. In 2006 the melanoma incidence was 17/100.000 in 
Hungary. If the 1/556 incidence is extrapolated to 100.000 persons, that would mean 
180 melanoma cases out of 100.000 persons. In our study the size of the screened 
population is too small, so we can not confi rm any enhanced incidence of melanoma.
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Targeting of human interleukin-12B by small hairpin RNAs in xenografted psoriatic 
skin
Karin Stenderup1, Rasmus Otkjær Bak2, Cecilia Rosada1, Line Barrett Petersen2, 
Brian Moldt2, Frederik Dagnæs-Hansen3, Maria Jakobsen2, Søren Kamp4, Thomas 
G Jensen2, Tomas Norman Dam4, Jacob Giehm Mikkelsen2 1Dept of Dermatology, 
Aarhus, Denmark, 2Dept of Human Genetics, Aarhus, Denmark, 3Dept of Medical 
Microbiol & Immunol, Aarhus, Denmark, 4Dept of Dermatology, Roskilde, Denmark
Psoriasis is a chronic infl ammatory skin disorder driven by a dysregulation of the cytokine production; 
monoclonal antibodies targeting the proinfl ammatory cytokines tumor necrosis factor alpha (TNFα), 
interleukin-12 (IL-12), and IL-23 have already been approved for clinical use. Previously, we 
documented a therapeutic applicability of targeting TNFα mRNA by anti-TNFα small hairpin RNAs 
(shRNAs) delivered by lentiviral vectors to xenografted psoriatic skin. The present study aimed at 
targeting mRNA encoding the shared p40 subunit (IL-12B) of IL-12 and IL-23 by cellular transduction 
with lentiviral vectors encoding anti-IL12B shRNAs. Effective anti-IL12B shRNAs were identifi ed 
and shRNA-expressing lentiviral vectors were intradermally injected in xenografted psoriatic skin. 
Treatment effects were evaluated by clinical psoriasis scoring and by measuring epidermal thickness 
and IL-12B mRNA levels. The effi ciency and persistency of lentiviral gene delivery were investigated 
by bioluminescence analysis of skin treated with lentiviral vectors encoding the luciferase gene. 
Intradermal injection of lentiviral vectors in xenografted human skin demonstrated potent and 
persistent transgene expression. Stable IL-12B mRNA knockdown and reduced epidermal thickness 
were achieved after three weeks treatment. These fi ndings mimic the results obtained with anti-
TNFα shRNAs but, in contrast, anti-IL12B shRNAs do not ameliorate the psoriatic phenotype as 
evaluated by semi-quantitative clinical scoring throughout the course of the experiment. Our 
studies consolidate the properties of lentiviral vectors as a tool for potent gene delivery and for 
evaluation of mRNA targets for anti-infl ammatory therapy. However, in contrast to local anti-TNFα 
treatment, the therapeutic potential of targeting IL-12B at the RNA level in psoriasis is questioned.
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Zebrafi sh Type XVII Collagen: Gene Structures, Expression Profi les, and Morpholino 
“Knock-Down“ Phenotypes
Qiaoli Li1, Michael Frank1, Seong-Hyun Kim2, Hae Young Choi3, Ju-Hoon So4, Cheol-
Hee Kim4, Shiu-Ying Ho5, Jouni Uitto1 1Jefferson Medical College, Philadelphia, 
PA, United States, 2Inje University, Ilsna Paik Hospital, Koyang, Korea, Democratic 
People‘s Republic of, 3Ewha Womans University, Seoul, Korea, Democratic People‘s 
Republic of, 4Chungnam National University, Daejeon, Korea, Democratic People‘s 
Republic of, 5Thomas Jefferson University, Philadelphia, PA, United States
The human COL17A1 gene encodes type XVII collagen (also known as the 180-kDa bullous 
pemphigoid antigen), an integral component of hemidesmosomes, attachment complexes 
providing integrity to the dermal-epidermal junction. Zebrafi sh, a facile model system to study 
skin development, displays fully developed hemidesmosomes at approximately 5 days post-
fertilization (dpf). We have identifi ed two COL17A1 orthologues in the zebrafi sh genome, col17a1a 
and col17a1b, which are expressed in the skin and the neural system, respectively, as determined 
by in situ hybridization. These genes have 26% identity at the amino acid level, and have 27 
and 51% identity with the corresponding human protein. The proteins coded by these genes 
have structural module organizations homologous to the human type XVII collagen, including 
collagenous segments within the ectodomain, a transmembrane segment, and a relatively small 
intracellular peptide segment with putative binding affi nities to other intracellular components of 
the hemidesmosomal protein complex. “Knock-down” of the expression of col17a1a with a specifi c 
morpholino targeting the 5’ UTR of the gene resulted in blister formation and manifested with 
perturbations in the basement membrane zone. “Knock-down” of col17a1b expression had no gross 
morphologic changes in the skin but resulted in reduction of hair cells in the neuromast in the lateral 
line. Thus, zebrafi sh has two COL17A1 orthologues which may have evolved into tissue-specifi c 
functions during vertebrate development. Collectively, zebrafi sh provides a model system to study 
the molecular aspects of skin development and offers insights to the corresponding human diseases.
444 [Oral 092]
Transcriptional profi ling after lipid raft disruption in keratinocytes identifi es new 
actors in atopic dermatitis
Conny Mathay1, Michael Pierre2, Mark R. Pittelkow3, Eric Depiereux2, Arjen F. 
Nikkels4, Alain Colige5, Yves Poumay1 1Cell & Tissue Lab, URPYHM, Univ of Namur, 
Belgium, 2Lab of Biostats & Bioinformatics, URBM, Univ of Namur, Belgium, 3Depts of 
Derm & Biochem & Molec Biol, Mayo Clinic, Rochester, USA, 4Dept of Derm, Univ of 
Liège, Belgium, 5Lab of Connective Tissues Biol, Univ of Liège, Belgium
Cholesterol is particularly important in cellular physiology of proliferating and differentiating 
keratinocytes. Lipid rafts are cholesterol-rich cell signaling platforms and their physiological role 
can be explored by cholesterol depletion. To characterize transcriptional changes ongoing after 
lipid raft disruption in epidermal keratinocytes, we performed whole-genome expression profi ling. 
Microarray results show that over 3000 genes are differentially regulated. Particularly, interleukin-8, 
urokinase-like plasminogen activator receptor (PLAUR) and metalloproteinases are highly 
upregulated after cholesterol extraction. qRT-PCR validation and protein release measurements 
demonstrate the physiological relevance of microarray data. Major enriched terms and functions, 
determined by IPA analysis, identify cholesterol biosynthesis as a major function, but also the 
infl ammatory disorder atopic dermatitis is the skin disease that associates most closely with the 
profi le of lipid raft-disrupted keratinocytes. This interesting fi nding is confi rmed in skin of atopic 
dermatitis patients where transcript levels of major lipid raft target genes were analysed. Gene 
expression in atopic lesional skin was compared to surrounding non-lesional skin, as well as to 
healthy skin. Our study demonstrates typical downregulations in atopic skin of fi laggrin and loricrin, 
two critical epidermal barrier proteins. Moreover, we show that HB-EGF, transglutaminase-1, IL-8 
and PLAUR are specifi cally upregulated in lesional skin. Possibly the gene expression profi le of 
these genes could constitute a new expression signature of atopic dermatitis. These results suggest 
that lipid raft organization and signaling may likely be perturbed in keratinocytes of atopic lesions.
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COL17A1 splicing mutations: lessons for design of molecular therapies
Dimitra Kiritsi1, Johannes-Steffen Kern1, Hauke Schumann1, Claus-Werner Franzke1, 
Jürgen Kohlhase2, Cristina Has1, Leena Bruckner-Tuderman1,3 1Dept of Dermatology, 
University Medical Center Freiburg, Germany, 2Center for Human Genetics Freiburg, 
Germany, 3Freiburg Institute for Advanced Studies, University of Freiburg, Germany
Recent pilot studies on causal therapies for genetic skin diseases have revealed that 
relatively small biological changes, e.g. moderately increased levels of a missing 
protein in the skin, can have substantial clinical effects. Epidermolysis bullosa (EB), a 
group of hereditary skin fragility disorders caused by mutations in the genes encoding 
components of the epidermal adhesion complex, has served as a prototype for such 
investigations. The junctional EB (JEB) subgroup is mostly associated with mutations in 
the genes for laminin 332 or collagen XVII (COL17A1) and characterized by trauma-
induced tissue separation within the lamina lucida. The phenotypes associated with 
COL17A1 mutations range from mild to severe, and features like dystrophy or loss of 
nails, mucosal involvement, enamel defects and alopecia occur to a differing extent. 
Here, the systematic analysis of 34 different COL17A1 mutations in 43 patients 
with JEB-other revealed new insights into the phenotypic variability. We focused on 
the effects of splice-site mutations, i.e. the nature and amounts of transcripts and 
polypeptides synthesized and their association with the phenotypic outcome. Careful 
molecular genetic and protein biochemical analysis revealed that even small amounts 
of collagen XVII have a remarkable effect on the phenotype. In contrast to complete 
null phenotypes, patients with only about 4 % of collagen XVII of the control levels 
had clearly milder cutaneous involvement and a long life span. These data have 
signifi cant implications for design of molecular therapies for JEB, since they suggest 
that a low degree of collagen XVII restoration may deliver substantial skin stability.
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Germline melanocortin-1-receptor variants are associated with severity of 
phenotype in individuals with congenital melanocytic naevi
Veronica Kinsler1, Raoul Hennekam4, Neil Sebire1, Sayeda Abu-Amero1, Philip 
Stanier1, Peter Budd3, Ian Jackson3, Gudrun Moore1, Eugene Healy2 1Great Ormond 
Street Hospital/Institute of Child Health, London, UK, 2University of Southampton, 
UK, 3MRC Human Genetics Unit, Edinburgh, UK, 4Univ of Amsterdam, Netherlands
During development neural crest-derived melanoblasts populate the epidermis and hair 
follicles of human skin.  In children with congenital melanocytic naevi (CMNs), collections 
of poorly-differentiated melanocytes also reside in the epidermis and dermis.  The genetic 
basis of CMNs has not been elucidated.  We noticed a high prevalence of red hair/freckling 
in families of children with CMNs, thus we hypothesised a role for melanocortin-1-receptor 
(MC1R) genotype in CMN development. MC1R sequencing was conducted in a cohort of 
100 children with CMNs and their parents.  Effect of MC1R status on phenotypic variables 
relating to the CMN was modelled using multiple logistic regression analysis; phenotypic 
variables included size of the largest CMN and total number of naevi, clinical features linked 
to risk of neurological and malignant complications in this condition. The prevalence of at 
least one non-synonymous MC1R variant in individuals with CMNs was 72%, with V92M 
the most common variant (allele frequency 0.105).  Carrying either V92M or an R allele 
(R151C, D294H, D84E, R160W) was signifi cantly associated with size of the principal CMN 
(projected adult size >60cm odds ratio 2.606, 95%CI 1.121-6.060, p=0.026) and with the 
number of naevi in this population (>50 naevi OR 2.386, 95%CI 1.041-5.471, p=0.040). 
The numbers of cutaneous melanocytes are comparable across ethnic groups and Mc1r-null 
mice have similar melanocyte numbers as wild-type mice.  However, our data suggest that 
MC1R genotype can infl uence the size and number of CMNs, and that MC1R variants play 
a role in the development of CMNs, increasing melanocyte numbers within these lesions.
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3‘ trans-splicing repair of COL7A1 mutations in recessive dystrophic epidermolysis 
bullosa patients
Eva M Murauer1, Yannick Gache3,2, Fernando Larcher5, Marcela Del Rio5, Wolfgang 
Muss4, Guerrino Meneguzzi3, Helmut Hintner1, Johann W Bauer1 1EB House Austria, 
Dept of Dermatology, Paracelsus Med Univ, Salzburg, Austria, 2INSERM U998 - CNRS 
UM6267, Univ of Nice-Sophia Antipolis, France, 3INSERM U634, Univ of Nice-Sophia 
Antipolis, France, 4Inst of Pathology, Paracelsus Medical Univ of Salzburg, Salzburg, 
Austria, 5Cutaneous Disease Modeling Unit, CIEMAT-CIBERER, Madrid, Spain
The severe autosomal recessive types of dystrophic epidermolysis bullosa (RDEB) are caused by 
premature termination codons on the COL7A1 gene. As a result, type VII collagen is absent at the 
dermal-epidermal junction (DEJ) of the skin, leading to skin blistering. Using RNA trans-splicing as 
a gene therapy tool we were able to restore type VII collagen expression in RDEB keratinocytes.
Trans-splicing exchanges parts of the coding sequence of the endogenous target transcript by 
the wildtype coding sequence, which is exogenously delivered by a repair molecule called pre-
trans-splicing molecule (PTM). Retroviral transduction of primary RDEB keratinocytes with a 3’ 
PTM encoding a 3,300-bp portion of the wildtype COL7A1 transcript resulted in correction of 
full-length type VII collagen expression in cultured keratinocytes and at the basement membrane 
zone in skin equivalents in vitro. To attest to the full phenotypic and functional reversion of trans-
splicing corrected RDEB keratinocytes in vivo, patches of skin equivalents cultured from these 
keratinocytes were grafted onto immunodefi cient mice. Histological and immunohistological 
analysis of fi ve-week old specimens of grafted tissue showed no blistering and strong labeling 
of human type VII collagen between dermis and epidermis. Localization of type VII collagen 
was restricted to the basement membrane, with no expression in the suprabasal cell layers. 
In this work we demonstrated that 3’ trans-splicing within the endogenous COL7A1 gene 
generates tissue-specifi c stable expression of human type VII collagen in vitro and in vivo. Thus, 
3’ trans-splicing may be suitable for an ex vivo gene therapy approach for treatment of DEB.
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Ex-vivo gene therapy restores LEKTI activity and corrects the architecture of 
Netherton syndrome derived skin grafts
Wei-Li Di1, Fernando Larcher2, Ekaterina Semenova1, Gill E Talbot1, John I Harper1, 
Marcela Del Rio2, Adrian J Thrasher1, Waseem Qasim1 1UCL Institute of Child Health, 
London, UK, 2Cutaneous Diseases Modelling Unit, Epithelial Biomedicine Division 
Centro de Investigaciones Energeticas Medioambientales y Tecnologicas-CIBERER, 
Madrid, Spain
Netherton syndrome is a debilitating congenital skin disorder caused by mutations in 
the SPINK5 gene which encodes the Lympho-epithelial Kazal-type-related inhibitor 
(LEKTI). The condition is characterised by defective keratinisation, recurrent infections 
and hypernatraemic dehydration and is associated with a mortality rate of about 
10% in the fi rst year of life. Currently, there are no curative treatments for NS. We 
have developed a HIV-1 based, self-inactivating lentiviral vector to express SPINK5 
in keratinocytes as part of an ex-vivo gene therapy strategy for this disease. High 
transduction effi ciency was achieved in primary Netherton syndrome keratinocytes 
and reconstitution of LEKTI expression was confi rmed in previously defi cient cells. 
These genetically corrected keratinocytes were further tested in a three dimensional in 
vitro organotypic culture system and also in vivo using a mouse model of human skin 
engraftment. Results showed correction of epidermal architecture in both organotypic 
cultures and regenerated skin grafts. Importantly, the results from corrected skin grafts 
indicated that even where detectable LEKTI expression was restored to a limited 
numbers of cells, a wider bystander benefi t occurred around these small populations. 
As LEKTI is a secreted protein, the genetically modifi ed graft may provide not only 
an immediate local protective barrier, but could also act as a source of secreted 
LEKTI which would then provide generalized benefi t following ex vivo gene therapy. 
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Loss of corneodesmosin due to early truncating autosomal recessive nonsense 
mutations leads to peeling skin disease
Heiko Traupe1, Katja Eckl2,3, Karin Aufenvenne1, Marc Nätebus2, Tatjana Walker1, 
Natalia Seller1, Regina Fölster-Holst4, Ozan Angün5, Patrick Terheyden5, Dieter 
Metze1, Ingrid Hausser6, Vinzenz Oji1, Hans Christian Hennies1,7 1Dept of Derm, Univ 
Hosp Münster, Germany, 2Cologne Ctr for Genomics, Germany, 3Ctr for Physiol & Pathophys, 
Univ Cologne, Germany, 4Univ Clinic of Derm, Kiel, Germany, 5Dept of Derm, Lübeck, 
Germany, 6Dept of Derm, Heidelberg, Germany, 7Ctr Molec Med Cologne, Germany
Generalized peeling skin disease (PSD) [MIM 270300] with pruritus and atopic diseases, referred to as 
peeling skin syndrome type B, is an unusual autosomal recessive congenital ichthyosiform erythroderma 
characterized by lifelong patchy peeling of the entire skin. It shares features with Netherton syndrome 
(NS) - clinically and at the ultrastructural level, e.g. enhanced detachment of corneocytes, and has to 
be differentiated from acral peeling skin syndrome (APSS). We characterized a large consanguineous 
family with PSD and carried out a whole-genome linkage analysis using chip-based SNP analysis, 
which identifi ed a candidate region on chromosome 6p, and for the fi rst time identifi ed recessive early 
N-terminal nonsense mutations in CDSN, the gene encoding corneodesmosin, an important adhesive 
protein of the extracellular part of the corneodesmosomes. As could be demonstrated by immunoblot 
and immunofl uorescence analysis skin of the patients shows a complete loss of corneodesmosin 
expression. Components of the desmosomes (Dsc1 and Dsg1) showed regular expression; LEKTI, 
missing in NS, presented a broadened signal; transglutaminase 5, affected in APSS, was normal; 
further late epidermal differentiation markers showed enhanced expression.We conclude that PSD is 
due to recessive CDSN nonsense mutations, which lay prior or within the fi rst functionally important 
glycine loop of the protein. Hence, the pathophysiologic basis as much as clinical expression of 
PSD is distinct from that of hypotrichosis simplex (HTSS), which is associated with particular 
dominant C-terminal CDSN mutations. Corneodesmosin is vastly important for the epidermal 
barrier integrity, and its absence may give rise to the strong predisposition to atopic manifestations.
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Skin grafts recruit bone marrow-derived mesenchymal stem cells through SDF-1α/
CXCR4 interaction to enhance tissue regeneration
Shin Iinuma1,5, Katsuto Tamai1, Takenao Chino1, John A. McGrath2, Jouni Uitto4, 
Noriko Umegaki3, Ichiro Katayama3, Hajime Iizuka5, Yasufumi Kaneda1 1Division 
of Gene Therapy Science, Osaka Univ Graduate School of Medicine, Suita, Osaka, 
Japan, 2St John’s Institute of Dermatology, King’s College London, London, UK, 3Dept 
of Dermatology, Osaka Univ Graduate School of Medicine, Suita, Osaka, Japan, 4Dept 
of Dermatology and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA, 
USA, 5Dept of Dermatology, Asahikawa Medical College, Hokkaido, Japan
Use of avascular skin grafts is common in surgical practice but how the vasculature is restored to 
maintain the engrafted skin is not known. In this study, we evaluated how bone marrow-derived 
cells contribute to the skin graft repair process. We evaluated mouse skin that had been grafted onto 
the back of a mouse that had received green fl uorescent protein (GFP) transgenic bone marrow 
cell-transplantation following lethal dose irradiation. On day 3 after engraftment, signifi cant 
numbers of microvasculature endothelial cells were noted to be GFP-positive in the skin graft, 
indicating a contribution of bone marrow-derived cells in vasculogenesis and thereby ensuring 
restoration of blood fl ow to the graft. On day 4, further GFP-positive cells were noted in the skin. 
We detected mesenchymal fi broblastic cells in the dermis and keratinocytes in the hair follicles 
that were GFP-positive. These data clearly demonstrate that engrafted skin can recruit endothelial, 
mesenchymal, and epithelial progenitor cells from bone marrow. We then analyzed the molecular 
mechanism that recruits bone marrow-derived mesenchymal stem cells (MSCs) to the grafted skin. 
We found that the skin graft could release a soluble factor or factors that resulted in MSCs highly 
expressing chemokine receptor CXCR4, which is a receptor for stromal derived factor-1α (SDF-1α) 
that is expressed in endothelial cells of hypoxic damaged tissues such as a skin graft. Our data 
suggest that the interaction between SDF-1α and CXCR4 could be a key mechanism to regenerate 
engrafted skin through the recruitment of bone marrow-derived circulating MSCs to the graft. 
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Identifi cation of novel psoriasis susceptibility loci and genetic interaction between 
HLA-C and ERAP1 provides evidence for an integrated pathogenic pathway
Richard Trembath for the Genetic Analysis of Psoriasis Consortium and Wellcome 
Trust Case Control Consortium II Division of Genetics and Molecular Medicine, King‘s 
College London, London, United Kingdom
To identify new susceptibility loci for psoriasis, we undertook a genome-wide 
association study (GWAS) powered through the analysis of 594,224 SNPs in 2,622 
unrelated psoriatic individuals from the British Isles and 5,667 control subjects. In 
addition to a strong signal at the Major Histocompatibility Complex (MHC; P < 10-
200), we confi rmed association for all eight previously reported non-MHC psoriasis 
susceptibility loci. We discovered new associations for a further eight independent 
regions of the genome, of which seven contain genes with recognised immune 
functions (IL28RA, REL, IFIH1, ERAP1, TRAF31P2, NFKBIA and TYK2). We found 
evidence for allelic heterogeneity at one of these loci, with inclusion of both risk 
classes substantially increasing estimates of genetic risk for the locus. These fi ndings 
were confi rmed through the analysis of seven replication panels ascertained from 
different regions of Europe (3,174 psoriasis cases and 5,464 controls). All of the loci 
generated a combined P < 5 x 10-8. We also report strong evidence for an interaction 
between the HLA-C and ERAP1 loci (interaction P < 10-4 in the discovery dataset and 
0.03 in the replication set), with the ERAP1 disease associated variant only affecting 
psoriasis susceptibility in individuals carrying the HLA-C risk allele. This is one of the 
fi rst compelling examples of interaction between GWAS loci. Taken together, these 
fi ndings provide robust genetic evidence to implicate specifi c pathways that integrate 
epidermal barrier dysfunction with innate and adaptive immune dysregulation in the 
pathogenesis of psoriasis.
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Long term genetic correction of xeroderma pigmentosum epidermal stem cells : a 
preclinical model of ex vivo and in vivo of cutaneous gene therapy 
Emilie Warrick1, Marta Garcia2, Del Rio Marcela2, Fernando Larcher2, Francoise 
Bernerd3, Thierry Magnaldo1 1Cnrs, Nice, France, 2Ciemat, Madrid, Spain, 3L‘Oreal 
Advanced Res., Clichy, France
A major challenge of corrective gene therapy ex vivo is a to safely target and 
select suffi cient numbers of somatic stem cells destined to correct the diseased 
organ they originate from. Here we aimed at permanent correction of epidermal 
stem cells derived from patients suffering from Xeroderma pigmentosum (XP), a 
rare, cancer prone photo genodermatosis due to innefi cient nucleotide excision 
repair (NER) of UV-induced DNA lesions. XP cells fall into seven groups of 
genetic complementation (XP-A to XP-G). XP-C patients are usually exempt 
from neurological problems and constitute priviledged candidate for resurfacing 
severly altered skin areas using genetically corrected stem keratinocytes.
To fully correct XP-C primary epidermal keratinocytes, a CD24-XPC cassette was 
retrovirally transduced, allowing CD24 immuno-affi nity selection together with 
nuclear XPC re-expression. Corrected mass population was serially propragated 
for 100 population doublings (PDs). 32 clones were derived form the initial mass 
populations and candidate holoclones were propagated until 100 PDs. The XPC 
gene was still present and expressed in high passage holoclones with some decrease 
from 50 to 65 PDs. However, both mass populations and individual clones at 100 
PDs exhibited normal levels of UV-cell survival. Mass population also retained a full 
capacity of skin regeneration both ex vivo and in vivo over the long term (22 weeks). 
Regenerated corrected skin exhibited normal levels of DNA repair UV resistance. 
Our results indicate for the fi rst time successful transduction and safe selection of 
epidermal stem cells in a preclical model of ex vivo cutaneous gene therapy of XP-C.
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Dysregulated tropomyosin receptor kinase (Trk) signalling in CYLD mutant tumours 
Neil Rajan1, Richard Elliott2, Christopher Lord2, Oliver Clewes1, John Burn1, Maya 
Sieber-Blum1, Alan Ashworth2 1Inst of Human Genetics, Newcastle upon Tyne, UK, 
2Breakthrough Breast Cancer Research Centre, Inst of Cancer Research, London, UK
Patients with germline mutations in the tumour suppressor gene CYLD develop 
disfi guring cutaneous appendageal tumours, of which the defi ning tumour is the 
cylindroma. The key pathways abrogated in human cylindroma tissue, however, 
are not fully understood and represent an important step in developing therapeutic 
agents. We adopted a genome wide approach, characterising the genomic and 
transcriptomic changes in 31 rare microdissected tumours from our pedigrees, and 
discovered dysregulated tropomyosin kinase signaling (Trk) in the tumour tissue. 
CYLD, an ubiquitin hydrolase, has been previously shown to regulate receptor 
internalisation and signal transduction of TrkA, by cleaving lysine 63 linked ubiquitin 
chains. TrkB and TrkC homeostasis may also be perturbed in the absence of functional 
CYLD as they have recently been shown to bind to p62, a component of the scaffold 
that facilitates TrkA regulation. Immunohistochemical validation at the protein level 
demonstrated increased membranous expression of TrkB and TrkC, compared to 
perilesional epidermis. To investigate the therapeutic utility of drugs that inhibit Trk 
signalling, we developed an in vitro cylindroma cell culture model. We demonstrated 
that stimulation of TrkB and TrkC with their cognate ligands resulted in upregulation of 
phospho ERK and BCL2, consistent with active Trk signalling in our model. Growth of 
these in vitro cylindroma models in the presence of the pan Trk inhibitors K252a, AG879, 
and lestaurtinib, demonstrated reduced cell viability at micromolar concentrations. 
Trk inhibition therefore represents a novel therapeutic target for CYLD mutation 
carriers that warrants further investigation as a non-surgical treatment alternative.
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Connecting base excision repair (BER) and nucleotide excision repair (NER) 
within mitochondria: Cockayne syndrome A and B interact in complexes with 
mitochondrial (mt)DNA repair associated proteins 8-oxo-guanosine glycosylase 
(hOGG)-1 as well as mt single strand binding protein (SSBP)-1
York Kamenisch1, Jennifer Knoch1, Anna-Katharina von Thaler1, Martin Schaller1, 
Harry van Steeg1,2, Martin Röcken1, Mark Berneburg1 1Eberhard Karls University, 
Tuebingen, Germany, 2Utrecht University, Utrecht, Netherlands
DNA damage induced by ultraviolet (UV)-B radiation predominantly gets 
repaired by the nucleotide excision repair (NER) mechanism, while UV-A 
induced oxidative DNA damage is preferentially repaired by base excision 
repair (BER). Defective NER either causes skin cancer prone Xeroderma 
pigmentosum (XP) or premature aging in Cockayne syndrome (CS).
While mitochondrial BER is well characterized, mitochondria are thought to be free of 
NER. Mutations of mitochondrial (mt)DNA have been linked to aging. We previously 
showed localization of CSA and CSB proteins in mitochondria, their enrichment upon 
oxidative stress, premature induction of oxidatively induced mtDNA mutations in 
CSA and CSB cells as well as binding of CSA and CSB proteins to mtDNA. However, 
it has been unclear if CSA or CSB interact with other mitochondrial proteins.
We provide evidence that CSA and CSB are associated to complexes of the DNA 
repair associated mitochondrial single strand binding protein (mtSSBP)-1 and the 
BER-associated 8-oxo-guanosine glycosylase (hOGG)-1 in oxidatively stressed 
mitochondria by Coimmunoprecipitation. These data present a link between mtCSA/
CSB proteins and protection from large scale deletions of the mtDNA via a previously 
unreported interaction of two hitherto separate repair mechanisms NER and BER.
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Distribution of mitochondrial DNA deletions in Csbm/m and Csa-/- mice of different 
ages
York Kamenisch1, Anna-Katharina von Thaler1, Raoul Kuiper1,2, Harry van Steeg1,2, 
Martin Röcken1, Leon Mullenders1,3, Mark Berneburg1 1Eberhard Karls University, 
Tuebingen, Germany, 2Utrecht University, Utrecht, Netherlands, 3Leiden University 
Medical Center, Leiden, Netherlands
Defects in the repair mechanism nucleotide excision repair either lead to skin tumors in 
Xeroderma pigmentosum or premature aging and neurodegeneration in Cockayne syndrome 
(CS). Aging-associated reduction of subcutaneous fat is a hallmark of physiological aging and 
premature aging of CS patients. Accumulated mutations of mitochondrial mtDNA are also 
linked to chronological aging, premature skin aging and neurodegeneration. Less is known 
about the age dependent distribution of mtDNA large scale deletions in multiple organs of 
prematurely aging mice. We investigated spleen, liver, skin, quadriceps, heart and brain of 
mice of different age and different genotypes (Csbm/m, Xpa-/- and wildtype) for the relative 
amount of large mitochondrial deletions (mtD17 and mtD1) and found an age dependent 
increase of mtD17 in many organs in all mice especially in the skin of aged Csbm/m . For further 
investigation we microdissected subcutaneous fat of Csa-/- and Csbm/m, Xpa-/- and wildtype 
mice of different age and analyzed the relative amount of mtD17 and the mtD1 deletion. 
Aged Csa-/- and Csbm/m mice show a strong increase of mtD17 and mtD1 in age-dependently 
reduced subcutaneous fat tissue which was not observed in other DNA repair defi cient mice 
without prematurely reduced subcutaneous fat. MtDNA deletions were increased in the 
epidermis and dermis of these animals but at lower levels compared to subcutaneous fat.
These data show that mtDNA mutations age-dependently increase in many tissues 
of progeroid animals with the highest levels in subcutaneous fat, indicating that 
these mutations may be involved in age dependent loss of subcutaneous tissue.
456
Increased risk of developing squamous cell carcinoma in adult junctional 
epidermolysis bullosa patients
Wing yan Yuen, Marcel Jonkman University Medical Center Groningen, Netherlands
In the literature the risk of developing squamous cell carcinoma (SCC) among patients 
suffering from the inherited trauma-induced blistering disease junctional epidermolysis 
bullosa (JEB) is unclear. In our centre we noticed an unexpected number of SCCs 
among adult JEB patients. The purpose of this study was to review all documented JEB 
patients who developed an SCC. A search in our EB-registry and a systematic literature 
search were performed. In our EB-registry we found seven cases complicated by SCC. 
The frequency of developing an SCC among adult JEB patients (n=28) was 25%. 
The incidence rate of a primary SCC in JEB patients is 4.6 per 1000 person-years; in 
the general population this is estimated at 0.08-1.36 per 1000 person-years. In the 
literature we found seven case reports of JEB complicated by SCC, bringing the total 
number to 14 documented cases. All cases were adults classifi ed as JEB, type non 
Herlitz. The fi rst SCC developed at an average age of 50 years (median 52 y, range 28-
70 y). In 64% of the cases multiple primary SCCs occurred. The localization of SCCs is 
most often seen on the lower extremities. Three (21%) patients developed metastases 
and died an average of 8.9 years after diagnosis of the initial SCC. In summary our 
results show that adult JEB patients have an increased risk (one out of four patients) of 
developing SCC. The SCCs have an aggressive behaviour with a tendency to metastize. 
Therefore we recommend annually checking all JEB patients for SCC from age 25.
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A novel enhancer in the fi rst intron is involved in transcriptional regulation of 
peptidylarginine deiminase type I gene by chromatin looping in human keratinocytes
Shibo Ying1,2, Toshio Kojima1,2, Akira Kawada3, Rachida Nachat4, Guy Serre4, Michel 
Simon4, Hidenari Takahara1,2 1Department of Applied Life Sciences, Tokyo University 
of Agriculture and Technology, Japan, 2Dept of Applied Biological Resource Sciences, 
Ibaraki University, Japan, 3Department of Dermatology, Kinki University, Osaka, 
Japan, 4CNRS-Toulouse III University, Toulouse, France
Peptidylarginine deiminase (PAD), which has fi ve isoforms (PAD1-4,6), catalyzes the conversion of 
protein-bound arginine residues to citrulline residues in a calcium-dependent manner. In human 
epidermis, three PADs (PAD1, 2 and 3) are detected with specifi c patterns of expression depending 
on the keratinocyte differentiation state. Their main target is fi laggrin, a major protein for the 
epidermal barrier function. It is unclear the mechanism controlling the transcriptions of PADI1-3 
in the human epidermis. Previous characterizations of the PAD-encoding gene promoters have 
shown that the proximal regulation alone is not suffi cient to explain this specifi city of expression. 
In present work, we describe an evolutionarily highly conserved nucleotide segment located in the 
fi rst intron of the PAD1 gene (PADI1). Luciferase reporter assays showed that it enhances the activity 
of the PADI1 promoter, in a calcium- and orientation-independent manner. Mutation of a putative 
NF-κB cis-element markedly reduced its enhancer activity, which also confi rmed its potential 
regulatory function. Chromatin immunoprecipitation assays evidenced the binding of both p65 
and p50 NF-κB subunits to the cis-element, and RNA interference inhibition assays confi rmed that 
NF-κB contributes to the PADI1 transcriptional control. Furthermore, the intronic enhancer and 
promoter of PADI1 potentially interact through chromatin-looping, as indicated by chromosome 
conformation capture assays. Eukaryotic gene transcription is controlled not only by promoters but 
also by intragenic cis-elements. In this study, Our fi ndings provide evidence that an intronic NF-
κB-mediated signaling pathway is involved in PADI1 regulation in human epidermal keratinocytes.
458
Revertant mosaicism due to second-site mutation in COL7A1 in patient with 
recessive dystrophic epidermolysis bullosa
A.M.G. Pasmooij1, M. Garcia2, M.J. Escámez2, A.M. Nijenhuis1, A. Azon3, N. 
Cuadrado-Corrales2, M.F. Jonkman1, M. Del Rio2 1Department of Dermatology, 
University Medical Center Groningen, Groningen, Netherlands, 2Regenerative 
Medicine Unit, CIEMAT and CIBERER (U714), ISCIII, Madrid, Spain, 3Department of 
Dermatology, University Hospital Sant Joan de Reus, Reus, Spain
Revertant mosaicism due to in vivo reversion of an inherited mutation has been described 
in the genetic skin disease epidermolysis bullosa (EB) for the genes COL17A1, KRT14 and 
LAMB3. Several mechanisms can underlie this reversion process, such as gene conversion, 
intragenic crossing-over, true back mutation, and second-site mutation. Despite of the 
high incidence of revertant mosaicism in patients with EB due to correcting mutations in 
the genes COL17A1 and LAMB3, i.e. 35%, revertant mosaicism has not been described 
for COL7A1. Mutations in COL7A1 are responsible for the most devastating form of EB 
in adults who will develop cocooned ‘mitten’ deformities of the hands. Our study shows 
in vivo reversion of an inherited COL7A1 mutation in a patient with recessive dystrophic 
epidermolysis bullosa (RDEB), who was homozygous for the frame-shift mutation 
COL7A1:c.6527insC,p.2176FsX337. The female patient displayed a patch of clinically 
healthy revertant skin on her left forearm. The second-site mutation c.6528delT, only present 
in revertant keratinocytes, resulted in correction of the reading frame. As the new CCC 
codon codes for the same amino acid proline as the wild-type codon CCT, the revertant 
cells expressed wild-type type VII collagen polypeptide leading to restoration of skin 
function. We hypothesize that revertant mosaicism might be more common in patients 
with type VII collagen-defi cient EB, if one looks carefully for it. Further, the revertant 
keratinocytes offer the possibility to explore cell-based therapeutic strategies, by culturing 
in vitro and grafting as part of bioengineered dermo-epidermal substitutes to affected skin.
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A case of novel G8569T mutation in the type VII collagen gene in dystrophic 
epidermolysis bullosa
Kyu-Suk Lee, Jun-Il Kwon, Sung-Ae Kim, Jae-We Cho Department of dermatology, 
School of medicine, Keimyung university, Daegu, Korea, Republic of
Dystrophic epidermolysis bullosa (DEB) is a hereditary mechanobullous disorder 
characterized by fragility of the skin and mucous membranes caused by abnormal 
anchoring fi brils. Both dominant and recessive DEB are caused by mutations in 
COL7A1, the gene encoding type VII collagen, the major component of anchoring 
fi brils. We performed mutation analysis of COL7A1 in one patient with recessive DEB. 
The diagnosis of DEB was based on the characteristic clinical features, such as mitten-
like deformity, and confi rmed by histopathologically and EM image. The mutation 
detection strategy consisted of PCR amplifi cation of genomic DNA, followed by 
heteroduplex analysis and nucleotide sequencing of the PCR products demonstrating 
altered mobility. All 118 exons and fl anking intron boundaries of COL7A1 were 
amplifi ed. One novel mutation (G8569T) was detected in Exon 116. This mutation 
resulted in substitution Gly to Tyr. Further studies will be required whether the clinically 
unaffected parents are heterozygous carriers of this mutation or this mutation arose as 
a de novo occurrence of autosomal dominant DEB. Importantly, using this mutational 
analysis and genetic pedigree, we will provide a precise genetic counseling of 
individuals at risk for recurrence of DEB in subsequent offspring or future generations.
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A sporadic case of hereditary angioedema with a heterozygous large deletion 
including C1-INH gene
Kazumasa Iwamoto, Akio Tanaka, Mikio Kawai, Shoji Mihara, Michihiro Hide
Hiroshima University, hiroshima, Japan
Hereditary angioedema (HAE; OMIN 106100) is an autosomal dominant disease 
with recurrent episodes of subcutaneous or submucosal edema typically involving 
the face, extrimities, hands, feet, tongue, bowels, or upper airways. We investigated 
the molecular basis of a sporadic Japanese patient 33-year-old woman with repeated 
episodes of edematous swelling especially on the face and arms. The blood 
examination showed a low level of C1 inhibitor (C1-INH) protein with a remarkably 
reduced C1-INH functional activity through the term of remissions and attacks of 
angioedema. The level of D-dimer was high during the angioedema attack, especially 
during severer attack. Her parents are healthy and showed normal levels of the CI-
INH activity. Direct sequencing of genomic DNA revealed no point mutation in the 
C1-INH gene. Gene copy number analysis of genomic DNA by using quantitative real 
time PCR identifi ed that the copy number of C1-INH gene in the patient was half that 
of the healthy control. This result indicated a heterozygous large deletion including 
C1-INH gene. Further analysis identifi ed the deleted genomic length was about 650 
kbp. We could not fi nd any reported evidence showing that any gene locating in 
the deleted region can link to the clinical phenotypes of angioedema. This study 
has identifi ed the heterozygous large deletion including C1-INH gene in a sporadic 
case of HAE. The level of D-dimer has refl ected the activity of HAE in this patient.
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Intracellular cholesterol traffi cking proteins, STARD4 and D5, regulate cholesterol 
homeostasis and differentiation status in HaCaT keratinocytes
Hossein Elbadawy, Particia Martin, Annette Graham Glasgow Caledonian University, 
Glasgow, United Kingdom
This study explored the hypothesis that cytosolic cholesterol traffi cking/sensing proteins, 
STARD4 and STARD5, members of the START family of lipid traffi cking proteins, impact 
on keratinocyte cholesterol homeostasis and differentiation status, providing a novel 
strategy to target defects in lipid metabolism causative of a range of skin disorders.Human 
immortalised keratinocytes (HaCaT) were transiently transfected (48h) with pCMV.6, 
pCMV.6_STARD4 or pCMV.6_STARD5, incorporation of [14C] acetic acid used to measure 
de novo lipid biosynthesis, and quantitative polymerase chain reaction determined steady 
state mRNA levels of transcription factors, enzymes, receptors and transporters implicated 
in cholesterol homeostasis, and markers of keratinocyte differentiation. Over-expression of 
STARD4 (≥ 75 fold; p< 0.05) or STARD5 (≥ 57 fold; p< 0.001) reduced levels of keratin 1 
mRNA by 88.2% (p<0.001) and 63.3% (p<0.05), respectively, while only STARD4 induced 
Loricrin (54%; p<0.05) gene expression.    Both cholesterol traffi cking proteins repressed 
cholesterol and cholesteryl ester biosynthesis, maximally by around 40% (p<0.01); 
these changes associated with distinct gene expression patterns.  STARD4 stimulated 
SREBPF2 gene expression (4.6 fold; p<0.01), while STARD5 increased the expression 
of PPARD (26 fold; p<0.001), PPARG (1.7 fold; p<0.001) and repressed SREBPF2 (43%; 
p<0.05). Downstream, these changes were refl ected in reciprocal regulation of ABCA1 
(D4: 98.2%; p<0.05; D5 12.5 fold increase; p<0.05) and ABCG4 (D4: 4.2 fold increase; 
p<0.05), while STARD5 additionally repressed expression of LDLR (82.8%; p<0.01).
Thus, cytosolic cholesterol transporters, STARD4 and STARD5, regulate 
keratinocyte cholesterol homeostasis and differentiation status, and may 
provide novel therapeutics for treatment of lipid-related clinical skin disorders.
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Lamellar ichthyosis in Ibadan, Nigeria - a case of two sisters
Perpetua Ibekwe, Adebola Ogunbiyi University College hospital, Ibadan, Nigeria
Lamellar ichthyosis, an autosomal recessive inheritable disorder of keratinization 
with estimated worldwide incidence of 1 per 300,000 live births is rarely reported in 
Nigeria despite being the most populous country in Africa.Two sisters, aged 18 and 
15 years presented to the Dermatology Clinic of the, University College Hospital 
Ibadan for evaluation of their skin conditions. They are from a monogamous family 
with a set of twins. The 18-year old girl ranks third while the younger sister is one of 
non identical twins and fourth in the family. They were born as full-term collodion 
babies and have had a lifelong history of dryness and excessive desquamation of 
the skin without notable waxing and waning period. They had episodes of heat 
intolerance and chronic infections. Both had typical features of lamellar ichthyosis: 
large, brown, polygonal scales diffusely present over the entire cutaneous surface 
with fl exural accentuation, no apparent underlying erythema. They had malodorous 
body odor, hyperkeratotic/hyperlinear palms and bilateral ectropion. Their nails, hair 
and extracutaneous systems were essentially normal. There is no history of similar skin 
conditions in the other siblings, or consanguinity in the family; their parents hail from 
Ibadan in Oyo State, Nigeria. Case studies of lamellar icthyosis will encourage attempts 
to better refi ne the classifi cation of this highly heterogeneous skin disorder. In Nigeria, 
the complications and social stigmatization associated with lamellar ichthyosis 
is unfavourable, thus an effective mode of management needs to be developed.
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Hyper-activation of kallikrein 5 does not up-regulate interleukin 8 expression in 
Netherton syndrome
Xilin Wu1, Yan-Nan Zhu1, John Harper1,2, Robin Callard1, Wei-Li Di1
1UCL Institute of Child Health, London, United Kingdom, 2Great Ormond Street 
Hospital, London, United Kingdom
Netherton syndrome (NS) is a congenital skin disease caused by mutations in SPNK5, 
resulting in loss of function of its encoding protein LEKTI. LEKTI regulates kallikrein 5 
(KLK5) which activates protease activated receptor2 (PAR2). PAR2 up-regulates pro-
infl ammatory factors including interleukin8 (IL-8). Previous studies have shown up-
regulation of KLK5 activity and  PAR2 expression in NS. However, whether the PAR2 
activity is up-regulated in NS is obscure.To further understand the patho-mechanism of 
NS, KLK5 and IL8 were examined in skin biopsies from NS patients (n=3) and normal 
donors (n=3). SPINK5 mutations in patients were confi rmed by DNA sequencing. LEKTI, 
KLK5 and IL-8 protein levels in the epidermis, detected by immunohistochemistry, 
were quantifi ed by optical intensity of staining using a computerised programme.
Heterozygous mutations were found in two NS patients but only one mutation was 
found in the third patient. Of the fi ve mutated alleles, one was a novel mutation 
(A1478G) in intron 16, near the intro-exon boundary to exon 17. All NS patients lacked 
LEKTI expression in the epidermis but had intensive KLK5 staining pattern throughout 
the entire epidermis. KLK5 expression was increased signifi cantly compared to 
normal skin (p<0.01). By contrast, the level of IL-8 remained unchanged (p>0.05).
In conclusion, we have identifi ed a novel mutation in SPINK5. Our results also suggest 
that PAR2 activity may not be up-regulated in NS, as levels of the PAR2 targeted 
chemokine IL-8 are unchanged; possibly because long-term sustained hyper-activation 
of KLK5 desensitises the PAR2 receptor, leading to relatively low activity of PAR2.
464
A recurrent COL7A1 silent mutation in an exonic splicing enhancer sequence 
underlies dominant dystrophic epidermolysis bullosa pruriginosa.
Daniele Castiglia1, Claudia Covaciu1, Giovanna Zambruno1, Mette Sommerlund2, 
Jens Michael Hertz2 1IDI-IRCCS, Rome, Italy, 2Aarhus Univ Hospital, Aarhus, Denmark
Intense itching and blistering tendency characterize dystrophic epidermolysis 
bullosa pruriginosa (DEB-Pr), a rare DEB subtype inherited either as dominant 
(DDEB-Pr) or recessive trait. At present, about 40 different COL7A1 mutations were 
documented as causing DEB-Pr, but no clear genotype-phenotype correlation has 
been found. Here, we report two unrelated Danish pedigrees presenting DDEB-Pr 
phenotypes and intrafamilial clinical variability. COL7A1 genotyping in patients 
from both families identifi ed a common haplotype distinguished by three novel 
heterozygous point variations with no obvious pathogenic role. One of these 
sequence variations, c.6846G>C in exon 87 (sited 15-bp from the acceptor splice 
site) was translationally silent. However, computer prediction with all available 
matrices revealed that nucleotide 6846G is embedded within overlapping exonic 
splicing enhancer (ESE) sequences recognized by serine/arginine-rich (SR) splicing 
factors SF2/ASF and SRp40 and that the mutation either creates a new juxtaposed 
binding site for SC35 SR protein or abolishes an ESE motif. Reverse transcription 
(RT)-PCR analysis of the mRNA transcribed from either the endogenous gene in 
patients‘ fi broblasts or a recombinant mutant COL7A1 minigene transfected in 
primate cells allowed to demonstrate that the c.6846G>C prevents exon 87 usage 
leading to in-frame skipping. These fi ndings demonstrate that exon 87 defi nition is 
strongly dependent on ESE. In addition to the identifi cation of a recurrent allele in 
DDEB-Pr families of Danish ancestry, our study substantiates for the fi rst time the 
involvement of an exonic splicing regulatory sequence in the pathogenesis of DEB.
465
ABCA12 regulates other ABCA subfamily expression in epidermis through PPARδ
Heather A. Long, Masashi Akiyama, Teruki Yanagi, Hiroshi Shimizu Department 
of Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, 
Hokkaido, Japan
Mutations in the lipid transporter ABCA12 have been linked to Harlequin Ichthyosis 
(HI), one of the most severe genodermatoses. ABCA12 belongs to the ABCA subfamily 
of lipid transporters, whose members play an important role in lipid transportation 
and homeostasis throughout the body. The expression of other ABCA subfamily 
members has been poorly explored in the epidermis. We screened the expression of 
all ABCA sub-family members and looked at the effect of loss of ABCA12 of ABCA 
subfamily member expression in the epidermis of both mouse and human. We used 
wild type (WT) and Abca12-/- mice and normal (NHEK) and harlequin Ichthyosis 
keratinocytes for this study. PCR revealed the expression of ABCA1, 3 and 7 in both 
mouse and human keratinocytes. ABCA 1, 3 and 7 were signifi cantly up-regulated 
in HI patient keratinocytes, but there was a signifi cant reduction in ABCA1 and 7 
expression in Abca12-/- mouse keratinocytes. At the protein level, there was a striking 
relocation of ABCA3 and 7 in HI patient epidermis. A loss of ABCA1 fl uorescence 
was observed in mouse skin. These discrepancies were refl ected in the changes 
in PPARδ, a known regulator of ABCA expression. In HI patient keratinocytes 
there was a signifi cant up regulation in expression, but little change in PPARδ 
was observed in Abca12-/- mouse keratinocytes compared to WT. Thus, ABCA12 
regulates ABCA subfamily expression in the epidermis, perhaps through PPARδ.
466
Molecular markers in forecasting of the effi ciency of treatment with Infl iximab in 
patients with psoriasis
Anna Kubanova, Nataliya Frigo, Sergey Rotanov, Alexey Kubanov, Ludmila 
Znamenskaya, Elena Vasileva, Irina Lesnaya, Marianna Zilova, Maria Butareva, 
Svetlana Yakovleva The State Scientifi c Centre of Dermatovenerology, Moscow, 
Russian Federation
Infl iximab selectively blocks the action of TNF-α which plays the important 
role in infl ammation in derma of psoriatic plaques. However not in all 
patients with psoriasis Infl iximab causes the expressed therapeutic effect.
For the purpose of forecasting of the therapeutic effi ciency of Infl iximab molecular 
markers biosamples (skin tissue samples taken from psoriatic plaques and blood 
serum) from 22 patients with moderate-to-severe psoriasis aged 19-57 treated with 
Infl iximab were analyzed. The molecular structure of genes TNF-α, TNF-R-I and 
TNF-R-II, contents of cytokine TNF-α and soluble receptors sTNF-RI and sTNF-
RII and proteome composition were analyzed in skin tissue samples; levels of 
cytokines TNF-α, IL-2, IL-4, IL-6, IL-8 and IL-10 were analyzed in the blood serum. 
The homozygous TT genotype of TNF-R-II gene at the 676 locus of 6 exon and high 
levels of IL-10 in the blood serum (>2.7 pg/ml) were associated with the high intensity 
of the response on treatment with Infl iximab in patients with psoriasis; the homozygous 
GG genotype of TNF-R-II gene at the 676 locus of 6 exon and low levels of IL-10 in 
the blood serum (<1.0 pg/ml) were associated with a poor response or no response 
on treatment with Infl iximab. These results were the basis for developing a method 
of forecasting the effi ciency of treatment with a genetically engineered biological 
drug as Infl iximab in patients with psoriasis. Pilot results of this investigation indicate 
a possible mutual relationship between the composition of the skin proteome and 
the therapeutic response on treatment with Infl iximab in patients with psoriasis.
467
Novel and recurrent fi laggrin gene mutations in Taiwanese ichthyosis vulgaris 
families
Chao-Kai Hsu1,2, Masashi Akiyama1, Yuki Miyamura1, W. H. Irwin McLean3, Julia 
Yu-Yun Lee2, Hiroshi Shimizu1 1Department of Dermatology, Hokkaido University 
Graduate School of Medicine, Sapporo, Japan, 2Department of Dermatology, National 
Cheng Kung University Medical College and Hospital, Tainan, Taiwan, 3Epithelial 
Genetics Group, Division of Molecular Medicine, Colleges of Life Sciences and 
Medicine, Dentistry and Nursing, University of Dundee, Dundee, United Kingdom
Filaggrin is a key structural protein that facilitates terminal differentiation of the keratinocytes and 
formation of the skin barrier. Filaggrin gene (FLG) mutations have been identifi ed as the cause of 
ichthyosis vulgaris (IV) and have been shown to be a major predisposing factor for atopic eczema 
(AE). FLG mutations were initially identifi ed in European populations, and subsequently in Japanese, 
Singaporean Chinese, Taiwanese, Korean, and mainland Chinese populations. Notably, there is a 
clear difference in fi laggrin genetics between the European and Asian populations. Our previous 
study showed that Taiwanese population, as an East Asian group, share FLG mutations with both the 
Japanese and the Singaporean Chinese population. The purpose of this current study was to identify 
novel and recurrent fi laggrin gene mutations in Taiwanese IV patients. Totally, six individuals from 
unrelated Taiwanese IV families were examined for FLG mutations by comprehensive sequencing 
of the entire FLG coding region using an overlapping PCR strategy. We identifi ed three recurrent 
mutations and four novel mutations in Taiwanese IV patients. Among the identifi ed recurrent 
mutations, c.3321delA is prevalent among Asian populations; p.Lys4022X and p.Gln2417X have 
been previously identifi ed in Japanese and Singaporean Chinese IV patients, respectively. The four 
novel mutations are located at FLG repeat 1, 5, 10 in exon 3. Our fi ndings further support the notion 
that FLG mutation spectra of the white European and the Asian ancestral groups are different, and 
facilitate the establishment of global population genetic maps for IV and AE patient FLG mutations.
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The Inversa Type of Recessive Dystrophic Epidermolysis Bullosa is Caused by 
Specifi c Arginine and Glycine Substitutions in Type VII Collagen
Peter van den Akker1, Jemima Mellerio2,3, Anna Martinez3, Lu Liu4, Patricia Dopping-
Hepenstal4, Anthonie van Essen1, Hans Scheffer5, Robert Hofstra1, John McGrath6, 
Marcel Jonkman7 1Dept of Genetics, Univ of Groningen, Netherlands, 2St John’s 
Institute of Dermatology, London, UK, 3Dept of Dermatology, Great Ormond Street 
Hospital NHS Trust, London, UK, 4The Robin Eady National Diagnostic EB Laboratory, 
St Thomas‘ Hospital, London, UK, 5Dept of Human Genetics, Radboud Univ 
Nijmegen Med Centre, Nijmegen, Netherlands, 6St John‘s Institute of Dermatology, 
King‘s College, London, UK, 7Dept of Dermatology, Univ of Groningen, Netherlands
The inversa type of recessive dystrophic epidermolysis bullosa (RDEB-I) is a rare variant of 
dystrophic epidermolysis bullosa, characterized by blistering in the body fl exures, trunk, and 
mucosae. The cause of this specifi c distribution is unknown. So far, only 12 COL7A1 genotypes 
have been described in RDEB-I and genotype-phenotype correlations have not been studied. 
The aim of the study was to gain more insight into the intriguing pathophysiology of RDEB-I. 
We identifi ed 20 Dutch and British RDEB-I patients, with genotypes in 18, and conducted the 
fi rst genotype-phenotype correlation study in RDEB-I. All had generalized blistering at birth and 
during early infancy. The age of transition from generalized to inversa distribution ranged from 
1 to 18 years, but in most before the age of 4. Most patients had severe involvement of the 
oral and esophageal mucosae, and genital mucosae in half of the female patients. We noted a 
spectrum of disease severity ranging from the mildest ‘mucosal only’ phenotype to the severest 
phenotype with limited acral involvement. The 21 complete genotypes of our RDEB-I patients and 
those reported in the literature revealed that RDEB-I is associated with specifi c recessive arginine 
and glycine substitutions in the triple-helix domain of type VII collagen. Why these substitutions 
cause the inversa distribution remains unknown. However, we hypothesize that the higher skin 
temperature in the affected areas plays an important role in the pathophysiology of RDEB-I.
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Zebrafi sh Model to Study Heritable Skin Diseases - Expression of the Structural 
Genes and “Knock-Down“ Phenotypes
Qiaoli Li, Michael Frank, Jouni Uitto Jefferson Medical College, Philadelphia, PA, 
United States
Zebrafi sh (Danio rerio) has a well characterized genome, comparable to mammals, 
which can be easily manipulated using morpholino-based antisense oligonucleotides 
to down-regulate the corresponding gene expression. The larvae develop rapidly, with 
all major organs, including the skin, having developed by 5-6 days post-fertilization 
(dpf). During the early stages of zebrafi sh skin development (<15 dpf) the epidermis 
consists of two layers, separated from the dermal matrix by a basement membrane 
zone, with fully developed hemidesmosomes at ~5.5 dpf. In this study, we have 
systematically surveyed the gene expression profi le of structural genes in 1 and 6 dpf 
larvae, and in adult zebrafi sh by RT-PCR. Expression of epidermal genes, keratins 1 
and 5, was readily detected at 6 dpf and in adult, similar to a number of basement 
membrane zone genes, including bpag1, itga6 and itgb4, as well as lama5 and plectin. 
A repertoire of collagen genes was also expressed, including those encoding type I, 
IV, V, VI, VII, XII, XIV, XV, XVI, XVII, XVIII and XIX collagen subunit polypeptides. 
Morpholino-mediated down-regulation of several genes have resulted in cutaneous 
phenotype, including blistering in col17a1 “knock-down” animals, mimicking 
junction epidermolysis bullosa. The expression of zebrafi sh genes also expressed in 
human skin suggest that zebrafi sh provides a facile model system to study molecular 
aspects of skin development, and pathogenesis and treatment of heritable skin diseases. 
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Large-scale analysis of COL29A1 gene variation for eczema and related traits
Elke Rodríguez1, Aline Naumann1,2, Cilla Söderhäll3, Regina Foelster-Holst4, Andreas 
Ruether5, Hansjörg Baurecht1,6, Natalija Novak7, Markus Gerhard8, Erik Melén9, Carl-
Fredrik Wahlgren10, Inger Kull11, Göran Pershagen12, Roger Lauener13, Josef Riedler14, 
Gert Doekes15, Annika Scheynius16, Erika von Mutius17, Juha Kere3,18, Michael 
Kabesch1, Stephan Weidinger1,4 1Munich, Germany, 2Munich, Germany, 3Stockholm, 
Sweden, 4Kiel, Germany, 5Kiel, Germany, 6Munich, Germany, 7Bonn, Germany, 
8Munich, Germany, 9Stockholm, Sweden, 10Stockholm, Sweden, 11Stockholm, 
Sweden, 12Stockholm, Sweden, 13Davos, Switzerland, 14Schwarzach, Australia, 
15Utrecht, Netherlands, 16Stockholm, Sweden, 17Munich, Germany, 18Helsinki, Finland, 
19Hannover, Germany
Eczema (atopic dermatitis) is one of the most common skin disorders infl uenced by both genetic and 
environmental factors. Based on a recent positional cloning approach it was suggested that COL29A1, 
which encodes a novel epidermal collagen, represents a major eczema disease gene. We investigated 
reported COL29A1 variants for association with eczema, subtypes of eczema, and related traits in 5 
independent and large study populations: a set of 1687 eczema cases and 2387 population controls, 
a collection of 274 eczema families, a cross-sectional population of German children (n = 3099), the 
Swedish population-based birth cohort BAMSE (n=2033), and the European cross-sectional PARSIFAL 
cohort (n=3113). An additional set of 19 COL29A1 coding SNPs was analyzed in BAMSE and PARSIFAL. 
We found no evidence for a relationship between COL29A1 SNPs or haplotypes and eczema or any 
other atopic trait. Furthermore, we were unable to confi rm an excess of maternal transmissions to 
eczema-affected offspring. The equivalence test rejected the hypothesis of association with eczema, 
even excluding small contributions (OR=0.80-1.25) to disease development. In situ hybridization did 
not show any differences in the cellular distribution pattern of COL29A1 expression between lesional 
and non-lesional eczema skin and skin from healthy controls. Our results suggest that COL29A1 
is unlikely to contain genetic variants that have a major impact on eczema or atopy susceptibility.
471
The Mouse Samd9L Gene: Transcriptional Regulation and Developmental Tissue-
Specifi c Expression
Quijie Jiang1, Benjamin Quaynor1, Alex Sun1, Qiaoli Li1, Hirotaka Matsui2, Hiroaki 
Honda2, Toshiya Inaba2, Eli Sprecher3, Jouni Uitto1 1Jefferson Medical College, 
Philadelphia, PA, United States, 2University of Hiroshima, Hiroshima, Japan, 3Sourasky 
Medical Center, Tel Aviv, Israel
Normophosphatemic familial tumoral calcinosis (NFTC) is characterized by 
progressive dermal calcifi cation, despite normal plasma calcium and phosphate levels, 
and caused by mutations in the sterile alpha motif domain 9 gene (SAMD9). SAMD9 
is deleted in mouse and its function is postulated to be substituted by its paralogous 
gene, Samd9L. We investigated the transcriptional regulation and the expression 
pattern of mouse Samd9L. A 1.5-kb mouse Samd9L promoter fragment was cloned, 
and a series of 5’ truncated constructs were linked to a luciferase reporter gene. All 
constructs displayed signifi cant activity in transfected cultured cells of diverse origins, 
suggesting the presence of regulatory cis-elements as close as 87 bp upstream of the 
transcription start site. Ras-responsive element binding protein (RREB-1) was identifi ed 
in this region by protein-DNA binding array. The expression of Samd9L mRNA was 
up-regulated in the cells cultured with calcitonin, preceded by signifi cant increase in 
expression of Rreb-1 mRNA. qRT-PCR analysis of Samd9L revealed near-ubiquitous 
expression, with the highest level in the kidney. The expression of Samd9L in the mouse 
embryos was fi rst noted at 12.5 pc, and the expression in the kidney progressively 
increased with age. Tissue-specifi c expression was also confi rmed both by in situ 
X-gal staining and quantitative enzymatic activity assay in a transgenic Samd9L-/- 
mouse model in which the LacZ gene replaced exon 2 in the Samd9L gene. These 
fi ndings assist in understanding the function of Samd9L and its paralogous genes, and 
in elucidation of the mechanisms responsible for extraosseous calcifi cation in NFTC.
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New insight into genotype/phenotype correlation in ABCA12 mutations in harlequin 
ichthyosis
Umemoto Hiroko1,2, Akiyama Masashi1, Yanagi Teruki1, Sakai Kaori1, Aoyama 
Yumi3, Oizumi Ami4, Suga Yasushi4, Kitagawa Yoshimasa2, Shimizu Hiroshi1
1Dept of Derm, Hokkaido Univ Grad School of Medicine, Sapporo, Japan, 2Dept of 
Oral Diagnosis & Oral Med Hokkaido Univ Graduate School of Dental Medicine, 
Sapporo, Japan, 3Dept of Dermatology, Okayama Univ Grad School of Medicine, 
Japan, 4Dept of Derm, Juntendo Univ School of Medicine, Urayasu Hospital, Japan
Harlequin ichthyosis (HI) is one of the most severe genodermatoses, caused by loss-of-function 
mutations in ABCA12 encoding a keratinocyte lipid transporter. To date, various ABCA12 
mutations have been reported in HI families, although the genotype/phenotype correlation in 
ABCA12 mutations has been little elucidated.We found two HI patients from two independent 
Japanese families, who were compound heterozygotes for ABCA12 mutations. Both patients had 
the same paternal nonsense mutation p.Arg1515X which leads to truncation in the fi rst ATP-
binding cassette of ABCA12 probably resulting in ABCA12 loss of function.In the other allele, the 
fi rst patient had a recurrent splice acceptor site mutation c.3295-2A>G. This splice site mutation 
was reported to result in production of mainly ABCA12 peptide lacking three amino acids 
(1099_1101delYMK) in the fi rst transmembrane domain.The second patient carried missense 
mutation p.Gly1179Arg in the other allele. The glycine 1179 is a highly conserved amino acid 
residue located in the fi rst transmembrane domain of ABCA12, and this mutation substitutes an 
uncharged polar glycine residue for a positively charged arginine residue.As for the phenotype 
expression, clinical symptoms of the fi rst patient have been remarkably improved during infancy. 
In contrast, the symptoms of the second patient did not improve apparently, and she died at the 
age of 5 months.The marked difference in clinical severity of the two patients indicated that the 
p.Gly1179Arg has far bigger negative functional effects than that of p.1099_1101del, and shows 
new insight into genotype/phenotype correlation in ABCA12 mutations in harlequin ichthyosis.
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Allogeneic fi broblast therapy in RDEB may induce mutant type VII collagen synthesis 
by keratinocytes through up-regulation of HBEGF.
Nikoletta Nagy, Noor Almaani, Akio Tanaka, Tanasit Techanukul, John McGrath
St. John’s Institute of Dermatology, King’s College London, Guy’s Campus, UK
When allogeneic fi broblasts are injected intradermally into individuals with recessive 
dystrophic epidermolysis bullosa (RDEB) they survive for only a few days but are able to 
increase type VII collagen (C7) expression at the dermal-epidermal junction (DEJ) for several 
weeks or months. However, the precise mechanism and duration of the response are not 
known. To investigate this further, we injected 5 x 106/cm2 allogeneic neonatal fi broblasts 
(VaveltaTM, Intercytex plc) into a 9 cm2 area of non-blistered skin in one RDEB individual 
(COL7A1 mutations: p.Arg682X and IVS87+4A>G) and examined COL7A1 gene and 
C7 protein expression, and undertook microarray profi ling on skin biopsy RNA (Sentrix 
Human-6 Whole Genome Microarray Gene Expression Analysis; Illumina Inc.) at serial time 
points up to one year. Immunofl uorescence microscopy of skin sections showed increased 
C7 labelling for up to 6 months (LH7.2 antibody) and RT-PCR (including primers specifi c 
for the splice site mutation) revealed increased COL7A1 expression for up to 3 months. The 
increased COL7A1 expression was paralleled by increased expression of HBEGF (encoding 
heparin-binding EGF-like growth factor). Treatment of control and patient cultured 
keratinocytes and fi broblasts with recombinant HBEGF led to increased COL7A1 gene 
expression, in association with increased AP-1 transcription factor levels; the responses 
were greatest in keratinocytes. Our data indicate that HBEGF maybe a key cytokine in 
the response of RDEB keratinocytes to allogeneic fi broblast injections in increasing mutant 
but partially functional C7 at the DEJ, and that a single injection of cells can alter a RDEB 
patient’s intrinsic skin defect for approximately 6 months.
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RNA trans-splicing technology facilitates targeted delivery of a suicide gene to 
cancer cells
Christina Gruber1, Iris K Gratz2, Elisabeth Mayr1, Eva M Murauer1, Leena Bruckner-
Tuderman3, Helmut Hintner1, Johann W Bauer1 1EB House Austria, Department 
of Dermatology, Paracelsus Medical University, Salzburg, Austria, 2Department of 
Pathology, University of California, San Francisco, United States, 3Department of 
Dermatology, University Medical Center Freiburg, Freiburg, Germany
Spliceosome mediated RNA trans-splicing constitutes a technology which has the 
ability to reprogram genetic information on the mRNA level, thus trans-splicing has 
already been successfully used to repair the mutated part of disease-causing genes in 
vitro and in vivo. This is accomplished by a specifi cally designed pre trans-splicing 
molecule (PTM) that binds to the endogenous target RNA and induces a trans-splicing 
reaction between the target and the PTM. We are investigating the ability of a PTM to be 
used as a therapeutic molecule in a suicide gene therapy approach for cancer treatment 
in recessive dystrophic epidermolysis bullosa (RDEB). In this experimental setup a 
tumor associated marker gene is reprogrammed in order to convert it into a new gene 
product coding for a cell death inducing peptide/toxin. Previously we have designed a 
PTM, targeting the pre- mRNA of matrix-metalloproteinase-9 via an antisense binding 
domain (BD) and have shown that the PTM is able to elicit cytotoxicity through the 
introduction of streptolysin O in an RDEB-associated squamous cell carcinoma 
(SCC) cell line. We further investigated the specifi city of the PTM to selectively target 
cancer cells expressing the marker gene. Notably, only RDEB SCC cells but not RDEB 
keratinocytes showed signifi cant reduction in cell viability upon transfection with the 
PTM which occured by a target-specifi c RNA replacement. Therefore trans-splicing 
offers great potential to be used in suicide gene therapy approaches because tumor 
restricted expression of the toxin represents one of most crucial aspects in this area.
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Screening for the best 5´pre-trans-splicing molecules in COL7A1 in order to develop 
a 5´trans-splicing gene therapy approach for dystrophic Epidermolysis bullosa
Elisabeth Mayr, Ulrich Koller, Eva M Murauer, Christina Gruber, Alfred Klausegger, 
Helmut Hintner, Johann W Bauer EB House Austria, Department of Dermatology, 
Paracelsus Medical University, Salzburg, Austria
Mutations in COL7A1, the gene coding for type VII collagen, are the cause of 
dystrophic Epidermolysis bullosa, a heritable mechanobullous skin disease. 
Because of its size COL7A1 exceeds the size capability of most viral vectors 
commonly used for delivery in gene therapy. Furthermore endogenous regulation 
of expression is crucial in tissues with a complex differentiation program. Therefore 
we chose a mRNA based gene therapy to repair defects in COL7A1. We repair 
mutated genes by trans-splicing a wild type copy mRNA of the mutated gene with 
the target gene. The advantages in comparison to a standard gene therapy are 
maintenance of endogenous transcription control, the ability to target dominant 
negative mutations and the size reduction of the delivery vector. To select the best 
molecules to correct mutations in the 5´part of COL7A1 we used a fl uorescence-
based screening procedure to evaluate a library of randomly cloned pre-trans-
splicing-molecules. Thereby we identifi ed molecules with a repair-rate of up to 
96% in our test system in Hek293FT cells. These constructs shall now be tested in 
keratinocytes on their endogenous trans-splicing potential. Endogenously functional 
test molecules will be adapted to exchange the 5´part of COL7A1 and therefore be 
able to correct mutations situated in the fi rst 64 exons of COL7A1 and recover type 
VII collagen expression in patient cells. The long term goal of our approach is an 
ex vivo gene therapy, in which skin grafts taken from patients are transfected with 
specifi c pre-trans-splicing molecules and are then transplanted to the patients again.
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Mutation and SNP analysis of TMC6 and TMC8 in patients with epidermodysplasia 
verruciformis
Bettina Burger1, Kirsten Mertz2, Werner Kempf2, Iris Spoerri1, Andreas Arnold1, Peter Itin1
1University Hospital Basel, Basel, Switzerland, 2Labor Kempf und Pfaltz, Zurich, 
Switzerland
Epidermodysplasia verruciformis (EV) is a rare autosomal recessive dermatosis, 
characterized by a combination of gene mutation and HPV infection. Patients 
with EV suffer from the development of planar warts, which may end in squamous 
cell cancer (SCC). In 2002 Ramoz et al. discovered that patients with EV reveal 
mutations in the genes TMC6 and TMC8 (both on chromosome 17q25.3). TMC6 
and TMC8 are members of the transmembrane channel-like proteins which are 
localized in the endoplasmic reticulum. The function of TMCs is widely unknown 
and the linkage to development of EV is not well understood. Both genes contain 
a numerous SNPs with unknown infl uence to EV. Mutations in TMC6 or TMC8 
could be found in 75% of all patients with EV. Further responsible genes are 
supposed on chromosome 2p and a X-chromosomal inheritance is also described.
We examined patients presenting the typical signs of EV and analyzed TMC6 
and TMC8 by direct sequencing on an ABI prism 3100. In this connection a 
high number of SNPs could be detected. We will analyze their occurrence 
and distribution more detailed, compare them to the general population, 
and discuss a possible connection of single SNPs to development of EV.
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The H Syndrome – A New Autosomal Recessive Genodermatosis with Systemic 
Manifestations
Yuval Ramot1, Vered Molho-Pessach1, Abdulasalam Abu Libdeh2, Victoria Doviner1, 
Nurith Hiller1, Valentina Broshtilova3, Abraham Zlotogorski1 1Hadassah - Hebrew 
Univeristy Medical Center, Jerusalem, Israel, 2Makassed Islamic Charitable Hospital, 
Jerusalem, Israel, 3Faculty of Medicine, Medical University, Sofi a, Sofi a, Bulgaria
The H syndrome is a recently described autosomal recessive disorder, characterized by 
cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hearing 
loss, hypogonadism, short stature (low height), hyperglycemia/diabetes mellitus, hallux valgus, 
camptodactyly or fi xed fl exion contractures of the toe joints and the hands‘ proximal interphalangeal 
joints. Histological fi ndings include a dermal and subcutaneous infi ltrate composed of monocyte-
derived cells (CD68 histiocytes and CD34 and FXIIIa dendrocytes), admixed with mast cells and 
plasma cells. Later, this infi ltrate is replaced by fi brosis with thickened, fragmented and partially 
calcifi ed elastic fi bers and psammoma bodies. Following homozygosity mapping and further 
sequencing we found a total of seven mutations in the SLC29A3 gene. Three different mutation 
have been detected in patients from Israel (p.G427S, p.G437R and c.1045delC), all in exon 6 of 
the gene. Four additional mutations have been detected in patients from Japan, India, Spain and 
Morocco (p.S184R, p.R133C p.R363Q and p.R363W). The SLC29A3 gene encodes the ubiquitously 
expressed equilibrative nucleoside transporter; hENT3. This transporter localizes to the mitochondria 
and assists mitochondrial homeostasis including mitochondrial DNA synthesis/repair. An increasing 
number of patients are being identifi ed around the world, some of them had been erroneously 
given other diagnoses prior to the recognition of the disorder, thus implying that the H syndrome 
is more common than previously thought. According to our knowledge this is the fi rst description 
of a disease caused by mutations in nucleoside transporters, and the prominent cutaneous 
fi ndings suggest a critical role for hENT3 in maintaining skin, pigmentation and hair homeostasis.
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A novel CYLD mutation identifi ed in Brooke-Spiegler syndrome causes decreased 
NEMO activity and thus increased NF-κB signaling
Márta Széll1, Nikoletta Nagy2, Ágnes Kinyó2, István Balázs Németh2, Ferenc Kovács-
Sólyom2, Erika Kis2, János Varga2, Zsuzsanna Bata-Csörgö1,2, Lajos Kemény1,2
1Dermatological Research Group of the Hungarian Academy of Sciences, University 
of Szeged, Szeged, Hungary, 2Department of Dermatology and Allergology, Universitiy 
of Szeged, Szeged, Hungary
Brooke-Spiegler syndrome (BSS; OMIM 605041) is an autosomal dominant disease 
characterized by the development of multiple skin appendage tumors, which are the 
consequences of mutations in the cylindromatosis (CYLD) gene. The encoded CYLD 
protein acts as a negative regulator for NF-kappaB-dependent infl ammation in vivo. 
We have recently identifi ed a Hungarian pedigree with two members (father and 
his daugther) affected by BSS . Using direct sequencing, a novel missense mutation 
of CYLD (c.2613C>G; p.His871Gln) was detected located in exon 19 and affecting 
the ubiquitin-specifi c protease domain of CYLD protein. To reveal the pathogenic 
role of the newly identifi ed mutation functional studies were performed on CD4+ 
T lymphocytes of the two patients since CYLD is highest expressed in this cell type. 
CD4+ cells of BSS patients were stimulated by TNFα and the activation of the NF-κB 
pathway was monitored by the expression of NEMO transcription factor. Our data 
demonstrated a signifi cant reduction in the protein level of NEMO in the samples of the 
BSS patients compared to healthy controls. Additionally, we characterized peripheral 
blood lymphocytes by fl ow cytometry and found minor alterations, the most signifi cant 
was an increase in CD3+/CD4+/CD26- cell numbers in the CYLD patient with more 
advanced symptoms. We hypothesize that this novel mutation leads to increased NF-
κB signaling via the impairment of the deubiquitinating activity of CYLD protein.
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H syndrome: a recurrent Arg363Gln mutation in SLC29A3 gene and ultrastructural 
skin analysis in three patients.
Frederic Caux1,2, Bakar Bouadjar3, Catherine Prost2,4, Annie Lévy5, Florence 
Ribierre6, Astrid Blom2, Liliane Laroche2, Judith Fischer6 1EA4222, University Paris 
13, Bobigny, France, 2Dermatology-MAGEC, Avicenne Hospital, Bobigny, France, 
3Dermatology, Bab-El-Oued Hospital, Algiers, Algeria, 4Histology, University Paris 13, 
Bobigny, France, 5Pathology, Avicenne Hospital, Bobigny, France, 6National Center of 
Genotypage, Evry, France
The SLC29A3 gene, located on 10q22.1, encodes the hENT3 equilibrative nucleoside transporter 
and has been shown to be mutated in H syndrome. This autosomal recessive disease described in 
2008 is characterized by hyperpigmented and hypertrichotic skin lesions, hearing loss, low height, 
hepatosplenomegaly, heart abnormalities, hypogonadism and hyperglycemia. We here report 
on molecular and ultrastructural analyses performed on 3 men from 2 consanguineous families 
with typical H syndrome. Cutaneous ultrastructural analysis showed numerous melanosomes in 
the keratinocytes of basal and spinous layers, laminated basement membranes surrounding the 
capillaries and perivascular infi ltrates of histiocytes and eosinophils. The 6 coding exons and the 
intron/exon boundaries of SLC29A3 were sequenced. In the three patients, a homozygous G-to-A 
transition in exon 6 at position 1088 was observed. This 1088 G>A transition substituted arginine 
for glutamine at position 363 and was not found in 384 normal controls. This Arg363Gln mutation 
reported once before and located between the 8th and 9th transmembranous domains probably is 
deleterious since i) it changed a positively-charged amino acid for a neutral amino acid, ii) conversion 
of arginine 363 to glutamine would be expected to affect the conformation of hENT3 protein since 
in silico analysis predicted a structural change of threonine 363 from sheet to coil, iii) arginine 363 
is highly conserved among all species suggesting a functionally important role of this amino acid. In 
conclusion we detected the recurrent Arg363Gln mutation in Algerian and Tunisian families evoking 
a founder effect and described ultrastructural cutaneous changes in the newly defi ned H syndrome.
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Induction of phenotype modifying cytokines by FERMT1 mutations
Anja Heinemann1, Yinghong He1, Elena Zimina1, Melanie Boerries2, Nadja 
Chmel1, Thorsten Kurz3, Leena Bruckner-Tuderman1,2, Cristina Has1 1Department 
of Dermatology, University of Freiburg, Freiburg, Germany, 2Freiburg Institute for 
Advanced Studies, School of Life Sciences –LIFENET, Freiburg, Germany, 33Core 
Facility Genomics, Centre for Systems Biology, University Freiburg, Freiburg, Germany
Kindler syndrome (KS) is a skin disorder caused by mutations in the FERMT1 gene 
encoding kindlin-1, an epithelial-specifi c phosphoprotein involved in b1 integrin 
activation. Early in life, KS manifests as a mechanobullous disease refl ecting 
diminished cell adhesion, but many aspects of its later phenotypic features, including 
progressive poikiloderma and fi brosis of the skin and mucosa, remain unclear. 
Against this background, we addressed the pathogenesis of dermal abnormalities in 
KS by exploring cytokine profi les of KS keratinocytes and by characterizing KS skin 
fi broblasts in vitro, and by validating the fi ndings in vivo in the skin of nine KS patients. 
We show that kindlin-1 negative keratinocytes upregulate the expression of IL-24, IL-
20, transforming growth factor-b2 (TGF-b2), IL1F5, platelet derived growth factor B 
(PDGFB) and connective tissue growth factor (CTGF), and that KS fi broblasts exhibit 
an activated phenotype. These fi ndings correlate with the presence of macrophages 
and of mediators of fi brosis, like a-smooth muscle actin, TGF-b1, IL-6 and CTGF, 
in KS skin. Based on these data we predict that mutations in FERMT1 gene cause 
epithelial cell stress and, as a stress response, secretion of cytokines that mediate 
local infl ammation and fi brosis. The repeated cycles of epidermal cell stress, cytokine 
secretion, dermal infl ammation and fi brotic processes underlie the phenotypic 
changes in different tissue compartments in the skin. Our data uncover cytokine-
mediated paracrine cell communication processes as novel phenotype modulators in 
KS and thereby yield a new starting point for development of therapeutic strategies.
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COL7A1 mutation spectrum in Polish Dystrophic Epidermolysis Bullosa patients.
Katarzyna Wertheim-Tysarowska1, A. Klausegger2, Agnieszka Sobczynska-
Tomaszewska11, Cezary Kowalewski3, Katrzyna Wozniak3, Anna Kutkowska-
Kazmierczak1, Jerzy Bal1 1Medical Genetics Department, Institute of Mother and 
Child, Warsaw, Poland, 2Division of Molecular Dermatology and eb house Austria, 
Department of Dermatology, Paracelsus Private Medical University, Salzburg, Austria 
3Department of Dermatology, Medical University of Warsaw, Poland, 
 The aim of the study was to investigate  the spectrum of mutations in Polish Dystrophic 
Epidermolysis Bullosa  (DEB)  patients and to implement  population specifi c 
scheme for molecular analysis of COL7A1 in Poland, as it  was already done in 
other countries of Central and Western Europe i.e. Germany, Hungary and  England. 
33 DEB patients (29 recessive DEB- RDEB, 4 dominant DEB-DDEB diagnosed on 
the basis of clinical symptoms  and immnofl uorescence mapping were enrolled to 
the study. DNA was isolated from leukocytes and analyzed by direct sequencing of 
COL7A1 coding region and intronic fl anking sequences.  Full genotype was identifi ed 
in 23 probands.  In further 10 cases molecular analysis is still proceeding due to 
incomplete genotypes (8 cases with one identifi ed mutation, 2/10 with no identifi ed 
mutations)  Our preliminary data shows that c.425G>A is the most frequent mutation 
in our group of patients  (62%  of RDEB patients;  40% of RDEB alleles), followed 
by equally distributed:  c.682+1G>A  and, unreported before,  c.7154delC (14%  of 
RDEB  patients; 7% RDEB of alleles).  In other cases we found also rare mutations, 
including 7 variants unreported before.  In conclusion,  we present  the fi rst molecular 
study performed in Polish DEB patients. Our results indicate that mutations spectrum 
and frequency in Polish DEB patients differs from other population tested and support 
the general idea of developing population specifi c molecular diagnostic scheme.
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Reconstructed human epidermis demonstrates a severe epidermal barrier defect 
caused by defi ciency of corneodesmosin
Katja Eckl1, Vinzenz Oji2, Karin Aufenvenne2, Marc Nätebus1, Tatjana Tarinski2, 
Katharina Ackermann3, Monika Schäfer-Korting3, Ingrid Hausser4, Heiko Traupe3, 
Hans Christian Hennies1,5 1Cologne Ctr for Genomics, Germany, 2Dept of Derm, Univ 
Hosp of Münster, Germany, 3Inst for Pharmacy, Freie Univ Berlin, Germany, 4Dept of 
Derm, Univ Hosp of Heidelberg, Germany, 5Ctr for Molec Med Cologne, Germany
Generalized peeling skin disease (PSD) is an autosomal recessive ichthyosiform erythroderma 
characterized by lifelong patchy peeling of the skin associated with pruritus and atopic disease. 
Whole-genome linkage analysis identifi ed a homozygous nonsense mutation in CDSN encoding 
corneodesmosin in four affected children, resulting in a premature termination codon, p.Lys59X. 
Western blot analysis demonstrated complete absence of corneodesmosin in the patients, 
whereas differentiated keratinocytes of healthy controls showed a strong signal. We generated 
a three-dimensional model using primary keratinocytes and a collagen matrix populated with 
fi broblasts, which precisely mimicked the epidermal skin, with regular formation of the basement 
membrane zone and expression of late differentiation markers such as involucrin and fi laggrin. 
The epidermis equivalents showed normal epidermal barrier activity and enabled us to further 
analyse its integrity. Test substances were the OECD validated standard compounds for cutaneous 
absorption studies, caffeine and testosterone. The Papp values with caffeine and testosterone were 
15.7 x 106cm/s and 8.58 x 106cm/s in patient models compared to 10.9 x 106cm/s and 5.30 x 
106cm/s, respectively, in control models (p<0.01). To further characterize the importance of 
corneodesmosin, we knocked down CDSN in normal keratinocytes used for model preparation. 
We observed ablation of corneodesmosin throughout the cultivation of the model, which replicated 
the patient epidermis with an increased granular layer and strong hyperkeratosis. Thus we 
demonstrate that lack of corneodesmosin accounts for the predisposition to atopy and propose 
PSD as a new model for atopic disorders induced by a disturbed and ineffective epidermal barrier.
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A new LAMA3 mutation in 2 patients with junctional epidermolysis bullosa
Astrid Blom1, Frederic Caux1, Alexandra Charlesworth2, Christine Chiaverini3, 
Catherine Prost1, Liliane Laroche1, Jean-Philippe Lacour3, Guerrino Meneguzzi2 
1Reference Center for Genetic Skin Diseases, University Avicenne, Bobigny, France, 
2INSERM U634, University of Nice, Nice, France, 3Reference Center for Hereditary 
Epidermolysis Bullosa, University of Nice, Nice, France
The LAMA3 gene encodes the α3 chain of laminin 5 and is mutated in 9% of 
junctional epidermolysis bullosa (JEB). Here we report 2 patients with non-Herlitz 
JEB and a novel LAMA3 mutation. Two Pakistani brothers with consanguineous 
parents presented with skin fragility and bullae starting after birth and regressing 
completely at adolescence except for a pretibial plaque. Enamel hypoplasia 
and nail dystrophy of hands and feet were also noted. Skin histology showed a 
subepidermal bulla, and immunomapping revealed a substantial reduction of 
laminin 5. Electron microscopy showed a cleavage in the lamina lucida and focally 
in basal keratinocytes, with abnormal and scarce hemidesmosomes. Sequencing 
of LAMA3 gene revealed in both patients a homozygotous mutation in exon 19 
(c.2444 T>C) leading to the substitution of phenylalanine 815 by a serine. This 
variation has not been found in 100 other individuals, ruling out that it could be 
a polymorphism. It is probably deleterious because a small hydrophilic amino 
acid replaces a large hydrophobic amino acid and because Phe 815 is highly 
conserved among species. This novel mutation is located in the C-terminal globular 
subdomain LG1 and could be pathogenic by disrupting the secretion of laminin 5.
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Association of the chromosome 11q13.5 variant with atopic eczema in Austrian 
patients
Elli Greisenegger1, Friedrich Zimprich2, Alexander Zimprich2, Andreas Gleiss3, 
Tamara Kopp1 1Department of Dermatology, DIAID, Medical University of Vienna, 
Austria, 2Department of Neurology, Medical University of Vienna, Austria, 3Core Unit 
for Medical Statistics and Informatics, Section of Clinical Biometrics, Vienna, Austria
Recently, the two single nucleotide polymorphisms rs7927894 on chromosome 
11q13.5 and rs877776 within the region of the hornerin gene were identifi ed as 
novel susceptibility variants for atopic eczema in the fi rst genome wide association 
study in atopic eczema. The aim of our study was to evaluate the infl uence of 
these two genetic variants on atopic eczema and disease-related phenotypes 
in the Austrian population. 275 atopic eczema patients and 228 controls were 
genotyped for the two variants rs7927894 and rs877776 by using Taqman based 
allelic discrimination assays. When comparing patients with controls we found a 
signifi cant association of the rs7927894 variant on chromosome 11q13.5 with 
atopic eczema (p= 0.005; OR: 1.81; CI 1.19-2.75). Subgroup analysis revealed no 
signifi cant association of rs7927894 with age of onset, concomitant asthma and 
allergic rhinoconjunctivitis, total serum IgE levels and family history of atopy. The 
analysis of the rs877776 variant showed neither a relevant difference in the allelic 
distribution between patients and controls nor a statistical signifi cant association 
with any of the analyzed atopic eczema phenotypes. In summary our data show a 
statistical signifi cant association of the rs7927894 variant on chromosome 11q13.5 
with atopic eczema but not with other disease-related phenotypes. Therefore, 
we assume that the rs7927894 single nucleotide polymorphism selectively 
infl uences eczema development. More investigations in distinct study populations 
are needed to assess the role of this interesting polymorphism in atopic eczema.
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Exon 87 skipping of the COL7A1 gene in dominant dystrophic epidermolysis bullosa
Hiroshi Koga1, Takahiro Hamada1, Norito Ishii1, Shunpei Fukuda1, Sachiko Sakaguchi1, 
Hajime Nakano2, Katsuto Tamai3, Daisuke Sawamura2, Takashi Hashimoto1
1Department of Dermatology,Kurume University School of Medicine, Kurume, Japan, 
2Department of Dermatology, Hirosaki University Graduate School of Medicine, 
Hirosaki, Japan, 3Division of Gene Therapy Science, Department of Molecular 
Therapeutics, Osaka University Graduate School of Medicine, Osaka, Japan
Dystrophic epidermolysis bullosa (DEB) is a rare inherited blistering disorder resulting 
from mutations in the COL7A1 gene, which encodes type VII collagen, the major 
component of anchoring fi brils at the dermal-epidermal junction. We here report 
a Japanese girl with dominant DEB (DDEB) with a recurrent splice-site mutation in 
COL7A1. The patient initially presented with scattered blistering and erosions healed 
with pruritic scars on the extremities, although these features markedly decreased by 
18 years of age. The clinical manifestations of the present case were very mild. Direct 
nucleotide sequencing of genomic DNA from the patient disclosed a heterozygous 
G to A transition at nucleotide c.6900 that does not lead to an amino acid change in 
p.Gln2300 residue. RT-PCR, using RNA extracted from skin biopsy, showed, in addition 
to a normal transcript, a short in-frame mutant transcript with exon 87 skipping and 
other minor mutant transcripts. This may account for the mild phenotype. Five different 
COL7A1 mutations leading to exon 87 skipping have been previously reported in 
rare forms of DEB: four DDEB pruriginosa and one pretibial DDEB. Therefore, exon 
87 skipping in COL7A1 seems to cause phenotype of DDEB pruriginosa. However, 
the present case was clinically quite different from DDEB pruriginosa. Modifi ed 
genes and/or environmental factors might infl uence the phenotypic variations 
in DEB. Genetic counseling in such cases is fraught with diffi culty. We should be 
aware of the clinical diversity in DEB and offer appropriate genetic counseling.
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Localization of psoriasis candidate gene product CCHCR1 at centrosomes
Mari Tervaniemi1,5, Cilla Söderhäll2, Annika Siitonen1,5, Lena Samuelsson4, Sari 
Suomela3, Ulpu Saarialho-Kere3, Juha Kere2,5, Outi Elomaa1,5 1University of Helsinki, 
Helsinki, Finland, 2Karolinska Institutet, Stockholm, Sweden, 3Helsinki University 
Central Hospital, Helsinki, Finland, 4Sahlgrenska University Hospital, Gothenburg, 
Sweden, 5Folkhalsan, Helsinki, Finland
CCHCR1 (coiled-coil alpha-helical rod protein 1) is a plausible PSORS1 candidate 
gene whose role as a psoriasis effector gene is unsettled although it resides in the 
region of strongest associations even in GWA studies. CCHCR1 has different 
expression pattern in psoriatic vs. healthy skin and is suggested to have a role in cell 
proliferation. We have recently cloned a novel variant of CCHCR1 (isoform 1) in which 
the N-terminal domain is 89aa longer than in the previously studied form (isoform 3). 
The SNP (rs3130453) that controls formation of the alternative isoforms has now been 
genotyped using samples from 435 Finnish and Swedish psoriasis families. The allele 
for the variant 3 shows preferential transmission from heterozygous parents to affected 
offspring (p<10-5). Here we show by immunofl uorescent staining that both CCHCR1 
isoforms have a centrosomal localization. They co-localize with a centrosome marker 
g-tubulin but not with microtubule proteins α- and β-tubulin. However, the localization 
of CCHCR1 is partially dependent of microtubules indicated by Nocodazole 
treatment that disrupts the microtubules. After the treatment CCHCR1 can still be 
observed in association with centrosomes but also as granules in the cytoplasm. 
Stable over-expression of CCHCR1 in HEK293 cells results in nuclear aberrations. 
As the centrosomes have a role in organization of the microtubules, cell cycle and 
division, the novel localization of CCHCR1 provides a connection to the abnormal 
proliferation and offers a link to the cellular pathways that are altered in psoriasis.
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Identifi cation and characterization of regulatory networks contributing to psoriasis 
susceptibility
Kornélia Szabó1,2, Zsuzsanna Bata-Csörgo1,2, Attila Dallos1,2, Attila Dobozy1,2, László 
Francziszti1, Lajos Kemény1,2, Márta Széll1 1Dermatological Research Group of the 
Hungarian Academy of Sciences, Szeged, Hungary, 2Department of Dermatology and 
Allergology, University of Szeged, Albert Szent-Györgyi Medical and Pharmaceutical 
Center, Szeged, Hungary
The non-lesional skin of psoriatic patients possess some inherent characteristics that 
are already present in the otherwise healthy-looking skin, and make them prone to 
develop the typical psoriatic symptoms in response to various stimuli. Our major aim 
was to identify and characterize genes and proteins that are differentially expressed 
in uninvolved psoriatic and normal epidermis, and to discover regulatory networks 
that are responsible for these differences. To this end, a cDNA microarray experiment 
was performed where we compared the gene expression profi le of 4 healthy and 
4 psoriatic uninvolved epidermis samples upon T cell lymphokine induction in 
organotypic cultures. The cDNA microarray experiment identifi ed 57 annotated 
genes with known functions, and another 11 expressed transcripts with unknown 
functions that were differentially regulated in psoriatic uninvolved and healthy 
epidermis following T cell lymphokine induction. 11 of the annotated genes have 
already been implicated in the pathogenesis of psoriasis. Pathway analysis using 
various software packages and public databases suggests that many of the identifi ed 
genes play an important role in cellular processes; regulation of cell morphology, 
development and cell death, and also in the metabolism of small molecules and 
lipids. Our results can help to uncover basic mechanisms of this complex disease 
and lead to novel therapeutic approaches to prevent disease development.
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The role of the 8.1 ancestral haplotype in the pathogenesis of acne vulgaris
Gábor Tax1, Kornélia Szabó1,2, Dragos Theodorescu-Brinzeu3, Andrea Koreck1,4, Lajos 
Kemény1,2 1University of Szeged, Albert Szent-Györgyi Medical and Pharmaceutical 
Centre, Szeged, Hungary, 2Dermatological Research Group of the Hungarian 
Academy of Sciences, Szeged, Hungary, 3Department of Dermatology, Victor Babes 
University, Timisoara, Romania, 4Department of Immunology, Victor Babes University, 
Timisoara, Romania
Acne is a common infl ammatory disease of the pilosebaceous follicles. As genetic 
predisposition clearly plays a role in its pathogenesis, earlier we investigated the 
function of single nucleotide polymorphisms (SNP) of primary cytokine genes (IL1A, 
TNFA). Functional polymorphisms of both genes resulting altered mRNA and protein 
functions were identifi ed as genetic predisposing or protective factors. Among these 
the TNFA 308G>A SNP was found to be a predisposing factor, and showed interesting 
gender differences in our study population. In order to investigate if this association 
is truly depending on the function of the SNP itself, or a result of other closely 
linked polymorphisms on the short arm of chromosome 6, we decided to extend our 
studies, and analyze the role of the 8.1 ancestral haplotype (AH) in acne. For that the 
distribution of known marker polymorphisms of the 8.1 AH (TNFA -308G>A, LTA 
+252A>G, HSP70-2 +1267A>G and AGER -429 T>C) are currently being investigated 
in case-control studies using the DNA collection of 126 controls and 226 acne 
patients by PCR-based methods.Preliminary results suggest that the carrier frequency 
of the 8.1 AH tends to be higher in patients, suggesting a role of this haplotype in 
the genetic predisposition of acne vulgaris.Carriage of the 8.1 AH has been shown to 
cause immune system dysfunctions, affecting especially the early stages of cellular 
activation, altering the balance of various cytokines. These results could help us to 
understand the genetic and molecular nature of individual differences in acne vulgaris.
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Cockayne syndrome mutations in TFIIH impair RNA polymerase I transcription
Anton Lebedev, Robin Assfalg, Adrian Schelling, Karin Scharffetter-Kochanek, 
Sebastian Iben University of Ulm, Ulm, Germany
Cockayne syndrome (CS) is a devastating childhood disease with signs of premature 
aging  and early death. It can be caused by the recessive mutation in fi ve different 
genes. The gene products are involved in DNA repair and basal transcription 
mechanisms. To defi ne the critical function altered in the severe disease we are 
investigating the function of CS-genes in transcription of RNA polymerase I. 
Analysis of RNA polymerase I transcription in XPB/CS and XPD/CS cells reveal a severe 
reduction of ongoing transcription in vivo. Nuclear extracts from these cells show a 
distinct impairment of RNA polymerase I transcription in vitro that can be overcome by 
addition of affi nity-purifi ed TFIIH. “Immobilized-template” experiments demonstrate 
that TFIIH associates with the initiation complex of RNA polymerase I and leaves 
the promoter with the polymerase after start of transcription. Binding of TFIIH to the 
rDNA promoter is signifi cantly reduced in nuclear extracts of TFIIH/CS cells. Density-
gradient centrifugation analysis and co-immunoprecipitation experiments revealed 
that TFIIH associates with the enzyme after one round of transcription, indicating that 
the function of TFIIH in RNA polymerase I transcription differs from its role in RNA 
polymerase II transcription. Moreover, ChIP analysis revealed that TFIIH associates in 
addition to the rDNA promoter with gene-internal sequences of the rDNA, implying a 
role of TFIIH in transcription elongation of RNA polymerase I. TFIIH/CS cells have less 
ribosomes per cell, indicating that a possible reduction of the protein synthesis capacity 
of the cells could contribute to the premature aging of Cockayne syndrome patients.
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The fi rst COL7A1 locus specifi c online mutation database
Katarzyna Wertheim-Tysarowska1, Agnieszka Sobczynska-Tomaszewska1, Cezary 
Kowalewski2, Anna Kutkowska-Kazmierczak1, Katarzyna Wozniak2, Michal Skronski3, 
Jerzy Bal1 1Medical Genetics Department, Institute of Mother and Child, Warsaw, 
Poland, 2Department of Dermatology, Medical University of Warsaw, Warsaw, 
Poland, 3Laboratory of Molecular Diagnostics and Immunology, National Institute of 
Tuberculosis and Lung Dieseases, Warsaw, Poland
Dystrophic Epidermolysis Bullosa (DEB) is a genodermatose characterized by spontaneous 
or mechanically induced  bullous formation. The COL7A1 gene, which defects cause DEB, 
spans 32 kb and comprise 118 exons. There are about 520 published mutations in the gene, 
although the real number remains unknown due to lack of the possibility to exchange the 
data between specialists worldwide. In this abstract we present COL7A1 mutation database, 
which is the fi rst tool aimed at gathering, integrating and sharing the data concerning 
genotype and phenotype details. There about 700 locus specifi c mutation databases 
dedicated to other genes/diseases, which are extremely useful in molecular diagnostics 
and research. The database project is in agreement with HGVS guidelines. The system is 
free of charge. The data can be submitted by every logged in user after being revised by 
curator. Information deposed in db include among others:  mutation name (traditional 
and HGVS’s nomenclature), graphic view of mutations and SNPs (DNA, RNA and protein 
level), identifi cation method, pattern of inheritance, and clinical summary in accordance 
with the Third International Consensus Meeting on Diagnosis and Classifi cation of EB and 
statistic data.  Majority of information gathered in the system is based on “yes/no” answers 
thus searching and statistic tools are expanded. COL7A1 mutation database was designed 
in order to unify and simplify molecular diagnostics and to collect multicenter genotype-
phenotype data, which will, as we hope, serve in the future to fi nd correlation between them.
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New insight into genotype-phenotype correlation in recessive dystrophic 
epidermolysis bullosa with a range of COL7A1 missense mutations.
Satoru Shinkuma, Wataru Nishie, Ken Natsuga, Hideki Nakamura, Kei Ito, Hiroshi 
Shimizu Department of Dermatology, Hokkaido University Graduate School of 
Medicine, Sapporo, Japan
Most cases of recessive dystrophic epidermolysis bullosa (RDEB) are caused by 
compound heterozygous COL7A1 mutations, therefore it is usually diffi cult to assess 
the clinical phenotype and function of each mutant type VII collagen (COL7) derived 
from different mutations; particularly missense mutations which produce a range of 
aberrant COL7. To clarify this question, genotype-phenotype correlation was analyzed 
in 12 RDEB patients specifi cally having common COL7A1 mutations (c.5818delC or 
c.6573+1G>C) on one allele, which is known to lead to complete loss of COL7 
expression through a premature termination codon (PTC). On the other allele, the 
patients have a range of other COL7A1 mutations, including 5 missense mutations, 3 
nonsense mutations, 2 deletion mutations, and 2 splice-site mutations. In patients having 
nonsense, deletion or splice-site mutation with PTC (c.5818delC or c.6573+1G>C), 
COL7 expression level detected by immunofl uorescence was well-correlated with 
clinical severity. In contrast, there was no correlation between clinical severity and 
COL7 expression levels in patients having missense mutations with PTC (c.5818delC 
or c.6573+1G>C). COL7 immunostaining was slightly reduced (R2063W, G2316R, 
G1815R, G2623S or R1957Q), however, clinical severity was varied according to 
respective mutations, severe (R2063W or G2316R), moderate (G1815R or G2623S), 
and mild (R1957Q) RDEB phenotypes. These results can show the functionality of 
each mutant COL7 produced by a specifi c missense mutation in RDEB patients.
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Upregulation of HERV-H env gene in psoriasis vulgaris
Michal J. Kowalczyk, Beata Szramka-Pawlak, Ryszard Zaba, Wojciech Silny Poznan 
University of Medical Sciences, Poznan, Poland
The infl uence of Human Endogenous Retroviruses (HERVs) on autoimmune 
disorders is a widely discussed matter. The pathomechanism of psoriasis 
vulgaris is apparently related with those remnants of ancient viral infections.
Here we investigate changes in RNA levels of a HERV-H group member with 
an ORF coding for a 62 kDa potential translational product. The expression 
levels of this particular sequence seem to vary signifi cantly between different 
autoimmune disorders including both increasing and decreasing trends.
Total RNA was isolated from PBMCs of 26 patients suffering from psoriasis vulgaris and 
20 healthy volunteers, following reverse transcription to cDNA with the use of random 
hexamer primers. The transcription levels of HERV-H envelope gene (101bp, HERV ID: 
10816, 2q24.3) was assessed by means of Real-Time PCR and normalized to GAPDH. 
The data was interpreted basing on three types of analyses. Median, windsorised mean 
and the Two Independent Sample Wilcoxon-Mann-Whitney (U) test were calculated.
The Two-Sided P-Value of the Two Independent Sample Wilcoxon-Mann-
Whitney (U) test was 0.005, which supports the claim of the groups differing 
statistically. The windorised mean of cDNA copies was 6.70-fold higher for the 
investigated psoriatic patients than for the control group. Median value was 2.12-
fold higher for the psoriasis group, which is similar to our previously reported 
upregulation of the same sequence in pepmhigus vulgaris by the factor of 2.87.
The results indicate an apparent increase of the HERV-H envelope RNA 
level in psoriasis vulgaris. The reason for such variation of expression 
of this sequence in different autoimmune diseases remains unclear.
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Gene Mapping Study of Constitutive Skin Color in a Genetically Isolated Population
Seung Hwan Paik1, Hyun-Jin Kim2,4, Ho-Young Son3, Seungbok Lee2,4, Young Seok 
Ju3,4, Seong Jin Jo1, Jeong-Sun Seo2,4, Jong-Il Kim3,4, Kyu Han Kim1,5, Oh Sang Kwon1,5
1Departments of Dermatology, Seoul National University College of Medicine, 
Republic of Korea, 2Department of Biomedical Sciences, Seoul National University 
Graduate School, Republic of Korea, 3Department of Biochemistry and Molecular 
Biology, Seoul National University College of Medicine, Republic of Korea, 4Genomic 
Medicine Institute (GMI), Medical Research Center, Seoul National University, Seoul, 
Republic of Korea, 5Laboratory of Cutaneous Aging and Hair Research, Institute of 
Dermatological Science, Seoul National University, Republic of Korea
To elucidate the responsible genes governing constitutive skin color, we measured the extent of 
skin pigmentation in buttock, the sun-unexposed area for the life time, and conducted a gene 
mapping study on skin color in genetically isolated population composed of 344 individuals from 
59 families who live in Dashbalbar, Dornod Province, Mongolia. Through the linkage analysis 
of 1039 short tandem repeat (STR) microsatellite markers, we found novel genomic region 
regulating constitutive skin color on 11q24.2 with an LOD score of 3.39. Moreover, we found 
other fi ve candidate regions controlling intrinsic skin color. To test further association in regions 
of linkage, we selected chromosome 11, 17, and 6 (maximum LOD score > 2.5), and in each 
chromosome, high linkage peak regions (LOD score >1.5) were analyzed. On linkage region 
of chromosome 11, we identifi ed 19 signifi cant SNPs (p < 9.29 × 10-6). Further we found two 
(p =9.74 × 10-7) and one (p=2.00×10-6) signifi cant SNPs on linkage regions of chromosome 17 
and chromosome 6, respectively. In that the strongest locus of linkage on 11q24.2 harbors and 
signifi cant SNP is located adjacent to ST3GAL4, we suggest ST3GAL4 as  the novel candidate 
gene responsible for controlling constitutive skin color. Taken together with our linkage 
analysis and association study, other candidate genes are DRD2, MPZL3, BRIP1 and ZBTB17.
494
Immortalized keratinocytes from Epidermolytic Ichthyosis-patients reproduce the 
disease phenotype in vitro
Jean Christopher Chamcheu1, Marie Virtanen1, Aristidis Moustakas1, Harshad 
Navsaria2, Anders Vahlquist1, Hans Törmä1 1Uppsala University, Uppsala, Sweden, 
2Queen Mary‘s School of Medicine and Dentistry, London, United Kingdom
Epidermolytic Ichthyosis (EI) is a rare, autosomal, dominantly inherited skin fragility 
disease caused by mutations in keratin genes. The phenotypes of the disease are 
heterogeneous and characterized by frequent blistering, redness and scaling and 
hyperkeratosis of the stratum corneum (EI). While the etiology is known, model 
systems that display structural defects in EI are needed for studies of cellular effects of 
mutations and development of putative therapies. We established and characterized 
immortalized keratinocyte lines in serum-free medium from three EI-affected 
patients; EH11 (K1_p.Val176_Lys197del), EH21 (K10_p.156Arg>Gly), EH31 (K10_p.
Leu161_Asp162del). Keratinocytes were cultured in the presence of low or high Ca2+ 
content in the medium. Cells were either heat stressed, in the presence or absence 
of chemical chaperones. The cells were stained with an antibody recognizing K1 
and the presence of keratin aggregates were assessed by immunofl uorescence. 
Furthermore, organotypic epidermis established on cell culture inserts were also 
exposed to heat stress. Under normal culture conditions only cells from a severe 
EI-phenotype (EH31) showed keratin aggregates. Heat stress induced aggregates in 
all EI cell lines which were reduced by pre-treatment with chemical chaperones. 
Heat stress exposure of organotypic EI epidermis resulted in suprabasal cytolysis.The 
results indicate that in vitro cultured EI-keratinocytes can recapitulate some of the 
abnormalities observed in vivo and could help for the understanding of the molecular 
pathomechanisms of EI as well as gives new ideas about therapeutic options.
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Tumour microenvironment is implicated by dermal fi broblast expression profi ling in 
the development of aggressive squamous cell carcinoma in patients with recessive 
dystrophic epidermolysis bullosa
Y.Z. Ng1,2, C. Pourreyron1, J.C Salas-Alanis3, D.F. Murrell4, J.A. McGrath5, E.B. Lane2, 
I.M. Leigh1, A.P. South1 1Centre for Oncol & Molec Medicine, Univ of Dundee, UK, 
2Epithelial Biol Group, A*STAR Inst of Medical Biology, Singapore, 3Dermatology Dept, 
Univ Autonoma de Nuevo Leon, Monterrey, Mexico, 4St George Hospital, Sydney, 
Australia, 5Genetic Skin Disease Group, St John‘s Inst of Dermatology, London, UK
Patients with recessive dystrophic epidermolysis bullosa (RDEB) suffer from skin blistering caused 
by mutations in the gene encoding type VII collagen and are predisposed to develop squamous 
cell carcinoma (SCC) at an early age. The SCCs developed in these patients are aggressive - 
almost 80% of the patients will die from metastatic SCC within 5 years. As we have previously 
demonstrated very few genetic differences between RDEBSCC and non-RDEBSCC primary 
keratinocyte cultures, we proceeded to examine the contribution of the dermal fi broblast in the 
development of RDEBSCC. Global gene expression analysis was performed using the Agilent 
platform and the data collected analyzed in Genespring GX. Primary fi broblast cell cultures 
were grouped into normal-F (n=3), RDEB-F (derived from SCC-free RDEB patients n=4), SCC-F 
(derived from UV-induced SCC n=5) and RDEBSCC-F (n=4). Based on one-way ANOVA statistical 
testing, 1098 genes transcripts were signifi cantly differentially expressed among the four groups. 
Hierarchical clustering analysis separated all three disease states from normal-F, with RDEBSCC-F 
clustering furthest away. Interestingly, this analysis was unable to separate SCC-F and RDEB-F, 
suggesting that RDEB and SCC dermal fi broblasts share a similar genetic profi le in culture and 
that the RDEB dermal microenvironment may be conducive to tumourigenesis. Furthermore, 
identifi cation of RDEBSCC-F as being distinct from RDEB-F and the most dysregulated among 
the three disease states indicates that the transformation from RDEB to RDEBSCC fi broblasts 
may be crucial in accounting for the aggressive nature of SCC observed in RDEB patients.
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Effect of synthetic retinoids on keratin aggregate formation in immortalized cells 
from Epidermolytic Ichthyosis patients
Hao Li, Jean Christopher Chamcheu, Anders Vahlquist, Hans Törmä Uppsala 
University, Uppsala, Sweden
Epidermolytic Ichthyosis (EI) is an autosomal dominant skin fragility disorder caused by 
mutations in genes coding for keratin 1 and 10. Despite the knowledge of its etiology, 
pharmacological treatments are limited to synthetic retinoids and calcipotriol. We 
have evaluated the effect of retinoic acid receptor (RAR)-selective retinoids in an 
in-vitro model for EI in hope of fi nding new therapies. Three immortalized cell lines 
from EI patients; EH11 (K1_p.Val176_Lys197del), EH21 (K10_p.156Arg>Gly), EH31 
(K10_p.Leu161_Asp162del) with varying clinical severity (EH31>EH21>EH11), and 
NKc21 cells (wildtype) were used. The cells were grown as monolayer cultures, 
differentiated by exposure to PD153035 (an epidermal growth factor receptor 
inhibitor) and treated with 1µM of CD336 (RAR-α agonist), CD2314 (RAR-β agonist), 
CD437 (RAR-γ agonist) and CD367 (pan-RAR agonist), respectively. The cells were 
subjected to a short period of heat stress and stained with a K1 antibody and keratin 
aggregates were monitored by immunofl uorescence microscopy. Cytoplasmic keratin 
aggregates after heat shock was observed in all cell lines except NKc21. Without 
retinoid treatment 12% of EH31 cells exhibited keratin aggregates, which was reduced 
to 3-7% when pre-treated with retinoids. No retinoid were signifi cantly more potent 
than the other. Heat stressed EH21 and EH11 cells showed less aggregates than 
EH31 (6% respectively), and the effect of retinoid treatments was almost similar as 
in EH31 cells. In conclusion, isoform-selective RAR-agonists reduced the formation 
of keratin aggregates in heat-shocked immortalized EI cells.  This effect on keratin 
aggregation could in parts explain the benefi cial effects of retinoid therapy in vivo.
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Gene expression profi les are differently affected by pimecrolimus and betamethasone 
in lesional skin in atopic dermatitis
Andreas Scherer3,2, Matthias Bräutigam2, Thomas Schwarz1, Regina Fölster-Holst1, 
Ehrhardt Proksch1, Jens-Michael Jensen1 1Dept. of Dermatology, Venerology and 
Allergology, University Hostpitals of Schleswig-Holstein, University of Kiel, Germany, 
2Novartis Pharma GmbH, Nuremberg, Germany, 3Spheromics, Kontiolahti, Finland
Topical corticosteroids and calcineurin inhibitors are effective in the treatment of atopic 
dermatitis (AD) but differ in their side effects. A study in AD patients has demonstrated 
that the repair of a disrupted skin barrier is impaired by betamethasone valerate (BM) but 
not by pimecrolimus. The present study elucidates the mode of action of topical BM and 
pimecrolimus cream in AD. These two components were subject for gene expression profi le 
analysis in lesional AD skin after topical treatment. BM resulted in a signifi cant reduction of 
mRNA levels of genes encoding for markers for dendritic cells, T cells, cytokines, chemokines 
and serine proteases, whereas pimecrolimus exerted minor effects only. This corroborates 
the clinical fi nding that BM reduces infl ammation more effectively than pimecrolimus. 
Genes encoding molecules important for skin barrier function were differently affected; 
both BM and pimecrolimus normalized the expression of fi laggrin and loricrin. BM, but 
not pimecrolimus, signifi cantly reduced the expression of rate-limiting enzymes for lipid 
synthesis and the expression of involucrin and small proline-rich proteins, which covalently 
bind ceramides. This may be the reason for the observed lack of restoration of functional 
stratum corneum layers after BM treatment. The gene expression profi les are consistent with 
previous fi ndings that corticosteroids may exert a more potent anti-infl ammatory effect but 
may impair the restoration of the skin barrier. Hence, this study confi rms on a molecular 
level the concept that corticosteroids are a suitable treatment for acutely exacerbated 
AD, but that pimecrolimus is preferable for long-term treatment and stabilization.
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Comparative quantitation of proteome alterations induced by loss-of-function of 
kindlin-1 in Kindler syndrome
Adrian Sprenger1, Jörn Dengjel1, Cristina Has2, Leena Bruckner-Tuderman1,2 1Freiburg 
Institute for Advanced Studies, Freiburg, Germany, 2University of Freiburg, Germany
Kindler syndrome is an autosomal recessive genetic condition involving severe 
disruption of the dermal epidermal junction characterized by skin fragility, skin 
atrophy, photosensitivity, and carcinogenesis. It results from loss-of-function of 
kindlin-1, an epithelial-specifi c phosphoprotein. As an intrinsic component of the 
focal adhesion complex and an interactor of integrins, kindlin-1 specifi cally regulates 
cell attachment to the extracellular matrix and infl uences cell shape and migration 
by controlling lamellipodia formation via Rho-GTPase signaling. Uncharacterized 
phosphorylation sites of kindlin-1 indicate its involvement also in other signaling 
pathway. Here, we used a comparative proteomic approach to address molecular 
interactions of kindlin-1 and to uncover hitherto unknown functions. We utilized 
stable isotope labeling in cell culture (SILAC) to reveal quantitative proteomic 
differences of Kindler Syndrome cells, as compared to primary normal human 
keratinocytes (pNHKs). To study skin diseases on a proteomic level in relevant 
model systems we also evaluated proteome changes of freshly isolated cells during 
culture conditions, compared the proteome of the respective primary cells to a 
softly immortalized keratinocyte line and to HaCaT (Human adult low Calcium high 
Temperature) cells. We found minor proteomic alterations in pNHKs in culture and 
in softly immortalized NHKs indicating aging and increased proliferative capacity, 
respectively. HaCaT cells and Kindler Syndrome cells showed major proteomic 
alterations relating to the cytoskeleton, cell junctions and matrix adhesion.
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ARNT controls the expression of epidermal differentiation genes through EGFR- and 
HDAC-dependent pathways
Douglas Robertson, Lynda Weir, Irene Leigh, Andrey Panteleyev University of 
Dundee, Dundee, United Kingdom
Previously we have demonstrated a role for the aryl hydrocarbon receptor nuclear 
translocator (ARNT - a key factor in hypoxia and toxic responses) in regulating 
expression of differentiation-associated genes (EDC complex) and EGFR ligands 
in mouse epidermis in vivo. In order to examine the potential role of ARNT in 
epigenetic and EGFR-mediated control of differentiation in human keratinocytes, 
we used stable shRNA-mediated suppression and plasmid-mediated transient over-
expression of ARNT in N-TERT and HaCaT cells. Expressional studies of ARNT-
depleted keratinocytes show an upregulation of differentiation markers such as 
keratins 1 and 10, fi laggrin and loricrin (up to 70 fold mRNA). Furthermore, ARNT-
depleted keratinocytes show signifi cantly reduced proliferation compared to control 
cells. ARNT defi ciency also results in the downregulation of EGFR ligands such as 
TGFα, EGF and AREG and in consequent suppression of EGFR phosphorylation. 
ARNT-depleted cells also show an increase in total HDAC activity and in the 
protein levels of HDAC1 and HDAC3. Conversely, ARNT over-expressing cells are 
characterized by prominent depletion of HDAC3 level. Finally we demonstrate that 
the increased expression of differentiation markers mediated by ARNT defi ciency 
can be abolished by TSA and AG1478 (HDAC and EGFR inhibitors respectively). 
These results further support a signifi cant role for ARNT in the regulation of epidermal 
differentiation and demonstrate at least two different mechanisms implicated in this 
regulation - modulation of EGFR pathway and control of HDAC activity. Possible 
interactions between these two ARNT-dependent pathways require further investigation.
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Activation of wnt5a in epidermis triggers massive hypersensitivity to double-
stranded RNA 
Louise Reilly, Malgorzata Romanowska, John Foerster University of Dundee, UK
Previously, we have shown that Wnt5a is expressed in the basal layer of the 
epidermis, that it is highly upregulated in psoriasis and that, functionally, Wnt5a 
causes hypersensitivity to type I interferon in vitro. This suggests that Wnt5a 
contributes to the upregulation of interferon responsive signalling in psoriasis. We 
have now established a transgenic mouse model to study the role of Wnt5a in 
adult skin in vivo. To avoid the pre-natal lethality associated with Wnt5a knock-
out or overexpression, we developed a doxcycline inducible system, in which full 
length Wnt5a is controlled by a keratin 14 promoter. In the absence of doxycycline, 
transcription of the transgene is feedback-repressed by a KRAB repressor fused 
to a tet-transactivator protein encoded in a second cistron, resulting in tightly 
regulated transcription of the transgene. In transgenic, as well as in wild type mice, 
endogenous Wnt5a is constitutively expressed in hair follicles. However, only the 
additional induction of Wnt5a in the epidermis, enforced through doxycycline 
administration, causes a massive hypersensitivity toward the double-stranded RNA 
model compound polyIC, which triggers the release of endogenous interferon. This 
leads to rapid release of lethal concentrations of infl ammatory cytokines IL-6 and 
TNF-α. Thus, it appears that the upregulation of Wnt5a seen in psoriasis is suffi cient 
to trigger signifi cant upregulation of interferon signalling characteristic of the disease.
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SIRT1 counteracts STAT3 activity and STAT3-dependent gene expression induced by 
IL-22 in human keratinocytes
Rosanna Sestito1, Claudia Scarponi1, Stefania Madonna1, Andrea Cavani1, Giampiero 
Girolomoni2, Cristina Albanesi11IDI-IRCCS, Rome, Italy, 2University of Verona, Italy
IL-22 is a cytokine highly released by T helper 22 and 17 lymphocyte subsets having 
a pivotal pathogenetic role in psoriasis. In psoriatic skin, IL-22 is responsible for 
the altered proliferative and differentiative processes observed in the epidermis, 
and, induces antimicrobial peptides as well as chemokines. The majority of the IL-
22-induced effects are mediated by signal transducer and activator of transcription 
(STAT)3, whose activity is proportional to acetylation in lys685 residue, which is, 
in turn, indispensable for the phosphorylation in tyr705 residue. Lys685 acetylation 
of STAT3 depends on acetylation and deacetylation processes executed by p300 
acetylase and sirtuin (SIRT)1 deacetylase enzymes, respectively. Interestingly, 
SIRT1 has been described as important inducer of keratinocyte differentiation. 
The aim of this study was to investigate on the possible involvement of SIRT1 in 
regulating IL-22-induced effects on keratinocytes. We found that SIRT1 opposes 
STAT3 activation and, thus, the STAT3-dependent effects of IL-22 on proliferative, 
infl ammatory and differentiative processes in keratinocytes, by deacetylating STAT3 
and reducing STAT3 tyr705 phosphorylation. In addition, although SIRT1 levels 
are similar in both healthy and psoriatic cultured keratinocytes, they are reduced 
in psoriatic lesions, especially in areas close to the infl ammatory CD3+ infi ltrate. 
Of note,  IFN-γ inhibited SIRT1 expression and, concomitantly, enhanced STAT3 
lys685 acetylation, and rendered keratinocytes more responsive to IL-22 effects, 
in terms of induction of STAT3 tyr705 phosphorylation. These data suggest that in 
psoriasis the STAT3-dependent IL-22 signalling and effects on keratinocytes can be 
amplifi ed by IFN-γ through a direct inhibition of SIRT1 expression and function.
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MicroRNA-21 mediates the effects of the BMP signalling pathway in keratinocytes
Mohammed Ahmed1, Andrei Mardaryev1, Andrey Sharov2, Natalia Botchkareva1
1University of Bradford, Bradford, United Kingdom, 2Boston University, Boston, MA, 
United States
Bone morphogenetic proteins (BMPs) play essential roles during skin development, 
postnatal tissue remodelling and tumorigenesis. BMP signaling inhibits the initiation 
phase of the hair follicle development, as well as operates as tumour suppressor in 
adult skin. To explore whether some of these inhibitory effects of the BMP signalling 
are mediated by micro-RNAs, miRNAs were isolated from the primary mouse 
epidermal keratinocytes treated with BMP4 and processed for analysis of global 
miRNA expression using the microarray approach. Microarray and real-time PCR 
analysis revealed BMP4-dependent changes in the expression of distinct miRNAs 
including miR-21, which expression was strongly decreased in the keratinocytes after 
BMP4 treatment. However, miR-21 expression was substantially higher in the skin 
of transgenic mice over-expressing BMP antagonist Noggin under K14 promoter. 
By in situ hybridisation, miR-21 expression was observed in the epidermis and hair 
follicle epithelium in mouse anagen VI skin. In K14-Noggin skin, miR-21 expression 
was seen in the peripheral portion of the tumours containing low differentiated, 
proliferative cells. Transfection of the keratinocytes with miR-21 mimic revealed 
existence of two groups of the BMP target genes, which are differentially regulated 
by miR-21. Some of the BMP target genes (i.e., PTEN) were down-regulated by miR-
21, whilst the others of others (i.e., Msx2) were not affected by miR-21. Thus, our 
study establishes a novel mechanism involved in the realisation of the BMP effects 
in the skin and suggests micro-RNAs as important regulators modulating the effects 
of growth factor signalling pathways on skin development and tumorigenesis.
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The survival of DNA damaged cancer cells is ensured by mTOR-dependent 
phosphorylation of Sirtuin 1
Arianna Kim, Jung Ho Back, Yucui Zhu, Desiree Ratner, David Bickers Columbia 
University, New York, NY, United States
Premature senescence (PS) is an irreversible stress condition in which damaged cells are 
unable to proliferate.  PS induction in cancer cells by DNA-damaging chemotherapeutic 
drugs is potentially a novel approach for controlling tumor growth. However, because 
prematurely senescent cancer cells are viable and inherently less sensitive to DNA-
damaging drugs, a major drawback with this approach is that PS tumor cells can re-enter the 
cell cycle and ultimately lead to tumor recurrence. Here, we identifi ed a novel mechanism 
that regulates the survival of DNA damage-induced prematurely senescent squamous cell 
carcinoma (SCC) cells. Treatment of human SCC cells with a plant polyphenol resveratrol 
(RES) or anticancer agent such as anthracycline antibiotic doxorubicin (DOX) induces DNA 
damage-dependent PS induction. RES/DOX-induced PS involves the nuclear translocation of 
mTOR, followed by the mTOR-dependent inhibitory phosphorylation of SIRT1 at S47. This 
phosphorylation-dependent inhibition of SIRT1 deacetylase activity leads to the concomitant 
upregulation of an anti-apoptotic Bcl-2 family gene, Bfl -1/A1, via increased acetylation 
of p65/RelA NF-kB. SIRT1 S47 phosphorylation requires physical interaction between the 
mTOR complex and SIRT1. This novel SIRT1 phosphorylation occurs predominantly in 
human recurrent/metastatic SCCs, suggesting a role in tumor progression. RES/DOX-induced 
PS SCC cells eventually re-enter the cell cycle, and rapamycin-mediated mTOR inhibition 
can subsequently block the re-growth of PS SCC cells.  Rapamycin treatment sensitizes 
UVB-induced DOX-resistant SCCs for apoptosis in mice. Our data indicate that the mTOR 
inhibition of SIRT1 fosters the survival of DNA damage-induced PS SCC cells, and that 
targeting mTOR/SIRT1 signaling may be effective in treating apoptosis-resistant cancer cells.
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Deletion of SOCS3 in the epidermis causes impaired skin wound healing in vivo
Yuji Shirakata1, Lujun Yang1, Teruko Tsuda1, Mikiko Tohyama1, Saori Miyawaki1, 
Kenji Kameda1, Koji Sayama1, Akihiko Toshimura2, Koji Hashimoto1
1Ehime University Graduate School of Medicine, Toon City, Ehime, Japan, 2Keio 
University, Tokyo, Japan
STAT3 is a latent cytoplasmic protein that transduces signals to the nucleus upon 
stimulation with IL-6, EGF and many other growth factors. STAT3 plays critical roles 
in biological function such as cell proliferation, migration and so on. Suppressors of 
cytokine signaling (SOCS) regulate the strength of cytokine signals. SOCS3 is strongly 
induced by a variety of cytokines and other stimulators. The suppressive effect of 
SOCS3 has been shown to be relatively specifi c to STAT3. Therefore we investigated 
the role of SOCS3 in epidermal keratinocytes. Since germline targeting of the SOCS3 
gene resulted in embryonic lethality, we generated keratinocyte-specifi c SOCS3-
defi cient mice (KS-SOCS3-/-mice) using Cre/loxP technology in combination with 
the keratin 5 promoter. KS-SOCS3-/-mice were viable and their skin appeared normal 
at birth. Previously we have reported KS-SOCS3-/-mice develop psoriasis-like skin 
phenotype. In this study we investigated whether wound healing was affected in KS-
SOCS3-/-mice. A cutaneous wound was made on the backs of 20 week-old mice 
using a 6-mm punch biopsy and wound area was measured. Wound closure was 
markedly impaired in KS-SOCS3-/- mice compared to wild-type mice (25 and 55% 
on day 3, 64 and 86% on day 5, 82 and 92% on day 7 in KS-SOCS3-/- and wild-type 
mice, respectively). Histological analysis of skin lesions showed a hyperproliferative 
epidermis at leading edges and neutrophil infi ltration. These results demonstrate 
an imbalance of SOCS3-STAT3 pathway results in delayed wound healing.
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Insulin resistance of keratinocytes contributes to the manifestation of the psoriatic 
phenotype
Claudia Buerger, Beatrice Richter, Sandra Diehl, Katja Hardt, Bartosz Malisiewicz, 
Wolf-Henning Boehncke Johann Goethe University, Frankfurt, Germany
Besides insulin’s well known effects on classic metabolic tissues, such as liver, muscle, 
and adipose tissue, several reports suggest a role in non-metabolic tissues such as the 
skin. Psoriasis patients often display signs of systemic insulin resistance. Therefore 
we examined the role of insulin signaling in the skin and whether a disturbed insulin 
response contributes to the development of the psoriatic phenotype.Psoriatic patients 
show locally (dermal) and systemically elevated levels of infl ammatory cytokines such 
as IL-1b, which is known to confer insulin resistance in metabolically active tissues. 
Using HaCaT cells we found that IL-1b transiently activates the Akt/PKB cascade. 
This effect is not only mediated via PI3-K but also via p38 MAPK, IKK and JNK. 
On the other hand we could show that chronic IL-1b treatment can indeed induce 
insulin resistance in keratinocytes that is mediated via p38 MAPK. We also found 
that insulin induces expression of cytokeratin 10, a marker of terminal differentiation, 
suggesting that insulin drives differentiation of healthy keratinocytes. This effect 
is blunted under chronic Il-1b treatment, resembling the infl ammatory situation 
in psoriasis, where keratinocytes differentiation is abnormal and shifted towards 
hyperproliferation. Using immunohistology we found that in patients, components 
of the PI3-Kinase signaling pathway show hyperactivation compared to control skin.
We therefore assume that IL-1b interferes at the intersection between insulin 
dependent differentiation and proliferation and that this mechanism contributes 
to the development of the disease’s pathology. Thus, controlling correct 
insulin signaling in the skin might represent a novel anti-psoriatic strategy.
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Valrubicin activates PKCα and inhibits phosphorylation of p38 MAPK
Ina Groenkjaer Laugesen1, Karin Stenderup1, Stine Maria Andersen1, Elisabeth 
de Darkó3, Tomas Norman Dam2, Cecilia Rosada1 1Department of Dermatology, 
Aarhus University Hospital, Aarhus, Denmark, 2Department of Dermatology, Roskilde 
Hospital, Roskilde, Denmark, 3Valderm ApS, Lyngby, Denmark
Valrubicin, a second-generation anthracycline, was recently shown to have a benefi cial 
effect in animal models of psoriasis and skin cancer; disorders both characterised 
by hyper-proliferative keratinocytes and by increased infl ammation.The aim of the 
present study was to investigate the effect of valrubicin on two separate signalling 
pathways: PKCα and p38 MAPK, respectively a proliferation and an infl ammation 
pathway.  Signalling through protein kinase C (PKC) is suggested as valrubicin 
structurally resembles diacylglycerol, a natural PKC ligand; moreover PKCα is located 
in the suprabasal layers of the epidermis and is important for keratinocyte growth. 
Signaling through p38 MAPK is investigated as it plays a pivotal role in infl ammation.
The effect of valrubicin on activation of PKC was evaluated by its translocation 
from the cytosol to the plasma membrane and of p38 MAPK by its level of 
phosphorylation.  The study was carried out in HaCaT-cells and the effect of 
valrubicin visualized by western blotting. Valrubicin stimulation increased the 
levels of PKCα in the plasma membrane mirrored by a decrease in the cytosol 
indicative of translocation and thus activation of PKCα.  Activation peaked 
after two minutes and returned to basal level after two hours; the rapid response 
suggests a direct effect of valrubicin binding.  Additionally, valrubicin decreased 
the level of phosphorylated p38 MAPK indicative of decreased activation.
In conclusion, the observed increase in PKCα activation and decrease in p38 
MAPK activation may help explain valrubicin’s mode of action in reducing both 
proliferation and infl ammation observed when treating psoriasis and skin cancer.
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Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, 
which resembles psoriasis
Takuya Takeichi1, Kazumitsu Sugiura1, Yoshinao Muro1, Kenji Matsumoto2, Yasushi 
Ogawa1, Kyoko Futamura1,2, Yasushi Tomita1 1Nagoya University Graduate School 
of Medicine, Nagoya, Japan, 2National Research Institute for Child Health & 
Development, Tokyo, Japan
Lens epithelium-derived growth factor (LEDGF)/dense fi ne speckles 70 kDa protein 
(DFS70) is a transcription cofactor that enhances growth and is overexpressed in 
various cancers. In the epidermis, LEDGF/DFS70 localizes to the nucleus of 
keratinocytes (KCs) in the basal layers and to the cytoplasm of cells in the upper 
layers. However, the biological and pathological relevance of LEDGF/DFS70 in the 
epidermis is virtually unknown. Compared to a normal epidermis, we detected strong 
nuclear staining of LEDGF/DFS70 in the spinous layer as well as the basal layer of the 
epidermis of psoriatic skin. To investigate the roles of LEDGF/DFS70 in the epidermis 
of psoriatic skin, we generated HaCaT cells that constitutively express enhanced 
green fl uorescence protein (EGFP)-LEDGF (EGFP-LEDGF-HaCaT) or EGFP alone 
(EGFP-HaCaT) as a control. EGFP-LEDGF-HaCaT cells had increased expression 
of interleukin-6 (IL-6), which was attenuated by LEDGF-specifi c RNA interference 
and the p38-specifi c inhibitors SB-239063 and SB-203580. Furthermore, EGFP-
LEDGF-HaCaT cells had increased expression of S100A7 and S100A9 and decreased 
expression of fi laggrin. These fi ndings are compatible with the expression pattern in 
psoriatic tissues. Taken together, these results strongly suggest that ectopic expression 
of LEDGF/DFS70 in KCs could be involved in the pathology of psoriasis vulgaris.
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Interferon (IFN) γ inhibits tumor necrosis factor (TNF) α-induced cutaneous T cell 
attracting chemokine (CTACK)/ C chemokine ligand (CCL) 27 production from 
keratinocytes through signal transducers and activators of transcription (STAT) 1 
and STAT3 signaling pathways
Masaru Karakawa1,2, Mayumi Komine1,2, Yasushi Hanakawa3, Koji Hashimoto3, 
Shinichi Sato2, Kunihiko Tamaki2, Mamitaro Ohtsuki1 1Jichi Medical University, 
Shimotsuke, Tochigi, Japan, 2University of Tokyo, Japan, 3Ehime University, Touon, 
Ehime, Japan
CTACK is one of the chemokines indispensable in skin infl ammation. Its expression is exclusively 
limited in epidermal keratinocytes, which characterizes the skin infl ammation. TNFα is an 
infl ammatory cytokine playing important roles in varieties of infl ammatory diseases including 
psoriasis and atopic dermatitis, and is reported to induce CTACK production. IFNγ is also a major 
inducer of infl ammation, and known to synergistically enhance the TNFα-induced production of 
various chemokines. In this study, we investigated the effect of IFNγ on TNFα-induced production 
of CTACK from keratinocytes and its signaling pathway using the cultured HaCaT keratinocytes and 
normal human keratinocytes (NHKs) in vitro. We stimulated keratinocytes by TNFα with or without 
IFNγ. TNFα induced, but IFNγ suppressed CTACK production at mRNA and protein levels. TNFα 
induced CTACK production through nuclear factor κ B (NFκB) as previously reported, but IFNγ did 
not inhibit NFκB activity. We investigated the effect of STAT1 or STAT3 by utilizing adenovirus vector 
of dominant negative or wild type STAT1 and 3. Introduction of dominant negative STAT1 partially 
reversed the inhibitory effect of IFNγ. IFNγ activated STAT3 in keratinocytes and transfection of wild 
type STAT3 inhibited TNFα-induced CTACK production. Inhibitor of Janus kinases (JAKs) reversed 
the suppression of CTACK by IFNγ, but dominant negative vector of suppressor of cytokine signalings 
(SOCSs) did not. From these results, we concluded that IFNγ suppressed CTACK production 
though activation of STAT1 and STAT3, a novel fi nding of the effect of IFNγ on keratinocytes.
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A pathological role for the IL-21 - STAT3 axis in Sézary Syndrome
Leslie van der Fits1, Coby Out1, Marieke van Leeuwen2, Fiona Smit1, Janneke Samsom2, 
Rein Willemze1, Kees Tensen1, Maarten Vermeer1 1LUMC, Leiden, Netherlands, 
2Erasmus MC, Rotterdam, Netherlands
Sézary Syndrome (SS) is a rare cutaneous T cell lymphoma with malignant CD4+ 
T cells (SS cells) present in skin, lymph nodes and blood. We previously showed 
that STAT3 is constitutively activated in SS cells, and that STAT3 inhibition results 
in apoptosis. Upon in vitro culturing of SS cells, STAT3 phosphorylation is lost, 
indicating that the activation observed in vivo is the result of STAT3 activating factors 
present in the micro-milieu of the malignant cells. The aim of current study is to assess 
which factors are involved in STAT3 activation in Sézary Syndrome, and to analyze 
its downstream effects.Stimulation of SS cells with cytokines of the common-gamma 
chain family showed that STAT3 is strongly activated by IL-21, whereas IL-2, IL-7 
and IL-15 mainly activate STAT5. SS cells freshly isolated from peripheral blood from 
SS patients displayed increased mRNA expression of IL-21 and its receptor, when 
compared to CD4+ cells from healthy controls and patients with benign erythroderma. 
In addition, IL-21-expressing neoplastic cells were detected in skin biopsies from SS 
patients. Stimulation of SS cells by IL-21 resulted in a STAT3 dependent increase 
in expression of the alpha subunit of the IL-2 receptor. Consequently, SS cells pre-
incubated with IL-21 appeared more sensitive to stimulation with IL-2. Thus, our 
results suggest that autocrine activation of SS cells by IL-21 is involved in the 
maintenance of constitutive STAT3 activation. In addition, SS cells are sensitized to 
the T cell proliferation and activating cytokine IL-2 via the IL-21 - STAT3 pathway.
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Basic fi broblast growth factor impairs PPAR-gamma ligand-induced adipogenesis in 
rat nestin-positive cutaneous stem cells
Nicholas Boulais, Nicolas Lebonvallet, Christelle Le Gall-Ianotto, Jeremy Cheret, 
Laurent Misery University Of Brest, Laboratory Of Skin Neurobiology, Brest, France
Neurosphere-forming nestin-positive skin progenitors (SKP) are easily reachable 
pluripotential stem cells with a promising potential in regenerative medicine, but a better 
understanding of the determination processes is required fi rst. In order to know how 
SKP commit into mesenchymal or neural lineage, we exposed rat SKP to a Peroxisome 
Proliferator-Activated Receptor gamma (PPAR-γ) agonist and/or basic fi broblast growth 
factor (bFGF). PPAR-γ is a major regulator of adipogenesis in Mesenchymal Stem 
Cells (MSCs) but it enhances neural differentiation in embryonic midbrain Neural 
Stem Cells (NSCs). Conversely, bFGF alone inhibits mesodermal differentiation in 
NSCs while it is known to cooperate with PPAR-γ to induce adipogenesis in MSCs.
SKP isolated from rat vibrissae were amplifi ed for a month as described in the 
literature. For differentiation, cells were exposed to bFGF and/or rosiglitazone (RGZ). 
After 15 days, almost all cells exposed to RGZ were adipocyte-like cells and only a 
few were neural-like cells. Compared with bFGF alone, 3.3% (+/- 4.3) of the cell were 
neurofi lament-positive and only few adipocytes were detected (< 1%). Surprisingly, 
with both bFGF and RGZ, adipogenesis was sharply inhibited since only one third 
of the cells presented lipid-droplets, while 6.5% (+/- 4.3) of the cells produced 
neurofi laments, similar to what observed with bFGF alone (Student t test, P-value=0.08).
To conclude, these data demonstrate that PPAR-γ is a potent inducer of adipogenesis 
in SKP but this PPAR-γ pathway is inhibited by bFGF. This result contrasts with the data 
obtained in MSC and suggests that these two pathways interact differentially in SKP.
ABSTRACTS
 S86 Journal of Investigative Dermatology (2010), Volume 130 
511
Divergent effect of EGFR- inhibitors on the expression of two functional distinct 
chemokines in keratinocytes
Anna Cecilie Lefèvre1, Claus Johansen1, Karen- Lise Garm Spindler2, Mette Deleuran1, 
Christian Vestergaard1 1Dept of Dermatology, Department of DAarhus University 
Hospital, Denmark, 2Department of Oncology, Vejle Municipal Hospital, Denmark
Treatment with Epidermal Growth Factor Receptor Inhibitors (EGFRI) in various 
cancer types does not have the severe systemic side effects usually seen with 
cytotoxic drugs. Unfortunately, treatment is often associated with severe cutaneous 
side effects, such as a papulo-pustular rash, dry skin and hair abnormalities, resulting 
in profound impact on the quality of life for the patients.Using ELISA and PCR, 
we investigated the chemokine- profi le of keratinocytes stimulated with EGFR-I 
(Panitumumab and Cetuximab), EGF (Epidermal Growth Factor), and TNFa with 
regard to CCL27 (CTACK), that primarily attracts skin prone T cells, and CXCL8 
(IL-8) which receptor is readily expressed by T cells and neutrophils.  Data are 
expressed as mean ± (SD).Cultured human keratinocytes treated with EGFR-I, in 
combination with TNFa, resulted in a 4.3 fold increase (Panitumumab), and a 6.8 
times increase (Cetuximab) in CTACK mRNA level, compared with TNFa alone. In 
contrast the IL-8 expression was regulated down 7.5 fold (Panitumumab) and 6.6 fold 
(Cetuximab). Similarly, protein synthesis of CTACK increased to 353.4 ±(95.6) pg/
ml for Panitumumab, and 236.7 ±(11.2) pg/ml for Cetuximab, compared with 104.1 
±(41.2) pg/ml in un-stimulated cells.Our data shows, that keratinocytes stimulated 
with EGFRI, induces a chemokine profi le with high CTACK, thus making it possible 
for skin prone T cells to home to the skin. We also show that this is not an unspecifi c 
effect, because CXCL8 is decreased. We believe this could play an important role 
in our understanding of EGFRI´s ability to induce side effects primarily in the skin.
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Up-regulation of Jagged 1 (Notch Ligand) and Hes 1 (Notch Response Gene) 
correlates with Calcium-induced Differentiation in HaCaT Keratinocytes
Mohamed Al-Shuaili, Tammy Easter, Paul Bowden Cardiff University, Cardiff, UK
While, Notch-Delta-Jagged signalling plays a key role in cell fate determination 
and growth control during embryonic development, the role in adult tissues is not 
so clear. We studied expression (both protein and mRNA) of two receptors (Notch 
1 [N1] and Notch 3 [N3]), three ligands (Jagged 1 [J1], Jagged 2 [J2] and Delta 1 
[DLL1]) and four response genes (Hes-1, Hes-5, Hey-2 and HeyL) during calcium-
induced differentiation of HaCaT keratinocytes. Terminal differentiation was defi ned 
using keratin expression (K1, K5, K10, K14) and Ki67 to indicate proliferation. HaCaT 
keratinocytes were grown in low calcium (0.06 mM) medium and shifted to high 
calcium (1.8 mM) when 70-80% confl uent and cultured for another 3, 6 or 10 days. 
Protein expression was determined by immunofl uorescence or immunoperoxidase 
microscopy, SDS-PAGE and western blotting using antibodies to K10, K14, Ki-67, 
N1, N3, J1, J2, DLL1 or Hes-1. Expression levels were estimated by Q-RT-PCR. As 
HaCaT cells proliferated, K14 mRNA levels increased but in high calcium medium, 
K14 levels reduced and K10 levels rose 10x by day 6 (p<0.01). N3 levels increased 
4x by day 3 (p>0.05), J1 levels increased 5x by day 6 (p<0.05) and Hes-1 expression 
increased 12x by day 3 (p>0.001). Housekeeping gene (human ARP) levels did not 
signifi cantly change. We conclude that notch signalling via N3, J1 and Hes-1 may be 
involved in the switch from a basal cell phenotype to a cell committed to terminal 
differentiation. Knock-down experiments are now in progress to test this hypothesis.
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Stress-induced PRINS gene expression in normal human cultured keratinocytes and 
HaCaT cells
Sarolta Bacsa, Lilla Bari, Enikö Sonkoly, Zsuzsanna Bata-Csörgö, Attila Dobozy, Lajos 
Kemény, Márta Széll Department of Dermatology and Allergology, University of 
Szeged, Szeged, Csongrad, Hungary
Psoriasis is a chronic infl ammatory skin disease affecting approximately 2-4% of 
the population. Recently we described a novel non-coding RNA, PRINS (psoriasis 
susceptibility related RNA gene induced by stress), that was overexpressed in 
psoriatic uninvolved epidermis, and its expression was induced by various stress 
factors in HaCaT keratinocytes. In our recent study, we further investigated the role 
of PRINS in cellular stress response in HaCaT keratinocytes and primary cultured 
keratinocytes. We found that PRINS expression was increased in HaCaT cells but 
not in normal cultured keratinocytes when cells were exposed to cycloheximide 
and lipopolysaccharide (LPS). To determine whether altered nuclear factor-κB 
(NF-κB) signaling in HaCaT cells was responsible for the observed differences, 
we silenced PRINS expression by siRNA in HaCaT cells and normal cultured 
keratinocytes transfected with an NF-κB responsive element containing luciferase 
reporter construct. In the transfected cells, we monitored NF-κB signal transduction 
after LPS treatment. Silencing of PRINS had no effect on LPS-induced NF-κB activity 
either in HaCaT cells or in primary keratinocytes. This indicates that PRINS may 
signal independently of NF-κB. Other yet undiscovered cellular processes may lie 
behind the differences in LPS induced PRINS expression between the two cell types.
514
IL-17C is Regulated by a p38 MAPK and NF-κB Dependent Mechanism in Cultured 
Human Keratinocytes
Claus Johansen, Hanne Vinter, Anne Gedebjerg, Knud Kragballe, Lars Iversen Aarhus 
University Hospital, Aarhus, Denmark
We have previously demonstrated that the expression of IL-17C is increased in lesional 
compared with nonlesional psoriatic skin. However, the precise role of IL-17C in 
psoriasis remains to be investigated. Thus, the purpose of this study was to identify 
and characterize the mechanisms regulating the expression of IL-17C. By quantitative 
PCR (qPCR) we found that the increased expression of IL-17C in lesional psoriatic 
skin was signifi cantly reduced already 4 days after start of adalimumab treatment, i.e. 
before clinical and histological improvement was detectable. Immunohistochemical 
analysis conducted on paraffi n-embedded psoriatic skin biopsies demonstrated IL-
17C to be localized primarily in the epidermis. In addition, IL-17C was found to 
be produced by cultured human keratinocytes after stimulation with TNFα, and this 
production was mediated by a NF-κB and p38 MAPK dependent mechanism as 
determined by both qPCR and ELISA. Moreover, we identifi ed four NF-κB binding 
sites in the promoter region of IL-17C and by electrophoretic mobility shift assay we 
demonstrated an increased DNA binding activity to these sites in cultured human 
keratinocytes after stimulation with TNFα. Finally, preincubation of cultured human 
keratinocytes with decoy oligonucleotides containing the identifi ed NF-κB binding 
sites signifi cantly reduced the TNFα-induced IL-17C expression. We conclude that 
IL-17C is one of the early gene targets of adalimumab treatment and that IL-17C is 
produced by human keratinocytes by a p38 MAPK and NF-κB dependent mechanism.
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Investigation of pathogenic roles of karyopherin alpha2 in keratinocyte proliferative 
disorders
Noriko Umegaki1, Katsuto Tamai2, Keisuke Nimura2, Satoshi Serada3, Tetsuji Naka3, 
Takehiko Yamazaki2, Hajime Nakano4, Yasufumi Kaneda2, Ichiro Katayama1 1Osaka 
Univ Grad School of Medicine, Suita, Japan, 2Div of Gene Therapy Science, Suita, 
Osaka, Japan, 3National Inst of Biomedical Innovation Lab for Immune Signal, Ibaraki, 
Osaka, Japan, 4Dept of Dermatology, Hirosaki Univ School of Med, Aomori, Japan
Despite a number of studies on signal transduction in keratinocyte proliferation and differentiation, 
very little is known about precise molecular mechanism how those signals selectively move from 
the cytosole to the nucleus. we reported that karyopherin alpha 2 (KPNA2) plays important roles 
for the regulation of keratinocyte differentiation. Recently, KPNA2 has been reported to be over 
expressed in the tumor cells including breast carcinoma and malignant melanoma, although the 
roles of the elevated KPNA2 is still unclear. Here, we investigated the roles and mechanism 
of KPNA2 in the cutaneous proliferative diseases. Immunohistochemical anlaysis showed that 
KPNA2 is over expressed in basal layer keratinocytes of psoriatic skin, and in both basal and 
suprabasal keratinocytes of epidermal tumors such as Bowen‘s disease and squamous cell 
carcinoma (SCC). These observations evoked us a hypothesis that a loss of suppressive regulation 
in KPNA2 expression may lead the abnormal keratinocyte proliferation. To explore the molecular 
mechanism underlying KPNA2-dependent proliferative regulation of keratinocytes, KPNA2-binding 
proteins in HaCaT keratinocytes were purifi ed by tandem affi nity purifi cation (TAP) method. 
Obtained KPNA2-binding protein library was analyzed by LC mass spectrometry. We explored 
that some unique transcriptional factors, several chromatin structural and regulatory proteins were 
shown to be transferred into the nucleus by KPNA2, that may contribute to the DNA replication 
or mitosis.  Although further precise studies are necessary to conclude, these data suggest that 
over-driven activity of KPNA2 in keratinocytes may induce both transcriptional dysregulation, 
resulting in hyper proliferative conditions in the cutaneous diseases such as psoriasis and SCC.
516
D type cyclins and Ki67 regulate each other and mitosis in HaCaT keratinocytes
Nóra Belsö1, Attila Bebes1, Bernadett Kormos1, Márta Széll2, Lajos Kemény1,2, 
Zsuzsanna Bata-Csörgö1,2 1Department of Dermatology and Allergology, Faculty of 
Medicine, University of Szeged, Hungary, 2Dermatological Research Group of the 
Hungarian Academy of Sciences, University of Szeged, Hungary
Results of our previous expression studies indicated that D type cyclins have 
differential functions in keratinocyte cell cycle regulation. In order to further examine 
the regulatory functions of D type cyclins in keratinocytes we silenced D1, D2 and 
D3 cyclins individually and together in HaCaT keratinocytes. The lack of one D type 
cyclin function had no effect on the cell cycle, but double and triple D type cyclin 
silencing resulted in G2/M arrest and the formation of multinucleated HaCaT cells. 
To elucidate the gene expression changes due to D type cyclin double and triple 
silencing, a real-time RT-PCR- based array method was applied. The results of this 
experiment showed a signifi cant decrease in Ki67 mRNA expression, indicating a 
regulatory connection between D type cyclins and Ki67 in these cells. Silencing 
of Ki67 resulted in the appearance of multinucleated aberrant cells and a relevant 
decrease in the mRNA expressions of all D type cyclins. These data indicate that 
beside their well known function during the G0-G1/S phase, D type cyclins also 
regulate mitosis. This regulatory function of D type cyclins during mitosis may take 
place via infl uencing Ki67 expression. Although widely used as a proliferation marker, 
not much is known about Ki67 function. The formation of multinucleated cells in 
Ki67 silenced HaCaT keratinocytes indicates that Ki67 has a cell cycle regulatory 
function in mitosis. Furthermore our data suggest the existence of a regulatory cycle 
between D type cyclins and Ki67 and it is a key in mitosis regulation in keratinocytes.
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Effective AP1 dependant repression of TGFα mediated MMP9 upregulation by PPAR 
δ agonists in keratinocytes
Markus Meissner, Barbara Berlinski, Jens Gille, Roland Kaufmann University of 
Frankfurt, Dept. of Dermatology, Frankfurt, Germany 
PPAR agonists have been shown to control infl ammatory processes by inhibition of 
distinct proinfl ammatory genes. Several studies demonstrate that aberrant activation of the 
epidermal growth factor (EGF) and/or overexpression of its ligand transforming growth factor 
(TGF)-α are key features of both neoplastic and infl ammatory hyperproliferative epithelia. 
Matrix metalloproteinase 9 (MMP9) belongs to the set of genes that are effectively induced 
by TGFα in keratinocytes. Induced MMP 9 expression has been linked to regenerative 
skin repair mechanisms and infl ammatory skin diseases. We therefore explored whether 
the known anti-infl ammatory effects of different PPARd-ligands are mediated in part 
through inhibition of TGFα-mediated MMP9 upregulation. PPARδ agonists are found to 
potently inhibit TGFα-induced MMP9 expression by HaCaT keratinocytes, This inhibition 
is demonstrated both at the level of protein and mRNA MMP9 expression. Zymographic 
assays of culture supernatants show that PPARδ ligands inhibit the catalytic activity of 
MMP9. As PPAR ligands do not interfere with expression and phosphorylation of the 
EGF receptor, we hypothesized that the inhibitory effects PPARδ agonists are mediated by 
suppressing the transcriptional activity of the MMP9 promoter. Transcriptional activation 
studies reveal that PPARd agonists mediate their inhibitory effects via an AP1 binding site. 
EMSA analysis demonstrated TGFa induced c-fos homodimer complex formation to this 
sequence is decreased by PPARd agonist treatment, indicating that MMP9 gene expression 
is inhibited by repressing c-fos site-dependent DNA binding and transactivation. Our data 
provide fi rst evidence that TGFα-induced keratinocyte MMP9 expression is a valid target of 
PPARδ ligands, involving distinct mechanisms of AP1 dependant transcriptional repression.
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A Novel DNA Damage Pathway Responsible for Reduced Ribosomal Protein S6 
Specifi c Translational Control Accelerates Aging in Connective Tissue Specifi c 
Manganese Superoxide Dismutase Defi cient Mice
Karmveer Singh1, Pallab Maity1, Nicolai Treiber1, Matthias Kohn1, Anca Sindrilaru1, 
Thorsten Peters1, Lea Sante1, Wilhelm Bloch2, Meinhard Wlaschek1, Karin Scharffetter-
Kochanek1 1Univ of Ulm, Germany, 2German Sports University, Cologne, Germany
Previously, the hypothesis was forwarded that DNA damage inhibits IGF-1 growth axis with 
substantial reallocation of energy from growth to DNA repair eventually leading to organ atrophy 
and aging. Here we have used connective tissue specifi c manganese superoxide dismutase 
defi cient mice, which closely recapitulate intrinsic aging including skin atrophy, osteoporosis, 
kyphosis, and reduced lifespan to understand the underlying mechanism of DNA damage 
response pathway. The mutant fi broblasts evidenced a decrease in intramitochondrial H2O2, 
with an increase in O2
.-. Western blotting and immunohistochemistry suggested higher oxidized 
and nitrosylated proteins and increase DNA double strand breaks in mutants. In fact, reduced 
serum IGF-1 concentration and impaired IGF-1 signalling were found with reduced levels of 
phosphorylated (activated) AKT/PKB (Ser473) and p70S6 Kinase in the mutant mice. Notably, 
the ribosomal S6 protein, a downstream target of the p70S6 kinase which specifi cally controls 
the translation of mRNA transcripts containing an oligopyrimidine tract in their 5´untranslated 
region (5´TOP), was less phosphorylated (activated) in mutant skin. 5´TOP genes, like Cyclin 
D1, responsible for cell cycle progression and the major structural protein, collagen type-I, 
were signifi cantly reduced on protein but not on mRNA level in mutant skin, while the cell 
cycle inhibitor p16 was highly induced. Collectively, these data for the fi rst time show that pro-
oxidant damage to the fi broblasts via double damage and attenuated IGF-1 signalling results 
in reduced translation of specifi c proteins responsible for the observed aging phenotype. These 
data unequivocally opens new avenues for the prevention and treatment of age-related diseases.
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KGF and KGFR expression and its changes induced by slight injury differ in normal 
appearing (uninvolved) skin of psoriatic patients compared to healthy skin
Szabolcs Hambalkó1, Attila Bebes1, Nóra Belsö1, Lajos Kemény1,2, Márta Széll2, 
Zsuzsanna Bata-Csörgö1,2 1Department of Dermatology and Allergology, Faculty of 
Medicine, University of Szeged, Hungary, 22Dermatological Research Group of the 
Hungarian Academy of Sciences, University of Szeged, Hungary
Beside immune dysregulation, data suggest that abnormal skin homeostasis maybe 
crucial in psoriasis development; in fact it may drive the immune response. In the 
past few years we focused on investigating the uninvolved psoriatic skin in order 
to uncover differences between the psoriatic and the healthy skin. We applied 
tape stripping on non-lesional skin of psoriatic patients and on normal skin of 
healthy subjects and looked at changes in the epidermis and the dermis. Last 
year we reported that we found a striking difference in epidermal alpha5 integrin 
expression between psoriatic and healthy people, here we report that both KGF and 
its receptor KGFR is expressed differentially in healthy and psoriatic uninvolved 
skin, even before injury occur. KGF was expressed in the dermis and all layers of 
the epidermis in both normal and psoriatic uninvolved skin; staining intensity was 
much stronger in psoriatic tissue compared to normal. Twenty-four and 48 hours 
after tape stripping KGF expression slightly increased in healthy skin and no change 
was noted in the psoriatic uninvolved tissue. Six hours after tape stripping KGF 
mRNA increased 10 fold in normal dermis and only 5 fold in psoriatic. In healthy 
skin KGFR was expressed only in the basal, immediate suprabasal keratinocytes, 
but in the psoriatic uninvolved skin KGFR expression was detected in all layers 
of keratinocytes. Injury enhanced the expression intensity, but did not change 
the localization of KGFR expression in both normal and psoriatic epidermis. 
These data provide additional evidence of altered skin homeostasis in psoriasis.
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Nickel differentially regulates NFAT and NFκB activation in T cell signaling
Rumiko Saito1, Satoshi Hirakawa1,2, Kenshi Yamasaki1, Setsuya Aiba1 1Tohoku 
University Graduate School of Medicine, Sendai, Japan, 2POLA Chemical Industries, 
Inc., Yokohama, Japan
Nickel is a potent hapten inducing contact hypersensitivity in human skin. While 
nickel induces the maturation of dendritic cells via NFκB and p38 MAPK activation, 
nickel also has immunosuppressant effects on T cells with unknown mechanism. To 
elucidate molecular mechanisms of its effects on T cells, we examined the effects 
of NiCl2 on mRNA expression in human CD3+ T cells activated with anti-CD3 and 
anti-CD28 antibodies. Using DNA microarray and Gene Ontology, we identifi ed 70 
up-regulated and 61 down-regulated immune responsive genes by NiCl2. The former 
contained IL-1β, IL-6, and IL-8, while the latter did IL-2, IL-4, IL-10, and IFN-γ. Real-time 
PCR and BioPlexTM suspension protein array followed DNA array results. Suppression 
of IL-2 and IFN-γ genes transcription by NiCl2 was also confi rmed using Jurkat T cells 
transfected with IL-2 or IFN-γ luciferase reporter genes. To explorer NiCl2 regulating 
signaling pathway, we examined the binding activity of the nuclear protein to NFAT, 
AP-1, and NFκB consensus sequences. NiCl2 signifi cantly and dose-dependently 
suppressed NFAT and AP-1, but augmented NFκB, binding activity. Moreover, 
NiCl2 decreased nuclear NFAT expression in stimulated T cells. Using Jurkat T cells 
stimulated with PMA/ionomycin, we demonstrated NiCl2 signifi cantly suppressed 
stimulation-evoked cytosolic Ca2+ increase, suggesting NiCl2 regulates NFAT signals 
by acting as a blocker of Ca2+ release-activated Ca2+ (CRAC) infl ux in T cells. These 
data showed that NiCl2 decreases NFAT and increases NFκB signaling in T cells. These 
results would shed light on nickel effects of the molecular regulation in T cell signaling.
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Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and 
induces keratinocytes proliferation
Olivia Isard1,2, Anne-Chantal Knol1,2, Marie-Françoise Aries4, Jean-Michel Nguyen3, 
Amir Khammari1,2, Nathalie Castex-Rizzi4, Brigitte Dreno1,2 1Inserm U892, Nantes, 
France, 2Unit Of Dermato Cancerology – Cic Biothérapies U0503, Nantes University 
Hospital, Nantes, France, 3Seb-Pimesp Saint Jacques Hospital Nantes University 
Hospital, Nantes, France, 4Pierre Fabre Dermo-Cosmétique, Cell Pharmacology, 
Toulouse, France
Propionibacterium acnes plays a major role in the development of infl ammatory acne. IGF-1 had 
been reported to stimulate the keratinocytes proliferation via an activation of IGF-1R and could 
play a central role in the potential link between diet and acne. Our fi rst objective was to study the 
modulation of epidermal IGF-1 and IGF-1R expression by P.acnes extracts, and the second one 
was to determine their modulation with zinc gluconate which has proven both effi ciency against 
infl ammatory acne lesions and modulation of the IGF-1 system. In vivo, we analysed biopsies 
of acne lesions and healthy skin, and in vitro we used human skin explants incubated with two 
P.acnes extracts (membrane fraction (MF) and cytosolic proteins (CP)) with or without zinc. The 
expression of IGF-1 and IGF-1R in keratinocytes was evaluated using immunohistochemistry, and 
the production of IGF-1 in culture medium was measured by ELISA. In vivo, we observed that 
both IGF-1 and IGF-1R were overexpressed in acne lesions compared to healthy skin. In vitro, MF 
both increased IGF-1 and IGF-1R expression by skin explants keratinocytes and this modulation 
was associated with an overexpression of both Ki-67 and fi laggrin. Zinc downregulated IGF-1 
and IGF-1R levels. These results demonstrate for the fi rst time that P.acnes can play a role in the 
formation of comedo via the modulation of the IGF-1/IGF-1R pathway in addition of the diet.
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Co-operation of Zinc Binding Protein 89 and Mitogen-activated Protein Kinase 
Pathways in the Enhancement of Matrix Metalloproteinase-1 and -3 Expression in 
Dermal Fibroblasts
Niina Hieta1, Risto Ala-aho1, Juanita Merchant2, Veli-Matti Kähäri1 1University of 
Turku, Turku, Finland, 2University of Michigan, Michigan, United States
Matrix metalloproteinases (MMPs) control connective tissue remodeling in physiologic 
situations including tissue repair and angiogenesis, but also in pathological situations 
like tumor invasion and metastasis.  Zinc binding protein 89 (ZBP-89) is a widely 
expressed transcription factor that binds to a variety of promoters involved in growth 
regulation, e.g. promoters for type I collagen and MMP-3. ZBP-89 may function both as 
a transcriptional activator and repressor. The up-regulation of MMP-1 (collagenase-1) 
and MMP-3 (stromelysin-1) expression is mediated by ERK1,2, JNK, and p38 mitogen-
activated protein kinase (MAPK) pathways. We show here, that MAPKs and ZBP-89 
function co-ordinately in the expression of MMP-1 and MMP-3. In normal dermal 
fi broblasts, enhancement of MMP-1 and MMP-3 expression and proMMP-1 and 
proMMP-3 protein production by tumor necrosis factor-α, but not by interleukin-1β, 
is enhanced by adenoviral expression of wild-type ZBP-89. Enhancement of MMP-1 
and MMP-3 expression by the activation of p38 MAPK pathway by the adenoviral 
transduction of constitutively active MKK3b is further enhanced by adenoviral 
overexpression of wild-type ZBP-89. Enhancement of MMP-1 and MMP-3 expression 
by the specifi c activation of p38β, but not p38α, by the transduction of constitutively 
active MKK3b and wild-type p38β or wild-type p38α, is further enhanced by 
overexpressing  wild-type ZBP-89. These results show that the expression of MMP-
1 and MMP-3 is regulated by ZBP-89 transcription factor in dermal fi broblasts, 
which may have a role in proteolysis in, e.g., wound repair and tumor invasion.
ABSTRACTS
 S88 Journal of Investigative Dermatology (2010), Volume 130 
523
Keratinocytes Cultured From Psoriatic Patients Overexpress IGFBP2
Saveria Pastore1, Francesca Mascia1, Lars Rogge2, Valentina Mariani1, Daniela Lulli1, 
Stefania Madonna3, Elena Dellambra1, Giampiero Girolomoni4, Cristina Albanesi3
1Lab. of Tissue Engineering and Cutaneous Physiopathology, Istituto Dermopatico 
Immacolata, Roma, Italy, 2Lab. of Immunoregulation, Dept. of Immunology, Institut 
Pasteur, Paris, France, 3Istituto Dermopatico Immacolata, Roma, Italy, 4Dept. of 
Biomedical & Surgical Sciences, University of Verona, Italy
Psoriasis is one of the most common infl ammatory skin disorders. In our search for a disease-
specifi c signature, we performed oligonucleotide microarray analysis of the transcripts of 
keratinocytes cultured from the plaques of psoriatic patients (n = 6) and normal skin of healthy 
controls (n = 6), and found that one of the most dysregulated transcripts encoded for insulin-like 
growth factor binding protein 2 (IGFBP2). Specifi city of IGFBP2 dysregulation was confi rmed on 
independent keratinocyte sets, with massive overexpression in cells from 8 out of 10 psoriatic 
patients, but no dysregulation in cells from healthy donors (n = 6) or atopic patients (n = 6). 
Psoriatic keratinocytes cultured in serum-free conditions were enriched of senescent cells with 
high expression of p16INK4a, a condition that further boosted IGFBP2 synthesis. Indeed, p16INK4a 
over-expression in normal keratinocytes led to enhanced IGFBP2, although p16INK4a was not 
indispensable for IGFBP2 expression. Conversely, IGFBP2 gene silencing led to down-regulation 
of the cyclin-dependent kinase inhibitors p16INK4a and p21WAF1. In cells from healthy subjects 
and psoriatic patients, IGFBP2 could be slowly induced by IGF1 or down-regulated by TNF-
alpha. When concentrated from the supernatant of unstimulated psoriatic keratinocytes, IGFBP2 
inhibited IGF1 bioactivity, with abrogation of proliferation and CXCL8 expression induced 
by IGF1 in normal keratinocytes. In the epidermis of psoriatic lesions, IGFBP2 accumulated 
suprabasally, and colocalized with high p16INK4a. Our study strongly suggests that IGFBP2 over-
expression could be involved in the counterregulation of pathological mechanisms leading to 
hyperproliferation and in the establishment of a senescent phenotype in the psoriatic epidermis.
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Altered Redox Signaling in Senescent Human Dermal Fibroblasts
Florentina Ferchiu1, Anca Sindrilaru1, Lea Sante1, Nicolai Treiber1, Adelina Rogowska-
Wrezescinska2, Pallab Maity1, Olivier Toussaint3, Stefan Kochanek4, Meinhard 
Wlaschek1, Karin Scharffetter-Kochanek1 1Dept of Derm & Allergic Diseases, Univ 
Ulm, Germany, 2Dept of Biochem & Molecular Biol, Univ Odense, Denmark, 3Lab of 
Cell Biochem & Biol, Namur, Belgium, 4Div of Gene Therapy, Univ of Ulm, Germany
The free radical theory of ageing postulating increased concentrations of reactive oxygen species 
(ROS) to drive ageing is still controversially discussed. We addressed the question whether alterations 
of redox balance may modulate signaling pathways in vitro and in vivo during ageing. Using 
proteomic approach with 2D fl uorescence difference gel electrophoresis and mass spectrometry, we 
identifi ed manganese superoxide dismutase (SOD2) to be 13-fold increased in senescent compared 
to young fi broblasts. Increased SOD2 expression and activity were confi rmed using immunostaining/
blot and activity assays. Most interestingly, SOD2 expression is also increased in the skin of old 
individuals (>70 years) compared to young individuals (≤ 25 years). Using adenoviral transduction 
of the H2O2 sensitive HyPer construct, we found increased mitochondrial H2O2 concentrations 
in senescent fi broblasts most likely due to enhanced SOD2 activity with enhanced superoxide 
dismutation to H2O2.  Interestingly, senescent fi broblasts revealed a 3-fold overexpression and 
increase in the activity of interstitial collagenase/matrix-metalloproteinase-1 (MMP-1) which is 
responsible for collagen degradation during skin ageing. We have used AP-1 Transcription Factor 
ELISA and complementary lentiviral vectors containing AP-1 transcription response element (TRE) 
coupled with fi refl y luciferase to measure AP-1 activation responsible for collagenase expression. 
We found increased AP-1 transactivation by cJUN phosphorylation in senescent and H2O2-treated 
young fi broblasts. Collectively, we have found that enhanced SOD2 activity in senescent fi broblasts 
via unbalanced H2O2 overproduction and detoxifi cation induces MMP-1 by transactivation 
of AP-1. Targeting strategies for fi broblasts may hold considerable promise to re-establish 
redox balance and prevent or treat connective tissue degradation, a hallmark in skin ageing.
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Novel neuroendocrine controls of amphibian and human skin reepithelialisation through 
thyrotropin-releasing hormone (TRH) and bombesin and its mammalian homologues
Natalia Meier1, David Pattwell2, Guo-You Zhang1, Jennifer Loconto2, Markus Geissen3, 
Tina Schäfer1, Vladimir Emelianov1, Jennifer Klöpper1, Roberto Paredes4, Matthias 
Augustin5, Sebastian Debus3, Enrique Amaya4, Ralf Paus1,2 1University of Lübeck, 
Germany, 2School of Translational Medicine, Manchester, UK, 3University Hospital 
Hamburg-Eppendorf, Germany, 4Healing Foundation Centre, Faculty of Life Sciences, 
University of Manchester, UK, 5University Hospital Hamburg-Eppendorf, Germany
Rapid reepithelialisation of chronic human skin ulcers is a largely unsolved medical problem for 
which new wound healing-promoters are urgently needed. However, there are not enough simple 
and physiologically relevant test systems for the preclinical screening of such candidate substances. 
Amphibian organisms possess a high capacity for tissue regeneration that has not yet been 
systematically exploited for human wound healing. Therefore, we have dveloped parallel wound 
healing assay systems in which whole skin „punch within a punch“ samples from frog and human 
were cultivated in comparable serum-free growth media. In the human samples the newly formed 
epithelial tongues were analyzed by immunofl uorescence using a new set of quantifi able markers 
for proliferation (Ki67), metabolic activity (cytochrome c oxidase subunit I MTCO), keratinocyte 
activation (K6) and early and late stages of differentiation (MSX2 and Involucrin, respectively). 
In the frog samples proliferation was measured by staining phosphorylated Histone 3 (pH3). 
Thyroid-stimulating hormone (TRH), which is highly expressed in frog and human skin, was tested 
fi rst and found to signifi cantly stimulate growth of epithelial tongues (compared to vehicle controls) 
in both frog and human samples. TRH also accelerated the onset and increased the intensity of 
K6, Ki67 and MTCO1 in human and of pH3 in frog samples, respectively. Bombesin, another very 
abundant peptide hormone in frog skin, and its mammalian homologues Neuromedin B (NMB) and 
Gastrin Releasing Peptide (GRP) also had stimulating effects on these parameters in human and frog 
samples. This demonstrates the effectiveness of our inter-species approach to wound healing research.
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Progressive Decrease in Number and Change in Niche Preference of the ABCB5+ 
Mesenchymal Stem Cell Subset in the Skin during Aging
Barbara Meier1, Yvonne Ziouta2, Abhijit Basu1, Anca Sindrilaru1, Adelheid Hainzl1, 
Pallab Maity1, Meinhard Wlaschek1, Christoph Ganss2, Markus F. Frank3, Natasha 
Y. Frank3,4, Karin Scharffetter-Kochanek1 1Department of Dermatology and Allergic 
Diseases, University of Ulm, Ulm, Germany, 2TICEBA GmbH, Heidelberg, Germany, 
3Transplantation Research Center, Children’s Hospital Boston, Harvard Medical 
School, Boston MA, United States, 4Division of Genetics, Brigham and Women’s 
Hospital, Harvard Medical School, Boston MA, United States
ABCB5, a P-glycoprotein of the ABC superfamily of transporter proteins, was expressed in a newly 
defi ned mesenchymal stem cell subpopulation in skin. Even though its decrease in number and/or 
function may result in impaired regenerative capacity and aging, in vivo data are not available. We 
studied cell surface expression pattern, number and localization of ABCB5-positive mesenchymal 
stem cells in young (0-20 years), middle aged (21-70 years) and old healthy individuals (>71 
years). Dermal ABCB5+ cells showed variability for expression of the hematopoietic progenitor cell 
antigen CD34 or CD133, indicating a distinct stem cell subset. In contrast, ABCB5+ cells expressed 
mesenchymal stem cell markers CD29, CD90, CD59 and CD44. A signifi cant decline in ABCB5+ 
cell numbers was found in the skin of old individuals. In an attempt to understand the mechanisms 
underlying the ABCB5+ stem cell decline in aging, we studied the expression of gH2AX, a 
phosphorylated histone protein detecting DNA double strand breaks and initiating a DNA damage 
response with the induction of cell cycle inhibitors like p16. We found that by contrast to age-
dependent increase in gH2AX and p16 in dermal fi broblasts, no consistent increase in gH2AX and 
p16 was found in ABCB5+ mesenchymal stem cells. Interestingly, ABCB5+ mesenchymal stem cells 
were found in close association of CD31+ vessels in younger individuals, while this perivascular 
localisation was lost in the old age group. Collectively, the decrease in ABCB5+ mesenchymal stem 
cells with changes in niche preference may contribute to a reduced regenerative capacity in skin aging.
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Functional importance and hormonal regulation of nestin expression in multipotent 
adult human skin progenitor cells in situ and in vitro
Stephan Tiede1, Peter Keckeis1, Anna Petschnik3, Mohd Hilmi Abu Bakar4, Charli 
Kruse3, Ralf Paus1,2 1Dept. of Dermatology, University of Lübeck, Lübeck, Germany, 
2School of Translational Medicine, University of Manchester, Manchester, United 
Kingdom, 3Fraunhofer Institute of Marine Biotechnology, Lübeck, Germany, 4Unit of 
Sciences Reconstructive, University Sains Malaysia, Kubang Kerian, Malaysia
Neurofi lament nestin+ cells of adult human skin are one focus of cell-based regenerative medicine 
strategies, since they may serve as an easily accessible source of adult, autologous progenitor cells 
for the generation of different tissue lineages. While the cultivation of nestin+ progenitors from 
murine and human skin have been achieved by several laboratories, it remains unclear which 
specifi c functional role(s) the expression of nestin itself plays in these progenitors, e.g. in terms 
of cell growth, differentiation, cell fate and hormonal regulation. To address these questions, we 
organ-cultured nestin+ progenitor-rich human scalp skin and isolated sweat gland (SwG)-derived 
nestin+ cells in the presence or absence of the adipokin leptin, which we had previously shown 
to up-regulate intra-mesenchymal nestin expression in human skin in situ. Therefore, leptin was 
used as a tool to up-regulate nestin expression. In addition, nestin expression was knocked-down 
by RNAi in cultured SwG-derived nestin+ cells. Both experimental approaches revealed that 
strong nestin expression is associated with increased cell proliferation and nestin expression is 
essential for the glial cell, but not for the neuronal cell fate of nestin+ cells. After leptin stimulation, 
nestin+ progenitors managed to continue on a glial differentiation path in vitro even after (likely 
incomplete) nestin silencing. As nestin+ cells could be differentiated into glial and neuronal 
derivatives, we conclude that nestin expression alone is primarily responsible for the glial 
differentiation fate of nestin+ progenitors and that leptin administration may facilitate the isolation, 
extended culture, and glial differentiation of primary, adult human skin-derived nestin+ stem cells.
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The Hedgehog response gene Gli1 marks multipotent stem cells in the telogen bulge
Isaac Brownell1, Cynthia A. Loomis2, Alexandra L. Joyner1 1Memorial Sloan-Kettering 
Cancer Center, New York, NY, United States, 2New York University School of Medicine, 
New York, NY, United States
Hair follicles cycle through phases of growth (anagen), regression (catagen), and 
quiescence (telogen). During anagen, stem cells in the bulge region regenerate the 
proximal follicle, whereas distinct stem cells maintain the interfollicular epidermis. 
The outer root sheath and matrix in the proliferative anagen follicle are known to 
express the Hedgehog (Hh) response gene Gli1.  Moreover, blockade of Hh signaling 
with neutralizing antibodies prevents anagen regeneration. However, it is not clear 
if Hh signals directly to follicle stem cells, or if it simply drives proliferation of 
transient amplifying cells during anagen regrowth. We identify a novel population 
of Hh-responding cells in the telogen bulge marked by Gli1 expression. These 
cells function as multipotent stem cells when observed in their native niche, 
with the ability to repeatedly regenerate the anagen follicle during homeostasis. 
Furthermore, fate mapping experiments suggest a role for Gli1-expressing follicle 
cells in the healing of epidermal wounds. Interestingly, follicle contributions to 
epidermal regeneration occur only during a limited period immediately after 
wounding. Finally, comparison of Gli1 expression with other stem cell markers 
provides a molecular map of the progenitor cells in the quiescent telogen hair follicle.
 www.jidonline.org S89 
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Genetic Dissection of a New Biochemical Pathway in Epidermal Differentiation
Patrick Zeeuwen1, Ivonne van Vlijmen-Willems1, Tsing Cheng1, Diana Rodijk-
Olthuis1, Kiyotaka Hitomi2, Susan John3, Ikuko Hara-Nishimura4, Thomas Reinheckel5, 
Wiljan Hendriks1, Joost Schalkwijk1 1Radboud University Nijmegen Medical Centre, 
Nijmegen, Netherlands, 2Nagoya University, Nagoya, Japan, 3University of Cologne, 
Cologne, Germany, 4Kyoto University, Kyoto, Japan, 5Albert-Ludwigs-University, 
Freiburg, Germany
Cystatin M/E (CST6) is a non-redundant, epithelium-specifi c protease inhibitor 
with a presumed role in epidermal differentiation and tumor suppression. We have 
previously reported that cystatin M/E defi ciency in Cst6-/- mice causes neonatal 
lethality due to excessive transepidermal water loss. Biochemical evidence suggests 
that cystatin M/E controls the activity of legumain, cathepsin L, cathepsin V and 
transglutaminase-3. Using a genetic approach we sought to defi ne the role of cystatin 
M/E in epithelial biology by identifi cation of its target proteases and their downstream 
functions. Ablation of cathepsin L in a Cst6-/- background (Cst6-/-Ctsl-/- double 
knockout mice) restored viability and resulted in normalization of stratum corneum 
morphology. Ablation of legumain or transglutaminase-3 in Cst6-/- mice, however, 
did not rescue the lethal phenotype. Intriguingly, both Cst6-/-Ctsl-/- and Cst6-/-Ctsl+/- 
mice were viable, but the absence of cystatin M/E caused scarring alopecia in adult 
animals. In the cornea of Cst6-/-Ctsl+/- mice, we observed keratitis, hyperplasia and 
transition to a cornifi ed epithelium. Evidence is provided that activation of cathepsin 
D and transglutaminase-1 are downstream events, dependent of cathepsin L activity. 
We conclude that a tightly regulated balance between cathepsin L and cystatin M/E 
is essential for tissue integrity in epidermis, hair follicles and corneal epithelium.
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Dissociation and re-complementation of Alpha Keratin and Melanin from hair to 
build a novel biopolymer that can be used as different biocompatible prostheses at 
wide polymerization ratios tensile and impact strength
Kiumars Pirkalani, Zahra Talaee Rad, Mohammad Nazari, Hadi Haddadmanesh, 
Bahman Khodabakhsh, Roshanak Khodabakhsh, Hossein Bigdeli, Gita Shareghi 
Ghahraman Mehr Medical group, Tehran, Islamic Republic of Iran
We tried to dissociate and re-complement Alpha Keratin and Melanin from hair 
to build a novel biopolymer that can be used as biocompatible prostheses at wide 
polymerization ratios  with a spectrum of tensile and impact strength. Keratin is a 
ubiquitous polymer of low tensile and impact strength. Melanin, the strongest 
natural UV absorbent is also a ubiquitous macromolecule whose function in brain 
and adrenals is not well understood. During treatment of alopecia, we encountered 
patients who regained only white hair upon treatment and never relapsed. Besides all 
patients show regrowth of white hair at beginning and the disease never attacks white 
hair. We postulated that interaction of Melanin and Keratin is not only a physical 
co-impaction as microscopic studies show but a chemical co-polymerization that 
gives rise to new antigenic determinants. In two different chemical environments, 
detergent treated black hair without fat was treated in a way that once Keratin and 
once Melanin could be extracted. After drying, the two were let to interact in a very 
delicate basic microenvironment that enabled growth of the crystals. Different non 
stochiometric proportions were used to evaluate chemical and physical properties. 
Co-polymerization of the two is a real event with birth of compounds distinct 
from the parents. The largest product is at present 30mmX20mmX7mm. Some are 
very resistant to tension and/or impact. As the condition of co-polymerization is 
not optimum shape and physical properties cannot be controlled yet but as they 
are biocompatible they open a new horizon for prostheses in plastic surgery.
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Spermidine as a stimulator of human hair follicle growth and regulator of stem cell 
function
Yuval Ramot1, Stephan Tiede2, Tamas Biro3, Mohd Abu Bakar2,4, Balasz Toth3, Michael 
Philpott5, Wesley Harrison5, Koji Sugawara2, Giammaria Giuliani6, Ralf Paus2,7
1Hadassah-Hebrew University Medical Center, Jerusalem, Israel, 2University of 
Lübeck, Lübeck, Germany, 3University of Debrecen, Debrecen, Hungary, 4Universiti 
Sains Malaysia, Kelantan, Malaysia, 5The London School of Medicine and Dentistry, 
London, United Kingdom, 6Giuliani S.p.A, Milan, Italy, 7University of Manchester, 
Manchester, United Kingdom
Polyamines are indispensable for cellular proliferation and for the growth of rapidly regenerating 
tissues. Given that the hair follicle (HF) is a highly proliferative organ, polyamines are also 
important for normal hair growth. Though inhibiting polyamine synthesis does inhibit human 
hair growth, the role of polyamines in human HF biology in situ remains largely unknown. To 
explore this, we have studied the effects of the prototypic polyamine spermidine (0.1-1 µM) 
on human scalp HFs in serum-free organ culture. Spermidine signifi cantly promoted hair shaft 
elongation, prolonged the growth phase of the hair cycle (anagen), and modulated hair keratin 
gene expression in situ (e.g., downregulation of KRT31, KRT32 and KRT35). In addition, 
spermidine was found to enhance the proliferation of cultured primary human keratinocytes. 
Microarray analysis suggested multiple differentially regulated spermidine-target genes. 
Spermidine upregulated expression of the epithelial stem cell-associated keratins K15 and 
K19, altered K15-promoter activity in situ, and dose-dependently affected colony forming 
capacities and K15 expression of isolated K15-GFP+ cells in vitro, thus suggesting a novel role 
for spermidine in regulating stem cell function. In contrast, the ornithine decarboyxlase inhibitor 
efl ornithine downregulated K15 expression. These physiologically and clinically relevant data 
provide the fi rst direct evidence that spermidine is a potent stimulator of human hair growth 
and that this polyamine is an important modulator of human epithelial stem cell functions. 
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Dermal perivascular niche of mesenchymal stem cells in human scalp skin
Tsutomu Soma, Haruyo Yamanishi, Yumiko Ishimatsu-Tsuji, Shigeyoshi Fujiwara
Shiseido Research Center, Yokohama, Japan
In mammalian skin, epidermal and follicular bulge stem cells are well characterized 
by numerous studies. In contrast, existence of stem cells in dermis is still poorly 
understood. Previous studies have indicated that mesenchymal stem cells (MSCs) are 
situated as pericytes in various mammalian tissues. In adipose tissue, progenitor cells 
of adipocytes reside in the mural cell compartment of the vasculature as CD34 positive 
cells. We speculated that human adult dermis also contains MSCs-like cells positive 
for CD34 at the perivascular sites. To prove this hypothesis, fi broblastic cells isolated 
from adult scalp were examined their self-renewing and differentiating potency in 
vitro. Confocal microscopic observation was also performed to visualize the sites 
of MSCs-like cells in human scalp dermis. At fi rst, fi broblastic cells from adult scalp 
skin tissues showed colony-forming ability, and differentiated into mesenchymal 
lineages (osteogenic, chondrogenic, and adipogenic). Three-dimensional analysis 
of scalp skin with a confocal microscope clearly demonstrated that perivascular 
cells were positive for not only NG2 but also CD34 immunoreactivity. Perivascular 
CD34 positive cells were abundant around follicular portions. Furthermore, 
CD34 positive cells collected with magnetic cell sorting from scalp dermis were 
indeed capable of differentiating into mesenchymal lineages. Consistent with 
these observations, cultured dermal sheath cells derived from lower hair follicles 
essentially displayed mesenchymal differentiation. This study suggests that dermal 
perivascular sites worked as a niche of mesenchymal stem cells in human scalp skin.
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The Development of the Cutaneous Neurofi bromas
Eeva-Mari Jouhilahti1, Sirkku Peltonen2, Tom Callens3, Elina Jokinen1, Anthony 
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Cutaneous neurofi bromas are the hallmarks of neurofi bromatosis type 1 (NF1). They 
are composed of multiple cell types, and are currently believed to arise from small 
nerve tributaries of the skin. A key fi nding in the context of this view has been that 
only subpopulations of tumor Schwann cells harbor bi-allelic inactivation of the 
NF1 gene (NF1-/-). Our aim was to further elucidate the pathogenesis of cutaneous 
neurofi bromas. Cells expressing biomarkers associated with multipotency were 
detected in cutaneous neurofi bromas. A method for isolating and expanding 
multipotent neurofi broma-derived precursor cells (NFPs) from dissociated human 
cutaneous neurofi bromas was developed and employed to analyze their growth 
and differentiation potential. In analogy to solitary cells resident in neurofi bromas, 
NFPs were found to express nestin, and had the potential to differentiate at least 
to Schwann cells, neurons, epithelial cells and adipocytes. Mutation analysis of the 
NFPs revealed that their genotype was NF1+/-. The results lead us to speculate that the 
development of cutaneous neurofi bromas includes the recruitment of multipotent 
NF1+/- precursor cells. These cells may be derived from the multipotent cells of the 
hair roots, which are often intimately associated with microscopic neurofi bromas.
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Vitamin-D3 modulates human hair follicle epithelial progenitor cells in situ and in 
vitro
Stephan Tiede1, Christian Plate1, Natalia Meier1, Mohd Hilmi Abu Bakar2, Ralf Paus1,3 
1Dept. of Dermatology, Univeristy of Lübeck, Lübeck, Germany, 2Unit of Sciences 
Reconstructive, University Sains Malaysia, Kubang Kerian, Malaysia, 3School of 
Translational Medicine, University of Manchester, Manchester, United Kingdom
Vitamin-D3 and its receptor (VDR) are key regulators of normal skin biology. For example, 
calcitriol (hormonally active form of vitamin D3) inhibits proliferation and stimulates 
differentiation of keratinocytes and VDR null-mice develop alopecia. This led us to 
hypothesize direct effects of calcitriol on human epithelial hair follicle stem cells (HFSCs), 
which we had recently shown to express VDR. Here, we have assessed the effects of calcitriol 
on HFSCs in vitro and in situ by using transfected cytokeratin-15 (K15)-promoter-driven GFP 
demarcated HFSCs or isolated HFSCs under serum- and calcium-free conditions. Within 3 
days, low dose calcitriol, signifi cantly up-regulated the recognized HFSC markers K15 and 
CD200 as well as VDR expression. After 6d, low dose calcitriol began to down-regulate K15 
mRNA, while a higher calcitriol dose selectively blocked K15 expression and induced a 
cytoplasmatic redistribution of VDR protein. In line with these fi ndings, a low dose of calcitriol 
slightly enhanced proliferation and colony forming effi ciency (CFE) whereas higher doses 
strongly induced apoptosis and impaired CFE. In addition, deiodinase-2 (converts thyroxin 
to triiodothyronin) and CYP27B1 (catalyzes the hydroxylation of calcidiol to calcitriol) 
were down-regulated by calcitriol. We conclude that HFSCs are sensitive to calcitriol/VDR-
mediated controls, which may contribute to maintaining or depleting HFSCs in a dose-
dependent manner. These newly identifi ed endocrine controls of human HFSCs in situ and 
in vitro encourage one to examine, whether topical calcitriol application may be clinically 
exploited to protect (alopecia) or delete (hirsutism) HFSCs in vivo. Calcitriol administration 
may also become useful for human HFSC-based regenerative medicine strategies.
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Starburst Perifollicular Hyperplasia – A New Trichoscopy Finding In Patients With 
Folliculitis Decalvans
Adriana Rakowska1, Monika Slowinska1, Elzbieta Kowalska-Oledzka1, Malgorzata 
Olszewska2, Lidia Rudnicka1,2 1Dept. Dermatology CSK MSWiA, Warsaw, Poland, 
2Warsaw Medical University, Warsaw, Poland
Trichoscopy (videodermoscopy of hair and scalp) is gaining popularity as a valuable 
tool in differential diagnosis of hair loss. This noninvasive method allows viewing hair 
and scalp at high magnifi cation. Characteristic trichoscopy fi ndings of numerous hair 
and scalp diaseases have been described. These include alopecia areata, androgenic 
alopecia, frontal fi brosing alopecia and several other diseases. The aim of the study was 
to evaluate trichoscopy features of folliculitis decalvans. We investigated a total of 1223 
patients, who visited our out-patients offi ces for hair loss and 60 normal controls. In all 
patients anamnesis, clinical evaluation, trichogram, trichoscopy and, if necessary for 
diagnosis, pathology evaluation of scalp biopsies were performed. Trichoscopy was 
performed with the use of FotoFinder 2 videodermoscope. Working magnifi cations 
were 20x and 70x. In all cases trichoscopy was performed in variants: dry and with 
the use of an alcohol solution as immersion fl uid. Six patients (6/1223, 0,049%) were 
diagnosed with folliculitis decalvans. In all these patients trichoscopy showed focal 
hair loss, whitish areas of skin fi brosis, multiple pilosebaceous units with multiple 
(4-13) hairs and, in affected areas, perifi llicular epidermal hyperplasia in a starburs 
pattern. This pattern was not observed in any other of the 1223 patients with hair loss 
nor in normal controls.  This trichoscopy fi nding corresponded to perifollicular excess 
of  fi brous tissue in the mid and deep dermis. In conclusion, perifollicular hyperplasia 
arranged in a starburst pattern is a specifi c fi nding in folliculitis decalvans.
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Development of a co-culture system using 3T3-L1 differentiated adipocytes and 
Reconstructed Human Epidermis (RHE) to test the effi cacy of an active on the lipid 
content of fat tissue.
Jennifer Molinari, Noelle Remoué, Sandra Hurtado--Medina, Carla Barrichello 
Natura, Paris, France
Cellulite or lipodystrophy is an aesthetically problem that is claimed to occur in most 
postpubertal females. The localized accumulation of fat is responsible for the vertical 
extension of the superbasal fatty nodules and their distribution between the bundles 
of connective tissue which results in a topographic skin change. The slimming process 
consists on reducing the adipocytes diameter and for that, slimming formulations have 
to penetrate the epidermis and the dermis, to reach the adipose tissue. To assess the 
effect of slimming active on the fat cells, an in vitro system was developed in which 
well differentiated 3T3-L1 cells were kept in co-culture with Reconstructed Human 
Epidermis (RHE) Episkin® for three days, with 2 topical applications (t+24h, t+48h) of 
26µg of the slimming product to test. Then, the cell viability of RHE is determined 
and the intracellular content of lipid in adipocytes is evaluated by Oil Red O staining. 
In parallel, human IL-1alpha and mouse IL-6 are quantifi ed each day in culture 
medium. Adipocytes cultivate alone in co-culture die, but stay alive in presence of 
RHE, showing a very close interaction between keratinocytes and adipocytes. The use 
of green coffee oil in a formulation containing Biobase (Bioderma, excipients cream), 
water and ethanol lead to a decrease of lipid content. RHE in the presence of adipocytes 
releases less amount of IL1 alpha and stimulates the secretion of IL6 by adipocytes. 
These fi ndings indicate that co-cultured keratinocytes and 3T3-L1 in vitro provides 
a potential new model to study infl ammation interactions and slimming effi cacy.
537
The role of γ1 chain containing laminins for the formation and function of the 
dermo-epidermal basement membrane
Anja Fleger-Weckmann1, Jennifer E. Kloepper2, Manuela Bechtel1, Zu-Lin Chen3, Lutz 
Langbein4, Wilhelm Bloch5, Ralf Paus2,6, Roswitha Nischt1 1Dermatology, University 
Hospital of Cologne, Germany, 2Dept of Dermatology, University of Lübeck, Germany, 
3Laboratory of Neurobiology and Genetics, Rockefeller Univ, New York, USA, 
4German Cancer Research Center, Heidelberg, Germany, 5German Sport University 
Cologne, Germany, 6School of Translational Medicine, Univ of Manchester, UK
The main laminin isoforms in the dermo-epidermal basement membrane (BM) are laminin 332 
containing the γ2 chain and laminin 511 and 311, both containing the γ1 chain. Mice lacking the 
laminin γ1 chain die around E5.5, thus not allowing analysis of skin development. Therefore, we have 
generated a mouse strain with keratinocyte-specifi c deletion of the laminin γ1 chain (LAMC1EKO mice). 
These mice die postnatally showing severe hair and pigmentation defects. Histological analysis 
revealed that hair follicles (HFs) were malformed, irregularly orientated and hyperproliferative in the 
outer root sheath. In contrast, proliferation of hair matrix cells was decreased. HF morphogenesis 
was delayed and the number of HFs reduced in knockout animals. However, HF differentiation was 
normal. The epidermis showed thickening and altered differentiation caused by hyperproliferation 
of basal keratinocytes. Immunofl uorescence revealed that laminin 511 was completely lost from 
the dermo-epidermal BM and replaced by ectopic deposition of laminin 211, whereas all other BM 
components were unchanged. Electron microscopy revealed local disruptions as well as thickening 
of the dermo-epidermal BM in the mutant skin. Interestingly, hemidesmosome formation seems to be 
unaffected. However, basal keratinocytes appear less polarized, rounded-up and desmosomal cell-
cell interactions are partially lost. These data indicate that laminin 511 plays an important role not 
only in HF development, but also in pigmentation and homeostasis of the interfollicular epidermis. 
However, laminin 511 appears to be dispensable for the maintenance of epidermal-dermal cohesion. 
Our data also demonstrate that laminin 211 is not able to functionally replace laminin 511.
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Scanning Electron Microscopy and Atomic Force Microscopy in the study of 
damaged and weak hair treatment
Bozena Tyszczuk1, Julita Nowakowska3, Janusz Strzelecki2, Dorota Adamczyk4, 
Renata Debowska1, Katarzyna Rogiewicz1, Irena Eris1 1Dr Irena Eris Cosmetic 
Laboratories, Centre for Science and Research, Warsaw, Poland, 2Nicolaus Copernicus 
University, Faculty of Physics, Astronomy and Informatics, Torun, Poland, 3Warsaw 
University, Laboratory of Electron Microscopy, Warsaw, Poland, 4Dr Irena Eris 
Cosmetic Laboratories, Technological Department, Piaseczno, Poland
Healthy hair is highly important and desired. There are a lot of causes of bad condition and 
weakness of the hair, which lead to hair loss. That’s why everyday hair care product and 
treatment must have high protecting properties. The aim of this study was to evaluate the 
in vivo effi cacy of the hair care products using Scanning Electron Microscopy (SEM) and 
Atomic Force Microscopy (AFM).The SEM and AFM study were conducted on volunteers 
hair. The samples had been collected in three batches: before the fi rst use of the test product, 
after 1 and 5 uses. The samples were examined using Zeiss Scanning Electron Microscope 
LEO 1430VP and AFM Bioscope II Veeco.The results showed visible improvement of hair 
condition noticed after fi rst use of products. We observed smoothing of hair surface, which 
could be achieved through the restoration of the slate-like hair scale arrangement. The 
products left a thin protective fi lm on the hair surface, fi lling all hollows and voids, and 
consequently restoring hair smoothness. This fi lm also protects hair from the negative impact 
of environmental factors and prevents mechanical damage during daily hair care procedures. 
We also examinated the micro/nanoscale properties of human hair. Scanning Microscopy 
(SEM) and Atomic Force Microscopy (AFM) are very interesting and advanced technology 
which let us to observe all the morphological and changes in examined hair samples. 
Collected results help to estimate objective impact of treatment on a hair structure, 
which is nowadays especially important on dermatological and cosmetological area. 
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Effect of aquaporin-7 modulation on glycerol release and fat droplet size in 3T3-
L1   adipocytes
Ludivine Mur1, Catherine Gondran1, Claude Dal Farra2, Nouha Domloge1 1Vincience 
, ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP Corporate Research 
Center, Wayne, NJ 07470, United States
Aquaporin-7 (AQP7) is an aquaglyceroporin abundantly expressed in adipose 
tissue and essential for glycerol release from adipocytes. In the current study, 
we were interested in modulating AQP7 expression and studying the incidence 
on glycerol release and fat droplet size in 3T3-L1 adipocyte cell line. For that 
purpose, immunofl uorescence staining of AQP7 on 3T3-L1 cells was performed 
after treatment of cells with a compound targeting aquaporin expression. Our 
results showed that IV09.010, increased the expression of AQP7. This effect 
was similarly observed in presence of caffeine or isoproterenol. Quantifi cation 
of glycerol indicated that IV09.010 increased glycerol release from adipocytes, 
when applied alone and in combination with isoproterenol. To further investigate 
the relation between AQP7 expression and the size of fat droplets, 3T3-L1 
cells were transfected with AQP7 specifi c siRNA and stained by Oil Red. This 
transfection provoked the differentiation of these cells as indicated by the presence 
of fat droplets. IV09.010 allowed to partially reversing the effect of AQP7 siRNA. 
Furthermore, the effect of IV09.010 on the size of fat droplets was evaluated. 
Nile red staining showed a reduction of the size of fat droplets in cells treated 
with IV09.010, with or without caffeine or isoproterenol. These results indicate 
that inducing the expression of AQP7 in 3T3-L1 cells would be of great interest 
to modulate fat cell content, especially in combination with lipolysis inducers.
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Enhancing anti-oxidative protection in the hair follicle
Celine Meyrignac1, Armelle Perrin1, Catherine Gondran1, Claude Dal Farra2, Nouha 
Domloge1 1Vincience , ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP 
Corporate Research Center, Wayne, NJ 07470, United States
Hair scalp is constantly exposed to different environmental stresses including UV 
radiation, as well as oxidative and chemical stresses that can infl uence hair growth and 
also affect hair color. In this study, we investigated the effects of UV, oxidative stress 
induced by H2O2, and chemical stress induced by SDS on human scalp skin grafts 
maintained in culture. For UV irradiation, the biopsies were submitted to successive 
exposure to 5 and 0.2 J/cm2 of UVA and UVB, respectively. For oxidative and 
chemical stress, H2O2 at 5 mM and SDS at 1% were topically applied. Outcomes on 
hair follicle structure were studied by hematoxylin-eosine (HE) staining 24 hours after 
stress exposure. Damage was mainly observed in the outer root sheath, and included 
apoptotic cells, vacuoles, oedemas, and disorganization of the basal layer of the ORS. 
Using immunofl uorescence staining, we observed an increase in catalase expression 
and a decrease in p63 staining, as a marker of hair regeneration. Moreover, application 
of an anti-oxidative stress compound (IV09.003) on human scalp skin grafts 24 hours 
before UV or H2O2 stress allowed to reduce the level of stress damage in the HF. This 
protective effect went along with a reduction of UV and H2O2 -induced increase in 
catalase expression, and maintenance of p63 expression. This study demonstrates the 
importance of hair follicle protection against environmental stress that can damage hair
 www.jidonline.org S91 
ABSTRACTS
541
Modulation of circadian protein expression and hair growth  
Armelle Perrin1, Celine Meyrignac1, Sandrine Ratz1, Catherine Gondran1, Claude 
Dal Farra2, Nouha Domloge1 1Vincience , ISP Global Skin Research Center, Sophia 
Antipolis, France, 2ISP Corporate Research Center, Wayne, NJ 07470, United States
Hair follicle is a complex organ that consists of mesenchymal and epithelial tissues, 
interacting together to ensure hair growth and regeneration. During the growth 
phase (anagen) of the hair cycle, the dermal papilla cells (DPC) interact with the 
hair matrix keratinocytes and activate them to proliferate and differentiate into 
several cell types.Hair follicle possesses a circadian clock cycle that correlates 
with the hair growth cycle. Circadian genes are up-regulated during the telogen-
anagen transition and regulate the cell cycle progression. In this study, we 
investigated the effects of a new active ingredient IV09-019 (1%) on the circadian 
protein expression on DPC, then on growth and structure of the hair follicle. DPC 
and scalp skin biopsies were fi rst treated with the active for 48h to study protein 
expression. Then, scalp skin biopsies were treated up to 17 days to evaluate hair 
growth. Our results indicated that DPC treated with the active showed an increase 
in expression of the circadian proteins Clock, B-mal1 and Period-1, as well as Ki67 
protein. In scalp skin biopsies, an increase in Ki67 and keratin 15 expression was 
also observed. Moreover, the hair growth measured by hair shaft elongation was 
signifi cantly increased after 7, 10, 14 and 17 days of treatment. This work shows 
the expression of circadian proteins in DPC, and demonstrates that their modulation 
could go along with an improvement of the hair follicle structure and hair growth.
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Androgen action inactivates canonical Wnt signalling in scalp dermal papilla cells 
impairing hair follicle stem cell differentiation in androgenetic alopecia
Gustavo José Leirós1,2, Sabrina Del Priore2, María Eugenia Balañá1,2 1Instituto de 
Ciencia y Tecnología “César Milstein“-CONICET, Buenos Aires, Argentina, 2Fundacion 
Pablo Cassará, Buenos Aires, Argentina
Hair follicle (HF) formation begins when signals from the mesenchyme-derived 
dermal papilla cells (DPC) reach multipotent epidermal stem cells in the bulge 
region. In androgenetic alopecia (AGA) androgens action causes HF miniaturization 
and baldness through a mechanism which remain unclear. Circulating androgens 
act on  DPC probably by altering the regulatory  paracrine factors involved in the 
differentiation and proliferation of the HF multipotent cells. The aim of this work 
is to determine the role of androgens in the differentiation of HF stem cells and to 
identify the DPC signaling pathways or effector molecules involved in its action. The 
profi le of DPC secreted proteins in response to androgens is modifi ed as revealed 
by bidimensional gels and HPLC analysis. In a co-culture model with human DPC 
from patients suffering AGA and HF stem cells, androgens treatment abrogates hair 
differentiation. The expression of the keratin K6hf, hair differentiation marker, was 
signifi cantly downregulated in HF stem cells co-cultured with androgen-treated 
DPC. Association of β-catenin to androgen receptor was observed, indicating 
that β-catenin is a cofactor of AR signalling in DPC. Androgens signifi cantly 
upregulate β-catenin expression, both at mRNA and protein levels. Analysis of 
the cytoplasmic pool by  Western blot showed that the ratio cytoplasmatic/total 
β-catenin  is signifi cantly lower in androgen-treated DPC showing  that androgens 
are able to inhibit canonical Wnt signalling in DPC. These results suggest that 
androgens may modulate the secretion of paracrine factors involved in normal 
HF stem cell differentiation inactivating the canonical Wnt signaling pathway.
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Multiple miliary osteoma cutis: Three case reports and review of the literature
Riina M. Myllylä1, Kirsi-Maria Haapasaari2, Riitta Palatsi3, Emily L. Germain-Lee4,5, 
Jaakko Ignatius6,7, Juha Tuukkanen1 1University of Oulu, Department of Anatomy 
and Cell Biology, Oulu, Finland, 2University of Oulu, Department of Pathology, Oulu, 
Finland, 3University of Oulu, Department of Dermatology, Oulu, Finland, 4Kennedy 
Krieger Institute, Hugo W. Moser Research Institute, Baltimore, United States, 5The 
Johns Hopkins University School of Medicine, Division of Pediatric Endocrinology, 
Baltimore, United States, 6Turku University Hospital, Department of Clinical Genetics, 
Turku, Finland, 7University of Oulu, Department of Clinical Genetics, Oulu, Finland
The purpose of this study was to describe three patients with multiple miliary osteoma cutis 
(MMOC) and to study if these patients have features related to other forms of primary cutaneous 
ossifi cation. MMOC is a rare nodular skin disease where tiny bony nodules are formed usually on 
the facial skin usually in middle age.The patients were examined clinically several times and a wide 
spectrum of laboratory tests was taken, including GNAS sequencing. Selected molecules taking 
part in bone formation were studied histologically. A review of literature was made. Histological 
analyses revealed intramembranous bone formation as in GNAS gene based osteoma cutis 
disorders. However, we could not fi nd any correlation to germ-line GNAS gene inactivation or 
endocrinologic disorders, which were studied from peripheral blood. In histological staining BMP2 
and BMP4 were positive in several skin cells but patient samples did not differ signifi cantly from 
controls. FGF8, collagen XIII and estrogen receptor were negative. In the literature, we found 47 
MMOC cases, both females (87%) and males (13%). 55 % had had pre-existing acne and 15 % had 
extra-facial osteomas. On the basis of literature review and our three cases we suggest that MMOC 
is a distinct disease entity of still unknown etiology. Tiny nodular osteomas show intramembranous 
superfi cial ossifi cation and they increase slowly in number after appearing in middle age. We 
could not fi nd any association with germ-line GNAS gene inactivation or the endocrinologic 
disorders. As a treatment, surgical extirpation is possible only in limited number of tumours.
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Trichohyalin-like 1, a novel human hair follicle-specifi c S100 fused-type protein
Zhihong Wu, Ties Latendorf, Ulf Meyer-Hoffert, Britta Hansmann, Jens-Michael 
Schröder Department of Dermatology, University Hospital of Schleswig-Holstein, 
Kiel, Germany
Genes of the S100 fused-type protein (SFTP) family, clustered within the epidermal 
differentiation complex on human chromosome 1q21.3, encode essential 
components that maintain epidermal homeostasis and barrier functions. We have 
recently identifi ed hornerin and fi laggrin-2 as two members of this family which are 
important components of healthy epidermis. Here we report the identifi cation of 
trichohyalin like-1 (TCHHL1), a novel member of the SFTP family, predominantly 
present in hair follicles. The TCHHL1 gene encodes a glutamine- and lysine-rich 
protein of approximately 99 kDa, which shares common structural features with 
other SFTP members. TCHHL1 transcripts were detected predominantly in the 
body sites where the skin is rich in hair follicles, such as in the chin and scalp. 
Immunohistochemical analysis revealed that unlike other SFTP members, TCHHL1 
is specially localized in the inner root sheath cells. In vitro studies demonstrated that 
TCHHL1 could be cross-linked to itself by transglutaminase 1. To investigate whether 
TCHHL1 contributes to antimicrobial skin barrier as similar as other SFTP members, 
we recombinantly expressed two anionic peptide fragments of TCHHL1, THHL190-
248 (17.5 kDa, pI 4.9) and THHL1369-784 (45 kDa, pI 4.6). Using radial-diffusion 
antimicrobial assays, we found that only the 45 kDa-protein showed killing activity 
against E. coli at a concentration of 22 µmol/l. Our data suggest that TCHHL1 might 
play a critical role in the maintenance of hair follicle homeostasis and barrier function.
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The Malassezia metabolites indirubin and malassezin are potent activators of the 
aryl hydrocarbon receptor in HaCaT cells
Georgios Gaitanis1, Maria Galanou2, Prokopios Magiatis3, Nikitia Mexia3, Konstantina 
Stathopoulou3, Alexios-Leandros Skaltsounis3, Marios Marselos2, Aristea Velegraki4, 
Ioannis Bassukas1, Periklis Pappas2 1Department for Skin and Venereal Diseases, 
Univ of Ioannina, Greece, 2Department of Pharmacology, Univ of Ioannina, Greece, 
3Department of Pharmacognocy and Natural Products Chemistry, Univ of Athens, 
Greece, 4Mycology Laboratory, Department of Microbiology, Univ of Athens, Greece
The association of Malassezia furfur produced Aryl hydrocarbon receptor (AhR) indolic ligands, 
malassezin, indolο[3,2-b]carbazol and indirubin with seborrheic dermatitis has been reported 
previously. These substances are synthesized in vitro by the yeast when L-tryptophan is used as the 
single nitrogen source. The biomimetic synthesis of indirubin by one step oxidation of the Malassezia 
metabolite indol-3-carboxaldehyde was described as a putative biosynthetic pathway. This pathway 
may also lead to the simultaneous synthesis of the potent AhR ligand tryptanthrin. Our aims were: 
1) to analyze Malassezia extracts for novel bioactive indoles, particularly tryptanthrin, as predicted 
by the biomimetic approach and 2) to quantify AhR agonistic activity of malassezin and indirubin. 
Analytical HPLC was employed in search for not yet identifi ed AhR agonists in Malassezia extracts. 
For AhR activation profi le, HaCaT cells in sub-confl uency were treated with indirubin and malassezin 
for 24h at different concentrations (1nM to 50µM). mRNA expression  of AhR related genes (AhR, 
AhRR, CYP1A1, CYP1B1, ALDH3A1, GST-P1, GST-T1) was assessed with quantitative RT-PCR. As 
expected tryptanthrin was identifi ed in M. furfur extracts. Malassezin and indirubin had a dose 
dependent agonistic effect at the mRNA levels of CYP1A1, CYP1B1 and ALDH3A1. The induction was 
~4 orders of magnitude higher and at lower concentrations with indirubin compared to malassezin 
(100nM vs 10µΜ). Both agents had insignifi cant effect on AhR, AhRR and GSTs’ transcription. 
The description of novel potent AhR agonists (tryptanthrin) that have the potential to differentially 
activate the AhR pathway underscores the biologic signifi cance of the Malassezia produced indoles.
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Induction of Broadly Cross-neutralizing Antisera against Mucosal and Cutaneous 
Human Papillomaviruses (HPV) by HPV16L1-16L2 Virus-like Particles (RG1-VLP) 
Christina Schellenbacher1, Saeed Shafti-Keramat1, Helena Faust2, Joakim Dillner2, 
Richard Roden3, Reinhard Kirnbauer1 1Lab of Viral Oncology,, Medical Univ Vienna, 
Austria, 2Malmö Univ Hosp, Malmö, Sweden, 3Johns Hopkins Univ, Baltimore, USA
Licensed HPV vaccines comprising major capsid protein L1-VLP induce persisting, high-titer, yet 
predominantly type-restricted antibody responses. In contrast, immunization with minor capsid 
protein L2 can induce low-titer cross-neutralizing antibodies. Particularly a highly conserved 
peptide motif HPV16L2 aa 17-36 (RG1) has been characterized as a broad-spectrum cross-
neutralization epitope. We have previously developed chimeric HPV16L1-VLP that display RG1 
within the DE-surface loop of L1 (RG1-VLP). Rabbit antisera raised against RG1-VLP plus human-
applicable adjuvant Alum-MPL showed high-titer neutralizing antibodies to HPV16 and cross-
neutralizing antibodies to mucosal high-risk HPV18/31/45/52/58, mucosal low-risk HPV6/11, and 
beta-skin HPV5. The objective was to more completely characterize the spectrum and robustness 
of RG1-VLP-based cross-neutralization. Rabbit antisera to RG1-VLP (50 microgram plus Alum-MPL 
i.m., weeks 0, 4, 6, 8) additionally cross-neutralized mucosal high-risk HPV33/68/76, alpha-skin 
HPV3 and Heck’s disease type HPV32 (titers 50 to 1,000) in newly developed pseudovirion assays. 
Moreover neutralization of cutaneous alpha types HPV2 and HPV27 was demonstrated by RT-
PCR infectivity assays, using native virions isolated from common warts. To evaluate the vaccine’s 
potential for long-lasting protection, sera were drawn 10 months after the 4th immunization. L2-
mediated cross-neutralizing antibodies were detectable with a similar decline (10- to 100-fold) 
to 16L1 antibody-titers. Importantly, an additional boost raised antibody titers to former levels 
at the minimum, indicating a functional B-cell memory response to cross-neutralization epitope 
RG1. Immunization with RG1-VLP in adjuvant applicable for human use can induce enduring and 
broadly cross-neutralizing antibodies to evolutionary divergent mucosal and cutaneous, high-risk 
and low-risk, alpha and beta HPV types.
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HIV-1 activates Cdc42 and induces fi lopodia in immature dendritic cells to facilitate 
cell-to-cell virus propagation
Damjan Nikolic1,2, Martin Lehmann1,2, Richard Felts3, Eduardo Garcia1,2, Fabien 
Blanchet1,2, Sriram Subramaniam3, Vincent Pigeut1,2 1University of Geneva, Faculty 
of Medicine, Department of Microbiology and Molecular Medicine, Geneva, 
Switzerland, 2University Hospitals of Geneva, Department of Dermatology and 
Venereology, Geneva, Switzerland, 3NIH, Bethesda MD, United States
Dendritic cells (DC), due to their unique localization at mucosal surfaces, coupled 
with their known profi ciency in capturing antigens, are among the fi rst potential 
targets for HIV-1 during transmission. One of the limiting steps for HIV-1 propagation 
is the transfer of virus at an infectious synapse (IS) between DC and CD4+ T cells.
Bacterial pathogens can hijack the host actin cytoskeleton to facilitate invasion and 
propagation. We report here the fi rst evidence that a virus, HIV-1, induces the formation of 
fi lopodia in DC through activation of the Rho GTPase Cdc42. We provide direct evidence 
that fi lopodia are obligate components of the HIV-1 induced DC-T cell infectious synapse 
and required for transfer of HIV-1 infection to target CD4+ T cells. HIV-1 at the surface and 
near the tip of fi lopodia was observed by confocal microscopy, electron microscopy, live 
imaging and 3D-EM. Silencing of Cdc42 in dendritic cells dramatically reduced number of 
fi lopodia and decreased HIV-1 transfer via dendritic cell-T lymphocyte infectious synapses. 
Transfection of dominant-negative or constitutively active mutants of Cdc42 in dendritic cells 
decreased or increased HIV-1 transfer, respectively. Finally, we show that fi lopodia play an 
essential role in the transfer of virus when a low number of DC are co-cultured with T cells, 
a situation that mimics DC-T cell ratios in mucosal tissues or lymph nodes. In conclusion we 
identify a critical role for Cdc42-dependent fi lopodia induction by HIV-1 in the transfer of HIV-
1 from DC to T cells thereby identifying a novel pathway for HIV-1 cell-to-cell propagation.
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Concerted activation of TLR2 and IL-4R mediates Staphylococcus aureus dependent 
exaggeration of atopic dermatitis infl ammation
Susanne Kaesler, Thomas Volz, Yuliya Böttcher, Ko-Ming Chen, Emmanuella Guenova, 
Ulrike Hein, Tilo Biedermann University of Tübingen, Tübingen, Germany
Atopic dermatitis (AD) is a chronic infl ammatory skin disease with Th2 cells 
preferentially found in acute fl ares and Th1 cells dominating chronic lesions. 
Staphylococcus aureus is detected in most AD patients providing potent TLR2 ligands, 
however, the impact of TLR2 ligands on AD infl ammation is unclear. Therefore, 
we established a model for acute AD infl ammation by adoptively transferring and 
activating OVA-specifi c Th2 cells in the ear skin of naive mice, where ear swelling 
correlates with antigen-specifi c infl ammation. While Th2 cells or OVA alone only lead 
to minor changes, Th2 cells plus OVA provoked infl ammation and strong ear swelling 
after 24h. Importantly, addition of Staphylococcus aureus cell wall component 
lipoteichoic acid, a pathogen associated molecular pattern and TLR2 ligand, or of 
synthetic TLR2 ligand Pam2Cys provoked prolonged and increased dermatitis similar 
to OVA-specifi c dermatitis following Th1 cell transfer. Cross-over experiments with 
TLR2-defi cient mice and Th cells revealed that TLR2 on accessory cells but not T cells 
is responsible for TLR2 mediated exacerbation of cutaneous infl ammation. Hence, 
dendritic cells were activated with TLR2 ligands and produced Th1 inducing IL-12 as 
well as IL-10. However, IL-10 is completely downregulated by IL-4-costimulation. This 
shift was also observed in vivo and applying our AD model to IL10ko mice resulted in 
prolonged cutaneous infl ammation compared to wildtype. Thus, we identifi ed IL-10 
as key regulator of TLR2 mediated infl ammation. These data indicate that S. aureus 
derived TLR2 ligands shift Th2 cell dominated cutaneous infl ammation towards 
chronic and persistent dermatitis through a concerted activation of TLR2 and IL-4R.
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Cure rate, duration required for complete cure and recurrence rate of onychomycosis 
according to clinical factors in Korean patients
Joo Yeon Ko, Ha Eun Lee, Jae Hur, Joung Soo Kim, Hee Joon Yu Hanyang university 
hospital, Seoul, Korea, Republic of
Despite great advances in the treatment of onychomycosis, there are still many problems 
with treatment, including a long duration required for a complete cure and a high 
rate of treatment failure. Many factors affect the cure rate (CR), duration for complete 
cure (DC) and the recurrence rate (RR). This study is to evaluate the CR, DC and RR 
in onychomycosis according to various clinical factors. We retrospectively reviewed 
medical records of the 637 Korean patients of onychomycosis between December 
2000 and December 2006. We examined six clinical factors for effects on the CR, 
DC and RR: age, sex, clinical type, treatment pattern, presence of diabetes mellitus 
(DM), and the extent of nail involvement. On the view of the clinical nail appearance 
and potassium hydroxide (KOH) preparation, we designated the CR, DC and RR. In 
addition, we examined the differences in the CR, DC, and RR in terms of the above-
mentioned clinical factors. A total of 207 eligible patients were fi nally analyzed. The 
CR as a whole was 78.3%, the DC was 31.7 ± 18.4 weeks, and the RR was 36.0%. 
There was signifi cant relevance of the CR, DC and RR according to the extent of nail 
involvement. Age affects the CR and DC, and DM also affects the DC and RR. On the 
other hand, there were no signifi cant differences according to gender, clinical types 
and treatment patterns. In conclusion, we hope that these results would be helpful 
in establishing therapeutic plans and predicting the prognosis of onychomycosis. 
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Role of microbial populations in wound healing: new molecular methods
Anne Han1, Jonathan Zenilman1, Johan Melendez1, Emmanuel Mongodin2, Alessandra 
Agostinho3, Garth James3, Mark Shirtliff4, Alexander Rickard5, Gerard Lazarus1
1Johns Hopkins Medical Institutions, Baltimore, MD, United States, 2Institute of 
Genome Sciences, Baltimore, MD, United States, 3Montana State University, 
Bozeman, MT, United States, 4University of Maryland, Baltimore, MD, United States, 
5University of Michigan, Ann Arbor, MI, United States
This study analyzes the microbial population of wounds using robust new molecular tools. 
Chronic wounds contain persistent microbial populations that can function as impediments 
to wound healing.  Recent genomic advances provide more accurate methods than standard 
culture to analyze the bacterial composition in wounds.  Metagenomic analysis of the microbial 
population in wounds was compared to similar analyses of bacteria from normal skin.  Increased 
proportions of anaerobes, gram negative rods (i.e. Pseudomonas, Proteus, E. coli, Klebsiella, etc.), 
Staphylococcus and Streptococci were found in chronic wounds.  Furthermore, chronic wounds 
had signifi cantly lower populations of Propionibacterium compared to normal skin.  Using 
epifl uorescence microscopy, a semi-quantitative biofi lm grading scale was developed to defi ne the 
morphology and bioburden of these bacterial communities.  Samples showed that wound bacteria 
exist in a spectrum from highly organized thick continuous biofi lms to individual bacterial cells in 
a planktonic state.  Fluorescent in-situ hybridization provided further information by visualizing 
the location of specifi c bacteria in the wound.  Quorum sensing molecules were measured by 
bioassay to understand signaling patterns among the bacterial colonies.  All samples had greater 
than normal levels of autoinducer-2, a quorum sensing molecule implicated in biofi lm formation 
and the regulation of virulence factors.  These data suggest that wounds have a signifi cantly 
different microbial biome from that of normal human skin and the presence of biofi lms may 
impede wound healing.  It is possible that certain bacteria play a greater role in the pathogenesis 
of chronic wounds, while large numbers of benign colonizers may improve healing rates.
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Impact of innate defense antimicrobial peptides in hidradenitis suppurativa
Silke Hofmann1, Viola Büsing1, Sylke Lange1, Siegbert Rieg2,3, Leena Bruckner-
Tuderman1 1Department of Dermatology, University Medical Center, Freiburg, 
Germany, 2Center for Infectious Diseases and Travel Medicine, University Medical 
Center, Freiburg, Germany, 3IFB-Center for Chronic Immunodefi ciency, University 
Medical Center, Freiburg, Germany
Hidradenitis suppurativa (HS) is a chronic and debilitating infl ammatory disorder 
of the apocrine gland bearing areas with frequent bacterial superinfection. We 
therefore aimed to investigate a potential defi cient expression of innate defense 
antimicrobial peptides (AMPs). Skin biopsies (n=36), sweat (n=26) and suction 
blister fl uid, gained 20 hours after blister formation to ensure neutrophilic 
infi ltration (n=13), were collected from HS patients for analysis of dermcidin, 
human neutrophil peptides 1-3 (HNP1-3), and human β-defensin-3 (hBD-3). 
Severity of HS was graded according to the classifi cation by Hurley in grade 1 
(n=5), grade 2 (n=21), and grade 3 (n=10). 54 healthy individuals served as controls.
Analysis of sweat samples and blister fl uids from HS patients and controls revealed 
overall comparable levels of dermcidin and HNP1-3 by ELISA. However, if patients 
were distinguished with regard to HS severity, patients with higher severity (grade 
3) had lower dermcidin and HNP1-3 levels than HS patients with less severe 
HS (grade 1 or 2). With regard to HBD-3 expression in lesional HS skin, there 
was a tendency to a lower expression of HBD-3 in more severe HS as assessed 
by RT-PCR (mean  CT ranged from 7,9 for HS grade I to 11,2 for HS grade III). 
In conclusion, we found lower levels of innate defense AMPs dermcidin, 
HNP 1-3 and HBD-3 in patients with severe HS. Thus, defi cient constitutive 
production of dermcidin and HNP1-3 and/or reduced HBD-3 induction possibly 
contribute to propensity of bacterial superinfection and thereby to HS severity.
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Removal of One or More Arsenic Related Infections by Using Medicinal Plants: 
Findings from a Rapid Assessment Study in Barguna District of Bangladesh
Ariful Haque Mollik1 1Peoples Integrated Alliance, Bogra, Bangladesh, 2University of 
Development Alternative, Dhaka, Bangladesh
One of the more perplexing ground water problems currently facing Bangladesh is 
the high concentration of arsenic in drinking water, which poses a relatively large risk 
to human health of this region. Traditional health practitioners (THPs) of Bangladesh 
primarily use medicinal plants for treatment of various ailments. The selection of 
medicinal plant is a closely guarded secret and is usually kept within the family. As 
a result, the use of medicinal plants varies widely between THPs of different areas 
within the country, and is based on both medicinal plant availability and the THP‘s 
unique knowledge derived from practice. The present study was to conduct a survey 
amongst the THPs to learn more about the medicinal plants used to treat one or more 
arsenic related infections in Barguna district of Bangladesh. This area is unique in 
its proximity to the Sunderbans forest region and contains quite different medicinal 
plants from other parts of the country because of high salinity in the soil and water. 
Semi-structured questionnaires were administered to twenty-one THPs to evaluate 
the THPs‘ perceptions and practice relating to causation and treatment of one or 
more arsenic related infections. The THPs described the signs, symptoms, and causes 
of one or more arsenic related infections. Information on twenty-four medicinal 
plants was obtained. Information on indigenous use of medicinal plants has led 
to discovery of many medicines in use today. Scientifi c studies conducted on the 
medicinal plants may lead to discovery of more effective drugs than in use at present.
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Expression and sequence diversity of the complement regulating outer surface 
protein E in Borrelia afzelii vs. B. garinii in patients with erythema migrans or 
neuroborreliosis
Jaana Panelius1, Annamari Ranki1, Taru Meri2, Ilkka Seppälä2, Seppo Meri2
1Department of Dermatology and Allergology, Skin and Allergy Hospital, Helsinki 
University Central Hospital, Helsinki, Finland, 2Haartman Institute, Department of 
Bacteriology and Immunology, University of Helsinki, Finland
Outer surface protein E (OspE) is a complement factor H-binding virulence factor of 
various borrelial subspecies. It is usually absent from in vitro grown Borrelia garinii, 
although in vivo B. garinii, the causative agent of neuroborreliosis (NB) appears to 
escape complement attack. We analyzed the presence and sequence spectrum of 
the ospE genes in vivo in Borrelia spirochetes. DNA samples from the skin, serum 
and cerebrospinal fl uid (CSF) of patients with infections caused by B. afzelii or B. 
garinii were studied, and anti-OspE antibodies in the corresponding patient sera 
were detected by IgG ELISA using recombinant OspE as an antigen. ospE genes 
were found in 20 of 23 erythema migrans (EM) skin biopsies with B. afzelii, in 2 
EM skin biopsies with unknown underlying subspecies, in 5 of 9 EM biopsies with 
B. garinii, and in 1 of 4 CSF samples of NB patients with B. garinii infection. All 
OspE sequences from B. garinii samples were identical. In contrast, OspE of B. afzelii 
origin showed more variation. Anti-OspE antibodies were found in 8/21 (38.0 %) 
sera from patients with B. afzelii-associated EM. In conclusion, our results indicate 
that all borrelial subspecies, but not necessarily all strains, causing human infections 
can carry ospE genes to protect themselves against complement attack in vivo.
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Reactive oxygen species and pro-infl ammatory cytokines are produced in an in vitro 
S. pyogenes-stimulated keratinocyte model
Regnier-Rosencher Elodie1, Grange Philippe1, Batteux Frederic2,3, Poyart Claire4, Weill 
Bernard2,3, Dupin Nicolas1,4 1Laboratoire de Recherche en Dermatologie, EA 1833, 
Faculté de Médecine, Univ Paris Descartes, Paris, France, 2Laboratoire d’Immunologie 
EA 1833, Fac de Médecine, Univ Paris Descartes, Paris, France, 3Lab d’Immunologie 
ERTi “Plateforme d’étude du stress oxydant en oncologie et dans les maladies 
infl ammatoires”, Faculté de Médecine, Univ Paris Descartes, Paris, France, 4Service 
de Bactériologie, Hôpital Cochin-Pavillon Achard, AP-HP, Paris, France, 5Service de 
Dermatologie-Vénéréologie, Hôpital Cochin-Pavillon Tarnier, AP-HP, Paris, France
Group A Streptococcus pyogenes (S. pyogenes) is responsible of major suppurative and 
infl ammatory infections of the skin like erysipelas. It has been shown that keratinocytes participate 
to the innate immune response through the production of reactive oxygen species (ROS) 
contributing to eliminate and/or enhance the infl ammatory reaction. To date, no information are 
available in the production of ROS and pro-infl ammatory molecules by keratinocytes stimulated 
by S. pyogenes. We stimulated HaCaT cells with S. pyogenes strains isolated from patients with 
erysipelas. Spectrofl uorometric analysis was used to measure the ROS production. PCR array and 
RT-qPCR were used to screen the genes implicated in the infl ammation reaction. HaCaT cells 
stimulated by S. pyogenes produced a large amount of O2•- in a dose and time-dependent manner 
while the production of H2O2 and NO appears to be steady. Superoxide anions are produced in 
the cytoplasm by the NADPH oxydase, detoxifi ed into H2O2 by the superoxide dismutase, and 
may be responsible for the large amount of cell death contributing to the infl ammatory reaction 
more than eliminating the bacteria. Cytokines and chemokines genes CXCL2, CXCL3, TNF-α, 
IL-8, IL-1α and IL-1β appears to be up-regulated from 2 to 100 time in our model suggesting 
a role of keratinocytes in the infl ammation response. All together, the results showed that the 
keratinocytes contribute to the early innate immune response after being stimulated by S. pyogenes.
555
Individualized therapy of patients with genitourinary chlamydiosis
Yuriy Andrashko1, Taras Dasyuk2 1Uzhgorod National University, Uzhgorod, Ukraine, 
2Danylo Halytskyy Lviv National University, Lviv, Ukraine
The incidence throughout the world, including Ukraine, is high, which is, in 
particular, associated both with the peculiarities of the course of the infection, 
ways of spreading of the agent in the body, variety of immune responses; and with 
certain diffi culties in diagnostics and treatment of diseases, caused by Chlamydia 
trachomatis. According to contemporary conception of genitourinary chlamydiosis, 
its treatment is based on general principles of complex and individualized 
therapy in infectious diseases. Since chlamydiosis is regarded as systemic disease, 
etiotropic, pathogenic and symptomatic therapies should be used in the treatment 
of this ailment. In administration of individualized therapy, medications necessary 
for individual patient were used, depending on localization of infl ammatory 
process, character of pathologic condition, which arose during course of the 
disease, and general condition of the body. The therapy also included correction 
of the immune system, physiotherapeutic treatment, fi ght against concomitant 
disorders and stases in pelvic organs, pharmacologic protection of the liver.
Starting from the fi rst day of treatment, patients took immunomodulator of 
plant origin.  Depending on the severity of the course of the disease, patients 
took azithromycin orally in the dose of 1.0g in the third day of treatment and 
starting from the 5th day 0.5g  every other day up to 13th-17th days of treatment. 
Following treatment 107 patients felt practically healthy. Two patients had slight 
periodic itching and burning sensations in the urethra and morning mucous 
discharge from the urethra. Individualized complex treatment of genitourinary 
chlamydiosis allowed achieving clinical and etiologic cure of 96.33% of patients.
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Problem of HIV/AIDS in Obstetrics and Neonatology
Tetyana Fartushok, Olga Tymoshchuk, Taras Dasyuk Danylo Halytskyi Lviv National 
Medical University, Lviv, Ukraine
A number of the HIV-infected among pregnant women has been rapidly increasing in 
recent decades. It is expedient to examine infants, born to HIV-infected mothers, for 
presence of perinatal infections. Infants, born to HIV-infected women, should be kept 
on artifi cial feeding.Examined pregnant women were placed into 2 clinical groups. The 
fi rst clinical group included 13 HIV-infected pregnant women, who had undergone 
prevention of HIV transmission; the second group included 7 HIV-infected women, 
who had not received proper prevention. Average body weight of the newborns 
from the fi rst group constituted 3200g, but 4 infants were born with the weight ≤ 
3000g (31%), 2 infants (15%) with signs of delayed intrauterine development of the I 
stage. Manifestations of prenatal impairment of the CNS were detected in fi ve (38%) 
infants from the fi rst group: increased nervous-refl exive excitement syndrome was 
marked in 3 (23%) infants, CNS inhibition syndrome - in 1 infant (7.6%), syndrome of 
vegetative-visceral disorders - in 1 infant (7.6%). Average body weight of infants from 
the second group constituted 2700g: two (28.5%) newborns with signs of delayed 
intrauterine development of the I stage, and 3 (42.8%) infants with signs of delayed 
intrauterine development of the II stage. In the 2nd group increased nervous-refl exive 
excitement syndrome was marked in 5 (71%) infants, CNS inhibition syndrome - in 
1 infant (14.2%), syndrome of vegetative-visceral disorders - in 1 infant (14.2%).
AIDS virus penetrates the brain and the spinal cord, thus, infants should be 
supervised by the neurologist, and undergo monthly neurosonography examinations.
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Generation of cytoplasmic DNA of an RNA virus by human LINE-1
Akira Shimizu1,2, Yoko Nakatani1, Takako Nakamura1, Osamu Ishikawa2, Yasuhiro 
Takeuchi3, Hiroo Hoshino1 1Department of Virology and Preventive Medicine Gunma 
Univ Graduate School of Medicine, Maebashi, Japan, 2Department of Dermatology 
Gunma Univ Graduate School of Medicine, Maebashi, Japan, 3MRC/UCL Centre for 
Medical Molecular Virology, University College London, UK
Formation of DNA complementary to non-retroviral RNA virus genomes has been 
rarely reported. This process can be mediated by endogenous retroviruses or 
retrotransposons that have been implicated in autoimmune disease, such as SLE. Here 
we detected cDNA of vesicular stomatitis virus (VSV) following acute, cytopathic 
infection of human cells. We aimed to defi ne the structure of the VSV DNA and to 
identify the cellular reverse transcriptase which is involved in the VSV DNA formation. 
We infected various human cell lines with VSV and the extracted DNA was subjected 
to PCR using VSV-specifi c primers and DNA sequencing. Inverse PCR was performed 
to determine the 5’ and 3’ sequence of the VSV DNA. Furthermore, human NP-2 cells 
producing little VSV DNA were transfected with a plasmid expressing long interspersed 
nuclear element 1 (LINE-1). The cells were infected with VSV and the amount of VSV 
DNA was compared by real-time PCR. Several reverse transcriptase inhibitors were 
tested whether they could inhibit the VSV DNA formation. VSV DNA complementary 
to VSV mRNA was present in cytoplasm and not integrated into the host genome. VSV 
DNA generation was cell dependent and over-expression of long interspersed nuclear 
element 1 (LINE-1) in cells restored this activity. The endogenous activity of VSV 
DNA generation and that induced by exogenous LINE-1 transfection showed similar 
sensitivity profi le against reverse transcriptase inhibitors, indicative that LINE-1 is 
responsible for VSV DNA generation. Such DNA copies of non-retrovural RNA viruses 
generated by LINE-1 might contribute to autoimmune diseases via DNA sensors.
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A Spectrum of Tuberculids And The Value of Interferon-Gamma Release Assays In 
Their Diagnosis
Hong Yi Koh, Liang Kiat Tay, Shiu Ming Pang, Beng Hock Ong Singapore General 
Hospital, Singapore, Singapore
The diagnosis of tuberculids is challenging and requires correlation of clinical 
fi ndings and diagnostic tests. Traditional tests such as tuberculin skin tests (TSTs) and 
detection of Mycobacterial DNA by polymerase chain reaction (PCR) are subject 
to interpreter variability, and limited in sensitivity and specifi city. The objective 
of this study is to demonstrate the usefulness of interferon-gamma release assays 
(IGRAs) as additional diagnostic tools in tuberculids. We present a series of different 
forms of tuberculids where skin biopsy could not demonstrate mycobacteria by 
stain, culture or PCR, but IGRA results are positive. All three patients in our study 
responded to anti-mycobacterial therapy, lending support to the initial diagnosis 
of tuberculids based on clinical features and IGRA results. Methodological 
limitation inherent of a case series, however, does not allow us to draw 
conclusions on the sensitivity of IGRAs in diagnosing tuberculids. Dermatologists 
accustomed to depending on traditional tests such as TST or PCR in diagnosing 
tuberculids should consider adding IGRA in their diagnostic work-up.
ABSTRACTS
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RNase 7 protects healthy skin from Staphylococcus aureus colonization
Maren Simanski, Stefanie Dressel, Regine Gläser, Jürgen Harder University Hospital 
of Schleswig-Holstein, Campus Kiel, Department of Dermatology, Kiel, Germany
Staphylococcus aureus (SA) is one of the most common pathogens related with 
human skin infections. Despite the high carrier rate in the normal population skin 
is usually not infected by SA which is explainable by the ability of healthy skin to 
keep the bacteria within a limited number. One mechanism to control the growth of 
SA may be the expression of antimicrobial proteins (AMP). The aim of our study was 
to investigate the physiological relevance of the AMP RNase 7 in cutaneous defense 
against SA.Therefore skin explants were exposed to SA for 2, 6 and 20 hours. ELISA 
revealed that the secretion of RNase 7 was induced after 2 hours, whereas 6 and 20 
hours showed no signifi cant change. To assess the functional relevance of RNase 
7 in cutaneous defense against SA we investigated whether the killing activity of 
skin extracts was inhibited through blocking of the antimicrobial activity of RNase 
7 by a RNase 7-specifi c antibody. As a result, the potent SA killing activity of the 
skin extract was reduced when RNase 7 was neutralized by the specifi c antibody. In 
further ex vivo experiments using skin explants and the RNase 7 neutralizing antibody 
we could confi rm the functional role of RNase 7 in cutaneous defense against SA.
These data demonstrate that skin infected with living SA responds with an increased 
secretion of RNase 7 which contributes to limit the growth of SA thus indicating 
the physiological relevance of RNase 7 to protect human skin from SA infection.
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A3 APO a proline-rich antibacterial peptide in burn infections
Eszter Ostorházi1, Ferenc Harmos1, Ilona Kovalszky2, Dóra Szabó3, Ferenc Rozgonyi1, 
Daniel Knappe4, Ralf Hoffmann4, Marco Cassone5, John D.Wade6, Laszlo Ötvös5
1Department of Dermatology Venerology and Dermatooncology Semmelweis 
University, Budapest, Hungary, 21st Department of Pathology and Experimental 
Cancer Research Semmelweis University, Budapest, Hungary, 3Department of Medical 
Microbiology, Semmelweis University, Budapest, Hungary, 4Institute of Bioanalytical 
Chemistry, Leipzig University, Budapest, Hungary, 5Department of Biology, Temple 
University, Philadelphia, United States, 6Howard Florey Institute and School of 
Chemistry University of Melbourne, Melbourne, Australia
The designer antibacterial peptide A3-APO is effi cacious in mouse models of 
Escherichia coli and Acinetobacter baumannii systemic infections.  Here we compare 
the effi cacy of the peptide with that of imipenem and colistin in A. baumannii wound 
infections after burn injury. In three sets of independent experiments, mice were infl icted 
with burn wounds and different loads of A. baumannii, isolated from a Canadian 
veteran, were placed into the injury site. The antibiotics were added intramuscularly 
1-5 times.  The systemic toxicity of colistin and A3-APO was studied in healthy mice.
While toxicity to colistin was observed at 25 mg/kg bolus drug administration, 
the lowest toxic dose of A3-APO was 75 mg/kg.  In all three A. baumannii 
models 5 mg/kg A3-APO reduced the bacterial counts in the blood and in 
the wounds and improved wound appearance signifi cantly better than any 
other antibiotic treatment. Peptide A3-APO with an intramuscular therapeutic 
index of 15 is more effi cacious and less toxic than any existing burn injury 
therapy modality against multi-drug resistant Gram-negative pathogens. 
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SLC24A5/NCKX5 infl uences melanocyte cholesterol homeostasis and MC1R 
expression: a novel mechanism for natural human skin colour variation?
Martin R. Green, Tony Dadd, David Gunn, Fei-Ling Lim, Magda Sawicka, Rebecca 
Ginger, Steve Wilson Unilever Research, Sharnbrook, Bedford, United Kingdom
Natural variation in human skin colour is determined by genetic variation in a very 
few genes. Variation of a non-synonymous single nucleotide polymorphism (pA111T, 
rs1426654) in one of these genes (SLC24A5) is associated with marked differences in 
constitutive skin colour in peoples from South Asia.  NCKX5 is expressed in melanocytes 
and functions as a potassium-dependent sodium-calcium exchanger.   Using NCKX5-
specifi c antibodies alongside trans-Golgi-network (TGN) disrupting treatments we have 
confi rmed that NCKX5 is a TGN resident protein.  When heterologously expressed the 
111Thr variant of NCKX5 confers signifi cantly lower ion-exchange activity than the Ala111 
variant, with reduced exchanger function proposed to mediate the lower melanogenic 
activity of lighter skinned individuals. Using genome wide expression microarrays we 
assessed the impact of siRNA-mediated knockdown of SLC24A5 on cultured normal 
human melanocytes.  Surprisingly the expression levels of very few genes associated with 
melanogenesis were changed with the notable exception of MC1R. Furthermore alpha-
MSH treatment increased both SLC24A5 transcript and NCKX5 protein expression, whilst 
MITF knockdown decreased their expression, suggesting that SLC24A5 interacts with 
this well characterized melanogenic signaling pathway.  Unexpectedly the expression 
of a number of sterol and cholesterol homeostatic genes was altered after SLC24A5 
knockdown and the total cholesterol content of NHM was increased. Cholesterol has 
previously been identifi ed as a potential melanogenic regulator and is known to be 
essential for vesicular budding at the TGN.  Our data imply that SLC24A5 affects natural 
variation in skin pigmentation through a TGN resident ion exchange mechanism and a 
novel mechanistic route for regulating melanocyte intracellular sterol/cholesterol levels.
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Shot gun proteome analysis identifi ed the PPARγ ligand 15d-PGJ2 (15-deoxy-
D12,14-prostaglandin J2) as a novel drug interfering with melanoma-stroma 
interaction
Verena Paulitschke1, Silke Gruber1, Christopher Gerner2, Hubert Pehamberger1, 
Rainer Kunstfeld1 1Department for Dermatology, Vienna, Austria, Austria, 2Clinic for 
Internal Medicine I, Vienna, Austria, Austria
Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone 
receptor superfamily, have been originally thought to be restricted to lipid and lipoprotein 
metabolism, glucose homeostasis and cellular differentiation. Recently, evidence is growing 
that PPARγ ligands have inhibitory effects on tumor growth by regulating cell proliferation 
and differentiation.To shed light on the potential therapeutic effects on melanoma we 
tested a panel of PPARγ agonists on a variety of melanoma cell lines in vitro. Whereas 
most of the PPARγ agonists showed only moderate effects on melanoma cell proliferation, 
15d-PGJ2 displayed profound anti tumor activity on all cell lines tested. Additionally, 
15d-PGJ2 inhibits proliferation of tumor associated fi broblasts and tube formation of 
endothelial cells.  Furthermore, 15d-PGJ2 led to an induction of the tumor suppressor 
gene p21, a G/2M arrest and an inhibition of tumor cell migration in a matrigel assay 
in a panel of melanoma cell lines. Shot gun proteome analysis revealed that 15d-PGJ2 
might exert its effects via downregulation of HSP-90 (heat shock protein 90) and other 
related chaperones. Applying the recently established CPL/MUW database with a panel 
of defi ned classifi cation signatures we demonstrated an interference of 15d-PGJ2 in 
replication and protein synthesis including a signifi cant regulation of mediators such as cell 
division cycle protein 27, angio-associated migratory cell protein, proliferating cell nuclear 
antigen, cell division protein kinase 2 or proliferation-associated protein 2G4. Our data 
revealed for the fi rst time a profound effect of a single compound 15d-PGJ2 on melanoma 
cells in addition to the tumor microenvironment suggesting high therapeutic effi ciency.
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-catenin is activated by cAMP in normal human melanocytes and melanoma cells: 
implication in melanogenesis regulation   
Barbara Bellei1, Angela Pitisci1, Lionel Larue2, Mauro Picardo1 1Laboratory of 
Cutaneous Physiopathology, San Gallicano Dermatologic Institute, IRCCS, Rome, 
Italy, 2Developmental Genetics of Melanocytes, UMR 3347 CNRS, U1021 INSERM, 
Institut Curie, Orsay Cedex, France
Wnt/β-catenin signaling plays important roles in many developmental processes, including 
neural crest-derived melanocyte determination, proliferation and differentiation. Accumulating 
evidence suggests that the Wnt/β-catenin signaling plays an important role in melanogenesis 
regulation of adult cells. Here we investigated the crosstalk between cAMP/PKA signaling, the 
principal pathway involved in control of pigmentation, and canonical Wnt/β-catenin signaling 
in B16-F0 mouse melanoma cells and normal human melanocytes (NHM). Using a β-catenin-
specifi c siRNA approach, we demonstrated that β-catenin is required for adenylyl cyclase 
signaling via PKA and its target transcription factor CREB-directed melanogenic gene expression. 
Chromatin immunoprecipitation assays demonstrated an increased association of β-catenin 
with the proximal promoter of microphthalmia-associated transcription factor (M-Mitf), the 
master regulator of pigmentation, as a consequence of cAMP level elevation. Activated PKA 
phosphorylated β-catenin at Ser675 stabilizing cytoplasmic and nuclear β-catenin. Consistent 
with nuclear β-catenin increase, several Wnt target genes (Axin2, Lef1, Mitf, Sox9 and Wisp1) 
were coordinately upregulated in B16 cells and the observed stimulation was signifi cantly reduced 
in β-catenin-siRNA-treated cells. Surprisingly, transfection of exogenous wild type β-catenin or 
a constitutively active mutant form, that cannot be phosphorylated by CK1 and GSK3β, did not 
signifi cantly up-regulated any of the genes studied indicating that in B16 cells, there might be some 
other limiting factors involved in the regulation of Wnt target genes, such as for example activating 
phosphorylation. It is of interest that in NHM increased cAMP was not able to stimulate Axin2 and 
Sox9 suggesting that β-catenin signaling is differently regulated in NHM and B16 melanoma cells.
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Astaxanthin attenuates the stem cell factor-stimulated pigmentation of human 
epidermal equivalents through interruption of Raf-1 activity within melanocytes
Genji Imokawa1, Katsunori Fukazawa1, Hiroaki Nakajima1, Kazumasa Wakamatsu2, 
Yashuhiro Senda3 1Tokyo University of Technology,, Tokyo, Japan, 2Fujita Health 
University, Nagya, Japan, 3Revanche Co. Ltd., Kanazawa, Japan
We previously demonstrated that MAPK signaling, including microphthalmia associated 
transcription factor (MITF) and CREB phosphorylation, is a major pathway involved in regulating 
melanogenesis within human melanocytes. Recently, a redox imbalance was shown to be linked to 
a variety of altered cellular responses in which the precise balance between levels of oxidizing and 
reducing equivalents that refl ect the intracellular redox condition profoundly affects intracellular 
signaling pathways, especially the MAPK pathway. To elucidate the effects of redox balance 
regulation on epidermal pigmentation, we used the potent antioxidant astaxanthin (AX) to assess 
its effect on the stem cell factor (SCF)-stimulated pigmentation of a human epidermal equivalent 
(Melano-Model) and analyzed its biological mechanisms. The addition of AX elicited a marked 
depigmenting effect on the SCF-stimulated pigmentation over 14 days of treatment, which was 
accompanied by diminished melanin production and a signifi cant decrease in eumelanin (PTCA) 
content. Real-time RT-PCR and western blotting revealed that the SCF-stimulated gene and protein 
expression of tyrosinase, tyrosinase-related proteins-1/2, Pmel17 and endothelin B receptor was 
signifi cantly suppressed at days 7 and 10, respectively, by AX, which suggests an impairment in 
intracellular signaling upstream of gene expression. Western blotting to detect the phosphorylation 
of intracellular signaling molecules revealed that in AX-treated ALM melanoma cells, there is a 
marked defi ciency in the SCF-stimulated phosphorylation of MEK, ERK, MITF and CREB but not of 
Raf-1 compared with the control cells at 15 min post-SCF incubation. These fi ndings indicate that 
AX attenuates the SCF-stimulated pigmentation by interrupting Raf-1 activity within melanocytes.
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Loss of E-cadherin increases metastasic potential of melanoma 
Lionel Larue1, Flavie Luciani1, Friedrich Beermann2, Rolf Kemler3, Véronique Delmas1
1Institut Curie, U1021 INSERM, UMR 146 CNRS, 91405 Orsay, France, 2EPFL, 1015 
Lausanne, Switzerland, 33Max-Planck Institut für Immunbiologie, 79108 Freiburg, 
Germany
E-cadherin is a calcium-dependent cell-cell adhesion molecule expressed by 
melanocytes and responsible for their adhesion to the surrounding keratinocytes 
in the epidermis. Disruption of E-cadherin-mediated cell-cell adhesion has been 
implicated in tumour progression and metastasis. In order to investigate its role in 
melanomagenesis in vivo, we have generated a mouse model in which E-cadherin 
is specifi cally deleted in melanocytes (Tyr::Cre/°, E-cadherinfl oxed/fl oxed = Ecad mice). At 
the molecular level, E-cadherin is neither replaced by N- nor P-cadherin in defl oxed 
melanocytes. Furthermore the amount of β-catenin, normally bound to E-cadherin, 
is less important at the membrane but accumulates in the cytoplasm and nucleus, 
which has been linked to 30% of human melanoma. However Ecad mice do not 
develop melanoma, suggesting a minor role of E-cadherin in the initiation steps of 
melanomagenesis including proliferation and immortalization. We crossed Ecad 
mice with Tyr::NrasQ61K and Ink4a mice to induce proliferation and immortalization 
in vivo. As expected the latency period and the penetrance of melanoma production 
were not altered in the absence of E-cadherin. However, the lack of E-cadherin in 
melanocytes promotes dramatically lymph node invasion and lung macrometastasis.
566 [Oral 103]
a-MSH-mediated melanocyte differentiation involves PPAR-γ activation through a 
Phospholipase-C mediated pathway 
Vittoria Maresca, Enrica Flori, Barbara Bellei, Nicaela Aspite, Emanuela Camera, 
Giorgia Cardinali, Mauro Picardo San Gallicano Dermatologic Institute, Rome, Italy
In melanocytes PPAR-γ is expressed at detectable levels and can promote differentiation 
when pharmacologically stimulated. We investigated, in primary cultures of 
human melanocytes, whether or not PPAR-γ could act as an effector component of 
differentiation, downstream a-MSH-dependent MC1R stimulation. We demonstrated 
that a-MSH up-regulated PPAR-γ expression and promoted its transcriptional activity. 
In order to defi ne the mechanism responsible for a-MSH-mediated PPAR-γ activation, 
we focused on the cAMP/PKA pathway, for its main role in mediating melanogenesis, 
and surprisingly, Forskolin failed to promote PPAR-γ activation. Since PPAR-γ is 
induced by lipid mediators, and being MC1R a seven-transmembrane G-protein-
coupled receptor, we have investigated whether or not stimulated MC1R could 
mediate PPAR-γ induction through the Phophoinositide-Phosphoplipase-C (PLC)-
dependent pathway. Treatment with the PLC inhibitor, U-73122, abrogated PPAR-γ 
activation induced by a-MSH, and exposure to 3M3FBS, a PLC inductor, promoted 
PPAR-γ activation. We obtained a direct evidence of phosphoinositide-PLC-
dependent pathway activation, in response to a-MSH, by assessing, by HPLC-MS-
TOFF analysis, the generation of inosytol triphosphate and diacylglycerol as products 
of PLC activity. We also investigated the infl uence of PPAR-γ downstream a-MSH-
dependent MC1R stimulation on melanogenesis. The silencing of PPARγ expression 
partially counteracted melanogenesis induced by a-MSH. This study delineates a new 
signalling axis from the a-MSH to its G-protein coupled receptor MC1R, through PLC, 
down to PPAR-γ. This pathway, which is independent from the well characterised 
cAMP/PKA pathway, is also involved in the control of melanocyte differentiation.
567 [Oral 104]
Inhibition of protein deacetylase SIRT1 suppresses in vitro and in vivo invasion of 
melanoma cells
Risa Kunimoto1,2, Kowichi Jimbow2, Toshiharu Yamashita2, Masae Okura2, Tomohisa 
Hirobe3, Masahiro Sato1, Shin Hisahara4, Yoshiyuki Horio1 1Departments of 
Pharmacology, Sapporo Medical University, Sapporo, Hokkaido, Japan, 2Departments 
of Dermatology, Sapporo Medical University, Sapporo, Hokkaido, Japan, 3Division 
of Biology, National Institute of Radiological Sciences, Anagawa,Chiba, Japan, 
4Departments of Neurology, Sapporo Medical University, Sapporo, Hokkaido, Japan
SIRT1 is a NAD-dependent protein deacetylase that deacetylates histones and 
transcription factors. It is a nucleocytoplasmic shuttling protein, but the role of 
SIRT1 in the cytoplasm is unknown. When SIRT1 is downregulated, mobilization 
of embryonic neural cells is signifi cantly inhibited. We found that SIRT1 was 
predominantly expressed in the cytoplasm of melanoma cells and accelerated 
their migration. SIRT1 was highly expressed beneath the cellular membranes 
and protrusions and colocalized with fi lamentous actin.  Administration of 
pharmacological inhibitors of SIRT1 prevented formation of protrusions and 
migration of B16F1 melanoma cells, whereas NAD and resveratrol, activators of 
SIRT1, enhanced cell migration. Among siRNAs for seven NAD-dependent protein 
deacetylases, only SIRT1-siRNA inhibited cell migration of B16F1 cells. Administration 
of nicotinamide, an inhibitor of SIRT1, suppressed abdominal invasion and lymph 
node metastasis of transplanted melanoma cells in vivo. These results suggested that 
SIRT1 might have some role in the progression of melanoma, and that suppression 
of SIRT1 by inhibitors of SIRT1 could inhibit metastasis of cutaneous melanomas.
568 [Oral 105]
Polo-like kinase 1 expression is indirectly regulated through MAPK signaling 
pathway and is a potential therapeutic target in human melanoma
Ahmad Jalili1, Anna Moser1, Mikhail Pashenkov1, Christine Wagner1, Gaurav Pathria1, 
Viola Borgdorff1, Melanie Gschaider1, Georg Stingl1, Sridhar Ramaswamy2, Jean-
Philippe Brunet2, Todd R. Golub2, Stephan N. Wagner1 1DIAID, Department of 
Dermatology, Medical University of Vienna, Vienna, Austria, 2The Broad Institute of 
Harvard University and Massachusetts Institute of Technology, Cambridge, USA
Disruption of the cell cycle regulation has been implicated in the development and progression 
of malignant melanoma. By using cDNA microarray technique and pathway enrichment analysis 
we could identify cell cycle pathway and its member polo-like kinase 1 (Plk-1, a mitotic serine/
threonine kinase) to be signifi cantly overexpressed in primary melanomas and melanoma 
metastases. This fi nding could be confi rmed using real-time RT-PCR analysis on an independent 
set of specimens. In in vitro analysis of 8 human melanoma cell lines we observed the peak 
expression of the Plk-1 to be at the G2/M phase of the cell cycle. Transfection of human 
melanoma cell lines with two independent Plk-1 siRNAs led to reduction of Plk-1 mRNA/
protein, signifi cant decrease in cell proliferation, induction of mitotic catastrophe, and apoptotic 
cell death. Apoptosis was caspase 3/8-, Bid- and Bcl-2-dependent but TP53-independent. CGH 
and SNP arrays showed no genetic alteration in Plk-1 locus. MAPK signaling pathway was 
also signifi cantly enriched in primary melanomas and melanoma metastases in our samples. 
Inhibition of this pathway using the 4 MAPK inhibitors resulted in decreased expression of 
Plk-1 (a result of G1 cell cycle arrest and not a direct regulation), cell death and apoptosis. 
This study shows that in human melanoma: Plk-1 expression is dynamically regulated during the 
cell cycle, knock down of Plk-1 can lead to inhibition of cell proliferation/survival and induction 
of apoptosis and, Plk-1 expression to be regulated indirectly through MAPK signaling pathway. 
We conclude that Plk-1 could be a potentially attractive target in melanoma therapy.
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A novel treatment for severe photodamage
Giammaria Giuliani1, Rinaldi Fabio1 1R&D Giuliani spa, Milan, Italy, 2Studio Rinaldi, 
Milan, Italy
Octatrienoic acid is a new molecule, belong to psittacolfulvin family, sharing with 
carotenoids and retinoids some structural features .20 subjects with severe facial 
photoaging were enrolled in this double-blind, randomized, parallel group study. 
Subjects were divided in two different groups: 10 subjects in the active cream group, 
10 subjects in eccipient cream group. All the subjects applied the topic (active or 
placebo) once a day for 45 days.. At basal time (T0), after 45 days (T1) and after 75 days 
(T2) from the beginning of therapy we evaluated: redness, dryness, scales, and texture 
of the face skin in all the subjects.  At T0 and T2 we evaluated the photoaged skin 
(face, front area) by the refl ectance confocal microscopy (RCM) to study the effect of 
octatrienoic acid on the skin. All the considered symptoms were signifi cantly modifi ed 
from T0 to T1 in the active group respect the placebo group (redness p< 0.01, dryness 
and scales p < 0.05).At T2 (1 month after the end of therapy) the same values were 
present. At the RCM the skin before the treatment showed an important hyperkeratosis, 
with scales, a signifi cative activation of epidermal melanocytes expression. In the 
dermis we could see a signifi cative enlargement of diameter of dermal capillaries 
(vasodilatation) and markers of infl ammation. At T2 we noted and improvement 
of the epidermis physiological condition and a decrease of vasodilatation and 
infl ammation in active group. The clinical evidence and the instrumental evaluation 
provide a strong evidence that octatrienoic acid can improve photoaged skin.
570
Targeting XIAP to increase endoplasmic reticulum stress-induced apoptosis for 
melanoma therapy
David Hill1, Emma Hiscutt1, Ryan Kerr1, Simone Fulda2, Jane Armstrong1, Penny Lovat1
1Newcastle University, Newcastle upon Tyne, United Kingdom, 2University of Ulm, 
Ulm, Germany
Malignant melanoma remains largely unresponsive to current chemotherapy due 
to the notorious resistance of such tumours to apoptosis. Recent evidence suggests 
increased expression of XIAP, a member of the inhibitor of apoptosis protein family, 
contributes to apoptosis resistance. We have recently demonstrated targeting 
endoplasmic reticulum stress with fenretinide (a synthetic retinoid) or bortezomib (a 
26S proteosome inhibitor) represents a novel strategy by which to induce apoptosis 
of metastatic melanoma cells both in vitro and in vivo, although the effi cacy of such 
treatment may be impaired by XIAP over-expression. The aim of the current study was 
to correlate XIAP expression with cancer stage and test the hypothesis that inhibition of 
XIAP signalling increases the effi cacy of ER stress-induced cell death. Western blotting 
confi rmed increased expression of XIAP in metastatic melanoma cell lines compared 
to normal melanocytes. Immunohistochemical studies of XIAP expression in primary 
melanoma tissue derived from a cohort of patients with differing stage disease also 
confi rmed XIAP expression signifi cantly increased with progressive cancer stage as 
defi ned by both Breslow thickness and the American Joint Committee on Cancer staging 
system (P<0.001). Retroviral transfection of metastatic melanoma cell lines (CHL-1, 
A375 and WM266-4) with a short hairpin RNA targeting XIAP resulted in signifi cantly 
increased apoptosis in response to both fenretinide and bortezomib (P<0.0001) in 
a caspase-dependent manner. Collectively these data suggest targeting XIAP with a 
small molecule inhibitor (currently in clinical development) may increase the effi cacy 
of ER stress-induced apoptosis as a more effective treatment for metastatic melanoma.
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Expression of CD10 predicts tumor progression and unfavorable prognosis in 
malignant melanoma
Junna Oba, Takeshi Nakahara, Sayaka Hayashida, Makiko Kido, Lining Xie, Masakazu 
Takahara, Hiroshi Uchi, Akihito Hagihara, Yoichi Moroi, Masutaka Furue Kyushu 
University, Fukuoka, Japan
CD10 expression in malignant melanoma (MM) has been reported to increase 
according to tumor progression and metastasis; however, its association with patient 
outcome has not been clarifi ed.We examined the immunohistochemical expression 
of CD10 in MM to determine whether or not it could serve as a marker for tumor 
progression and prognosis.Sixty-four formalin-fi xed, paraffi n-embedded samples 
of primary MM from 64 patients were immunostained for CD10. Similarly, 35 
samples of melanocytic nevus and 20 samples of metastatic MM were analyzed 
for comparison. The following clinicopathologic variables were evaluated: age, 
gender, histologic type, tumor site, Breslow thickness, Clark’s level, and overall 
survival. Statistical analyses were performed to assess for associations. Several 
parameters were analyzed for overall survival using the Kaplan-Meier method and 
Cox proportional-hazards model. Immunohistochemical analysis revealed that 34 of 
64 cases (53%) of primary MM expressed CD10, compared to 15 of 20 cases (75%) of 
metastatic MM and only 2 of 35 cases (6%) of nevus. There was a signifi cant positive 
relationship between CD10 expression and Breslow thickness and Clark’s level. 
Univariate analysis revealed three signifi cant factors for shorter survival periods: 
CD10 expression, high Breslow thickness, and high Clark’s level (p < 0.01 each). In 
multivariate analysis, only CD10 expression and Breslow thickness were statistically 
signifi cant and independent prognostic factors.CD10 expression may serve as a 
progression marker and can predict unfavorable prognosis in melanoma patients.
572
HSP70 inducers from Chinese herbs and their effect on melanin production
Yasuhiro Yamashita, Tohru Mizushima Graduate School of Medical and 
Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
Skin hyperpigmentation disorders due to abnormal melanin production induced by 
ultraviolet (UV) irradiation are both a clinical and a cosmetic problem. This melanin 
production is mediated by tyrosinase whose expression is positively regulated by 
microphthalmia-associated transcription factor (MITF). On the other hand, UV-
induced modest melanin production plays an important role in protection against UV-
dependent skin damage. Expression of heat shock proteins (HSPs), particularly HSP70, 
is induced by various stressors, including UV irradiation to provide cellular resistance 
against such stressors. We recently found that expression of HSP70 inhibits melanin 
production and proposed that HSP70 inducers could be benefi cial as hypopigmenting 
cosmetics and medicines. In this study, we searched for HSP70 inducers from Chinese 
herbs and selected an ethanol extract of Eupatorium lindleyanum (E. lindleyanum) 
which induced expression of HSP70 in mouse melanoma cells (B16) at concentrations 
that did not signifi cantly affect cell viability. Not only melanin production but 
also the activity and expression of tyrosinase were signifi cantly suppressed in 
B16 cells treated with E. lindleyanum extract as well as in HSP70-overexpressing 
cells. The expression of MITF was clearly suppressed in B16 cells treated with E. 
lindleyanum extract but not in HSP70-overexpressing cells. These results suggest 
that E. lindleyanum extract suppresses the expression of tyrosinase and melanin 
production through both HSP70-dependent and HSP70-independent mechanisms. 
We propose that E. lindleyanum extract could be benefi cial as a hypopigmenting 
cosmetic and medicine because it would not only suppress melanin production but 
also protect against UV-induced skin damage through its HSP70-inducing ability.
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TPA inhibits melanoma growth by dephosphorylation of Tyr705 on STAT3 through 
PKC-activated tyrosine phosphatase(s)
Masahiro Oka1, Naoko Sumita1, Masanobu Sakaguchi1, Tetsushi Iwasaki2, Toshinori 
Bito1, Toshiro Kageshita1, Ken-ichi Sato4, Yasuo Fukami2, Chikako Nishigori1 1Division 
of Dermatology, Kobe Univ Graduate School of Medicine, Japan, 2Research Center for 
Environmental Genomics, Kobe University, Japan, 3Dept of Dermatology, Kumamoto 
University, Japan, 4Department of Biotechnology, Kyoto Sangyo University, Japan
The growth of most melanoma cells is inhibited by the tumor-promoting phorbol ester 
12-O-tetradecanoylphorbol-13-acetate (TPA). In this study, the involvement of the signal transducer 
and activator of transcription 3 (STAT3) in the TPA-induced growth inhibition of melanoma 
cells was examined. The growth of fi ve melanoma cell lines, whose Tyr705 on STAT3 was 
strongly phosphorylated (activated), was inhibited by TPA, whereas that of WM35 and WM39 
cells, whose phosphorylation of Tyr705 on STAT3 was at negligible levels, was considerably 
slow and not affected by TPA. Blockade of STAT3 activity by siRNAs suppressed the growth of 
WM1205Lu cells containing constitutively activated STAT3. Treatment of WM1205Lu cells 
with TPA decreased both the phosphorylated STAT3 and the DNA-binding activity of STAT3. 
Pretreatment of WM1205Lu cells with either a protein-tyrosine phosphatase inhibitor or a protein 
kinase C (PKC) inhibitor prevented the inhibitory effects of TPA on the level of phosphorylated 
STAT3. The fi ve melanoma cell lines containing phosphorylated STAT3 commonly expressed 
PKCα, PKCδ, and PKC . Introduction of the dominant negative mutant of one of these PKC 
isoforms into WM1205Lu cells inhibited the TPA-induced dephosphorylation of STAT3. A Src 
inhibitor attenuated the STAT3 phosphorylation in WM1205Lu cells. These results indicate that 
constitutively activated STAT3 is positively regulated by c-Src and negatively regulated by a 
PKC-activated tyrosine phosphatase(s) in melanoma cells. Because TPA did not affect c-Src 
activity, we conclude that the growth inhibitory effect of TPA on melanoma cells is mediated 
through dephosphorylation of Tyr705 on STAT3 by a PKC-activated tyrosine phosphatase(s).
574
Association study between IL-4 gene polymorphism and susceptibility to vitiligo in 
Korean populations
EJ Lee1, MK Shin1, MS Hong1,2, MJ Kim1,2, JH Chung1,2, MH Lee1 1Department of 
Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea, Republic of, 
2Department of Clinical Pharmacology, School of Medicine, Kyung Hee University, 
Seoul, Korea, Republic of
Vitiligo is a depigmenting disorder characterised by the loss of melanocytes from 
the cutaneous epidermis. Although the exact cause of the condition remains to be 
established, an autoimmune etiology has been suggested, and several observations 
support this theory. In this study, we searched if the genetic polymorphism of IL-4 
intron3 could be demonstrated in Korean vitiligo patients. And we examined 
the differences in the distribution of the IL-4 alleles and genotypes between each 
clinical subtype of vitiligo. Patients with vitiligo (n=358) and the healthy controls 
(n=744) were genotyped for IL-4 variable number of tandem repeat(VNTR) 
polymorphism using polymerase chain reaction(PCR) or PCR restriction fragment 
length polymorphism. Genotype distributions and allelic frequencies were 
compared between patients and controls. No signifi cant differences between 
patients and controls were found in allele and genotype frequencies of IL-4 
VNTR polymorphism. There were no signifi cant differences between generalized 
type and localized type or between non-segmental type and segmental type. 
IL-4 polymorphism was not associated with susceptibility to vitiligo patients.
575
The role of Smac/DIABLO, p53, NF-kB, and MAPKs in Apoptosis of Keratinocytes 
from Perilesional Vitiligo Skin: Protective Effects of Curcumin and Capsaicin.
Francesca Prignano1, Matteo Becatti2, Claudia Fiorillo2, Leonardo Pescitelli1, Paolo 
Nassi2, Niccolò Taddei2, Torello Lotti1 1Department of Dermatological Sciences, 
University of Florence, Florence, Italy, 2Department of Biochemical Sciences, 
University of Florence, Florence, Italy
Vitiligo is a chronic acquired hypomelanotic disorder affecting 0.5-2% of the world’s 
population. Oxidative stress, has been suggested as one of the possible initial pathogenetic 
event in melanocyte degeneration in vitiligo, but also the possible responsible 
for the ultrastrucural alterations of keratinocytes observed in our previous study.
We have taken biopsies from the perilesional skin of 12 patients 
suffering from nonsegmental vitiligo to better investigate the intracellular 
pathways involved in keratinocytes damage and apoptosis and the 
antioxidant protection of curcumin and capsaicin in these cells.
High levels of activated p38, NF-kB p65 subunit, p53, and Smac/
DIABLO proteins were observed in keratinocytes from perilesional 
vitiligo skin while low levels of ERK phosphorylation were present.
For the fi rst time, our study demonstrates the pivotal role of p38 MAP kinase 
as an upstream signal of perilesional keratinocyte damage, and the important 
contribution of p38 and NF-kB on p53 accumulation. Curcumin and capsaicin 
also increase ERK phosphorylation, thus inhibiting apoptosis. Moreover, 
pretreatment with such natural antioxidants inhibited caspase activation, 
increased total antioxidant capacity, repressed intracellular ROS generation 
and lipid peroxidation, and improved mitochondrial activity. These results 
suggest the possible protective role of antioxidants against vitiligo progression.
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The microRNA molecular signature of atypic and common acquired melanocytic 
nevi: Differential expression of miR-125b and let-7c
Line Holst1, Bogumil Kaczkowski3,2, Robert Gniadecki1 1Bispebjerg Hospital, 
Copenhagen, Denmark, 2University of Copenhagen, Faculty of Health Sciences, 
Copenhagen, Denmark, 3BRIC Center, Copenhagen, Denmark
MicroRNAs (miRNAs) are small, non-coding RNA species, which regulate gene 
expression through base pairing with the target messenger RNA. A proportion of 
miRNAs the so-called oncomiRs have been shown to be functionally involved in 
carcinogenesis. The presence of acquired melanocytic nevi showing clinical atypia 
(atypic nevi, AN) is an independent predictor of malignant melanoma (MM). We 
compared the miRNA molecular signature between AN and common acquired nevi (CN).
We obtained 22 biopsies of AN and 19 biopsies of CN from patients with no priory 
history of melanoma. The miRNA expression profi les were obtained from total RNA. 
Data were validated with qRT-PCR. We show that AN can be differentiated from CN 
on the basis of the expression of 35 miRNAs (adjusted p-value <0.05). Cluster analysis 
showed a complex clustering pattern of AN into two major groups. The microarray data 
and qRT-PCR analysis identifi ed miR-125b and Let-7c as the species the expression 
of which differed most between AN and CN. This is the fi rst report showing that AN 
and CN differ on the molecular level. Interestingly, we have showing an independent 
study that miR-125b is downregulated in maligant melanoma producing sentinel node 
metastasis comparing to the non-metastasizing tumors. Deregulation of miR-125b 
and let-7c may constitue early steps in the malignant transformation of melanocytes.
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The Phenolic Compound, N-Propionyl-Cysteaminylphenol is Selectively 
Incorporated into B16F1 Melanoma Cells and Induces Apoptotic Cell death.
Yasue Osai1, Yasuaki Tamura2, Noriyuki Sato2, Kazumasa Wakamatsu3, Shosuke 
Ito3, Akira Ito4, Hiroyuki Honda5, Masae Okura1, Toshiharu Yamashita1, Kowichi 
Jimbow1 1Department of Dermatology, Sapporo Medical University, Sapporo, 
Japan, 2Department of 1st Pathology, Sapporo Medical University, Sapporo, Japan, 
3Department of Chemistry, Fujita Health University, Toyoake, Japan, 4Department 
of Chemical Engineering, Kyushu University, Fukuoka, Japan, 5Department of 
Biotechnology, Nagoya University, Nagoya, Japan
Melanin synthesis uniquely occurs in pigmented cells and is highly elevated in malignant melanoma. 
Thus, therapy that targets to melanin synthesis can be a new molecular targeting therapy for 
malignant melanoma. We have previously reported that phenolic compounds are good substrates 
for tyrosinase as they are selectively incorporated into melanoma cells and induce a melanoma-
specifi c antitumor effect. However, it has not been determined how they inhibit the growth of 
melanoma cells. In this study, we aimed to elucidate the mechanism of the cell death induced by 
N-propionyl-4-S- cysteaminylphenol (NPrCAP) and its antimelanoma effect. We fi rst conducted MTT 
viability assay for assessment of the growth-inhibitory activity, followed by fl ow cytometric analysis 
and caspase assay to elucidate the mechanism of the cell death induced by NPrCAP in vitro. Our 
results showed that the cytotoxic effect of B16F1 mouse melanoma cells induced by NPrCAP was 
dose-dependent and an evident sub-G1 fraction with activation of caspase 3 was observed when 
cells were cultured in NPrCAP-containing medium. Furthermore, we examined whether NPrCAP 
could suppress B16F1 tumors transplanted via three or fi ve intratumoral administrations of 24.4 mM 
NPrCAP every day or every other day. Our in vivo study showed that NPrCAP injection resulted in 
the inhibition of growth of melanoma tissue and an increase in the life span of melanoma-bearing 
mice. These results suggest that NPrCAP has an anti-melanoma growth effect by inducing apoptotic 
cell death and that it can be utilized as a chemotherapeutic agent specifi c to malignant melanoma.
578
The intracellular traffi cking of tyrosinase-related proteins-1/2, Pmel17 and MART-
1 to melanosomes is interrupted independent of the traffi cking of tyrosinase in 
amelanotic B-16 melanoma cells induced by the Golgi secretory inhibitor monensin: 
A model similar to the silver mutation
Hiroaki Nakajima, Takeshi Nagata, Reiko Kumazawa, Genji Imokawa School of 
Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Japan
We have previously demonstrated that the Golgi secretory inhibitor monensin (MS) disrupts the 
melanosome membrane, resulting in completely unpigmented B-16 melanoma cells despite the 
successful transfer of tyrosinase (TYR) to those vacuolated melanosomes. To characterize the 
traffi cking of other melanosomal proteins (TYR-related proteins (TRP) 1/2, Pmel17, and MART-1) 
in the MS-induced amelanotic B-16 (MS-B-16) cells, we used subcellular fractionation, western 
blotting and confocal laser microscopy (CFLM) to examine differences in their intracellular 
distribution compared with melanotic non-MS-treated B-16 (Non-B-16) cells. Although the 
melanosome-rich large granule fraction contained similar levels of TYR protein/activity in the 
amelanotic MS-B-16 and the melanotic Non-B-16 cells, there were signifi cantly decreased 
levels of TRP-1(80KDa)/2(100KDa) and Rab27A/B proteins or the complete loss of processed 
Pmel17 (HMB45) in the amelanotic MS-B-16 cells compared with the melanotic Non-B-16 
cells. This suggests that the disrupted melanosomes in the amelanotic Mon-B-16 cells contain 
TYR but not the other melanosomal proteins (processed Pmel17 and Rab27A/B). Analysis of 
merged images obtained by CFLM revealed that whereas all melanosomal proteins studied 
(TYR, TRPs-1/2, Pmel17, and MART-1) sharply co-localized with each other in the vicinity of 
the nuclei in the melanotic Non-B-16 cells, those proteins, except for TYR, also co-localized 
with each other in the amelanotic MS-B-16 cells. These results suggest that the intracellular 
traffi cking of TRPs-1/2, MART-1 and Pmel17 to melanosomes is interrupted independent of the 
traffi cking of TYR in the amelanotic MS-B-16 cells. This provides a model similar to the silver 
mutation where melanosomes are structurally disrupted, leading to the loss of melanization.
579
Glucosamine, an asparagine-linked carbohydrate core synthesis inhibitor, attenuates 
endothelin-1+stem cell factor-stimulated pigmentation in human epidermal 
equivalents by interrupting the endothelin-1-triggered intracellular signaling 
pathway within melanocytes.
Yuki Wakabayashi1, Shouhei Oka1, Hiroaki Nakajima1, Kazumasa Wakamatsu2, Genji 
Imokawa1 1Tokyo University of Technology, hachioji-city, Tokyo, Japan, 2Fujita Health 
University, tsu-city, Mie, Japan
Although a carbohydrate core synthesis inhibitor, glucosamine (Glc) has been implicated in 
producing amelanotic B-16 melanoma cells, it remains unclear whether the inhibition is also 
effective in preventing the stimulation of pigmentation in human skin. In this study, we evaluated 
the effects of Glc on the stimulation of pigmentation in a human epidermal equivalent (Melano-
Model) and analyzed its biological mechanism. Epidermal equivalents were cultured in DMEM 
medium supplemented with endothelin-1 (ET-1: 10 nM) and stem cell factor (SCF: 5 nM) and 
were treated with or without Glc (0.1%). The addition of Glc elicited a marked depigmenting 
effect on the stimulation of pigmentation in the epidermal equivalents after 14 days of culture. 
Real-time RT-PCR and western blotting revealed that increased gene and protein expression 
levels of melanogenic proteins (MITF, tyrosinase, tyrosinase-related proteins-1/2, Pmel17 and 
ETB Receptor) were signifi cantly suppressed at days 7 and 10, respectively, which suggested 
an impairment in intracellular signaling upstream of their gene expression. Western blotting of 
intracellular signaling intermediates and the melanogenic proteins in human melanocytes or ALM 
human melanoma cells revealed that in Glc-treated cells, there is a marked defi ciency in the ET-
1+SCF-stimulated phosphorylation of CREB but not of ERK and MITF at 15 min post-stimulation 
and a signifi cant decrease in the gene and protein expression of the melanogenic proteins at 
12 or 24 h post-stimulation, respectively, compared with the control non Glc-treated cells. 
These fi ndings indicate that Glc attenuates the ET-1+SCF-stimulated pigmentation in epidermal 
equivalents by interrupting the preferentially ET-1-triggered intracellular signaling pathway.
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The intracellular traffi cking of tyrosinase to melanosomes is disrupted independent 
of the traffi cking of tyrosinase-related proteins-1/2 and Pmel17 in reduced 
glutathione-induced amelanotic B-16 melanoma cells: A model for oculocutaneous 
albinism type 2.
Takeshi Nagata1,2, Hiroaki Nakajima1, Yuta Fujiwara Fujiwara1, Genji Imokawa1 
1I.T.O. Co., Ltd., Musashino, Japan, 2School of Bioscience and Biotechnology, Tokyo 
University of Technology, Hachioji, Japan
We have previously reported that reduced glutathione (GSH) abolishes the intracellular traffi cking 
of tyrosinase (TYR) to melanosomes, which results in completely unpigmented B-16 melanoma cells 
during the glucosamine (Glc)-depleted recovery of melanization in Glc-treated B-16 amelanotic 
melanoma cells. To characterize the traffi cking of other melanocyte-specifi c (melanosomal) 
proteins, such as TYR-related proteins (TRP) 1/2, Pmel17, MART-1 and Rabs27A/B in amelanotic 
GSH-induced B-16 (GSH-B-16) cells, we used subcellular fractionation, western blotting and 
confocal laser microscopy (CFLM) to examine differences in intracellular distribution of those 
melanosomal proteins compared with control melanotic non-GSH-treated B-16 (Non-B-16) 
cells. In the melanosome-rich large granule fraction, whereas the amelanotic GSH-B-16 cells had 
a signifi cantly diminished protein/activity of TYR compared with the melanotic Non-B-16 cells, 
there was substantially no difference in the distribution of TRP-2, processed Pmel17 (HMB45) or 
Rab27A/B proteins, which suggested that melanosomes in the amelanotic GSH-B-16 cells contain 
those melanosomal proteins except for TYR. Analysis of merged images obtained by CFLM revealed 
that while all melanosomal proteins studied (TYR, TRP-1/2, processed processed Pmel17, MART-1 
and Rab27A/B) co-localized with each other in the vicinity of the nuclei of the melanotic Non-B-16 
cells, those proteins, except for TYR, also co-localized with each other in the amelanotic GSH-B-16 
cells. These results suggest that the intracellular traffi cking of TYR to melanosomes is selectively 
disrupted independent of the traffi cking of TRPs-1/2, and Pmel17 in the amelanotic GSH-B-16 cells, 
providing a model similar to oculocutaneous albinism type 2.
581
MicroRNA miR-125b expression in early progression of malignant melanoma. 
Martin Glud1,2, Krzysztof T. Drzewiecki2, Robert Gniadecki1 1Bispebjerg Hospital, 
Copenhagen, Denmark, 2Rigshospitalet, Copenhagen, Denmark
MicroRNAs (miRNAs) are are involved in the regulation of many cellular processes, 
including differentiation, proliferation, and apoptosis. Recent studies have suggested 
that deregulation of diverse miRNAs plays an important role in pathological 
processes such as cancer. The aim of this study was to identify potential miRNAs 
involved in progression of cutaneous malignant melanoma. Furthermore, we wanted 
to examine, the effect of transfection by a specifi c miRNA on melanoma cell lines. 
28 archived melanoma FFPE samples (T2) were laser microdissected. MiRNA 
expression profi les established by use of microarrays and differentially expressed 
miRNAs were identifi ed. Results were validated by qRT-PCR. Melanoma cell lines 
were transfected by miR-125b and the effect evaluated by use of proliferation and 
apoptosis assays. By using microdissection it was possible to obtain a pure sample 
of malignant melanoma cells. By looking at our microarray data, we recognized 
microRNA miR-125b to be downregulated in the sentinel-node positive malignant 
melanomas compared to sentinel-node negative. This was validated by qRT-PCR. In 
our functional studies, exogenenous expression of miR-125b resulted in lower levels 
of proliferation, whereas inhibition of miR-125b didn’t had any effect. Regarding 
apoptosis, inhibition of miR-125b resulted in lower levels apoptosis, while mimicking 
of miR-125b had no effect. Laser microdissected cells of FFPE melanoma specimens 
seem suitable as a source for miRNA microarray profi ling. MiR-125b may be 
involved in an early progression of cutaneous MM, with tumor suppressor potential.
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Tight Junction-specifi c proteins are absent from melanoma while ZO-1 is widely 
expressed
Claudia Bohner1, Sabine Vidal-y-Sy1, Ingrid Moll1, Peter von den Driesch2, Johanna 
M. Brandner1 1Department of Dermatology and Venerology, University Hospital 
Hamburg-Eppendorf, Hamburg, Germany, 2Department of Dermatology and 
Allergology, Clinical Centre Stuttgart, Stuttgart, Germany
Malignant Melanoma (MM) is the most aggressive form of skin cancer and is highly resistant 
to conventional chemotherapy, immunotherapy and targeted therapy. The presence of Tight 
Junctions (TJ) in these tumors might result in the encapsulation of specifi c areas which are no longer 
accessible for the immune system or for therapeutics, therefore contributing to this resistance.
We investigated various TJ proteins, including members of the TJ specifi c claudin family 
and the multifunctional protein ZO-1 in the tumor and the tumor-microenvironment in 
MM and nevi, including borderline cases and MM cell lines. ZO-1 was clearly positive in 
MM and nevi, but its increased localization in invasive areas of MM was correlated with 
tumor progression (Breslow Index). Other TJ proteins were only expressed in a minority of 
cells or absent. Tracer assays in spheroids generated from cultured MM cells showed no 
stop of the tracer arguing for the absence of barrier forming TJs. But we found a correlation 
of ZO-1 protein levels and MM invasiveness. Investigating the tumor-microenvironment 
of nevi and melanoma including borderline cases we saw a striking difference in ZO-1 
expression in the epidermis: While nevi exhibited only a slight upregulation compared 
to normal skin, in MM a broadened ZO-1 expression in all epidermal layers was found. 
We conclude that functional TJ reducing the accessibility for therapeutics are absent in MM but 
protein levels of ZO-1 might be involved in invasiveness of tumor cells. Expression of ZO-1 in 
the tumor-microenvironment might be used for diagnostic delineation between MM and nevi.
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A New Reconstructed Human Epidermis to Address Challenges in Melanocyte 
Biology
Bernd Becker1, Jens Hoffmann1, Eckhard Heisler2, Sascha Hopf1, Oliver Engelking1, 
Horst Fuchs1 1Cellsystems Biotechnologie Vertrieb GmbH, St. Katharinen, Germany, 
2Evonik Stockhausen GmbH, Krefeld, Germany
Studying human melanocyte biology either depends on in vitro cell culture models or 
on the availability of fresh skin biopsies, which harbour pathologically changed tissue 
in most cases. Most in vitro culture models do not allow physiological interactions 
between melanocytes and keratinocytes, since melanocytes need very special 
culture conditions for growth. Even in co-culture models there is no physiological 
spatial organisation of melanocytes together with keratinocytes. Here we present 
a new reconstructed epidermis with integrated melanocytes which is based on the 
already established technology of Epidermal Skin Test 1000 (EST1000, CellSystems, 
Germany). We tested different ratios of melanocytes and keratinocytes for the 
production of the skin models and used melanocytes from different ethnic groups. 
To demonstrate the physiological behaviour of this epidermis model we successfully 
stimulated the melanin synthesis with chemical inducers and also by UV-radiation. 
Blocking melanin synthesis by chemical inhibition of the tyrosinase activity 
demonstrated that tanning of the models is due to the specifi c activity of melanocytes. 
Finally the melanin content could be correlated with different tanning intensities. 
This epidermis model can be cultivated for at least 4 weeks and allows short term as 
well as long term studies. We conclude from these results that CellSystems´ newly 
reconstructed epidermis with integrated melanocytes is able to cover all necessary 
applications in studies where tanning and bleaching of the skin is of importance.
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A systems biology approach to tumor suppression in malignant melanoma
Julio Vera1, Yvonne Raatz2, Olaf Wolkenhauer1, Manfred Kunz2 1University of Rostock, 
Rostock, Germany, 2University of Schleswig-Holstein, Lübeck, Germany
The inactivation of tumor suppressor proteins like p53 and p16 is involved in the 
development of many malignant tumors including malignant melanoma. Recently, 
evidence has been provided that 14-3-3 sigma, a downstream target of p53, might play 
an important role in tumor suppression in malignant melanoma.To better understand 
the complex process of tumor suppression in malignant melanoma, we established 
a mathematical model integrating the effects of 14-3-3 sigma gene silencing, the 
dynamics of 14-3-3 sigma induction and intracellular compartmentalisation and the 
role of interacting proteins such as p53, MDM2, WEE1 and Cdc25. In vitro experiments 
with different melanoma cell lines were performed and a mathematical model was 
subjected to computer simulations to analyse different scenarios of protein activation 
and interaction. Our analyses showed that strong stimulations, exerted for example 
by genotoxic stress, are necessary to induce 14-3-3 sigma expression in malignant 
melanoma even in cases of intermediate levels of gene methylation. More importantly, 
our model suggests that downregulation of p53 expression via 14-3-3 sigma gene 
methylation and reduction of its nuclear localisation signifi cantly affect p53 activity.
Taken together, the complex regulation of tumor suppression in malignant 
melanoma is described by a mathematical model using a systems biology approach. 
The proposed model allowed us to predict tumor cell behavior under different 
conditions of stimulation and emphasized the important role of gene methylation 
of tumor suppressor molecules for tumor malignancy. These fi ndings might 
open new perspectives for future treatment strategies of malignant melanoma.
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N-trans-Feruloyl-3-Hydroxytyramine: a substrate-mimicking inhibitor of human 
tyrosinase in vitro
Sabrina Leoty-Okombi1, Sébastien Bonnet1, Delphine Rival1, Véronique Degrave1, 
Boris Vogelgesang1, Xiaolan Lin1,2 1BASF Beauty Care Solutions France S.A.S, Lyon, 
France, 2Beauty Care Solutions BASF Corporation, Stony Brook, NY, United States
Melanin synthesis (melanogenesis) is under the control of complex regulatory 
pathways but tyrosinase is the rate limiting enzyme and thus remains the most effi cient 
way to downregulate melanin production.The goal of our work was to develop a 
characterized molecule with effi cacy comparable to that of existing products 
without long term toxicity. We focused our investigations on compounds with high 
structural similarities with tyrosine and L-DOPA - the natural substrates of tyrosinase 
- that would act as substrate-mimicking inhibitors. This way, we identifi ed N-trans-
Feruloyl-3-Hydroxytyramine, as the best candidate. The ability of N-trans-Feruloyl-3-
Hydroxytyramine to inhibit tyrosinase activity in vitro was evaluated using the human 
and mushroom tyrosinase model systems as well as total melanin quantifi cation in the 
murine B16 cell line. Moreover, using quantitative RT-PCR, we measured the mRNA 
expression of Pmel 17, a melanosome specifi c protein critical for melanin maturation. In 
vitro, this molecule inhibited human tyrosinase with higher effi cacy than the reference 
inhibitors kojic acid and arbutin and without cell toxicity as measured in normal 
human melanocytes. Using this model, IC50 was estimated at about 38µM. Moreover 
the inhibition appeared to be specifi c to mammalian tyrosinases as shown by a very 
poor inhibition of mushroom tyrosinase but a signifi cant decrease of total melanin 
in the murine B16 cell line. In this latter model, IC50 was evaluated at about 30µM. 
Finally, the derivative exhibited signifi cant inhibition of Pmel-17 gene expression 
at 100µM. These in vitro data suggest that N-trans-Feruloyl-3-Hydroxytyramine 
could be an interesting ingredient for complexion lightening cosmetic formulas.
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Ionizing radiation induces serotonin release from mast cells: Implications for 
malignant melanoma cells
Kerstin Müller, Viktor Meineke Bundeswehr Institute of Radiobiology affi liated to the 
University of Ulm, Munich, Germany
Mast cells are key effector cells of the immune system and accumulate around 
the margin of cutaneous malignancies. Previous studies have demonstrated that 
exposure to ionizing radiation results in degranulation of dermal mast cells and 
release of mediators. The purpose of our study was to evaluate the specifi c effect 
of serotonin on malignant melanoma cells. Irradiation of the human mast cell line 
HMC-1 with 5 Gy and subsequent ELISA analysis revealed serotonin as an ionizing 
radiation-induced mast cell secretory product. The presence of serotonin receptors 
5-HT2AR, 5-HT2BR and 5-HT2CR on the human melanoma cell line IPC-298 was 
verifi ed using immunofl uorescence. To investigate the effect of serotonin on cell 
proliferation of melanoma cells, IPC-298 cells were stimulated with serotonin and 
examined by proliferation assay. The results showed that serotonin dose-dependently 
inhibited melanoma cell proliferation. It is well established that melanoma metastasis 
is regulated by adhesion molecules. Therefore, we next aimed to determine the 
infl uence of serotonin on adhesion molecule expression by IPC-298 cells. As shown 
by gene array and fl ow cytometry, IPC-298 cells constitutively expressed a variety 
of adhesion molecules. Stimulation with serotonin caused a signifi cant increase 
of the cell surface expression of intercellular adhesion molecule-1 (ICAM-1) and 
integrins beta1 (CD29), alpha2 (CD49b), alpha5 (CD49e) and alpha6 (CD49f) on 
melanoma cells.Taken together, our data imply ionizing radiation-induced serotonin 
release by mast cells to be a crucial factor in malignant melanoma development.
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The dual role of IFN-α in TRAIL-induced apoptosis of melanoma cells
Madeleine L. Kalb, Astrid Glaser, Georg Stingl Department of Dermatology, DIAID, 
Medical University of Vienna, Vienna, Austria
Human peripheral blood leukocytes acquire the cytotoxic molecule TNF-related 
apoptosis-inducing ligand (TRAIL) in response to IFN-α treatment. Since IFN-α is 
used adjuvantly in melanoma therapy, we asked the question whether the induction 
of TRAIL+ immune cells has a role in preventing disease progression. To this end we 
analyzed the susceptibility of established melanoma cell lines and such generated 
from metastases of stage IV melanoma patients to TRAIL. Overnight treatment 
of melanoma cells with soluble TRAIL induced apoptosis ranging from 6-54%, as 
determined by Annexin V/PI staining. Since TRAIL acts via TRAIL receptors (TRAIL-R) 
we analyzed the TRAIL-R expression pattern on melanoma cells by fl ow cytometry. 
We generally detected moderate to high levels of the pro-apoptotic TRAIL-R2, 
but little to no expression of TRAIL-R1, -R3 and -R4. This was refl ected in the 
TRAIL-R2 mRNA levels, which were generally 2-log higher compared to the other 
receptors. Interestingly, the magnitude of TRAIL-induced apoptosis did not correlate 
with TRAIL-R mRNA levels or protein surface expression. Since the role of IFN-α 
in melanoma may not be confi ned to leukocyte effector cells, we also studied its 
effects on melanoma cells. Treatment of melanoma cells with IFN-α alone inhibited 
proliferation but did not induce apoptosis. IFN-α pre-treatment, however, enhanced 
subsequent TRAIL-induced apoptosis, suggesting effects on TRAIL-R expression or 
other molecules of the apoptotic cascade. In summary our fi ndings suggest that 
by inducing cytotoxic TRAIL on effector leukocytes and enhancing melanoma cell 
susceptibility to TRAIL, the role of IFN-α in melanoma therapy may be a dual one.
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2,4,6-octatrienoic acid promotes melanogenesis in normal human melanocytes
Enrica Flori1, Arianna Mastrofrancesco1, Vittoria Maresca1, Barbara Bellei1, Giammaria 
Giuliani2, Stefania Briganti1, Mauro Picardo1 1San Gallicano Dermatologic Institute, 
Rome, Italy, 2Giuliani Spa, Milan, Italy
Skin pigmentation is the outcome of melanin synthesis, which acts as a fi lter against 
UV and possesses also scavenger properties capable to protect UV-related skin 
damage. Melanin synthesis is a complex process controlled by several regulators 
affecting intracellular signal transduction pathways. We have observed that 
parrodienes, a class of compounds sharing some structural features with carotenoids, 
natural precursors of retinoids, counteract senescence-like phenotype in fi broblasts 
and induce peroxisome-activated receptor gamma (PPARg), a receptor involved in 
an intracellular mechanism of retinoid-like molecules and exerting a crucial role in 
the control of cell proliferation and differentiation. Considering that PPARg agonists 
can stimulate melanogenesis, we selected 2,4,6-octatrienoic acid, a derivative 
of parrodienes, to study its ability to promote melanogenesis in normal human 
melanocytes (NHM). Exposure of NHM to Octa resulted in a signifi cant induction 
of tyrosinase expression and activity, known to be a rate-limiting enzyme in melanin 
synthesis. The melanin content was also signifi cantly increased by Octa treatment. 
Moreover we examined the expression level of PPARg and microphthalmia-associated 
transcription factor (MITF), the master transcription factor regulating melanocyte 
differentiation, proliferation and survival. The observed increase in pigmentation 
was associated with a stimulation of both PPARg and MITF expression. These results 
demonstrate that Octa is able to regulate melanogenesis in NHM, suggesting its 
promising use to enhance skin photoprotection and counteract pigmentary disorders.
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Protodynamic intracellular acidifi cation by cis-urocanic acid promotes apoptosis of 
melanoma cells in vitro and in vivo
Jarmo K. Laihia1, Janne P. Kallio2,3, Pekka Taimen4,5, Harry Kujari5, Veli-Matti Kähäri2,3, 
Lasse Leino1 1BioCis Pharma Ltd., Turku, Finland, 2Department of Dermatology, 
University of Turku, and Turku University Hospital, Turku, Finland, 3MediCity Research 
Laboratory, University of Turku, Turku, Finland, 4Department of Pathology, University 
of Turku, Turku, Finland, 5Department of Pathology, Turku University Hospital, Turku, 
Finland
The extracellular tumour microenvironment is acidifi ed whereas the intracellular pH 
of tumour and stromal cells is neutral. cis-Urocanic acid (cis-UCA), an endogenous 
compound of the skin, can acidify the cytosol by transporting protons into the cells. 
This phenomenon termed the protodynamic concept was studied in human cancer 
cells. cis-UCA dose dependently reduced the number of viable human melanoma, 
cervical carcinoma, and fi brosarcoma cells at weakly acidic extracellular pH. The 
intracellular pH decreased by up to 0.5 pH units in a concentration-dependent manner 
with 0.3–30mM cis-UCA at extracellular pH 6.5 but not at pH 7.4. Under the same 
conditions, 30mM cis-UCA induced annexin-V binding and activation of caspase-3 
in A2058 melanoma cells as signs of apoptotic cell death. Finally, growth of human 
melanoma xenografts in SCID mice was suppressed by 60% following intratumoural 
injection of cis-UCA. Accordingly, the percentage of tumour necrosis and active 
caspase-3-immunopositive cells increased whereas proliferation activity decreased. 
These results identify cis-UCA as an anticancer agent inhibiting melanoma growth 
by immediate intracellular acidifi cation followed by apoptotic cell death in vivo.
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Melanoma cell-derived factors stimulate hyaluronan synthesis in dermal fi broblasts 
by upregulating HAS2 through AKT –signaling
Piia Takabe1, Raija Tammi1, Michael Edward2, Markku Tammi1, Sanna Pasonen-
Seppänen1 1University of Eastern Finland, Institute of Biomedicine/anatomy, Kuopio, 
Finland, 2University of Glasgow, Section of Dermatology, Glasgow, United Kingdom
Hyaluronan is a large extracellular matrix molecule, which is produced by hyaluronan 
synthases (Has1, 2, 3) on the plasma membrane. Several cancers are associated with 
hyaluronan overproduction either by tumor cells or the surrounding stromal cells. This 
increased hyaluronan accumulation has been shown to enhance tumor cell invasion and 
metastasis leading to an unfavourable clinical prognosis. In the present work, we studied 
the effects of melanoma cell-derived factors on fi broblast hyaluronan synthesis. We found 
that melanoma cell-conditioned medium (CM) stimulated strongly fi broblast hyaluronan 
synthesis and changed the morphology of fi broblasts. The fi broblasts treated with melanoma 
cell CM were more elongated, contained numerous long protrusions and displayed a wide 
pericellular hyaluronan coat. The elevated hyaluronan production in CM-treated cultures 
was associated to upregulation of HAS2 mRNA, approximately 7-fold, respectively as 
determined with qRT-PCR. The expression levels of HAS1, CD44 and Hyal2 did not change 
after treatment with melanoma CM and the expression of Has3 was slightly upregulated. 
To fi nd out the signalling routes to HAS2 upregulation, we screened the phosphorylation 
profi les of 46 kinases with a phospho-kinase-array. Melanoma cell CM treatment strongly 
induced the phosphorylation of AKT, JNK, p38, CREB, HSP27 and cJUN in fi broblasts. An 
inhibitor of AKT suppressed the melanoma cell CM –induced hyaluronan production in 
fi broblasts.The data suggests that the induced hyaluronan synthesis by HAS2 upregulation 
in fi broblasts is, at least partly, due to activation of AKT signalling. In the future, prevention 
of hyaluronan overproduction in tumor stroma is a potential target for anticancer drugs.
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Risk for a second primary melanoma in patients with a history of melanoma and 
multiple melanocytic nevi:  A 5 year follow up study 
Alexander Salava, Annamari Ranki, Olli Saksela Helsinki University Central Hospital, 
Department of Skin and allergic diseases, Skin Tumor Unit, Helsinki, Finland
To evaluate the risk for a second primary melanoma in patients with a past history 
of melanoma and multiple melanocytic nevi. Secondly, to compare the risk and 
risk factors with patients with multiple nevi but without a history of melanoma. 
Altogether 113 patients with a history of primary melanoma and 98 patients 
without a history of melanoma were followed for over 5 years. In both groups 
all patients had over 100 melanocytic nevi and on clinical grounds 5 or more 
atypical nevi. Additional risk factors, such as a family history of melanoma and 
former dysplastic nevi were equally present. Dermatologic examinations including 
dermatoscopy and whole body photographs were performed 1-2 times a year.
29 second primary melanomas were diagnosed in 20 (17,7%) patients of the 
melanoma group, while in the non melanoma group only 1 (1,0%) melanoma 
was diagnosed. The melanomas were superfi cial (average depth 0,39 mm) with a 
favourable prognosis. The melanoma group showed a 25 times higher risk for a second 
primary melanoma than the non melanoma group for a fi rst primary melanoma. 
86,2% of the melanomas were diagnosed in patients with no additional risk factors.
In conclusion, patients with a past history of melanoma and multiple melanocytic 
nevi have a high risk for developing a second primary melanoma. A history of 
melanoma is the most important risk factor for a second primary melanoma 
and long-term follow-up of such patients is warranted. The follow up proved 
to be effective in diagnosing superfi cial melanomas with a good prognosis.
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Neuron navigator 3, a new cancer-associated gene, shows copy number changes in 
dysplastic nevi, primary melanomas and in metastasizing melanoma cells.
Pilvi Maliniemi1, Alexander Salava1, Sanna Virtanen2, Kirsi Niiranen1, 
Leila Jeskanen3, Olli Saksela1, Paula Kujala2, Kai Krohn2, Annamari Ranki1
1Department of Dermatology and Allergology, University of Helsinki and Helsinki 
University Hospital, Helsinki, Finland, 2Department of Pathology, Tampere University 
Hospital, Tampere, Finland, 3HUSLAB, Helsinki, Finland
Melanomas are heterogenic tumors and carry hundreds of mutations, the most common 
being those of the BRAF (50-60%), NRAS (15%) and c-kit (3%) genes. Melanocytic nevi 
frequently harbor these oncogenic mutations but only a minority progresses to melanoma. 
Neuron navigator 3 (NAV3) belongs to the group of Navigator proteins that bind to the 
+ ends of microtubules and are involved in cell proliferation and motility. NAV3 gene 
mutations or copy number changes have been reported in melanoma, glioblastomas and 
colorectal cancer, and downregulation of NAV3 has been shown in some brain tumors 
and in adrenal carcinoma. We looked for NAV3 aberrations, using FISH, in dysplastic 
nevi, primary melanomas, and corresponding sentinel lymph nodes or  metastases. 
Also, two established melanoma cell lines were analyzed. Cut-off values for the FISH 
results were based on fi ndings in benign nevi. We observed NAV3 amplifi cations and/
or deletions in 68% of the primary melanomas (17/25; range of deletion 6-98 % and 
amplifi cation 10-79 % in the cell nuclei)  and in 4/6 dysplastic nevi. NAV3-deleted 
cells were found in all involved sentinel lymph nodes examined. In the two metastases 
so far analyzed, one pair showed few NAV3-deleted cells in the primary tumor but up 
to 40 % in the metastases. The melanoma cell lines were heterogenic, WM-793 showing 
20% of amplifi cations and 36% of deletions, whereas metastatic WM-239 showed 
21% of deletions. We suggest that lack of NAV3 function could interrupt the normal 
behaviour of the cellular microtubule network and might induce a malignant phenotype.
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Identifi cation of priming events in sentinel lymph nodes in a murine model of 
cutaneous melanoma
Andreas Bracher, Stefanie Tauber, Robert Loewe Department of Dermatology, Medical 
University of Vienna, Vienna, Austria
Cutaneous melanoma fi rst metastasizes into sentinel lymph nodes that control the 
lymphatic drain from the area of the primary tumor. Sentinel lymph node biopsy 
has therefore become an important diagnostic procedure in patients with primary 
melanomas at tumor stages ≥T2a. Successful colonization of tumor cells into sentinel 
lymph nodes is thought to require priming of this environment, but these priming 
factors are yet undefi ned.  Using our previously described xenotransplantation 
model, in which human melanoma cells injected into the skin of SCID mice 
metastasize to sentinel lymph nodes, we aimed to identify and analyze a gene 
expression signature refl ecting priming events. Tumor negative sentinel lymph 
node expression profi les have been compared to expression profi les i) of micro- 
and macrometastases and ii) of lymph nodes of control (= non tumor-bearing) 
animals. For analysis, Affymetrix® gene arrays have been used. Results obtained 
from these experiments have been validated by using RT-PCR based mRNA analysis 
and immunohistochemistry. With these techniques we were able to identify 
gene products which may serve as potential candidates responsible for initiating 
melanoma lymph node metastasis by altering the lymph node microenvironment.
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Characterization of in vitro cultured dedifferentiated melanocytes
Bernadett Kormos1, Nóra Belsö1, Attila Bebes1, Márta Széll2, Lajos Kemény1,2, 
Zsuzsanna Bata-Csörgö1,2 1Department of Dermatology and Allergology, Faculty of 
Medicine, University of Szeged, Szeged, Hungary, 2Dermatological Research Group 
of the Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary
Previously we described that normal human adult epidermal melanocytes 
dedifferentiated when cultured in vitro in a chemical mitogen-free medium (Mel-
mix®). These in vitro dedifferentiated cells are bipolar, proliferate rapidly, lose melanin 
content and TRP-1 and c-Kit expressions. To further characterize these cells we 
compared them to melanocytes grown in conventional chemical mitogen containing 
medium in which cells regain a differentiated phenotype: they are dendritic, contain 
pigment and express TRP-1 and c-Kit. The proliferation rate of the dedifferentiated 
cells was twice as fast as the differentiated ones based on CFSE analysis. Senescence-
associated β-galactosidase assay showed similar rates of senescence in both cultures. 
Translocator protein (TSPO) and nestin mRNAs are expressed at similar levels in 
both cells, however nestin protein expression was higher in the dedifferentiated 
cells; both TSPO and nestin are characteristically expressed in neuronal precursor 
cells. Interestingly, p53 an important tumor suppressor in UV-induced cellular stress 
response showed a highly increased expression in the non-pigmented, dedifferentiated 
cells compared to pigmented, differentiated cells after UVB irradiation.
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Evaluation of the long-term effi cacy of UVB-311nm-therapy in vitiligo patients
Daniela Wiesinger, Alexandra Gruber-Wackernagel, Franz Legat, Peter Wolf, Angelika 
Hofer Medical University of Graz, Graz, Austria
Vitiligo is a common idiopathic acquired depigmentation disorder characterized by 
the loss of melanocytes from the epidermis. Narrow-band UVB therapy is a well-
established treatment modality in this disease but there is only little data on long-
term effi cacy available. In this retrospective university-based hospital study we 
enrolled 73 patients (45 women and 28 men female) with vitiligo who had been 
treated with UVB-311nm-therapy twice a week during the 8-year period from 1999 
to 2006. The median number of treatments was 34 and the median cumulative dose 
33.9 J/cm2. A follow-up questionnaire was sent in 2008 to all patients in order to 
evaluate the effi cacy of therapy and the course of the disease after treatment. Forty-
seven (63%) patients returned the questionnaire. UVB-311nm treatment resulted in at 
least partial repigmentation of vitiligo lesions in 25 out of 47 patients (53%). Certain 
lesions showed complete repigmentation in 9 (19%) patients. Stable disease for at 
least 12 months was observed upon UVB-311nm treatment in 23 (49%) patients. 
At the present UVB-311nm-therapy remains the gold standard in the treatment of 
vitiligo. The therapy can induce repigmentation and stability of disease. It also may 
improve the quality of life of patients with vitiligo, as reported by many patients.
596
Role and regulation of Raf kinases in melanoma
Amélie Marquette1, Jocelyne André1, Martine Bagot1, Armand Bensussan1, Nicolas 
Dumaz1 1INSERM U976, Paris, France, 2Dermatology Department, Saint Louis 
Hospital, Paris, France
Melanoma has become a major public health problem in many countries. In order 
to develop new therapies for this tumour, we are studying signaling pathways 
which play a role in proliferation, survival and differentiation of melanocytes and 
melanoma. The Mitogen Activated Protein Kinase (MAPK) pathway regulates 
melanocyte proliferation in culture and in vivo. Constitutive activation of the MAPK 
pathway in melanoma, either by mutations in the Ras gene or by mutations in B-Raf, 
has been reported in 15% and 50% of melanoma respectively. The presence of B-Raf 
mutations in approximately 50% of human melanoma highlights the oncogenic 
properties of this kinase in melanocytes and inhibitors of B-Raf are currently under 
clinical development. However, we have shown that B-Raf was inactivated in 
melanoma containing a Ras mutation. This inhibition was due to a down-regulation 
of B-Raf by its substrate Erk, which phosphorylates B-Raf on its amino-terminus to 
prevent its interaction with Ras. This mechanism of B-Raf negative regulation forces 
these melanoma cell lines to use the other Raf isoform, C-Raf. The inactivation of 
B-Raf in Ras mutated melanoma suggests that B-Raf inhibitors will be ineffective 
in these cancers. Moreover, we have demonstrated that an inhibitor inactivating 
both B-Raf and C-Raf, which is in clinical development (Sorafenib), paradoxically 
induced activation of these kinases by heterodimerization. Together, our results 
highlight novel Raf kinase regulation mechanisms, which will play an important role 
in the resistance of melanoma to the inhibitors currently in clinical development.
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The SCF/KIT signaling pathway is a key regulator of epidermal melanocytes 
migration and of the skin pigmentation homogenization.
Catherine Serre1, Alexia Lebleu1, Christelle Plaza1, Celine Meyrignac1, Florian 
Labarrade1, Jean Marie Botto1, Claude Dal Farra2, Nouha Domloge1 1Vincience, 
ISP Global Skin Research Center, Sophia Antipolis, France, 2ISP Corporate Research 
Center, Wayne, NJ 07470, United States
The stem cell factor (SCF) is the natural ligand of the KIT receptor which is a member 
of subfamily III of the Receptor Tyrosine Kinase family. In the skin, this pathway 
regulates melanocyte homeostasis and their epidermal distribution. In the present 
study, we analyzed the localization of SCF and KIT expression in the skin and in 
several skin-related cell lines, and evaluated their implication in the pigmentation 
process. To help us in our approach, we developed a specifi c compound (IV09.007) 
and studied its ability to modulate the SCF/KIT signaling pathway. IV09.007 
treatment of ex vivo skin or cultured cells markedly increased the expression of 
both SCF and KIT (as revealed by immunohistological studies and western blotting). 
IV09.007 also increased melanin content in the basal layer of the epidermis 
(Fontana-Masson staining). These effects could contribute to a better protection of 
the epidermal basal layer. Interestingly, migration of cultured human melanocytes 
was enhanced in the presence of IV09.007 in the culture medium. The action of 
the compound on the global phosphorylation state of the skin and on players of 
the SCF/KIT signaling cascade (ERK1/2) was also investigated. Taken together, these 
studies confi rm the importance of the SCF/KIT pathway in the skin and suggest 
that modulating this pathway could enhance the homogeneity of melanocyte 
repartition in the skin, and favor a higher production and content of protective me
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The Forkhead Box Transcription Factor FoxP3, a prognostic marker for progression-
free survival in stage III melanoma
Anne-Chantal Knol2, Jean-Michel Nguyen3,2, Amir Khammari1,2, Gaëlle Quéreux1, 
Anabelle Brocard1, Brigitte Dréno1,2 1Unité de Cancéro-Dermatologie-CIC biothérapie 
INSERM0503, CHU de Nantes, Nantes, France, 2INSERM, U892, Nantes, Nantes, 
France, 3SEB-PIMESP, CHU de Nantes, Nantes, France
Regulatory T cells have already been associated to poor prognosis in various types 
of cancer. It was previously reported, in ovarian carcinoma, that high expression 
of Foxp3 identifi ed a subgroup of patients characterized by a signifi cantly worse 
prognosis in terms of overall survival and progression-free survival. This result 
suggests that high expression levels of Foxp3 might represent a surrogate marker for 
an immunosuppressive microenvironment contributing to tumor immune escape. 
Regarding melanoma, it was previously shown that CD4+CD25high T cells were 
overrepresented in metastatic lymph nodes. The aim of the present study was to 
evaluate the prognostic value of Foxp3 as a single marker regarding progression-
free survival and overall survival in stage III (AJCC) melanoma patients. For this 
purpose, we analyzed Foxp3 expression in 102 tumor invaded lymph nodes, using 
quantitative real-time PCR, normalized on T lymphocytes. A Cox model was used 
to analyze patients’ survival. High Foxp3 expression level was independently 
associated with poor prognosis in terms of progression-free survival (p=0.005) but 
not in terms of overall survival (p=0.87). In the group of patients receiving TIL, the 
expression level of Foxp3 was not a prognostic factor for progression-free survival 
or overall survival (p=0.36 and 0.8). No signifi cant difference in Foxp3 expression 
was observed between patients with one invaded LN and patients with more than 
one invaded LN (p=0.3775). In conclusion, Foxp3 expression using qPCR might 
represent a prognostic factor in stage III melanoma for progression-free survival.
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Different patterns of micro RNA expression in cutaneous and uveal melanomas
Anne Rosbjerg1, Line Holst1, Martin Glud1, Steffen Heegaard2,3, Ann-Cathrine 
Larsen2,3, Miriam Kolko2, Robert Gniadecki1,2 1Department of Dermatology, Bispebjerg 
Hospital, Copenhagen, Denmark, 2University of Copenhagen, Faculty of Health 
Sciences, Copenhagen, Denmark, 3Eye Pthology Institute, Copenhagen, Denmark
Uveal melanoma (UM) is the most common ocular primary tumour in adults. 
Metastasis, which develops in 50% of patients, has often a fatal outcome. In contrast 
to cutaneous melanoma, UM disseminates by hematogenous spread primarily to 
the liver. In this experiment we dissected 26 paraffi n embedded UM samples for 
the microarray micro RNAs (miRNA) analysis. The samples originated from UM 
patients (mean age of 64,4 years) of whom 11 had metastatic disease. The control 
material was 28 microdissected samples of primary cytaneous melanomas (PCM) 
(stage T2). We found that miRNA expression profi les of UM differed radically from 
those of PCM. Although based on the hierarchical cluster analysis 4 different groups 
of UM was apparent, these groups did not correspond to the presence or absence 
of metastasis. In conclusion, the molecular miRNA signatures of UM and PCM are 
very different suggesting basic differences in the pathogenesis of these tumors. The 
metastatic behaviour of UM cannot be predicted from the miRNA expression pattern.
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Metastasizing preferences of melanoma subtypes
Nicola Schoenewolf, Sabina Tonolla, Reinhard Dummer Department of Dermatology, 
Zurich, Switzerland
Several cancer entities show distinct organ-preferences for their metastatic spread.
In melanoma such affectation has not been systematically studied. In order to gain 
insights into correlations between tumor metastasis and genetic background of 
melanoma subtypes, a retrospective study was performed.137 patients of melanoma 
stage IV were included into the study. Two groups were formed according to their 
molecular background: Superfi cially Spreading (SSM) and Nodular (NMM) were 
pooled in group 1 and compared towards Acrolentiginous (ALM) and Mucosal 
(MM) melanoma (group 2). Group 1 shows a high frequency of BRAF mutations, 
while group 2 shows genetic aberrations in cKIT. Over-all survival was identical 
in both groups witsh mean survival of 10 months. LDH presented prognostic 
implications. The time interval until appearance of the fi rst distant metastasis and 
the distribution pattern were analysed and correlated to the median survival time. 
Metastasis to distant organs was shown to be slightly faster in group 2 (p= 0.075). 
However, the preference to present bone metastases was signifi cantly higher for 
group 2 in comparison to group 1 (p = 0.002), which revealed a preferential spread 
of metastases into the brain (p < 0.0001). This study has disclosed new insights into 
melanoma subtype distinction in the context of distant metastasis and prognosis.  The 
differentiation of two melanoma groups confi rmed the rearrangements of melanoma 
classifi cation according to genetic similarities. Further knowledge about melanoma 
subtype specifi c characteristics might help to improve targeted therapeutic 
employment but and to understand and manage the disease in terms of prognosis.
